(2 or 3)-decenoate (10:1n7 or n8) levels
(N(1) + N(8))-acetylspermidine levels
(N(1) + N(8))-acetylspermidine levels in elite athletes
(S)-3-hydroxybutyrylcarnitine levels
(Z)-4-hydroxytamoxifen levels in tamoxifen-treated hormone-receptor-positive breast cancer
(Z)-4-hydroxytamoxifen to tamoxifen ratio in tamoxifen-treated hormone-receptor-positive breast cancer
[Protein ADP-ribosylarginine] hydrolase level in Chronic kidney disease with hypertension and no diabetes (18395_5)
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial levels
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial levels (PDK1.5227.60.3)
β2-Glycoprotein I (β2-GPI) plasma levels
1-(1-enyl-oleoyl)-GPC (p-18:1) levels
1-(1-enyl-oleoyl)-GPE (P-18:1) levels in elite athletes
1-(1-enyl-palmitoyl)-2-arachidonoyl-gpc (p-16:0/20:4) levels
1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4) levels in elite athletes
1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (p-16:0/20:4) levels
1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4) levels in elite athletes
1-(1-enyl-palmitoyl)-2-docosahexaenoyl-GPC (p-16:0/22:6) levels
1-(1-enyl-palmitoyl)-2-linoleoyl-GPC (p-16:0/18:2) levels
1-(1-enyl-palmitoyl)-2-linoleoyl-GPC (P-16:0/18:2) levels in elite athletes
1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (p-16:0/18:2) levels
1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (P-16:0/18:2) levels in elite athletes
1-(1-enyl-palmitoyl)-2-myristoyl-GPC (p-16:0/14:0) levels
1-(1-enyl-palmitoyl)-2-oleoyl-gpc (p-16:0/18:1) levels
1-(1-enyl-palmitoyl)-2-oleoyl-GPC (P-16:0/18:1) levels in elite athletes
1-(1-enyl-palmitoyl)-2-oleoyl-GPE (p-16:0/18:1) levels
1-(1-enyl-palmitoyl)-2-oleoyl-GPE (P-16:0/18:1) levels in elite athletes
1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) levels
1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) levels in elite athletes
1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) levels
1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) levels in elite athletes
1-(1-enyl-palmitoyl)-GPC (p-16:0) levels
1-(1-enyl-palmitoyl)-GPC (P-16:0) levels in elite athletes
1-(1-enyl-stearoyl)-2-arachidonoyl-GPC (p-18:0/20:4) levels
1-(1-enyl-stearoyl)-2-arachidonoyl-GPE (p-18:0/20:4) levels
1-(1-enyl-stearoyl)-2-arachidonoyl-GPE (P-18:0/20:4) levels in elite athletes
1-(1-enyl-stearoyl)-2-linoleoyl-GPC (p-18:0/18:2) levels
1-(1-enyl-stearoyl)-2-linoleoyl-GPE (p-18:0/18:2) levels
1-(1-enyl-stearoyl)-2-linoleoyl-GPE (P-18:0/18:2) levels in elite athletes
1-(1-enyl-stearoyl)-2-oleoyl-GPC (p-18:0/18:1) levels
1-(1-enyl-stearoyl)-2-oleoyl-GPE (P-18:0/18:1) levels in elite athletes
1-(1-enyl-stearoyl)-GPE (p-18:0) levels
1-adrenoyl-GPC (22:4) levels
1-aminocyclopropane-1-carboxylate levels
1-arachidonoyl-GPA (20:4) levels in elite athletes
1-arachidonoyl-gpc (20:4n6) levels
1-arachidonoyl-GPC (20:4n6) levels in elite athletes
1-arachidonoyl-GPE (20:4n6) levels
1-arachidonoyl-GPE (20:4n6) levels in elite athletes
1-arachidonoyl-GPI (20:4) levels
1-arachidonoyl-GPI (20:4) levels in elite athletes
1-arachidonoylglycerophosphocholine levels
1-arachidonoylglycerophosphocholine levels (Biocrates platform)
1-arachidonoylglycerophosphocholine levels (Metabolon platform)
1-arachidonoylglycerophosphoethanolamine levels
1-arachidonoylglycerophosphoinositol levels
1-arachidonylglycerol (20:4) levels
1-arachidoyl-2-arachidonoyl-GPC (20:0/20:4) levels
1-carboxyethylisoleucine levels
1-carboxyethylleucine levels
1-carboxyethylphenylalanine levels
1-carboxyethylvaline levels
1-dihomo-linolenoyl-GPC (20:3n3 or 6) levels
1-dihomo-linolenoyl-GPE (20:3n3 or 6) levels
1-dihomo-linolenylglycerol (20:3) levels in elite athletes
1-dihomo-linoleoyl-GPC (20:2) levels
1-docosahexaenoyl-GPC (22:6) levels
1-docosahexaenoyl-GPE (22:6) levels
1-docosahexaenoylglycerophosphocholine levels (Biocrates platform)
1-docosapentaenoyl-GPC (22:5n3) levels
1-eicosapentaenoyl-GPC (20:5) levels
1-eicosapentaenoyl-GPE (20:5) levels
1-eicosatrienoylglycerophosphocholine levels
1-eicosatrienoylglycerophosphocholine levels (Metabolon platform)
1-heptadecanoylglycerophosphocholine levels (Biocrates platform)
1-heptadecanoylglycerophosphocholine levels (Metabolon platform)
1-lignoceroyl-GPC (24:0) levels
1-lignoceroyl-GPC (24:0) levels in elite athletes
1-linolenoyl-GPC (18:3) levels in elite athletes
1-linolenoyl-GPE (18:3) levels
1-linolenoylglycerol (18:3) levels in elite athletes
1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6) levels
1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6) levels in elite athletes
1-linoleoyl-2-docosahexaenoyl-GPC (18:2/22:6) levels
1-linoleoyl-2-linolenoyl-GPC (18:2/18:3) levels
1-linoleoyl-2-linolenoyl-GPC (18:2/18:3) levels in elite athletes
1-linoleoyl-gpc (18:2) levels
1-linoleoyl-GPC (18:2) levels in elite athletes
1-linoleoyl-GPE (18:2) levels
1-linoleoyl-GPE (18:2) levels in elite athletes
1-linoleoyl-GPG (18:2) levels
1-linoleoyl-GPG (18:2) levels in elite athletes
1-linoleoyl-GPI (18:2) levels
1-linoleoylglycerol (18:2) levels in elite athletes
1-linoleoylglycerol 1-monolinolein levels
1-linoleoylglycerophosphocholine levels (Biocrates platform)
1-linoleoylglycerophosphocholine levels (Metabolon platform)
1-linoleoylglycerophosphoethanolamine levels
1-margaroyl-2-arachidonoyl-GPC (17:0/20:4) levels
1-margaroyl-2-linoleoyl-GPC (17:0/18:2) levels
1-meadoyl-GPC (20:3n9) levels
1-methyl-4-imidazoleacetate levels
1-methylguanidine levels in elite athletes
1-methylguanosine levels
1-methylhistidine levels
1-methylhistidine levels in elite athletes
1-methylimidazoleacetate levels
1-methylimidazoleacetate levels in elite athletes
1-methylnicotinamide levels
1-methylnicotinamide levels in elite athletes
1-methylurate levels
1-methylurate levels in elite athletes
1-methylxanthine levels
1-methylxanthine levels in elite athletes
1-myristoyl-2-arachidonoyl-GPC (14:0/20:4) levels
1-myristoyl-2-arachidonoyl-GPC (14:0/20:4) levels in elite athletes
1-myristoyl-2-docosahexaenoyl-GPC (14:0/22:6) levels
1-myristoyl-2-eicosapentaenoyl-GPC (14:0/20:5) levels
1-myristoyl-2-linoleoyl-GPC (14:0/18:2) levels
1-myristoyl-2-palmitoyl-GPC (14:0/16:0) levels in elite athletes
1-myristoyl-GPC (14:0) levels
1-myristoylglycerol (14:0) levels
1-oleoyl-2-arachidonoyl-GPE (18:1/20:4) levels
1-oleoyl-2-dihomo-linolenoyl-GPC (18:1/20:3) levels
1-oleoyl-2-docosahexaenoyl-GPC (18:1/22:6) levels
1-oleoyl-2-docosahexaenoyl-GPC (18:1/22:6) levels in elite athletes
1-oleoyl-2-docosahexaenoyl-GPE (18:1/22:6) levels
1-oleoyl-2-docosapentaenoyl-GPC (18:1/22:5n3) levels
1-oleoyl-2-eicosapentaenoyl-GPC (18:1/20:5) levels
1-oleoyl-2-linoleoyl-GPC (18:1/18:2) levels
1-oleoyl-2-linoleoyl-GPE (18:1/18:2) levels
1-oleoyl-2-linoleoyl-GPE (18:1/18:2) levels in elite athletes
1-oleoyl-GPA (18:1) levels in elite athletes
1-oleoyl-GPC (18:1) levels
1-oleoyl-GPC (18:1) levels in elite athletes
1-oleoyl-GPE (18:1) levels
1-oleoyl-GPE (18:1) levels in elite athletes
1-oleoyl-GPG (18:1) levels
1-oleoyl-GPG (18:1) levels in elite athletes
1-oleoyl-GPI (18:1) levels
1-oleoylglycerol (18:1) levels in elite athletes
1-oleoylglycerophosphocholine levels (Biocrates platform)
1-oleoylglycerophosphocholine levels (Metabolon platform)
1-palmitoleoyl-2-linolenoyl-GPC (16:1/18:3) levels
1-palmitoleoyl-2-linoleoyl-GPC (16:1/18:2) levels
1-palmitoleoyl-2-linoleoyl-GPC (16:1/18:2) levels in elite athletes
1-palmitoleoyl-GPC (16:1) levels
1-palmitoleoylglycerol (16:1) levels
1-palmitoleoylglycerol (16:1) levels in elite athletes
1-palmitoleoylglycerophosphocholine levels (Biocrates platform)
1-palmitoyl-2-arachidonoyl-gpc (16:0/20:4n6) levels
1-palmitoyl-2-arachidonoyl-GPC (16:0/20:4n6) levels in elite athletes
1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) levels
1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) levels in elite athletes
1-palmitoyl-2-arachidonoyl-GPI (16:0/20:4) levels
1-palmitoyl-2-arachidonoyl-GPI (16:0/20:4) levels in elite athletes
1-palmitoyl-2-dihomo-linolenoyl-GPC (16:0/20:3n3 or 6) levels
1-palmitoyl-2-dihomo-linolenoyl-GPE (16:0/20:3) levels
1-palmitoyl-2-docosahexaenoyl-gpc (16:0/22:6) levels
1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) levels in elite athletes
1-palmitoyl-2-docosahexaenoyl-GPE (16:0/22:6) levels
1-palmitoyl-2-docosahexaenoyl-GPE (16:0/22:6) levels in elite athletes
1-palmitoyl-2-eicosapentaenoyl-GPC (16:0/20:5) levels
1-palmitoyl-2-eicosapentaenoyl-GPE (16:0/20:5) levels
1-palmitoyl-2-linoleoyl-gpc (16:0/18:2) levels
1-palmitoyl-2-linoleoyl-GPE (16:0/18:2) levels
1-palmitoyl-2-linoleoyl-GPE (16:0/18:2) levels in elite athletes
1-palmitoyl-2-linoleoyl-GPI (16:0/18:2) levels
1-palmitoyl-2-linoleoyl-GPI (16:0/18:2) levels in elite athletes
1-palmitoyl-2-meadoyl-GPC (16:0/20:3n9) levels
1-palmitoyl-2-oleoyl-GPC (16:0/18:1) levels in elite athletes
1-palmitoyl-2-oleoyl-GPE (16:0/18:1) levels
1-palmitoyl-2-oleoyl-GPE (16:0/18:1) levels in elite athletes
1-palmitoyl-2-oleoyl-GPI (16:0/18:1) levels
1-palmitoyl-2-oleoyl-GPI (16:0/18:1) levels in elite athletes
1-palmitoyl-2-stearoyl-gpc (16:0/18:0) levels
1-palmitoyl-2-stearoyl-GPC (16:0/18:0) levels in elite athletes
1-palmitoyl-GPC (16:0) levels
1-palmitoyl-GPC (16:0) levels in elite athletes
1-palmitoyl-GPE (16:0) levels
1-palmitoyl-GPE (16:0) levels in elite athletes
1-palmitoyl-GPG (16:0) levels
1-palmitoyl-GPG (16:0) levels in elite athletes
1-palmitoyl-GPI (16:0) levels in elite athletes
1-palmitoylglycerol (16:0) levels in elite athletes
1-palmitoylglycerophosphocholine levels (Biocrates platform)
1-palmitoylglycerophosphocholine levels (Metabolon platform)
1-palmitoylglycerophosphoinositol levels
1-palmityl-2-arachidonoyl-GPC (o-16:0/20:4) levels
1-palmityl-2-linoleoyl-GPC (O-16:0/18:2) levels
1-palmityl-2-oleoyl-GPC (o-16:0/18:1) levels
1-palmityl-2-palmitoyl-GPC (O-16:0/16:0) levels
1-palmityl-2-stearoyl-GPC (O-16:0/18:0) levels
1-pentadecanoyl-2-arachidonoyl-GPC (15:0/20:4) levels
1-pentadecanoyl-2-docosahexaenoyl-GPC (15:0/22:6) levels
1-pentadecanoyl-2-linoleoyl-GPC (15:0/18:2) levels
1-pentadecanoylglycerol (15:0) levels in elite athletes
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 levels
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 levels
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 levels
1-ribosyl-imidazoleacetate (X-11334) levels
1-ribosyl-imidazoleacetate levels
1-stearoyl-2-adrenoyl-GPC (18:0/22:4) levels
1-stearoyl-2-arachidonoyl-gpc (18:0/20:4) levels
1-stearoyl-2-arachidonoyl-GPC (18:0/20:4) levels in elite athletes
1-stearoyl-2-arachidonoyl-GPE (18:0/20:4) levels
1-stearoyl-2-arachidonoyl-GPE (18:0/20:4) levels in elite athletes
1-stearoyl-2-arachidonoyl-GPI (18:0/20:4) levels
1-stearoyl-2-arachidonoyl-GPI (18:0/20:4) levels in elite athletes
1-stearoyl-2-dihomo-linolenoyl-GPC (18:0/20:3n3 or 6) levels
1-stearoyl-2-dihomo-linolenoyl-GPI (18:0/20:3n3 or 6) levels
1-stearoyl-2-docosahexaenoyl-gpc (18:0/22:6) levels
1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6) levels
1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n3) levels
1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n6) levels
1-stearoyl-2-linoleoyl-gpc (18:0/18:2) levels
1-stearoyl-2-linoleoyl-GPC (18:0/18:2) levels in elite athletes
1-stearoyl-2-linoleoyl-GPE (18:0/18:2) levels
1-stearoyl-2-linoleoyl-GPI (18:0/18:2) levels
1-stearoyl-2-linoleoyl-GPI (18:0/18:2) levels in elite athletes
1-stearoyl-2-meadoyl-GPC (18:0/20:3n9) levels
1-stearoyl-2-oleoyl-gpc (18:0/18:1) levels
1-stearoyl-2-oleoyl-GPC (18:0/18:1) levels in elite athletes
1-stearoyl-2-oleoyl-GPE (18:0/18:1) levels
1-stearoyl-2-oleoyl-GPI (18:0/18:1) levels
1-stearoyl-2-oleoyl-GPI (18:0/18:1) levels in elite athletes
1-stearoyl-2-oleoyl-GPS (18:0/18:1) levels
1-stearoyl-2-oleoyl-GPS (18:0/18:1) levels in elite athletes
1-stearoyl-GPA (18:0) levels in elite athletes
1-stearoyl-gpc (18:0) levels
1-stearoyl-GPC (18:0) levels in elite athletes
1-stearoyl-GPE (18:0) levels
1-stearoyl-GPE (18:0) levels in elite athletes
1-stearoyl-GPG (18:0) levels
1-stearoylglycerol (1-monostearin) levels
1-stearoylglycerophosphocholine levels (Biocrates platform)
1-stearoylglycerophosphocholine levels (Metabolon platform)
1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase level in Chronic kidney disease with hypertension and no diabetes (12457_10)
1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase levels
1,2-dilinoleoyl-GPC (18:2/18:2) levels
1,2-dilinoleoyl-GPE (18:2/18:2) levels
1,2-dipalmitoyl-gpc (16:0/16:0) levels
1,2-dipalmitoyl-GPC (16:0/16:0) levels in elite athletes
1,2-dipalmitoyl-GPE (16:0/16:0) levels in elite athletes
1,2,3-benzenetriol sulfate (2) levels in elite athletes
1,3-dimethylurate levels in elite athletes
1,3,7-trimethylurate levels
1,3,7-trimethylurate levels in elite athletes
1,4-dihydro-1-Methyl-4-oxo-3-pyridinecarboxamide levels in coronary artery disease
1,5-anhydroglucitol (1,5-ag) levels
1,5-anhydroglucitol (1,5-AG) levels in elite athletes
1,5-anhydroglucitol levels
1,7-dimethylurate levels
10-nonadecenoate (19:1n9) levels in elite athletes
10-undecenoate (11:1n1) levels
10-undecenoate (11:1n1) levels in elite athletes
10-undecenoate 11:1n1-to-X-11438 ratio
11beta-hydroxyandrosterone glucuronide (X-12846) levels
11beta-hydroxyandrosterone glucuronide levels
11beta-hydroxyetiocholanolone glucuronide levels
12-HETE levels in elite athletes
13-HODE + 9-HODE levels in elite athletes
14-3-3 protein beta/alpha levels
14-3-3 protein sigma levels
14-HDoHE/17-HDoHE levels in elite athletes
15 kDa selenoprotein level in Chronic kidney disease with hypertension and no diabetes (20087_3)
15-hydroxyprostaglandin dehydrogenase [NAD(+)] levels
15-year breast cancer-specific survival (ER negative treated with chemotherapy)
15-year breast cancer-specific survival (ER positive treated with endocrine therapy)
16a-hydroxy DHEA 3-sulfate levels
16a-hydroxy DHEA 3-sulfate levels in elite athletes
17-beta-hydroxysteroid dehydrogenase 14 levels
17-hydroxyprogesterone (17-OHP) levels
17-methylstearate levels in elite athletes
17alpha-hydroxypregnanolone glucuronide levels
17alpha-hydroxypregnenolone 3-sulfate levels
2-aminoadipate levels in elite athletes
2-aminobutyrate levels
2-aminobutyrate levels in elite athletes
2-aminoheptanoate levels in elite athletes
2-aminoisobutyric acid levels in chronic kidney disease
2-aminooctanoate levels
2-aminooctanoate levels in chronic kidney disease
2-aminooctanoate levels in elite athletes
2-aminophenol sulfate levels in elite athletes
2-arachidonoyl-GPC (20:4) levels
2-arachidonoyl-GPE (20:4) levels
2-butenoylglycine levels
2-docosahexaenoyl-GPE (22:6) levels
2-hour postprandial insulin levels in prediabetes
2-hour postprandial proinsulin levels in prediabetes
2-hydroxy-3-methylvalerate levels
2-hydroxy-3-methylvalerate levels in elite athletes
2-hydroxy-4-(methylthio)butanoic acid levels
2-hydroxyacyl-CoA lyase 1 level in Chronic kidney disease with hypertension and no diabetes (23645_49)
2-hydroxyadipate levels in elite athletes
2-hydroxybutyrate/2-hydroxyisobutyrate levels
2-hydroxybutyrate/2-hydroxyisobutyrate levels in elite athletes
2-hydroxydecanoate levels in elite athletes
2-hydroxyglutarate levels
2-hydroxyglutarate levels in elite athletes
2-hydroxyglutaric acid levels
2-hydroxyhippurate (salicylurate) levels in elite athletes
2-hydroxyisobutyrate levels
2-hydroxylaurate levels in elite athletes
2-hydroxyoctanoate levels
2-hydroxyoctanoate levels in elite athletes
2-hydroxypalmitate levels
2-hydroxypalmitate levels in elite athletes
2-hydroxyphenylacetate levels
2-hydroxysebacate levels
2-hydroxystearate levels in elite athletes
2-ketocaprylate levels
2-linoleoyl-GPE (18:2) levels
2-linoleoylglycerol (18:2) levels in elite athletes
2-linoleoylglycerophosphocholine levels (Biocrates platform)
2-methylcitrate/homocitrate levels in elite athletes
2-methylmalonylcarnitine (C4-DC) levels
2-methylserine levels in elite athletes
2-Methylsuccinic acid levels in coronary artery disease
2-myristoyl-GPC (14:0) levels
2-myristoylglycerol (14:0) levels in elite athletes
2-o-methylascorbic acid levels
2-oleoylglycerol (18:1) levels in elite athletes
2-oleoylglycerophosphocholine levels (Biocrates platform)
2-oleoylglycerophosphocholine levels (Metabolon platform)
2-oxoarginine levels
2-oxoarginine levels in elite athletes
2-palmitoleoyl-GPC (16:1) levels in elite athletes
2-palmitoleoylglycerol (16:1) levels in elite athletes
2-palmitoyl-GPC (16:0) levels
2-palmitoyl-GPC (16:0) levels in elite athletes
2-palmitoylglycerol (16:0) levels in elite athletes
2-palmitoylglycerophosphocholine levels (Biocrates platform)
2-palmitoylglycerophosphocholine levels (Metabolon platform)
2-phosphoxylose phosphatase 1 level in Chronic kidney disease with hypertension and no diabetes (6079_59)
2-phosphoxylose phosphatase 1 levels
2-phosphoxylose phosphatase 1 levels (ACPL2.6079.59.3)
2-piperidinone levels in elite athletes
2-pyrrolidinone levels in elite athletes
2-stearoyl-GPE (18:0) levels
2-stearoyl-GPE (18:0) levels in elite athletes
2-stearoylglycerophosphocholine levels (Biocrates platform)
2-stearoylglycerophosphocholine levels (Metabolon platform)
2-tetradecenoyl carnitine levels (Biocrates platform)
2-tetradecenoyl carnitine levels (Metabolon platform)
2,3-dihydroxy-2-methylbutyrate levels in elite athletes
2,3-dihydroxy-5-methylthio-4-pentenoate (dmtpa) levels
2,4,5-trichlorophenol levels
2,4,5-trichlorophenol-2 levels
2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)
2'-deoxyinosine levels in elite athletes
2'-deoxyuridine levels
2'-deoxyuridine levels in elite athletes
2'-o-methylcytidine levels
2'-o-methyluridine levels
2'-O-methyluridine levels in elite athletes
21-hydroxypregnenolone disulfate levels
21-hydroxypregnenolone disulfate levels in elite athletes
21-hydroxypregnenolone monosulfate (1) levels
25-Hydroxyvitamin D levels
26S proteasome non-ATPase regulatory subunit 10 levels
26S proteasome non-ATPase regulatory subunit 4 levels
26S proteasome non-ATPase regulatory subunit 9 levels
28 kDa heat- and acid-stable phosphoprotein levels
2R,3R-dihydroxybutyrate levels
3- 4-hydroxyphenyl lactate-to-alpha-hydroxyisovalerate ratio
3-(3-hydroxyphenyl)propionate levels in elite athletes
3-(3-hydroxyphenyl)propionate sulfate levels in elite athletes
3-(4-hydroxyphenyl) lactate levels
3-(4-hydroxyphenyl)lactate levels
3-(4-hydroxyphenyl)lactate levels in elite athletes
3-(cystein-S-yl)acetaminophen levels
3-acetylphenol sulfate levels in elite athletes
3-amino-2-piperidone levels
3-aminoisobutyrate levels
3-aminoisobutyrate levels in elite athletes
3-bromo-5-chloro-2,6-dihydroxybenzoic acid levels
3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) (X-02249) levels
3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) levels
3-carboxy-4-methyl-5-propyl-2-furanpropanoate (cmpf) levels
3-decenoylcarnitine levels
3-dehydrocarnitine levels
3-ethylcatechol sulfate (1) levels
3-formylindole (X-16071) levels
3-formylindole levels
3-hydroxy-1-methylpropylmercapturic acid levels in smokers
3-hydroxy-2-ethylpropionate levels
3-hydroxy-2-ethylpropionate levels in elite athletes
3-hydroxy-5-cholestenoic acid levels
3-hydroxyadipate levels
3-hydroxyanthranilate 3,4-dioxygenase level in Chronic kidney disease with hypertension and no diabetes (5861_78)
3-hydroxyanthranilate 3,4-dioxygenase levels
3-hydroxyanthranilate 3,4-dioxygenase levels (HAAO.5861.78.3)
3-hydroxybutyrate (bhba) levels
3-hydroxybutyrate (BHBA) levels in elite athletes
3-hydroxybutyrate + 3-aminoisobutyrate levels
3-hydroxybutyrate dehydrogenase type 2 levels
3-Hydroxybutyrate levels
3-hydroxybutyrate levels (UKB data field 23474)
3-hydroxybutyroylglycine levels
3-hydroxybutyrylcarnitine (2) levels in elite athletes
3-hydroxydecanoate levels
3-hydroxydecanoate levels in elite athletes
3-hydroxydecanoylcarnitine levels
3-hydroxyhexanoate levels
3-hydroxyhexanoate levels in elite athletes
3-hydroxyhexanoylcarnitine (1) levels
3-hydroxyhippurate levels in elite athletes
3-hydroxyisobutyrate levels in elite athletes
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial level in Chronic kidney disease with hypertension and no diabetes (12396_19)
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial levels
3-hydroxylaurate levels
3-hydroxylaurate levels in elite athletes
3-hydroxymyristate levels in elite athletes
3-hydroxyoctanoate levels
3-hydroxyoctanoate levels in elite athletes
3-hydroxyoctanoylcarnitine (1) levels
3-hydroxyoctanoylcarnitine (2) levels
3-hydroxyoleoylcarnitine levels
3-hydroxypropylmercapturic acid levels in smokers
3-hydroxysebacate levels
3-hydroxysebacate levels in elite athletes
3-indoleglyoxylic acid levels
3-Indolepropionic acid levels in coronary artery disease
3-indoxyl sulfate levels in elite athletes
3-keto-steroid reductase levels
3-ketoacyl-CoA thiolase, peroxisomal levels
3-ketodihydrosphingosine reductase levels
3-methoxycatechol sulfate (2) levels in elite athletes
3-methoxytyrosine levels
3-methoxytyrosine levels in elite athletes
3-methyl catechol sulfate (1) levels
3-methyl catechol sulfate (1) levels in elite athletes
3-methyl-2-oxobutyrate levels
3-methyl-2-oxobutyrate levels in elite athletes
3-methyl-2-oxovalerate levels
3-methyl-2-oxovalerate levels in elite athletes
3-methyladipate levels in elite athletes
3-methylcytidine levels
3-methylglutaconate levels
3-methylglutaconate levels in elite athletes
3-methylglutarate/2-methylglutarate levels in elite athletes
3-methylglutarylcarnitine (2) levels
3-methylglutarylcarnitine (2) levels in elite athletes
3-methylxanthine levels in elite athletes
3-month functional outcome in ischaemic stroke (modified Rankin score)
3-month functional outcome in lacunar ischaemic stroke (modified Rankin score)
3-month functional outcome in non-lacunar ischaemic stroke (modified Rankin score)
3-phenylpropionate (hydrocinnamate) levels in elite athletes
3-phenylpropionate hydrocinnamate levels
3-phosphoinositide-dependent protein kinase 1 levels
3-ureidopropionate levels
3-ureidopropionate levels in elite athletes
3,5-dichloro-2,6-dihydroxybenzoic acid levels
3,7-dimethylurate levels
3,7-dimethylurate levels in elite athletes
3(2),5-bisphosphate nucleotidase 1 levels
39S ribosomal protein L2, mitochondrial levels
39S ribosomal protein L21, mitochondrial levels
39S ribosomal protein L33, mitochondrial levels
39S ribosomal protein L33, mitochondrial levels (MRPL33.13453.2.3)
39S ribosomal protein L55, mitochondrial levels
3b-hydroxy-5-cholenoic acid levels
3b-hydroxy-5-cholenoic acid levels in elite athletes
3beta-hydroxy-5-cholestenoate levels
3beta-hydroxy-5-cholestenoate levels in elite athletes
3beta,7alpha-dihydroxy-5-cholestenoate levels
3beta,7alpha-dihydroxy-5-cholestenoate levels in elite athletes
4-acetamidobutanoate levels
4-acetamidobutanoate levels in chronic kidney disease
4-acetamidobutanoate levels in elite athletes
4-acetamidobutanoate-to-N1-methyladenosine ratio
4-acetamidobutanoate-to-X-03056--N-[3-(2-Oxopyrrolidin-1-yl)propyl]acetamide ratio
4-acetylphenol sulfate levels in elite athletes
4-allylphenol sulfate levels
4-allylphenol sulfate levels in elite athletes
4-androsten-3alpha,17alpha-diol monosulfate (3) levels
4-androsten-3beta,17beta-diol disulfate (1) levels
4-androsten-3beta,17beta-diol disulfate (2) levels
4-androsten-3beta,17beta-diol disulfate 1 levels
4-androsten-3beta,17beta-diol disulfate 2 levels
4-androsten-3beta,17beta-diol monosulfate (2) levels
4-cholesten-3-one levels
4-cholesten-3-one levels in elite athletes
4-ethylphenylsulfate levels
4-ethylphenylsulfate levels in elite athletes
4-guanidinobutanoate levels
4-HDoHE levels in elite athletes
4-hydroxychlorothalonil levels
4-hydroxychlorothalonil levels in elite athletes
4-hydroxycoumarin levels in elite athletes
4-hydroxyglutamate levels
4-hydroxyglutamate levels in elite athletes
4-hydroxyphenylacetoylcarnitine levels
4-hydroxyphenylacetylglutamine levels
4-hydroxyphenylacetylglutamine levels in elite athletes
4-hydroxyphenylpyruvate levels
4-hydroxyphenylpyruvate levels in elite athletes
4-imidazoleacetate levels in elite athletes
4-methyl-2-oxopentanoate levels
4-methyl-2-oxopentanoate levels in elite athletes
4-methylcatechol sulfate levels in elite athletes
4-methylhexanoylglutamine levels
4-oxo-retinoic acid levels
4-vinylphenol sulfate levels in elite athletes
4,6-dinitro-o-cresol levels
40S ribosomal protein S10 levels
40S ribosomal protein S19 levels
40S ribosomal protein S3 levels
40S ribosomal protein S3a levels
40S ribosomal protein S4, X isoform levels
40S ribosomal protein S5 levels
40S ribosomal protein S7 levels
5-acetylamino-6-amino-3-methyluracil levels
5-acetylamino-6-amino-3-methyluracil levels in elite athletes
5-acetylamino-6-formylamino-3-methyluracil levels
5-acetylamino-6-formylamino-3-methyluracil levels in elite athletes
5-bromotryptophan levels
5-bromotryptophan levels in elite athletes
5-dodecenoate (12:1n7) levels in elite athletes
5-dodecenoylcarnitine (C12:1) levels
5-formyltetrahydrofolate cyclo-ligase level in Chronic kidney disease with hypertension and no diabetes (14107_1)
5-formyltetrahydrofolate cyclo-ligase levels
5-formyltetrahydrofolate cyclo-ligase levels (MTHFS.14107.1.3)
5-HEPE levels in elite athletes
5-HETE levels in elite athletes
5-HETrE levels in elite athletes
5-HTT brain serotonin transporter levels
5-hydroxy-2-methylpyridine sulfate levels
5-hydroxyindole sulfate levels
5-hydroxylysine levels
5-hydroxytryptamine receptor 2A levels
5-hydroxytryptamine receptor 6 level in Chronic kidney disease with hypertension and no diabetes (13561_5)
5-hydroxytryptamine receptor 7 levels
5-methylcytidine levels in chronic kidney disease
5-methylthioadenosine (mta) levels
5-methylthioadenosine (MTA) levels in elite athletes
5-methyluridine (ribothymidine) levels
5-methyluridine (ribothymidine) levels in elite athletes
5-nucleotidase domain-containing protein 3 levels
5-Nucleotidase levels
5-oxoproline levels
5,6-dihydrothymine levels
5,6-dihydrothymine levels in elite athletes
5'-Nucleotidase level in Chronic kidney disease with hypertension and no diabetes (15452_5)
5(3)-deoxyribonucleotidase, cytosolic type levels
5(3)-deoxyribonucleotidase, mitochondrial levels
5alpha-androstan-3alpha,17alpha-diol disulfate levels in elite athletes
5alpha-androstan-3alpha,17alpha-diol monosulfate levels
5alpha-androstan-3alpha,17alpha-diol monosulfate levels in elite athletes
5alpha-androstan-3alpha,17beta-diol disulfate levels
5alpha-androstan-3alpha,17beta-diol disulfate levels in elite athletes
5alpha-androstan-3alpha,17beta-diol monosulfate (1) levels
5alpha-androstan-3alpha,17beta-diol monosulfate (1) levels in elite athletes
5alpha-androstan-3alpha,17beta-diol monosulfate (2) levels
5alpha-androstan-3alpha,17beta-diol monosulfate (2) levels in elite athletes
5alpha-androstan-3beta,17alpha-diol disulfate levels
5alpha-androstan-3beta,17alpha-diol disulfate levels in elite athletes
5alpha-androstan-3beta,17beta-diol disulfate levels
5alpha-androstan-3beta,17beta-diol disulfate levels in elite athletes
5alpha-androstan-3beta,17beta-diol monosulfate (1) levels
5alpha-androstan-3beta,17beta-diol monosulfate (2) levels
5alpha-androstan-3beta,17beta-diol monosulfate (2) levels in elite athletes
5alpha-pregnan-3(alpha or beta),20beta-diol disulfate levels in elite athletes
5alpha-pregnan-3beta-ol,20-one sulfate levels in elite athletes
5alpha-pregnan-3beta,20alpha-diol disulfate levels
5alpha-pregnan-3beta,20alpha-diol disulfate levels in elite athletes
5alpha-pregnan-3beta,20alpha-diol monosulfate (2) levels
5alpha-pregnan-3beta,20alpha-diol monosulfate (2) levels in elite athletes
5alpha-pregnan-3beta,20beta-diol monosulfate (1) levels
5alpha-pregnan-3beta,20beta-diol monosulfate (1) levels in elite athletes
5alpha-pregnan-diol disulfate levels
6-bromotryptophan levels
6-hydroxyindole sulfate levels in elite athletes
6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)
6-oxopiperidine-2-carboxylate levels
6-oxopiperidine-2-carboxylate levels in elite athletes
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 levels
6-phosphogluconate dehydrogenase, decarboxylating levels
6-phosphogluconolactonase levels
60S ribosomal protein L12 levels
60S ribosomal protein L30 levels
7-alpha-hydroxy-3-oxo-4-cholestenoate (7-hoca) levels
7-methylguanine levels
7-methylxanthine levels
7,8-dihydro-8-oxoguanine triphosphatase levels
72 kDa inositol polyphosphate 5-phosphatase levels
72 kDa type IV collagenase levels
8-hydroxydeoxyguanosine x triclosan interaction
8-isoprostaglandin-F2alpha x bisphenol A interaction
8-isoprostaglandin-F2alpha x triclosan interaction
9,10-DiHOME levels
9,10-DiHOME levels in elite athletes
A body shape index
A disintegrin and metalloproteinase with thrombospondin motifs 13 levels
A disintegrin and metalloproteinase with thrombospondin motifs 13 levels (ADAMTS13.3175.51.5)
A disintegrin and metalloproteinase with thrombospondin motifs 15 levels
A disintegrin and metalloproteinase with thrombospondin motifs 3 levels
A disintegrin and metalloproteinase with thrombospondin motifs 4 levels
Abdominal adipose tissue volumes
Abdominal adipose tissue volumes (adjusted for BMI and height)
Abdominal adipose tissue volumes to gluteofemoral adipose tissue volumes ratio
Abdominal aortic aneurysm
Abdominal aortic calcification levels
Abdominal aortic diameter
Abdominal fat cell number
Abdominal fat ratio
Abdominal subcutaneous adipose tissue
Abdominal subcutaneous adipose tissue normalized
Abdominal subcutaneous adipose tissue volume
Abelson tyrosine-protein kinase 2 levels
Abelson tyrosine-protein kinase 2 levels (ABL2.5261.13.3)
Ability to confide in someone
Abstraction and mental flexibility
Academic attainment (English)
Academic attainment (maths)
Academic attainment (science)
Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction)
Accelerated lung function decline (FEV1) and worsened/persistent change in fatty liver (pleiotropy)
Accelerated lung function decline (FVC) and worsened/persistent change in fatty liver (pleiotropy)
Accelerometer measured moderate to vigorous physical activity
Accelerometer-based physical activity measurement (average acceleration)
Accelerometer-based physical activity measurement (fraction of time with accelerations >425 milli-gravities)
Acceptance of an invitation to participate in a mental health questionnaire
Acceptance of an invitation to wear a physical activity monitor
Accrued duration of remission in mepolizumab-treated eosinophilic granulomatosis with polyangiitis
ACE plasma levels
ACE-inhibitor discontinuation
Acenocoumarol maintenance dosage
Acesulfame levels in elite athletes
Acetate levels
Acetate levels (UKB data field 23475)
Acetoacetate levels
Acetoacetate levels (UKB data field 23476)
Acetone levels
Acetone levels (UKB data field 23477)
Acetyl-CoA acetyltransferase, cytosolic levels
Acetyl-CoA acetyltransferase, mitochondrial levels
Acetyl-coenzyme A synthetase, cytoplasmic level in Chronic kidney disease with hypertension and no diabetes (25094_9)
Acetylcarnitine (c2) levels
Acetylcarnitine (C2) levels in elite athletes
Acetylcarnitine levels
Acetylcarnitine levels (Biocrates platform)
Acetylcarnitine-to-hexanoylcarnitine ratio
Acetylornithine levels
Achilles tendinopathy
Achilles tendon injury
Achromobacter abundance in stool
Acid ceramidase levels
Acid sphingomyelinase-like phosphodiesterase 3a level in Chronic kidney disease with hypertension and no diabetes (4771_10)
Acid sphingomyelinase-like phosphodiesterase 3a levels
Acid sphingomyelinase-like phosphodiesterase 3a levels (SMPDL3A.14086.11.3)
Acid-sensing ion channel 4 levels
Acidic fibroblast growth factor intracellular-binding protein levels
Acidic leucine-rich nuclear phosphoprotein 32 family member A levels
Acidic leucine-rich nuclear phosphoprotein 32 family member B levels (ANP32B.4194.26.3)
Acidic mammalian chitinase levels
Acisoga levels
Acisoga levels in elite athletes
Acne (severe)
acne vulgaris
Aconitate [cis or trans] levels in elite athletes
Acoustic startle blink response
Acrosomal protein SP-10 levels
Actin filament-associated protein 1-like 1 levels
Actin-binding LIM protein 3 levels
Actin-related protein 2/3 complex subunit 1B levels
Actin-related protein 2/3 complex subunit 3 levels
Actin-related protein 2/3 complex subunit 5 levels
Actinic keratosis
Actinobacteria abundance in stool
Actinobacteriota abundance in stool
Actinomycetales abundance in stool
Activated & resting CD4 regulatory T cell %CD4 regulatory T cell
Activated & secreting CD4 regulatory T cell %CD4 regulatory T cell
Activated & secreting CD4 regulatory T cell %CD4+ T cell
Activated partial thromboplastin time
Activated Protein C level in Chronic kidney disease with hypertension and no diabetes (3758_63)
Activator of 90 kDa heat shock protein ATPase homolog 1 levels
Activator of apoptosis harakiri levels
Activin receptor type-2A levels
Acute anterior uveitis (with or without ankylosing spondylitis)
Acute anterior uveitis in ankylosing spondylitis
Acute encephalopathy with biphasic seizures and late reduced diffusion
Acute graft versus host disease in bone marrow transplantation (donor effect)
Acute graft versus host disease in bone marrow transplantation (recipient effect)
Acute graft-versus-host disease (gut) (recipient effect)
Acute graft-versus-host disease (stage 2 to 4) (recipient effect)
Acute graft-versus-host disease (stage 3 to 4) (recipient effect)
Acute insulin response
Acute insulin response (insulin secretion adjusted)
Acute ischemic stroke x type 2 diabetes interaction
Acute kidney injury in coronary artery bypass surgery (creatinine rise)
Acute kidney injury in critical illness
Acute lymphoblastic leukemia (B-cell precursor)
Acute lymphoblastic leukemia (childhood)
Acute lymphoblastic leukemia in childhood (B cell precursor)
Acute myeloid leukemia (all cytogenetic sub-types)
Acute myeloid leukemia (normal cytogenetics)
Acute pancreatitis
Acute post-radiotherapy pain in breast cancer
Acute respiratory distress syndrome
Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced)
Acyl-CoA-binding domain-containing protein 6 levels
Acyl-CoA-binding domain-containing protein 7 level in Chronic kidney disease with hypertension and no diabetes (13563_259)
Acyl-CoA-binding domain-containing protein 7 levels
Acyl-CoA-binding protein levels
Acyl-coenzyme A thioesterase 12 level in Chronic kidney disease with hypertension and no diabetes (23601_43)
Acyl-coenzyme A thioesterase 8 levels
Acylcarnitine (10:1) levels
Acylcarnitine (12:0) levels
Acylcarnitine (13:0) levels
Acylcarnitine (14:0) levels
Acylcarnitine (14:1) levels
Acylcarnitine (14:2) levels
Acylcarnitine (15:0) (a) levels
Acylcarnitine (15:0) (b) levels
Acylcarnitine (16:0) levels
Acylcarnitine (16:1) levels
Acylcarnitine (17:0) (a) levels
Acylcarnitine (17:0) (b) levels
Acylcarnitine (18:0) levels
Acylcarnitine (18:1) levels
Acylcarnitine (18:2) levels
Acylphosphatase-2 levels
Acylpyruvase FAHD1, mitochondrial levels
ADAMTS-like protein 1 levels
ADAMTS-like protein 2 levels
ADAMTS13 levels
Adapter molecule crk levels
Added salt consumption
Addison's disease
Adenine levels
Adenine levels in elite athletes
Adenocarcinoma
Adenocarcinoma in never smokers
Adenosine 3',5'-cyclic monophosphate (camp) levels
Adenosine deaminase CECR1 levels
Adenosine deaminase CECR1 levels (CECR1.6077.63.3)
Adenosine kinase levels
Adenosylhomocysteinase 2 levels
Adenylate kinase 4, mitochondrial levels
Adenylate kinase isoenzyme 5 levels
Adenylosuccinate synthetase isozyme 1 levels
ADHD vs anorexia nervosa (ordinary least squares (OLS))
ADHD vs autism spectrum disorder (ordinary least squares (OLS))
ADHD vs obsessive compulsive disorder (ordinary least squares (OLS))
ADHD vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS))
Adhesion G protein-coupled receptor B3 levels
Adhesion G protein-coupled receptor E2 levels
Adhesion G protein-coupled receptor F5 levels
Adhesion G-protein coupled receptor F1 level in Chronic kidney disease with hypertension and no diabetes (11243_90)
Adhesion G-protein coupled receptor F1 levels
Adhesion G-protein coupled receptor F1 levels (ADGRF1.11243.90.3)
Adipocyte plasma membrane-associated protein levels (APMAP.10605.22.3)
Adiponectin levels
Adiponectin levels (BMI-adjusted)
Adiponectin levels in pregnancy
Adiponectin levels x Mediterranean diet adherence interaction
Adipose morphology
Adiposity
Adipoylcarnitine (C6-DC) levels
Adipoylcarnitine (C6-DC) levels in elite athletes
Adipsin levels
Adipsin levels in type 2 diabetes
ADMA levels
Adolescent idiopathic scoliosis
ADP-ribose pyrophosphatase, mitochondrial levels
ADP-ribose pyrophosphatase, mitochondrial levels (NUDT9.9482.110.3)
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 levels
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 level in Chronic kidney disease with hypertension and no diabetes (4535_50)
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 levels
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 levels (BST1.4535.50.2)
ADP-ribosylation factor 1 levels
ADP-ribosylation factor 4 levels
ADP-ribosylation factor 5 levels
ADP-ribosylation factor GTPase-activating protein 1 levels
ADP-ribosylation factor GTPase-activating protein 2 levels
ADP-ribosylation factor-binding protein GGA1 levels
ADP-ribosylation factor-binding protein GGA3 levels
ADP-ribosylation factor-like protein 11 levels
ADP-ribosylation factor-like protein 15 level in Chronic kidney disease with hypertension and no diabetes (18411_83)
ADP-ribosylation factor-like protein 3 levels
ADP-ribosylation factor-like protein 4D levels
ADP-ribosylation factor-like protein 6 levels
ADP-ribosylation factor-like protein 9 levels
ADP-sugar pyrophosphatase levels
ADpSGEGDFXAEGGGVR levels
Adrenate (22:4n6) levels
Adrenate (22:4n6) levels in elite athletes
Adrenate 22:4n6 levels
Adrenomedullin levels
Adrenoylcarnitine (C22:4) levels in elite athletes
Adseverin levels (SCIN.12684.5.3)
ADSGEGDFXAEGGGVR-to-ADpSGEGDFXAEGGGVR ratio
Adult asthma
Adult body size
Adult diffuse glioma (IDH mutation, 1p/19q non-codeleted)
Adult diffuse glioma (IDH mutation)
Adult diffuse glioma (IDH wildtype)
Adult diffuse glioma (TERT mutation only)
Adult diffuse triple positive glioma (IDH and TERT mutations, 1p19q codeletion)
Adult hearing aid use
Adult hearing difficulty
Adult onset asthma and/or BMI
Adult onset asthma and/or waist-to-hip ratio adjusted for BMI
Adult onset asthma or fasting glucose levels
Adult onset asthma or type 2 diabetes
Advanced age-related macular degeneration
Advanced glycation end-product levels
Advanced glycosylation end product-specific receptor, soluble levels
Advanced glycosylation end product-specific receptor, soluble levels (AGER.4125.52.2)
Advanced metachronous adenoma
Adventurousness
Adverse cardiovascular outcome x ACE inhibitors/ARBs interaction in hypertension
Adverse cardiovascular outcome x beta blockers interaction in hypertension
Adverse cardiovascular outcome x calcium channel blockers interaction in hypertension
Adverse cardiovascular outcome x thiazide/thiazide-like diuretics interaction in hypertension
Adverse response to antithyroid drugs in Graves disease
Adverse response to aromatase inhibitors
Adverse response to benznidazole in Chagas disease
Adverse response to chemotherapy (amenorrhea) in breast cancer
Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)
Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)
Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)
Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)
Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)
Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)
Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)
Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)
Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)
Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)
Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)
Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)
Adverse response to chemotherapy in breast cancer (alopecia)
Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)
Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)
Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)
Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)
Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)
Adverse response to chemotherapy in breast cancer (grade 3/4 neutropenic or leukopenic events)
Adverse response to chemotherapy in colorectal cancer (FOLFOX,Cetuximab) (Nausea)
Adverse response to drug
Adverse response to inhaled corticosteroid treatment x age interaction in asthma
Adverse response to lamotrigine and phenytoin
Adverse response to radiation therapy
Aerodigestive squamous cell cancer (pleiotropy)
Afamin level in Chronic kidney disease with hypertension and no diabetes (4763_31)
Afamin levels
Affective disorder and suicide attempts
Aflatoxin B1 aldehyde reductase member 2 levels
Aflatoxin B1 aldehyde reductase member 3 levels
AFP levels
Age at adiposity rebound
Age at adiposity rebound x sex interaction
Age at first birth
Age at first sexual intercourse
Age at last live birth
Age at loss of ambulation in Duchenne muscular dystrophy
Age at menarche
Age at menopause
Age at smoking initiation in chronic obstructive pulmonary disease
Age at voice drop
Age of onset of adult onset asthma
Age of onset of childhood onset asthma
Age of onset of depression x felt loved as a child interaction
Age of onset of parkinson disease
Age of smoking initiation
Age of smoking initiation (MTAG)
Age related hearing loss-related regional glucose metabolism (Bilateral Heschl’s gyrus)
Age related hearing loss-related regional glucose metabolism (Cochlear nucleus)
Age related hearing loss-related regional glucose metabolism (Inferior colliculus)
Age spots
Age when finished full-time education (standard GWA)
Age when finished full-time education (weighted GWA)
Age-related cataracts
Age-related cataracts (age at onset)
Age-related cognitive decline (attention/processing speed) (slope of z-scores)
Age-related cognitive decline (executive function) (slope of z-scores)
Age-related cognitive decline (global cognition) (slope of z-scores)
Age-related cognitive decline (language) (slope of z-scores)
Age-related cognitive decline (memory) (slope of z-scores)
Age-related cognitive decline (visuospatial skill) (slope of z-scores)
Age-related disease endophenotypes
Age-related diseases and mortality
Age-related diseases, mortality and associated endophenotypes
Age-related hearing impairment
Age-related hearing impairment (high frequency)
Age-related hearing impairment (high minus low frequency)
Age-related hearing impairment (low/mid frequency)
Age-related hearing impairment (MTAG)
Age-related macular degeneration
Age-related macular degeneration (choroidal neovascularisation)
Age-related macular degeneration (extreme sampling)
Age-related macular degeneration (geographic atrophy)
Age-related macular degeneration (MTAG)
Age-related macular degeneration or COVID-19 critical illness (MTAG)
Age-related macular degeneration or COVID-19 hospitalization (MTAG)
Age-related macular degeneration or COVID-19 infection (MTAG)
Age-related nuclear cataracts
Aggrecan core protein levels
Aggressive periodontitis
Aggressive periodontitis (sex interaction)
Aggressiveness in attention deficit hyperactivity disorder
Aging
Aging (facial)
Aging (time to death)
Aging (time to event)
Aging traits
Aging traits (healthspan, parental lifespan or longevity) (multivariate analysis)
Agouti-related protein levels
Agouti-related protein levels (AGRP.2813.11.2)
Agouti-signaling protein level in Chronic kidney disease with hypertension and no diabetes (5676_54)
Agouti-signaling protein levels
Agrin levels
AH receptor-interacting protein levels
AIDS
AIDS progression
Airflow obstruction
Airflow obstruction in ever smokers
Airway hyperresponsiveness
Airway imaging phenotypes
Airway obstruction (FEV1/FVC<70%) in never smokers
Airway obstruction (FEV1/FVC
Airway responsiveness in chronic obstructive pulmonary disease
Airway wall thickness
Akkermansia muciniphila B abundance in stool
Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)
Alanine aminotransferase 1 levels
Alanine aminotransferase elevation after methotrexate initiation in rheumatoid arthritis (>1.5 × ULN)
Alanine aminotransferase level after methotrexate initiation in rheumatoid arthritis
Alanine aminotransferase levels
Alanine aminotransferase levels in excessive alcohol consumption
Alanine aminotransferase levels in low alcohol consumption
Alanine aminotransferase levels in non-alcoholic fatty liver disease
Alanine levels
Alanine levels (UKB data field 23460)
Alanine levels in elite athletes
Alanine transaminase levels
Alanine transaminase levels in high alcohol intake
Alanine--tRNA ligase, cytoplasmic levels
Albumin levels
Albumin levels (UKB data field 23479)
Albumin-globulin ratio
Albuminuria
Alcohol and nicotine co-dependence
Alcohol consumption
Alcohol consumption (drinkers vs non-drinkers)
Alcohol consumption (drinks per month) (UKB data field 1578, 4424)
Alcohol consumption (drinks per week)
Alcohol consumption (drinks per week) (MTAG)
Alcohol consumption (heavy vs. light/non-drinkers)
Alcohol consumption (max-drinks)
Alcohol consumption (transferrin glycosylation)
Alcohol consumption in current drinkers
Alcohol consumption over the past year
Alcohol consumption x experiences in childhood (felt loved by family member) interaction
Alcohol consumption x hours spent using computers interaction
Alcohol consumption x hours spent watching television interaction
Alcohol consumption x playing computer games interaction
Alcohol consumption x traumatic event in childhood (felt hated by family member) interaction
Alcohol dehydrogenase [NADP(+)] levels
Alcohol dehydrogenase [NADP(+)] levels (AKR1A1.4192.10.2)
Alcohol dehydrogenase 1B levels (ADH1B.9834.62.3)
Alcohol dehydrogenase 4 levels
Alcohol dehydrogenase 6 levels
Alcohol dehydrogenase class-3 levels
Alcohol dependence
Alcohol dependence (age at onset)
Alcohol dependence (codominant genetic model)
Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis
Alcohol dependence or heroin dependence or methamphetamine dependence
Alcohol dependence symptom count
Alcohol drinker status: current or former vs never (UKB data field 20117)
Alcohol frequency weekly (standard GWA)
Alcohol liking
Alcohol use disorder
Alcohol use disorder (consumption score)
Alcohol use disorder (dependence and problematic use scores)
Alcohol use disorder (total score)
Alcohol usually taken with meals (UKB data field 1618)
Alcohol-associated liver disease in heavy drinkers
Alcohol-associated liver disease in light drinkers
Alcohol-associated liver disease in non drinkers
Alcohol-related hepatocellular carcinoma
Alcoholic chronic pancreatitis
Alcoholism (alcohol dependence factor score)
Alcoholism (alcohol use disorder factor score)
Alcoholism (heaviness of drinking)
Aldehyde dehydrogenase family 1 member A3 levels
Aldehyde dehydrogenase, dimeric NADP-preferring levels
Aldehyde dehydrogenase, dimeric NADP-preferring levels (ALDH3A1.11480.1.3)
Aldo-keto reductase family 1 member B10 levels
Aldo-keto reductase family 1 member C1 levels
Aldo-keto reductase family 1 member C1 levels (AKR1C1.12618.50.3)
Aldo-keto reductase family 1 member C3 levels
Aldo-keto reductase family 1 member C4 levels
Aldose reductase levels
Aldosterone levels
Aldrin levels
Alkaline phosphatase (UKB data field 30610)
Alkaline phosphatase, placental type levels
Alkaline phosphatase, placental-like levels
Alkaline phosphatase, tissue-nonspecific isozyme levels
Alkenylphosphatidylcholine (P-15:0/20:4) (a) levels
Alkenylphosphatidylcholine (P-15:0/20:4) (b) levels
Alkenylphosphatidylcholine (P-16:0/14:0) levels
Alkenylphosphatidylcholine (P-16:0/16:0) levels
Alkenylphosphatidylcholine (P-16:0/16:1) levels
Alkenylphosphatidylcholine (P-16:0/18:0) levels
Alkenylphosphatidylcholine (P-16:0/18:1) levels
Alkenylphosphatidylcholine (P-16:0/18:2) levels
Alkenylphosphatidylcholine (P-16:0/18:3) levels
Alkenylphosphatidylcholine (P-16:0/20:4) levels
Alkenylphosphatidylcholine (P-16:0/20:5) levels
Alkenylphosphatidylcholine (P-16:0/22:6) levels
Alkenylphosphatidylcholine (P-17:0/20:4) (a) levels
Alkenylphosphatidylcholine (P-17:0/20:4) (b) levels
Alkenylphosphatidylcholine (P-18:0/18:2) levels
Alkenylphosphatidylcholine (P-18:0/20:4) levels
Alkenylphosphatidylcholine (P-18:0/22:5) levels
Alkenylphosphatidylcholine (P-18:0/22:6) levels
Alkenylphosphatidylcholine (P-18:1/22:6) levels
Alkenylphosphatidylcholine (P-20:0/20:4) levels
Alkenylphosphatidylcholine (P-36:3) levels
Alkenylphosphatidylcholine (P-38:5) (a) levels
Alkenylphosphatidylcholine (P-38:5) (b) levels
Alkenylphosphatidylethanolamine (P-15:0/20:4) levels
Alkenylphosphatidylethanolamine (P-16:0/18:1) levels
Alkenylphosphatidylethanolamine (P-16:0/18:2) levels
Alkenylphosphatidylethanolamine (P-16:0/18:3) levels
Alkenylphosphatidylethanolamine (P-16:0/20:3) (a) levels
Alkenylphosphatidylethanolamine (P-16:0/20:3) (b) levels
Alkenylphosphatidylethanolamine (P-16:0/20:4) levels
Alkenylphosphatidylethanolamine (P-16:0/20:5) levels
Alkenylphosphatidylethanolamine (P-16:0/22:5) (n3) levels
Alkenylphosphatidylethanolamine (P-16:0/22:5) (n6) levels
Alkenylphosphatidylethanolamine (P-16:0/22:6) levels
Alkenylphosphatidylethanolamine (P-17:0/20:4) (a) levels
Alkenylphosphatidylethanolamine (P-17:0/20:4) (b) levels
Alkenylphosphatidylethanolamine (P-18:0/18:1) levels
Alkenylphosphatidylethanolamine (P-18:0/18:2) levels
Alkenylphosphatidylethanolamine (P-18:0/18:3) levels
Alkenylphosphatidylethanolamine (P-18:0/20:3) (a) levels
Alkenylphosphatidylethanolamine (P-18:0/20:4) levels
Alkenylphosphatidylethanolamine (P-18:0/22:5) (n6) levels
Alkenylphosphatidylethanolamine (P-18:0/22:6) levels
Alkenylphosphatidylethanolamine (P-18:1/18:1) (a) levels
Alkenylphosphatidylethanolamine (P-18:1/18:1) (b) levels
Alkenylphosphatidylethanolamine (P-18:1/18:1) levels
Alkenylphosphatidylethanolamine (P-18:1/18:2) (a) levels
Alkenylphosphatidylethanolamine (P-18:1/18:2) (b) levels
Alkenylphosphatidylethanolamine (P-18:1/18:3) levels
Alkenylphosphatidylethanolamine (P-18:1/20:3) (a) levels
Alkenylphosphatidylethanolamine (P-18:1/20:3) (b) levels
Alkenylphosphatidylethanolamine (P-18:1/20:4) (a) levels
Alkenylphosphatidylethanolamine (P-18:1/20:4) (b) levels
Alkenylphosphatidylethanolamine (P-18:1/22:5) (b) levels
Alkenylphosphatidylethanolamine (P-19:0/20:4) (a) levels
Alkenylphosphatidylethanolamine (P-19:0/20:4) (b) levels
Alkenylphosphatidylethanolamine (P-20:0/18:1) levels
Alkenylphosphatidylethanolamine (P-20:0/18:2) levels
Alkenylphosphatidylethanolamine (P-20:0/20:4) levels
Alkenylphosphatidylethanolamine (P-20:0/22:6) levels
Alkenylphosphatidylethanolamine (P-20:1/20:4) levels
Alkyldiacylglycerol (O-50:1) [NL-16:0] levels
Alkyldiacylglycerol (O-52:0) [NL-16:0] levels
Alkylphosphatidylcholine (O-16:0/16:0) levels
Alkylphosphatidylcholine (O-16:0/20:3) levels
Alkylphosphatidylcholine (O-16:0/20:4) levels
Alkylphosphatidylcholine (O-16:0/22:6) levels
Alkylphosphatidylcholine (O-18:0/18:1) levels
Alkylphosphatidylcholine (O-18:0/18:2) levels
Alkylphosphatidylcholine (O-18:0/20:4) levels
Alkylphosphatidylcholine (O-18:1/18:1) levels
Alkylphosphatidylcholine (O-18:1/18:2) levels
Alkylphosphatidylcholine (O-32:1) levels
Alkylphosphatidylcholine (O-32:2) levels
Alkylphosphatidylcholine (O-34:1) levels
Alkylphosphatidylcholine (O-34:2) levels
Alkylphosphatidylcholine (O-34:4) levels
Alkylphosphatidylcholine (O-38:5) levels
Alkylphosphatidylcholine (O-40:5) levels
Alkylphosphatidylethanolamine (O-16:0/18:2) levels
Alkylphosphatidylethanolamine (O-16:0/20:3) levels
Alkylphosphatidylethanolamine (O-16:0/22:6) levels
Alkylphosphatidylethanolamine (O-18:0/20:4) levels
Alkylphosphatidylethanolamine (O-18:0/22:6) levels
Alkylphosphatidylethanolamine (O-18:1/18:2) levels
Alkylphosphatidylethanolamine (O-34:1) levels
Allergic disease (asthma, hay fever and/or eczema) (age of onset)
Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)
Allergic disease (asthma, hay fever or eczema)
Allergic rhinitis
Allergic sensitization
Allergin-1 levels
Allergin-1 levels (MILR1.11173.29.3)
Allergy
Alliin levels
Allograft inflammatory factor 1-like levels
Alloimmunization response to red blood cell transfusion in sickle cell anemia
Alopecia areata
Alpha angle
Alpha synuclein levels (MTAG)
Alpha- and gamma-adaptin-binding protein p34 levels
Alpha-(1,3)-fucosyltransferase 10 levels
Alpha-(1,3)-fucosyltransferase 10 levels (FUT10.7156.2.3)
Alpha-(1,3)-fucosyltransferase 5 levels
Alpha-(1,3)-fucosyltransferase 5 levels (FUT5.4549.78.2)
Alpha-(1,3)-fucosyltransferase 9 level in Chronic kidney disease with hypertension and no diabetes (6991_24)
Alpha-(1,3)-fucosyltransferase 9 levels
Alpha-(1,3)-fucosyltransferase 9 levels (FUT9.6991.24.3)
Alpha-(1,6)-fucosyltransferase level in Chronic kidney disease with hypertension and no diabetes (8244_16)
Alpha-(1,6)-fucosyltransferase levels
Alpha-(1,6)-fucosyltransferase levels (FUT8.8244.16.3)
alpha-1-antichymotrypsin complex levels
Alpha-1-antichymotrypsin levels
Alpha-1-antitrypsin level in Chronic kidney disease with hypertension and no diabetes (3580_25)
Alpha-1-antitrypsin levels
Alpha-1-microglobulin levels
Alpha-1-syntrophin levels
Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A levels
Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B levels
Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C levels
Alpha-1,4-N-acetylglucosaminyltransferase levels
Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase levels
Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase levels (MGAT2.6909.40.3)
Alpha-1B-glycoprotein level in Chronic kidney disease with hypertension and no diabetes (16561_9)
Alpha-1B-glycoprotein levels
Alpha-2-antiplasmin levels
Alpha-2-HS-glycoprotein level in Chronic kidney disease with hypertension and no diabetes (10966_1)
Alpha-2-HS-glycoprotein level in Chronic kidney disease with hypertension and no diabetes (3581_53)
Alpha-2-HS-glycoprotein levels
Alpha-2-HS-glycoprotein levels (AHSG.3581.53.3)
Alpha-2-macroglobulin levels
alpha-2-macroglobulin receptor-associated protein levels
Alpha-actinin-1 levels
Alpha-actinin-2 levels
alpha-Aminoadipic acid levels
Alpha-aminoadipic semialdehyde dehydrogenase level in Chronic kidney disease with hypertension and no diabetes (21498_3)
Alpha-CEHC sulfate levels in elite athletes
Alpha-crystallin A chain levels
Alpha-endosulfine levels
alpha-Fetoprotein levels
Alpha-hemoglobin-stabilizing protein levels
Alpha-hydroxyisocaproate levels in elite athletes
Alpha-hydroxyisovalerate levels
Alpha-hydroxyisovalerate levels in elite athletes
Alpha-internexin levels
Alpha-ketoglutarate levels
Alpha-ketoglutarate levels in elite athletes
Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 levels
Alpha-L-fucoside fucohydrolase level in Chronic kidney disease with hypertension and no diabetes (21384_2)
Alpha-L-iduronidase levels
Alpha-L-iduronidase levels (IDUA.3169.70.2)
Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 levels
Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 levels (ST6GALNAC1.7867.154.3)
Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 levels
Alpha-N-acetylglucosaminidase levels
Alpha-parvin levels
Alpha-soluble NSF attachment protein levels
Alpha-synuclein levels
Alpha-synuclein levels (SNCA.8458.111.3)
Alpha-taxilin levels
Alpha-tocopherol levels in elite athletes
Aluminium levels
Alzheimer disease (MTAG)
Alzheimer disease and age of onset
Alzheimer's disease
Alzheimer's disease (age of onset)
Alzheimer's disease (age of onset) (adjusted for APOE e4 carrier status)
Alzheimer's disease (age of onset) in APOE e4 non-carriers
Alzheimer's disease (APOE e4 interaction)
Alzheimer's disease (cognitive decline)
Alzheimer's disease (late onset)
Alzheimer's disease (onset between ages 58 and 79)
Alzheimer's disease (survival time)
Alzheimer's disease biomarkers
Alzheimer's disease in APOE e4- carriers
Alzheimer's disease in APOE e4+ carriers
Alzheimer's disease in hypertension-negative individuals
Alzheimer's disease in non-APOE e4 carriers
Alzheimer's disease or body fat percentage (pleiotropy)
Alzheimer's disease or diastolic blood pressure (pleiotropy)
Alzheimer's disease or educational attainment (pleiotropy)
Alzheimer's disease or family history of Alzheimer's disease
Alzheimer's disease or fasting glucose levels (pleiotropy)
Alzheimer's disease or fasting insulin levels (pleiotropy)
Alzheimer's disease or gastroesophageal reflux disease
Alzheimer's disease or gastroesophageal reflux disease and/or peptic ulcer disease
Alzheimer's disease or HDL levels (pleiotropy)
Alzheimer's disease or LDL levels (pleiotropy)
Alzheimer's disease or peptic ulcer disease
Alzheimer's disease or related dementias (adjusted for APOE E4 dosage)
Alzheimer's disease or systolic blood pressure (pleiotropy)
Alzheimer's disease or waist-hip ratio (pleiotropy)
Alzheimer's disease progression score
Alzheimer's disease with language domain impairment
Alzheimer's disease with memory domain impairment
Alzheimer's disease with multiple cognitive domain impairments
Alzheimer's disease with no specific cognitive domain impairment
Alzheimer's disease with visuospatial domain impairment
Alzheimer's disease, proxy Alzheimer's disease or related dementias
Alzheimer's disease, proxy Alzheimer's disease or related dementias (adjusted for APOE E4 dosage)
Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)
Ambidextrousness
Amblyopia
Ameloblastin levels (AMBN.6522.57.3)
Amiloride-sensitive amine oxidase [copper-containing] level in Chronic kidney disease with hypertension and no diabetes (15486_126)
Amiloride-sensitive amine oxidase [copper-containing] level in Chronic kidney disease with hypertension and no diabetes (6209_2)
Amiloride-sensitive amine oxidase [copper-containing] levels
Amino-terminal enhancer of split levels
Aminopeptidase B level in Chronic kidney disease with hypertension and no diabetes (12386_11)
Aminopeptidase B levels
Aminopeptidase N levels
AMP Kinase (alpha2beta2gamma1) levels
Amphiregulin levels
Amphoterin-induced protein 1 level in Chronic kidney disease with hypertension and no diabetes (20120_101)
Amphoterin-induced protein 2 levels
AMSH-like protease levels
Amygdala volume
Amygdala volume change rate
Amygdala volume change rate x age interaction (1df)
AmygNuclei lh volume Accessory-Basal-nucleus
AmygNuclei lh volume Central-nucleus
AmygNuclei lh volume Cortical-nucleus
AmygNuclei lh volume Medial-nucleus
AmygNuclei rh volume Accessory-Basal-nucleus
AmygNuclei rh volume Central-nucleus
AmygNuclei rh volume Cortical-nucleus
AmygNuclei rh volume Lateral-nucleus
AmygNuclei rh volume Medial-nucleus
AmygNuclei rh volume Paralaminar-nucleus
Amyloid (PET imaging) (24 month visit)(adjusted for APOE e4 dosage)
Amyloid (PET imaging) (baseline)
Amyloid (PET imaging) (baseline)(adjusted for APOE e4 dosage)
Amyloid A serum levels
Amyloid beta A4 precursor protein-binding family B member 1 level in Chronic kidney disease with hypertension and no diabetes (12822_34)
Amyloid beta A4 precursor protein-binding family B member 1 levels
Amyloid beta A4 precursor protein-binding family B member 2 levels
Amyloid beta A4 precursor protein-binding family B member 3 level in Chronic kidney disease with hypertension and no diabetes (12784_10)
Amyloid beta A4 precursor protein-binding family B member 3 levels
Amyloid beta A4 protein levels
Amyloid beta positivity in normal cognition
Amyloid-like protein 1 levels
Amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (age of onset)
Amyotrophic lateral sclerosis (C9orf72 mutation interaction)
Amyotrophic lateral sclerosis (sporadic)
Amyotrophic lateral sclerosis in C9orf72 mutation negative individuals
Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals
Amyotrophic lateral sclerosis or frontotemporal dementia
AN1-type zinc finger protein 1 levels
AN1-type zinc finger protein 2B level in Chronic kidney disease with hypertension and no diabetes (23319_6)
AN1-type zinc finger protein 5 levels
An181 abundance in stool
Anaphase-promoting complex subunit 7 levels
Anaphase-promoting complex subunit 7 levels (ANAPC7.11690.47.3)
Andro steroid monosulfate (1) levels
Andro steroid monosulfate C19H28O6S (1) levels
Andro steroid monosulfate C19H28O6S (1) levels in elite athletes
Androgen levels
Androgenetic alopecia
Android fat/gynoid fat ratio
Androstenediol (3alpha, 17alpha) monosulfate (2) levels
Androstenediol (3alpha, 17alpha) monosulfate (2) levels in elite athletes
Androstenediol (3alpha, 17alpha) monosulfate (3) levels
Androstenediol (3alpha, 17alpha) monosulfate (3) levels in elite athletes
Androstenediol (3beta,17beta) disulfate (1) levels
Androstenediol (3beta,17beta) disulfate (1) levels in elite athletes
Androstenediol (3beta,17beta) disulfate (2) levels
Androstenediol (3beta,17beta) disulfate (2) levels in elite athletes
Androstenediol (3beta,17beta) monosulfate (1) levels
Androstenediol (3beta,17beta) monosulfate (1) levels in elite athletes
Androstenediol (3beta,17beta) monosulfate (2) levels
Androstenediol levels
Androstenedione levels
Androsterone glucuronide (X-22379) levels
Androsterone glucuronide levels
Androsterone sulfate levels
Androsterone sulfate levels in elite athletes
Androsterone sulfate-to-4-androsten-3beta,17beta-diol disulfate 2 ratio
Androsterone sulfate-to-epiandrosterone sulfate ratio
Anger
Angina pectoris
Angioedema in response to angiotensin-converting enzyme inhibitor and/or angiotensin receptor blocker
Angiogenic factor with G patch and FHA domains 1 levels
Angiogenin levels
Angiopoietin-1 receptor levels
Angiopoietin-1 receptor, soluble levels
Angiopoietin-2 levels
Angiopoietin-related protein 1 levels
Angiopoietin-related protein 1 levels (ANGPTL1.9092.33.3)
Angiopoietin-related protein 3 levels
Angiopoietin-related protein 4 levels
Angiopoietin-related protein 7 levels
Angiostatin levels
Angiotensin-converting enzyme 2 levels
Angiotensin-converting enzyme activity
Angiotensin-converting enzyme inhibitor intolerance
Angiotensin-converting enzyme level in Chronic kidney disease with hypertension and no diabetes (10714_7)
Angiotensin-converting enzyme levels
Angiotensinogen levels
Aniseed liking
Ankle injury
Ankle-brachial index
Ankylosing spondylitis
Ankyrin repeat and SOCS box protein 13 level in Chronic kidney disease with hypertension and no diabetes (21234_7)
Ankyrin repeat and SOCS box protein 9 levels
Ankyrin repeat domain-containing protein 1 levels
Ankyrin repeat domain-containing protein 27 levels
Ankyrin-2 levels
Annexin A10 levels
Annexin A10 levels (ANXA10.13605.16.3)
Annexin A11 levels
Annexin A13 levels
Annexin A2 levels
Annexin A4 levels
Annexin A5 levels
Annexin A6 levels
Annexin A7 levels
Annexin A8 levels
Annualised percent change of cerebrospinal fluid AB1-42 levels
Anorexia nervosa
Anorexia nervosa vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS))
Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)
Anosmin-1 levels
Anterior chamber depth
Anterior cruciate ligament rupture
Anterior gradient protein 3 levels
Anterior thalamic nuclei volume
Anterior thigh muscle fat infiltration percentage
Anterior thigh muscle volume
Anthracycline-induced cardiotoxicity in childhood cancer
Anthracycline-induced cardiotoxicity in early breast cancer
Anthrax toxin receptor 2 levels
Anthropometric traits
Anthropometric traits (multi-trait analysis)
Anti-anoctamin 2 antibody levels
Anti-chlamydia trachomatis IgG seropositivity
Anti-drug antibodies in autoimmune disease (time to event)
Anti-herpes simplex virus 2 IgG seropositivity
Anti-human herpes virus 6 IE1A IgG seropositivity
Anti-influenza subtype H1N1 IgG levels
Anti-influenza subtype H3N2 IgG levels
Anti-JC polyomavirus IgG seropositivity
Anti-measles virus IgG levels
Anti-Merkel cell polyomavirus IgG seropositivity
Anti-Mullerian hormone levels
Anti-Mullerian hormone levels in pre-menopausal women of late reproductive age
Anti-N-methyl-D-aspartate receptor encephalitis
Anti-polyomavirus 2 IgG seropositivity
Anti-saccade response
Anti-thyroid peroxidase (TPOAb) and anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis
Anti-thyroid peroxidase (TPOAb) levels in Hashimoto's thyroiditis
Anti-Toxoplasma gondii IgG levels
Anti-Toxoplasma gondii IgG seropositivity
Antibacterial protein LL-37 levels
Antibody level in response to infection
Antibody status in Tripanosoma cruzi seropositivity
Anticoagulant levels
Antidepressant treatment resistance (number of drugs prescribed)
Antineutrophil cytoplasmic antibody-associated vasculitis
antipsychotic drug dosage in schizophrenia or schizoaffective disorder
Antipsychotic drug-induced QTc interval change in schizophrenia
Antipsychotic drug-induced QTc interval prolongation
Antipsychotic drug-induced weight gain
Antipsychotic drug-induced weight gain (time interaction)
Antipsychotic drug-induced weight gain in schizophrenia
Antipsychotic drug-induced weight gain in schizophrenia or autism
Antipsychotic-induced metabolic syndrome in schizophrenia
Antisaccade task score
Anxiety
Anxiety and major depressive disorder
Anxiety and stress-related disorders
Anxiety disorder
Anxiety disorder (factor score)
Anxiety in major depressive disorder
Anxiety severity x hours spent watching television interaction
Anxiety severity x playing computer games interaction
Anxiety x maternal smoking during pregnancy interaction
Anxiety/tension (special factor of neuroticism)
Anxious temperament
Aortic aneurysm
Aortic root size
Aortic valve stenosis
AP-2 complex subunit alpha-2 levels
AP-4 complex subunit mu-1 levels (AP4M1.10076.1.3)
aparc-a2009s lh area G-cingul-Post-ventral
aparc-a2009s lh area G-cuneus
aparc-a2009s lh area G-oc-temp-med-Lingual
aparc-a2009s lh area S-calcarine
aparc-a2009s lh area S-central
aparc-a2009s lh area S-collat-transv-ant
aparc-a2009s lh area S-orbital-med-olfact
aparc-a2009s lh area S-subparietal
aparc-a2009s lh area S-temporal-sup
aparc-a2009s lh thickness G-cuneus
aparc-a2009s lh thickness Pole-occipital
aparc-a2009s lh volume G-cuneus
aparc-a2009s lh volume G-oc-temp-med-Lingual
aparc-a2009s lh volume S-calcarine
aparc-a2009s lh volume S-circular-insula-sup
aparc-a2009s lh volume S-subparietal
aparc-a2009s rh area G-cingul-Post-ventral
aparc-a2009s rh area G-cuneus
aparc-a2009s rh area G-oc-temp-lat-fusifor
aparc-a2009s rh area G-oc-temp-med-Lingual
aparc-a2009s rh area G-pariet-inf-Angular
aparc-a2009s rh area G-pariet-inf-Supramar
aparc-a2009s rh area G-precentral
aparc-a2009s rh area G-precuneus
aparc-a2009s rh area S-calcarine
aparc-a2009s rh thickness G-cuneus
aparc-a2009s rh thickness G-oc-temp-med-Lingual
aparc-a2009s rh thickness Pole-occipital
aparc-a2009s rh volume G-cuneus
aparc-a2009s rh volume G-precuneus
aparc-a2009s rh volume S-calcarine
aparc-a2009s rh volume S-collat-transv-ant
aparc-a2009s rh volume S-oc-middle+Lunatus
aparc-a2009s rh volume S-postcentral
aparc-Desikan lh area cuneus
aparc-Desikan lh area lateraloccipital
aparc-Desikan lh area lingual
aparc-Desikan lh area parstriangularis
aparc-Desikan lh area pericalcarine
aparc-Desikan lh area precuneus
aparc-Desikan lh thickness cuneus
aparc-Desikan lh thickness GlobalMeanThickness
aparc-Desikan lh thickness inferiortemporal
aparc-Desikan lh thickness lateraloccipital
aparc-Desikan lh thickness paracentral
aparc-Desikan lh thickness precentral
aparc-Desikan lh volume cuneus
aparc-Desikan lh volume lateraloccipital
aparc-Desikan lh volume lingual
aparc-Desikan lh volume pericalcarine
aparc-Desikan lh volume precuneus
aparc-Desikan rh area cuneus
aparc-Desikan rh area fusiform
aparc-Desikan rh area inferiorparietal
aparc-Desikan rh area isthmuscingulate
aparc-Desikan rh area lingual
aparc-Desikan rh area pericalcarine
aparc-Desikan rh area precentral
aparc-Desikan rh area precuneus
aparc-Desikan rh area supramarginal
aparc-Desikan rh thickness cuneus
aparc-Desikan rh thickness GlobalMeanThickness
aparc-Desikan rh thickness lateraloccipital
aparc-Desikan rh thickness lingual
aparc-Desikan rh thickness paracentral
aparc-Desikan rh thickness pericalcarine
aparc-Desikan rh thickness transversetemporal
aparc-Desikan rh volume cuneus
aparc-Desikan rh volume lingual
aparc-Desikan rh volume pericalcarine
aparc-Desikan rh volume precuneus
aparc-Desikan rh volume supramarginal
aparc-DKTatlas lh area cuneus
aparc-DKTatlas lh area entorhinal
aparc-DKTatlas lh area lateraloccipital
aparc-DKTatlas lh area lingual
aparc-DKTatlas lh area pericalcarine
aparc-DKTatlas lh area precuneus
aparc-DKTatlas lh thickness cuneus
aparc-DKTatlas lh thickness lateraloccipital
aparc-DKTatlas lh thickness paracentral
aparc-DKTatlas lh thickness precentral
aparc-DKTatlas lh volume cuneus
aparc-DKTatlas lh volume lateraloccipital
aparc-DKTatlas lh volume lingual
aparc-DKTatlas lh volume pericalcarine
aparc-DKTatlas lh volume precuneus
aparc-DKTatlas rh area cuneus
aparc-DKTatlas rh area fusiform
aparc-DKTatlas rh area inferiorparietal
aparc-DKTatlas rh area insula
aparc-DKTatlas rh area lingual
aparc-DKTatlas rh area pericalcarine
aparc-DKTatlas rh area precuneus
aparc-DKTatlas rh area supramarginal
aparc-DKTatlas rh thickness cuneus
aparc-DKTatlas rh thickness lateraloccipital
aparc-DKTatlas rh thickness lingual
aparc-DKTatlas rh thickness paracentral
aparc-DKTatlas rh thickness pericalcarine
aparc-DKTatlas rh thickness transversetemporal
aparc-DKTatlas rh volume cuneus
aparc-DKTatlas rh volume lingual
aparc-DKTatlas rh volume pericalcarine
aparc-DKTatlas rh volume precuneus
aparc-DKTatlas rh volume supramarginal
aparc-pial lh area cuneus
aparc-pial lh area lateraloccipital
aparc-pial lh area lingual
aparc-pial lh area pericalcarine
aparc-pial lh area precuneus
aparc-pial rh area cuneus
aparc-pial rh area fusiform
aparc-pial rh area inferiorparietal
aparc-pial rh area lateralorbitofrontal
aparc-pial rh area lingual
aparc-pial rh area pericalcarine
aparc-pial rh area precuneus
aparc-pial rh area superiorparietal
aparc-pial rh area supramarginal
aparc-pial rh area TotalSurface
Apelin levels
Apolipoprotein A-I levels
Apolipoprotein A-II level in Chronic kidney disease with hypertension and no diabetes (7127_3)
Apolipoprotein A-II levels
Apolipoprotein A-IV levels
Apolipoprotein A-V levels
Apolipoprotein A-V levels (APOA5.12908.15.3)
Apolipoprotein A1 levels
Apolipoprotein A1 levels (UKB data field 23440)
Apolipoprotein B levels
Apolipoprotein B levels (UKB data field 23439)
Apolipoprotein B to apolipoprotein A1 ratio (UKB data field 23441)
Apolipoprotein C-II levels
Apolipoprotein C-III levels
Apolipoprotein D level in Chronic kidney disease with hypertension and no diabetes (4712_28)
Apolipoprotein D levels
Apolipoprotein E levels
Apolipoprotein F levels
Apolipoprotein L1 level in Chronic kidney disease with hypertension and no diabetes (11510_31)
Apolipoprotein L1 level in Chronic kidney disease with hypertension and no diabetes (11510_51)
Apolipoprotein L1 levels
Apolipoprotein L1 levels (APOL1.9506.10.3)
Apolipoprotein L3 levels
Apolipoprotein Levels
Apolipoprotein M levels (APOM.10445.20.3)
Apoptosis-inducing factor 1, mitochondrial levels (AIFM1.13424.51.3)
Appendicitis
Appendicular lean mass
Appetite-regulating hormone levels
Apple juice liking
Aprataxin levels
AR-C124910XX levels in individuals with acute coronary syndromes treated with ticagrelor
Arabinose levels in elite athletes
Arabitol/xylitol levels
Arabonate/xylonate levels
Arabonate/xylonate levels in elite athletes
Arachidate (20:0) levels in elite athletes
Arachidonate (20:4n6) levels
Arachidonate (20:4n6) levels in elite athletes
Arachidonate 20:4n6-to-dihomo-linolenate 20:3n3 or n6 ratio
Arachidonoylcarnitine (C20:4) levels
Arachidonoylcarnitine (C20:4) levels in elite athletes
Arachidonoylcholine levels
Arachidonoylcholine levels in elite athletes
Arachidoylcarnitine (C20) levels
Area under the curve of insulin levels
Arecaidine levels
Arf-GAP domain and FG repeat-containing protein 1 levels
Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2 levels
Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3 levels
Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 level in Chronic kidney disease with hypertension and no diabetes (13518_5)
Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 levels
Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 levels (ASAP2.13518.5.3)
Arfaptin-1 levels
Arfaptin-1 levels (ARFIP1.13488.3.3)
Arfaptin-2 levels
Arginase-2, mitochondrial levels
Argininate levels
Argininate levels in elite athletes
Arginine levels
Arginine levels in elite athletes
Arginine-hydroxylase NDUFAF5, mitochondrial level in Chronic kidney disease with hypertension and no diabetes (22509_9)
Argininosuccinate lyase levels
Armadillo repeat-containing protein 10 levels
Aromatic-L-amino-acid decarboxylase levels
Arrhythmia
Arsenic metabolism
Arsenite methyltransferase levels
Arterial stiffness
Arterial stiffness (carotid-femoral pulse wave velocity)
Arterial stiffness index
Arthritis (juvenile idiopathic)
Aryl hydrocarbon receptor nuclear translocator level in Chronic kidney disease with hypertension and no diabetes (21951_32)
Arylamine N-acetyltransferase 1 levels
Arylamine N-acetyltransferase 1 levels (NAT1.12632.14.3)
Arylsulfatase A levels
Arylsulfatase B level in Chronic kidney disease with hypertension and no diabetes (3172_28)
Arylsulfatase B levels
Arylsulfatase B levels (ARSB.3172.28.2)
Arylsulfatase K levels
Arylsulfatase K levels (ARSK.8269.327.3)
Ascending aorta diameter
Ascending aorta distensibility
Ascending aorta distensibility (MTAG)
Ascending aorta maximum area
Ascending aorta maximum area (MTAG)
Ascending aorta minimum area
Ascending aorta strain
Ascending thoracic aortic diameter
Ascorbic acid 3-sulfate (X-12206) levels
aseg global intensity 4th-Ventricle
aseg global intensity WM-hypointensities
aseg global volume 3rd-Ventricle
aseg global volume 4th-Ventricle
aseg global volume Brain-Stem
aseg global volume BrainSeg
aseg global volume BrainSegNotVent
aseg global volume BrainSegNotVentSurf
aseg global volume CC-Anterior
aseg global volume CC-Central
aseg global volume SupraTentorial
aseg global volume TotalGray
aseg global volume VentricleChoroid
aseg global volume WM-hypointensities
aseg global volume-ratio BrainSegVol-to-eTIV
aseg lh intensity Accumbens-area
aseg lh intensity Caudate
aseg lh intensity Cerebellum-Cortex
aseg lh intensity Pallidum
aseg lh intensity Putamen
aseg lh intensity VentralDC
aseg lh volume Accumbens-area
aseg lh volume Caudate
aseg lh volume Cerebellum-Cortex
aseg lh volume Cerebellum-White-Matter
aseg lh volume CerebralWhiteMatter
aseg lh volume choroid-plexus
aseg lh volume Hippocampus
aseg lh volume Inf-Lat-Vent
aseg lh volume Lateral-Ventricle
aseg lh volume Pallidum
aseg lh volume Putamen
aseg lh volume VentralDC
aseg rh intensity Accumbens-area
aseg rh intensity Caudate
aseg rh intensity Cerebellum-Cortex
aseg rh intensity Pallidum
aseg rh intensity Putamen
aseg rh volume Caudate
aseg rh volume Cerebellum-Cortex
aseg rh volume Cerebellum-White-Matter
aseg rh volume CerebralWhiteMatter
aseg rh volume choroid-plexus
aseg rh volume Hippocampus
aseg rh volume Lateral-Ventricle
aseg rh volume Pallidum
aseg rh volume Putamen
aseg rh volume VentralDC
Aseptic loosening in total joint arthroplasty
Asialoglycoprotein receptor 1 levels
Asparaginase hypersensitivity in acute lymphoblastic leukemia
Asparagine levels
Asparagine levels in elite athletes
Aspartate aminotransferase levels
Aspartate aminotransferase levels in excessive alcohol consumption
Aspartate aminotransferase levels in low alcohol consumption
Aspartate aminotransferase levels in low dose methotrexate treatment
Aspartate aminotransferase levels in non-alcoholic fatty liver disease
Aspartate aminotransferase platelet ratio index in high alcohol intake
Aspartate aminotransferase to alanine aminotransferase ratio
Aspartate aminotransferase, cytoplasmic levels
Aspartate aminotransferase, cytoplasmic levels (GOT1.4912.17.1)
Aspartate levels
Aspartate levels in elite athletes
Aspartate transaminase levels in high alcohol intake
Aspartate--tRNA ligase, cytoplasmic levels
Aspartoacylase levels
Aspartyl/asparaginyl beta-hydroxylase levels
Aspartylphenylalanine levels
Aspartylphenylalanine-to-X-14450--phenylalanylleucine ratio
Asperger disorder
Aspirin hydrolysis (plasma)
Asporin levels
Asporin levels (ASPN.6451.64.3)
Asthma
Asthma (adult onset)
Asthma (age of onset)
Asthma (bronchodilator response)
Asthma (childhood onset)
Asthma (moderate or severe)
Asthma (sex interaction)
Asthma (time to childhood onset) x early life tobacco smoke interaction
Asthma (time to event)
Asthma (time to onset)
Asthma (toluene diisocyanate-induced)
Asthma and anxiety disorder
Asthma and attention deficit hyperactivity disorder
Asthma and cardiovascular disease
Asthma and eczema
Asthma and hay fever
Asthma and major depressive disorder
Asthma control x inhaled corticosteroid treatment interaction (2df)
Asthma exacerbations
Asthma exacerbations in inhaled corticosteroid treatment
Asthma in any disease
Asthma in cardiovascular disease
Asthma in gastrointestinal disease
Asthma in lymphoma
Asthma onset (childhood vs adult)
Asthma or allergic disease (pleiotropy)
Asthma or chronic obstructive pulmonary disease
Asthma or chronic obstructive pulmonary disease (pleiotropy)
Asthma or COVID-19 (pleiotropy)
Asthma with severe exacerbations
Asthma x air pollution interaction (2df)
Asthma x Hispanic interaction (2df)
Asthma-chronic obstructive pulmonary disease overlap syndrome
Asthma-COPD overlap syndrome
Asymmetrical dimethylarginine levels
Asymmetrical dimethylarginine levels in osteoarthritis
Asymptomatic COVID-19 infection
Asymptomatic hyperuricaemia (age <50)
Asymptomatic hyperuricaemia (age >=50)
AT-rich interactive domain-containing protein 3A levels
Ataxin-3 levels
Atopic asthma
Atopic dermatitis
Atopic dermatitis (moderate to severe)
Atopic march
Atopy
Atopy in childhood asthma x sex interaction
Atorvastatin-induced myalgia
Atorvastatin-induced myopathy
ATP synthase subunit beta, mitochondrial levels
ATP synthase subunit f, mitochondrial levels
ATP-dependent 6-phosphofructokinase, muscle type levels
ATP-dependent Clp protease proteolytic subunit, mitochondrial levels
ATP-dependent DNA helicase Q1 levels
ATP-dependent RNA helicase A levels
ATP-dependent RNA helicase DDX19A levels
ATP-dependent RNA helicase DDX19B levels
ATP-dependent RNA helicase DHX8 levels
ATP-dependent RNA helicase DHX8 levels (DHX8.11601.26.3)
ATPase ASNA1 levels
ATPase family AAA domain-containing protein 1 levels
Atrial fibrillation
Atrial fibrillation (MTAG)
Atrial fibrillation/atrial flutter
Atrioventricular conduction
Attention deficit hyperactivity disorder
Attention deficit hyperactivity disorder (childhood)
Attention deficit hyperactivity disorder (combined symptoms)
Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
Attention deficit hyperactivity disorder (inattention symptoms)
Attention deficit hyperactivity disorder (MTAG)
Attention deficit hyperactivity disorder (persistent)
Attention deficit hyperactivity disorder (time to onset)
Attention deficit hyperactivity disorder and conduct disorder
Attention deficit hyperactivity disorder or autism spectrum disorder (pleiotropy)
Attention deficit hyperactivity disorder or autism spectrum disorder or intelligence (pleiotropy)
Attention deficit hyperactivity disorder or cannabis use
Attention deficit hyperactivity disorder or intracranial volume (pleiotropy)
Attention deficit hyperactivity disorder symptom score
Attention deficit hyperactivity disorder symptoms (maternal expressed emotions interaction)
Attention function in attention deficit hyperactive disorder
Attractin levels
Atypical femoral fracture in phosphonate treatment
AUC of simvastatin acid
Aurora kinase B levels
Aurora kinase B levels (AURKB.3346.72.2)
Autism
Autism and major depressive disorder (MTAG)
Autism and schizophrenia (MTAG)
Autism spectrum disorder
Autism spectrum disorder (MTAG)
Autism spectrum disorder or schizophrenia
Autism spectrum disorder-related traits
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
Autism spectrum disorders (social interaction)
Autoimmune hepatitis type-1
Autoimmune neurological syndromes with anti-GAD65 autoantibodies
Autoimmune thyroid disease
Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)
Autoimmune traits
Autoimmune traits (pleiotropy)
Automobile speeding propensity
Average diameter for HDL particles
Average diameter for HDL particles (UKB data field 23433)
Average diameter for LDL particles
Average diameter for LDL particles (UKB data field 23432)
Average diameter for VLDL particles
Average diameter for VLDL particles (UKB data field 23431)
Average oral glucocorticoid dose in mepolizumab-treated eosinophilic granulomatosis with polyangiitis
Avocado liking
Axial length
Axial length or spherical error (univariate decomposition analysis)
Axin interactor, dorsalization-associated protein levels
Axin-2 levels
Axin-2 levels (AXIN2.8429.16.3)
Ayurvedic kapha prakriti specific rheumatoid arthritis
Ayurvedic pitta prakriti specific rheumatoid arthritis
Ayurvedic vata prakriti specific rheumatoid arthritis
Azelate (nonanedioate) levels in elite athletes
Azinphos methyl levels
Azurocidin levels
B cell %CD3- lymphocyte
B cell %lymphocyte
B cell acute lymphoblastic leukaemia (hyperdiploid negative)
B cell acute lymphoblastic leukaemia (normal cytogenetics)
B cell acute lymphoblastic leukaemia (Philadelphia chromosome negative)
B cell lymphocyte profile difference (7 days post influenza vaccination)
B cell lymphocyte profile difference (90 days post influenza vaccination)
B cell non-Hodgkin lymphoma
B melanoma antigen 2 levels
B melanoma antigen 3 levels
B- and T-lymphocyte attenuator level in Chronic kidney disease with hypertension and no diabetes (16308_14)
B- and T-lymphocyte attenuator levels
B-cell acute lymphoblastic leukaemia
B-cell antigen receptor complex-associated protein alpha chain levels
B-cell differentiation antigen CD72 levels
B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)
B-cell receptor CD22 levels (CD22.2891.1.3)
B-cell telomere length
B-type natriuretic peptide levels
B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio
B6 vitamer levels (multivariate analysis)
BA-exvivo lh area BA45
BA-exvivo lh area entorhinal
BA-exvivo lh area V1
BA-exvivo lh area V2
BA-exvivo lh thickness BA4a
BA-exvivo lh thickness BA4p
BA-exvivo lh thickness V2
BA-exvivo lh volume entorhinal
BA-exvivo lh volume V1
BA-exvivo lh volume V2
BA-exvivo rh area BA3b
BA-exvivo rh area entorhinal
BA-exvivo rh area perirhinal
BA-exvivo rh area V1
BA-exvivo rh area V2
BA-exvivo rh thickness BA4a
BA-exvivo rh thickness V1
BA-exvivo rh thickness V2
BA-exvivo rh volume BA3b
BA-exvivo rh volume V1
BA-exvivo rh volume V2
Bacillaceae A abundance in stool
Bacillales A abundance in stool
Bacilli A abundance in stool
Bacillus U abundance in stool
Back pain
Bacteremia
Bacterial meningitis
Bactericidal permeability-increasing protein levels
Bactericidal permeability-increasing protein levels (BPI.4126.22.1)
Bacteroides A abundance in stool
Bacteroides A plebeius A abundance in stool
Bacteroides clarus abundance in stool
Bacteroides faecis abundance in stool
Baculoviral IAP repeat-containing protein 2 levels
Baculoviral IAP repeat-containing protein 5 levels
Baculoviral IAP repeat-containing protein 7 Isoform beta levels
Baculoviral IAP repeat-containing protein 7 levels
BAFF-R on B cell
BAFF-R on CD20- B cell
BAFF-R on CD20- CD38- B cell
BAFF-R on CD24+ CD27+ B cell
BAFF-R on IgD- CD24- B cell
BAFF-R on IgD- CD27- B cell
BAFF-R on IgD- CD38- B cell
BAFF-R on IgD- CD38+ B cell
BAFF-R on IgD- CD38dim B cell
BAFF-R on IgD+ B cell
BAFF-R on IgD+ CD24- B cell
BAFF-R on IgD+ CD24+ B cell
BAFF-R on IgD+ CD38- B cell
BAFF-R on IgD+ CD38+ B cell
BAFF-R on IgD+ CD38dim B cell
BAFF-R on memory B cell
BAFF-R on naive-mature B cell
BAFF-R on switched memory B cell
BAFF-R on transitional B cell
BAFF-R on unswitched memory B cell
BAG family molecular chaperone regulator 2 levels
BAG family molecular chaperone regulator 3 levels
BAG family molecular chaperone regulator 4 levels
BAG family molecular chaperone regulator 5 levels
Baked/steamed fish liking
Balding type 1
Band 4.1-like protein 1 levels
Barrett's esophagus
Barrett's esophagus or Esophageal adenocarcinoma
Barrett's esophagus or esophageal adenocarcinoma x sex interaction (2df test)
Barrett's esophagus x BMI interaction
Barrett's esophagus x pack-years of smoking exposure interaction
Basal cell carcinoma
Basal cell carcinoma (MTAG)
Basal metabolic rate
Basal metabolic rate variance
Basic leucine zipper transcriptional factor ATF-like 3 levels
Basic leucine zipper transcriptional factor ATF-like 3 levels (BATF3.8858.21.3)
Basophil %CD33dim HLA DR- CD66b-
Basophil Absolute Count
Basophil count
Basophil percentage of granulocytes
Basophil percentage of white cells
BBQ/grilled meat liking
Bcl-2-like protein 1 level in Chronic kidney disease with hypertension and no diabetes (4423_77)
Bcl-2-like protein 10 levels
Bcl-2-like protein 11 levels
Bcl2-associated agonist of cell death levels
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 levels
BDNF/NT-3 growth factors receptor levels
Beans liking
Beard thickness
Beef consumption
Beef consumption (UKB data field 1369)
Beef/steak liking
Beer or cider consumption (glasses per month) (UKB data field 1578, 4420)
Beetroot liking
Behavioral disturbance or psychiatric symptoms and prion disease
Behavioral disturbance or psychiatric symptoms in prion disease
Behavioural changes in frontotemporal lobe dementia
Behavioural disinhibition (generation interaction)
Behcet's disease
Behenoyl dihydrosphingomyelin (d18:0/22:0) levels
Behenoyl dihydrosphingomyelin (d18:0/22:0) levels in elite athletes
Behenoyl sphingomyelin (d18:1/22:0) levels in elite athletes
Behenoylcarnitine (C22) levels
Bell's palsy
Benign childhood epilepsy with centro-temporal spikes
Benign prostatic hyperplasia and lower urinary tract symptoms
Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)
Benign prostatic hyperplasia and/or lower urinary tract symptoms
Benzoate levels in elite athletes
BET1-like protein levels
Beta 1 electroencephalogram power
Beta blocker survival benefit in heart failure with reduced ejection fraction (time to all cause mortality x beta blocker interaction)
Beta thalassemia/hemoglobin E disease
Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 level in Chronic kidney disease with hypertension and no diabetes (10842_7)
Beta-1,3-galactosyltransferase 2 levels
Beta-1,3-glucosyltransferase levels
Beta-1,4-galactosyltransferase 1 levels
Beta-1,4-galactosyltransferase 1 levels (B4GALT1.13381.49.3)
Beta-1,4-galactosyltransferase 2 levels
Beta-1,4-galactosyltransferase 2 levels (B4GALT2.9595.11.3)
Beta-1,4-galactosyltransferase 6 levels
Beta-1,4-galactosyltransferase 7 levels
Beta-1,4-glucuronyltransferase 1 levels (B3GNT1.8259.25.3)
Beta-2 microglubulin plasma levels
Beta-2-microglobulin levels
beta-adrenergic receptor kinase 1 levels
Beta-Ala-His dipeptidase levels
Beta-alanine levels in elite athletes
Beta-casein levels
Beta-citrylglutamate levels
Beta-citrylglutamate levels in elite athletes
Beta-crystallin B1 levels
Beta-crystallin B2 levels (CRYBB2.10000.28.3)
Beta-crystallin S levels
Beta-defensin 1 levels
Beta-defensin 1 levels (DEFB1.6629.3.3)
Beta-defensin 104 levels
Beta-defensin 105 levels (DEFB105A.10962.46.3)
Beta-defensin 106 levels
Beta-defensin 107 levels
Beta-defensin 108B levels
Beta-defensin 110 levels
Beta-defensin 113 levels
Beta-defensin 119 levels
Beta-defensin 119 levels (DEFB119.13455.10.3)
Beta-defensin 128 levels
Beta-defensin 129 levels
Beta-defensin 136 levels
Beta-defensin 4A levels
Beta-endorphin levels
Beta-endorphin levels (POMC.2558.51.3)
Beta-enolase levels
Beta-glucuronidase levels
Beta-guanidinopropanoate levels in elite athletes
Beta-hexosaminidase subunit beta levels
Beta-hydroxyisovalerate levels
Beta-hydroxyisovalerate levels in elite athletes
Beta-hydroxyisovaleroylcarnitine levels
Beta-klotho level in Chronic kidney disease with hypertension and no diabetes (19557_3)
Beta-klotho levels
Beta-mannosidase levels
Beta-mannosidase levels (MANBA.6382.17.3)
Beta-microseminoprotein level in Chronic kidney disease with hypertension and no diabetes (10620_21)
Beta-microseminoprotein levels
Beta-microseminoprotein levels (MSMB.10620.21.3)
beta-nerve growth factor levels
Beta-sarcoglycan levels (SGCB.7034.4.3)
Beta-sitosterol levels in elite athletes
Beta-soluble NSF attachment protein levels
Beta-soluble NSF attachment protein levels (NAPB.12655.30.3)
Beta-thromboglobulin levels
Beta-trace protein levels
Beta-ureidopropionase level in Chronic kidney disease with hypertension and no diabetes (22091_14)
Betacellulin levels
Betaine levels
Betaine levels in elite athletes
Betaine levels in individuals undergoing cardiac evaluation
Betaine-to-pyroglutamine ratio
Betonicine levels in elite athletes
Bevacizumab-induced composite toxicity (either hypertension or proteinuria)
Bevacizumab-induced hypertension
Bevacizumab-induced proteinuria
Bicuspid aortic valve
Bifidobacteriaceae abundance in stool
Bifidobacterium abundance in stool
Bifidobacterium adolescentis abundance in stool
Bifidobacterium angulatum abundance in stool
Bifidobacterium bifidum abundance in stool
Bifidobacterium breve abundance in stool
Bifidobacterium catenulatum abundance in stool
Bifidobacterium infantis abundance in stool
Bifidobacterium kashiwanohense abundance in stool
Bifidobacterium longum abundance in stool
Bifidobacterium pseudocatenulatum abundance in stool
Bifidobacterium ruminantium abundance in stool
Bifunctional 3-phosphoadenosine 5-phosphosulfate synthase 1 levels
Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 levels
Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 levels
Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial levels
Bifunctional polynucleotide phosphatase/kinase levels
Biglycan levels
Bilateral cleft lip
Bilateral cleft lip and palate
Bile acid(DCA)_[M-H]1- levels
Bile salt sulfotransferase levels
Bile salt-activated lipase levels
Bile salt-activated lipase levels (CEL.9796.4.3)
Biliary atresia
Bilirubin (E,E) levels
Bilirubin (E,Z or Z,E) levels
Bilirubin (z,z) levels
Bilirubin (Z,Z) levels in elite athletes
Bilirubin concentration in dolutegravir-treated HIV infection
Bilirubin degradation product, C16H18N2O5 (1) levels
Bilirubin degradation product, C16H18N2O5 (2) levels
Bilirubin degradation product, C16H18N2O5 (3) levels
Bilirubin degradation product, C16H18N2O5 (4) levels
Bilirubin degradation product, C17H18N2O4 (3) levels
Bilirubin degradation product, C17H20N2O5 (1) levels
Bilirubin degradation product, C17H20N2O5 (2) levels
Bilirubin levels
Bilirubin levels in chronic kidney disease
Bilirubin levels in extreme obesity
Bilirubin levels in tenofovir-treated HIV infection
Biliverdin levels
Biliverdin levels in chronic kidney disease
Biliverdin levels in elite athletes
Bin127 abundance in stool
Binge eating behaviour in bipolar disorder
Bioavailable testosterone levels
Biochemical measures
Biogenesis of lysosome-related organelles complex 1 subunit 5 levels
Biological age (BioAge)
Biological age (PhenoAge)
Biological sex
Biomedical quantitative traits
Biotinidase levels
Bipolar disorder
Bipolar disorder (age of onset less than 21) or attention deficit hyperactivity disorder
Bipolar disorder (age of onset and psychotic symptoms)
Bipolar disorder (body mass index interaction)
Bipolar disorder (early vs late onset)
Bipolar disorder (inflammation and infection response interaction)
Bipolar disorder (mania)
Bipolar disorder (MTAG)
Bipolar disorder and eating disorder
Bipolar disorder and schizophrenia
Bipolar disorder lithium response (categorical) or schizophrenia
Bipolar disorder lithium response (continuous) or schizophrenia
Bipolar disorder or attention deficit hyperactivity disorder
Bipolar disorder or body mass index
Bipolar disorder or major depressive disorder
Bipolar disorder or type 2 diabetes
Bipolar disorder type I vs bipolar disorder type II
Bipolar disorder vs ADHD (ordinary least squares (OLS))
Bipolar disorder vs anorexia nervosa (ordinary least squares (OLS))
Bipolar disorder vs autism spectrum disorder (ordinary least squares (OLS))
Bipolar disorder vs major depressive disorder (ordinary least squares (OLS))
Bipolar disorder vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS))
Bipolar disorder with mood-incongruent psychosis
Bipolar disorder x sex interaction
Bipolar I disorder
Bipolar II disorder
Birdshot chorioretinopathy
Birth length
Birth length (MTAG)
Birth weight
Birth weight (MTAG)
Birth year infant mortality rates
Bis(5-adenosyl)-triphosphatase levels
Bis(5-nucleosyl)-tetraphosphatase [asymmetrical] levels
Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical] level in Chronic kidney disease with hypertension and no diabetes (16583_8)
Bisoprolol clearance in non-ST elevation acute coronary syndrome
Bisphosphonate-associated atypical femoral fracture
Bisphosphonate-related osteonecrosis of the jaw
Bisphosphonate-related osteonecrosis of the jaw in cancer (i.v. bisphosphonate)
Bitter alcoholic beverage consumption
Bitter ale liking
Bitter beverage consumption
Bitter non-alcoholic beverage consumption
Bitter taste perception
Bitter taste perception (6-n-propylthiouracil) in obesity with metabolic syndrome
Bitter taste perception (multivariate analysis)
Bitter taste perception (phenylthiocarbamide) in obesity with metabolic syndrome
BK polyomavirus VP1 antibody levels
Black vs. blond hair color
Black vs. red hair color
Bladder cancer
Bladder cancer (smoking interaction)
Bladder cancer adjusted for industrial classification factors
Bladder cancer adjusted for occupational classification factors
Bladder cancer in selected industrial classification factors (Information and communications, Scientific research, professional and technical services, Government, except elsewhere classified)
Bladder cancer in selected industrial classification factors within Construction, Manufacturing, and Transport and Postal Services
Bladder cancer in selected occupational classification factor (security workers)
Blautia A sp900066355 abundance in stool
Bleomycin hydrolase levels
Blond vs non-blond hair color
Blond vs. brown hair color
Blond vs. brown/black hair color
Blood and toenail selenium levels
Blood cell traits (multivariate analysis)
Blood glucose levels
Blood metabolite levels
Blood osmolality (transformed sodium)
Blood pressure
Blood pressure (age interaction)
Blood pressure (anthropometric measures interaction)
Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)
Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)
Blood pressure (smoking interaction)
Blood pressure measurement (cold pressor test)
Blood pressure measurement (high sodium and potassium intervention)
Blood pressure measurement (high sodium intervention)
Blood pressure traits (multi-trait analysis)
Blood protein levels
Blood protein levels in cardiovascular risk
Blood sugar levels
Blood trace element (Cu levels)
Blood trace element (Se levels)
Blood trace element (Zn levels)
Blood urea nitrogen levels
Blue vs. brown eyes
Blue vs. green eyes
BMI (adjusted for smoking behaviour)
BMI (smoking interaction)
BMI (standard GWA)
BMI (weighted GWA)
BMI at 1 year old
BMI at 1.5 -2.5 years old interval
BMI at 1.5 years old
BMI at 2 years old
BMI at 3 months old
BMI at 3 years old
BMI at 5 years old
BMI at 6 months old
BMI at 6 weeks old
BMI at 7 years old
BMI at 8 months old
BMI at 8 years old
BMI at 8.5 - 9.5 years old interval
BMI at adiposity peak
BMI at adiposity rebound
BMI at adiposity rebound x sex interaction
BMI at birth
BMI in non-smokers
BMI in smokers
BMI x environmental factors (excluding physical activity) interaction
BMI x environmental factors (including physical activity) interaction
BMP and activin membrane-bound inhibitor homolog levels
BMP-binding endothelial regulator protein levels
Body composition (MOSTest)
Body composition traits
Body fat distribution (arm fat ratio)
Body fat distribution (leg fat ratio)
Body fat distribution (trunk fat ratio)
Body fat mass
Body fat percentage
Body fat percentage and fasting glucose (pairwise)
Body fat percentage and fasting insulin (pairwise)
Body fat percentage and HDL-C (pairwise)
Body fat percentage and LDL-C (pairwise)
Body fat percentage and triglycerides (pairwise)
Body fat percentage and type 2 diabetes (pairwise)
Body fat percentage or coronary artery disease (MTAG)
Body fat percentage or heart failure (MTAG)
Body fat percentage variance
Body mass (lean)
Body mass in chronic obstructive pulmonary disease
Body mass index
Body mass index (smoking years interaction)
Body mass index (adult)
Body mass index (age <50)
Body mass index (age interaction)
Body mass index (age>50)
Body mass index (aged 64-69 years)
Body mass index (change over time)
Body mass index (change over time) in cancer
Body mass index (change over time) in cancer or chronic obstructive pulmonary disease
Body mass index (change over time) in chronic obstructive pulmonary disease
Body mass index (change over time) in gastrointestinal cancer
Body mass index (change over time) in lung cancer
Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease
Body mass index (dietary energy interaction)
Body mass index (education interaction)
Body mass index (ever vs never smoking interaction)
Body mass index (joint analysis main effects and physical activity interaction)
Body mass index (joint analysis main effects and smoking interaction)
Body mass index (MTAG)
Body mass index (recreational physical activity interaction)
Body mass index (SNP x SNP interaction)
Body mass index and bone mineral density (pleiotropy)
Body mass index and cholesterol (psychopharmacological treatment)
Body mass index and coronary artery disease (pairwise)
Body mass index and diastolic blood pressure (bivariate analysis)
Body mass index and fasting glucose (pairwise)
Body mass index and fasting insulin (pairwise)
Body mass index and HDL-C (pairwise)
Body mass index and LDL-C (pairwise)
Body mass index and systole blood pressure (pairwise)
Body mass index and systolic blood pressure (bivariate analysis)
Body mass index and triglycerides (pairwise)
Body mass index and type 2 diabetes (pairwise)
Body mass index in asthmatics
Body mass index in childhood asthma
Body mass index in non-asthmatics
Body mass index in physically active individuals
Body mass index in physically inactive individuals
Body mass index in prediabetes
Body mass index variance
Body mass index x age interaction
body mass index x broccoli consumption interaction
body mass index x carrot consumption interaction
body mass index x pumpkin consumption interaction
Body mass index x sex x age interaction (4df test)
Body size at age 10
Body surface area
BolA-like protein 1 levels
BolA-like protein 2 levels
BolA-like protein 3 levels
Bone erosion in rheumatoid arthritis
Bone fracture in osteoporosis
Bone marrow proteoglycan levels
Bone marrow stromal antigen 2 levels
Bone mineral accretion in asthma (oral corticosteroid dose interaction)
Bone mineral content
Bone mineral density
Bone mineral density (femoral neck)
Bone mineral density (femoral neck) in inflammatory bowel disease
Bone mineral density (hip)
Bone mineral density (hip) and age at menarche
Bone mineral density (hip) and hip bone size
Bone mineral density (lumbar spine) in inflammatory bowel disease
Bone mineral density (paediatric, lower limb)
Bone mineral density (paediatric, skull)
Bone mineral density (paediatric, total body less head)
Bone mineral density (paediatric, upper limb)
Bone mineral density (spine)
Bone mineral density (spine) and age at menarche
Bone mineral density (total hip)
Bone mineral density (Ward's triangle area)
Bone mineral density at left femoral neck (model 1)
Bone mineral density at left intertrochanter (model 1)
Bone mineral density at left intertrochanter (model 2)
Bone mineral density at left total hip (model 1)
Bone mineral density at left total hip (model 2)
Bone mineral density at left trochanter (model 1)
Bone mineral density at left trochanter (model 2)
Bone mineral density at lumbar spine (model 1)
Bone mineral density at right femoral neck (model 2)
Bone mineral density at right total hip (model 1)
Bone mineral density at right total hip (model 2)
Bone mineral density at right trochanter (model 1)
Bone mineral density at right trochanter (model 2)
Bone mineral density change response to combined chemotherapy in acute lymphoblastic leukemia
Bone mineral density or leg lean mass (pleiotropy)
Bone mineral density or trunk lean mass (pleiotropy)
Bone mineral density x blood lead interaction in current smokers (2df test)
Bone morphogenetic protein 15 levels
Bone morphogenetic protein 3 levels
Bone morphogenetic protein 4 levels
Bone morphogenetic protein 6 levels
Bone morphogenetic protein 6 levels (BMP6.8459.10.3)
Bone morphogenetic protein 7 levels
Bone morphogenetic protein 7 levels (BMP7.2972.57.2)
Bone morphogenetic protein 8B levels
Bone morphogenetic protein receptor type-1B levels
Bone properties (heel)
Bone sialoprotein 2 levels
Bone sialoprotein 2 levels (IBSP.14023.84.3)
Bone stiffness index
Bone ultrasound measurement (broadband ultrasound attenuation)
Bone ultrasound measurement (velocity of sound)
Borderline personality disorder
Borderline personality disorder features
Bortezomib-induced peripheral neuropathy in multiple myeloma
BPI fold-containing family A member 1 levels
BPI fold-containing family A member 2 level in Chronic kidney disease with hypertension and no diabetes (5695_5)
BPI fold-containing family A member 2 levels
BPI fold-containing family B member 1 levels
BPI fold-containing family B member 1 levels (BPIFB1.11246.3.3)
Bradykinin, des-arg 9 levels
Brain age (difference between predicted and chronological age)
Brain amyloid deposition (PET imaging)
Brain asymmetrical skew (vertical)
Brain connectivity
Brain functional connectivity measurement (characteristic path length)
Brain functional connectivity measurement (global efficiency)
Brain functional connectivity measurement (strength limbic)
Brain functional connectivity measurement (strength salience)
Brain functional connectivity measurement (strength somatomotor)
Brain imaging
Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)
Brain imaging measurements
Brain imaging measurements (variance)
Brain lesion load
Brain morphology (min-P)
Brain morphology (MOSTest)
Brain region volumes
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node1)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node10)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node11)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node12)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node13)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node15)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node17)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node18)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node19)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node2)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node22)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node24)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node25)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node26)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node27)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node28)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node29)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node30)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node31)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node35)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node37)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node38)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node40)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node42)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node44)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node46)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node48)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node49)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node5)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node51)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node55)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node7)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node1)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node11)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node13)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node14)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node16)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node17)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node18)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node2)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node20)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node21)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node3)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node5)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node7)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node9)
Brain rsFMRI measurement (functional connectivity) (Net_Edge_ICA2)
Brain rsFMRI measurement (functional connectivity) (Net_Edge_ICA3)
Brain rsFMRI measurement (functional connectivity) (Net_Edge_ICA6)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair11_42)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair11_45)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair13_29)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair2_15)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair2_29)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair21_49)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair24_44)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair28_44)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair29_44)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair30_41)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair34_48)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair5_21)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair7_11)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair9_29)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair9_44)
Brain rsFMRI measurement (functional connectivity) (Net25_Pair10_11)
Brain rsFMRI measurement (functional connectivity) (Net25_Pair10_12)
Brain rsFMRI measurement (functional connectivity) (Net25_Pair11_12)
Brain rsFMRI measurement (functional connectivity) (Net25_Pair12_17)
Brain shape (segment 1)
Brain shape (segment 10)
Brain shape (segment 106)
Brain shape (segment 116)
Brain shape (segment 117)
Brain shape (segment 119)
Brain shape (segment 120)
Brain shape (segment 122)
Brain shape (segment 131)
Brain shape (segment 14)
Brain shape (segment 140)
Brain shape (segment 15)
Brain shape (segment 150)
Brain shape (segment 155)
Brain shape (segment 188)
Brain shape (segment 196)
Brain shape (segment 197)
Brain shape (segment 198)
Brain shape (segment 199)
Brain shape (segment 2)
Brain shape (segment 20)
Brain shape (segment 202)
Brain shape (segment 204)
Brain shape (segment 205)
Brain shape (segment 21)
Brain shape (segment 213)
Brain shape (segment 219)
Brain shape (segment 22)
Brain shape (segment 220)
Brain shape (segment 230)
Brain shape (segment 231)
Brain shape (segment 238)
Brain shape (segment 26)
Brain shape (segment 27)
Brain shape (segment 270)
Brain shape (segment 273)
Brain shape (segment 280)
Brain shape (segment 281)
Brain shape (segment 285)
Brain shape (segment 3)
Brain shape (segment 31)
Brain shape (segment 40)
Brain shape (segment 43)
Brain shape (segment 45)
Brain shape (segment 47)
Brain shape (segment 5)
Brain shape (segment 52)
Brain shape (segment 53)
Brain shape (segment 56)
Brain shape (segment 58)
Brain shape (segment 6)
Brain shape (segment 62)
Brain shape (segment 63)
Brain shape (segment 7)
Brain shape (segment 77)
Brain shape (segment 80)
Brain shape (segment 81)
Brain shape (segment 83)
Brain shape (segment 86)
Brain structure
Brain structure (hippocampal volume)
Brain structure (temporal lobe volume)
Brain surface area change rate
Brain surface area change rate x age interaction (1df)
Brain surface area change rate x age interaction (2df)
Brain volume in infants (grey matter)
Brain volume in infants (intracranial brain volume)
Brain volume in infants (white matter)
Brain-derived neurotrophic factor levels
Brain-specific angiogenesis inhibitor 1-associated protein 2 levels
Brain-specific serine protease 4 levels
Brainstem global volume Medulla
Brainstem global volume Pons
Brainstem global volume Whole-brainstem
Brainstem volume
Branched-chain amino acid levels (Isoleucine)
Branched-chain amino acid levels (Leucine)
Branched-chain amino acid levels (Valine)
Branched-chain, straight-chain, or cyclopropyl 12:1 fatty acid levels
BRCA1 mutation in breast cancer
BRCA1-A complex subunit Abraxas levels
BRCA1-associated RING domain protein 1 levels
BRCA1/2-negative high-risk breast cancer
BRCA2 and CDKN1A-interacting protein levels
BRCA2 mutation in breast cancer
Bread consumption (slices per week) (UKB data field 1438)
Bread type: White (UKB data field 1448_1)
Bread type: White vs wholemeal/wholegrain and brown (UKB data field 1448)
Bread type: Wholemeal or wholegrain (UKB data field 1448_3)
Breakfast cereal skipping frequency
Breakfast skipping
Breast cancer
Breast cancer (early onset)
Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)
Breast cancer (estrogen-receptor negative)
Breast cancer (estrogen-receptor positive)
Breast cancer (male)
Breast cancer (menopausal hormone therapy interaction)
Breast cancer (progesterone-receptor positive)
Breast cancer (prognosis)
Breast cancer (survival)
Breast cancer and/or colorectal cancer
Breast cancer anti-estrogen resistance protein 3 levels
Breast Cancer in BRCA1 mutation carriers
Breast cancer in BRCA2 mutation carriers
Breast cancer in childhood cancer survivors
Breast cancer or lung cancer (pleiotropy)
Breast cancer or ovarian cancer (pleiotropy)
Breast cancer specific mortality in breast cancer
Breast cancer specific mortality in estrogen receptor negative breast cancer
Breast cancer specific mortality in estrogen receptor positive breast cancer
Breast cancer-free interval (treatment with aromatase inhibitor)
Breast cancer, ovarian cancer or prostate cancer (pleiotropy)
Breast milk fatty acid composition (infant genotype effect)
Breast milk fatty acid composition (maternal genotype effect)
Breast size
Breastfeeding duration
Brevibacillaceae abundance in stool
Brevibacillales abundance in stool
Brevican core protein levels
BRICHOS domain-containing protein 5 levels
BRISC complex subunit Abro1 levels
Broad bean liking
Broad depression or bipolar disorder
Broad depression or major depressive disorder (recurrent)
Broad depression or schizophrenia
Bromodomain testis-specific protein levels
Bronchial hyperresponsiveness in asthma
Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)
Bronchopulmonary dysplasia
Bronchopulmonary dysplasia in preterm infants
Brooding (response to stress)
Brother of CDO levels
Brown vs. black hair color
Brown vs. non-brown hair color
Brugada syndrome
Brussel sprout liking
BTB/POZ domain-containing protein KCTD5 levels
Bulimia nervosa
Bullous pemphigoid
Burning or tingling in extremities in Charcot-Marie-Tooth disease type 1A
Butternut squash liking
Butyrate/isobutyrate (4:0) levels
Butyricimonas sp900258545 abundance in stool
Butyrobetaine levels
Butyrophilin subfamily 2 member A2 level in Chronic kidney disease with hypertension and no diabetes (22586_24)
Butyrophilin subfamily 3 member A2 level in Chronic kidney disease with hypertension and no diabetes (21433_3)
Butyrophilin subfamily 3 member A3 level in Chronic kidney disease with hypertension and no diabetes (17692_2)
Butyrophilin subfamily 3 member A3 level in Chronic kidney disease with hypertension and no diabetes (22950_6)
Butyrophilin subfamily 3 member A3 levels
Butyrophilin-like protein 3 levels
Butyrophilin-like protein 8 level in Chronic kidney disease with hypertension and no diabetes (9026_40)
Butyrophilin-like protein 8 levels
Butyrylcarnitine (C4) levels
Butyrylcarnitine levels
Butyrylcarnitine levels (Biocrates platform)
Butyrylcarnitine levels (Metabolon platform)
Butyrylcholinesterase levels
Butyrylglycine levels
C_Actinobacteria abundance
C_Alphaproteobacteria abundance
C_Alphaproteobacteria prevalence
C_Negativicutes abundance
C_Negativicutes prevalence
C-C motif chemokine 1 levels
C-C motif chemokine 14 level in Chronic kidney disease with hypertension and no diabetes (2900_53)
C-C motif chemokine 14 levels
C-C motif chemokine 14 levels (CCL14.2900.53.3)
C-C motif chemokine 15 level in Chronic kidney disease with hypertension and no diabetes (14109_15)
C-C motif chemokine 15 level in Chronic kidney disease with hypertension and no diabetes (18289_16)
C-C motif chemokine 15 level in Chronic kidney disease with hypertension and no diabetes (3509_1)
C-C motif chemokine 15 levels
C-C motif chemokine 15 levels (CCL15.14109.15.3)
C-C motif chemokine 16 levels
C-C motif chemokine 17 levels
C-C motif chemokine 18 level in Chronic kidney disease with hypertension and no diabetes (3044_3)
C-C motif chemokine 18 levels
C-C motif chemokine 19 levels
C-C motif chemokine 2 levels
C-C motif chemokine 20 levels
C-C motif chemokine 21 levels
C-C motif chemokine 21 levels (CCL21.2516.57.3)
C-C motif chemokine 22 levels
C-C motif chemokine 23 level in Chronic kidney disease with hypertension and no diabetes (2913_1)
C-C motif chemokine 23 levels
C-C motif chemokine 23 levels (CCL23.2913.1.2)
C-C motif chemokine 24 levels
C-C motif chemokine 25 levels
C-C motif chemokine 25 levels (CCL25.2705.5.2)
C-C motif chemokine 27 levels
C-C motif chemokine 28 levels
C-C motif chemokine 28 levels (CCL28.2890.59.2)
C-C motif chemokine 3 levels
C-C motif chemokine 3 levels (CCL3.3040.59.1)
C-C motif chemokine 3-like 1 levels
C-C motif chemokine 3-like 1 levels (CCL3L1.2783.18.2)
C-C motif chemokine 4 levels
C-C motif chemokine 4-like levels
C-C motif chemokine 5 levels
C-C motif chemokine 7 level in Chronic kidney disease with hypertension and no diabetes (4886_3)
C-C motif chemokine 7 levels
C-C motif chemokine 8 level in Chronic kidney disease with hypertension and no diabetes (13748_4)
C-C motif chemokine 8 levels
C-C motif chemokine 8 levels (CCL8.2785.15.2)
C-glycosyltryptophan levels in elite athletes
C-glycosyltryptophan-to-succinylcarnitine ratio
C-reactive protein
C-reactive protein (red blood cell fatty acid level interaction)
C-reactive protein and white blood cell count
C-reactive protein levels
C-reactive protein levels (CRP.4337.49.2)
C-reactive protein levels (MTAG)
C-reactive protein levels in ischemic stroke
C-reactive protein levels or HDL-cholesterol levels (pleiotropy)
C-reactive protein levels or LDL-cholesterol levels (pleiotropy)
C-reactive protein levels or total cholesterol levels (pleiotropy)
C-reactive protein levels or triglyceride levels (pleiotropy)
C-terminal-binding protein 1 levels
C-type lectin domain family 1 member B level in Chronic kidney disease with hypertension and no diabetes (4332_6)
C-type lectin domain family 1 member B levels
C-type lectin domain family 12 member A level in Chronic kidney disease with hypertension and no diabetes (11187_11)
C-type lectin domain family 12 member A levels
C-type lectin domain family 12 member A levels (CLEC12A.11187.11.3)
C-type lectin domain family 2 member D levels
C-type lectin domain family 2 member D levels (CLEC2D.7054.87.3)
C-type lectin domain family 4 member C levels
C-type lectin domain family 4 member E levels (CLEC4E.7077.9.4)
C-type lectin domain family 4 member G levels
C-type lectin domain family 4 member M levels
C-type lectin domain family 6 member A levels
C-type lectin domain family 7 member A levels
C-type mannose receptor 2 levels
C-type mannose receptor 2 levels (MRC2.3041.55.2)
C-X-C motif chemokine 1 levels
C-X-C motif chemokine 10 levels
C-X-C motif chemokine 11 level in Chronic kidney disease with hypertension and no diabetes (3038_9)
C-X-C motif chemokine 11 levels
C-X-C motif chemokine 11 levels (CXCL11.3038.9.2)
C-X-C motif chemokine 13 levels
C-X-C motif chemokine 16 levels
C-X-C motif chemokine 16 levels (CXCL16.2436.49.4)
C-X-C motif chemokine 5 level in Chronic kidney disease with hypertension and no diabetes (2979_8)
C-X-C motif chemokine 5 levels
C-X-C motif chemokine 6 level in Chronic kidney disease with hypertension and no diabetes (3495_15)
C-X-C motif chemokine 6 levels
C-X-C motif chemokine 9 levels
C18:0 Sphingomyelin levels in chronic kidney disease
C1GALT1-specific chaperone 1 levels
C1q-related factor levels
C20:4 Cholesteryl ester levels in chronic kidney disease
C20:4 Lysophosphatidylcholine levels in chronic kidney disease
C20:5 Cholesteryl ester levels in chronic kidney disease
C34:4 Phosphatidylcholine levels in chronic kidney disease
C36:3 Phosphatidylcholine levels in chronic kidney disease
C36:4 Phosphatidylcholine-A levels in chronic kidney disease
C36:5 Phosphatidylcholine plasmalogen levels in chronic kidney disease
C38:2 Phosphatidylcholine levels in chronic kidney disease
C38:4 Diacylglycerol levels in chronic kidney disease
C38:4 Phosphatidylcholine levels in chronic kidney disease
C38:5 Diacylglycerol levels in chronic kidney disease
C4 Carnitine levels in chronic kidney disease
C4b binding protein levels
C54:9 Triacylglycerol levels in chronic kidney disease
C56:10 Triacylglycerol levels in chronic kidney disease
C56:6 Triacylglycerol levels in chronic kidney disease
C56:9 Triacylglycerol levels in chronic kidney disease
C5a anaphylatoxin levels
C6 Carnitine levels in chronic kidney disease
C8 Carnitine levels in chronic kidney disease
Cabbage liking
Cadherin-1 levels
Cadherin-11 level in Chronic kidney disease with hypertension and no diabetes (7763_25)
Cadherin-11 levels
Cadherin-12 levels (CDH12.10701.30.3)
Cadherin-15 levels
Cadherin-15 levels (CDH15.11215.6.3)
Cadherin-17 levels
Cadherin-3 level in Chronic kidney disease with hypertension and no diabetes (2643_57)
Cadherin-3 levels
Cadherin-3 levels (CDH3.2643.57.2)
Cadherin-5 levels
Cadherin-6 level in Chronic kidney disease with hypertension and no diabetes (3591_51)
Cadherin-6 levels
Cadherin-7 levels
Cadherin-7 levels (CDH7.7959.34.3)
Cadherin-8 levels
Cadherin-related family member 5 levels
Cadmium chloride levels
Caffeic acid sulfate levels in elite athletes
Caffeine consumption
Caffeine consumption from coffee
Caffeine consumption from coffee or tea
Caffeine consumption from tea
Caffeine levels
Caffeine levels in elite athletes
Caffeine metabolism (plasma 1,3-dimethylxanthine (theophylline) level)
Caffeine metabolism (plasma 1,3,7-trimethylxanthine (caffeine) level)
Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) level)
Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) to 1,3,7-trimethylxanthine (caffeine) ratio)
CAG-245 abundance in stool
CAG-245 sp000435175 abundance in stool
CAG-269 sp001915995 abundance in stool
CAG-269 sp001916065 abundance in stool
CAG-273 sp003507395 abundance in stool
CAG-349 abundance in stool
CAG-390 sp003523225 abundance in stool
CAG-81 sp000435795 abundance in stool
CAG-877 abundance in stool
CAG-877 sp000433455 abundance in stool
Cake icing liking
Calbindin levels
Calbindin levels (CALB1.9918.23.3)
Calcaneal bone ultrasound measurement (speed of sound)
Calcaneus stiffness index
Calcific aortic valve stenosis
Calcineurin B homologous protein 1 levels
Calcineurin B homologous protein 3 levels
Calcineurin levels
Calcineurin subunit B type 1 levels
Calcineurin subunit B type 2 levels
Calcipressin-1 levels (RCAN1.13465.5.3)
Calcium levels
Calcium uptake protein 2, mitochondrial levels
Calcium-activated chloride channel regulator 1 levels
Calcium-activated potassium channel subunit beta-3 levels
Calcium-binding and coiled-coil domain-containing protein 2 levels
Calcium-binding protein 7 levels
Calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase 1A levels
Calcium/calmodulin-dependent protein kinase kinase 1 levels
Calcium/calmodulin-dependent protein kinase type 1 levels
Calcium/calmodulin-dependent protein kinase type 1 levels (CAMK1.3592.4.3)
Calcium/calmodulin-dependent protein kinase type 1D level in Chronic kidney disease with hypertension and no diabetes (3418_12)
Calcium/calmodulin-dependent protein kinase type 1D levels
Calcium/calmodulin-dependent protein kinase type 1D levels (CAMK1D.3418.12.2)
Calcyclin-binding protein levels
Calgranulin A level in Chronic kidney disease with hypertension and no diabetes (25216_8)
California verbal learning test score
Calmegin levels
Calnexin levels (CANX.8834.58.3)
Calpain I levels
Calpain small subunit 1 levels
Calpain-13 level in Chronic kidney disease with hypertension and no diabetes (24915_123)
Calpain-2 catalytic subunit levels
Calpastatin levels
Calpastatin levels (CAST.3026.5.2)
Calponin-1 levels
Calponin-2 levels
Calsequestrin-1 level in Chronic kidney disease with hypertension and no diabetes (11263_57)
Calsyntenin-2 levels
cAMP-regulated phosphoprotein 19 levels
Campesterol levels
Campesterol levels in elite athletes
Cancer
Cancer (pleiotropy)
Cancer (pleiotropy)(bidirectional)
Cancer (standard GWA)
Candidemia
Candidiasis
Cannabis dependence
Cannabis dependence symptom count
Cannabis smoking or cigarette smoking or schizophrenia
Cannabis use
Cannabis use (initiation)
Cannabis use disorder
Capecitabine sensitivity
Capecitabine-induced hand-foot syndrome in breast or colorectal cancer
Capers liking
Caprate (10:0) levels in elite athletes
Caproate (6:0) levels
Caproate (6:0) levels in elite athletes
Caprylate (8:0) levels
Caprylate (8:0) levels in elite athletes
Caprylic acid levels
CAR DC3:0;2Me levels
Carbamazepine metabolism (carbamazepine-10,11-diol to carbamazepine ratio) in epilepsy
Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy
Carbamazepine-induced hyponatremia in epilepsy
Carbohydrate sulfotransferase 1 levels (CHST1.7803.4.3)
Carbohydrate sulfotransferase 12 levels
Carbohydrate sulfotransferase 14 levels
Carbohydrate sulfotransferase 15 levels
Carbohydrate sulfotransferase 4 levels
Carbohydrate sulfotransferase 9 levels
Carbohydrate sulfotransferase 9 levels (CHST9.11646.4.3)
Carbonic anhydrase 12 levels
Carbonic anhydrase 13 levels
Carbonic anhydrase 2 levels
Carbonic anhydrase 3 levels
Carbonic anhydrase 3 levels (CA3.3799.11.2)
Carbonic anhydrase 5A, mitochondrial levels
Carbonic anhydrase 5A, mitochondrial levels (CA5A.8791.151.3)
Carbonic anhydrase 5A,mitochondrial levels
Carbonic anhydrase 5B, mitochondrial levels
Carbonic anhydrase 6 levels
Carbonic anhydrase 9 levels
Carbonic anhydrase-related protein 10 levels
Carbonic anhydrase-related protein 10 levels (CA10.13666.222.3)
Carbonyl reductase [NADPH] 1 levels
Carbonyl reductase [NADPH] 1 levels (CBR1.12381.26.3)
Carbonyl reductase [NADPH] 3 level in Chronic kidney disease with hypertension and no diabetes (14091_42)
Carbonyl reductase [NADPH] 3 levels
Carbonyl reductase [NADPH] 3 levels (CBR3.14091.42.3)
Carboplatin disposition in epthelial ovarian cancer
Carboxyethyl-gaba levels
Carboxyethyl-GABA levels in elite athletes
Carboxylesterase 3 level in Chronic kidney disease with hypertension and no diabetes (25292_6)
Carboxymethylenebutenolidase homolog levels
Carboxypeptidase A1 levels
Carboxypeptidase A2 levels
Carboxypeptidase A2 levels (CPA2.9276.7.3)
Carboxypeptidase A4 level in Chronic kidney disease with hypertension and no diabetes (9267_2)
Carboxypeptidase A4 levels
Carboxypeptidase A4 levels (CPA4.9267.2.3)
Carboxypeptidase B levels
Carboxypeptidase B levels (CPB1.6356.3.3)
Carboxypeptidase B2 level in Chronic kidney disease with hypertension and no diabetes (3518_54)
Carboxypeptidase B2 levels
Carboxypeptidase D levels
Carboxypeptidase E levels
Carboxypeptidase M level in Chronic kidney disease with hypertension and no diabetes (7768_10)
Carboxypeptidase M levels
Carboxypeptidase M levels (CPM.7768.10.3)
Carboxypeptidase N catalytic chain levels
Carboxypeptidase N subunit 2 level in Chronic kidney disease with hypertension and no diabetes (6415_90)
Carboxypeptidase N subunit 2 levels
Carboxypeptidase Q levels
Carboxypeptidase Z levels
Carboxypeptidase Z levels (CPZ.6493.9.3)
Carcinoembryonic antigen-related cell adhesion molecule 1 levels (CEACAM1.8031.11.3)
Carcinoembryonic antigen-related cell adhesion molecule 19 levels
Carcinoembryonic antigen-related cell adhesion molecule 20 levels
Carcinoembryonic antigen-related cell adhesion molecule 21 levels
Carcinoembryonic antigen-related cell adhesion molecule 3 levels
Carcinoembryonic antigen-related cell adhesion molecule 7 levels
Carcinoembryonic antigenrelated cell adhesion molecule 8 levels
Cardia gastric cancer
Cardiac hypertrophy
Cardiac muscle measurement
Cardiac structure and function
Cardiac troponin-I levels
Cardiac Troponin-T levels
Cardiac valvular disease
Cardio-cerebrovascular disease in diabetes mellitus
Cardio-cerebrovascular disease in dyslipidemia
Cardio-cerebrovascular disease in hypertension
Cardioembolic stroke
Cardioembolic stroke (CCS and TOAST classification)
Cardioembolic stroke (CCS or TOAST classification)
Cardioembolic stroke (CCSc classification)
Cardioembolic stroke (CCSp classification)
Cardioembolic stroke (MTAG)
Cardioembolic stroke (TOAST classification)
Cardiometabolic and hematological traits
Cardiorespiratory fitness (800m run time)
Cardiorespiratory fitness (vo2 max)
Cardiorespiratory fitness slope
Cardiotrophin-1 levels
Cardiovascular death or myocardial infarction in response to clopidogrel treatment
Cardiovascular death, myocardial infarction or stroke in response to clopidogrel treatment
Cardiovascular delta age (difference between ECG-predicted and chronological age)
Cardiovascular disease
Cardiovascular disease in hypertension (calcium channel blocker interaction)
Cardiovascular disease risk factors
Cardiovascular event in colchicine-treated recent myocardial infarction (time to event)
Cardiovascular risk factors
Cardiovascular risk factors (age interaction)
Carnitine C10 levels
Carnitine C12 levels
Carnitine C14 levels
Carnitine C18:2 levels
Carnitine C4 levels
Carnitine C5:1 levels
Carnitine C6 levels
Carnitine C8 levels
Carnitine C9 levels
Carnitine levels
Carnitine levels in elite athletes
Carnitine O-palmitoyltransferase 1, muscle isoform levels
Carnosine levels in chronic kidney disease
Carotene diol (1) levels
Carotene diol (1) levels in elite athletes
Carotene diol (2) levels
Carotene diol (2) levels in elite athletes
Carotenoid and tocopherol levels
Carotenoid levels (alpha-carotene)
Carotid artery external diameter
Carotid artery internal diameter
Carotid artery intima media thickness (sex interaction)
Carotid artery intima-media thickness in type 2 diabetes
Carotid artery stenosis
Carotid atherosclerosis in HIV infection
Carotid intima media thickness
Carotid intima media thickness (maximum)
Carotid intima media thickness (mean-maximum)
Carotid intima media thickness (mean)
Carotid intima media thickness (minimum)
Carotid intima media thickness in rheumatoid arthritis
Carotid intima media thickness x smoking interaction
Carotid Intima-media thickness (mean of the maximum cIMT)
Carotid plaque
Carotid plaque burden
Carotid plaque burden (smoking interaction)
Carotid plaque maximum area
Carpal tunnel syndrome
Cartilage acidic protein 1 levels
Cartilage oligomeric matrix protein levels
Cas scaffolding protein family member 4 levels
Casein kinase I isoform alpha-like level in Chronic kidney disease with hypertension and no diabetes (22484_17)
Casein kinase I isoform gamma-2 levels
Casein kinase II 2-alpha:2-beta heterotetramer levels
Casein kinase II 2-alpha':2-beta heterotetramer levels
Casein kinase II subunit alpha levels
Casein kinase II subunit beta levels
Caspase 8 levels
Caspase recruitment domain-containing protein 18 levels
Caspase recruitment domain-containing protein 9 levels
Caspase-2 levels
Caspase-3 levels
Caspase-5 level in Chronic kidney disease with hypertension and no diabetes (25895_29)
Caspase-8 levels
Catalase levels
Catalase levels (CAT.3488.64.2)
Cataract
Cataracts
Cataracts (operation)
Cataracts in type 2 diabetes
Catechol O-methyltransferase levels
Catechol sulfate levels in elite athletes
Catenin alpha-2 levels
Catenin beta-1 level in Chronic kidney disease with hypertension and no diabetes (8424_269)
Catenin beta-1 levels
Cathelicidin antimicrobial peptide levels
Cathepsin B level in Chronic kidney disease with hypertension and no diabetes (8007_19)
Cathepsin B levels
Cathepsin B levels (CTSB.3061.61.2)
Cathepsin D levels
Cathepsin D plasma levels
Cathepsin F levels
Cathepsin F levels (CTSF.9212.22.3)
Cathepsin H level in Chronic kidney disease with hypertension and no diabetes (8644_46)
Cathepsin H levels
Cathepsin H levels (CTSH.8465.52.3)
Cathepsin L1 levels
Cathepsin L2 levels
Cathepsin O levels
Cathepsin S levels
Cathepsin S levels (CTSS.3181.50.2)
Cathepsin Z levels
Cathepsin Z levels (CTSZ.4971.1.1)
Cation-dependent mannose-6-phosphate receptor levels (M6PR.10491.21.3)
Cation-independent mannose-6-phosphate receptor level in Chronic kidney disease with hypertension and no diabetes (16057_6)
Cation-independent mannose-6-phosphate receptor level in Chronic kidney disease with hypertension and no diabetes (3676_15)
Cation-independent mannose-6-phosphate receptor levels
Cation-independent mannose-6-phosphate receptor levels (IGF2R.3676.15.3)
Caudal anterior-cingulate cortex volume
Caudal middle frontal gyrus volume
Caudate activity during reward
Caudate nucleus volume
Caudate volume change rate
Caudate volume change rate x age interaction (1df)
Caudate volume in trauma-exposed individuals
Cauliflower liking
Caveolin-2 levels
Caveolin-3 levels
CB1 cannabinoid receptor-interacting protein 1 level in Chronic kidney disease with hypertension and no diabetes (18218_48)
CB1 cannabinoid receptor-interacting protein 1 levels
CCAAT/enhancer-binding protein alpha levels
CCL23 levels
CCL24 levels
CCL25 levels
CCR2 on CD14- CD16-
CCR2 on CD14+ CD16- monocyte
CCR2 on CD62L+ plasmacytoid Dendritic Cell
CCR2 on monocyte
CCR2 on myeloid Dendritic Cell
CCR2 on plasmacytoid Dendritic Cell
CCR4-NOT transcription complex subunit 1 levels
CCR7 on naive CD4+ T cell
CCR7 on naive CD8+ T cell
CD109 antigen levels
CD109 antigen levels (CD109.3290.50.2)
CD11b on basophil
CD11b on CD14+ monocyte
CD11b on CD33+ HLA DR+ CD14dim
CD11b on CD33dim HLA DR-
CD11b on Monocytic Myeloid-Derived Suppressor Cells
CD11c on CD62L+ myeloid Dendritic Cell
CD11c on granulocyte
CD11c on monocyte
CD11c on myeloid Dendritic Cell
CD11c+ CD62L- monocyte Absolute Count
CD127 on CD28+ CD4+ T cell
CD127 on CD28+ CD45RA+ CD8+ T cell
CD127 on CD4+ T cell
CD127 on CD45RA- CD4 not regulatory T cell
CD127 on CD45RA+ CD4+ T cell
CD14 on CD14+ CD16- monocyte
CD14 on CD14+ CD16+ monocyte
CD14 on CD33dim HLA DR+ CD11b+
CD14- CD16- Absolute Count
CD14- CD16+ monocyte %monocyte
CD14+ CD16+ monocyte %monocyte
CD14+ CD16+ monocyte Absolute Count
CD16 on CD14+ CD16+ monocyte
CD16-CD56 on HLA DR+ Natural Killer
CD166 antigen levels
CD177 antigen levels
CD177 antigen levels (CD177.13116.25.3)
CD19 on B cell
CD19 on CD20- CD38- B cell
CD19 on switched memory B cell
CD20 on CD24+ CD27+ B cell
CD20 on IgD- CD24- B cell
CD20 on IgD- CD27- B cell
CD20 on IgD- CD38- B cell
CD20 on IgD- CD38dim B cell
CD20 on IgD+ B cell
CD20 on IgD+ CD24- B cell
CD20 on IgD+ CD24+ B cell
CD20 on IgD+ CD38- B cell
CD20 on IgD+ CD38+ B cell
CD20 on IgD+ CD38dim B cell
CD20 on memory B cell
CD20 on naive-mature B cell
CD20 on switched memory B cell
CD20 on transitional B cell
CD20 on unswitched memory B cell
CD209 antigen levels
CD226 antigen levels
CD24 on CD24+ CD27+ B cell
CD24 on IgD- CD38- B cell
CD24 on IgD- CD38dim B cell
CD24 on IgD+ CD24+ B cell
CD24 on IgD+ CD38- B cell
CD24 on IgD+ CD38+ B cell
CD24 on memory B cell
CD24 on switched memory B cell
CD24 on transitional B cell
CD24 on unswitched memory B cell
CD24+ CD27+ B cell %lymphocyte
CD25 on B cell
CD25 on CD24+ CD27+ B cell
CD25 on CD39+ activated CD4 regulatory T cell
CD25 on CD39+ CD4 regulatory T cell
CD25 on CD39+ CD4+ T cell
CD25 on CD39+ resting CD4 regulatory T cell
CD25 on CD45RA+ CD4 not regulatory T cell
CD25 on IgD- CD27- B cell
CD25 on IgD- CD38- B cell
CD25 on IgD- CD38dim B cell
CD25 on IgD+ CD24- B cell
CD25 on IgD+ CD24+ B cell
CD25 on IgD+ CD38+ B cell
CD25 on memory B cell
CD25 on naive-mature B cell
CD25 on unswitched memory B cell
CD25++ CD4+ T cell %T cell
CD25++ CD45RA+ CD4 not regulatory T cell %CD4+ T cell
CD25++ CD45RA+ CD4 not regulatory T cell %T cell
CD25++ CD45RA+ CD4 not regulatory T cell Absolute Count
CD25++ CD8+ T cell %CD8+ T cell
CD25++ CD8+ T cell %T cell
CD25++ CD8+ T cell Absolute Count
CD27 antigen level in Chronic kidney disease with hypertension and no diabetes (5412_53)
CD27 antigen levels
CD27 on CD24+ CD27+ B cell
CD27 on IgD- CD38- B cell
CD27 on IgD- CD38+ B cell
CD27 on IgD- CD38dim B cell
CD27 on IgD+ CD24+ B cell
CD27 on memory B cell
CD27 on Plasma Blast-Plasma Cell
CD27 on switched memory B cell
CD27 on unswitched memory B cell
CD28 on activated & secreting CD4 regulatory T cell
CD28 on activated CD4 regulatory T cell
CD28 on CD28+ CD4-CD8- T cell
CD28 on CD28+ CD4+ T cell
CD28 on CD28+ CD45RA- CD8+ T cell
CD28 on CD39+ activated CD4 regulatory T cell
CD28 on CD39+ CD4+ T cell
CD28 on CD39+ CD8+ T cell
CD28 on CD39+ secreting CD4 regulatory T cell
CD28 on CD4 regulatory T cell
CD28 on CD4+ T cell
CD28 on CD45RA- CD4 not regulatory T cell
CD28 on CD45RA+ CD4+ T cell
CD28 on resting CD4 regulatory T cell
CD28 on secreting CD4 regulatory T cell
CD28- CD4-CD8- T cell %CD4-CD8- T cell
CD28- CD4-CD8- T cell %T cell
CD28- CD4-CD8- T cell Absolute Count
CD28- CD8+ T cell %CD8+ T cell
CD28- CD8+ T cell Absolute Count
CD28- CD8dim T cell %CD8dim T cell
CD28- CD8dim T cell %T cell
CD28- CD8dim T cell Absolute Count
CD28+ CD4-CD8- T cell %CD4-CD8- T cell
CD28+ CD45RA- CD8+ T cell %CD8+ T cell
CD28+ CD45RA+ CD8+ T cell %T cell
CD28+ CD45RA+ CD8dim T cell %CD8dim T cell
CD28+ CD45RA+ CD8dim T cell %T cell
CD28+ CD45RA+ CD8dim T cell Absolute Count
CD3 on activated & secreting CD4 regulatory T cell
CD3 on activated CD4 regulatory T cell
CD3 on CD28- CD8+ T cell
CD3 on CD28+ CD4+ T cell
CD3 on CD28+ CD45RA- CD8+ T cell
CD3 on CD28+ CD45RA+ CD8+ T cell
CD3 on CD39+ activated CD4 regulatory T cell
CD3 on CD39+ CD4+ T cell
CD3 on CD39+ CD8+ T cell
CD3 on CD39+ resting CD4 regulatory T cell
CD3 on CD39+ secreting CD4 regulatory T cell
CD3 on CD4 regulatory T cell
CD3 on CD4+ T cell
CD3 on CD45RA- CD4+ T cell
CD3 on CD45RA+ CD4+ T cell
CD3 on CD8+ T cell
CD3 on Central Memory CD4+ T cell
CD3 on Central Memory CD8+ T cell
CD3 on Effector Memory CD4+ T cell
CD3 on Effector Memory CD8+ T cell
CD3 on HLA DR+ CD4+ T cell
CD3 on HLA DR+ CD8+ T cell
CD3 on HLA DR+ T cell
CD3 on Naive CD4+ T cell
CD3 on naive CD8+ T cell
CD3 on resting CD4 regulatory T cell
CD3 on secreting CD4 regulatory T cell
CD3 on Terminally Differentiated CD4+ T cell
CD3 on Terminally Differentiated CD8+ T cell
CD3- lymphocyte %leukocyte
CD3- lymphocyte %lymphocyte
CD33 on basophil
CD33 on CD14+ monocyte
CD33 on CD33+ HLA DR+
CD33 on CD33+ HLA DR+ CD14-
CD33 on CD33+ HLA DR+ CD14dim
CD33 on CD33dim HLA DR-
CD33 on CD33dim HLA DR+ CD11b-
CD33 on CD33dim HLA DR+ CD11b+
CD33 on CD66b++ myeloid cell
CD33 on Granulocytic Myeloid-Derived Suppressor Cells
CD33 on Immature Myeloid-Derived Suppressor Cells
CD33 on Monocytic Myeloid-Derived Suppressor Cells
CD33- HLA DR- Absolute Count
CD33- HLA DR+ Absolute Count
CD33+ HLA DR+ Absolute Count
CD33+ HLA DR+ CD14- %CD33+ HLA DR+
CD33+ HLA DR+ CD14- Absolute Count
CD33+ HLA DR+ CD14dim Absolute Count
CD33dim HLA DR- Absolute Count
CD33dim HLA DR+ CD11b- %CD33dim HLA DR+
CD33dim HLA DR+ CD11b- Absolute Count
CD33dim HLA DR+ CD11b+ %CD33dim HLA DR+
CD33dim HLA DR+ CD11b+ Absolute Count
CD34 on Hematopoietic Stem Cell
CD39 on CD39+ activated CD4 regulatory T cell
CD39 on CD39+ CD4+ T cell
CD39 on CD39+ CD8+ T cell
CD39 on CD39+ secreting CD4 regulatory T cell
CD39 on granulocyte
CD39+ activated CD4 regulatory T cell %activated CD4 regulatory T cell
CD39+ activated CD4 regulatory T cell %CD4 regulatory T cell
CD39+ activated CD4 regulatory T cell Absolute Count
CD39+ CD4+ T cell %CD4+ T cell
CD39+ CD4+ T cell %T cell
CD39+ CD4+ T cell Absolute Count
CD39+ CD8+ T cell %CD8+ T cell
CD39+ CD8+ T cell %T cell
CD39+ CD8+ T cell Absolute Count
CD39+ resting CD4 regulatory T cell %CD4 regulatory T cell
CD39+ resting CD4 regulatory T cell %resting CD4 regulatory T cell
CD39+ resting CD4 regulatory T cell Absolute Count
CD39+ secreting CD4 regulatory T cell %CD4 regulatory T cell
CD39+ secreting CD4 regulatory T cell %secreting CD4 regulatory T cell
CD39+ secreting CD4 regulatory T cell Absolute Count
CD4 on CD39+ CD4+ T cell
CD4 on CD39+ secreting CD4 regulatory T cell
CD4 on CD4+ T cell
CD4 on monocyte
CD4 on naive CD4+ T cell
CD4 regulatory T cell %CD4+ T cell
CD4-CD8- Natural Killer T %lymphocyte
CD4-CD8- Natural Killer T %T cell
CD4-CD8- Natural Killer T Absolute Count
CD4-CD8- T cell %leukocyte
CD4-CD8- T cell %T cell
CD4-CD8- T cell Absolute Count
CD4+ CD8dim T cell %lymphocyte
CD4+ T cell Absolute Count
CD4+ T cell-associated HIV-1 DNA levels in long-term suppressive antiretroviral treated HIV-1 (adjusted for cell-associated HIV-1 RNA)
CD4+ T cell-associated HIV-1 RNA-to-DNA ratio in long-term suppressive antiretroviral treated HIV-1
CD4+CD8+ T cell %leukocyte
CD4+CD8+ T cell %T cell
CD4+CD8+ T cell Absolute Count
CD40 levels
CD40 on CD14- CD16+ monocyte
CD40 on CD14+ CD16- monocyte
CD40 on CD14+ CD16+ monocyte
CD40 on monocytes
CD40 plasma levels
CD45 on B cell
CD45 on CD33- HLA DR-
CD45 on granulocyte
CD45 on HLA DR+ CD4+ T cell
CD45 on HLA DR+ T cell
CD45 on Immature Myeloid-Derived Suppressor Cells
CD45 on Natural Killer
CD45RA on naive CD4+ T cell
CD45RA on resting CD4 regulatory T cell
CD45RA on Terminally Differentiated CD8+ T cell
CD45RA- CD4+ T cell %CD4+ T cell
CD45RA- CD4+ T cell %T cell
CD45RA- CD4+ T cell Absolute Count
CD45RA+ CD8+ T cell %T cell
CD48 antigen levels (CD48.3292.75.1)
CD5 antigen-like levels
CD59 glycoprotein levels
CD59 glycoprotein levels (CD59.11514.196.3)
CD5L plasma levels
CD6 levels
CD62L on CD62L+ Dendritic Cell
CD62L on CD62L+ myeloid Dendritic Cell
CD62L on CD62L+ plasmacytoid Dendritic Cell
CD62L on monocyte
CD62L- CD86+ myeloid Dendritic Cell %Dendritic Cell
CD62L- CD86+ myeloid Dendritic Cell Absolute Count
CD62L- Dendritic Cell %Dendritic Cell
CD62L- Dendritic Cell Absolute Count
CD62L- monocyte %monocyte
CD62L- monocyte Absolute Count
CD62L- myeloid Dendritic Cell %Dendritic Cell
CD62L- myeloid Dendritic Cell Absolute Count
CD62L- plasmacytoid Dendritic Cell %Dendritic Cell
CD63 antigen levels
CD63 antigen levels (CD63.9190.7.3)
CD64 on CD14- CD16-
CD64 on CD14- CD16+ monocyte
CD64 on CD14+ CD16- monocyte
CD64 on CD14+ CD16+ monocyte
CD64 on monocyte
CD8 on CD28+ CD45RA- CD8+ T cell
CD8 on CD28+ CD45RA+ CD8+ T cell
CD8 on CD39+ CD8+ T cell
CD8 on CD8+ T cell
CD8 on Central Memory CD8+ T cell
CD8 on Effector Memory CD8+ T cell
CD8 on HLA DR+ CD8+ T cell
CD8 on naive CD8+ T cell
CD8 on Natural Killer T
CD80 on CD62L+ myeloid Dendritic Cell
CD80 on monocyte
CD80 on myeloid Dendritic Cell
CD86+ myeloid Dendritic Cell %Dendritic Cell
CD86+ myeloid Dendritic Cell Absolute Count
CD86+ plasmacytoid Dendritic Cell %Dendritic Cell
CD8dim Natural Killer T %lymphocyte
CD8dim Natural Killer T Absolute Count
CD8dim T cell Absolute Count
CD9 antigen levels
CD99 antigen-like protein 2 levels
CDGSH iron-sulfur domain-containing protein 1 levels (CISD1.7745.3.3)
CDK5 and ABL1 enzyme substrate 2 levels
Celiac disease
Celiac disease and Rheumatoid arthritis
Celiac disease or Rheumatoid arthritis
Cell adhesion molecule 1 levels
Cell adhesion molecule-related/down-regulated by oncogenes level in Chronic kidney disease with hypertension and no diabetes (4541_49)
Cell adhesion molecule-related/down-regulated by oncogenes levels
Cell adhesion molecule-related/down-regulated by oncogenes levels (CDON.4541.49.2)
Cell cycle progression protein 1 levels
Cell differentiation protein RCD1 homolog levels
Cell growth regulator with EF hand domain protein 1 levels
Cell growth regulator with EF hand domain protein 1 levels (CGREF1.6257.56.3)
Cell surface glycoprotein CD200 receptor 1 levels
Cell surface glycoprotein CD200 receptor 1 levels (CD200R1.5103.30.3)
Cell surface glycoprotein CD200 receptor 2 levels
Cellular nuclear factor (erythroid-derived 2)-like 2 levels
Cellular retinoic acid-binding protein 1 levels
Cellular retinoic acid-binding protein 1 levels (CRABP1.11967.23.3)
Cellular retinoic acid-binding protein 2 levels
Cellular tumor antigen p53 levels
Cellular tumor antigen p53 levels (TP53.6152.111.3)
Cellular tumor antigen p53 R175H mutant level in Chronic kidney disease with hypertension and no diabetes (6168_11)
Cellular tumor antigen p53 R175H mutant levels
Central cerebrospinal fluid amyloid beta 42 to 40 ratio
Central cerebrospinal fluid amyloid beta 42 to 40 ratio (abnormal vs normal)
Central corneal thickness
Central corneal thickness (MTAG)
Central Memory CD4+ T cell Absolute Count
Central pulse pressure
Central retinal vein equivalent
Central serous chorioretinopathy
Centrin-2 level in Chronic kidney disease with hypertension and no diabetes (13078_3)
Centrin-3 levels
Centromere protein W levels
Cephalic index
Ceramide (d16:1/16:0) levels
Ceramide (d16:1/18:0) levels
Ceramide (d16:1/20:0) levels
Ceramide (d16:1/22:0) levels
Ceramide (d16:1/24:0) levels
Ceramide (d16:1/24:1, d18:1/22:1) levels
Ceramide (d16:1/24:1, d18:1/22:1) levels in elite athletes
Ceramide (d16:1/24:1) levels
Ceramide (d17:1/16:0) levels
Ceramide (d17:1/18:0) levels
Ceramide (d17:1/20:0) levels
Ceramide (d17:1/22:0) levels
Ceramide (d17:1/24:0) levels
Ceramide (d17:1/24:1) levels
Ceramide (d18:1/14:0, d16:1/16:0) levels in elite athletes
Ceramide (d18:1/18:0) levels
Ceramide (d18:1/20:0, d16:1/22:0, d20:1/18:0) levels
Ceramide (d18:1/20:0, d16:1/22:0, d20:1/18:0) levels in elite athletes
Ceramide (d18:1/20:0) levels
Ceramide (d18:1/22:0) levels
Ceramide (d18:1/24:0) levels
Ceramide (d18:1/24:1) levels
Ceramide (d18:1/26:0) levels
Ceramide (d18:2/16:0) levels
Ceramide (d18:2/18:0) levels
Ceramide (d18:2/20:0) levels
Ceramide (d18:2/22:0) levels
Ceramide (d18:2/24:0) levels
Ceramide (d18:2/24:1, d18:1/24:2) levels
Ceramide (d18:2/24:1, d18:1/24:2) levels in elite athletes
Ceramide (d18:2/24:1) levels
Ceramide (d18:2/26:0) levels
Ceramide (d19:1/16:0) levels
Ceramide (d19:1/18:0) levels
Ceramide (d19:1/20:0) levels
Ceramide (d19:1/22:0) levels
Ceramide (d19:1/24:0) levels
Ceramide (d19:1/24:1) levels
Ceramide (d19:1/26:0) levels
Ceramide (d20:1/22:0) levels
Ceramide (d20:1/24:0) levels
Ceramide (d20:1/24:1) levels
Ceramide (d34:0) levels
Ceramide (d36:1) levels
Ceramide (d39:1) levels
Ceramide (d42:2)A levels
Ceramide (d43:1) levels
Ceramide (d44:1) levels
Ceramide [N(22)S(19)] levels
Ceramide [N(23)S(20)] levels
Ceramide [N(24)DS(19)] levels
Ceramide [N(24)DS(20)] levels
Ceramide [N(24)S(16)] levels
Ceramide [N(24)S(19)] levels
Ceramide [N(24)S(19)] product-precursor ratio
Ceramide [N(24)S(20)] levels
Ceramide [N(26)S(19)] levels
Ceramide levels
Ceramide levels (C22:0)
Ceramide levels (C24:0)
Ceramide_40:1_[M-H]1- levels
Ceramide_41:1_[M-H]1- levels
Ceramide_42:1_[M+H-H2O]1+ levels
Ceramide_42:2_[M-H]1- levels
Ceramide_42:2_[M+H-H2O]1+ levels
Ceramide(40:0)_[M-H]1- levels
Ceramide(40:1)_[M-H]1- levels
Ceramide(40:2)_[M-H]1- levels
Ceramide(41:0)_[M-H]1- levels
Ceramide(41:1)_[M-H]1- levels
Ceramide(41:2)_[M-H]1- levels
Ceramide(42:0)_[M-H]1- levels
Cerberus levels
Cereal consumption (bowls per week) (UKB data field 1458)
Cereal type: Biscuit cereal (e.g. Weetabix) (UKB data field 1468_2)
Cereal type: Other (e.g. Cornflakes, Frosties) (UKB data field 1468_5)
Cerebellin-1 level in Chronic kidney disease with hypertension and no diabetes (9313_27)
Cerebellin-1 levels
Cerebellin-1 levels (CBLN1.9313.27.3)
Cerebellin-2 level in Chronic kidney disease with hypertension and no diabetes (21887_2)
Cerebellin-4 levels
Cerebellum cortex volume
Cerebellum cortex volume change rate
Cerebellum cortex volume change rate x age interaction (2df)
Cerebellum growth
Cerebellum white matter volume
Cerebellum white matter volume change rate
Cerebellum white matter volume change rate x age interaction (1df)
Cerebellum white matter volume change rate x age interaction (2df)
Cerebral amyloid angiopathy
Cerebral amyloid angiopathy in Alzheimer’s disease
Cerebral amyloid angiopathy in APOEe4 non-carrier Alzheimer’s disease
Cerebral amyloid angiopathy x APOEe4 status interaction in Alzheimer’s disease
Cerebral amyloid angiopathy x sex interaction in Alzheimer’s disease
Cerebral amyloid deposition (PET imaging)
Cerebral aneurysm
Cerebral blood flow
Cerebral cavernous malformations 2 protein levels
Cerebral cortical growth
Cerebral dopamine neurotrophic factor levels
Cerebral glucose metabolic decline (posterior cingulate cortex)
Cerebral glucose metabolic decline (right temporal gyrus)
Cerebral microbleeds
Cerebral microbleeds (lobar)
Cerebral venous thrombosis
Cerebral white matter volume
Cerebral white matter volume change rate
Cerebral white matter volume change rate x age interaction (1df)
Cerebral white matter volume change rate x age interaction (2df)
Cerebrospinal AB1-42 levels in Alzheimer's disease dementia
Cerebrospinal AB1-42 levels in normal cognition
Cerebrospinal fluid AB1-42 levels
Cerebrospinal fluid amyloid beta 42 levels
Cerebrospinal fluid amyloid beta 42 levels (12 month visit)
Cerebrospinal fluid amyloid beta 42 levels (12 month visit)(adjusted for APOE e4 dosage)
Cerebrospinal fluid beta-site APP cleaving enzyme levels
Cerebrospinal fluid biomarker levels
Cerebrospinal fluid clusterin levels
Cerebrospinal fluid clusterin levels in APOEe4- carriers
Cerebrospinal fluid clusterin levels in APOEe4+ carriers
Cerebrospinal fluid levels of Alzheimer's disease-related proteins
Cerebrospinal fluid neurofilament light levels
Cerebrospinal fluid p-tau levels
Cerebrospinal fluid p-tau levels (24 month visit)(adjusted for APOE e4 dosage)
Cerebrospinal fluid p-tau levels in abnormal amyloid levels
Cerebrospinal fluid p-tau levels in APOE e4 carriers
Cerebrospinal fluid p-tau levels in APOE e4 non-carriers
Cerebrospinal fluid p-tau levels in normal amyloid levels
Cerebrospinal fluid p-tau levels in normal cognition
Cerebrospinal fluid p-Tau181p:AB1-42 ratio
Cerebrospinal fluid progranulin levels
Cerebrospinal fluid pyridoxal phosphate levels
Cerebrospinal fluid pyridoxal phosphate to pyridoxal ratio
Cerebrospinal fluid sTREM-2 levels
Cerebrospinal fluid t-tau levels
Cerebrospinal fluid t-tau levels in mild cognitive impairment
Cerebrospinal fluid t-tau levels in normal cognition
Cerebrospinal fluid t-tau:AB1-42 ratio
Cerebrospinal fluid α-synuclein levels
Cerebrospinal P-tau181p levels
Cerebrospinal T-tau levels
Ceroid-lipofuscinosis neuronal protein 5 levels
Cerotoylcarnitine (C26) levels
Cerotoylcarnitine (C26) levels in elite athletes
Cervical artery dissection
Cervical artery dissection (MTAG)
Cervical cancer
Cervical cancer (MTAG)
Cervical dysplasia
Cervical dysplasia or cervical cancer (MTAG)
Cervical ectropion
Cervical high-risk human papilloma virus infection
Cervical intraepithelial neoplasia grade 3 and invasive cervical cancer
Cervicitis
CFH plasma levels
CFHR1 plasma levels
cFib plasma levels
CFTR mutation F508del heterozygosity in cystic fibrosis
CFTR mutation F508del heterozygosity in cystic fibrosis (PC-adjusted model)
cGMP-dependent protein kinase 1, beta isozyme levels
cGMP-inhibited 3,5-cyclic phosphodiesterase A levels
cGMP-specific 3,5-cyclic phosphodiesterase levels
cGMP-specific 3',5'-cyclic phosphodiesterase levels
Chagas cardiomyopathy in Tripanosoma cruzi seropositivity
Champagne or white wine consumption (glasses per month) (UKB data field 1578, 4418)
Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer
Change in neurofilament light levels
Change in serum metabolite levels
Change in serum metabolite levels (CMS)
Charged multivesicular body protein 2a levels
Charged multivesicular body protein 2b levels
Charged multivesicular body protein 3 levels
Cheese consumption
Chemerin levels
Chenodeoxycholate levels in elite athletes
Chicken liking
Chickenpox
Childhood aggressive behavior
Childhood ALL/LBL (acute lymphoblastic leukemia/lymphoblastic lymphoma) treatment-related venous thromboembolism
Childhood and early adolescence aggressive behavior
Childhood asthma
Childhood asthma exacerbations in long-acting beta2-agonist treatment
Childhood asthma with severe exacerbations
Childhood asthma x sex interaction
Childhood body fatness
Childhood body mass index
Childhood ear infection
Childhood gender nonconformity
Childhood lung function (FEV1 percent predicted) in low-income urban environment
Childhood maltreatment
Childhood median systolic blood pressure percentile
Childhood median systolic blood pressure percentile (0-3 years old)
Childhood median systolic blood pressure percentile (13-18 years old)
Childhood median systolic blood pressure percentile (4-7 years old)
Childhood median systolic blood pressure percentile (8-12 years old)
Childhood obesity
Childhood onset type 2 diabetes
Childhood steroid-sensitive nephrotic syndrome
Chin dimples
Chin morphology
Chiro-inositol levels in elite athletes
Chitinase-3-like protein 1 level in Chronic kidney disease with hypertension and no diabetes (11104_13)
Chitinase-3-like protein 1 levels
Chitinase-3-like protein 1 levels (CHI3L1.11104.13.3)
Chitinase-3-like protein 2 levels
Chitinase-3-like protein 2 levels (CHI3L2.9383.24.3)
Chitotriosidase-1 level in Chronic kidney disease with hypertension and no diabetes (10460_1)
Chitotriosidase-1 level in Chronic kidney disease with hypertension and no diabetes (3600_2)
Chitotriosidase-1 levels
Chitotriosidase-1 levels (CHIT1.3600.2.3)
CHKCI006 sp900018345 abundance in stool
Chlamydia trachomatis-related tubal factor infertility
Chloride intracellular channel protein 4 levels
Chloride intracellular channel protein 5 levels
Chloride levels
Chlorpyrifos levels
Cholangiocarcinoma in primary sclerosing cholangitis (time to event)
Cholate levels in elite athletes
Cholecystitis
Cholelithiasis
Cholelithiasis-related traits in sickle cell anemia
Cholesterol
Cholesterol and Triglycerides
Cholesterol efflux capacity
Cholesterol efflux capacity (cAMP stimulated assay)
Cholesterol esters in chylomicron and extremely large VLDL meal response (OrNLSr)
Cholesterol esters in very large VLDL meal response (OrNLSr)
Cholesterol in chylomicrons and extremely large VLDL (UKB data field 23484)
Cholesterol in IDL (UKB data field 23526)
Cholesterol in large HDL (UKB data field 23561)
Cholesterol in large LDL (UKB data field 23533)
Cholesterol in large VLDL (UKB data field 23498)
Cholesterol in medium HDL (UKB data field 23568)
Cholesterol in medium LDL (UKB data field 23540)
Cholesterol in medium VLDL (UKB data field 23505)
Cholesterol in small HDL (UKB data field 23575)
Cholesterol in small LDL (UKB data field 23547)
Cholesterol in small VLDL (UKB data field 23512)
Cholesterol in very large HDL (UKB data field 23554)
Cholesterol in very large VLDL (UKB data field 23491)
Cholesterol in very small VLDL (UKB data field 23519)
Cholesterol levels in chylomicrons and extremely large VLDL
Cholesterol levels in IDL
Cholesterol levels in large HDL
Cholesterol levels in large LDL
Cholesterol levels in large VLDL
Cholesterol levels in medium HDL
Cholesterol levels in medium LDL
Cholesterol levels in medium VLDL
Cholesterol levels in small HDL
Cholesterol levels in small LDL
Cholesterol levels in small VLDL
Cholesterol levels in very large HDL
Cholesterol levels in very large VLDL
Cholesterol levels in very small VLDL
Cholesterol to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23580)
Cholesterol to total lipids in IDL percentage (UKB data field 23610)
Cholesterol to total lipids in large HDL percentage (UKB data field 23635)
Cholesterol to total lipids in large LDL percentage (UKB data field 23615)
Cholesterol to total lipids in large VLDL percentage (UKB data field 23590)
Cholesterol to total lipids in medium HDL percentage (UKB data field 23640)
Cholesterol to total lipids in medium LDL percentage (UKB data field 23620)
Cholesterol to total lipids in medium VLDL percentage (UKB data field 23595)
Cholesterol to total lipids in small HDL percentage (UKB data field 23645)
Cholesterol to total lipids in small LDL percentage (UKB data field 23625)
Cholesterol to total lipids in small VLDL percentage (UKB data field 23600)
Cholesterol to total lipids in very large HDL percentage (UKB data field 23630)
Cholesterol to total lipids in very large VLDL percentage (UKB data field 23585)
Cholesterol to total lipids in very small VLDL percentage (UKB data field 23605)
Cholesterol to total lipids ratio in chylomicrons and extremely large VLDL
Cholesterol to total lipids ratio in IDL
Cholesterol to total lipids ratio in large HDL
Cholesterol to total lipids ratio in large LDL
Cholesterol to total lipids ratio in large VLDL
Cholesterol to total lipids ratio in medium HDL
Cholesterol to total lipids ratio in medium LDL
Cholesterol to total lipids ratio in medium VLDL
Cholesterol to total lipids ratio in small HDL
Cholesterol to total lipids ratio in small LDL
Cholesterol to total lipids ratio in small VLDL
Cholesterol to total lipids ratio in very large HDL
Cholesterol to total lipids ratio in very large VLDL
Cholesterol to total lipids ratio in very small VLDL
Cholesterol_[M+H-H2O]1+ levels
Cholesterol, total
Cholesteryl ester (15:0) levels
Cholesteryl ester (16:0) levels
Cholesteryl ester (17:0) levels
Cholesteryl ester (17:1) levels
Cholesteryl ester (18:0) levels
Cholesteryl ester (18:2) levels
Cholesteryl ester (18:3) levels
Cholesteryl ester (20:1) levels
Cholesteryl ester (20:2) levels
Cholesteryl ester (20:3) levels
Cholesteryl ester (20:4) levels
Cholesteryl ester (20:5) levels
Cholesteryl ester (22:0) levels
Cholesteryl ester (22:1) levels
Cholesteryl ester (22:4) levels
Cholesteryl ester (22:5) (n3) levels
Cholesteryl ester (22:5) (n6) levels
Cholesteryl ester (22:6) levels
Cholesteryl ester (24:0) levels
Cholesteryl ester (24:1) levels
Cholesteryl ester (24:4) levels
Cholesteryl ester (24:5) levels
Cholesteryl ester (24:6) levels
Cholesteryl ester levels
Cholesteryl ester levels in chylomicrons and extremely large VLDL
Cholesteryl ester levels in HDL
Cholesteryl ester levels in IDL
Cholesteryl ester levels in large HDL
Cholesteryl ester levels in large LDL
Cholesteryl ester levels in large VLDL
Cholesteryl ester levels in LDL
Cholesteryl ester levels in medium HDL
Cholesteryl ester levels in medium LDL
Cholesteryl ester levels in medium VLDL
Cholesteryl ester levels in small HDL
Cholesteryl ester levels in small LDL
Cholesteryl ester levels in small VLDL
Cholesteryl ester levels in very large HDL
Cholesteryl ester levels in very large VLDL
Cholesteryl ester levels in very small VLDL
Cholesteryl ester levels in VLDL
Cholesteryl ester transfer protein levels
Cholesteryl ester_14:0_[M+NH4]1+ levels
Cholesteryl ester_15:0_[M+NH4]1+ levels
Cholesteryl ester_16:0_[M+NH4]1+ levels
Cholesteryl ester_16:1_[M+NH4]1+ levels
Cholesteryl ester_17:1_[M+NH4]1+ levels
Cholesteryl ester_18:0_[M+NH4]1+ levels
Cholesteryl ester_18:1_[M+NH4]1+ levels
Cholesteryl ester_18:2_[M+NH4]1+ levels
Cholesteryl ester_18:3_[M+NH4]1+ levels
Cholesteryl ester_20:3_[M+NH4]1+ levels
Cholesteryl ester_20:5_[M+NH4]1+ levels
Cholesteryl ester_22:5_[M+NH4]1+ levels
Cholesteryl ester_22:6_[M+NH4]1+ levels
Cholesteryl ester(16:0)_[M+NH4]1+ levels
Cholesteryl ester(16:1)_[M+NH4]1+ levels
Cholesteryl ester(17:1)_[M+NH4]1+ levels
Cholesteryl ester(18:0)_[M+NH4]1+ levels
Cholesteryl ester(18:1)_[M+NH4]1+ levels
Cholesteryl ester(18:2)_[M+NH4]1+ levels
Cholesteryl ester(18:3)_[M+NH4]1+ levels
Cholesteryl ester(20:3)_[M+NH4]1+ levels
Cholesteryl ester(20:4)_[M+NH4]1+ levels
Cholesteryl ester(20:5)_[M+NH4]1+ levels
Cholesteryl esters in chylomicrons and extremely large VLDL (UKB data field 23485)
Cholesteryl esters in HDL (UKB data field 23418)
Cholesteryl esters in IDL (UKB data field 23527)
Cholesteryl esters in large HDL (UKB data field 23562)
Cholesteryl esters in large LDL (UKB data field 23534)
Cholesteryl esters in large VLDL (UKB data field 23499)
Cholesteryl esters in LDL (UKB data field 23417)
Cholesteryl esters in medium HDL (UKB data field 23569)
Cholesteryl esters in medium LDL (UKB data field 23541)
Cholesteryl esters in medium VLDL (UKB data field 23506)
Cholesteryl esters in small HDL (UKB data field 23576)
Cholesteryl esters in small LDL (UKB data field 23548)
Cholesteryl esters in small VLDL (UKB data field 23513)
Cholesteryl esters in very large HDL (UKB data field 23555)
Cholesteryl esters in very large VLDL (UKB data field 23492)
Cholesteryl esters in very small VLDL (UKB data field 23520)
Cholesteryl esters in VLDL (UKB data field 23416)
Cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23581)
Cholesteryl esters to total lipids in IDL percentage (UKB data field 23611)
Cholesteryl esters to total lipids in large HDL percentage (UKB data field 23636)
Cholesteryl esters to total lipids in large LDL percentage (UKB data field 23616)
Cholesteryl esters to total lipids in large VLDL percentage (UKB data field 23591)
Cholesteryl esters to total lipids in medium HDL percentage (UKB data field 23641)
Cholesteryl esters to total lipids in medium LDL percentage (UKB data field 23621)
Cholesteryl esters to total lipids in medium VLDL percentage (UKB data field 23596)
Cholesteryl esters to total lipids in small HDL percentage (UKB data field 23646)
Cholesteryl esters to total lipids in small LDL percentage (UKB data field 23626)
Cholesteryl esters to total lipids in small VLDL percentage (UKB data field 23601)
Cholesteryl esters to total lipids in very large HDL percentage (UKB data field 23631)
Cholesteryl esters to total lipids in very large VLDL percentage (UKB data field 23586)
Cholesteryl esters to total lipids in very small VLDL percentage (UKB data field 23606)
Cholesteryl esters to total lipids ratio in chylomicrons and extremely large VLDL
Cholesteryl esters to total lipids ratio in IDL
Cholesteryl esters to total lipids ratio in large HDL
Cholesteryl esters to total lipids ratio in large LDL
Cholesteryl esters to total lipids ratio in large VLDL
Cholesteryl esters to total lipids ratio in medium HDL
Cholesteryl esters to total lipids ratio in medium LDL
Cholesteryl esters to total lipids ratio in medium VLDL
Cholesteryl esters to total lipids ratio in small HDL
Cholesteryl esters to total lipids ratio in small LDL
Cholesteryl esters to total lipids ratio in small VLDL
Cholesteryl esters to total lipids ratio in very large HDL
Cholesteryl esters to total lipids ratio in very large VLDL
Cholesteryl esters to total lipids ratio in very small VLDL
Choline levels
Choline levels in elite athletes
Choline phosphate levels
Choline phosphate levels in elite athletes
Choline/ethanolamine kinase level in Chronic kidney disease with hypertension and no diabetes (13117_232)
Choline/ethanolamine kinase levels
Choline/ethanolamine kinase levels (CHKB.13117.232.3)
Cholinesterase levels
Chondrocalcin level in Chronic kidney disease with hypertension and no diabetes (18875_125)
Chondrocalcin levels
Chondroitin sulfate N-acetylgalactosaminyltransferase 2 levels
Chondroitin sulfate N-acetylgalactosaminyltransferase 2 levels (CSGALNACT2.10772.21.3)
Chondroitin sulfate proteoglycan 4 levels
Chordin-like protein 2 levels
Chordin-like protein 2 levels (CHRDL2.6086.15.3)
Choriogonadotropin subunit beta variant 2 levels
Choroid plexus volume
Choroidal melanoma
Chromodomain Y-like protein 2 level in Chronic kidney disease with hypertension and no diabetes (10752_8)
Chromodomain Y-like protein 2 levels
Chromogranin-A levels (CHGA.8476.11.3)
Chromosomal aberration frequency (chromatid type)
Chromosomal aberration frequency (chromosome type)
Chromosomal aberration frequency (chromosome type) in genotoxic compound exposure
Chromosomal aberration frequency (total)
Chromosomal aberration frequency (total) in genotoxic compound exposure
Chronic back pain
Chronic bronchitis
Chronic bronchitis and chronic obstructive pulmonary disease
Chronic central serous retinopathy
Chronic Chagas Cardiomyopathy in Chagas disease
Chronic elevation of alanine aminotransferase (cALT) levels
Chronic graft-versus-host disease (donor effect)
Chronic heart failure
Chronic hepatitis B infection
Chronic hepatitis C infection
Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
Chronic kidney disease
Chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes
Chronic kidney disease and serum creatinine levels
Chronic lymphocytic leukemia
Chronic lymphocytic leukemia or multiple sclerosis
Chronic lymphocytic leukemia or rheumatoid arthritis
Chronic lymphocytic leukemia or systemic lupus erythematosus
Chronic mountain sickness
Chronic mucus hypersecretion
Chronic myeloid leukemia
Chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (moderate to severe)
Chronic obstructive pulmonary disease (severe)
Chronic obstructive pulmonary disease in current smokers
Chronic obstructive pulmonary disease in ever smokers
Chronic obstructive pulmonary disease in never smokers
Chronic obstructive pulmonary disease in non-current smokers
Chronic obstructive pulmonary disease liability (machine learning-based score)
Chronic obstructive pulmonary disease or coronary artery disease (pleiotropy)
Chronic obstructive pulmonary disease or high blood pressure (pleiotropy)
Chronic obstructive pulmonary disease or resting heart rate (pleiotropy)
Chronic obstructive pulmonary disease x current smoker interaction (1df)
Chronic obstructive pulmonary disease x current smoker interaction (2df)
Chronic obstructive pulmonary disease x current smoker interaction (main effect)
Chronic obstructive pulmonary disease x ever smoker interaction (1df)
Chronic obstructive pulmonary disease x ever smoker interaction (2df)
Chronic obstructive pulmonary disease x ever smoker interaction (main effect)
Chronic obstructive pulmonary disease-related biomarkers
Chronic pain
Chronic periodontitis
Chronic periodontitis (localised)
Chronic periodontitis (mean interproximal clinical attachment level)
Chronic rhinosinusitis
Chronic rhinosinusitis with nasal polyps
Chronic sinus infection
Chronic spontaneous urticaria
Chronic sputum production
Chronic venous disease
Chronic widespread musculoskeletal pain
Chronotype
Chronotype (sMEQ score)
Chronotype in high daytime light exposure
Chronotype in low daytime light exposure
Chronotype x daytime light exposure interaction
Chylomicron and extremely large VLDL particle concentration meal response (OrNLSr)
Chymase levels
Chymotrypsin-C levels
Chymotrypsin-like elastase family member 1 levels
Chymotrypsin-like elastase family member 2A levels
Chymotrypsin-like protease CTRL-1 levels
Chymotrypsinogen B levels
Chymotrypsinogen B levels (CTRB1.5671.1.3)
Chymotrypsinogen B2 level in Chronic kidney disease with hypertension and no diabetes (5648_28)
Cigarette consumption x hours spent using computers interaction
Cigarette consumption x hours spent watching television interaction
Cigarette consumption x playing computer games interaction
Cigarettes smoked per day
Cigarettes smoked per day (current)
Cigarettes smoked per day (MTAG)
Cigarettes smoked per day (past)
Cigarettes smoked per day in Schizophrenia
Cilia- and flagella-associated protein 45 levels
Ciliary neurotrophic factor receptor subunit alpha levels
Cinnamoylglycine levels in elite athletes
Circulating cell-free DNA
Circulating chemerin levels
Circulating chromogranin peptide levels
Circulating complement factor I levels
Circulating docosahexaenoic acid levels
Circulating fibroblast growth factor 21 levels
Circulating fibroblast growth factor 23 levels
circulating leptin levels
circulating leptin levels adjusted for BMI
Circulating leptin levels in high cardiovascular risk
Circulating leptin levels or fasting insulin levels
Circulating leptin levels or HOMA-IR
Circulating leptin levels or type 2 diabetes
Circulating leptin levels x sex interaction in high cardiovascular risk
Circulating levels of total-tau
Circulating myeloperoxidase levels (plasma)
Circulating myeloperoxidase levels (serum)
Circulating odd-numbered chain saturated fatty acid levels (C15:0)
Circulating odd-numbered chain saturated fatty acid levels (C15:0+C17:0)
Circulating odd-numbered chain saturated fatty acid levels (C17:0)
Circulating odd-numbered chain saturated fatty acid levels (C19:0)
Circulating phylloquinone levels
Circulating plasma alpha-Klotho levels
Circulating vasoactive peptide levels
Cirrhosis (alcohol related)
Cirrhosis (multi-trait analysis)
Cis 3,4-methyleneheptanoate levels
Cis-3,4-methyleneheptanoylcarnitine levels
Cis-3,4-methyleneheptanoylglycine levels
Cis-4-decenoate (10:1n6) (X-23293) levels
Cis-4-decenoate (10:1n6) levels
Cis-4-decenoyl carnitine levels
Cis-4-decenoylcarnitine (C10:1) levels
Cis-4-decenoylcarnitine (C10:1) levels in elite athletes
Cis-5,8,11,14,17-eicosapentaenoic acid (C20:5n3) levels in coronary artery disease
Cisplatin-induced nephrotoxicity (decreased eGFR)
Cisplatin-induced nephrotoxicity (increased serum creatinine AKI-CTCAE)
Cisplatin-induced ototoxicity
Citraconate/glutaconate levels in elite athletes
Citrate levels
Citrate levels (UKB data field 23473)
Citrulline levels
Ck-beta-8-1 level in Chronic kidney disease with hypertension and no diabetes (3028_36)
Ck-beta-8-1 levels
Ck-beta-8-1 levels (CCL23.3028.36.2)
Classic bladder exstrophy
Clathrin heavy chain 1 levels
Clathrin interactor 1 levels
Claudin-1 level in Chronic kidney disease with hypertension and no diabetes (24641_10)
Cleavage stimulation factor 50 kDa subunit level in Chronic kidney disease with hypertension and no diabetes (24055_44)
Cleft lip with or without cleft palate
Cleft lip with or without cleft palate (maternal periconceptional cigarette smoking interaction)
Cleft lip with or without cleft palate (maternal periconceptional vitamin use interaction)
Cleft lip with or without cleft palate or cleft palate (pleiotropy)
Cleft lip with or without cleft palate x maternal periconceptional alcohol use interaction (parent of origin effect)
Cleft lip with or without cleft palate x maternal periconceptional smoking interaction (parent of origin effect)
Cleft lip with or without cleft palate x maternal periconceptional vitamin use interaction (parent of origin effect)
Cleft palate
Cleft plate (environmental tobacco smoke interaction)
Clinical depression
Clinical laboratory measurements
Clinical LDL cholesterol levels
Clinical LDL cholesterol levels (UKB data field 23404)
Clopidogrel active metabolite levels
Clostridia abundance in stool
Clostridioides difficle infection
Clostridioides difficle infection in antibiotics-users
Clostridium difficile infection in multiple myeloma
Clostridium tertium abundance in stool
Clozapine concentration in schizophrenia
Clozapine-induced agranulocytosis
Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia
Clozapine-induced cytotoxicity
Clozapine-induced myocarditis in schizophrenia
Clozapine-to-N-desmethylclozapine metabolic ratio in schizophrenia
Clubfoot
Cluster headache
Clustered mitochondria protein homolog level in Chronic kidney disease with hypertension and no diabetes (24941_14)
Clusterin levels
Clusterin-like protein 1 levels
CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 levels
CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2 levels
CMRF35-like molecule 1 levels
CMRF35-like molecule 6 levels
CMRF35-like molecule 7 levels
CMRF35-like molecule 8 level in Chronic kidney disease with hypertension and no diabetes (5630_48)
CMRF35-like molecule 8 levels
Coactosin-like protein level in Chronic kidney disease with hypertension and no diabetes (4905_63)
Coagulation factor IX levels
Coagulation factor IXab levels
Coagulation factor levels
Coagulation Factor V levels
Coagulation factor VII level in Chronic kidney disease with hypertension and no diabetes (3184_25)
Coagulation Factor VII levels
Coagulation Factor VIII levels
Coagulation Factor X levels
Coagulation Factor X levels (F10.4878.3.1)
Coagulation factor Xa levels
Coagulation factor Xa levels (F10.3077.66.2)
Coagulation Factor XI levels
Coagulation factor XIII B chain levels
Coagulation factor XIII levels
Coatomer subunit epsilon levels
Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial levels
Cobalt levels
Cocaine dependence
Cocaine dependence (time to event)
Cocaine use disorder x change in residence interaction
Cochlin levels
Cochlin levels (COCH.7227.75.3)
Coenzyme Q10 levels
Coffee consumption
Coffee consumption (cups per day)
Coffee difference liking
Coffee intake (standard GWA)
Coffee max liking
Coffee type: Decaffeinated coffee (any type) (UKB data field 1508_1)
Cofilin-1 levels (CFL1.4203.50.2)
Cognitive ability
Cognitive ability (MTAG)
Cognitive ability in schizophrenia
Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)
Cognitive aspects of educational attainment
Cognitive decline (age-related)
Cognitive decline in depression
Cognitive decline rate in late mild cognitive impairment
Cognitive empathy
Cognitive flexibility
Cognitive function
Cognitive function (delayed memory)
Cognitive function (generalized correlation coefficient)
Cognitive function (global cognition) x major depressive disorder interaction (2df)
Cognitive function (immediate memory)
Cognitive function (immediate memory) (longitudinal)
Cognitive function (kinship model)
Cognitive function (mixed linear model)
Cognitive function (processing speed) x major depressive disorder interaction (2df)
Cognitive function in longevity
Cognitive impairment
Cognitive impairment in depression
Cognitive impairment level
Cognitive impairment test score
Cognitive performance
Cognitive performance (attention) (longitudinal)
Cognitive performance (language ability)
Cognitive performance (language ability) (longitudinal)
Cognitive performance (MTAG)
Cognitive performance (processing speed)
Cognitive performance (visuoconstruction)
Cognitive performance (visuoconstruction) (longitudinal)
Cognitive test performance
Cognitive traits (MTAG)
Coiled-coil domain-containing protein 126 levels
Coiled-coil domain-containing protein 126 levels (CCDC126.6388.21.3)
Coiled-coil domain-containing protein 134 levels
Coiled-coil domain-containing protein 167 levels
Coiled-coil domain-containing protein 50 levels
Coiled-coil domain-containing protein 51 levels
Coiled-coil domain-containing protein 80 levels
Coiled-coil domain-containing protein 90B, mitochondrial level in Chronic kidney disease with hypertension and no diabetes (7792_58)
Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications
Cold shock domain-containing protein E1 levels
Cold sores
Cold-inducible RNA-binding protein levels
Colipase levels
Colipase levels (CLPS.5749.53.3)
Colipase-like protein 1 level in Chronic kidney disease with hypertension and no diabetes (9526_3)
Colipase-like protein 1 levels
Colipase-like protein 2 levels
Collagen alpha-1(I) chain levels
Collagen alpha-1(I) chain levels (COL1A1.11140.56.3)
Collagen alpha-1(IX) chain levels
Collagen alpha-1(VI) chain levels (COL6A1.11150.3.3)
Collagen alpha-1(X) chain levels
Collagen alpha-1(XV) chain levels
Collagen alpha-1(XV) chain levels (COL15A1.8974.172.3)
Collagen alpha-2(IX) chain levels (COL9A2.9804.11.3)
Collagen alpha-2(VI) chain levels
Collagen alpha-2(XI) chain levels
Collagen alpha-3(VI) chain levels
Collagen triple helix repeat-containing protein 1 levels
Collagen Type II levels
Collagen Type III levels
Collagen type IV alpha-3-binding protein levels
Collagenase 3 levels
Collectin-10 levels
Collectin-11 levels (COLEC11.4430.44.3)
Collectin-12 levels
Colon cancer
Colon polyp
Colonoscopy-negative controls vs population controls
Colorectal adenoma (advanced)
Colorectal cancer
Colorectal cancer (alcohol consumption interaction)
Colorectal cancer (aspirin and/or NSAID use interaction)
Colorectal cancer (calcium intake interaction)
Colorectal cancer (diet interaction)
Colorectal cancer (oestrogen-progestogen hormone therapy interaction)
Colorectal cancer or advanced adenoma
Colorectal cancer vs inflammatory bowel disease
Colorectal cancer x estrogen hormone therapy interaction
Colorectal cancer x estrogen hormone therapy interaction (2df test)
Colorectal cancer x estrogen hormone therapy interaction (3df test)
Colorectal cancer x estrogen-progesterone hormone therapy interaction
Colorectal cancer x estrogen-progesterone hormone therapy interaction (2df test)
Colorectal cancer x estrogen-progesterone hormone therapy interaction (3df test)
Colorectal cancer x fine particulate matter exposure levels interaction
Colorectal cancer x menopausal hormone therapy interaction
Colorectal cancer x menopausal hormone therapy interaction (2df test)
Colorectal cancer x menopausal hormone therapy interaction (3df test)
Colorectal cancer x smoking status interaction (3df)
Colorectal or endometrial cancer
Colorectal polyp and colorectal cancer (MTAG)
Combined resilience (covariance of educational attainment with residual cognitive resilience)
COMM domain-containing protein 10 level in Chronic kidney disease with hypertension and no diabetes (23257_14)
COMM domain-containing protein 7 levels
COMM domain-containing protein 9 levels
Common carotid intima-media thickness
Common carotid intima-media thickness in HIV infection
Common carotid intima-media thickness in HIV negative individuals
Common executive function
Common neurobiological substrate measurement (PC1)
Common traits (Other)
Complement C1q and tumor necrosis factor-related protein 9A level in Chronic kidney disease with hypertension and no diabetes (16605_2)
Complement C1q and tumor necrosis factor-related protein 9A levels
Complement C1q subcomponent levels
Complement C1q subcomponent subunit C levels
Complement C1q subcomponent subunit C levels (C1QC.14100.63.3)
Complement C1q tumor necrosis factor-related protein 1 levels
Complement C1q tumor necrosis factor-related protein 1 levels (C1QTNF1.6304.8.3)
Complement C1q tumor necrosis factor-related protein 3 levels
Complement C1q tumor necrosis factor-related protein 5 levels
Complement C1q tumor necrosis factor-related protein 5 levels (C1QTNF5.7810.20.3)
Complement C1q-like protein 2 level in Chronic kidney disease with hypertension and no diabetes (15670_15)
Complement C1q-like protein 2 levels
Complement C1r subcomponent levels
Complement C1r subcomponent-like protein levels
Complement C1s subcomponent levels
Complement C3 and C4 levels
Complement C3 levels
Complement C3b, inactivated levels
Complement C3d fragment levels
Complement C4 levels
Complement C5 levels
Complement C5b-C6 complex levels
Complement component 1 Q subcomponent-binding protein, mitochondrial levels
Complement component 1 Q subcomponent-binding protein, mitochondrial levels (C1QBP.4967.1.1)
Complement component C1q receptor levels
Complement component C6 levels
Complement component C7 levels
Complement component C8 gamma chain levels
Complement component C8 levels
Complement decay-accelerating factor levels
Complement decay-accelerating factor levels (CD55.5069.9.3)
Complement factor B levels
Complement factor B levels (CFB.4129.72.1)
Complement factor D levels
Complement factor H binding to malondialdehyde
Complement factor H levels
Complement factor H levels (CFH.4159.130.1)
Complement factor H measurement
Complement factor H-like 1 protein levels
Complement factor H-related protein 1 levels
Complement factor H-related protein 2 level in Chronic kidney disease with hypertension and no diabetes (15584_9)
Complement factor H-related protein 2 levels
Complement factor H-related protein 3 levels
Complement factor H-related protein 4 levels
Complement factor H-related protein 4A levels
Complement factor H-related protein 5 level in Chronic kidney disease with hypertension and no diabetes (16055_3)
Complement factor H-related protein 5 levels
Complement factor H-related protein 5 levels (CFHR5.3666.17.4)
Complement factor I levels
Complement factor I levels (CFI.2567.5.6)
Complement receptor type 1 levels
Complement receptor type 2 levels
Completion of the aide-memoire
Composite immunoglobulin trait (IgA x IgG)
Composite immunoglobulin trait (IgA x IgG/IgM)
Composite immunoglobulin trait (IgA/IgG)
Composite immunoglobulin trait (IgA/IgM)
Composite immunoglobulin trait (IgG/IgM)
Comprehensive listening
Comprehensive strength and appendicular lean mass
Compulsion score in obsessive compulsive disorder
Computer vision syndrome
Concentration of chylomicrons and extremely large VLDL particles
Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481)
Concentration of HDL particles
Concentration of HDL particles (UKB data field 23430)
Concentration of IDL particles
Concentration of IDL particles (UKB data field 23523)
Concentration of large HDL particles
Concentration of large HDL particles (UKB data field 23558)
Concentration of large LDL particles
Concentration of large LDL particles (UKB data field 23530)
Concentration of large VLDL particles
Concentration of large VLDL particles (UKB data field 23495)
Concentration of LDL particles
Concentration of LDL particles (UKB data field 23429)
Concentration of medium HDL particles
Concentration of medium HDL particles (UKB data field 23565)
Concentration of medium LDL particles
Concentration of medium LDL particles (UKB data field 23537)
Concentration of medium VLDL particles
Concentration of medium VLDL particles (UKB data field 23502)
Concentration of small HDL particles
Concentration of small HDL particles (UKB data field 23572)
Concentration of small LDL particles
Concentration of small LDL particles (UKB data field 23544)
Concentration of small VLDL particles
Concentration of small VLDL particles (UKB data field 23509)
Concentration of very large HDL particles
Concentration of very large HDL particles (UKB data field 23551)
Concentration of very large VLDL particles
Concentration of very large VLDL particles (UKB data field 23488)
Concentration of very small VLDL particles
Concentration of very small VLDL particles (UKB data field 23516)
Concentration of VLDL particles
Concentration of VLDL particles (UKB data field 23428)
Conduct disorder
Conduct disorder (maternal expressed emotions interaction)
Conduct disorder (symptom count)
Congenital heart disease
Congenital heart disease (anomalies of thoracic arteries and veins)
Congenital heart disease (inherited effect)
Congenital heart disease (maternal effect)
Congenital heart disease (septal defects)
Congenital heart malformation
Congenital left-sided heart lesions
Congenital solitary functioning kidney
Congenital Zika syndrome
Congestive heart failure
Conjunctival UV autofluorescence (CUVAF)
Connective tissue-activating peptide III levels
Conotruncal heart defects
Conotruncal heart defects (inherited effects)
Conotruncal heart defects (maternal effects)
Conotruncal heart defects with normally related great vessels
Conotruncal heart defects with normally related great vessels (without 22q.11.2 deletion syndrome)
Conotruncal heart defects with normally related great vessels in 22q.11.2 deletion syndrome
Conscientiousness
Constipation
Contactin-1 levels
Contactin-2 level in Chronic kidney disease with hypertension and no diabetes (3296_92)
Contactin-2 levels
Contactin-2 levels (CNTN2.3296.92.2)
Contactin-4 levels
Contactin-5 levels
Contrast sensitivity
Conversion from active surveillance to active treatment in prostate cancer
Cooked vegetable consumption
Cooked vegetables consumption
COP9 signalosome complex subunit 2 level in Chronic kidney disease with hypertension and no diabetes (14029_42)
COP9 signalosome complex subunit 2 levels
COP9 signalosome complex subunit 2 levels (COPS2.14029.42.3)
COP9 signalosome complex subunit 7b level in Chronic kidney disease with hypertension and no diabetes (12384_92)
COP9 signalosome complex subunit 7b levels
Copine-1 levels
Copine-1 levels (CPNE1.5346.24.3)
Copper chaperone for superoxide dismutase levels
Copper homeostasis protein cutC homolog levels
Copper levels
Copper transport protein ATOX1 levels
Coprococcus comes
Core-binding factor subunit beta levels
Coriander liking
Corneal astigmatism
Corneal curvature
Corneal endothelial cell density
Corneal endothelial cell shape (percentage of hexagonally shaped cells)
Corneal endothelial cell size variation coefficient
Corneal hysteresis
Corneal resistance factor
Corneal resistance factor (MTAG)
Corneal structure
Corneodesmosin levels
Corneodesmosin levels (CDSN.7085.81.3)
Cornulin level in Chronic kidney disease with hypertension and no diabetes (17738_7)
Cornulin levels
Coronary artery aneurysm in Kawasaki disease
Coronary artery calcification
Coronary artery calcification in type 2 diabetes (excluding prevalent cardiovascular disease)
Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes
Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes
Coronary artery calcified atherosclerotic plaque score in type 2 diabetes
Coronary artery disease
Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)
Coronary artery disease and HDL cholesterol levels (multivariate analysis)
Coronary artery disease and LDL cholesterol levels (multivariate analysis)
Coronary artery disease and total cholesterol levels (multivariate analysis)
Coronary artery disease and triglyceride levels (multivariate analysis)
Coronary artery disease in diabetes
Coronary artery disease in dyslipidemia
Coronary artery disease in hypertension
Coronary artery disease in individuals without type 2 diabetes
Coronary artery disease in type 1 diabetes
Coronary artery disease or factor VII levels (pleiotropy)
Coronary artery disease or factor VIII levels (pleiotropy)
Coronary artery disease or factor XI levels (pleiotropy)
Coronary artery disease or fibrinogen levels (pleiotropy)
Coronary artery disease or ischemic stroke
Coronary artery disease or large artery stroke
Coronary artery disease or plasminogen activator inhibitor 1 levels (pleiotropy)
Coronary artery disease or tissue plasminogen activator levels (pleiotropy)
Coronary artery disease or von Willebrand factor levels (pleiotropy)
Coronary atherosclerosis (increased number of diseased vessels) (traffic exposure interaction)
Coronary atherosclerosis (time to event)
Coronary heart disease
Coronary heart disease event reduction (statin therapy interaction)
Coronary heart disease x type 2 diabetes interaction
Coronary restenosis
Corpus callosum anterior volume
Corpus callosum central volume
Corpus callosum mid-anterior volume
Corpus callosum Mid-posterior volume
Corpus callosum posterior volume
Corrected insulin response
Corrected insulin response adjusted for insulin sensitivity index
Cortex volume
Cortex volume change rate
Cortex volume change rate x age interaction (1df)
Cortex volume change rate x age interaction (2df)
Cortexin-3 levels (CTXN3.10467.58.3)
Cortical amyloid beta load
Cortical brain region measurements (area, volume and thickness)
Cortical surface area
Cortical surface area (global PC1)
Cortical surface area (min-P)
Cortical surface area (MOSTest)
Cortical surface area (visual PC2)
Cortical thickness
Cortical thickness (min-P)
Cortical thickness (MOSTest)
Cortical thickness change rate
Cortical thickness change rate x age interaction (1df)
Cortical thickness change rate x age interaction (2df)
Cortical volume
Corticobasal degeneration
Corticoliberin levels
Corticosteroid-binding globulin levels
Corticotropin levels
Corticotropin-releasing factor-binding protein levels
Cortisol levels
Cortisol levels (plasma)
Cortisol levels (saliva)
Cortisol levels in elite athletes
Cortisone levels in elite athletes
Cortolone glucuronide (1) (X-17359) levels
Cortolone glucuronide (1) levels
Corynebacterium abundance in stool
Cotinine and 3'-hydroxycotinine levels in current smokers
Cotinine glucuronidation
Cotinine levels in current smokers
Cotinine levels in smokers with chronic obstructive pulmonary disease
Cough in response to angiotensin-converting enzyme inhibitor drugs
COVID-19
COVID-19 (covid pneumonia vs population)
COVID-19 (covid respiratory support vs population)
COVID-19 (covid vs negative)
COVID-19 (critical illness vs mild symptoms)
COVID-19 (critical illness vs population or mild symptoms)
COVID-19 (critical illness vs population)
COVID-19 (hospitalized covid vs population)
COVID-19 (hospitalized vs negative or unknown)
COVID-19 (hospitalized vs not hospitalized)
COVID-19 (hospitalized vs population)
COVID-19 (hospitalized vs tested, not hospitalized)
COVID-19 (severe respiratory symptoms vs population)
COVID-19 (severe vs negative or unknown)
COVID-19 (severe vs non-severe with positive test)
COVID-19 (severe vs population)
COVID-19 (severe vs population) x cardiometabolic health status interaction (joint test)
COVID-19 (severe vs population) x multiple deprivation index interaction
COVID-19 (severe vs population) x multiple deprivation index interaction (joint test)
COVID-19 (severe vs tested, not severe)
COVID-19 critical illness or age-related macular degeneration (MTAG)
COVID-19 death (death vs population)
COVID-19 death (death vs tested and survived)
COVID-19 hospitalization or age-related macular degeneration (MTAG)
COVID-19 hospitalization or rheumatoid arthritis (MTAG)
COVID-19 hospitalization or systemic lupus erythematosus (MTAG)
COVID-19 infection or age-related macular degeneration (MTAG)
COVID-19 infection or rheumatoid arthritis (MTAG)
COVID-19 infection or systemic lupus erythematosus (MTAG)
COVID-19 or coronary artery disease (pleiotropy)
COVID-19 or hypertension (pleiotropy)
COVID-19 or obesity (pleiotropy)
COVID-19 or psoriasis (trans-disease meta-analysis)
COVID-19 or type 2 diabetes (pleiotropy)
COVID-19 related pneumonia
COVID-19 severity
COVID-19 symptoms (loss of smell or taste vs no loss of smell or taste)
Cranial base width
Craniofacial microsomia
Cream liking
Creatine kinase levels
Creatine kinase S-type, mitochondrial levels
Creatine kinase U-type, mitochondrial levels
Creatine levels
Creatine levels in elite athletes
Creatinine levels
Creatinine levels (UKB data field 23478)
Creatinine levels in elite athletes
Creatinine levels in ischemic stroke
Creativity
CREB-binding protein levels
Creutzfeldt-Jakob disease
Creutzfeldt-Jakob disease (sporadic)
Creutzfeldt-Jakob disease (variant)
Crisps liking
Crohn's disease
Crohn's disease (indolent vs progressive)
Crohn's disease (time to first abdominal surgery)
Crohn's disease (time to progression)
Crohn's disease (time to surgery)
Crohn's disease and celiac disease
Crohn's disease and psoriasis
Crohn's disease and sarcoidosis (combined)
Crohn's disease or Leprosy
Crohn's disease or Leprosy (opposite effect)
Crohn's disease or systemic sclerosis
Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS))
Crohn's disease vs ulcerative colitis
Crohn's disease vs ulcerative colitis (ordinary least squares (OLS))
Crohn's disease x smoking status (never vs current smoking) interaction
Crohn's disease x smoking status (never vs ever smoking) interaction
Crohn's disease-related phenotypes
Croissant liking
Cryptic phenotype that captures alpha-1-antitrypsin deficiency severity
Cryptic phenotype that captures Alport syndrome severity
Cryptic phenotype that captures autosomal dominant polycystic kidney disease severity
Cryptic protein levels
Cryptococcosis in HIV infection
Cryptosporidiosis
CSF tryptophan concentration in tuberculous meningitis
CTACK levels
CTSB plasma levels
CUB and sushi domain-containing protein 1 level in Chronic kidney disease with hypertension and no diabetes (9598_23)
CUB and sushi domain-containing protein 1 levels
CUB and sushi domain-containing protein 1 levels (CSMD1.9598.23.3)
CUB and sushi domain-containing protein 2 levels
CUB domain-containing protein 1 levels
cubilin levels
Cullin-1 levels
Cullin-4B levels
Cullin-9 levels
Cuneus cortex volume
Current cigarettes per day in chronic obstructive pulmonary disease
Curry liking
Cutaneous leishmaniasis
Cutaneous lupus erythematosus
Cutaneous malignant melanoma
Cutaneous mastocytosis
Cutaneous mastocytosis (adult)
Cutaneous mastocytosis (childhood)
Cutaneous melanoma (MTAG)
Cutaneous melanoma or hair colour
Cutaneous nevi
Cutaneous psoriasis
Cutaneous squamous cell carcinoma
CV-A6-associated hand, foot, and mouth disease (severe vs mild)
CX3CL1 levels
CX3CR1 on CD14- CD16-
CX3CR1 on CD14- CD16+ monocyte
CX3CR1 on CD14+ CD16- monocyte
CX3CR1 on CD14+ CD16+ monocyte
CX3CR1 on monocyte
CXADR-like membrane protein levels
CXADR-like membrane protein levels (CLMP.10440.26.3)
CXCL5 levels
CXCL6 levels
Cyclic AMP-dependent transcription factor ATF-6 alpha levels
Cyclic AMP-dependent transcription factor ATF-6 beta levels
Cyclic AMP-responsive element-binding protein 3-like protein 4 levels
Cyclic AMP-responsive element-binding protein 3-like protein 4 levels (CREB3L4.11308.8.3)
Cyclic nucleotide-gated olfactory channel levels
Cyclin-A1 levels
Cyclin-A2 levels
Cyclin-dependent kinase 15; EC=2.7.11.22 level in Chronic kidney disease with hypertension and no diabetes (21581_87)
Cyclin-dependent kinase 4 inhibitor D levels
Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex level in Chronic kidney disease with hypertension and no diabetes (3358_51)
Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex levels
Cyclin-dependent kinase 8:Cyclin-C complex levels
Cyclin-dependent kinase inhibitor 1 levels
Cyclin-dependent kinase inhibitor 1B levels
Cyclin-dependent kinase inhibitor 3 levels
Cyclin-H levels
Cyclo(leu-pro) levels
Cyclothymic temperament
Cys-gly, oxidized levels
Cystathionine beta-synthase levels
Cystathionine levels in elite athletes
Cystatin B plasma levels
Cystatin C levels
Cystatin C plasma levels
Cystatin-8 levels
Cystatin-B levels
Cystatin-C levels
Cystatin-D levels
Cystatin-F levels
Cystatin-F levels (CST7.3302.58.1)
Cystatin-like 1 levels
Cystatin-M levels (CST6.3303.23.2)
Cystatin-S levels
Cystatin-SA levels
Cystatin-SN levels
Cysteine and glycine-rich protein 1 levels
Cysteine and glycine-rich protein 2 levels
Cysteine levels in elite athletes
Cysteine s-sulfate levels in elite athletes
Cysteine sulfinic acid levels in elite athletes
Cysteine--tRNA ligase, cytoplasmic levels
Cysteine-glutathione disulfide levels
Cysteine-glutathione disulfide levels in elite athletes
Cysteine-rich hydrophobic domain-containing protein 2 levels (CHIC2.10914.4.3)
Cysteine-rich motor neuron 1 protein levels
Cysteine-rich PDZ-binding protein levels
Cysteine-rich protein 1 levels
Cysteine-rich protein 2 levels
Cysteine-rich secretory protein 2 level in Chronic kidney disease with hypertension and no diabetes (9282_12)
Cysteine-rich secretory protein 2 levels
Cysteine-rich secretory protein 2 levels (CRISP2.9282.12.3)
Cysteine-rich secretory protein LCCL domain-containing 2 levels
Cysteine-rich with EGF-like domain protein 1 levels
Cysteine-rich with EGF-like domain protein 1 levels (CRELD1.7628.40.3)
Cysteinylglycine disulfide levels
Cysteinylglycine levels
Cystic fibrosis severity
Cystic fibrosis-related diabetes
Cystic fibrosis-related diabetes in cystic fibrosis
Cystic Fibrosis-Related Diabetes in Cystic Fibrosis (adjusted for Meconium Ileus)
Cystine levels in elite athletes
Cytidine deaminase level in Chronic kidney disease with hypertension and no diabetes (18336_31)
Cytidine levels
Cytidine levels in elite athletes
Cytochrome b-c1 complex subunit 7 levels
Cytochrome c levels
Cytochrome c oxidase assembly factor 3 homolog, mitochondrial levels
Cytochrome c oxidase subunit 5A, mitochondrial levels
Cytochrome c oxidase subunit 6C levels
Cytochrome c oxidase subunit 8A, mitochondrial levels (COX8A.10497.242.3)
Cytohesin-2 levels
Cytohesin-2 levels (CYTH2.12533.135.3)
Cytokine levels
Cytokine network levels (multivariate analysis)
Cytokine receptor common subunit gamma levels
Cytokine receptor-like factor 1 levels
Cytokine SCM-1 beta levels
Cytokine-like protein 1 levels
Cytomegalovirus antibody response
Cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation (recipients)
Cytoplasmic tyrosine-protein kinase BMX levels
Cytoskeleton-associated protein 2 levels
Cytoskeleton-associated protein 2 levels (CKAP2.5345.51.3)
Cytosol aminopeptidase levels
Cytosolic 5-nucleotidase 3A levels
Cytosolic endo-beta-N-acetylglucosaminidase levels
Cytosolic non-specific dipeptidase levels
Cytosolic purine 5-nucleotidase levels
Cytotoxic and regulatory T-cell molecule levels
D-amino-acid oxidase levels
D-dimer levels
D-dimer levels in HIV infection
D-dopachrome decarboxylase levels
D-glucuronyl C5-epimerase level in Chronic kidney disease with hypertension and no diabetes (7808_5)
D-glucuronyl C5-epimerase levels
D-glucuronyl C5-epimerase levels (GLCE.7808.5.3)
D-tyrosyl-tRNA(Tyr) deacylase 1 levels
Daunorubicin drug response (IC50)
Daytime nap
Daytime sleep phenotypes
DCN1-like protein 1 levels
DCN1-like protein 3 levels
DCN1-like protein 5 levels
DCN1-like protein 5 levels (DCUN1D5.8760.10.3)
DDB1- and CUL4-associated factor 11 level in Chronic kidney disease with hypertension and no diabetes (22120_4)
DDT metabolite (DDD p-p') levels
DDT metabolite (DDT o-p') levels
DDT metabolite (DDT p-p') levels
DDT metabolite (p,p'-DDE levels)
Death-associated protein 1 levels
Death-associated protein kinase 1 levels
Death-associated protein kinase 2 levels
Decadienedioic acid (c10:2-dc) (X-21792) levels
Decadienedioic acid (C10:2-DC) levels
Decaffeinated coffee consumption and/or alcohol consumption score
Decaffeinated coffee consumption and/or alcohol dependence and hazardous-use score
Decaffeinated coffee consumption and/or alcohol use disorder score
Decaffeinated coffee consumption and/or insomnia
Decaffeinated coffee consumption and/or lifetime cannabis use
Decaffeinated coffee consumption and/or neuroticism
Decaffeinated coffee consumption or major depression disorder
Decanoylcarnitine (C10) levels
Decanoylcarnitine (C10) levels in elite athletes
Decanoylcarnitine levels
Decanoylcarnitine levels (Biocrates platform)
Decanoylcarnitine levels (Metabolon platform)
Decenoylcarnitine levels
Decline in glucose metabolism in posterior cingulate cortex
Declining hemoglobin trajectory in blood donors
Decreased low contrast letter acuity in multiple sclerosis
Dedicator of cytokinesis protein 9 levels (DOCK9.14002.18.3)
Deep ovarian and/or rectovaginal disease with dense adhesions
Deep white matter hyperintensities
Deformed epidermal autoregulatory factor 1 homolog levels
Deformed epidermal autoregulatory factor 1 homolog levels (DEAF1.6369.82.3)
Degraded stimulus continuous performance test score
Degree of unsaturation
Degree of unsaturation (UKB data field 23443)
Dehydrocholesteryl ester (16:0) levels
Dehydrocholesteryl ester (18:1) levels
Dehydrocholesteryl ester (18:2) levels
Dehydrocholesteryl ester (20:4) levels
Dehydrocholesteryl ester (20:5) levels
Dehydrocholesteryl ester (22:6) levels
Dehydroepiandrosterone sulfate (DHEA-S) levels
Dehydroepiandrosterone sulphate levels
Dehydrogenase/reductase SDR family member 9 levels
Dehydroisoandrosterone sulfate (DHEA-S) levels in elite athletes
Dehydroisoandrosterone sulfate DHEA-S levels
Delayed reward discounting
Deliberate self-harm
Delta and Notch-like epidermal growth factor-related receptor levels
Delta-5 desaturase activity
Delta-5 desaturase activity response to n3-polyunsaturated fat supplement
Delta-6 desaturase activity
Delta-6 desaturase activity response to n3-polyunsaturated fat supplement
Delta-aminolevulinic acid dehydratase levels
Delta-like protein 1 levels
Delta-like protein 1 levels (DLL1.5349.69.3)
Delta-like protein 3 level in Chronic kidney disease with hypertension and no diabetes (9974_8)
Delta-like protein 3 levels
Delta-like protein 4 levels
Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial levels
Dementia and core Alzheimer's disease neuropathologic changes
Dementia in APOE e4+ carriers
Dementia in non-APOE e4 carriers
Dementia with Lewy bodies
Dementia with Lewy bodies in APOE e4+ carriers
Dendritic Cell Absolute Count
Dengue shock syndrome
Dental anomalies (Displacement, Rotation and Mamelon)
Dental anomalies (Hypoplasia, displacement and rotation)
Dental anomalies (Tooth Agenesis, impaction and Rotation)
Dental caries
Dental caries (decayed and filled deciduous teeth)
Dental caries (decayed and filled deciduous tooth surfaces)
Dental caries (decayed, missing and filled teeth)
Dental caries (decayed, missing and filled tooth surfaces)
Dental caries, Agenesis and Hypoplasia
Dental development
Dentate gyrus granule cell layer volume
Dentate gyrus molecular layer volume
Dentate gyrus molecular layer volume (corrected for total hippocampal volume)
Dentate gyrus volume x schizophrenia interaction
Dentures
Deoxycarnitine levels
Deoxycarnitine levels in elite athletes
Deoxycholate levels
Deoxycholic acid (12 or 24)-sulfate levels
Deoxycholic acid 12-sulfate levels
Deoxycholic acid glucuronide (X-11491) levels
Deoxycholic acid glucuronide levels
Deoxycytidine kinase levels
Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 levels
Deoxyribonuclease-2-beta levels
Depressed affect
Depression
Depression (age of onset)
Depression (broad)
Depression (quantitative trait)
Depression (time to event)
Depression and alcohol dependence
Depression in multiple sclerosis (post-diagnosis)
Depression in response to interferon-based therapy in chronic hepatitis C
Depression in smokers
Depression severity x hours spent watching television interaction
Depression severity x playing computer games interaction
Depression x environmental factor score interaction
Depression x maternal smoking during pregnancy interaction
Depression, cognition and memory (multivariate analysis)
Depression/anxiety (standard GWA)
Depressive and manic episodes in bipolar disorder
Depressive episodes in bipolar disorder
Depressive symptom (anhedonia) (binary trait)
Depressive symptom (appetite changes) (binary trait)
Depressive symptom (fatigue) (ordinal trait)
Depressive symptom (low self-esteem) (ordinal trait)
Depressive symptom (sleep problems) (binary trait)
Depressive symptom improvement
Depressive symptom measurement or major depressive disorder
Depressive symptoms
Depressive symptoms (binary sum-score)
Depressive symptoms (MTAG)
Depressive symptoms (SSRI exposure interaction)
Depressive symptoms (stressful life events interaction)
Depressive symptoms (sum-score)
Depressive symptoms x dependent stressful life events interaction (1df test)
Depressive symptoms x dependent stressful life events interaction (2df test)
Depressive symptoms x herpes simplex 1 infection interaction
Depressive symptoms x independent stressful life events interaction (1df test)
Depressive symptoms x independent stressful life events interaction (2df test)
Depressive temperament
Derlin-1 levels
Dermatomyositis
Dermatomyositis or juvenile dermatomyositis
Dermatopontin levels
Dermatopontin levels (DPT.4979.34.2)
Dermokine level in Chronic kidney disease with hypertension and no diabetes (5963_9)
Dermokine levels
Descending aorta diameter
Descending aorta distensibility
Descending aorta distensibility (MTAG)
Descending aorta maximum area
Descending aorta maximum area (MTAG)
Descending aorta minimum area
Descending aorta strain
Descending thoracic aortic diameter
Desert hedgehog protein N-product levels
Desmocollin-1 level in Chronic kidney disease with hypertension and no diabetes (10882_12)
Desmocollin-1 levels
Desmocollin-2 levels
Desmocollin-2 levels (DSC2.13126.52.3)
Desmocollin-3 levels
Desmoglein-2 levels
Desmoglein-2 levels (DSG2.9484.75.3)
Desmoglein-3 levels
Desulfobacterota A abundance in stool
Desulfovibrionaceae abundance in stool
Desulfovibrionales abundance in stool
Desulfovibrionia abundance in stool
Detectable estradiol levels
Detectable estradiol levels in postmenopausal women
Detectable estradiol levels in premenopausal women
Developmental dysplasia of the hip
Developmental language disorder (linguistic errors)
Developmental language disorder (syntactic complexity)
Developmental stuttering
Developmentally-regulated GTP-binding protein 1 levels
dexamethasone sensitivity in B-cell precursor acute lymphoblastic leukaemia
DG(38:5) levels
DHEA-S-to-4-androsten-3beta,17beta-diol disulfate 2 ratio
DHEAS levels
Di-N-acetylchitobiase levels (CTBS.6115.40.3)
Di-n-butyl phthalate levels
Diabetes (gestational)
Diabetes (standard GWA)
Diabetes (weighted GWA)
Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)
Diabetes related insulin traits
Diabetic kidney disease
Diabetic kidney disease in type 2 diabetes
Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)
Diabetic macular edema in type 2 diabetes
Diabetic maculopathy in type 2 diabetes
Diabetic maculopathy with decreased visual acuity in type 2 diabetes
Diabetic nephropathy
Diabetic nephropathy in type 1 diabetes
Diabetic neuropathy in type 2 diabetes
Diabetic peripheral neuropathy in type 2 diabetes
Diabetic retinopathy
Diabetic retinopathy (all NPDR and PDR)
Diabetic retinopathy (moderate NPDR and PDR)
Diabetic retinopathy in type 2 diabetes
Diablo homolog, mitochondrial level in Chronic kidney disease with hypertension and no diabetes (3122_6)
Diablo homolog, mitochondrial levels
Diacetylspermine levels
Diacylglycerol (16:0_18:2) levels
Diacylglycerol (16:0_20:4) levels
Diacylglycerol (16:0_22:5) levels
Diacylglycerol (16:0_22:6) levels
Diacylglycerol (16:1/18:2 [2], 16:0/18:3 [1]) levels in elite athletes
Diacylglycerol (18:0_20:4) levels
Diacylglycerol (18:1_18:3) levels
Diacylglycerol (18:1_20:3) levels
Diacylglycerol (18:1_20:4) levels
Diacylglycerol (18:2_18:2) levels
Diacylglycerol (18:2_20:4) levels
Diacylglycerol kinase beta levels
Diacylglycerol_32:2_[M+H-H2O]1+ levels
Diacylglycerol_34:1_[M+H-H2O]1+ levels
Diacylglycerol_34:2_[M+H-H2O]1+ levels
Diacylglycerol_34:3_[M+H-H2O]1+ levels
Diacylglycerol_36:2_[M+H-H2O]1+ levels
Diacylglycerol_36:3_[M+H-H2O]1+ levels
Diacylglycerol_36:4_[M+H-H2O]1+ levels
Diacylglycerol_38:3_[M+H-H2O]1+ levels
Diacylglycerol_38:4_[M+H-H2O]1+ levels
Diacylglycerol_38:5_[M+H-H2O]1+ levels
Diacylglycerol_38:6_[M+H-H2O]1+ levels
Diacylglycerol_42:7_[M+H-H2O]1+ levels
Diacylglycerol_44:6_[M+H-H2O]1+ levels
Diacylglycerol_44:7_[M+H-H2O]1+ levels
Diacylglycerol(32:2)_[M+H-H2O]1+ levels
Diacylglycerol(34:0)_[M+H-H2O]1+ levels
Diacylglycerol(34:1)_[M+H-H2O]1+ levels
Diacylglycerol(34:2)_[M+H-H2O]1+ levels
Diacylglycerol(34:2)_[M+NH4]1+ levels
Diacylglycerol(34:3)_[M+H-H2O]1+ levels
Diacylglycerol(36:1)_[M+H-H2O]1+ levels
Diacylglycerol(36:2)_[M+H-H2O]1+ levels
Diacylglycerol(36:2)_[M+NH4]1+ levels
Diacylglycerol(36:3)_[M+H-H2O]1+ levels
Diacylglycerol(36:3)_[M+NH4]1+ levels
Diacylglycerol(36:4)_[M+H-H2O]1+ levels
Diacylglycerol(44:6)_[M+H-H2O]1+ levels
Dialysis-related mortality
Diamine acetyltransferase 2 levels
diarrhoeal disease at age 1
diarrhoeal disease at age 1 with doctor diagnosis
diarrhoeal disease at age 2
diarrhoeal disease at age 2 with doctor diagnosis
Diastolic blood pressure
Diastolic blood pressure (alcohol consumption interaction)
Diastolic blood pressure (baseline)
Diastolic blood pressure (cigarette smoking interaction)
Diastolic blood pressure (education interaction)
Diastolic blood pressure (long-term average)
Diastolic blood pressure change trajectory
Diastolic blood pressure in preeclampsia
Diastolic blood pressure night-to-day ratio in hypertension
Diastolic blood pressure response to hydrochlorothiazide in hypertension
Diastolic blood pressure response to thiazide and thiazide-like diuretics in hypertension
Diastolic blood pressure variability
Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)
Diastolic blood pressure x alcohol consumption interaction (1df test)
Diastolic blood pressure x alcohol consumption interaction (2df test)
Diastolic blood pressure x depressive symptoms interaction (2df test)
Diastolic blood pressure x educational attainment (some college) interaction (2df)
Diastolic blood pressure x low social support interaction (2df test)
Diastolic blood pressure x quantitative lifestyle risk score interaction (1df test)
Diastolic blood pressure x quantitative lifestyle risk score interaction (2df test)
Diastolic blood pressure x smoking status (current vs non-current) interaction (1df test)
Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)
Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)
Diastolic blood pressure x sodium interaction (1df test)
Diastolic blood pressure x sodium interaction (2df test)
Diazinon levels
Dickkopf-like protein 1 level in Chronic kidney disease with hypertension and no diabetes (16309_30)
Dickkopf-like protein 1 levels
Dickkopf-like protein 1 levels (DKKL1.3644.5.4)
Dickkopf-related protein 1 levels
Dickkopf-related protein 1 levels (DKK1.3535.84.1)
Dickkopf-related protein 2 levels
Dickkopf-related protein 3 levels
Dickkopf-related protein 3 levels (DKK3.3607.71.6)
Dickkopf-related protein 4 levels
Dickkopf-related protein 4 levels (DKK4.3365.7.2)
Dicofol levels
Dieldrin levels
Dietary Approaches to Stop Hypertension (DASH) diet
Dietary macronutrient intake
Dietary macronutrient intake (multi-trait analysis)
Differential aging (frontal cortex)
Differential aging in older adults (frontal cortex)
Differentially expressed in FDCP 6 homolog levels
Differentiated thyroid cancer
Diffuse cutaneous systemic sclerosis
Diffuse idiopathic skeletal hyperostosis flow score
Diffuse large B cell lymphoma
Diffuse large B-cell lymphoma or multiple sclerosis
Diffuse large B-cell lymphoma or rheumatoid arthritis
Diffuse large B-cell lymphoma or systemic lupus erythematosus
Diffuse plaques
Diffusing capacity of carbon monoxide
Diffusing capacity of the lung for carbon monoxide traits
Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)
Digit length ratio
Digit length ratio (left hand)
Digit length ratio (right hand)
Diglycerides (36:2) levels
Diglycerol levels in elite athletes
Dihexosylceramide (d16:1/16:0) levels
Dihexosylceramide (d16:1/24:1) levels
Dihexosylceramide (d18:1/16:0) levels
Dihexosylceramide (d18:1/18:0) levels
Dihexosylceramide (d18:1/20:0) levels
Dihexosylceramide (d18:1/22:0) levels
Dihexosylceramide (d18:1/24:0) levels
Dihexosylceramide (d18:1/24:1) levels
Dihexosylceramide (d18:2/16:0) levels
Dihexosylceramide (d18:2/24:1) levels
Dihomo-linoleate (20:2n6) levels in elite athletes
Dihomo-linolenate (20:3n3 or n6) levels
Dihomo-linolenate (20:3n3 or n6) levels in elite athletes
Dihomo-linolenate 20:3n3 or n6 levels
Dihomo-linolenoyl-choline levels in elite athletes
Dihomo-linolenoylcarnitine (20:3n3 or 6) levels in elite athletes
Dihomo-linolenoylcarnitine (C20:3n3 or 6) levels
Dihomo-linoleoylcarnitine (C20:2) levels
Dihomo-linoleoylcarnitine (C20:2) levels in elite athletes
Dihydroceramide (d18:0/18:0) levels
Dihydroceramide (d18:0/20:0) levels
Dihydroceramide (d18:0/22:0) levels
Dihydroceramide (d18:0/24:0) levels
Dihydroceramide (d18:0/24:1) levels
Dihydrofolate reductase level in Chronic kidney disease with hypertension and no diabetes (9823_2)
Dihydrofolate reductase levels
Dihydrofolate reductase levels (DHFR.9823.2.3)
Dihydrolipoyl dehydrogenase, mitochondrial levels
Dihydroorotate levels
Dihydroorotate levels in elite athletes
Dihydropteridine reductase levels
Dihydropteridine reductase levels (QDPR.11257.1.3)
Dihydropyrimidinase-related protein 3 levels
Diisocyanate-induced asthma
Dilated cardiomyopathy
Dilated cardiomyopathy (MTAG)
Dimethyl sulfone levels in elite athletes
Dimethylarginine (sdma + adma) levels
Dimethylarginine (SDMA + ADMA) levels in elite athletes
Dimethylglycine levels
Dimethylglycine levels in chronic kidney disease
Dimethylglycine levels in elite athletes
Dimethylguanido valerate levels in chronic kidney disease
Dipeptidase 1 levels
Dipeptidase 2 levels
Dipeptidyl peptidase 1 levels
Dipeptidyl peptidase 2 levels
Dipeptidyl peptidase 2 levels (DPP7.8346.9.3)
Dipeptidyl peptidase 4 levels
Diphosphomevalonate decarboxylase levels
Diphthine methyl ester synthase level in Chronic kidney disease with hypertension and no diabetes (23373_77)
Direct bilirubin levels
Direct bilirubin levels x insomnia interaction
Disability (impaired activities of daily living)
Disability level (impaired activities of daily living)
Disc degeneration (lumbar)
Discoidin, CUB and LCCL domain-containing protein 2 levels (DCBLD2.9338.2.3)
Discordance in emotional problems in monozygotic twins
Disease free survival in colorectal cancer
Disease progression in age-related macular degeneration
Disease progression in age-related macular degeneration (adjusted for baseline)
Disease progression to choroidal neovascularization form in age-related macular degeneration
Disease severity in uveal melanoma (TNM stage 3 or 4 vs TNM stage 1 or 2)
Disease-related mortality after unrelated donor allogeneic hematopoietic cell transplantation (donor effect)
Disintegrin and metalloproteinase domain-containing protein 10 levels
Disintegrin and metalloproteinase domain-containing protein 11 levels
Disintegrin and metalloproteinase domain-containing protein 15 level in Chronic kidney disease with hypertension and no diabetes (9956_7)
Disintegrin and metalloproteinase domain-containing protein 23 levels
Disintegrin and metalloproteinase domain-containing protein 23 levels (ADAM23.7049.2.3)
Disintegrin and metalloproteinase domain-containing protein 30 levels
Disintegrin and metalloproteinase domain-containing protein 7 levels
Disks large homolog 2 levels
Disks large homolog 3 levels
Disks large homolog 4 levels
Disrupted circadian rhythm (low relative amplitude of rest-activity cycles)
Disruptive behavior (multivariate analysis)
Disruptive behavior disorder and attention deficit hyperactivity disorder
Distal colorectal cancer
Distal/Left-sided colorectal cancer
Disturbances of the gamma-frequency band of electroencephalography measures in schizophrenia
Disulfoton levels
Diverticular disease
Diverticulitis
Dixin levels
DMGV levels
DNA (cytosine-5)-methyltransferase 3-like levels
DNA damage-inducible transcript 3 protein levels
DNA damage-inducible transcript 4 protein levels
DNA dC->dU-editing enzyme APOBEC-3G levels
DNA excision repair protein ERCC-1 levels
DNA methylation (parent-of-origin)
DNA methylation (variation)
DNA methylation GrimAge acceleration
DNA methylation Hannum age acceleration
DNA methylation PhenoAge acceleration
DNA methylation variation (age effect)
DNA methylation-estimated granulocyte proportions
DNA methylation-estimated plasminogen activator inhibitor-1 levels
DNA mismatch repair protein Msh2 levels
DNA polymerase epsilon subunit 2 levels
DNA polymerase epsilon subunit 3 levels
DNA repair protein RAD51 homolog 1 levels
DNA repair protein RAD51 homolog 4 levels
DNA repair protein XRCC1 levels
DNA repair protein XRCC4 levels
DNA repair protein XRCC4 levels (XRCC4.9886.28.3)
DNA-binding protein SATB1 levels
DNA-directed DNA/RNA polymerase mu levels
DNA-directed RNA polymerase II subunit RPB11-a levels
DNA-directed RNA polymerase III subunit RPC9 level in Chronic kidney disease with hypertension and no diabetes (17771_35)
DNA-directed RNA polymerase III subunit RPC9 levels
DNA-directed RNA polymerases I, II, and III subunit RPABC4 levels
DNA-incorporated thioguanine levels in 6-mercaptopurine-treated acute lymphoblastic leukaemia
DNA/RNA-binding protein KIN17 levels
DnaJ homolog subfamily A member 2 levels
DnaJ homolog subfamily A member 4 levels
DnaJ homolog subfamily B member 1 levels
DnaJ homolog subfamily B member 11 levels
DnaJ homolog subfamily B member 12 levels
DnaJ homolog subfamily B member 14 level in Chronic kidney disease with hypertension and no diabetes (8037_53)
DnaJ homolog subfamily B member 14 levels
DnaJ homolog subfamily B member 2 levels
DnaJ homolog subfamily B member 4 levels
DnaJ homolog subfamily B member 6 levels
DnaJ homolog subfamily B member 9 levels
DnaJ homolog subfamily B member 9 levels (DNAJB9.11214.40.3)
DnaJ homolog subfamily C member 10 levels
DnaJ homolog subfamily C member 15 levels
DnaJ homolog subfamily C member 16 levels
DnaJ homolog subfamily C member 17 levels
DnaJ homolog subfamily C member 30 levels
DnaJ homolog subfamily C member 4 levels
Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer
Docking protein 2 levels
Docosadioate levels in elite athletes
Docosahexaenoic acid levels
Docosahexaenoic acid levels (UKB data field 23450)
Docosahexaenoic acid to total fatty acids percentage (UKB data field 23457)
Docosahexaenoylcarnitine (C22:6) levels in elite athletes
Docosahexaenoylcholine levels in elite athletes
Docosapentaenoate (n3 DPA; 22:5n3) levels
Docosapentaenoate (n3 DPA; 22:5n3) levels in elite athletes
Docosapentaenoate (n6 DPA; 22:5n6) levels
Docosapentaenoate (n6 DPA; 22:5n6) levels in elite athletes
Docosapentaenoate n3 DPA; 22:5n3 levels
Docosapentaenoate n3 DPA; 22:5n3-to-X-12627 ratio
Docosapentaenoylcarnitine (C22:5n3) levels
Docosatrienoate (22:3n3) levels
Docosatrienoate (22:3n6) levels
Dodecadienoate (12:2) (X-21343) levels
Dodecadienoate (12:2) levels
Dodecanedioate (C12-DC) levels
Dodecanedioate levels
Dodecanedioate levels in elite athletes
Dodecanedioic aicd levels in coronary artery disease
Dodecanoylcarnitine levels
Dodecenedioate (C12:1-DC) levels
Dodecenoylcarnitine levels
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 levels
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 levels (RPN1.6458.6.3)
Dopamine 3-o-sulfate levels
Dopamine 3-O-sulfate levels in elite athletes
Dopamine sulfate (2) levels
Dorea phocaeense abundance in stool
Double-strand break repair protein MRE11 levels
Double-stranded RNA-binding protein Staufen homolog 1 levels
Double-stranded RNA-binding protein Staufen homolog 2 levels
Draxin levels
Drebrin-like protein levels
Drebrin-like protein levels (DBNL.4978.54.2)
Dried fruit consumption
Dried fruit liking
Drink temperature
Drinking behavior
Drinks per week
Drinks usually with meals in current drinkers (yes and it varies vs no) (UKB data field 1618)
Drinks usually with meals in current drinkers (yes vs no) (UKB data field 1618)
Driving (hours per day)
Drug abuse
Drug experimentation measurement
Drug-induced hepatocellular liver injury
Drug-induced liver injury (flucloxacillin)
Drug-induced liver injury (fluoroquinolones)
Drug-induced liver injury (nitrofurantoin)
Drug-induced liver injury (nonsteroidal anti-inflammatory drugs)
Drug-induced liver injury in interferon-beta-treated multiple sclerosis
Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)
Drug-induced torsades de pointes
Drusen area within a central 3 mm circle (model 1)
Drusen area within a central 3 mm circle (model 2)
Drusen area within a central 5 mm circle (model 1)
Drusen area within a central 5 mm circle (model 2)
Drusen volume within a central 3 mm circle (model 1)
Drusen volume within a central 3 mm circle (model 2)
Drusen volume within a central 5 mm circle (model 1)
Drusen volume within a central 5 mm circle (model 2)
DSGEGDFXAEGGGVR levels in elite athletes
DSGEGDFXAEGGGVR-to-ADpSGEGDFXAEGGGVR ratio
Dual 3,5-cyclic-AMP and -GMP phosphodiesterase 11A levels
Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide levels
Dual specificity mitogen-activated protein kinase kinase 1 levels
Dual specificity mitogen-activated protein kinase kinase 2 levels
Dual specificity mitogen-activated protein kinase kinase 4 level in Chronic kidney disease with hypertension and no diabetes (5242_37)
Dual specificity mitogen-activated protein kinase kinase 4 levels
Dual specificity mitogen-activated protein kinase kinase 4 levels (MAP2K4.5242.37.3)
Dual specificity mitogen-activated protein kinase kinase 5 level in Chronic kidney disease with hypertension and no diabetes (22041_26)
Dual specificity protein kinase CLK2 levels (CLK2.11327.56.3)
Dual specificity protein phosphatase 13 isoform A levels
Dual specificity protein phosphatase 13 isoform A levels (DUSP13.6525.17.3)
Dual specificity protein phosphatase 15 levels
Dual specificity protein phosphatase 23 levels
Dual specificity protein phosphatase 4 levels
Dual specificity protein phosphatase 4 levels (DUSP4.10035.6.3)
Dual specificity protein phosphatase 6 levels
Dual specificity tyrosine-phosphorylation-regulated kinase 3 levels
Duloxetine response in major depressive disorder (% change in symptom score)
Duodenal ulcer
Dupuytren's disease
Dynactin subunit 2 levels
Dynactin-associated protein levels (DYNAP.10692.48.3)
Dynamin-1-like protein level in Chronic kidney disease with hypertension and no diabetes (21452_3)
Dynamin-2 levels
Dynein light chain roadblock-type 1 levels
Dynein light chain Tctex-type 1 levels
Dynein light chain Tctex-type 3 levels
Dynorphin A (1-17) levels
Dyslexia
Dyslexia-associated protein KIAA0319-like protein levels
Dyslipidemia
Dysmenorrheic pain
Dysmenorrheic pain severity
Dysphagia
E Cad plasma levels
E-selectin levels
E3 ISG15--protein ligase HERC5 level in Chronic kidney disease with hypertension and no diabetes (12934_1)
E3 SUMO-protein ligase PIAS3 levels
E3 ubiquitin-protein ligase CBL levels
E3 ubiquitin-protein ligase CHIP levels
E3 ubiquitin-protein ligase DTX3L levels
E3 ubiquitin-protein ligase HECW1 levels
E3 ubiquitin-protein ligase LNX levels
E3 ubiquitin-protein ligase NEURL1 levels
E3 ubiquitin-protein ligase parkin levels
E3 ubiquitin-protein ligase pellino homolog 2 levels
E3 ubiquitin-protein ligase RNF114 levels
E3 ubiquitin-protein ligase RNF128 levels
E3 ubiquitin-protein ligase RNF128 levels (RNF128.6510.56.3)
E3 ubiquitin-protein ligase RNF13 levels
E3 ubiquitin-protein ligase RNF13 levels (RNF13.8087.250.3)
E3 ubiquitin-protein ligase RNF146 levels
E3 ubiquitin-protein ligase RNF34 levels
E3 ubiquitin-protein ligase RNF8 level in Chronic kidney disease with hypertension and no diabetes (14663_44)
E3 ubiquitin-protein ligase RNF8 levels
E3 ubiquitin-protein ligase RNF8 levels (RNF8.14663.44.3)
E3 ubiquitin-protein ligase SMURF2 levels
E3 ubiquitin-protein ligase ZNRF3 level in Chronic kidney disease with hypertension and no diabetes (10390_21)
E3 ubiquitin-protein ligase ZNRF3 levels
Ear morphology
Ear protrusion
Earlobe attachment
Early age-related macular degeneration
Early cardiac repolarization
Early childhood aggressive behavior
Early childhood caries
Early chronic obstructive pulmonary disease
Early chronic obstructive pulmonary disease in never smokers
Early diabetic kidney disease in diabetes
Early diabetic kidney disease in type 2 diabetes
Early endosome antigen 1 levels
Early neurological instability after acute ischemic stroke
Early onset atrial fibrillation
Early onset periodontitis x sex interaction
Early onset periodontitis x smoking status interaction
Early spontaneous preterm birth
Early-onset ischemic stroke
Early-onset schizophrenia
Ease of getting up in the morning
Ease of skin tanning
Ease of sunburn
Eating disorder in bipolar disorder
Eating disorders
Eating disorders (purging via substances)
Ebbinghaus illusion (overestimation)
Ebbinghaus illusion (underestimation)
Echocardiographic traits
Economic and political preferences
Economic and political preferences (fairness)
Economic and political preferences (feminism/equality)
Economic and political preferences (immigration/crime)
Economic and political preferences (time)
Ecto-ADP-ribosyltransferase 3 level in Chronic kidney disease with hypertension and no diabetes (10970_3)
Ecto-ADP-ribosyltransferase 3 level in Chronic kidney disease with hypertension and no diabetes (7970_315)
Ecto-ADP-ribosyltransferase 3 levels (ART3.10970.3.3)
Ecto-ADP-ribosyltransferase 4 level in Chronic kidney disease with hypertension and no diabetes (6576_1)
Ecto-ADP-ribosyltransferase 4 levels
Ecto-ADP-ribosyltransferase 4 levels (ART4.6576.1.3)
Ecto-NOX disulfide-thiol exchanger 2 levels
Ectodysplasin-A, secreted form levels
Ectoine levels in elite athletes
Ectonucleoside triphosphate diphosphohydrolase 1 levels
Ectonucleoside triphosphate diphosphohydrolase 1 levels (ENTPD1.7999.23.3)
Ectonucleoside triphosphate diphosphohydrolase 5 level in Chronic kidney disease with hypertension and no diabetes (4437_56)
Ectonucleoside triphosphate diphosphohydrolase 5 levels
Ectonucleoside triphosphate diphosphohydrolase 5 levels (ENTPD5.4437.56.3)
Ectonucleoside triphosphate diphosphohydrolase 6 levels
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 levels
Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 level in Chronic kidney disease with hypertension and no diabetes (6556_5)
Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 levels
Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 levels (ENPP5.6556.5.3)
Ectonucleotide pyrophosphatase/phosphodiesterase family member 6 levels
Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 level in Chronic kidney disease with hypertension and no diabetes (4435_66)
Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 levels
Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 levels (ENPP7.4435.66.2)
Eczema
Edge-level brain connectivity (multivariate analysis)
Educational attainment
Educational attainment (college completion)
Educational attainment (MTAG)
Educational attainment (years of education)
EF-hand calcium-binding domain-containing protein 14 levels
Effector Memory CD4-CD8- T cell %CD4-CD8- T cell
Effector Memory CD4-CD8- T cell %T cell
Effector Memory CD4-CD8- T cell Absolute Count
Effector Memory CD4+ T cell %T cell
Effector Memory CD4+ T cell Absolute Count
EGF plasma levels
EGF-containing fibulin-like extracellular matrix protein 1 levels
EGF-like module-containing mucin-like hormone receptor-like 2 levels
EGF-like repeat and discoidin I-like domain-containing protein 3 levels
eGFR decline after treatment with platinum based chemotherapy
EGFR mutation-positive lung adenocarcinoma
eGFR slope in non-diabetic chronic kidney disease
Egg allergy
Egg allergy (maternal genetic effects)
Egg allergy (parent-of-origin effect)
Egl nine homolog 1 levels
EH domain-binding protein 1 levels
EH domain-containing protein 4 levels
Eicosanedioate (C20-DC) levels
Eicosanodioate levels in elite athletes
Eicosapentaenoate (EPA; 20:5n3) levels
Eicosapentaenoate (EPA; 20:5n3) levels in elite athletes
Eicosapentaenoate EPA; 20:5n3 levels
Eicosapentaenoylcholine levels
Eicosenedioate (C20:1-DC) levels
Eicosenoylcarnitine (C20:1) levels
Eicosenoylcarnitine (C20:1) levels in elite athletes
Ejection fraction
Ejection fraction in Tripanosoma cruzi seropositivity
EKC/KEOPS complex subunit TPRKB levels
Elafin levels
Elafin levels (PI3.4982.54.1)
ELAV-like protein 1 levels
Electrocardiogram morphology (amplitude at temporal datapoints)
Electrocardiographic conduction measures
Electrocardiographic traits
Electrocardiographic traits (multivariate)
Electrodermal activity
Electroencephalogram traits
Electroencephalographic traits in alcoholism
Electron transfer flavoprotein subunit alpha, mitochondrial level in Chronic kidney disease with hypertension and no diabetes (17435_43)
Electron transfer flavoprotein subunit alpha, mitochondrial levels
Electroneutral sodium bicarbonate exchanger 1 levels
Elevated fasting plasma glucose
Elevated serum carcinoembryonic antigen levels
Elevated serum prostate-specific antigen levels in healthy men
Elongation factor 1-delta levels
Elongation factor 1-gamma level in Chronic kidney disease with hypertension and no diabetes (24111_10)
Elusimicrobiota abundance in stool
Embryonal Fyn-associated substrate levels
EMILIN-3 levels
EMILIN-3 levels (EMILIN3.8773.172.3)
Emotional dysregulation
Emotional lability
Emotional lability in attention deficit hyperactivity disorder
Emotional recognition
Empathy quotient
Emphysema annual change measurement in smokers (adjusted lung density)
Emphysema annual change measurement in smokers (percent low attenuation area)
Emphysema distribution in smoking
Emphysema imaging phenotypes
Emphysema in chronic obstructive pulmonary disease
Emphysema-related traits
ENA 78 plasma levels
Ena/VASP-like protein levels
End stage renal disease in APOL1 risk genotype-negative individuals
End stage renal disease x APOL1 genotype interaction
End-stage coagulation
End-stage kidney disease
End-stage knee osteoarthritis
End-stage renal disease
End-stage renal disease in type 2 diabetes
Endogenous retrovirus group V member 1 Env polyprotein levels (ERVV.1.12531.5.3)
Endoglin levels
Endometrial cancer
Endometrial cancer (endometrioid histology)
Endometrial cancer (MTAG)
Endometrial endometrioid carcinoma
Endometriosis
Endometriosis (MTAG)
Endometriosis (stage 3 or 4)
Endometriosis or asthma (pleiotropy)
Endometriosis or depression (pleiotropy)
Endometriosis or endometrial cancer (pleiotropy)
Endometriosis or migraine
Endometriosis-associated infertility
Endophilin-A1 levels
Endophilin-A3 levels
Endophilin-B1 levels
Endophilin-B2 levels
Endoplasmic reticulum aminopeptidase 1 level in Chronic kidney disease with hypertension and no diabetes (4964_67)
Endoplasmic reticulum aminopeptidase 1 levels
Endoplasmic reticulum aminopeptidase 1 levels (ERAP1.4964.67.1)
Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)
Endoplasmic reticulum aminopeptidase 2 levels
Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)
Endoplasmic reticulum lectin 1 levels
Endoplasmic reticulum lectin 1 levels (ERLEC1.8957.72.3)
Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase levels
Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase levels (MAN1B1.7071.23.4)
Endoplasmic reticulum resident protein 29 levels
Endoplasmin level in Chronic kidney disease with hypertension and no diabetes (6393_63)
Endoplasmin levels
Endoplasmin levels (HSP90B1.6393.63.3)
Endosialin levels
Endostatin levels
Endostatin levels (COL18A1.2201.17.6)
Endostatin plasma levels
Endosulfan levels
Endothelial cell-selective adhesion molecule levels
Endothelial cell-selective adhesion molecule levels (ESAM.7841.84.3)
Endothelial cell-specific molecule 1 levels
Endothelial differentiation-related factor 1 levels
Endothelial function traits
Endothelial monocyte-activating polypeptide 2 levels
Endothelial monocyte-activating polypeptide 2 levels (AIMP1.2714.78.2)
Endothelin-1 levels
Endothelin-2 levels (EDN2.12574.36.3)
Endothelin-3 level in Chronic kidney disease with hypertension and no diabetes (15383_200)
Endothelin-3 levels
Endothelin-converting enzyme 1 level in Chronic kidney disease with hypertension and no diabetes (3611_70)
Endothelin-converting enzyme 1 levels
Endothelin-converting enzyme 1 levels (ECE1.3611.70.4)
Endothelin-converting enzyme-like 1 levels
Endoxifen levels in tamoxifen-treated hormone-receptor-positive breast cancer
Endoxifen to N-desmethyl tamoxifen ratio in tamoxifen-treated hormone-receptor-positive breast cancer
Endrin levels
Energy expenditure
Energy expenditure (24h)
Engulfment and cell motility protein 1 levels
Enhancer of mRNA-decapping protein 4 levels
Enhancer of zeste homolog 2 level in Chronic kidney disease with hypertension and no diabetes (24914_10)
Enoyl-CoA delta isomerase 2, mitochondrial levels
Enterobacteriaceae abundance in stool
Enterococcus abundance in stool
Enterococcus B abundance in stool
Entorhinal cortical thickness
Entorhinal cortical volume
Entorhinal cortical volume (Alzheimer's disease interaction)
Environmental pollutants exposure (AC50 high)
Environmental pollutants exposure (AC50 low)
Environmental pollutants exposure (Expo high)
Environmental pollutants exposure (Expo low)
Environmental pollutants exposure (POD high)
Environmental pollutants exposure (POD low)
Environmental pollutants exposure (RfD high)
Environmental pollutants exposure (RfD low)
Eosinophil cationic protein levels
Eosinophil cationic protein levels and Eosinophil-derived neurotoxin levels
Eosinophil counts
Eosinophil percentage of granulocytes
Eosinophil percentage of white cells
Eosinophil-derived neurotoxin levels
Eosinophilic esophagitis
Eosinophilic esophagitis (pediatric)
Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)
Eotaxin 2 plasma levels
Eotaxin level in Chronic kidney disease with hypertension and no diabetes (5301_7)
Eotaxin levels
Eotaxin levels (CCL11.5301.7.3)
Ephrin type-A receptor 1 level in Chronic kidney disease with hypertension and no diabetes (3431_54)
Ephrin type-A receptor 1 levels
Ephrin type-A receptor 1 levels (EPHA1.3431.54.2)
Ephrin type-A receptor 2 levels
Ephrin type-A receptor 4 levels
Ephrin type-A receptor 5 levels
Ephrin type-B receptor 1 levels
Ephrin type-B receptor 2 levels
Ephrin type-B receptor 2 levels (EPHB2.8225.86.3)
Ephrin type-B receptor 3 levels (EPHB3.9220.7.3)
Ephrin type-B receptor 4 levels
Ephrin-A2 levels
Ephrin-B1 levels (EFNB1.5746.37.3)
Ephrin-B3 levels
Ephrin-B3 levels (EFNB3.7785.1.3)
Epiandrosterone sulfate levels
Epiandrosterone sulfate levels in elite athletes
Epidermal growth factor levels
Epidermal growth factor levels (EGF.5509.7.3)
Epidermal growth factor receptor substrate 15-like 1 levels
Epidermal growth factor receptor variant III levels
Epidermal growth factor-like protein 6 levels
Epididymal secretory protein E3-beta levels
Epididymal-specific lipocalin-10 levels
Epididymal-specific lipocalin-8 levels
Epididymis-specific alpha-mannosidase levels
Epigenetic age acceleration (Horvath) in childhood cancer survivors
Epigenetic age acceleration in alcohol use disorder
Epilepsy
Epilepsy (remission after treatment)
Epilepsy and lamotrigine-induced maculopapular eruptions
Epiregulin levels
Epirubicin-induced leukopenia
Episodic memory
Episodic memory (pairs-matching)
epithelial cell adhesion molecule levels
Epithelial ovarian cancer
Epithelial splicing regulatory protein 1 levels
Epstein Barr virus nuclear antigen 1 IgG levels or multiple sclerosis
Epstein-Barr virus copy number in lymphoblastoid cell lines
Epstein-Barr virus EBNA-1 antibody levels
Epstein-Barr virus VCA p18 antibody levels
ER membrane protein complex subunit 1 levels
ER membrane protein complex subunit 1 levels (EMC1.11989.35.3)
ER membrane protein complex subunit 4 level in Chronic kidney disease with hypertension and no diabetes (13516_46)
ER membrane protein complex subunit 4 levels
Erectile dysfunction
Erectile dysfunction and prostate cancer treatment
Erectile dysfunction in type 1 diabetes
Ergothioneine levels
Ergothioneine levels in elite athletes
Erlin-1 levels
Erlin-1 levels (ERLIN1.8776.10.3)
ERO1-like protein alpha levels
ERO1-like protein alpha levels (ERO1L.7060.2.3)
ERO1-like protein beta levels
ERO1-like protein beta levels (ERO1LB.7994.41.3)
Erosive tooth wear (severe vs non-severe)
Erosive tooth wear (severe vs none or mild)
Erythema nodosum in inflammatory bowel disease
Erythritol levels
Erythritol levels in elite athletes
Erythrocyte aggregation index
Erythrocyte band 7 integral membrane protein levels
Erythrocyte band 7 integral membrane protein levels (STOM.8261.51.3)
Erythrocyte cadmium concentration
Erythrocyte cadmium concentration in never smokers
Erythrocyte methylated 6-mercaptopurine metabolite concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia
Erythrocyte sedimentation rate
Erythrocyte thioguanine concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia
Erythroid membrane-associated protein levels (ERMAP.8631.13.3)
Erythronate levels
Erythronate levels in elite athletes
Erythropoietin levels
Escherichia abundance in stool
Escherichia flexneri abundance in stool
Esophageal adenocarcinoma
Esophageal adenocarcinoma x smoking interaction
Esophageal cancer
Esophageal cancer (alcohol interaction)
Esophageal cancer (squamous cell)
Esophageal cancer and gastric cancer
Esophageal or stomach cancer
Esophageal squamous cell cancer (length of survival)
Esophageal squamous cell carcinoma
Esophageal varix
Esotropia
Essential hypertension (time to event)
Essential tremor
Estimated glomerular filtration rate
Estimated glomerular filtration rate (creatinine, CKDi25)
Estimated glomerular filtration rate (creatinine, Rapid3)
Estimated glomerular filtration rate (creatinine)
Estimated glomerular filtration rate (cystatin c)
Estimated glomerular filtration rate after 1 year in renal transplantation (donor effect)
Estimated glomerular filtration rate after 1 year in renal transplantation (recipient effect)
Estimated glomerular filtration rate after 5 years in renal transplantation (donor effect)
Estimated glomerular filtration rate after 5 years in renal transplantation (recipient effect)
Estimated glomerular filtration rate change in renal transplantation (donor effect)
Estimated glomerular filtration rate change in renal transplantation (recipient effect)
Estimated glomerular filtration rate in diabetes
Estimated glomerular filtration rate in non-diabetics
Estimated glomerular filtration rate in type 2 diabetes
Estimated glomerular filtration rate reduction (30%)
Estradiol 17-beta-dehydrogenase 8 levels
Estradiol levels
Estradiol levels in premenopausal women
Estradiol plasma levels (breast cancer)
Estriol levels
Estrogen receptor status in breast cancer
Estrogen sulfotransferase levels
Estrogen sulfotransferase levels (SULT1E1.9878.3.3)
Estrone 3-sulfate levels
Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer
Estrone levels
Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer
Ethion levels
Ethylmalonate levels
Ethylmalonate levels in elite athletes
Etiocholanolone glucuronide levels
Etiocholanolone glucuronide levels in elite athletes
Etoposide drug response (IC50)
ETS domain-containing protein Elk-1 levels
ETS domain-containing protein Elk-3 levels
ETS-related transcription factor Elf-5 levels
Eubacterium F sp000434115 abundance in stool
Eubacterium I ramulus A abundance in stool
Eubacterium R coprostanoligenes abundance in stool
Eudaimonic well-being
Eudesmic acid (3,4,5-trimethoxybenzoic acid) levels in coronary artery disease
Eugenol sulfate levels in elite athletes
Eukaryotic initiation factor 4A-I levels
Eukaryotic initiation factor 4A-II levels
Eukaryotic initiation factor 4A-III levels
Eukaryotic translation initiation factor 1A, X-chromosomal levels
Eukaryotic translation initiation factor 1A, Y-chromosomal levels
Eukaryotic translation initiation factor 1b levels
Eukaryotic translation initiation factor 2 subunit 1 levels
Eukaryotic translation initiation factor 3 subunit G levels
Eukaryotic translation initiation factor 3 subunit J levels
Eukaryotic translation initiation factor 4 gamma 2 levels
Eukaryotic translation initiation factor 4 gamma 3 levels
Eukaryotic translation initiation factor 4B levels
Eukaryotic translation initiation factor 4E levels
Eukaryotic translation initiation factor 4E type 2 levels
Eukaryotic translation initiation factor 4E-binding protein 2 levels
Eukaryotic translation initiation factor 4H levels
Eukaryotic translation initiation factor 5 levels
Eukaryotic translation initiation factor 5A-1 levels
Eukaryotic translation initiation factor 5A-2 levels
Evening vs. morning chronotype (self-assessed)
Evening vs. morning chronotype (sMEQ score)
Event-related brain oscillations
Ewing sarcoma
Exacerbations requiring hospitalisation in asthma
Excessive alcohol consumption
Excessive daytime sleepiness
Excessive hairiness
Excessive sweating
Excessive vomiting in pregnancy
Executive function
Executive function (longitudinal)
Executive function (trail making test B)
Executive inhibition (Stroop WIT and CIT) in attention deficit hyperactivity disorder
Exercise treadmill test traits
Exhaled carbon monoxide levels
Exhaled carbon monoxide levels in smokers with chronic obstructive pulmonary disease
Exhaled nitric oxide levels
Exhaled nitric oxide output
Exostosin-like 2 levels
Exostosin-like 2 levels (EXTL2.6528.95.3)
Experiencing mood swings
Exploratory eye movement dysfunction in schizophrenia (cognitive search score)
Exploratory eye movement dysfunction in schizophrenia (mean eye scanning length)
Exploratory eye movement dysfunction in schizophrenia (number of eye fixations)
Exploratory eye movement dysfunction in schizophrenia (responsive search score)
Exploratory eye movement dysfunction in schizophrenia (total eye scanning length)
Expressive language ability
Expressive vocabulary in infants
Extensive basal ganglia perivascular space burden
Extensive hippocampal perivascular space burden
Extensive white matter perivascular space burden
Externalizing behaviour (multivariate analysis)
Externalizing behaviour score
Extracellular glycoprotein lacritin levels
Extracellular matrix protein 1 levels
Extracellular sulfatase Sulf-2 levels
Extracellular sulfatase Sulf-2 levels (SULF2.8305.18.3)
Extracellular superoxide dismutase [Cu-Zn] levels
Extranodal natural killer T-cell lymphoma (nasal type)
Extraversion
Extremely high intelligence
Extrinsic epigenetic age acceleration
Exudative age-related macular degeneration
Eye color
Eye color (brightness)
Eye color (hue)
Eye color (saturation)
Eye color traits
Eye morphology
Eye movement (horizontal position gain)
Eye movement in schizophrenia (horizontal position gain)
Eyebrow thickness
Ezrin levels
F_Acidaminococcaceae abundance
F_Acidaminococcaceae prevalence
F_Bacteroidaceae abundance
F_Coriobacteriaceae abundance
F_Lachnospiraceae abundance
F_Prevotellaceae abundance
F_Prevotellaceae prevalence
F_Rikenellaceae abundance
F_Ruminococcaceae abundance
F_Sutterellaceae abundance
F-acquired taste liking (derived food-liking factor)
F-bitter food liking (derived food-liking factor)
F-box/LRR-repeat protein 4 level in Chronic kidney disease with hypertension and no diabetes (9951_36)
F-box/LRR-repeat protein 4 levels
F-burn/spicy liking (derived food-liking factor)
F-caffeinated/sweet liking (derived food-liking factor)
F-cake/biscuits liking (derived food-liking factor)
F-capsicum liking (derived food-liking factor)
F-carbohydrate liking (derived food-liking factor)
F-cell distribution
F-cell distribution in sickle cell anaemia
F-cheese liking (derived food-liking factor)
F-chocolate/coffee liking (derived food-liking factor)
F-coffee/alcohol liking (derived food-liking factor)
F-cooking flavour liking (derived food-liking factor)
F-cooking vegetables liking (derived food-liking factor)
F-dairy liking (derived food-liking factor)
F-deep fried food liking (derived food-liking factor)
F-dessert liking (derived food-liking factor)
F-fatty food liking (derived food-liking factor)
F-fatty/dairy food liking (derived food-liking factor)
F-fatty/salty food liking (derived food-liking factor)
F-fish liking (derived food-liking factor)
F-fruit liking (derived food-liking factor)
F-glutamate liking (derived food-liking factor)
F-healthy breakfast food liking (derived food-liking factor)
F-healthy food liking (derived food-liking factor)
F-highly palatable foods liking (derived food-liking factor)
F-lentils/beans liking (derived food-liking factor)
F-low caloric food liking (derived food-liking factor)
F-meat liking (derived food-liking factor)
F-oily fish liking (derived food-liking factor)
F-salad vegetables liking (derived food-liking factor)
F-salty food liking (derived food-liking factor)
F-sauces liking (derived food-liking factor)
F-savour/caloric food liking (derived food-liking factor)
F-savoury food liking (derived food-liking factor)
F-seafood liking (derived food-liking factor)
F-sharp flavour liking (derived food-liking factor)
F-small fish liking (derived food-liking factor)
F-sodas liking (derived food-liking factor)
F-strong alcohol liking (derived food-liking factor)
F-strong flavour liking (derived food-liking factor)
F-strong vegetable liking (derived food-liking factor)
F-sweet food liking (derived food-liking factor)
F-sweetened coffee drink liking (derived food-liking factor)
F-vegetarian liking (derived food-liking factor)
F-whole food liking (derived food-liking factor)
F-wine liking (derived food-liking factor)
Face memory
Facial attractiveness (female raters)
Facial depth
Facial emotion recognition
Facial emotion recognition (angry faces)
Facial emotion recognition (happy faces)
Facial emotion recognition (sad faces)
Facial morphology
Facial morphology (brow ridge protrusion 1)
Facial morphology (brow ridge protrusion 2)
Facial morphology (brow ridge protrusion 3)
Facial morphology (chin protrusion 1)
Facial morphology (chin protrusion 2)
Facial morphology (columella inclination)
Facial morphology (ear size)
Facial morphology (factor 1, breadth of lateral portion of upper face)
Facial morphology (factor 10, width of nasal floor)
Facial morphology (factor 11, projection of the nose)
Facial morphology (factor 12, vertical position of sublabial sulcus relative to central midface)
Facial morphology (factor 13, vertical position of alar curvature relative to upper lip)
Facial morphology (factor 14, intercanthal width)
Facial morphology (factor 15, philtrum width)
Facial morphology (factor 16)
Facial morphology (factor 17, height of vermillion upper lip)
Facial morphology (factor 18)
Facial morphology (factor 19)
Facial morphology (factor 20)
Facial morphology (factor 21, depth of nasal alae)
Facial morphology (factor 22)
Facial morphology (factor 23)
Facial morphology (factor 3, length of philtrum)
Facial morphology (factor 5, width of mouth relative to central midface)
Facial morphology (factor 6, height of vermillion lower lip)
Facial morphology (factor 7, width of cartilaginous portion of nose)
Facial morphology (factor 8, orbital inclination due to vertical and horizontal position of exocanthion)
Facial morphology (factor 9, facial height related to vertical position of nasion)
Facial morphology (forehead protrusion 1)
Facial morphology (jaw protrusion 2)
Facial morphology (jaw protrusion 5)
Facial morphology (lip protrusion)
Facial morphology (lip thickness 1)
Facial morphology (lip thickness ratio 1)
Facial morphology (lip thickness ratio 2)
Facial morphology (lower lip protrusion)
Facial morphology (lower lip thickness 1)
Facial morphology (lower lip thickness 2)
Facial morphology (multitrait analysis)
Facial morphology (nasion depth 2)
Facial morphology (nose protrusion)
Facial morphology (nose roundness 1)
Facial morphology (nose size)
Facial morphology (segment 1)
Facial morphology (segment 10)
Facial morphology (segment 11)
Facial morphology (segment 13)
Facial morphology (segment 14)
Facial morphology (segment 15)
Facial morphology (segment 17)
Facial morphology (segment 18)
Facial morphology (segment 19)
Facial morphology (segment 2)
Facial morphology (segment 20)
Facial morphology (segment 21)
Facial morphology (segment 22)
Facial morphology (segment 23)
Facial morphology (segment 24)
Facial morphology (segment 25)
Facial morphology (segment 26)
Facial morphology (segment 27)
Facial morphology (segment 28)
Facial morphology (segment 29)
Facial morphology (segment 3)
Facial morphology (segment 30)
Facial morphology (segment 31)
Facial morphology (segment 32)
Facial morphology (segment 34)
Facial morphology (segment 35)
Facial morphology (segment 38)
Facial morphology (segment 43)
Facial morphology (segment 44)
Facial morphology (segment 45)
Facial morphology (segment 46)
Facial morphology (segment 49)
Facial morphology (segment 5)
Facial morphology (segment 51)
Facial morphology (segment 52)
Facial morphology (segment 53)
Facial morphology (segment 54)
Facial morphology (segment 57)
Facial morphology (segment 58)
Facial morphology (segment 6)
Facial morphology (segment 60)
Facial morphology (segment 61)
Facial morphology (segment 7)
Facial morphology (segment 9)
Facial morphology (upper face flatness)
Facial morphology traits (59 NSCL/P endophenotypic segments)
Facial morphology traits (63 three-dimensional facial segments)
Facial phenotypes (intercanthal width)
Facial phenotypes (interpalpebral inferius length)
Facial phenotypes (interpalpebral superius length)
Facial phenotypes (left palpebral fissure length)
Facial phenotypes (left palpebrale fissure height)
Facial phenotypes (midendocanthion to labiale superius )
Facial phenotypes (midendocanthion to pogonion)
Facial phenotypes (midendocanthion to subnasale)
Facial phenotypes (mouth width)
Facial phenotypes (nasal bridge height)
Facial phenotypes (nasal height)
Facial phenotypes (nasion to pogonion)
Facial phenotypes (outercanthal width)
Facial phenotypes (right palpebral fissure length)
Facial phenotypes (right palpebrale fissure height)
Facial phenotypes (subnasale to left alare)
Facial phenotypes (subnasale to pogonion)
Facial phenotypes (subnasale to right alare)
Facial pigmentation
Facial pigmentation measurement (polar light)
Facial pigmentation measurement (UV light)
Facial skin colour (CIELAB index b* value)
Facial skin elasticity
Facial skin gloss
Facial skin hydration
Facial skin melanin
Facial wrinkles
Facial wrinkles (crow's feet)
Facial wrinkles (frown lines)
Facial wrinkles (principal components analysis)
Facial wrinkles (under eye)
Factor VII
Factor VII activity
Factor VII activity or levels
Factor VII levels
Factor VIII levels
Factor VIII levels or von Willebrand factor levels (pleiotropy)
Factor XI
FAD-dependent oxidoreductase domain-containing protein 1 levels
Faecalibacterium sp002160895 abundance in stool
Faecalicatena sp000364245 abundance in stool
Faecalicatena sp002161355 abundance in stool
Fagerstrӧm test for nicotine dependence
Falling risk
Familial combined hyperlipidemia defined by Brunzell criteria
Familial combined hyperlipidemia defined by Consensus criteria
Familial combined hyperlipidemia defined by Dutch criteria
Familial combined hyperlipidemia defined by Goldstein criteria
Familial combined hyperlipidemia defined by Mexico criteria
Familial hepatitis B virus-related hepatocellular carcinoma
Familial lung cancer
Familial squamous cell lung carcinoma
Family history of Alzheimer's disease
Fanconi anemia group F protein levels
Fas apoptotic inhibitory molecule 1 levels
Fas apoptotic inhibitory molecule 3 levels
FAS-associated death domain protein levels
Fast beta electroencephalogram
Fasting acetate
Fasting apolipoprotein A-I
Fasting apolipoprotein B
Fasting blood glucose
Fasting blood glucose (BMI interaction)
Fasting blood glucose adjusted for BMI
Fasting blood insulin
Fasting blood insulin (BMI interaction)
Fasting blood insulin adjusted for BMI
Fasting blood proinsulin levels
Fasting cholesterol esters in chylomicrons and extremely large VLDL
Fasting cholesterol esters in IDL
Fasting cholesterol esters in large HDL
Fasting cholesterol esters in large LDL
Fasting cholesterol esters in large VLDL
Fasting cholesterol esters in medium HDL
Fasting cholesterol esters in medium LDL
Fasting cholesterol esters in medium VLDL
Fasting cholesterol esters in small LDL
Fasting cholesterol esters in small VLDL
Fasting cholesterol esters in very large HDL
Fasting cholesterol esters in very large VLDL
Fasting cholesterol esters in very small VLDL
Fasting chylomicrons and extremely large VLDL particle concentration
Fasting citrate
Fasting docosahexaenoic acid (22:6)
Fasting esterified cholesterol
Fasting estimated degree of unsaturation
Fasting free cholesterol
Fasting free cholesterol in chylomicrons and extremely large VLDL
Fasting free cholesterol in IDL
Fasting free cholesterol in large HDL
Fasting free cholesterol in large LDL
Fasting free cholesterol in large VLDL
Fasting free cholesterol in medium HDL
Fasting free cholesterol in medium LDL
Fasting free cholesterol in medium VLDL
Fasting free cholesterol in small HDL
Fasting free cholesterol in small LDL
Fasting free cholesterol in small VLDL
Fasting free cholesterol in very large HDL
Fasting free cholesterol in very large VLDL
Fasting free cholesterol in very small VLDL
Fasting glucose
Fasting glucose (adjusted for BMI) or polycystic ovary syndrome (pleiotropy)
Fasting glucose adjusted for BMI
Fasting glucose change
Fasting glucose change (long-term)
Fasting glucose change (short-term)
Fasting glutamine
Fasting glycoprotein acetyls (mainly a1-acid glycoprotein)
Fasting histidine
Fasting IDL particle concentration
Fasting insulin
Fasting insulin (adjusted for BMI) or polycystic ovary syndrome (pleiotropy)
Fasting insulin (dietary factor interaction)
Fasting insulin adjusted for BMI
Fasting isoleucine
Fasting lactate
Fasting large HDL particle concentration
Fasting large LDL particle concentration
Fasting large VLDL particle concentration
Fasting leucine
Fasting linoleic acid (18:2)
Fasting mean diameter of HDL particles
Fasting mean diameter of VLDLD particles
Fasting medium HDL particle concentration
Fasting medium LDL particle concentration
Fasting medium VLDL particle concentration
Fasting monounsaturated fatty acids (16:1, 18:1)
Fasting omega-3 fatty acids
Fasting omega-6 fatty acids
Fasting phospholipid levels in chylomicrons and extremely large VLDL
Fasting phospholipid levels in IDL
Fasting phospholipid levels in large HDL
Fasting phospholipid levels in large LDL
Fasting phospholipid levels in large VLDL
Fasting phospholipid levels in medium HDL
Fasting phospholipid levels in medium LDL
Fasting phospholipid levels in medium VLDL
Fasting phospholipid levels in small HDL
Fasting phospholipid levels in small LDL
Fasting phospholipid levels in small VLDL
Fasting phospholipid levels in very large HDL
Fasting phospholipid levels in very large VLDL
Fasting phospholipid levels in very small VLDL
Fasting plasma glucose
Fasting plasma glucose (childhood)
Fasting plasma glucose change
Fasting plasma glycochenodeoxycholate 3-O-glucuronide concentration
Fasting plasma glycodeoxycholate 3-O-glucuronide concentration
Fasting polyunsaturated fatty acids
Fasting proinsulin levels in prediabetes
Fasting remnant cholesterol
Fasting saturated fatty acids
Fasting serum total cholesterol
Fasting serum total triglycerides
Fasting small HDL particle concentration
Fasting small LDL particle concentration
Fasting small VLDL particle concentration
Fasting total cholesterol in chylomicrons and extremely large VLDL
Fasting total cholesterol in HDL
Fasting total cholesterol in HDL2
Fasting total cholesterol in HDL3
Fasting total cholesterol in IDL
Fasting total cholesterol in large HDL
Fasting total cholesterol in large LDL
Fasting total cholesterol in large VLDL
Fasting total cholesterol in LDL
Fasting total cholesterol in medium HDL
Fasting total cholesterol in medium LDL
Fasting total cholesterol in medium VLDL
Fasting total cholesterol in small HDL
Fasting total cholesterol in small LDL
Fasting total cholesterol in small VLDL
Fasting total cholesterol in very large HDL
Fasting total cholesterol in very large VLDL
Fasting total cholesterol in very small VLDL
Fasting total cholesterol in VLDL
Fasting total fatty acids
Fasting total lipids in chylomicrons and extremely large VLDL
Fasting total lipids in IDL
Fasting total lipids in large HDL
Fasting total lipids in large LDL
Fasting total lipids in large VLDL
Fasting total lipids in medium HDL
Fasting total lipids in medium LDL
Fasting total lipids in medium VLDL
Fasting total lipids in small HDL
Fasting total lipids in small LDL
Fasting total lipids in small VLDL
Fasting total lipids in very large HDL
Fasting total lipids in very large VLDL
Fasting total lipids in very small VLDL
Fasting total phosphoglycerides
Fasting triglyceride levels
Fasting triglycerides in HDL
Fasting triglycerides in LDL
Fasting triglycerides in VLDL
Fasting triglycerides levels in chylomicrons and extremely large VLDL
Fasting triglycerides levels in IDL
Fasting triglycerides levels in large HDL
Fasting triglycerides levels in large LDL
Fasting triglycerides levels in large VLDL
Fasting triglycerides levels in medium HDL
Fasting triglycerides levels in medium LDL
Fasting triglycerides levels in medium VLDL
Fasting triglycerides levels in small HDL
Fasting triglycerides levels in small LDL
Fasting triglycerides levels in small VLDL
Fasting triglycerides levels in very large HDL
Fasting triglycerides levels in very large VLDL
Fasting triglycerides levels in very small VLDL
Fasting tyrosine
Fasting valine
Fasting very large HDL particle concentration
Fasting very large VLDL particle concentration
Fasting very small VLDL particle concentration
Fat body mass
Fat distribution (HIV)
Fat-free mass
Fatty acid desaturase activity (adipose tissue)
Fatty acid desaturase activity (serum)
Fatty acid synthase levels
Fatty acid-binding protein 12 levels
Fatty acid-binding protein 9 levels
Fatty acid-binding protein, adipocyte levels
Fatty acid-binding protein, heart levels
Fatty acid-binding protein, intestinal level in Chronic kidney disease with hypertension and no diabetes (15385_116)
Fatty acid-binding protein, intestinal levels
Fatty acid-binding protein, liver levels
Fatty acid-binding protein, liver levels (FABP1.11516.7.3)
Fatty acid-binding protein,intestinal levels
Fatty acid(18:4)_[M-H]1- levels
Fatty acid(20:3)_[M-H]1- levels
Fatty acid(20:4)_[M-H]1- levels
Fatty acid(22:4)_[M-H]1- levels
Fatty acid(22:5)_[M-H]1- levels
Fatty acid(22:6)_[M-H]1- levels
Fatty acids (20:3)W6 levels
Fc receptor-like B levels
Fc receptor-like protein 1 levels
Fc receptor-like protein 1 levels (FCRL1.5728.60.3)
Fc receptor-like protein 3 level in Chronic kidney disease with hypertension and no diabetes (4440_15)
Fc receptor-like protein 3 levels
Fc receptor-like protein 3 levels (FCRL3.4440.15.2)
Fc receptor-like protein 4 levels
Fc receptor-like protein 4 levels (FCRL4.8973.23.3)
Fc receptor-like protein 5 levels
Fc receptor-like protein 6 levels
Fc receptor-like protein 6 levels (FCRL6.6617.12.3)
Fear of medical pain (dental)
Fear of minor pain
Fear of severe pain
Febrile seizures
Febrile seizures (MMR vaccine-related)
Febrile seizures (MMR vaccine-unrelated)
Fecal incontinence
Feeling fed-up
Feeling guilty
Feeling hurt
Feeling lonely
Feeling miserable
Feeling nervous
Feeling tense
Feeling worry
Femoral hernia
Femoral neck bone geometry and menarche (age at onset)
Femoral neck bone mineral density
Femoral neck bone mineral density and trunk fat mass adjusted by trunk lean mass
Femoral neck section modulus
Femoral neck size
Femur bone mineral density x serum urate levels interaction
Femur total bone mineral density x gut microbiota (genus Lactococcus) interaction
Fentanyl consumption in laparoscopic-assisted colectomy (first 24 hours)
Ferritin levels
Ferritin levels (FTH1.FTL.3031.66.1)
Ferritin light chain levels
Ferulic acid 4-sulfate levels
Ferulic acid 4-sulfate levels in elite athletes
Fervidobacteriaceae abundance in stool
Fetal hemoglobin levels
Fetal hemoglobin levels in sickle cell anemia
Fetuin A plasma levels
Fetuin-B levels
FEV1
FGF21 levels in alcohol use disorder
Fibrinogen
Fibrinogen beta chain levels
Fibrinogen C domain-containing protein 1 levels
Fibrinogen gamma chain levels
Fibrinogen levels
Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction)
Fibrinogen levels or factor VII levels (pleiotropy)
Fibrinogen levels or factor VII levels or factor XI levels or tissue plasminogen activator levels (pleiotropy)
Fibrinogen levels or plasminogen activator inhibitor 1 levels (pleiotropy)
Fibrinogen levels or tissue plasminogen activator levels (pleiotropy)
Fibrinogen-like protein 1 levels
Fibrinopeptide A (3-15) levels
Fibroblast growth factor 10 levels
Fibroblast growth factor 12 levels
Fibroblast growth factor 16 levels
Fibroblast growth factor 18 levels
Fibroblast growth factor 19 levels
Fibroblast growth factor 19 levels (FGF19.2762.30.2)
Fibroblast growth factor 2 levels
Fibroblast growth factor 20 levels
Fibroblast growth factor 21 levels
Fibroblast growth factor 22 levels
Fibroblast growth factor 23 levels
Fibroblast growth factor 5 levels
Fibroblast growth factor 6 levels
Fibroblast growth factor 7 levels
Fibroblast growth factor 7 levels (FGF7.14031.18.3)
Fibroblast growth factor 8 isoform F level in Chronic kidney disease with hypertension and no diabetes (17166_4)
Fibroblast growth factor 8 levels
Fibroblast growth factor basic levels
Fibroblast growth factor receptor 1 levels
Fibroblast growth factor receptor 3 levels
Fibroblast growth factor receptor substrate 2 levels
Fibroblast growth factor receptor-like 1 levels
Fibroblast growth factor-binding protein 1 levels
Fibroblast growth factor-binding protein 3 levels
Fibroleukin levels
fibromodulin level in Chronic kidney disease with hypertension and no diabetes (6367_66)
fibromodulin levels
Fibromuscular dysplasia
Fibronectin Fragment 3 levels
Fibronectin Fragment 4 levels
Fibronectin levels
Fibronectin type 3 and ankyrin repeat domains protein 1 levels
Fibronectin type III domain-containing protein 4 levels
Fibronectin type III domain-containing protein 5 levels (FNDC5.8041.5.3)
Fibrosis-4 index in high alcohol intake
Fibulin-1 levels
Fibulin-5 levels
Fibulin-7 level in Chronic kidney disease with hypertension and no diabetes (21891_31)
Ficolin 3 plasma levels
Ficolin-1 levels
Ficolin-1 levels (FCN1.3613.62.5)
Ficolin-2 level in Chronic kidney disease with hypertension and no diabetes (13717_15)
Ficolin-2 levels
Ficolin-2 levels (FCN2.3313.21.2)
Ficolin-3 levels
Figural/spatial cognitive ability
Filamin-A level in Chronic kidney disease with hypertension and no diabetes (11245_43)
Filamin-A levels (FLNA.11124.9.3)
Finger osteoarthritis
Finger osteoarthritis severity (hand Klsum)
Firmicutes A abundance in stool
First fracture in long-term childhood cancer survivors (time to event)
First year height change in growth hormone-treated short stature
Fish intake frequency
Fish- and plant-related diet
Flap endonuclease 1 levels
Flavonifractor sp002159265 abundance in stool
Flavonifractor sp900199495 abundance in stool
Fluorodeoxyglucose (PET imaging) (12 month visit)
Fms-related tyrosine kinase 3 ligand levels
Folate pathway vitamin levels
Folate receptor beta levels
Folding of antihelix
Follicle stimulating hormone in healthy women
Follicle stimulating hormone levels
Follicle stimulating hormone levels in idiopathic male infertility
Follicle stimulating hormone levels in polycystic ovary syndrome
Follicular lymphoma
Follicular lymphoma or multiple sclerosis
Follistatin levels
Follistatin-related protein 1 levels
Follistatin-related protein 3 levels
Follistatin-related protein 4 levels
Food addiction
Food allergy
Food allergy (maternal genetic effects)
Food allergy (parent-of-origin effect)
Food antigen IgG levels
Foot deformity in Charcot-Marie-Tooth disease 1A
Foot ulcer in diabetes and neuropathy
Forced expiratory volume in 1 second (environmental tobacco smoke interaction)
Forced expiratory volume in 1 second (occupational environmental exposures interaction)
Forehead morphology
Forkhead box protein G1 levels
Forkhead box protein M1 levels
Forkhead box protein O1A level in Chronic kidney disease with hypertension and no diabetes (22055_31)
Forkhead box protein O3 levels
Formal thought disorder in schizophrenia
Fornix volume
Forns index in high alcohol intake
Four and a half LIM domains protein 1 levels
Four-jointed box protein 1 levels
Four-jointed box protein 1 levels (FJX1.7921.65.3)
Fournierella massiliensis abundance in stool
Fourth ventricle volume
Fractalkine levels
Fractional excretion of metabolites in chronic kidney disease
Fractional exhaled nitric oxide (childhood)
Fractional exhaled nitric oxide levels
Fractional shortening
Fractures
Fractures (paediatric)
Fractures (vertebral)
Fragile X mental retardation protein 1 levels
Fragile X mental retardation syndrome-related protein 1 levels
Frailty index
Freckles
Freckling
Free brassicasterol to free lanosterol
Free cholesterol in chylomicron and extremely large VLDL meal response (OrNLSr)
Free cholesterol in chylomicrons and extremely large VLDL (UKB data field 23486)
Free cholesterol in HDL (UKB data field 23422)
Free cholesterol in IDL (UKB data field 23528)
Free cholesterol in large HDL (UKB data field 23563)
Free cholesterol in large LDL (UKB data field 23535)
Free cholesterol in large VLDL (UKB data field 23500)
Free cholesterol in LDL (UKB data field 23421)
Free cholesterol in medium HDL (UKB data field 23570)
Free cholesterol in medium LDL (UKB data field 23542)
Free cholesterol in medium VLDL (UKB data field 23507)
Free cholesterol in small HDL (UKB data field 23577)
Free cholesterol in small LDL (UKB data field 23549)
Free cholesterol in small VLDL (UKB data field 23514)
Free cholesterol in very large HDL (UKB data field 23556)
Free cholesterol in very large VLDL (UKB data field 23493)
Free cholesterol in very large VLDL meal response (OrNLSr)
Free cholesterol in very small VLDL (UKB data field 23521)
Free cholesterol in VLDL (UKB data field 23420)
Free cholesterol levels
Free cholesterol levels in chylomicrons and extremely large VLDL
Free cholesterol levels in HDL
Free cholesterol levels in IDL
Free cholesterol levels in large HDL
Free cholesterol levels in large LDL
Free cholesterol levels in large VLDL
Free cholesterol levels in LDL
Free cholesterol levels in medium HDL
Free cholesterol levels in medium LDL
Free cholesterol levels in medium VLDL
Free cholesterol levels in small HDL
Free cholesterol levels in small LDL
Free cholesterol levels in small VLDL
Free cholesterol levels in very large HDL
Free cholesterol levels in very large VLDL
Free cholesterol levels in very small VLDL
Free cholesterol levels in VLDL
Free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23582)
Free cholesterol to total lipids in IDL percentage (UKB data field 23612)
Free cholesterol to total lipids in large HDL percentage (UKB data field 23637)
Free cholesterol to total lipids in large LDL percentage (UKB data field 23617)
Free cholesterol to total lipids in large VLDL percentage (UKB data field 23592)
Free cholesterol to total lipids in medium HDL percentage (UKB data field 23642)
Free cholesterol to total lipids in medium LDL percentage (UKB data field 23622)
Free cholesterol to total lipids in medium VLDL percentage (UKB data field 23597)
Free cholesterol to total lipids in small HDL percentage (UKB data field 23647)
Free cholesterol to total lipids in small LDL percentage (UKB data field 23627)
Free cholesterol to total lipids in small VLDL percentage (UKB data field 23602)
Free cholesterol to total lipids in very large HDL percentage (UKB data field 23632)
Free cholesterol to total lipids in very large VLDL percentage (UKB data field 23587)
Free cholesterol to total lipids in very small VLDL percentage (UKB data field 23607)
Free cholesterol to total lipids ratio in chylomicrons and extremely large VLDL
Free cholesterol to total lipids ratio in IDL
Free cholesterol to total lipids ratio in large HDL
Free cholesterol to total lipids ratio in large LDL
Free cholesterol to total lipids ratio in large VLDL
Free cholesterol to total lipids ratio in medium HDL
Free cholesterol to total lipids ratio in medium LDL
Free cholesterol to total lipids ratio in medium VLDL
Free cholesterol to total lipids ratio in small HDL
Free cholesterol to total lipids ratio in small LDL
Free cholesterol to total lipids ratio in small VLDL
Free cholesterol to total lipids ratio in very large HDL
Free cholesterol to total lipids ratio in very large VLDL
Free cholesterol to total lipids ratio in very small VLDL
Free testosterone levels
Free thyroxine concentration
Frequency of relapse in mepolizumab-treated eosinophilic granulomatosis with polyangiitis
Fresh fruit consumption
Frizzled-1 level in Chronic kidney disease with hypertension and no diabetes (22590_68)
Frizzled-10 level in Chronic kidney disease with hypertension and no diabetes (20056_7)
Frizzled-10 levels
Frontal fibrosing alopecia
Frontal pole volume
Frontal QRS-T angle
Frontotemporal dementia
Frontotemporal dementia (age at onset)
Frontotemporal dementia with GRN mutation
Frontotemporal dementia with GRN mutation (age at onset)
Frozen shoulder
Fructosamine levels
Fructosamine-3-kinase level in Chronic kidney disease with hypertension and no diabetes (21147_9)
Fructose levels in elite athletes
Fructose-1,6-bisphosphatase 1 levels
Fructose-1,6-bisphosphatase isozyme 2 levels
Fructose-bisphosphate aldolase A levels
Fructose-bisphosphate aldolase B levels
Fructosyllysine levels
Fruit consumption
Fruit intake (standard GWA)
Fruit intake (weighted GWA)
Fruit juice liking
Fruit liking
FSC-A on HLA DR+ Natural Killer
FSC-A on monocyte
FSC-A on myeloid Dendritic Cell
FSC-A on Natural Killer
FSC-A on Natural Killer T
FSC-A on plasmacytoid Dendritic Cell
Fuchs's corneal dystrophy
Full scale intelligence quotient (cesarean section interaction)
Fulminant type 1 diabetes
Fumarate levels
Fumarylacetoacetase levels
Functional activities questionnaire (24 month visit)
Functional activities questionnaire (baseline)
Functional activities questionnaire (baseline)(adjusted for APOE e4 dosage)
Functional impairment in major depressive disorder, bipolar disorder and schizophrenia
Functional MRI
Furaneol sulfate levels
Furin levels (FURIN.6276.16.3)
Fusiform gyrus volume
Fusobacteriaceae abundance in stool
Fusobacterium A abundance in stool
FVC
G antigen 2 level in Chronic kidney disease with hypertension and no diabetes (25413_80)
G antigen 2D level in Chronic kidney disease with hypertension and no diabetes (22968_9)
G antigen 2D levels
G_Alistipes abundance
G_Alloprevotella abundance
G_Alloprevotella prevalence
G_Alphaproteobacteria prevalence
G_Bacteroidales abundance
G_Bacteroidales prevalence
G_Bacteroides abundance
G_Bacteroidetes abundance
G_Bacteroidetes prevalence
G_Catenibacterium prevalence
G_Clostridium_XlVa abundance
G_Coprococcus abundance
G_Coprococcus prevalence
G_Faecalibacterium abundance
G_Firmicutes abundance
G_Holdemanella abundance
G_Holdemanella prevalence
G_Lachnospiraceae abundance
G_Oscillibacter abundance
G_Paraprevotella abundance
G_Paraprevotella prevalence
G_Parasutterella abundance
G_Phascolarctobacterium abundance
G_Phascolarctobacterium prevalence
G_Porphyromonadaceae abundance
G_Porphyromonadaceae prevalence
G_Prevotella abundance
G_Prevotella prevalence
G_Roseburia abundance
G_Ruminococcus prevalence
G_Sutterella abundance
G_Sutterella prevalence
G-protein coupled receptor 26 levels
G-protein coupled receptor 64 level in Chronic kidney disease with hypertension and no diabetes (10767_52)
G0/G1 switch protein 2 levels
G2/mitotic-specific cyclin-B2 level in Chronic kidney disease with hypertension and no diabetes (18208_3)
G2/mitotic-specific cyclin-B2 levels
Gait rhythm
Gait speed in old age
Gait variability
Galactonate levels
Galactonate levels in elite athletes
Galactoside 3(4)-L-fucosyltransferase levels
Galactoside 3(4)-L-fucosyltransferase levels (FUT3.4548.4.2)
Galactoside-binding soluble lectin 13 levels
Galactosylceramide sulfotransferase levels
Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 level in Chronic kidney disease with hypertension and no diabetes (21770_18)
Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 levels
Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 levels (B3GAT3.6897.38.3)
Galanin levels
Galanin peptide levels
Galanin peptides levels (GAL.13389.8.3)
Galectin 3 plasma levels
Galectin-1 levels
Galectin-2 levels
Galectin-2 levels (LGALS2.3033.57.1)
Galectin-3 levels
Galectin-3-binding protein levels
Galectin-4 levels
Galectin-7 levels
Galectin-8 levels
Galectin-9 levels
Gallbladder cancer
Gallbladder polyp
Gallstone disease
Gambling
Gamma glutamyl transferase levels
Gamma glutamyl transferase levels in excessive alcohol consumption
Gamma glutamyl transferase levels in low alcohol consumption
Gamma glutamyl transpeptidase
Gamma-aminobutyric acid receptor-associated protein levels
Gamma-aminobutyric acid receptor-associated protein-like 1 levels
Gamma-aminobutyric acid receptor-associated protein-like 2 levels
Gamma-aminobutyric acid type B receptor subunit 1 levels
Gamma-aminobutyric acid type B receptor subunit 2 levels
Gamma-CEHC glucuronide levels
Gamma-CEHC levels
Gamma-CEHC levels in elite athletes
Gamma-crystallin C level in Chronic kidney disease with hypertension and no diabetes (18203_9)
Gamma-crystallin D levels
Gamma-glutamyl hydrolase levels
Gamma-glutamyl hydrolase levels (GGH.9370.69.3)
Gamma-glutamyl-2-aminobutyrate levels in elite athletes
Gamma-glutamyl-alpha-lysine levels
Gamma-glutamyl-alpha-lysine levels in elite athletes
Gamma-glutamyl-epsilon-lysine levels in elite athletes
Gamma-glutamylalanine levels in elite athletes
Gamma-glutamylcitrulline levels
Gamma-glutamylglutamate levels
Gamma-glutamylglutamate levels in elite athletes
Gamma-glutamylglutamine levels
Gamma-glutamylglutamine levels in elite athletes
Gamma-glutamylglycine levels in elite athletes
Gamma-glutamylhistidine levels in elite athletes
Gamma-glutamylleucine levels
Gamma-glutamylleucine levels in elite athletes
Gamma-glutamylmethionine levels
Gamma-glutamylmethionine levels in elite athletes
Gamma-glutamylphenylalanine levels in elite athletes
Gamma-glutamylthreonine levels
Gamma-glutamylthreonine levels in elite athletes
Gamma-glutamyltryptophan levels
Gamma-glutamyltryptophan levels in elite athletes
Gamma-glutamyltyrosine levels
Gamma-glutamyltyrosine levels in elite athletes
Gamma-glutamylvaline levels
Gamma-interferon-inducible protein 16 levels (IFI16.12893.159.3)
Gamma-soluble NSF attachment protein levels
Gamma-tocopherol/beta-tocopherol levels in elite athletes
Ganglion cell inner plexiform layer (GCIPL) thickness
Ganglioside GM2 activator levels
Gap junction alpha-1 protein levels (GJA1.9937.7.3)
Gap junction delta-2 protein levels
Gastric adenocarcinoma (histologically verified)
Gastric atrophy
Gastric cancer
Gastric inhibitory polypeptide levels
Gastric intrinsic factor levels
Gastric polyp
Gastric ulcer
Gastrin-releasing peptide level in Chronic kidney disease with hypertension and no diabetes (8400_74)
Gastrin-releasing peptide levels
Gastrin-releasing peptide levels (GRP.8339.72.3)
Gastritis
Gastroesophageal reflux disease
Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment
Gastrointestinal event in colchicine-treated recent myocardial infarction (time to event)
Gastrointestinal infection
Gastrokine-1 levels
Gastrokine-2 levels
Gastrotropin levels
Gaucher disease severity
GDH/6PGL endoplasmic bifunctional protein levels
GDH/6PGL endoplasmic bifunctional protein levels (H6PD.7161.25.3)
GDNF family receptor alpha-2 levels
GDNF family receptor alpha-2 levels (GFRA2.2515.14.3)
GDNF family receptor alpha-like levels
GDP-fucose protein O-fucosyltransferase 1 levels
GDP-fucose protein O-fucosyltransferase 2 levels (POFUT2.6042.52.3)
Gelsolin levels
Gem-associated protein 7 level in Chronic kidney disease with hypertension and no diabetes (22155_44)
Gemcitabine-induced early high-grade neutropenia in pancreatic cancer
Geminocystis abundance in stool
General cognitive ability
General factor of neuroticism
General risk tolerance (MTAG)
General transcription factor II-I levels
General transcription factor IIE subunit 1 level in Chronic kidney disease with hypertension and no diabetes (24322_1)
General vesicular transport factor p115 levels
Generalized anxiety disorder (mental health questionnaire or predicted)
Generalized anxiety disorder (phenotype risk score)
Generalized epilepsy
Genetically independent pain phenotypes (GIP1)
Genetically independent pain phenotypes (GIP2)
Geobacter C abundance in stool
Geographic atrophy lesion growth rate in age-related macular degeneration
Geographic atrophy within a central 5 mm circle (model 1)
Geranylgeranyl pyrophosphate synthase levels
Germline telomere length in neuroblastoma
Gestational age (fetal effect)
Gestational age (maternal effect)
Gestational age at birth (child effect)
Gestational age at birth (maternal effect)
Gestational age at birth in labor-initiated deliveries (child effect)
Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)
Gestational age at birth in premature rupture of membrane-initiated deliveries (maternal effect)
Gestational diabetes mellitus
Gestational insulin sensitivity
ghrelin levels
Giant cell arteritis
Gigaxonin levels
Gillisia abundance in stool
GIP levels in response to oral glucose tolerance test (120 minutes)
GIP levels in response to oral glucose tolerance test (fasting)
Glasses or contact lenses use (age of onset) (UKB data field 2217)
Glaucoma
Glaucoma (high intraocular pressure)
Glaucoma (low intraocular pressure)
Glaucoma (multi-trait analysis)
Glaucoma (primary angle closure)
Glaucoma (primary open-angle)
GlcNAc sulfate conjugate of C21H34O2 steroid levels
Glia-derived nexin levels
Glial fibrillary acidic protein levels
Glioblastoma
Glioblastoma (age-stratified)
Glioma
Glioma (high-grade)
Glioma pathogenesis-related protein 1 levels
Gliomedin level in Chronic kidney disease with hypertension and no diabetes (20591_48)
Global cognition (Clinical Dementia Rating Scale Sum of Boxes)
Global cognition (Clinical Dementia Rating Scale Sum of Boxes) (baseline)
Global cognition (Clinical Dementia Rating Scale Sum of Boxes) (baseline)(adjusted for APOE e4 dosage)
Global cognition (Mini Mental State Examination)
Global cognition (Mini Mental State Examination) (longitudinal)
Global electrical heterogeneity phenotypes
Globe artichoke liking
Glomerular filtration rate
Glomerular filtration rate (creatinine)
Glomerular filtration rate (cystatin C)
Glomerular filtration rate change in heart transplantation
Glomerular filtration rate in chronic kidney disease
Glomerular filtration rate in diabetes
Glomerular filtration rate in diabetics (creatinine)
Glomerular filtration rate in non diabetics (creatinine)
Glomerular filtration rate in type 2 diabetes
Glomerulosclerosis
GLP-1 levels in response to oral glucose tolerance test (120 minutes)
Glucagon levels
Glucagon levels (GCG.4891.50.1)
Glucagon levels in response to oral glucose tolerance test (120 minutes)
Glucagon levels in response to oral glucose tolerance test (30 minutes)
Glucagon levels in response to oral glucose tolerance test (decremental area under the curve for 0-120 minutes)
Glucagon levels in response to oral glucose tolerance test (decremental area under the curve for 0-30 minutes)
Glucagon levels in response to oral glucose tolerance test (fasting)
Glucagon-like peptide 1 receptor levels
Glucagon-like peptide-1 levels
Glucocorticoid receptor gene expression in B-cell precursor acute lymphoblastic leukaemia
Glucocorticoid-induced osteonecrosis
Glucocorticoid-induced osteonecrosis (age 10 years and older)
Glucocorticoid-induced osteonecrosis (time dependent analysis)
Glucokinase levels
Glucokinase levels (GCK.12960.9.3)
Glucokinase regulatory protein levels
Gluconate levels in elite athletes
Glucosamine 6-phosphate N-acetyltransferase levels
Glucosamine-6-phosphate isomerase 1 levels
Glucose homeostasis traits
Glucose levels
Glucose levels (Biocrates platform)
Glucose levels (Metabolon platform)
Glucose levels (UKB data field 23470)
Glucose levels in elite athletes
Glucose-6-phosphate isomerase levels
Glucose-dependent insulinotropic peptide levels
Glucose-dependent insulinotropic peptide levels in overweight individuals
Glucose-dependent insulinotropic peptide levels in type 2 diabetes
Glucose-to-mannose ratio
Glucosidase 2 subunit beta levels
Glucosidase 2 subunit beta levels (PRKCSH.5687.5.3)
Glucoside xylosyltransferase 1 levels
Glucoside xylosyltransferase 1 levels (GXYLT1.8229.1.3)
Glucosuria
Glucosuria (mild)
Glucosuria (moderate to severe)
Glucuronate levels in elite athletes
Glucuronide of piperine metabolite c17h21no3 (4) (X-01911) levels
Glutamate carboxypeptidase 2 levels
Glutamate levels
Glutamate levels in elite athletes
Glutamate receptor ionotropic, delta-2 levels
Glutamate receptor ionotropic, delta-2 levels (GRID2.12758.47.3)
Glutamate--cysteine ligase regulatory subunit levels
Glutamine conjugate of C6H10O2 (1) levels
Glutamine conjugate of c6h10o2 (2) (X-12472) levels
Glutamine conjugate of C6H10O2 (2) levels
Glutamine conjugate of C7H12O2 levels
Glutamine degradant levels
Glutamine levels
Glutamine levels (Biocrates platform)
Glutamine levels (Metabolon platform)
Glutamine levels (UKB data field 23461)
Glutamine levels in elite athletes
Glutamine synthetase levels
Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2 level in Chronic kidney disease with hypertension and no diabetes (23669_20)
Glutamine-to-histidine ratio
Glutaminyl-peptide cyclotransferase levels
Glutaminyl-peptide cyclotransferase-like protein level in Chronic kidney disease with hypertension and no diabetes (8866_53)
Glutaminyl-peptide cyclotransferase-like protein levels
Glutamyl aminopeptidase levels
Glutarate (C5-DC) levels
Glutarate (pentanedioate) levels in elite athletes
Glutaredoxin-1 level in Chronic kidney disease with hypertension and no diabetes (18386_36)
Glutaredoxin-2, mitochondrial levels
Glutaredoxin-3 levels
Glutaredoxin-like protein C5orf63 levels
Glutaredoxin-like protein C5orf63 levels (C5orf63.13378.80.3)
Glutaroyl carnitine levels
Glutaroyl carnitine levels (Biocrates platform)
Glutaroyl carnitine levels (Metabolon platform)
Glutaryl-CoA dehydrogenase, mitochondrial levels
Glutarylcarnitine (c5-dc) levels
Glutarylcarnitine (C5-DC) levels in elite athletes
Glutathione peroxidase 7 levels
Glutathione peroxidase 7 levels (GPX7.8345.27.3)
Glutathione peroxidase in non-alcoholic fatty liver disease x mastiha supplementation interaction
Glutathione S-transferase A1 levels
Glutathione S-transferase A1 levels (GSTA1.12446.49.3)
Glutathione S-transferase A4 levels (GSTA4.14645.253.3)
Glutathione S-transferase kappa 1 levels
Glutathione S-transferase Mu 1 level in Chronic kidney disease with hypertension and no diabetes (15395_15)
Glutathione S-transferase Mu 1 levels
Glutathione S-transferase Mu 3 levels
Glutathione S-transferase Mu 4 levels
Glutathione S-transferase omega-1 levels
Glutathione S-transferase omega-1 levels (GSTO1.12436.84.3)
Glutathione S-transferase P level in Chronic kidney disease with hypertension and no diabetes (13576_15)
Glutathione S-transferase P level in Chronic kidney disease with hypertension and no diabetes (4911_49)
Glutathione S-transferase P levels
Glutathione S-transferase P levels (GSTP1.4911.49.2)
Glutathione S-transferase theta-1 levels
Glutathione S-transferase theta-2B levels
Glutathione synthetase levels
Gluteofemoral adipose tissue volumes
Gluteofemoral adipose tissue volumes (adjusted for BMI and height)
Glycated haemoglobin HbA1c levels adjusted for BMI
Glycated hemoglobin HbA1c levels
Glycated hemoglobin levels
Glycated hemoglobin levels in type 1 diabetes
Glycemic traits
Glycemic traits (multi-trait analysis)
Glycemic traits (pleiotropy)
Glycemic traits (pregnancy)
Glyceraldehyde-3-phosphate dehydrogenase levels
Glycerate levels in elite athletes
Glycerol 3-phosphate levels
Glycerol 3-phosphate levels in elite athletes
Glycerol-3-phosphate dehydrogenase 1-like protein levels
Glycerol-3-phosphate dehydrogenase 1-like protein levels (GPD1L.12420.10.3)
Glycerol-3-phosphate phosphatase levels
Glycerophosphocholine phosphodiesterase GPCPD1 levels
Glycerophosphoethanolamine levels
Glycerophosphoinositol levels in elite athletes
Glycerophosphorylcholine (GPC) levels
Glycerophosphorylcholine (GPC) levels in elite athletes
Glycine amidinotransferase, mitochondrial levels
Glycine cleavage system H protein, mitochondrial levels
Glycine conjugate of C10H12O2 levels
Glycine conjugate of C10H14O2 (1) levels
Glycine levels
Glycine levels (UKB data field 23462)
Glycine levels in elite athletes
Glycine N-acyltransferase levels
Glycine N-methyltransferase levels
Glyco-beta-muricholate levels
Glycochenodeoxycholate 3-sulfate levels
Glycochenodeoxycholate glucuronide (1) levels
Glycochenodeoxycholate glucuronide (1) levels in elite athletes
Glycochenodeoxycholate levels
Glycochenodeoxycholate levels in elite athletes
Glycochenodeoxycholate sulfate levels
Glycochenodeoxycholate sulfate levels in elite athletes
Glycochenodeoxycholic acid levels
Glycochenodeoxycholic acid levels in coronary artery disease
Glycocholate levels in elite athletes
Glycocholenate sulfate levels
Glycocholenate sulfate levels in elite athletes
Glycodeoxycholate 3-sulfate levels
Glycodeoxycholate glucuronide (1) levels
Glycodeoxycholate sulfate levels
Glycodeoxycholate sulfate levels in elite athletes
Glycodeoxycholate/glycochenodeoxycholate levels
Glycogen phosphorylase, liver form levels
Glycogen synthase kinase-3 alpha/beta levels
Glycohyocholate levels
Glycohyocholate levels in elite athletes
Glycolipid transfer protein domain-containing protein 2 levels
Glycolithocholate levels in elite athletes
Glycolithocholate sulfate levels
Glycolithocholate sulfate levels in elite athletes
Glycoprotein acetyls (mainly a1-acid glycoprotein)
Glycoprotein acetyls levels
Glycoprotein acetyls levels (UKB data field 23480)
Glycoprotein endo-alpha-1,2-mannosidase level in Chronic kidney disease with hypertension and no diabetes (8014_359)
Glycoprotein endo-alpha-1,2-mannosidase levels
Glycoprotein endo-alpha-1,2-mannosidase levels (MANEA.8014.359.3)
Glycoprotein hormone alpha-2 levels
Glycoprotein hormones alpha chain levels
Glycoprotein Xg levels (XG.8044.90.3)
Glycosaminoglycan xylosylkinase levels
Glycosphingolipids (d38:1) levels
Glycosphingolipids (d40:1) levels
Glycosphingolipids (d41:1) levels
Glycosphingolipids (d42:1) levels
Glycosphingolipids (d42:2) levels
Glycosuria in pregnancy (maternal and offspring genotype effect)
Glycosuria in pregnancy (maternal genotype effect)
Glycosyl ceramide (d16:1/24:1, d18:1/22:1) levels
Glycosyl ceramide (d18:1/20:0, d16:1/22:0) levels
Glycosyl ceramide (d18:1/20:0, d16:1/22:0) levels in elite athletes
Glycosyl ceramide (d18:1/23:1, d17:1/24:1) levels in elite athletes
Glycosyl ceramide (d18:2/24:1, d18:1/24:2) levels
Glycosyl ceramide (d18:2/24:1, d18:1/24:2) levels in elite athletes
Glycosyl-N-(2-hydroxynervonoyl)-sphingosine (d18:1/24:1(2OH)) levels
Glycosyl-N-(2-hydroxynervonoyl)-sphingosine (d18:1/24:1(2OH)) levels in elite athletes
Glycosyl-N-behenoyl-sphingadienine (d18:2/22:0) levels
Glycosyl-N-behenoyl-sphingosine (d18:1/22:0) levels in elite athletes
Glycosyl-N-palmitoyl-sphingosine (d18:1/16:0) levels
Glycosyl-N-palmitoyl-sphingosine (d18:1/16:0) levels in elite athletes
Glycosyl-N-stearoyl-sphingosine (d18:1/18:0) levels
Glycosyl-N-stearoyl-sphingosine (d18:1/18:0) levels in elite athletes
Glycosyl-N-tricosanoyl-sphingadienine (d18:2/23:0) levels
Glycosyltransferase 8 domain-containing protein 1 levels (GLT8D1.8955.60.3)
Glycosyltransferase-like protein LARGE1 levels
Glycoursodeoxycholate levels in elite athletes
Glycoursodeoxycholic acid sulfate (1) levels
Glycylpeptide N-tetradecanoyltransferase 1 levels
Glycylpeptide N-tetradecanoyltransferase 2 levels
Glycylvaline levels in elite athletes
Glyoxylate reductase/hydroxypyruvate reductase levels
Glypican-1 level in Chronic kidney disease with hypertension and no diabetes (8697_38)
Glypican-1 levels
Glypican-1 levels (GPC1.8697.38.3)
Glypican-3 levels
Glypican-4 levels
Glypican-5 levels
Glypican-6 levels
GM3 ganglioside (d18:1/18:0) levels
GM3 ganglioside (d18:1/20:0) levels
GM3 ganglioside (d18:1/22:0) levels
GM3 ganglioside (d18:1/24:0) levels
GM3 ganglioside (d18:1/24:1) levels
GMP synthase [glutamine-hydrolyzing] levels
Goiter
Golgi membrane protein 1 levels
Golgi membrane protein 1 levels (GOLM1.8983.7.3)
Golgi SNAP receptor complex member 1 levels
Golgi SNAP receptor complex member 1 levels (GOSR1.7805.52.3)
Golgi-associated plant pathogenesis-related protein 1 levels
Golgin subfamily A member 7 levels
Gondoic acid (20:1n-9) levels
Gout
Gout (age >=50)
Gout (combined type)
Gout (normal type)
Gout in chronic kidney disease
Gout vs asymptomatic hyperuricemia
Gout vs. Hyperuricemia
GPN-loop GTPase 1 levels
Graft survival time in renal transplantation (donor effect)
Graft survival time in renal transplantation (donor effect) x APOL1 genotype interaction
GRAM domain-containing protein 1C levels
GRAM domain-containing protein 1C levels (GRAMD1C.8842.16.3)
Granulins level in Chronic kidney disease with hypertension and no diabetes (4992_49)
Granulins levels
Granulins levels (GRN.4992.49.1)
Granulocyte colony-stimulating factor levels
Granulocyte count
Granulocyte percentage of myeloid white cells
Granulocyte telomere length
Granulocyte-colony stimulating factor levels
Granulocytic Myeloid-Derived Suppressor Cells Absolute Count
Granulysin level in Chronic kidney disease with hypertension and no diabetes (14102_6)
Granulysin level in Chronic kidney disease with hypertension and no diabetes (3195_50)
Granulysin levels
Granulysin levels (GNLY.3195.50.2)
Granzyme B levels (GZMB.4133.54.2)
Granzyme K levels
Granzyme M levels
Grapefruit juice consumption
Grapefruit liking
Graves' disease
GRB2-related adapter protein 2 levels
GRB2-related adapter protein levels
Gremlin-1 levels
Gremlin-2 levels
Gro-beta level in Chronic kidney disease with hypertension and no diabetes (22972_26)
Gro-beta level in Chronic kidney disease with hypertension and no diabetes (3148_49)
Gro-gamma level in Chronic kidney disease with hypertension and no diabetes (22973_8)
Gro-gamma level in Chronic kidney disease with hypertension and no diabetes (2986_49)
Group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP
Group XIIB secretory phospholipase A2-like protein levels
Group XIIB secretory phospholipase A2-like protein levels (PLA2G12B.9380.2.3)
Growth arrest and DNA damage-inducible proteins-interacting protein 1 levels
Growth arrest-specific protein 1 levels
Growth arrest-specific protein 6 levels
Growth factor receptor-bound protein 10 levels
Growth factor receptor-bound protein 14 levels (GRB14.13628.58.3)
Growth factor receptor-bound protein 7 levels
Growth factor receptor-bound protein 7 levels (GRB7.11281.6.3)
Growth hormone receptor levels
Growth hormone receptor levels (GHR.2948.58.2)
Growth-regulated alpha protein level in Chronic kidney disease with hypertension and no diabetes (2985_35)
Growth-regulated alpha protein levels
Growth-regulated alpha protein levels (CXCL1.2985.35.1)
Growth-regulated protein alpha levels
Growth/differentiation factor 11 levels
Growth/differentiation factor 11/8 levels
Growth/differentiation factor 11/8 levels (GDF11.MSTN.2765.4.3)
Growth/differentiation factor 15 levels
Growth/differentiation factor 15 levels (GDF15.4374.45.2)
Growth/differentiation factor 2 levels
Growth/differentiation factor 5 levels
Growth/differentiation factor 5 levels (GDF5.2752.62.2)
Growth/differentiation factor 8 levels
Growth/differentiation factor 9 level in Chronic kidney disease with hypertension and no diabetes (3067_67)
GrpE protein homolog 1, mitochondrial levels
GSK3-beta interaction protein levels
GTP cyclohydrolase 1 levels
GTP-binding nuclear protein Ran levels
GTP-binding protein Di-Ras3 levels
GTP-binding protein GEM level in Chronic kidney disease with hypertension and no diabetes (12817_1)
GTP-binding protein GEM levels
GTP-binding protein GEM levels (GEM.12817.1.3)
GTP-binding protein SAR1a levels
GTP-binding protein SAR1b level in Chronic kidney disease with hypertension and no diabetes (21220_11)
GTPase HRas level in Chronic kidney disease with hypertension and no diabetes (18900_37)
GTPase HRas levels
GTPase NRas levels
Guanidinoacetate levels
Guanidinoacetate levels in elite athletes
Guanidinosuccinate levels in elite athletes
Guanine levels
Guanine levels in chronic kidney disease
Guanine nucleotide exchange factor DBS levels
Guanine nucleotide exchange factor MSS4 levels
Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 levels
Guanosine levels
Guanylate cyclase activator 2B levels
Guanylate kinase levels
Guanylate-binding protein 1 levels
Guanylate-binding protein 2 levels
Guanylate-binding protein 6 levels
Guanylate-binding protein 6 levels (GBP6.7818.101.3)
Guanylyl cyclase-activating protein 1 levels
Gut bacterial pathway abundance (HISDEG.PWY..L.histidine.degradation.I)
Gut bacterial pathway abundance (HISTSYN.PWY..L.histidine.biosynthesis)
Gut bacterial pathway abundance (PWY.6353..purine.nucleotides.degradation.II..aerobic.)
Gut bacterial pathway abundance (PWY.6612..superpathway.of.tetrahydrofolate.biosynthesis)
Gut bacterial pathway abundance (PWY.7209..superpathway.of.pyrimidine.ribonucleosides.degradation)
Gut microbiome composition (summer and winter)
Gut microbiome composition (summer)
Gut microbiome composition (winter)
Gut microbiota (alpha diversity)
Gut microbiota (bacterial taxa, hurdle binary method)
Gut microbiota (bacterial taxa, rank normal transformation method)
Gut microbiota (bacterial taxa)
Gut microbiota (beta diversity)
Gut microbiota (functional units)
Gut microbiota abundance (class Actinobacteria id.419)
Gut microbiota abundance (family Bifidobacteriaceae id.433)
Gut microbiota abundance (family Peptostreptococcaceae id.2042)
Gut microbiota abundance (family Streptococcaceae id.1850)
Gut microbiota abundance (genus Allisonella id.2174)
Gut microbiota abundance (genus Bifidobacterium id.436)
Gut microbiota abundance (genus Candidatus Soleaferrea id.11350)
Gut microbiota abundance (genus Erysipelatoclostridium id.11381)
Gut microbiota abundance (genus Eubacterium coprostanoligenes group id.11375)
Gut microbiota abundance (genus Intestinibacter id.11345)
Gut microbiota abundance (genus Oxalobacter id.2978)
Gut microbiota abundance (genus Peptococcus id.2037)
Gut microbiota abundance (genus Ruminococcus torques group id.14377)
Gut microbiota abundance (genus Ruminococcus1 id.11373)
Gut microbiota abundance (genus Streptococcus id.1853)
Gut microbiota abundance (genus Tyzzerella3 id.11335)
Gut microbiota abundance (k_Bacteria.p_Actinobacteria.c_Actinobacteria.o_Bifidobacteriales.f_Bifidobacteriaceae.g_Bifidobacterium.s_Bifidobacterium_adolescentis)
Gut microbiota abundance (k_Bacteria.p_Actinobacteria.c_Actinobacteria.o_Bifidobacteriales.f_Bifidobacteriaceae.g_Bifidobacterium.s_Bifidobacterium_longum)
Gut microbiota abundance (k_Bacteria.p_Actinobacteria.c_Actinobacteria.o_Bifidobacteriales.f_Bifidobacteriaceae.g_Bifidobacterium)
Gut microbiota abundance (k_Bacteria.p_Actinobacteria.c_Actinobacteria.o_Bifidobacteriales.f_Bifidobacteriaceae)
Gut microbiota abundance (k_Bacteria.p_Actinobacteria.c_Actinobacteria.o_Bifidobacteriales)
Gut microbiota abundance (k_Bacteria.p_Actinobacteria.c_Actinobacteria)
Gut microbiota abundance (k_Bacteria.p_Actinobacteria)
Gut microbiota abundance (order Bifidobacteriales id.432)
Gut microbiota abundance (order Gastranaerophilales id.1591)
Gut microbiota abundance (phylum Actinobacteria id.400)
Gut microbiota abundance (unknown family id.1000001214)
Gut microbiota abundance (unknown genus id.1000001215)
Gut microbiota alpha diversity (Chao1 index)
Gut microbiota alpha diversity (Inverse Simpson index)
Gut microbiota alpha diversity (PD_whole_tree index)
Gut microbiota alpha diversity (Shannon index)
Gut microbiota alpha diversity (Simpson index)
Gut microbiota beta diversity (weighted UniFrac distance)
Gut microbiota presence (family Bacteroidales S24 7group id.11173)
Gut microbiota presence (genus Lachnospiraceae UCG 010 id.11330)
Gut microbiota presence (genus Ruminiclostridium6 id.11356)
Gut microbiota presence (genus Turicibacter id.2162)
Gut microbiota relative abundance (bacterial taxa)
Gut microbiota relative abundance (Bacteroides)
Gut microbiota relative abundance (Bifidobacterium)
Gut microbiota relative abundance (Blautia)
Gut microbiota relative abundance (Dorea)
Gut microbiota relative abundance (Eubacterium belonging to family Erysipelotrichaceae)
Gut microbiota relative abundance (Faecalibacterium)
Gut microbiota relative abundance (Oscillospira)
Gut microbiota relative abundance (Parabacteroides)
Gut microbiota relative abundance (Prevotella)
Gut microbiota relative abundance (Ruminococcus belonging to family Erysipelotrichaceae)
Gut microbiota relative abundance (Ruminococcus belonging to family Lachnospiraceae)
Gut microbiota relative abundance (Streptococcus)
Gut microbiota relative abundance (Sutterella)
Gut microbiota relative abundance (unassigned genus belonging to family Clostridiales)
Gut microbiota relative abundance (unassigned genus belonging to family Lachnospiraceae)
Gut microbiota relative abundance (unclassified genus belonging to family Clostridiaceae)
Gut microbiota relative abundance (unclassified genus belonging to family Erysipelotrichaceae)
Gut microbiota relative abundance (unclassified genus belonging to family Lachnospiraceae)
Gut microbiota relative abundance (unclassified genus belonging to family Ruminococcaceae)
Gut microbiota relative abundance (unclassified genus belonging to the order Clostridiales)
Gynecologic disease
Gynecologic disease (multivariate analysis)
Haddock liking
Haemophilus D sp001679485 abundance in stool
Haemorrhoidal disease
Hair color
Hair colour (natural, before greying): Black (UKB data field 1747_5)
Hair colour (natural, before greying): Blonde (UKB data field 1747_1)
Hair colour (natural, before greying): Red (UKB data field 1747_2)
Hair curvature (observational)
Hair curvature (quantitative)
Hair greying
Hair morphology
Hair morphology traits
Hair shape
Hallux valgus
Haloacid dehalogenase-like hydrolase domain-containing protein 2 levels
Haloacid dehalogenase-like hydrolase domain-containing protein 2 levels (HDHD2.13472.35.3)
Haloacid dehalogenase-like hydrolase domain-containing protein 3 levels
Haloplasmatales abundance in stool
Hand grip strength
Hand grip strength (Mahalanobis distance)
Hand Osteoarthritis
Hand osteoarthritis severity (hand Klsum)
Handedness
Handedness (Left-handed vs. non-left-handed)
Handedness (left-handed vs. right-handed)
Handedness (non-right-handed vs right-handed)
Handedness (Right-handed vs. non-right-handed)
Handedness in dyslexia
Haptoglobin levels
Haptoglobin levels (HP.3054.3.2)
Haptoglobin plasma levels
Hashimoto thyroiditis
Hashimoto thyroiditis versus Graves' disease
HATA volume
Hay fever and/or eczema
HbA1c or polycystic ovary syndrome (pleiotropy)
HbA2 levels
HDL cholesterol
HDL Cholesterol - Triglycerides (HDLC-TG)
HDL cholesterol and triglyceride levels
HDL cholesterol and triglyceride levels (pleiotropy)
HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes
HDL cholesterol change in response to niacin in statin-treated individuals
HDL Cholesterol in HIV-infection
HDL cholesterol levels
HDL cholesterol levels (UKB data field 23406)
HDL cholesterol levels adjusted for adiponectin levels
HDL cholesterol levels in current drinkers
HDL cholesterol levels in HIV infection
HDL cholesterol levels in never smokers
HDL cholesterol levels in non smokers
HDL cholesterol levels in type 2 diabetes
HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)
HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)
HDL cholesterol levels x long total sleep time interaction (1df test)
HDL cholesterol levels x long total sleep time interaction (2df test)
HDL cholesterol levels x loop diuretics use interaction
HDL cholesterol levels x short total sleep time interaction (2df test)
HDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)
HDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)
HDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)
HDL cholesterol levels x thiazide or thiazide-like diuretics use interaction
HDL cholesterol x physical activity interaction (1df test)
HDL cholesterol x physical activity interaction (2df test)
HDL levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder
HDL levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder
Head and neck squamous cell carcinoma
Head circumference (infant)
Headache
Headache or migraine
Headache or type 2 diabetes
Health literacy
Healthspan
Hearing function
Hearing function (0.5 kHz)
Hearing function (1 kHz)
Hearing function (2 kHz)
Hearing function (4 kHz)
Hearing function (8 kHz)
Hearing function (left/right asymmetry)
Hearing loss
Hearing loss in Charcot-Marie-Tooth disease 1A
Hearing loss in noise exposure
Heart failure
Heart failure (multivariate analysis)
Heart rate
Heart rate in heart failure with reduced ejection fraction
Heart rate increase in response to exercise
Heart rate response to beta blockers
Heart rate response to beta blockers (atenolol add-on therapy)
Heart rate response to beta blockers (atenolol monotherapy)
Heart rate response to exercise
Heart rate response to recovery post exercise
Heart rate response to recovery post exercise (10 sec)
Heart rate response to recovery post exercise (20 sec)
Heart rate response to recovery post exercise (30 sec)
Heart rate response to recovery post exercise (40 sec)
Heart rate response to recovery post exercise (50 sec)
Heart rate variability traits
Heart rate variability traits (pvRSA/HF)
Heart rate variability traits (RMSSD)
Heart rate variability traits (SDNN)
Heat shock 27 kDa protein levels
Heat shock 70 kDa protein 1-like levels
Heat shock 70 kDa protein 1-like levels (HSPA1L.12041.33.3)
Heat shock 70 kDa protein 13 levels
Heat shock 70 kDa protein 1A level in Chronic kidney disease with hypertension and no diabetes (11157_35)
Heat shock 70 kDa protein 1B levels
Heat shock 70 kDa protein 6 level in Chronic kidney disease with hypertension and no diabetes (13672_3)
Heat shock 70 kDa protein 6 levels
Heat shock 70 kDa protein 6 levels (HSPA6.13672.3.3)
Heat shock cognate 71 kDa protein levels
Heat shock factor protein 1 levels
Heat shock protein beta-1 levels
Heat shock protein HSP 90-alpha/beta levels
Heat shock protein HSP 90-beta levels
Heavy menstrual bleeding
Heavy vaginal discharge
Hedgehog-interacting protein levels
Hedonic well-being
Heel bone mineral density
Heel bone mineral density (MTAG)
Heel bone mineral density variance
Heel bone mineral density x serum urate levels interaction
Height
Height (standard GWA)
Height (weighted GWA)
Height adjusted BMI
Helicobacter pylori serologic status
Helix rolling
Help-seeking from a GP
Help-seeking from a GP (without major depressive disorder symptoms)
Help-seeking from a psychiatrist
Helping behaviour (self reported)
Hematocrit
Hematological and biochemical traits
Hematological and neurological expressed 1 protein level in Chronic kidney disease with hypertension and no diabetes (19335_2)
Hematological and neurological expressed 1 protein levels
Hematological parameters
Hematology traits
Hematopoietic progenitor cell antigen CD34 levels (CD34.9023.9.3)
Hematopoietic prostaglandin D synthase levels
Hematopoietic prostaglandin D synthase levels (HPGDS.12549.33.3)
Hematuria
Hematuria (mild)
Hematuria (moderate to severe)
Heme levels in elite athletes
Heme oxygenase 1 levels
Heme-binding protein 1 level in Chronic kidney disease with hypertension and no diabetes (18225_13)
Heme-binding protein 1 levels
HemK methyltransferase family member 2 levels
Hemoglobin
Hemoglobin A1c levels
Hemoglobin A2 levels in sickle cell anemia
Hemoglobin concentration
Hemoglobin levels
Hemoglobin levels in non-alcoholic fatty liver disease x mastiha supplementation interaction
Hemoglobin subunit beta level in Chronic kidney disease with hypertension and no diabetes (17137_160)
Hemoglobin subunit delta levels
Hemoglobin subunit theta-1 levels
Hemoglobin subunit zeta levels
Hemoglobin subunit zeta levels (HBZ.6919.3.3)
Hemojuvelin levels
Hemojuvelin levels (HFE2.3332.57.1)
hemolysis of donated blood (osmotic)
hemolysis of donated blood (oxidative)
Hemopexin levels
Hemostatic factors and hematological phenotypes
Hen's egg allergy
HEPACAM family member 2 levels
Heparan sulfate glucosamine 3-O-sulfotransferase 1 levels
Heparan sulfate glucosamine 3-O-sulfotransferase 3A1 levels
Heparan sulfate glucosamine 3-O-sulfotransferase 3B1 levels
Heparan sulfate glucosamine 3-O-sulfotransferase 4 level in Chronic kidney disease with hypertension and no diabetes (19370_30)
Heparan sulfate glucosamine 3-O-sulfotransferase 4 levels
Heparan sulfate glucosamine 3-O-sulfotransferase 5 level in Chronic kidney disease with hypertension and no diabetes (10731_10)
Heparan sulfate glucosamine 3-O-sulfotransferase 5 levels
Heparan-sulfate 6-O-sulfotransferase 1 levels
Heparan-sulfate 6-O-sulfotransferase 1 levels (HS6ST1.5465.32.3)
Heparan-sulfate 6-O-sulfotransferase 3 levels
Heparin cofactor 2 levels
Heparin-binding EGF-like growth factor levels
Heparin-binding EGF-like growth factor levels (HBEGF.14094.29.3)
Heparin-induced thrombocytopenia
Hepatic cancer
Hepatic lipid content in extreme obesity
Hepatitis
Hepatitis A
Hepatitis A virus cellular receptor 1 levels
Hepatitis A virus cellular receptor 1 levels (HAVCR1.9021.1.3)
Hepatitis A virus cellular receptor 2 level in Chronic kidney disease with hypertension and no diabetes (5134_52)
Hepatitis A virus cellular receptor 2 levels
Hepatitis A virus cellular receptor 2 levels (HAVCR2.5134.52.2)
Hepatitis B
Hepatitis B surface antigen seroclearance in chronic hepatitis B infection
Hepatitis B virus-related hepatocellular carcinoma
Hepatitis B virus-related hepatocellular carcinoma vs chronic hepatitis B infection
Hepatitis B virus-related hepatocellular carcinoma vs hepatitis B virus-related decompensated cirrhosis
Hepatitis C (spontaneous viral clearance)
Hepatitis C induced liver fibrosis
Hepatocellular carcinoma
Hepatocellular carcinoma in alcohol related cirrhosis
Hepatocellular carcinoma in hepatitis B infection
Hepatocyte growth factor activator level in Chronic kidney disease with hypertension and no diabetes (3617_80)
Hepatocyte growth factor activator level in Chronic kidney disease with hypertension and no diabetes (8385_248)
Hepatocyte growth factor activator levels
Hepatocyte growth factor levels
Hepatocyte growth factor-like protein levels
Hepatoma-derived growth factor levels
Hepatoma-derived growth factor-related protein 3 level in Chronic kidney disease with hypertension and no diabetes (18899_82)
Hepatoma-derived growth factor-related protein 3 levels
Hepcidin levels
Hepcidin/ferritin ratio
Hepcidin/transferrin saturation ratio
Heptachlor epoxide levels
Heptachlor levels
Heptanoate (7:0) levels in elite athletes
HER2 status in breast cancer
Herbidospora abundance in stool
Hereditary hemochromatosis-related traits (HFE mutation homozygotes)
Hernia
Hernia (any subtypes)
Hernia (two or more subtypes)
Hernia abdominopelvic cavity
Heroin dependence
Herring liking
HERV-H LTR-associating protein 2 level in Chronic kidney disease with hypertension and no diabetes (14132_21)
Heschl's gyrus morphology
Heterogeneous nuclear ribonucleoprotein A/B levels
Heterogeneous nuclear ribonucleoprotein A1 levels
Heterogeneous nuclear ribonucleoprotein D-like levels
Heterogeneous nuclear ribonucleoprotein D0 levels
Heterogeneous nuclear ribonucleoprotein F levels
Heterogeneous nuclear ribonucleoprotein H levels
Heterogeneous nuclear ribonucleoprotein M level in Chronic kidney disease with hypertension and no diabetes (12783_29)
Heterogeneous nuclear ribonucleoprotein M levels
Heterogeneous nuclear ribonucleoprotein Q levels
Heterogeneous nuclear ribonucleoprotein R levels
Heterogeneous nuclear ribonucleoproteins A2/B1 levels
Heterogeneous nuclear ribonucleoproteins C1/C2 levels
Heterogeneous nuclear ribonucleoproteins C1/C2 levels (HNRNPC.11429.80.3)
Hexadecanedioate (C16-DC) levels
Hexadecanedioate (C16) levels
Hexadecanedioate levels
Hexadecanoylcarnitine levels
Hexadecenedioate (c16:1-dc) (X-11905) levels
Hexadecenedioate (C16:1-DC) levels
Hexadecenoylcarnitine levels
Hexanoylcarnitine (C6) levels
Hexanoylcarnitine (C6) levels in elite athletes
Hexanoylcarnitine levels
Hexanoylcarnitine levels (Biocrates platform)
Hexanoylcarnitine levels (Metabolon platform)
Hexanoylcarnitine-to-octanoylcarnitine ratio
Hexanoylglutamine levels
Hexanoylglutamine levels in elite athletes
Hexanoylglycine levels
Hexanoylglycine levels in elite athletes
Hexokinase-2 levels
Hexokinase-3 levels
Hexose levels
Hiatus hernia
High activity stress
High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor levels
High altitude adaptation
High aspartate aminotransferase or alanine aminotransferase levels in low dose methotrexate treatment
High chromosomal aberration frequency (chromatid type)
High chromosomal aberration frequency (chromatid type) in genotoxic compound exposure
High chromosomal aberration frequency (chromosome type)
High chromosomal aberration frequency (chromosome type) in genotoxic compound exposure
High chromosomal aberration frequency (total)
High density lipoprotein cholesterol levels
High fetal hemoglobin in sickle cell disease
High general stress
High IL-1beta levels in gingival crevicular fluid
High light scatter reticulocyte count
High light scatter reticulocyte percentage of red cells
High mobility group protein 20A levels
High mobility group protein B1 levels
High mobility group protein B2 levels
High myopia
High physical stress
High-density lipoprotein 2 cholesterol levels
High-density lipoprotein 3 cholesterol levels
High-density lipoprotein levels (MTAG)
High-density lipoprotein mediated cholesterol efflux capacity
High-grade serous ovarian cancer
High-sensitivity C-reactive protein levels in HIV infection
High-sensitivity cardiac troponin I concentration
High-sensitivity cardiac troponin I concentration (MTAG)
High-sensitivity cardiac troponin T levels
High-sensitivity cardiac troponin T levels (MTAG)
Highest math class taken
Highest math class taken (MTAG)
Highly plant-based diet
Hip bone mineral content accrual during adolescent growth spurt
Hip bone mineral density and total body fat mass (bivariate analysis)
Hip bone size
Hip circumference
Hip circumference (psychosocial stress interaction)
Hip circumference adjusted for BMI
Hip circumference variance
Hip fracture
Hip geometry
Hip index
Hip minimal joint space width
Hip pain
Hip shape (DXA scan)
Hippocampal atrophy
Hippocampal atrophy rate
Hippocampal sclerosis
Hippocampal sclerosis of aging
Hippocampal subfield CA1 volume
Hippocampal subfield CA3 volume
Hippocampal subfield CA4 volume
Hippocampal tail volume
Hippocampal volume
Hippocampal volume in Alzheimer's disease dementia
Hippocampal volume in normal cognition
Hippocampus volume change rate
Hippocampus volume change rate x age interaction (1df)
Hippocampus volume change rate x age interaction (2df)
HippSubfield lh volume CA1-head
HippSubfield lh volume CA3-head
HippSubfield lh volume CA4-body
HippSubfield lh volume CA4-head
HippSubfield lh volume GC-ML-DG-body
HippSubfield lh volume GC-ML-DG-head
HippSubfield lh volume Hippocampal-tail
HippSubfield lh volume presubiculum-head
HippSubfield lh volume subiculum-body
HippSubfield lh volume subiculum-head
HippSubfield lh volume Whole-hippocampal-body
HippSubfield lh volume Whole-hippocampal-head
HippSubfield lh volume Whole-hippocampus
HippSubfield rh volume CA1-body
HippSubfield rh volume CA1-head
HippSubfield rh volume CA3-head
HippSubfield rh volume CA4-body
HippSubfield rh volume CA4-head
HippSubfield rh volume GC-ML-DG-body
HippSubfield rh volume GC-ML-DG-head
HippSubfield rh volume Hippocampal-tail
HippSubfield rh volume presubiculum-body
HippSubfield rh volume presubiculum-head
HippSubfield rh volume subiculum-body
HippSubfield rh volume subiculum-head
HippSubfield rh volume Whole-hippocampal-body
HippSubfield rh volume Whole-hippocampal-head
HippSubfield rh volume Whole-hippocampus
Hirschsprung disease
Histamine N-methyltransferase level in Chronic kidney disease with hypertension and no diabetes (23178_95)
Histatin-1 levels
Histatin-1 levels (HTN1.10608.9.3)
Histatin-3 levels
Histidine betaine (hercynine) levels
Histidine levels
Histidine levels (Biocrates platform)
Histidine levels (Metabolon platform)
Histidine levels (UKB data field 23463)
Histidine levels in elite athletes
Histidine triad nucleotide-binding protein 1 levels
Histidine--tRNA ligase, cytoplasmic levels
Histidine-rich glycoprotein levels
Histidylalanine levels in elite athletes
Histone acetyltransferase KAT2A levels
Histone acetyltransferase type B catalytic subunit levels
Histone deacetylase 2 levels
Histone deacetylase 8 levels
Histone deacetylase complex subunit SAP18 levels
Histone deacetylase complex subunit SAP30 levels
Histone H2A deubiquitinase MYSM1 levels
Histone H2A type 3 levels
Histone H2B type 2-E levels
Histone H2B type 3-B levels
Histone-binding protein RBBP4 levels
Histone-lysine N-methyltransferase 2C levels
Histone-lysine N-methyltransferase 2D levels
Histone-lysine N-methyltransferase 2D levels (MLL2.13623.4.3)
Histone-lysine N-methyltransferase ASH1L levels
Histone-lysine N-methyltransferase EHMT2 levels
Histone-lysine N-methyltransferase SETD2 levels
Histone-lysine N-methyltransferase SETMAR levels
HIV progression (CD4 and viral load)
HIV-1 control
HIV-1 replication
HIV-1 susceptibility
HIV-1 viral setpoint
HIV-associated neurocognitive disorder
HIV-associated neurocognitive disorder (asymptomatic neurocogntive impairment)
HIV-associated neurocognitive disorder (mild neurocognitive disorder or asymptomatic neurocognitive impairment)
HIV-associated neurocognitive disorder (mild neurocognitive disorder)
HLA class I histocompatibility antigen, alpha chain E level in Chronic kidney disease with hypertension and no diabetes (25918_60)
HLA class I histocompatibility antigen, alpha chain G levels
HLA class II histocompatibility antigen gamma chain levels
HLA class II histocompatibility antigen, DM alpha chain levels (HLA.DMA.10639.1.3)
HLA class II histocompatibility antigen, DP beta 1 chain levels (HLA.DPB1.8755.202.3)
HLA class II histocompatibility antigen, DR beta 3 chain levels
HLA DR on B cell
HLA DR on CD14- CD16+ monocyte
HLA DR on CD33dim HLA DR+ CD11b-
HLA DR on CD33dim HLA DR+ CD11b+
HLA DR on Dendritic Cell
HLA DR on HLA DR+ CD4+ T cell
HLA DR on HLA DR+ Natural Killer
HLA DR on HLA DR+ T cell
HLA DR on myeloid Dendritic Cell
HLA DR on plasmacytoid Dendritic Cell
HLA DR+ CD4+ T cell %lymphocyte
HLA DR+ CD4+ T cell %T cell
HLA DR+ CD4+ T cell Absolute Count
HLA DR+ CD8+ T cell %lymphocyte
HLA DR+ CD8+ T cell %T cell
HLA DR+ CD8+ T cell Absolute Count
HLA DR+ Natural Killer %CD3- lymphocyte
HLA DR+ Natural Killer %Natural Killer
HLA DR+ Natural Killer Absolute Count
HLA DR+ T cell Absolute Count
HLA DR+ T cell%lymphocyte
HLA DR+ T cell%T cell
HLA risk haplotype in IgA deficiency
HLA risk haplotype in IgA deficiency (homozygous HLA-DRB1*01 HLA-DQB1*05:01)
HLA risk haplotype in IgA deficiency (homozygous HLA-DRB1*07:01 HLA-DQB1*02:02)
Hoarding
Hoarding symptoms
Hodgkin's lymphoma
Holdemania sp900120005 abundance in stool
Holo-Transcobalamin-2 level in Chronic kidney disease with hypertension and no diabetes (5584_21)
Holo-Transcobalamin-2 levels
HOMA-B (corrected for HOMA-IR)
Homeobox protein DLX-3 levels
Homeobox protein DLX-4 levels
Homeobox protein Hox-C11 level in Chronic kidney disease with hypertension and no diabetes (22474_28)
Homeobox protein MOX-2 levels
Homeobox protein NANOG levels
Homeodomain-interacting protein kinase 3 levels
Homeodomain-only protein levels
Homeostasis model assessment of beta-cell function
Homeostasis model assessment of beta-cell function (dietary factor interaction)
Homeostasis model assessment of insulin resistance
Homeostasis model assessment of insulin resistance (dietary factor interaction)
Homer protein homolog 1 levels
Homer protein homolog 2 levels
Homoarginine levels
Homoarginine levels in elite athletes
Homocitrulline levels
Homocitrulline levels in elite athletes
Homocysteine levels
Homostachydrine levels
Honey liking
Hormone measurements
Hormone-sensitive cancer
Horseradish liking
Hospital contact for infections
Household income
Household income (MTAG)
HSP 70 levels
HTLV-1 associated myelopathy
Human Chorionic Gonadotropin level in Chronic kidney disease with hypertension and no diabetes (4914_10)
Human Chorionic Gonadotropin levels
Human Chorionic Gonadotropin levels (CGA.CGB.4914.10.1)
Human herpes virus 7 U14 antibody levels
Human milk oligosaccharide concentration (2'-fucosyllactose)
Human milk oligosaccharide concentration (difucosyllactose)
Human milk oligosaccharide concentration (fucodisialyllacto-N-hexaose)
Human milk oligosaccharide concentration (fucosyllacto-N-hexaose)
Human milk oligosaccharide concentration (lacto-N-fucopentaose I)
Human milk oligosaccharide concentration (lacto-N-fucopentaose II)
Human milk oligosaccharide concentration (lacto-N-fucopentaose III)
Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in non-secretors
Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in secretors
Human milk oligosaccharide concentration (lacto-N-tetrose)
Human milk oligosaccharide concentration (sialyl-lacto-N-tetraose b)
Human papilloma virus 16 negative oropharyngeal cancer
Human papilloma virus 16 positive oropharyngeal cancer
Huntington's disease (age at onset)
Huntington's disease progression
HVEM on CD4+ T cell
HVEM on CD45RA- CD4+ T cell
HVEM on CD8+ T cell
HVEM on Central Memory CD4+ T cell
HVEM on Central Memory CD8+ T cell
HVEM on Effector Memory CD8+ T cell
HVEM on T cell
HWESASXX levels in elite athletes
Hyaluronan and proteoglycan link protein 1 levels
Hyaluronan and proteoglycan link protein 4 levels
Hydantoin-5-propionate levels
Hydantoin-5-propionic acid levels in elite athletes
Hydrocinnamic acid levels in coronary artery disease
Hydroquinone sulfate levels in elite athletes
Hydroxy-cmpf (X-02269) levels
Hydroxy-cmpf levels
Hydroxy-N6,N6,N6-trimethyllysine levels
Hydroxyacid oxidase 1 levels
Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial levels
Hydroxyacylglutathione hydrolase, mitochondrial levels
Hydroxycholesterol_[M+H-2H2O]1+ levels
Hydroxyhexadecanoylcarnitine levels
Hydroxyisovaleroyl carnitine levels
Hydroxypalmitoyl sphingomyelin (d18:1/16:0(OH)) levels
Hydroxysphingomyeline C14:1 levels
Hydroxysphingomyeline C16:1 levels
Hydroxysphingomyeline C22:1 levels
Hydroxysphingomyeline C22:2 levels
Hydroxysphingomyeline C24:1 levels
Hydroxysteroid dehydrogenase-like protein 2 level in Chronic kidney disease with hypertension and no diabetes (23588_9)
Hyocholate levels in elite athletes
Hyperactive-impulsive symptoms
Hyperemesis gravidarum
Hyperglycemia
Hyperglycemia in more-fat diet
Hyperlipidemia
Hyperlipidemia (time to event)
Hyperopia
Hypersomnia (HLA-DQB1*06:02 negative)
Hypertension
Hypertension complicating pregnancy
Hypertension risk in short sleep duration
Hypertensive renal disease
Hyperthymic temperament
Hyperthyroidism
Hypertriglyceridemia
Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (MTAG)
Hypertrophic cardiomyopathy (sarcomere negative)
Hypertrophic cardiomyopathy (sarcomere positive)
Hyperuricemia
Hypo-HDL-cholesterolemia
Hypoalbuminemia
Hypospadias
Hypospadias (moderate to severe)
Hypotaurine levels
Hypotaurine levels in elite athletes
Hypothyroidism
Hypoxanthine levels
Hypoxanthine levels in elite athletes
Hypoxia-inducible factor 1-alpha inhibitor levels
ICD10 K44: Diaphragmatic hernia
ICD10 R55: Syncope and collapse
ICD10 Z72.0: Tobacco use
ICOS ligand levels
Ideal cardiovascular health (clinical and behavioral)
Ideal cardiovascular health score (clinical and behavioral)
Idiopathic achalasia
Idiopathic central precocious puberty
Idiopathic dilated cardiomyopathy
Idiopathic downbeat nystagmus
Idiopathic inflammatory myopathy
Idiopathic intracranial hypertension
Idiopathic membranous nephropathy
Idiopathic osteonecrosis of the femoral head
Idiopathic polyneuropathy
Idiopathic pulmonary fibrosis
IDP dMRI ProbtrackX FA ar r
IDP dMRI ProbtrackX FA cgc r
IDP dMRI ProbtrackX FA fma
IDP dMRI ProbtrackX FA fmi
IDP dMRI ProbtrackX FA ifo r
IDP dMRI ProbtrackX FA str l
IDP dMRI ProbtrackX FA str r
IDP dMRI ProbtrackX ICVF ar l
IDP dMRI ProbtrackX ICVF ar r
IDP dMRI ProbtrackX ICVF atr l
IDP dMRI ProbtrackX ICVF atr r
IDP dMRI ProbtrackX ICVF cgc l
IDP dMRI ProbtrackX ICVF cgc r
IDP dMRI ProbtrackX ICVF cst l
IDP dMRI ProbtrackX ICVF cst r
IDP dMRI ProbtrackX ICVF fma
IDP dMRI ProbtrackX ICVF fmi
IDP dMRI ProbtrackX ICVF ifo l
IDP dMRI ProbtrackX ICVF ifo r
IDP dMRI ProbtrackX ICVF ilf l
IDP dMRI ProbtrackX ICVF ilf r
IDP dMRI ProbtrackX ICVF mcp
IDP dMRI ProbtrackX ICVF ptr l
IDP dMRI ProbtrackX ICVF ptr r
IDP dMRI ProbtrackX ICVF slf l
IDP dMRI ProbtrackX ICVF slf r
IDP dMRI ProbtrackX ICVF str l
IDP dMRI ProbtrackX ICVF str r
IDP dMRI ProbtrackX ICVF unc r
IDP dMRI ProbtrackX ISOVF ar r
IDP dMRI ProbtrackX ISOVF cgc l
IDP dMRI ProbtrackX ISOVF cgc r
IDP dMRI ProbtrackX ISOVF fma
IDP dMRI ProbtrackX ISOVF fmi
IDP dMRI ProbtrackX ISOVF ifo l
IDP dMRI ProbtrackX ISOVF ifo r
IDP dMRI ProbtrackX ISOVF ilf l
IDP dMRI ProbtrackX ISOVF ilf r
IDP dMRI ProbtrackX ISOVF slf l
IDP dMRI ProbtrackX ISOVF slf r
IDP dMRI ProbtrackX ISOVF str l
IDP dMRI ProbtrackX ISOVF str r
IDP dMRI ProbtrackX ISOVF unc l
IDP dMRI ProbtrackX ISOVF unc r
IDP dMRI ProbtrackX L1 atr r
IDP dMRI ProbtrackX L1 cgc r
IDP dMRI ProbtrackX L1 fmi
IDP dMRI ProbtrackX L1 ilf l
IDP dMRI ProbtrackX L1 ptr l
IDP dMRI ProbtrackX L1 slf r
IDP dMRI ProbtrackX L1 str r
IDP dMRI ProbtrackX L1 unc l
IDP dMRI ProbtrackX L1 unc r
IDP dMRI ProbtrackX L2 atr l
IDP dMRI ProbtrackX L2 fma
IDP dMRI ProbtrackX L2 fmi
IDP dMRI ProbtrackX L2 ifo l
IDP dMRI ProbtrackX L2 ifo r
IDP dMRI ProbtrackX L2 slf r
IDP dMRI ProbtrackX L2 unc l
IDP dMRI ProbtrackX L2 unc r
IDP dMRI ProbtrackX L3 cgc l
IDP dMRI ProbtrackX L3 fma
IDP dMRI ProbtrackX L3 fmi
IDP dMRI ProbtrackX L3 ifo l
IDP dMRI ProbtrackX L3 ilf r
IDP dMRI ProbtrackX L3 slf r
IDP dMRI ProbtrackX L3 unc r
IDP dMRI ProbtrackX MD atr l
IDP dMRI ProbtrackX MD cgc l
IDP dMRI ProbtrackX MD cgc r
IDP dMRI ProbtrackX MD fma
IDP dMRI ProbtrackX MD fmi
IDP dMRI ProbtrackX MD ifo l
IDP dMRI ProbtrackX MD ifo r
IDP dMRI ProbtrackX MD ilf l
IDP dMRI ProbtrackX MD slf r
IDP dMRI ProbtrackX MD unc l
IDP dMRI ProbtrackX MD unc r
IDP dMRI ProbtrackX MO str l
IDP dMRI ProbtrackX MO str r
IDP dMRI ProbtrackX OD fma
IDP dMRI ProbtrackX OD slf l
IDP dMRI ProbtrackX OD slf r
IDP dMRI ProbtrackX OD str l
IDP dMRI ProbtrackX OD str r
IDP dMRI TBSS FA Fornix
IDP dMRI TBSS FA Genu of corpus callosum
IDP dMRI TBSS FA Posterior limb of internal capsule L
IDP dMRI TBSS FA Posterior limb of internal capsule R
IDP dMRI TBSS FA Splenium of corpus callosum
IDP dMRI TBSS FA Superior cerebellar peduncle L
IDP dMRI TBSS FA Superior cerebellar peduncle R
IDP dMRI TBSS FA Tapetum L
IDP dMRI TBSS FA Tapetum R
IDP dMRI TBSS ICVF Anterior corona radiata L
IDP dMRI TBSS ICVF Anterior corona radiata R
IDP dMRI TBSS ICVF Anterior limb of internal capsule L
IDP dMRI TBSS ICVF Anterior limb of internal capsule R
IDP dMRI TBSS ICVF Body of corpus callosum
IDP dMRI TBSS ICVF Cerebral peduncle L
IDP dMRI TBSS ICVF Cerebral peduncle R
IDP dMRI TBSS ICVF Cingulum cingulate gyrus L
IDP dMRI TBSS ICVF Cingulum cingulate gyrus R
IDP dMRI TBSS ICVF Cingulum hippocampus L
IDP dMRI TBSS ICVF Cingulum hippocampus R
IDP dMRI TBSS ICVF External capsule L
IDP dMRI TBSS ICVF External capsule R
IDP dMRI TBSS ICVF Fornix
IDP dMRI TBSS ICVF Fornix cres+Stria terminalis L
IDP dMRI TBSS ICVF Fornix cres+Stria terminalis R
IDP dMRI TBSS ICVF Genu of corpus callosum
IDP dMRI TBSS ICVF Inferior cerebellar peduncle L
IDP dMRI TBSS ICVF Inferior cerebellar peduncle R
IDP dMRI TBSS ICVF Medial lemniscus L
IDP dMRI TBSS ICVF Medial lemniscus R
IDP dMRI TBSS ICVF Middle cerebellar peduncle
IDP dMRI TBSS ICVF Pontine crossing tract
IDP dMRI TBSS ICVF Posterior corona radiata L
IDP dMRI TBSS ICVF Posterior corona radiata R
IDP dMRI TBSS ICVF Posterior limb of internal capsule L
IDP dMRI TBSS ICVF Posterior limb of internal capsule R
IDP dMRI TBSS ICVF Posterior thalamic radiation L
IDP dMRI TBSS ICVF Posterior thalamic radiation R
IDP dMRI TBSS ICVF Retrolenticular part of internal capsule L
IDP dMRI TBSS ICVF Retrolenticular part of internal capsule R
IDP dMRI TBSS ICVF Sagittal stratum L
IDP dMRI TBSS ICVF Sagittal stratum R
IDP dMRI TBSS ICVF Splenium of corpus callosum
IDP dMRI TBSS ICVF Superior cerebellar peduncle L
IDP dMRI TBSS ICVF Superior cerebellar peduncle R
IDP dMRI TBSS ICVF Superior corona radiata L
IDP dMRI TBSS ICVF Superior corona radiata R
IDP dMRI TBSS ICVF Superior longitudinal fasciculus L
IDP dMRI TBSS ICVF Superior longitudinal fasciculus R
IDP dMRI TBSS ICVF Tapetum L
IDP dMRI TBSS ICVF Uncinate fasciculus R
IDP dMRI TBSS ISOVF Anterior corona radiata L
IDP dMRI TBSS ISOVF Anterior corona radiata R
IDP dMRI TBSS ISOVF Cingulum cingulate gyrus R
IDP dMRI TBSS ISOVF Corticospinal tract R
IDP dMRI TBSS ISOVF External capsule L
IDP dMRI TBSS ISOVF External capsule R
IDP dMRI TBSS ISOVF Fornix
IDP dMRI TBSS ISOVF Posterior corona radiata L
IDP dMRI TBSS ISOVF Sagittal stratum L
IDP dMRI TBSS ISOVF Sagittal stratum R
IDP dMRI TBSS ISOVF Superior longitudinal fasciculus L
IDP dMRI TBSS ISOVF Superior longitudinal fasciculus R
IDP dMRI TBSS L1 Anterior corona radiata L
IDP dMRI TBSS L1 Anterior limb of internal capsule R
IDP dMRI TBSS L1 Cerebral peduncle L
IDP dMRI TBSS L1 Cerebral peduncle R
IDP dMRI TBSS L1 Cingulum cingulate gyrus R
IDP dMRI TBSS L1 Corticospinal tract R
IDP dMRI TBSS L1 External capsule L
IDP dMRI TBSS L1 External capsule R
IDP dMRI TBSS L1 Fornix
IDP dMRI TBSS L1 Genu of corpus callosum
IDP dMRI TBSS L1 Posterior limb of internal capsule L
IDP dMRI TBSS L1 Posterior limb of internal capsule R
IDP dMRI TBSS L1 Retrolenticular part of internal capsule L
IDP dMRI TBSS L1 Splenium of corpus callosum
IDP dMRI TBSS L1 Superior corona radiata L
IDP dMRI TBSS L1 Superior longitudinal fasciculus L
IDP dMRI TBSS L1 Superior longitudinal fasciculus R
IDP dMRI TBSS L2 Anterior corona radiata L
IDP dMRI TBSS L2 Anterior limb of internal capsule R
IDP dMRI TBSS L2 Cingulum hippocampus R
IDP dMRI TBSS L2 Corticospinal tract R
IDP dMRI TBSS L2 External capsule R
IDP dMRI TBSS L2 Fornix
IDP dMRI TBSS L2 Genu of corpus callosum
IDP dMRI TBSS L2 Posterior limb of internal capsule L
IDP dMRI TBSS L2 Posterior limb of internal capsule R
IDP dMRI TBSS L2 Splenium of corpus callosum
IDP dMRI TBSS L2 Superior cerebellar peduncle L
IDP dMRI TBSS L2 Superior cerebellar peduncle R
IDP dMRI TBSS L2 Superior fronto-occipital fasciculus L
IDP dMRI TBSS L2 Tapetum L
IDP dMRI TBSS L3 Anterior limb of internal capsule R
IDP dMRI TBSS L3 Cingulum cingulate gyrus L
IDP dMRI TBSS L3 Cingulum cingulate gyrus R
IDP dMRI TBSS L3 Fornix
IDP dMRI TBSS L3 Genu of corpus callosum
IDP dMRI TBSS L3 Posterior limb of internal capsule R
IDP dMRI TBSS L3 Sagittal stratum L
IDP dMRI TBSS L3 Sagittal stratum R
IDP dMRI TBSS L3 Splenium of corpus callosum
IDP dMRI TBSS L3 Superior cerebellar peduncle L
IDP dMRI TBSS L3 Superior cerebellar peduncle R
IDP dMRI TBSS L3 Superior corona radiata R
IDP dMRI TBSS L3 Superior fronto-occipital fasciculus R
IDP dMRI TBSS L3 Superior longitudinal fasciculus R
IDP dMRI TBSS MD Anterior corona radiata R
IDP dMRI TBSS MD Anterior limb of internal capsule R
IDP dMRI TBSS MD Cerebral peduncle L
IDP dMRI TBSS MD Cingulum cingulate gyrus L
IDP dMRI TBSS MD Cingulum cingulate gyrus R
IDP dMRI TBSS MD Corticospinal tract R
IDP dMRI TBSS MD External capsule L
IDP dMRI TBSS MD External capsule R
IDP dMRI TBSS MD Fornix
IDP dMRI TBSS MD Genu of corpus callosum
IDP dMRI TBSS MD Pontine crossing tract
IDP dMRI TBSS MD Posterior limb of internal capsule L
IDP dMRI TBSS MD Posterior limb of internal capsule R
IDP dMRI TBSS MD Sagittal stratum R
IDP dMRI TBSS MD Splenium of corpus callosum
IDP dMRI TBSS MD Superior cerebellar peduncle R
IDP dMRI TBSS MD Superior corona radiata L
IDP dMRI TBSS MD Superior corona radiata R
IDP dMRI TBSS MD Superior longitudinal fasciculus L
IDP dMRI TBSS MD Superior longitudinal fasciculus R
IDP dMRI TBSS MO Body of corpus callosum
IDP dMRI TBSS MO Cerebral peduncle L
IDP dMRI TBSS MO Cerebral peduncle R
IDP dMRI TBSS MO Fornix
IDP dMRI TBSS MO Pontine crossing tract
IDP dMRI TBSS MO Posterior corona radiata R
IDP dMRI TBSS MO Posterior limb of internal capsule L
IDP dMRI TBSS MO Posterior limb of internal capsule R
IDP dMRI TBSS MO Retrolenticular part of internal capsule R
IDP dMRI TBSS MO Superior corona radiata L
IDP dMRI TBSS MO Superior corona radiata R
IDP dMRI TBSS OD Anterior limb of internal capsule L
IDP dMRI TBSS OD Anterior limb of internal capsule R
IDP dMRI TBSS OD Body of corpus callosum
IDP dMRI TBSS OD Cerebral peduncle L
IDP dMRI TBSS OD Cerebral peduncle R
IDP dMRI TBSS OD External capsule L
IDP dMRI TBSS OD External capsule R
IDP dMRI TBSS OD Fornix
IDP dMRI TBSS OD Genu of corpus callosum
IDP dMRI TBSS OD Pontine crossing tract
IDP dMRI TBSS OD Posterior corona radiata R
IDP dMRI TBSS OD Posterior limb of internal capsule L
IDP dMRI TBSS OD Posterior limb of internal capsule R
IDP dMRI TBSS OD Superior corona radiata L
IDP dMRI TBSS OD Superior corona radiata R
IDP dMRI TBSS OD Superior fronto-occipital fasciculus R
IDP SWI T2star left caudate
IDP SWI T2star left pallidum
IDP SWI T2star left putamen
IDP SWI T2star left thalamus
IDP SWI T2star right caudate
IDP SWI T2star right pallidum
IDP SWI T2star right putamen
IDP SWI T2star right thalamus
IDP T1 FAST ROIs brain stem
IDP T1 FAST ROIs L caudate
IDP T1 FAST ROIs L cerebellum crus I
IDP T1 FAST ROIs L cerebellum crus II
IDP T1 FAST ROIs L cerebellum I-IV
IDP T1 FAST ROIs L cerebellum IX
IDP T1 FAST ROIs L cerebellum V
IDP T1 FAST ROIs L cerebellum VI
IDP T1 FAST ROIs L cerebellum VIIb
IDP T1 FAST ROIs L cerebellum VIIIa
IDP T1 FAST ROIs L cerebellum VIIIb
IDP T1 FAST ROIs L cerebellum X
IDP T1 FAST ROIs L cuneal cortex
IDP T1 FAST ROIs L hippocampus
IDP T1 FAST ROIs L intracalc cortex
IDP T1 FAST ROIs L pallidum
IDP T1 FAST ROIs L putamen
IDP T1 FAST ROIs L subcallosal cortex
IDP T1 FAST ROIs L supracalc cortex
IDP T1 FAST ROIs L thalamus
IDP T1 FAST ROIs L ventral striatum
IDP T1 FAST ROIs R caudate
IDP T1 FAST ROIs R cerebellum crus I
IDP T1 FAST ROIs R cerebellum crus II
IDP T1 FAST ROIs R cerebellum IX
IDP T1 FAST ROIs R cerebellum V
IDP T1 FAST ROIs R cerebellum VI
IDP T1 FAST ROIs R cerebellum VIIb
IDP T1 FAST ROIs R cerebellum VIIIb
IDP T1 FAST ROIs R cerebellum X
IDP T1 FAST ROIs R hippocampus
IDP T1 FAST ROIs R intracalc cortex
IDP T1 FAST ROIs R occ pole
IDP T1 FAST ROIs R planum temporale
IDP T1 FAST ROIs R putamen
IDP T1 FAST ROIs R subcallosal cortex
IDP T1 FAST ROIs R sup temp gyrus ant
IDP T1 FAST ROIs R thalamus
IDP T1 FAST ROIs R ventral striatum
IDP T1 FAST ROIs V cerebellum crus II
IDP T1 FAST ROIs V cerebellum IX
IDP T1 FAST ROIs V cerebellum VIIb
IDP T1 FAST ROIs V cerebellum VIIIa
IDP T1 FAST ROIs V cerebellum VIIIb
IDP T1 FAST ROIs V cerebellum X
IDP T1 FIRST brain stem+4th ventricle volume
IDP T1 FIRST left caudate volume
IDP T1 FIRST left hippocampus volume
IDP T1 FIRST left pallidum volume
IDP T1 FIRST left putamen volume
IDP T1 FIRST right caudate volume
IDP T1 FIRST right pallidum volume
IDP T1 FIRST right putamen volume
IDP T1 SIENAX brain-normalised volume
IDP T1 SIENAX brain-unnormalised volume
IDP T1 SIENAX CSF normalised volume
IDP T1 SIENAX CSF unnormalised volume
IDP T1 SIENAX white normalised volume
IDP T1 SIENAX white unnormalised volume
IDP T2 FLAIR BIANCA WMH volume
Iduronate 2-sulfatase levels
IFN-related cytopenia
Ig gamma-2, Kappa levels
Ig Kappa chain V-I region HK102- like levels
IgA levels
IgA nephropathy
IgD on IgD+ CD24- B cell
IgD on IgD+ CD38+ B cell
IgD on IgD+ CD38dim B cell
IgD on transitional B cell
IgD- CD27- B cell %B cell
IgD- CD27- B cell %lymphocyte
IgD- CD27- B cell Absolute Count
IgD- CD38+ B cell %B cell
IgD- CD38dim B cell %lymphocyte
IgD+ B cell %Lymphocyte
IgD+ B cell Absolute Count
IgD+ CD24- B cell Absolute Count
IgD+ CD24+ B cell %lymphocyte
IgD+ CD38+ B cell Absolute Count
IgE grass sensitization
IgE levels
IgE levels in asthmatics
IgE levels in asthmatics (D.p. specific)
IGF-1 and IGFBP-3 levels (bivariate analysis)
IGF-like family receptor 1 levels
IGF-like family receptor 1 levels (IGFLR1.7244.16.3)
IGFBP 3 plasma levels
IgG antibody levels in response to SARS-CoV-2 vaccination
IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis)
IgG digalactosylation phenotypes (multivariate analysis)
IgG disialylation phenotypes (multivariate analysis)
IgG fucosylation phenotypes (multivariate analysis)
IgG galactosylation phenotypes (multivariate analysis)
IgG glycosylation
IgG glycosylation patterns
IgG levels
IgG monogalactosylation phenotypes (multivariate analysis)
IgG monosialylation phenotypes (multivariate analysis)
IgG N-glycosylation phenotypes (multivariate analysis)
IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7)
IgG sialylation phenotypes (multivariate analysis)
IgG1 response to Plasmodium falciparum antigen (GLURP)
IgM levels
IL 18 plasma levels
IL 1RII plasma levels
IL-17/ IL-17F level in Chronic kidney disease with hypertension and no diabetes (21897_4)
Ileal carcinoids
Illicit drug use
Imidazole lactate levels
Imidazole lactate levels in elite athletes
Imidazole propionate levels
Imidazole propionate levels in elite athletes
Immature fraction of reticulocytes
Immature Myeloid-Derived Suppressor Cells %CD33dim HLA DR- CD66b-
Immature Myeloid-Derived Suppressor Cells Absolute Count
Immune reponse to smallpox (secreted IFN-alpha)
Immune reponse to smallpox (secreted IL-10)
Immune reponse to smallpox (secreted IL-12p40)
Immune reponse to smallpox (secreted IL-1beta)
Immune reponse to smallpox (secreted IL-2)
Immune reponse to smallpox (secreted TNF-alpha)
Immune response to anthrax vaccine
Immune response to measles vaccine (measles-specific neutralising antibody titre)
Immune response to measles-mumps-rubella vaccine
Immune response to smallpox vaccine (IL-6)
Immunoglobulin A
Immunoglobulin A vasculitis
Immunoglobulin E levels
Immunoglobulin G index levels in multiple sclerosis
Immunoglobulin lambda-like polypeptide 1 levels
Immunoglobulin lambda-like polypeptide 1 levels (IGLL1.6485.59.3)
Immunoglobulin light chain (AL) amyloidosis
Immunoglobulin light chain (AL) amyloidosis (liver involvement)
Immunoglobulin M against phosphorylcholine (IgM anti-PC) levels
Immunoglobulin M levels
Immunoglobulin measurement (zinc sulfate turbidity test)
Immunoglobulin N-glycan 10 levels
Immunoglobulin N-glycan 11 levels
Immunoglobulin N-glycan 12 levels
Immunoglobulin N-glycan 16 levels
Immunoglobulin N-glycan 17 levels
Immunoglobulin N-glycan 2 levels
Immunoglobulin N-glycan 21 levels
Immunoglobulin N-glycan 22 levels
Immunoglobulin N-glycan 23 levels
Immunoglobulin N-glycan 7 levels
Immunoglobulin superfamily containing leucine-rich repeat protein 2 levels
Immunoglobulin superfamily containing leucine-rich repeat protein 2 levels (ISLR2.13124.20.3)
Immunoglobulin superfamily member 3 levels
Immunoglobulin superfamily member 8 levels
Impaired insulin sensitivity in response to n-3 PUFA supplementation
Importin subunit alpha-1 levels
Importin subunit alpha-7 levels
Importin subunit beta-1 levels
Inactive gamma-glutamyltranspeptidase 2 levels
Inactive pancreatic lipase-related protein 1 levels
Inactive pancreatic lipase-related protein 1 levels (PNLIPRP1.6627.25.3)
Inactive peptidyl-prolyl cis-trans isomerase FKBP6 level in Chronic kidney disease with hypertension and no diabetes (12529_32)
Inactive peptidyl-prolyl cis-trans isomerase FKBP6 levels
Inactive peptidyl-prolyl cis-trans isomerase FKBP6 levels (FKBP6.12529.32.3)
Inactive ribonuclease-like protein 10 levels
Inactive serine protease 35 levels
Inactive tyrosine-protein kinase 7 levels
Inactive tyrosine-protein kinase transmembrane receptor ROR1 levels
Inattentive symptoms
Incident atrial fibrillation
Incident chronic kidney disease
Incident hormone-sensitive cancer
Incident myocardial infarction
Inclusion body myositis
Increased healthspan
Increased healthspan in old age
Incremental insulin
Indian hedgehog protein levels
Indoleacetoylcarnitine levels
Indoleacetylglutamine levels
Indoleacetylglutamine levels in elite athletes
Indoleamine 2,3-dioxygenase 1 levels
Indolebutyrate levels
Indolelactate levels
Indolepropionate levels
Indolepropionate levels in elite athletes
Induced myeloid leukemia cell differentiation protein Mcl-1 levels
Inducible T-cell costimulator levels (ICOS.14084.191.3)
Infant head circumference (MTAG)
Infant length
Infant, child and juvenile death (proportion of children died <15 years)
Infant, child and juvenile death in continuous marriage (proportion of children died <15 years)
Infantile hypertrophic pyloric stenosis
Infection persistence (>18 months) in genital human papillomavirus 16 infection
Inferior parietal cortex volume
Inferior temporal gyrus volume
Inflammatory biomarkers
Inflammatory biomarkers (multivariate analysis)
Inflammatory biomarkers in Kawasaki disease
Inflammatory bowel disease
Inflammatory bowel disease (early onset)
Inflammatory skin disease
Infliximab-induced mucosal healing in Crohn's disease
Influenza A (H1N1) infection
Influenza A (H1N1) severity
Information processing speed
Inguinal hernia
Inhibin B levels
Inhibin beta A chain levels
Inhibin beta A chain:Inhibin beta C chain heterodimer levels
Inhibin beta B chain (mixed) levels
Inhibin beta B chain levels
Inhibin beta C chain level in Chronic kidney disease with hypertension and no diabetes (15686_49)
Inhibin beta C chain levels
Inhibin beta C chain levels (INHBC.6408.2.3)
Inhibitor of growth protein 1 levels
Inhibitory control
Initial alcohol sensitivity
Initial pursuit acceleration
Initial pursuit acceleration in psychotic disorders
Inorganic pyrophosphatase 2, mitochondrial levels
Inorganic pyrophosphatase level in Chronic kidney disease with hypertension and no diabetes (5021_13)
Inorganic pyrophosphatase levels
Inosine levels
Inosine triphosphate pyrophosphatase level in Chronic kidney disease with hypertension and no diabetes (18916_25)
Inosine triphosphate pyrophosphatase levels
Inosine-5-monophosphate dehydrogenase 1 levels
Inosine-5-monophosphate dehydrogenase 2 levels
Inosine-5'-monophosphate dehydrogenase 1 levels
Inosine-5'-monophosphate dehydrogenase 2 levels
Inositol 1,4,5-trisphosphate receptor-interacting protein-like 1 levels
Inositol monophosphatase 1 level in Chronic kidney disease with hypertension and no diabetes (17796_15)
Inositol monophosphatase 1 levels
Inositol polyphosphate 5-phosphatase OCRL-1 levels
Inositol polyphosphate 5-phosphatase OCRL-1 levels (OCRL.10011.65.3)
Inositol-trisphosphate 3-kinase A levels
Inositol-trisphosphate 3-kinase C levels
Insomnia
Insomnia (caffeine-induced)
Insomnia (standard GWA)
Insomnia (weighted GWA)
Insomnia in chronic migraine
Insomnia in migraine with aura
Insomnia symptoms (never/rarely vs. sometimes/usually)
Insomnia symptoms (never/rarely vs. usually)
Insular cortex volume
Insulin disposition index
Insulin growth factor-like family member 3 levels (IGFL3.6961.14.3)
Insulin growth factor-like family member 4 levels (IGFL4.6353.60.3)
Insulin levels
Insulin levels adjusted for BMI
Insulin levels in lean individuals
Insulin levels in overweight individuals
Insulin levels in response to oral glucose tolerance test (30 minutes)
Insulin receptor levels
Insulin resistance/response
Insulin secretion rate
Insulin-degrading enzyme levels
Insulin-induced gene 1 protein levels
Insulin-like 3 levels
Insulin-like growth factor 1 levels
Insulin-like growth factor 1 receptor levels
Insulin-like growth factor I levels
Insulin-like growth factor-binding protein 1 levels
Insulin-like growth factor-binding protein 3 levels
Insulin-like growth factor-binding protein 7 levels
Insulin-like growth factor-binding protein 7 levels (IGFBP7.3320.49.2)
Insulin-like growth factor-binding protein complex acid labile subunit levels
Insulin-like growth factor-binding protein-like 1 levels
Insulin-like growth factors
Insulin-like peptide INSL6 levels
Insulin-related traits
Insulin-related traits (multivariate analysis)
Insulinogenic index
Insulinoma-associated antigen 2 autoantibody levels in type 1 diabetes
Intake of sweets
Intake of total sugars
Integral membrane protein 2A levels
Integral membrane protein 2B levels
Integrin alpha-2 levels
Integrin beta-5 levels
Intelectin-1 levels
Intelligence
Intelligence (childhood)
Intelligence (MTAG)
Inter-alpha-trypsin inhibitor heavy chain H1 level in Chronic kidney disease with hypertension and no diabetes (7955_195)
Inter-alpha-trypsin inhibitor heavy chain H1 levels
Inter-alpha-trypsin inhibitor heavy chain H1 levels (ITIH1.7955.195.3)
Inter-alpha-trypsin inhibitor heavy chain H3 levels
Inter-alpha-trypsin inhibitor heavy chain H4 levels
Inter-alpha-trypsin inhibitor heavy chain H5 levels
Inter-alpha-trypsin inhibitor heavy chain H5 levels (ITIH5.8233.2.3)
Intercellular adhesion molecule 1 level in Chronic kidney disease with hypertension and no diabetes (4342_10)
Intercellular adhesion molecule 1 levels
Intercellular adhesion molecule 1 levels (ICAM1.4342.10.3)
Intercellular adhesion molecule 2 levels
Intercellular adhesion molecule 4 levels
Intercellular adhesion molecule 4 levels (ICAM4.6550.4.3)
Intercellular adhesion molecule 5 level in Chronic kidney disease with hypertension and no diabetes (5124_62)
Intercellular adhesion molecule 5 levels
Intercellular adhesion molecule 5 levels (ICAM5.8245.27.3)
Interferon alpha levels in systemic lupus erythematosus
Interferon alpha-16 levels
Interferon alpha-2 level in Chronic kidney disease with hypertension and no diabetes (3497_13)
Interferon alpha-4 levels
Interferon alpha-5 levels
Interferon alpha-7 levels
Interferon alpha/beta receptor 1 level in Chronic kidney disease with hypertension and no diabetes (6055_53)
Interferon alpha/beta receptor 1 level in Chronic kidney disease with hypertension and no diabetes (9183_7)
Interferon alpha/beta receptor 1 levels
Interferon alpha/beta receptor 1 levels (IFNAR1.9183.7.3)
Interferon gamma levels
Interferon gamma receptor 1 levels
Interferon gamma receptor 2 levels
Interferon gamma-induced protein 10 levels
Interferon lambda receptor 1 levels
Interferon lambda-1 levels
Interferon lambda-2 levels
Interferon lambda-3 levels
Interferon lambda-4 level in Chronic kidney disease with hypertension and no diabetes (21895_36)
Interferon regulatory factor 3 levels
Interferon regulatory factor 9 levels
Interferon-induced GTP-binding protein Mx1 levels
Interferon-induced protein with tetratricopeptide repeats 3 levels
Interferon-inducible double-stranded RNA-dependent protein kinase activator A level in Chronic kidney disease with hypertension and no diabetes (22010_36)
interferon-related traits
interleukin 12 receptor subunit beta-1 levels
interleukin 15 receptor subunit alpha levels
interleukin 17 receptor B levels
Interleukin enhancer-binding factor 3 levels
Interleukin-1 beta levels
Interleukin-1 Receptor accessory protein levels
Interleukin-1 receptor antagonist protein levels
Interleukin-1 receptor antagonist protein levels (IL1RN.5353.89.2)
Interleukin-1 receptor type 1 levels
Interleukin-1 receptor type 2 levels
Interleukin-1 receptor type 2 levels (IL1R2.14133.93.3)
Interleukin-1 receptor-associated kinase 4 levels
Interleukin-1 receptor-like 1 level in Chronic kidney disease with hypertension and no diabetes (4234_8)
Interleukin-1 receptor-like 1 levels
Interleukin-1 receptor-like 1 levels (IL1RL1.4234.8.2)
Interleukin-1 receptor-like 2 levels
Interleukin-1 receptor-like 2 levels (IL1RL2.2994.71.2)
Interleukin-1-beta levels
Interleukin-1-receptor antagonist levels
Interleukin-10 levels
Interleukin-10 levels in non-alcoholic fatty liver disease x mastiha supplementation interaction
Interleukin-10 receptor B levels
Interleukin-10 receptor subunit alpha levels
Interleukin-10 receptor subunit beta levels
Interleukin-11 levels
Interleukin-11 receptor subunit alpha levels
Interleukin-11 receptor subunit alpha levels (IL11RA.3814.63.1)
Interleukin-12 receptor subunit beta-1 levels
Interleukin-12 subunit B levels
Interleukin-12 subunit beta levels
Interleukin-12p70 levels
Interleukin-13 levels
Interleukin-13 receptor subunit alpha-1 levels (IL13RA1.2633.52.2)
Interleukin-15 levels
Interleukin-15 receptor subunit alpha levels
Interleukin-15 receptor subunit alpha levels (IL15RA.14054.17.3)
Interleukin-16 level in Chronic kidney disease with hypertension and no diabetes (2774_10)
Interleukin-16 levels
Interleukin-16 levels (IL16.2774.10.3)
Interleukin-17 levels
Interleukin-17 receptor A levels
Interleukin-17 receptor A levels (IL17RA.2992.59.2)
interleukin-17 receptor B levels
Interleukin-17 receptor B levels (IL17RB.5084.154.3)
Interleukin-17 receptor D levels
Interleukin-17A levels
Interleukin-17C levels
Interleukin-17D levels
Interleukin-18 levels
Interleukin-18 receptor 1 level in Chronic kidney disease with hypertension and no diabetes (3446_7)
interleukin-18 receptor 1 levels
Interleukin-18 receptor 1 levels (IL18R1.3446.7.2)
Interleukin-18 receptor accessory protein levels
Interleukin-19 levels
Interleukin-2 levels
Interleukin-2 levels (IL2.3070.1.2)
Interleukin-2 receptor antagonist levels
Interleukin-2 receptor subunit alpha levels
Interleukin-20 receptor subunit alpha levels
Interleukin-20 receptor subunit beta levels
Interleukin-22 levels
Interleukin-22 receptor subunit alpha-2 levels
Interleukin-23 levels
Interleukin-23 receptor levels
Interleukin-23 receptor levels (IL23R.5088.175.3)
Interleukin-25 levels
Interleukin-26 levels
Interleukin-27 levels
Interleukin-27 levels (IL27.EBI3.2829.19.2)
Interleukin-27 receptor subunit alpha levels
Interleukin-27 subunit beta level in Chronic kidney disease with hypertension and no diabetes (10851_77)
Interleukin-27 subunit beta levels
Interleukin-31 level in Chronic kidney disease with hypertension and no diabetes (10455_196)
Interleukin-31 levels
Interleukin-31 levels (IL31.10455.196.3)
Interleukin-34 level in Chronic kidney disease with hypertension and no diabetes (4556_10)
Interleukin-35 level in Chronic kidney disease with hypertension and no diabetes (20533_39)
Interleukin-36 alpha levels (IL36A.10928.7.3)
Interleukin-36 receptor antagonist protein level in Chronic kidney disease with hypertension and no diabetes (18375_28)
Interleukin-36 receptor antagonist protein levels
Interleukin-37 levels
Interleukin-4 levels
Interleukin-4 receptor subunit alpha levels
Interleukin-5 level in Chronic kidney disease with hypertension and no diabetes (3741_4)
Interleukin-5 levels
Interleukin-5 levels (IL5.3741.4.3)
Interleukin-5 receptor subunit alpha levels
Interleukin-6 levels
Interleukin-6 levels in HIV infection
Interleukin-6 levels in non-alcoholic fatty liver disease x mastiha supplementation interaction
Interleukin-6 levels in overweight individuals
Interleukin-6 receptor subunit alpha levels
Interleukin-6 receptor subunit beta level in Chronic kidney disease with hypertension and no diabetes (2620_4)
Interleukin-6 receptor subunit beta levels
Interleukin-6 receptor subunit beta levels (IL6ST.2620.4.2)
Interleukin-7 levels
Interleukin-7 receptor subunit alpha levels
Interleukin-8 levels
Interleukin-9 levels
Internet addiction disorder
Intersectin-1 levels
Intersectin-1 levels (ITSN1.14070.56.3)
Interstitial collagenase levels
Interstitial lung abnormalities
Interstitial lung disease
Interstitial lung diseases in rheumatoid arthritis
Intertrochanteric region size
Intestinal permeability measurement
Intestinal-type alkaline phosphatase level in Chronic kidney disease with hypertension and no diabetes (17441_4)
Intestinal-type alkaline phosphatase levels
Intestinal-type alkaline phosphatase levels (ALPI.10463.23.3)
Intracerebral hemorrhage
Intracranial aneurysm
Intracranial volume
Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)
Intrahepatic cholestasis of pregnancy
Intralaminar thalamic nuclei volume
Intraocular pressure
Intraocular pressure (corneal compensated)
Intraocular pressure (Goldman correlated)
Intraocular pressure and central corneal thickness (multi-trait analysis)
Intrinsic epigenetic age acceleration
Invasive breast cancer
Invasive epithelial ovarian cancer
IQ domain-containing protein F1 levels
IQ domain-containing protein F3 levels
Iris characteristics
Iris color
Iris color (a* coordinate)
Iris color (b* coordinate)
Iris color (L* coordinate)
Iris heterochromicity
Iritis
Iron levels
Iron status biomarkers
Iron status biomarkers (ferritin levels)
Iron status biomarkers (iron levels)
Iron status biomarkers (total iron binding capacity)
Iron status biomarkers (transferrin levels)
Iron status biomarkers (transferrin saturation)
Iron-sulfur cluster co-chaperone protein HscB, mitochondrial level in Chronic kidney disease with hypertension and no diabetes (19316_2)
Iron-sulfur cluster co-chaperone protein HscB, mitochondrial levels
Irritable bowel syndrome
Irritable mood
Ischemic heart disease in rheumatoid arthritis
Ischemic stroke
Ischemic stroke (cardioembolic)
Ischemic stroke (large artery atherosclerosis)
Ischemic stroke (small artery occlusion)
Ischemic stroke (small-vessel)
Ischemic stroke in diabetes mellitus
Ischemic stroke in dyslipidemia
Ischemic stroke in hypertension
Ischemic stroke or factor VII levels (pleiotropy)
Ischemic stroke or factor VIII levels (pleiotropy)
Ischemic stroke or factor XI levels (pleiotropy)
Ischemic stroke or fibrinogen levels (pleiotropy)
Ischemic stroke or plasminogen activator inhibitor 1 levels (pleiotropy)
Ischemic stroke or tissue plasminogen activator levels (pleiotropy)
Ischemic stroke or von Willebrand factor levels (pleiotropy)
Islet amyloid polypeptide levels
Isoaspartyl peptidase/L-asparaginase levels
Isobutyrylcarnitine (c4) levels
Isobutyrylcarnitine (C4) levels in elite athletes
Isobutyrylcarnitine levels
Isochorismatase domain-containing protein 1 levels
Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial levels
Isocitrate dehydrogenase [NADP] cytoplasmic levels
Isocitric lactone levels
Isoeugenol sulfate levels in elite athletes
Isoform L-VEGF165 levels
Isoleucine levels
Isoleucine levels (UKB data field 23465)
Isoleucine levels in elite athletes
Isoleucine-to-X-11529 ratio
Isoleucylglycine levels
Isoleucylleucine/leucylisoleucine levels
Isopentenyl-diphosphate Delta-isomerase 1 levels
Isopentenyl-diphosphate delta-isomerase 2 levels
Isoursodeoxycholate levels in elite athletes
Isovalerate levels in elite athletes
Isovaleryl-CoA dehydrogenase, mitochondrial levels
Isovalerylcarnitine (C5) levels
Isovalerylcarnitine (C5) levels in elite athletes
Isovalerylcarnitine levels
Isovalerylcarnitine levels (Biocrates platform)
Isovalerylcarnitine levels (Metabolon platform)
Isthmin-1 levels
Isthmin-1 levels (ISM1.8355.80.3)
Isthmus-cingulate cortex volume
Itch intensity from mosquito bite
Itch intensity from mosquito bite adjusted by bite size
Janus kinase and microtubule-interacting protein 3 level in Chronic kidney disease with hypertension and no diabetes (9068_17)
Janus kinase and microtubule-interacting protein 3 levels
Janus kinase and microtubule-interacting protein 3 levels (JAKMIP3.9068.17.3)
JC polyomavirus VP1 antibody levels
Job-related exhaustion
Job-related exhaustion in shift workers
Johnsonella ignava abundance in stool
Joint damage in rheumatoid arthritis
joint destruction in rheumatoid arthritis (rapid vs slow)
Joint mobility (Beighton score)
JT interval
JT interval (sulfonylurea treatment interaction)
Junctional adhesion molecule B levels (JAM2.2997.8.1)
Junctional adhesion molecule C levels
Junctional adhesion molecule-like levels (AMICA1.8232.90.3)
Junctophilin-1 levels
Junctophilin-3 levels
Juvenile dermatomyositis
Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)
Juvenile myoclonic epilepsy
Juvenile osteochondritis dissecans
Kallikrein 5 plasma levels
Kallikrein-10 levels
kallikrein-11 levels
Kallikrein-12 level in Chronic kidney disease with hypertension and no diabetes (3199_54)
Kallikrein-12 levels
Kallikrein-13 levels
Kallikrein-14 levels
Kallikrein-15 levels
Kallikrein-5 levels
Kallikrein-6 levels (KLK6.3450.4.2)
Kallikrein-7 levels
Kallikrein-7 levels (KLK7.3378.49.2)
Kallikrein-8 levels
Kallistatin level in Chronic kidney disease with hypertension and no diabetes (14105_5)
Kallistatin level in Chronic kidney disease with hypertension and no diabetes (3449_58)
Kallistatin levels
Kallistatin levels (SERPINA4.3449.58.2)
Kandleria vitulina abundance in stool
KANNO antigen negativity
Kashin-Beck disease
Katanin p60 ATPase-containing subunit A-like 1 level in Chronic kidney disease with hypertension and no diabetes (24494_67)
Kawasaki disease
Kawasaki disease or immunoglobulin A vasculitis (pleiotropy)
KDEL motif-containing protein 2 levels
KDEL motif-containing protein 2 levels (KDELC2.8296.117.3)
Kelch-like ECH-associated protein 1 levels
Kelch-like protein 12 levels
Kelch-like protein 13 levels
Kelch-like protein 13 levels (KLHL13.12463.7.3)
Kell blood group glycoprotein levels
Keloid
Keratin-associated protein 2-4 levels (KRTAP2.4.14615.46.3)
Keratin, type I cytoskeletal 14 level in Chronic kidney disease with hypertension and no diabetes (22482_87)
Keratin, type I cytoskeletal 16 levels
Keratin, type I cytoskeletal 19 levels
Keratin, type II cytoskeletal 1 levels
Keratin, type II cytoskeletal 5 levels
Keratin, type II cytoskeletal 7 levels
Keratin, type II cytoskeletal 72 levels
Keratinocyte cancer (MTAG)
Keratinocyte differentiation-associated protein levels
Keratoconus
Ketonuria
Ketonuria (mild)
Ketonuria (moderate to severe)
Kidney cancer
Kidney disease (early and late stages) in type 1 diabetes
Kidney disease (early stage) in type 1 diabetes
Kidney disease (end stage renal disease or albuminuria) in type 1 diabetes
Kidney disease (end stage renal disease or macroalbuminuria or microalbuminuria) in diabetes
Kidney disease (end stage renal disease vs non-end stage renal disease) in type 1 diabetes
Kidney disease (reduced eGFR and albuminuria or end stage renal disease) in diabetes
Kidney disease (reduced eGFR and albuminuria or end stage renal disease) in type 1 diabetes
Kidney disese (macroalbuminuria or end-stage renal disease) in diabetes
Kidney function decline traits
Kidney injury 5 years post-surgery in obstructive uropathies
Kidney injury molecule 1 levels
Kidney Injury Molecule levels
Kidney stones
Kidney volume
Kidney-associated antigen 1 levels
KIF1-binding protein levels
Killer cell immunoglobulin-like receptor 2DL1 levels
Killer cell immunoglobulin-like receptor 2DL2 levels (KIR2DL2.7773.20.3)
Killer cell immunoglobulin-like receptor 2DL4 levels
Killer cell immunoglobulin-like receptor 2DS4 levels
Killer cell immunoglobulin-like receptor 3DL1 levels
Killer cell immunoglobulin-like receptor 3DL2 levels
Killer cell immunoglobulin-like receptor 3DS1 levels
Killer cell lectin-like receptor subfamily B member 1 levels
Killer cell lectin-like receptor subfamily F member 1 levels (KLRF1.5098.79.3)
Killer cell lectin-like receptor subfamily G member 2 levels
Kin of IRRE-like protein 2 levels
Kin of IRRE-like protein 3 levels
Kinesin light chain 1 level in Chronic kidney disease with hypertension and no diabetes (12656_1)
Kinesin-like protein KIF16B levels
Kinesin-like protein KIF23 levels
Kinesin-like protein KIF3A level in Chronic kidney disease with hypertension and no diabetes (13961_18)
Kinesin-like protein KIF3A levels
Kinesin-like protein KIF3C level in Chronic kidney disease with hypertension and no diabetes (24407_31)
Kinetochore protein NDC80 homolog levels
Kinetochore protein NDC80 homolog levels (NDC80.12730.3.3)
Kininogen-1 levels
Kininogen, HMW, Two Chain levels
Kininostatin levels
Kit ligand levels
Kit ligand levels (KITLG.9377.25.3)
Kiwi liking
Klotho levels
Knee osteoarthritis
Knee pain
Kremen protein 1 levels
Kunitz-type protease inhibitor 1 levels
Kunitz-type protease inhibitor 2 level in Chronic kidney disease with hypertension and no diabetes (2843_13)
Kunitz-type protease inhibitor 2 levels
Kunitz-type protease inhibitor 2 levels (SPINT2.2843.13.2)
Kunitz-type protease inhibitor 3 level in Chronic kidney disease with hypertension and no diabetes (7926_13)
Kunitz-type protease inhibitor 3 levels
Kunitz-type protease inhibitor 3 levels (SPINT3.7926.13.3)
Kv channel-interacting protein 1 levels
Kv channel-interacting protein 1 levels (KCNIP1.13650.11.3)
Kynurenate levels
Kynureninase levels
Kynureninase levels (KYNU.4559.64.2)
Kynurenine levels
Kynurenine levels in elite athletes
Kynurenine--oxoglutarate transaminase 3 levels
Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)
Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial level in Chronic kidney disease with hypertension and no diabetes (22023_3)
L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase levels
L-arginine levels
L-Histidine to Uric acid ratio in coronary artery disease
L-lactate dehydrogenase A chain levels
L-lactate dehydrogenase B chain levels
L-lactate dehydrogenase C chain levels
L-Selectin level in Chronic kidney disease with hypertension and no diabetes (4831_4)
L-selectin levels
L-Selectin levels (SELL.4831.4.2)
L-urobilin levels
L-xylulose reductase levels
L1-L4 bone mineral density x serum urate levels interaction
Laccase domain-containing protein 1 level in Chronic kidney disease with hypertension and no diabetes (23595_6)
Lachnospira rogosae abundance in stool
Lachnospiraceae abundance in stool
Lachnospirales abundance in stool
Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis
Lack of behavioral control
Lactadherin levels
Lactadherin levels (MFGE8.4455.89.2)
Lactase-like protein levels
Lactase-phlorizin hydrolase level in Chronic kidney disease with hypertension and no diabetes (9017_58)
Lactase-phlorizin hydrolase levels
Lactase-phlorizin hydrolase levels (LCT.9017.58.3)
Lactate dehydrogenase levels
Lactate levels
Lactate levels (UKB data field 23471)
Lactate meal response (LMM)
Lactobacillus B abundance in stool
Lactobacillus B ruminis abundance in stool
Lactoperoxidase levels
Lactosyl-N-behenoyl-sphingosine (d18:1/22:0) levels
Lactosyl-N-behenoyl-sphingosine (d18:1/22:0) levels in elite athletes
Lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) levels
Lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) levels in elite athletes
Lactosyl-N-palmitoyl-sphingosine (d18:1/16:0) levels
Lactosyl-N-palmitoyl-sphingosine (d18:1/16:0) levels in elite athletes
Lactosylceramide 4-alpha-galactosyltransferase levels
Lactosylceramide alpha-2,3-sialyltransferase levels
Lactotransferrin levels
Lactotransferrin levels (LTF.2780.35.2)
Lactoylglutathione lyase levels
Lacunar stroke
Ladinin-1 levels
Lager liking
Lamb consumption
Lamb liking
Lamb or mutton consumption (UKB data field 1379)
Lamina-associated polypeptide 2, isoforms beta/gamma levels
Laminin levels
Laminin levels (LAMA1.LAMB1.LAMC1.2728.62.2)
Laminin subunit alpha-4 levels
Laminin subunit alpha-4 levels (LAMA4.6577.64.3)
Laminin subunit gamma-2 levels
Laminin subunit gamma-2 levels (LAMC2.9580.5.3)
LanC-like protein 1 levels
Language functional connectivity
Language impairment in frontotemporal lobe dementia
Language performance
Language performance in older adults (adjusted for episodic memory)
Large artery stroke
Large artery stroke (CCS and TOAST classification)
Large artery stroke (CCS or TOAST classification)
Large artery stroke (CCSp classification)j
Large artery stroke (MTAG)
Large artery stroke (TOAST classification)
Large B-cell lymphoma
Laryngeal squamous cell carcinoma
Late-onset Alzheimer's disease
Late-onset myasthenia gravis
Latent autoimmune diabetes
Latent autoimmune diabetes vs. type 2 diabetes
Latent naming speed
Latent-transforming growth factor beta-binding protein 4 levels
Lateral occipital cortex volume
Lateral orbital frontal cortex volume
Lateral thalamic nuclei volume
Lateral ventricle temporal horn volume
Lateral ventricle volume
Lateral ventricle volume change rate
Lateral ventricle volume change rate x age interaction (1df)
Lateral ventricle volume change rate x age interaction (2df)
Lateral ventricular volume in normal aging
Laterality in neovascular age-related macular degeneration
Laurate (12:0) levels in elite athletes
Laurylcarnitine (C12) levels
Laurylcarnitine (C12) levels in elite athletes
Laurylcarnitine levels
Laurylcarnitine levels (Biocrates platform)
Laurylcarnitine levels (Metabolon platform)
Lawsonibacter sp002161175 abundance in stool
Layilin levels
LDL (oxidized)
LDL (standard GWA)
LDL (weighted GWA)
LDL cholesterol
LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes
LDL cholesterol levels
LDL cholesterol levels (UKB data field 23405)
LDL cholesterol levels in current drinkers
LDL cholesterol levels in HIV infection
LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)
LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)
LDL cholesterol levels x long total sleep time interaction (2df test)
LDL cholesterol levels x loop diuretics use interaction
LDL cholesterol levels x short total sleep time interaction (1df test)
LDL cholesterol levels x short total sleep time interaction (2df test)
LDL cholesterol levels x thiazide or thiazide-like diuretics use interaction
LDL cholesterol to HDL cholesterol ratio
LDL cholesterol x physical activity interaction (2df test)
LDL levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder
LDL levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder
LDL peak particle diameter (total fat intake interaction)
LDLR chaperone MESD levels
Lead levels in blood
Lean body mass
Lean body mass and age at menarche (combined)
Lean mass index
Lean nonalcoholic fatty liver disease
Lectin-like oxidized LDL receptor 1 levels
Left ventricle systolic dysfunction
Left atrial active emptying fraction
Left atrial antero-posterior diameter
Left atrial maximum volume
Left atrial minimum volume
Left atrial passive emptying fraction
Left atrial total emptying fraction
Left colon cancer vs right colon cancer
Left hippocampal volume
Left superior temporal gyrus thickness (schizophrenia interaction)
Left unilateral cleft lip
Left unilateral cleft lip and palate
Left ventricle diastolic internal dimension
Left ventricle short axis
Left ventricle sphericity index
Left ventricle wall thickness
Left ventricular ejection fraction
Left ventricular end diastolic mass
Left ventricular end diastolic mass end diastolic volume ratio
Left ventricular end-diastolic volume
Left ventricular end-diastolic volume (MTAG)
Left ventricular end-systolic volume
Left ventricular end-systolic volume (MTAG)
Left ventricular fractional shortening
Left ventricular global circumferential strain
Left ventricular global circumferential strain (MTAG)
Left ventricular global longitudinal strain
Left ventricular global longitudinal strain (MTAG)
Left ventricular global radial strain
Left ventricular internal dimension in diastole
Left ventricular internal dimension in systole
Left ventricular mass
Left ventricular mass indexed by body surface area
Left ventricular mass to end-diastolic volume ratio
Left ventricular mass to end-diastolic volume ratio (MTAG)
Left ventricular mass x antihypertensive treatment interaction
Left ventricular obstructive tract defect (inherited effect)
Left ventricular obstructive tract defect (maternal effect)
Left ventricular stroke volume
Left-handedness
Left-right determination factor 2 levels
Left–right brain asymmetry
Leg fat mass (lean adjusted)
Leg fat mass and leg lean mass (pleiotropy)
Leg lean mass
Leg lean mass (fat adjusted)
Legumain levels
Leiomodin-1 levels
Leisure screen time
Leisure screen time (MTAG)
Leisure sedentary behaviour (computer use)
Leisure sedentary behaviour (television watching)
Leisure-time exercise behaviour
Lengsin level in Chronic kidney disease with hypertension and no diabetes (24499_36)
Length of menstrual cycle
Lentiform nucleus volume
Lentimicrobiaceae abundance in stool
Leprosy
Leptin receptor levels
Leptin receptor levels (LEPR.5400.52.3)
Leptin receptor, soluble level in Chronic kidney disease with hypertension and no diabetes (5400_52)
Lesional skin FLG expression levels in childhood atopic dermatitis
Lethal(3)malignant brain tumor-like protein 2 levels
LETM1 domain-containing protein 1 levels
Letter-number span reordering
Leucine levels
Leucine levels (UKB data field 23466)
Leucine levels in elite athletes
Leucine-rich PPR motif-containing protein, mitochondrial levels (LRPPRC.9046.46.3)
Leucine-rich repeat and calponin homology domain-containing protein 4 levels
Leucine-rich repeat and fibronectin type III domain-containing protein 1 levels
Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 levels
Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3 levels
Leucine-rich repeat and transmembrane domain-containing protein 1 levels
Leucine-rich repeat and transmembrane domain-containing protein 2 levels
Leucine-rich repeat and transmembrane domain-containing protein 2 levels (LRTM2.8906.60.3)
Leucine-rich repeat neuronal protein 1 levels
Leucine-rich repeat neuronal protein 1 levels (LRRN1.11293.14.3)
Leucine-rich repeat serine/threonine-protein kinase 2 level in Chronic kidney disease with hypertension and no diabetes (10990_21)
Leucine-rich repeat serine/threonine-protein kinase 2 levels
Leucine-rich repeat serine/threonine-protein kinase 2 levels (LRRK2.10990.21.3)
Leucine-rich repeat transmembrane neuronal protein 1 levels
Leucine-rich repeat transmembrane neuronal protein 4 levels
Leucine-rich repeat transmembrane protein FLRT1 levels
Leucine-rich repeat transmembrane protein FLRT2 levels
Leucine-rich repeat transmembrane protein FLRT2 levels (FLRT2.13122.19.3)
Leucine-rich repeat transmembrane protein FLRT3 level in Chronic kidney disease with hypertension and no diabetes (13123_3)
Leucine-rich repeat transmembrane protein FLRT3 levels
Leucine-rich repeat transmembrane protein FLRT3 levels (FLRT3.13123.3.3)
Leucine-rich repeat-containing G-protein coupled receptor 5 levels
Leucine-rich repeat-containing protein 15 levels
Leucine-rich repeat-containing protein 15 levels (LRRC15.6557.50.3)
Leucine-rich repeat-containing protein 19 levels (LRRC19.7014.27.3)
Leucine-rich repeat-containing protein 25 levels
Leucine-rich repeat-containing protein 4B levels
Leucine-rich repeat-containing protein 52 levels
Leucine-rich repeat-containing protein 59 levels
Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 2 levels
Leucine-rich repeats and immunoglobulin-like domains protein 1 levels
Leucine-rich repeats and immunoglobulin-like domains protein 3 levels
Leuconostoc abundance in stool
Leuconostoc mesenteroides abundance in stool
Leucylalanine levels in elite athletes
Leucylglycine levels in elite athletes
Leukemia inhibitory factor levels
Leukemia inhibitory factor levels (LIF.7790.21.3)
Leukemia inhibitory factor receptor levels
Leukocyte antigen CD37 levels
Leukocyte cell-derived chemotaxin 1 levels
Leukocyte elastase inhibitor levels
Leukocyte immunoglobulin-like receptor subfamily A member 1 level in Chronic kidney disease with hypertension and no diabetes (21706_29)
Leukocyte immunoglobulin-like receptor subfamily A member 2 level in Chronic kidney disease with hypertension and no diabetes (15614_168)
Leukocyte immunoglobulin-like receptor subfamily A member 2 levels
Leukocyte immunoglobulin-like receptor subfamily A member 4 levels
Leukocyte immunoglobulin-like receptor subfamily A member 5 levels
Leukocyte immunoglobulin-like receptor subfamily A member 5 levels (LILRA5.7787.25.3)
Leukocyte immunoglobulin-like receptor subfamily B member 1 level in Chronic kidney disease with hypertension and no diabetes (5090_49)
Leukocyte immunoglobulin-like receptor subfamily B member 1 levels
Leukocyte immunoglobulin-like receptor subfamily B member 1 levels (LILRB1.5090.49.2)
Leukocyte immunoglobulin-like receptor subfamily B member 3 levels
Leukocyte immunoglobulin-like receptor subfamily B member 4 level in Chronic kidney disease with hypertension and no diabetes (6453_70)
Leukocyte immunoglobulin-like receptor subfamily B member 4 levels
Leukocyte immunoglobulin-like receptor subfamily B member 4 levels (LILRB4.6453.70.3)
Leukocyte surface antigen CD47 levels
Leukocyte telomere length
Leukocyte-specific transcript 1 protein levels
Leukoderma in response to rhododendrol
Leukotriene A-4 hydrolase levels
Leukotriene B4 levels in elite athletes
Leukotriene B4 receptor 1 levels
Leukotriene B5 levels in elite athletes
Levodopa wearing off effect (time symptoms uncontrolled) in Parkinson's disease (response to zonisamide)
Levodopa-induced dyskinesia in levodopa treated Parkinson's disease
Levulinoylcarnitine levels
Lewy body disease
Life satisfaction
Life threatening arrhythmia
Lifelong premature ejaculation
Lifespan
Lifetime anxiety disorder
Lifetime average cigarettes per day in chronic obstructive pulmonary disease
Lifetime smoking
Lifetime smoking (without educational attainment)
Lifetime smoking index
Light vs. dark hair color
Light-intensity physical activity duration
Lignoceroyl sphingomyelin (d18:1/24:0) levels in elite athletes
Lignoceroylcarnitine (C24) levels
Lignoceroylcarnitine (C24) levels in elite athletes
LIM domain and actin-binding protein 1 levels
LIM domain kinase 1 level in Chronic kidney disease with hypertension and no diabetes (25308_8)
LIM domain only transcription factor protein 4 level in Chronic kidney disease with hypertension and no diabetes (23284_5)
Limited cutaneous systemic scleroderma
Lingual gyrus volume
Linker for activation of T-cells family member 2 levels
Linoleate (18:2n6) levels in elite athletes
Linoleate 18:2n6-to-dihomo-linolenate 20:3n3 or n6 ratio
Linoleate 18:2n6-to-X-12442--5,8-tetradecadienoate ratio
Linoleic acid levels
Linoleic acid levels (UKB data field 23449)
Linoleic acid to total fatty acids percentage (UKB data field 23456)
Linolenoylcarnitine (C18:3) levels
Linolenoylcarnitine (C18:3) levels in elite athletes
Linoleoyl ethanolamide levels
Linoleoyl ethanolamide levels in elite athletes
Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] levels
Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] levels
Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] levels in elite athletes
Linoleoyl-linolenoyl-glycerol (18:2/18:3) [2] levels in elite athletes
Linoleoylcarnitine (C18:2) levels
Linoleoylcarnitine (C18:2) levels in elite athletes
Linoleoylcarnitine levels
Linoleoylcholine levels in elite athletes
Lip morphology
Lipase member K levels
Lipase member N level in Chronic kidney disease with hypertension and no diabetes (8097_77)
Lipase member N levels
Lipase member N levels (LIPN.8097.77.3)
Lipid metabolism phenotypes
Lipid or lipoprotein levels
Lipid traits
Lipid traits (pleiotropy) (HIPO component 1)
Lipid traits (pleiotropy) (HIPO component 2)
Lipocalin-1 levels
Lipopolysaccharide-binding protein levels
Lipoprotein (a) - cholesterol levels
Lipoprotein (a) levels
Lipoprotein (a) levels in coronary artery disease (percutaneous coronary intervention)
Lipoprotein (a) levels in response to niacin in statin-treated individuals
Lipoprotein A levels (UKB data field 30790)
Lipoprotein lipase levels
Lipoprotein phospholipase A2 activity in cardiovascular disease
Lipoprotein-associated phospholipase A2 activity and mass
Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease
Lipoprotein-associated phospholipase A2 activity change in response to statin therapy
Lipoprotein(a) levels adjusted for apolipoprotein(a) isoforms
Liprin-alpha-1 levels
Lithium clearance (adjusted for clinical predictors)
Lithocholate sulfate (1) (X-17469) levels
Lithocholate sulfate (1) levels
Lithostathine-1-alpha levels
Lithostathine-1-beta levels
Liver carboxylesterase 1 levels
Liver enzyme levels
Liver enzyme levels (alanine transaminase)
Liver enzyme levels (alkaline phosphatase)
Liver enzyme levels (aspartate transaminase)
Liver enzyme levels (gamma-glutamyl transferase)
Liver fat
Liver fat content (MRI proton density fat fraction measure)
Liver fibrogenesis (alpha smooth muscle actin levels)
Liver fibrosis (total hepatic collagen content)
Liver fibrosis and steatohepatitis severity (MRI cT1 measure)
Liver fibrosis in non-alcoholic fatty liver disease
Liver fibrosis in pediatric non-alcoholic fatty acid liver disease
Liver fibrosis severity in HIV/hepatitis C co-infection
Liver injury in anti-tuberculosis drug treatment
Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis
Liver iron content
Liver liking
Liver proton density fat fraction
Liver stiffness changes at sustained virological response following antiviral therapy in HCV infection
Liver volume
Liver-expressed antimicrobial peptide 2 levels
Lobe attachment
Lobe attachment (rater scored)
Lobe attachment (rater-scored or self-reported)
Lobe size
Lobular breast cancer (menopausal hormone therapy interaction)
Local histogram emphysema pattern
Logical memory (delayed recall)
Logical memory (immediate recall) in normal cognition
Lon protease homolog, mitochondrial levels
Loneliness
Loneliness (linear analysis)
Loneliness (MTAG)
Loneliness (multivariate analysis)
Loneliness (standard GWA)
Long QT syndrome
Long-chain dicarboxylacylcarnitines levels (dominant genetic model)
Long-chain specific acyl-CoA dehydrogenase, mitochondrial levels
Long-term memory (delayed word recall task)
Longevity
Longevity (85 years and older)
Longevity (90 years and older)
Longevity (age >90th survival percentile)
Longevity (age >99th survival percentile)
Longitudinal alcohol consumption
Longitudinal brain connectivity change (characteristic path length)
Longitudinal brain connectivity change (Louvain modularity)
Longitudinal change in brain amyloid plaque burden
Longitudinal peak diastolic strain rate
Low affinity immunoglobulin epsilon Fc receptor levels
Low affinity immunoglobulin gamma Fc region receptor II-a level in Chronic kidney disease with hypertension and no diabetes (3309_2)
Low affinity immunoglobulin gamma Fc region receptor II-a levels
Low affinity immunoglobulin gamma Fc region receptor II-a levels (FCGR2A.3309.2.2)
Low affinity immunoglobulin gamma Fc region receptor II-a/b levels
Low affinity immunoglobulin gamma Fc region receptor II-b level in Chronic kidney disease with hypertension and no diabetes (3310_62)
Low affinity immunoglobulin gamma Fc region receptor II-b levels
Low affinity immunoglobulin gamma Fc region receptor II-b levels (FCGR2B.3310.62.1)
Low affinity immunoglobulin gamma Fc region receptor III-B levels
Low density lipoprotein cholesterol levels
Low density lipoprotein cholesterol levels (on statin treatment)
Low hand grip strength
Low hand grip strength (60 years and older) (EWGSOP)
Low hand grip strength (60 years and older) (FNIH)
Low HDL-cholesterol levels
Low high density lipoprotein cholesterol levels
Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)
Low molecular weight phosphotyrosine protein phosphatase levels
Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)
Low myopia
Low myopia vs hyperopia
Low susceptibility to hepatitis C infection
Low tan response
Low testosterone levels
Low urine pH
Low vWF levels
Low white blood cell count (conditioned on rs2814778)
Low-density lipoprotein levels (MTAG)
Low-density lipoprotein receptor class A domain-containing protein 4 levels
Low-density lipoprotein receptor levels
Low-density lipoprotein receptor-related protein 1, soluble levels
Low-density lipoprotein receptor-related protein 10 levels
Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (15472_16)
Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)
Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)
Low-density lipoprotein receptor-related protein 11 levels
Low-density lipoprotein receptor-related protein 12 levels
Low-density lipoprotein receptor-related protein 1B level in Chronic kidney disease with hypertension and no diabetes (11275_94)
Low-density lipoprotein receptor-related protein 1B levels
Low-density lipoprotein receptor-related protein 4 level in Chronic kidney disease with hypertension and no diabetes (19558_10)
Low-density lipoprotein receptor-related protein 4 levels
Low-density lipoprotein receptor-related protein 8 levels
Low-grade serous and serous borderline ovarian cancer
Lower body strength
Lower lip height
Lower thalamus volume
Lowest magnesium plasma levels after treatment with platinum based chemotherapy
Lp (a) levels
Lumbar spine bone mineral density
Lumbar spine bone mineral density (integral)
Lumbar spine bone mineral density (trabecular)
Lumican levels
Lung adenocarcinoma
Lung adenocarcinoma (survival time) in never smokers
Lung cancer
Lung cancer (asbestos exposure interaction)
Lung Cancer (DNA repair capacity)
Lung cancer (smoking interaction)
Lung cancer (survival time) in never smokers
Lung cancer in ever smokers
Lung cancer in never smokers
Lung cancer or head/neck cancer (pleiotropy)
Lung cancer x radon exposure interaction (1df)
Lung disease severity in cystic fibrosis
Lung function
Lung function (FEV1)
Lung function (FEV1) and body mass index
Lung function (FEV1) and waist circumference adjusted for BMI
Lung function (FEV1) and waist to hip ratio adjusted for BMI
Lung function (FEV1/FVC)
Lung function (FEV1/FVC) in asthma (dust mite allergen exposure interaction)
Lung function (FEV1/FVC) variance
Lung function (forced expiratory flow during mid-portion (25% and 75%) of forced vital capacity)
Lung function (forced expiratory volume in 1 second)
Lung function (forced vital capacity)
Lung function (FVC)
Lung function (FVC) and body mass index
Lung function (FVC) and waist circumference adjusted for BMI
Lung function (FVC) and waist to hip ratio adjusted for BMI
Lung function (low FEV1 vs high FEV1)
Lung function (low FEV1 vs high FEV1) x smoking interaction
Lung function in heavy smokers (high FEV1 vs average FEV1)
Lung function in heavy smokers (low FEV1 vs high FEV1)
Lung function in never smokers (low FEV1 vs average FEV1)
Lung function in never smokers (low FEV1 vs high FEV1)
Lung volume
Lupus La protein levels
Lupus nephritis in systemic lupus erythematosus
Luteinizing hormone level in Chronic kidney disease with hypertension and no diabetes (2953_31)
Luteinizing hormone levels
Luteinizing hormone levels (CGA.LHB.2953.31.2)
Luteinizing hormone levels in polycystic ovary syndrome
Lutropin subunit beta levels
Lutropin subunit beta levels (LHB.8376.25.4)
Lutropin-choriogonadotropic hormone receptor level in Chronic kidney disease with hypertension and no diabetes (14634_13)
Lutropin-choriogonadotropic hormone receptor levels
Ly6/PLAUR domain-containing protein 3 levels
Lymphatic vessel endothelial hyaluronic acid receptor 1 levels
Lymphocyte Absolute Count
Lymphocyte activation gene 3 protein levels
Lymphocyte antigen 6 complex locus protein G6c levels
Lymphocyte antigen 75 level in Chronic kidney disease with hypertension and no diabetes (16620_26)
Lymphocyte antigen 75 levels
Lymphocyte count
Lymphocyte percentage of white cells
Lymphocyte telomere length
Lymphocyte-to-monocyte ratio
Lymphocytic leukemia
Lymphokine-activated killer T-cell-originated protein kinase levels
Lymphoma
Lymphotactin levels
Lymphotactin levels (XCL1.14078.69.3)
Lymphotoxin alpha1:beta2 levels
Lymphotoxin alpha2:beta1 levels
Lymphotoxin-alpha levels
Lysine levels
Lysine levels in elite athletes
Lysine--tRNA ligase levels
Lysine-to-glutaroyl carnitine ratio
LysM and putative peptidoglycan-binding domain-containing protein 4 levels
Lysoalkenylphosphatidylcholine (P-16:0) levels
Lysoalkenylphosphatidylcholine (P-18:0) levels
Lysoalkenylphosphatidylcholine (P-18:1) levels
Lysoalkenylphosphatidylcholine (P-20:0) levels
Lysoalkenylphosphatidylethanolamine (P-16:0) levels
Lysoalkenylphosphatidylethanolamine (P-20:0) levels
Lysoalkylphosphatidylcholine (O-16:0) levels
Lysoalkylphosphatidylcholine (O-18:0) levels
Lysoalkylphosphatidylcholine (O-18:1) levels
Lysoalkylphosphatidylcholine (O-20:0) levels
Lysoalkylphosphatidylcholine (O-20:1) levels
Lysoalkylphosphatidylcholine (O-22:0) levels
Lysoalkylphosphatidylcholine (O-22:1) levels
Lysoalkylphosphatidylcholine (O-24:0) levels
Lysoalkylphosphatidylcholine (O-24:1) levels
Lysoalkylphosphatidylcholine (O-24:2) levels
Lysophosphatidic acid phosphatase type 6 levels
Lysophosphatidylcholine (16:1) [sn2] levels
Lysophosphatidylcholine (17:0) [sn1] levels
Lysophosphatidylcholine (18:0) [sn1] levels
Lysophosphatidylcholine (18:0) [sn2] levels
Lysophosphatidylcholine (18:2) [sn1] levels
Lysophosphatidylcholine (18:2) [sn2] levels
Lysophosphatidylcholine (18:3) [sn1] (a) levels/Lysophosphatidylcholine (18:3) [sn2] (b) levels
Lysophosphatidylcholine (18:3) [sn1] levels (b)
Lysophosphatidylcholine (18:3) [sn2] levels (a)
Lysophosphatidylcholine (20:2) [sn1] levels
Lysophosphatidylcholine (20:2) [sn2] levels
Lysophosphatidylcholine (20:3) [sn1] levels
Lysophosphatidylcholine (20:3) [sn2] levels
Lysophosphatidylcholine (20:4) [sn1] levels
Lysophosphatidylcholine (20:4) [sn2] levels
Lysophosphatidylcholine (20:5) [sn1] levels
Lysophosphatidylcholine (20:5) [sn2] levels
Lysophosphatidylcholine (22:0) [sn1] levels
Lysophosphatidylcholine (22:1) [sn1] levels
Lysophosphatidylcholine (22:4) [sn1] levels
Lysophosphatidylcholine (22:4) [sn2] levels
Lysophosphatidylcholine (22:5) [sn1] (n3) levels/Lysophosphatidylcholine (22:5) [sn2] (n6) levels
Lysophosphatidylcholine (22:5) [sn1] (n6) levels
Lysophosphatidylcholine (22:5) [sn2] (n3) levels
Lysophosphatidylcholine (22:6) [sn1] levels
Lysophosphatidylcholine (22:6) [sn2] levels
Lysophosphatidylcholine (24:0) [sn1] levels
Lysophosphatidylcholine (24:0) [sn2] levels
Lysophosphatidylcholine (26:0) [sn1] levels
Lysophosphatidylcholine (26:0) [sn2] levels
Lysophosphatidylcholine 20:4 levels
lysoPhosphatidylcholine acyl C14:0 levels
lysoPhosphatidylcholine acyl C16:0 levels
lysoPhosphatidylcholine acyl C16:1 levels
lysoPhosphatidylcholine acyl C17:0 levels
lysoPhosphatidylcholine acyl C18:0 levels
lysoPhosphatidylcholine acyl C18:1 levels
lysoPhosphatidylcholine acyl C18:2 levels
lysoPhosphatidylcholine acyl C20:3 levels
lysoPhosphatidylcholine acyl C20:4 levels
lysoPhosphatidylcholine acyl C24:0 levels
lysoPhosphatidylcholine acyl C26:0 levels
lysoPhosphatidylcholine acyl C26:1 levels
lysoPhosphatidylcholine acyl C28:0 levels
Lysophosphatidylcholine levels
Lysophosphatidylcholine_16:0_[M+H]1+/Lysophosphatidylethanolamine_19:0_[M+H]1+ levels
Lysophosphatidylcholine_16:1_[M+H]1+/Lysophosphatidylethanolamine_19:1_[M+H]1+ levels
Lysophosphatidylcholine_18:2_[M+OAc]1-/Lysophosphatidylserine_22:1_[M-H]1- levels
Lysophosphatidylcholine_20:4_[M+H]1+ levels
Lysophosphatidylcholine_22:6_[M+H]1+ levels
Lysophosphatidylcholine-2O_18:0_[M+H]1+ levels
Lysophosphatidylcholine-O_16:1_[M+H]1+/Lysophosphatidylcholine-P_16:0_[M+H]1+ levels
Lysophosphatidylcholine(20:4)_[M+H]1+ levels
Lysophosphatidylcholines (20:4) levels
Lysophosphatidylcholines (20:5) levels
Lysophosphatidylcholines (22:5) levels
Lysophosphatidylcholines (22:6) levels
Lysophosphatidylethanolamine (16:0) [sn1] levels
Lysophosphatidylethanolamine (16:0) [sn2] levels
Lysophosphatidylethanolamine (18:0) [sn1] levels
Lysophosphatidylethanolamine (18:0) [sn2] levels
Lysophosphatidylethanolamine (18:1) [sn1] levels
Lysophosphatidylethanolamine (18:1) [sn2] levels
Lysophosphatidylethanolamine (18:2) [sn1] levels
Lysophosphatidylethanolamine (18:2) [sn2] levels
Lysophosphatidylethanolamine (20:4) [sn1] levels
Lysophosphatidylethanolamine (20:4) [sn2] levels
Lysophosphatidylethanolamine (22:6) [sn1] levels
Lysophosphatidylethanolamine (22:6) [sn2] levels
Lysophosphatidylethanolamine levels
Lysophosphatidylethanolamine_16:0_[M-H]1- levels
Lysophosphatidylethanolamine_18:0_[M-H]1- levels
Lysophosphatidylethanolamine_18:2_[M-H]1- levels
Lysophosphatidylethanolamine_20:0_[M-H]1- levels
Lysophosphatidylethanolamine_20:2_[M-H]1- levels
Lysophosphatidylethanolamine_20:4_[M-H]1- levels
Lysophosphatidylethanolamine_22:4_[M-H]1- levels
Lysophosphatidylethanolamine_22:6_[M-H]1- levels
Lysophosphatidylethanolamine-O_18:1_[M-H]1-/Lysophosphatidylethanolamine-P_18:0_[M-H]1- levels
Lysophosphatidylethanolamine-P_20:0_[M-H]1- levels
Lysophosphatidylinositol (18:0) [sn1] levels
Lysophosphatidylinositol (18:0) [sn2] levels
Lysophosphatidylinositol (18:2) [sn1] levels
Lysophosphatidylinositol (18:2) [sn2] levels
Lysophosphatidylinositol (20:4) [sn1] levels
Lysophosphatidylinositol (20:4) [sn2] levels
Lysophospholipase-like protein 1 levels
Lysosomal acid phosphatase levels
Lysosomal acid phosphatase levels (ACP2.9237.54.3)
Lysosomal alpha-glucosidase levels
Lysosomal Pro-X carboxypeptidase levels
Lysosomal Pro-X carboxypeptidase levels (PRCP.5722.78.3)
Lysosomal protective protein levels
Lysosomal protective protein levels (CTSA.3179.51.2)
Lysozyme C levels
Lysozyme C levels (LYZ.4920.10.1)
Lysozyme-like protein 2 levels
Lysozyme-like protein 2 levels (LYZL2.6377.54.3)
Lysyl oxidase homolog 3 levels
M-phase inducer phosphatase 2 levels
M-phase inducer phosphatase 2 levels (CDC25B.12427.8.3)
Machado-Joseph disease (age at onset)
Mackerel liking
Macoilin levels
Macroalbuminuria in type 1 diabetes
Macrophage colony stimulating factor levels
Macrophage colony-stimulating factor 1 levels
Macrophage colony-stimulating factor 1 receptor levels
Macrophage inflammatory protein 1a levels
Macrophage inflammatory protein 1b levels
Macrophage mannose receptor 1 levels
Macrophage metalloelastase levels
Macrophage metalloelastase levels (MMP12.4496.60.2)
Macrophage Migration Inhibitory Factor levels
Macrophage receptor MARCO level in Chronic kidney disease with hypertension and no diabetes (20134_27)
Macrophage receptor MARCO levels
Macrophage scavenger receptor types I and II levels
Macrophage-capping protein levels
Macroscopic brain infarct
Macrosialin levels
Macrovascular complications in type 2 diabetes
Macular telangiectasia type 2
Macular thickness
Magnesium levels
Magnesium transporter NIPA4 levels
MAGUK p55 subfamily member 6 levels
MAGUK p55 subfamily member 6 levels (MPP6.13490.1.3)
MAGUK p55 subfamily member 7 levels
Major adverse cardiovascular events in response to aspirin and clopidogrel treatment
Major CVD
Major depression and alcohol dependence
Major depressive disorder
Major depressive disorder (broad)
Major depressive disorder (ICD-10 coded)
Major depressive disorder (lifetime)
Major depressive disorder (MTAG)
Major depressive disorder (probable)
Major depressive disorder (unexposed to adversity)
Major depressive disorder and major depressive episode treated with electroconvulsive therapy
Major depressive disorder in trauma exposed individuals
Major depressive disorder in trauma-unexposed individuals
Major depressive disorder or stress-related disorder
Major depressive disorder or stroke (pleiotropy)
Major depressive disorder vs ADHD (ordinary least squares (OLS))
Major depressive disorder vs anorexia nervosa (ordinary least squares (OLS))
Major depressive disorder vs autism spectrum disorder (ordinary least squares (OLS))
Major depressive disorder x sex interaction
Major depressive episode treated with electroconvulsive therapy
Major mood disorders
Major prion protein levels
Malaria
Malate dehydrogenase, mitochondrial levels
Malate levels
Malate levels in elite athletes
Male fertility
Male puberty timing (age at voice breaking MTAG)
Male puberty timing (early vs. average onset facial hair)
Male puberty timing (early vs. average onset voice breaking)
Male puberty timing (late vs. average onset facial hair)
Male puberty timing (late vs. average onset voice breaking)
Male sexual orientation
Male-pattern baldness
Maleate levels in elite athletes
Malectin levels
Maleylacetoacetate isomerase level in Chronic kidney disease with hypertension and no diabetes (16872_248)
Maleylacetoacetate isomerase levels
Malignant lymphoma
Malignant lymphoma (Non-Hodgkin lymphoma, multiple myeloma, or Hodgkin lymphoma)
Malignant T-cell-amplified sequence 1 levels
Malonyl-CoA decarboxylase, mitochondrial levels
Maltotriose levels
MAM domain-containing glycosylphosphatidylinositol anchor protein 1 level in Chronic kidney disease with hypertension and no diabetes (16900_29)
MAM domain-containing glycosylphosphatidylinositol anchor protein 1 levels
MAM domain-containing protein 2 levels
Mammographic density
Mammographic density (dense area)
Mammographic density (non-dense area)
Manganese-transporting ATPase 13A1 levels
Manic episodes in bipolar disorder
Mannan-binding lectin serine protease 1 levels
Mannitol/sorbitol levels
Mannitol/sorbitol levels in elite athletes
Mannonate levels
Mannose levels
Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB levels
Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC levels
MANSC domain-containing protein 1 levels
MANSC domain-containing protein 1 levels (MANSC1.9557.5.3)
MANSC domain-containing protein 4 levels
MANSC domain-containing protein 4 levels (MANSC4.9578.263.3)
MAP kinase-activated protein kinase 3 level in Chronic kidney disease with hypertension and no diabetes (3822_54)
MAP kinase-activated protein kinase 3 levels
MAP kinase-activated protein kinase 5 levels
MAP kinase-activated protein kinase 5 levels (MAPKAPK5.8382.47.3)
MAP/microtubule affinity-regulating kinase 3 levels
MAP6 domain-containing protein 1 level in Chronic kidney disease with hypertension and no diabetes (24661_4)
MARCKS-related protein levels
Margarate (17:0) levels in elite athletes
Margaroylcarnitine (C17) levels
Margaroylcarnitine levels in elite athletes
Marginal zone B- and B1-cell-specific protein levels
Marginal zone lymphoma or multiple sclerosis
Marginal zone lymphoma or systemic lupus erythematosus
Marzipan liking
Maspardin levels
Mast cell-expressed membrane protein 1 levels
Mast/stem cell growth factor receptor Kit levels
Mastocytosis
Mastocytosis (KIT D816V positive)
Maternal history of Alzheimer's disease
Maternal nondisjunction of chromosome 21 (MI error vs fathers)
Maternal nondisjunction of chromosome 21 (MI error vs MII error)
Maternal nondisjunction of chromosome 21 (MII error vs fathers)
Maternal nondisjunction of chromosome 21 (mothers vs fathers)
Mathematical ability in children with dyslexia
Matrilin-2 levels
Matrilin-3 level in Chronic kidney disease with hypertension and no diabetes (19361_78)
Matrilin-3 levels
Matrilin-4 levels
Matrilin-4 levels (MATN4.7083.74.3)
Matrilysin levels
Matrix extracellular phosphoglycoprotein levels
Matrix Gla protein levels
Matrix metalloproteinase levels
Matrix metalloproteinase-1 levels
Matrix metalloproteinase-10 levels
Matrix metalloproteinase-12 levels
Matrix metalloproteinase-14 levels
Matrix metalloproteinase-16 levels
Matrix metalloproteinase-17 levels
Matrix metalloproteinase-19 levels
Matrix metalloproteinase-20 levels
Matrix metalloproteinase-3 levels
Matrix metalloproteinase-7 levels
Matrix metalloproteinase-8 levels
Matrix metalloproteinase-9 levels
Matrix metalloproteinase-9 levels (MMP9.2579.17.5)
Matrix-remodeling-associated protein 7 levels
Matrix-remodeling-associated protein 7 levels (MXRA7.8005.1.3)
Matrix-remodeling-associated protein 8 levels
MAX gene-associated protein level in Chronic kidney disease with hypertension and no diabetes (11587_5)
MAX gene-associated protein levels (MGA.11587.5.3)
MAX-interacting protein 1 levels
Maximal oxygen uptake response
Maximum cranial length
Maximum cranial width
Maximum creatine kinase levels in statin users
Maximum habitual alcohol consumption
Maximum habitual alcohol consumption (MTAG)
Maximum indexed left atrial volume
Maximum measurement of hepatic fat
Maximum retinal arteriolar tortuosity
Maximum stenosis
MCP 2 plasma levels
Mean arterial pressure
Mean arterial pressure (alcohol consumption interaction)
Mean arterial pressure (long-term average)
Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)
Mean arterial pressure x alcohol consumption interaction (2df test)
Mean arterial pressure x depressive symptoms interaction (2df test)
Mean arterial pressure x low social support interaction (2df test)
Mean arterial pressure x sodium interaction (2df test)
Mean corpuscular hemoglobin
Mean corpuscular hemoglobin concentration
Mean corpuscular volume
Mean degree of stenosis
Mean diameter of HDL particles
Mean diameter of VLDL particles
Mean forced vital capacity from 2 exams
Mean platelet volume
Mean reticulocyte volume
Mean spheric corpuscular volume
Measles
Meat-related diet
Meconium ileus in cystic fibrosis
Meconium Ileus in Cystic Fibrosis (adjusted for Cystic Fibrosis-Related Diabetes)
Medial orbital frontal cortex volume
Medial temporal lobe substructure volumes
Medial thalamic nuclei volume
Median measurement of hepatic fat
Mediator of RNA polymerase II transcription subunit 1 levels
Mediator of RNA polymerase II transcription subunit 20 level in Chronic kidney disease with hypertension and no diabetes (20427_18)
Mediator of RNA polymerase II transcription subunit 4 levels
Mediator of RNA polymerase II transcription subunit 4 levels (MED4.14021.81.3)
Medication adherence in chronic diseases
Medication use (adrenergics, inhalants)
Medication use (agents acting on the renin-angiotensin system)
Medication use (anilides)
Medication use (anti-inflammatory and antirheumatic products, non-steroids)
Medication use (antiglaucoma preparations and miotics)
Medication use (antihistamines for systemic use)
Medication use (antihypertensives)
Medication use (antimigraine preparations)
Medication use (antithrombotic agents)
Medication use (beta blocking agents)
Medication use (calcium channel blockers)
Medication use (diuretics)
Medication use (drugs affecting bone structure and mineralization)
Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)
Medication use (drugs used in diabetes)
Medication use (glucocorticoids)
Medication use (HMG CoA reductase inhibitors)
Medication use (immunosuppressants)
Medication use (opioids)
Medication use (salicylic acid and derivatives)
Medication use (thyroid preparations)
Medication use (vasodilators used in cardiac diseases)
Medication use for hyperlipidemia (number of purchases)
Medication use for hypertension (number of purchases)
Medication use for T2D (number of purchases)
Medication use for T2D (use of second-line agents)
Medium chain acylcarnitines levels (additive genetic model)
Medium chain acylcarnitines levels (dominant genetic model)
Medium VLDL particle concentration
Megakaryocyte-associated tyrosine-protein kinase levels
Meiotic recombination protein DMC1/LIM15 homolog level in Chronic kidney disease with hypertension and no diabetes (23341_16)
Melanocyte protein PMEL levels
Melanocyte protein PMEL levels (PMEL.6472.40.3)
Melanoma
Melanoma x citrus consumption interaction (2df)
Melanoma-associated antigen 10 levels
Melanoma-associated antigen 10 levels (MAGEA10.13610.9.3)
Melanoma-associated antigen 3 levels
Melanoma-associated antigen 3 levels (MAGEA3.12576.21.3)
Melanoma-associated antigen 5 levels
Melanoma-associated antigen 6 levels
Melanoma-associated antigen 8 levels
Melanoma-associated antigen B10 levels
Melanoma-derived growth regulatory protein level in Chronic kidney disease with hypertension and no diabetes (2687_2)
melanoma-derived growth regulatory protein levels
Melanoma-derived growth regulatory protein levels (MIA.2687.2.1)
Melanoregulin levels
Melusin levels
Membrane cofactor protein levels
Membrane magnesium transporter 1 levels
Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 levels
Membrane-associated progesterone receptor component 2 levels
Membrane-associated progesterone receptor component 2 levels (PGRMC2.10631.9.3)
Membrane-bound aminopeptidase P levels
Membranous nephropathy
Memory B cell %lymphocyte
Memory decline
Memory dysfunction in frontotemporal lobe dementia
Memory T-cell telomere length
Menarche (age at onset)
Menarche and menopause (age at onset)
Meningioma
Meningococcal C functional antibody titers post childhood immunization
Meningococcal C IgG concentrations post childhood immunization
Meningococcal disease
Menopause (age at onset)
Menstruation quality of life impact (acne)
Menstruation quality of life impact (aggressiveness)
Menstruation quality of life impact (bowel movement)
Menstruation quality of life impact (depression)
Menstruation quality of life impact (dysmenorrhea)
Menstruation quality of life impact (fever)
Menstruation quality of life impact (headache)
Menstruation quality of life impact (increased appetite)
Menstruation quality of life impact (loss of concentration)
Menstruation quality of life impact (nervousness)
Menstruation quality of life impact (pressure in breast)
Menstruation quality of life impact (sleepiness)
Menstruation quality of life impact (stiff neck)
Mental composite score
Mental disorder (without autoimmune disease)
Mental health related quality of life
Mental health study participation (completed survey)
Mental health study participation (provided email address)
Meprin A subunit beta levels
Mercuric chloride levels
Mercuric chloride-2 levels
Merdibacter massiliensis abundance in stool
Merkel cell polyomavirus VP1 antibody levels
Mesencephalic astrocyte-derived neurotrophic factor levels
Mesothelin levels (MSLN.3893.55.2)
Metabolic biomarkers (multivariate analysis)
Metabolic syndrome
Metabolic syndrome (bivariate traits)
Metabolic syndrome (multivariate analysis)
Metabolic traits
Metabolically unhealthy in normal weight
Metabolically unhealthy in obesity
Metabolite levels
Metabolite levels (X-11787)
Metabolite levels (5-HIAA)
Metabolite levels (5-HIAA/ MHPG Ratio)
Metabolite levels (Dihydroxy docosatrienoic acid)
Metabolite levels (HVA-5-HIAA Factor score)
Metabolite levels (HVA)
Metabolite levels (HVA/5-HIAA ratio)
Metabolite levels (HVA/MHPG ratio)
Metabolite levels (MHPG)
Metabolite levels (Pyroglutamine)
Metabolite peak levels (QI1027)
Metabolite peak levels (QI10291)
Metabolite peak levels (QI10524)
Metabolite peak levels (QI10664)
Metabolite peak levels (QI10705)
Metabolite peak levels (QI1071)
Metabolite peak levels (QI10761)
Metabolite peak levels (QI10834)
Metabolite peak levels (QI1087)
Metabolite peak levels (QI10958)
Metabolite peak levels (QI10969)
Metabolite peak levels (QI10980)
Metabolite peak levels (QI10992)
Metabolite peak levels (QI11083)
Metabolite peak levels (QI11242)
Metabolite peak levels (QI11307)
Metabolite peak levels (QI11461)
Metabolite peak levels (QI11833)
Metabolite peak levels (QI12000)
Metabolite peak levels (QI12380)
Metabolite peak levels (QI12439)
Metabolite peak levels (QI12470)
Metabolite peak levels (QI12472)
Metabolite peak levels (QI12488)
Metabolite peak levels (QI1249)
Metabolite peak levels (QI12506)
Metabolite peak levels (QI12663)
Metabolite peak levels (QI12764)
Metabolite peak levels (QI13326)
Metabolite peak levels (QI13343)
Metabolite peak levels (QI13392)
Metabolite peak levels (QI13613)
Metabolite peak levels (QI13644)
Metabolite peak levels (QI13749)
Metabolite peak levels (QI13785)
Metabolite peak levels (QI1379)
Metabolite peak levels (QI13969)
Metabolite peak levels (QI13988)
Metabolite peak levels (QI14010)
Metabolite peak levels (QI14012)
Metabolite peak levels (QI14032)
Metabolite peak levels (QI14055)
Metabolite peak levels (QI14127)
Metabolite peak levels (QI14216)
Metabolite peak levels (QI14562)
Metabolite peak levels (QI14564)
Metabolite peak levels (QI14569)
Metabolite peak levels (QI1459)
Metabolite peak levels (QI14719)
Metabolite peak levels (QI14741)
Metabolite peak levels (QI14769)
Metabolite peak levels (QI1478)
Metabolite peak levels (QI14798)
Metabolite peak levels (QI1480)
Metabolite peak levels (QI1481)
Metabolite peak levels (QI1483)
Metabolite peak levels (QI14931)
Metabolite peak levels (QI15290)
Metabolite peak levels (QI15385)
Metabolite peak levels (QI15436)
Metabolite peak levels (QI15536)
Metabolite peak levels (QI1565)
Metabolite peak levels (QI1568)
Metabolite peak levels (QI15805)
Metabolite peak levels (QI15953)
Metabolite peak levels (QI15965)
Metabolite peak levels (QI2044)
Metabolite peak levels (QI2146)
Metabolite peak levels (QI2179)
Metabolite peak levels (QI2180)
Metabolite peak levels (QI2187)
Metabolite peak levels (QI2188)
Metabolite peak levels (QI2190)
Metabolite peak levels (QI2222)
Metabolite peak levels (QI2236)
Metabolite peak levels (QI2240)
Metabolite peak levels (QI2435)
Metabolite peak levels (QI2551)
Metabolite peak levels (QI261)
Metabolite peak levels (QI2689)
Metabolite peak levels (QI2694)
Metabolite peak levels (QI2718)
Metabolite peak levels (QI2727)
Metabolite peak levels (QI2815)
Metabolite peak levels (QI2974)
Metabolite peak levels (QI3426)
Metabolite peak levels (QI3436)
Metabolite peak levels (QI3710)
Metabolite peak levels (QI3722)
Metabolite peak levels (QI3783)
Metabolite peak levels (QI3785)
Metabolite peak levels (QI3819)
Metabolite peak levels (QI4123)
Metabolite peak levels (QI4144)
Metabolite peak levels (QI4246)
Metabolite peak levels (QI4288)
Metabolite peak levels (QI4378)
Metabolite peak levels (QI445)
Metabolite peak levels (QI4508)
Metabolite peak levels (QI4584)
Metabolite peak levels (QI4667)
Metabolite peak levels (QI4689)
Metabolite peak levels (QI4690)
Metabolite peak levels (QI4708)
Metabolite peak levels (QI4887)
Metabolite peak levels (QI4952)
Metabolite peak levels (QI5099)
Metabolite peak levels (QI5101)
Metabolite peak levels (QI5169)
Metabolite peak levels (QI5171)
Metabolite peak levels (QI5469)
Metabolite peak levels (QI5541)
Metabolite peak levels (QI5684)
Metabolite peak levels (QI5745)
Metabolite peak levels (QI5780)
Metabolite peak levels (QI5884)
Metabolite peak levels (QI6080)
Metabolite peak levels (QI6095)
Metabolite peak levels (QI618)
Metabolite peak levels (QI6204)
Metabolite peak levels (QI6252)
Metabolite peak levels (QI6365)
Metabolite peak levels (QI6523)
Metabolite peak levels (QI6693)
Metabolite peak levels (QI6701)
Metabolite peak levels (QI6703)
Metabolite peak levels (QI6721)
Metabolite peak levels (QI68)
Metabolite peak levels (QI7003)
Metabolite peak levels (QI7090)
Metabolite peak levels (QI7106)
Metabolite peak levels (QI7191)
Metabolite peak levels (QI7214)
Metabolite peak levels (QI7232)
Metabolite peak levels (QI7338)
Metabolite peak levels (QI7389)
Metabolite peak levels (QI7417)
Metabolite peak levels (QI750)
Metabolite peak levels (QI7549)
Metabolite peak levels (QI7638)
Metabolite peak levels (QI8492)
Metabolite peak levels (QI8556)
Metabolite peak levels (QI8703)
Metabolite peak levels (QI8853)
Metabolite peak levels (QI890)
Metabolite peak levels (QI8919)
Metabolite peak levels (QI8972)
Metabolite peak levels (QI8984)
Metabolite peak levels (QI904)
Metabolite peak levels (QI9297)
Metabolite peak levels (QI9389)
Metabolite peak levels (QI9489)
Metabolite peak levels (QI961)
Metabolite peak levels (QI9645)
Metabolite peak levels (QI9655)
Metabolite peak levels (QI9680)
Metabolite peak levels (QI9845)
Metabolite peak levels (QI9862)
Metabolite peak levels (QI9912)
Metabolite risk score for predicting weight gain
Metabolonic lactone sulfate (X-12063) levels
Metabolonic lactone sulfate levels
Metalloprotease TIKI1 levels
Metalloproteinase inhibitor 1 levels
Metalloproteinase inhibitor 3 level in Chronic kidney disease with hypertension and no diabetes (2480_58)
Metalloproteinase inhibitor 3 levels
Metalloproteinase inhibitor 4 levels
Metalloproteinase inhibitor 4 levels (TIMP4.6462.12.3)
Metallothionein-1F levels (MT1F.10416.79.3)
Metamizole-induced agranulocytosis
Metastasis at diagnosis in osteosarcoma
Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event)
Metastasis-suppressor KiSS-1 levels
Metastatic colorectal cancer survival in treatment with chemotherapy plus biologics
Metaxin-2 levels
Methadone dose in opioid dependence
Methenyltetrahydrofolate synthase domain-containing protein levels
Methionine adenosyltransferase 2 subunit beta levels
Methionine aminopeptidase 2 levels
Methionine levels
Methionine levels (Biocrates platform)
Methionine levels in elite athletes
Methionine sulfone levels
Methionine sulfone levels in elite athletes
Methionine sulfoxide levels in elite athletes
Methionine-R-sulfoxide reductase B2, mitochondrial levels
Methionine-R-sulfoxide reductase B3 levels
Methioninesulfoxide levels
Methotrexate clearance (acute lymphoblastic leukemia)
Methotrexate pharmacokinetics (acute lymphoblastic leukemia)
Methotrexate-induced interstitial lung disease in rheumatoid arthritis
Methotrexate-induced liver injury in rheumatoid arthritis
Methotrexate-related central neurotoxicity in children treated for acute lymphoblastic leukemia
Methoxychlor levels
Methyl glucopyranoside (alpha + beta) levels in elite athletes
Methyl-4-hydroxybenzoate sulfate levels in elite athletes
Methyl-CpG-binding domain protein 1 levels
Methylated-DNA--protein-cysteine methyltransferase level in Chronic kidney disease with hypertension and no diabetes (21437_77)
Methylglutarylcarnitine levels
Methylmalonate (mma) levels
Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial levels
Methylmalonyl-CoA epimerase, mitochondrial levels
Methylsuccinate levels
Methylsuccinate levels in elite athletes
Methylsuccinoylcarnitine levels
Methyltransferase-like protein 24 levels
Metopic nonsyndromic craniosynostosis
Mevalonate kinase levels
MGMT methylation in smokers
MHC class I polypeptide-related sequence A levels
MHC class I polypeptide-related sequence B levels
MICAL-like protein 2 levels
MICAL-like protein 2 levels (MICALL2.12891.1.3)
MICOS complex subunit MIC10 level in Chronic kidney disease with hypertension and no diabetes (7956_11)
MICOS complex subunit MIC10 levels
MICOS complex subunit MIC10 levels (MINOS1.7956.11.3)
Microalbuminuria
Microfibrillar-associated protein 2 levels
Microfibrillar-associated protein 2 levels (MFAP2.9294.45.3)
Microfibrillar-associated protein 3-like level in Chronic kidney disease with hypertension and no diabetes (8837_8)
Microfibrillar-associated protein 5 levels
Microscopic brain infarct
Microtubule-associated protein RP/EB family member 1 levels
Microtubule-associated protein RP/EB family member 2 levels
Microtubule-associated protein tau levels
Microtubule-associated proteins 1A/1B light chain 3A levels
Microtubule-associated proteins 1A/1B light chain 3B levels
Middle childhood and early adolescence aggressive behavior
Middle temporal gyrus volume
Middle temporal gyrus volume (baseline)
Middle temporal gyrus volume (baseline)(adjusted for APOE e4 dosage)
Midgestational circulating levels of PBDEs (fetal genetic effect)
Midgestational circulating levels of PCBs
Midgestational circulating levels of PCBs (fetal genetic effect)
Midgestational total 25-hydroxyvitamin D levels (antenatal blood)
Midgestational total 25-hydroxyvitamin D levels (fetal genetic effect)
Midgestational total 25-hydroxyvitamin D levels (maternal genetic effect)
Midline nonsyndromic craniosynostosis
Midregional pro atrial natriuretic peptide levels
MIF plasma levels
Migraine
Migraine - clinic-based
Migraine (MTAG)
Migraine and/or diastolic blood pressure
Migraine and/or pulse pressure
Migraine and/or systolic blood pressure
Migraine or type 2 diabetes
Migraine with aura
Migraine with aura and/or diastolic blood pressure
Migraine with aura and/or pulse pressure
Migraine with aura and/or systolic blood pressure
Migraine without aura
Migraine without aura (MTAG)
Migraine without aura and/or diastolic blood pressure
Migraine without aura and/or pulse pressure
Migraine without aura and/or systolic blood pressure
Mild age-related type 2 diabetes
Mild influenza (H1N1) infection
Mild obesity-related type 2 diabetes
Mild to moderate chronic kidney disease
Milk allergy
Milk allergy (maternal genetic effects)
Milk chocolate liking
Milk type: Skimmed, semi-skimmed or full cream (UKB data field 1418)
Milky sweets liking
Mimecan levels
Mini-mental state examination / Folstein test (24 month visit)(adjusted for APOE e4 dosage)
Mini-mental state examination / Folstein test (baseline)
Mini-mental state examination / Folstein test (baseline)(adjusted for APOE e4 dosage)
Minimum ankle–brachial index
Minimum measurement of hepatic fat
Mismatch repair endonuclease PMS2 levels
Mitochondrial DNA copy number
Mitochondrial DNA levels
Mitochondrial fission 1 protein levels
Mitochondrial fission regulator 1 levels
Mitochondrial heteroplasmy measurement
Mitochondrial import inner membrane translocase subunit TIM14 levels
Mitochondrial import inner membrane translocase subunit Tim21 levels
Mitochondrial sodium/hydrogen exchanger 9B2 levels (SLC9B2.9088.20.3)
Mitochondrial ubiquitin ligase activator of NFKB 1 levels
Mitochondrial ubiquitin ligase activator of NFKB 1 levels (MUL1.9315.16.3)
Mitochondrial-processing peptidase subunit alpha level in Chronic kidney disease with hypertension and no diabetes (24907_3)
Mitogen-activated protein kinase 1 levels
Mitogen-activated protein kinase 12 levels
Mitogen-activated protein kinase 13 levels
Mitogen-activated protein kinase 13 levels (MAPK13.5006.71.1)
Mitogen-activated protein kinase 14 levels
Mitogen-activated protein kinase 3 levels
Mitogen-activated protein kinase 8 levels
Mitogen-activated protein kinase 9 levels
Mitogen-activated protein kinase kinase kinase kinase 1 levels
Mitogen-activated protein kinase kinase kinase kinase 3 levels
Mitotic checkpoint serine/threonine-protein kinase BUB1 levels
Mitotic spindle assembly checkpoint protein MAD1 levels
Mitotic spindle assembly checkpoint protein MAD1 levels (MAD1L1.13618.15.3)
Mitotic spindle assembly checkpoint protein MAD2A levels
Mitral valve annular diameter (left ventricle diastole)
Mitral valve annular diameter (left ventricle systole)
Mitral valve prolapse
Mitral valve prolapse after mitral valve surgery
MMP 1 plasma levels
MMP 3 plasma levels
MMP 7 plasma levels
Moderate physical activity
Moderate to vigorous physical activity levels
Moderate-to-late spontaneous preterm birth
Moderate-to-vigorous intensity physical activity during leisure time
Moderate-to-vigorous intensity physical activity during leisure time (MTAG)
Modic changes
Modified Stumvoll Insulin Sensitivity Index
Modified Stumvoll Insulin Sensitivity Index (BMI interaction)
Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI)
Moesin levels
Molar-incisor hypomineralization
Mono [ADP-ribose] polymerase PARP16 levels
Monobrow
Monobrow thickness
Monocarboxylate transporter 4 levels
Monoclonal gammopathy of undetermined significance
Monocyte chemoattractant protein-1 levels
Monocyte chemoattractant protein-3 levels
Monocyte chemoattractant protein-4 levels
Monocyte count
Monocyte differentiation antigen CD14 levels
Monocyte differentiation antigen CD14, soluble levels
Monocyte early outgrowth colony forming units
Monocyte percentage of white cells
Monocyte-lymphocyte ratio
Monocytic Myeloid-Derived Suppressor Cells Absolute Count
Monohexosylceramide (d16:1/18:0) levels
Monohexosylceramide (d16:1/20:0) levels
Monohexosylceramide (d16:1/22:0) levels
Monohexosylceramide (d16:1/24:0) levels
Monohexosylceramide (d18:1/16:0) levels
Monohexosylceramide (d18:1/18:0) levels
Monohexosylceramide (d18:1/20:0) levels
Monohexosylceramide (d18:1/22:0) levels
Monohexosylceramide (d18:1/24:0) levels
Monohexosylceramide (d18:1/24:1) levels
Monohexosylceramide (d18:2/20:0) levels
Monohexosylceramide (d18:2/22:0) levels
Monohexosylceramide (d18:2/24:0) levels
Monokine induced by gamma interferon levels
Mononucleosis
Monounsaturated fatty acid levels
Monounsaturated fatty acids levels (UKB data field 23447)
Monounsaturated fatty acids to total fatty acids percentage (UKB data field 23454)
Mood disorder and prion disease
Mood disorder in prion disease
Mood instability
Morbidity in COVID-19 (deceased vs asymptomatic)
Morbidity-free survival
Morganella abundance in stool
Morning person
Morning vs. evening chronotype
Morningness
Morphine dose requirement in tonsillectomy and adenoidectomy surgery
Morphological facial height
Mortality
Mortality after unrelated donor allogeneic hematopoietic cell transplantation (recipient effect)
Mortality in COVID-19
Mortality in heart failure
Mosaic loss of chromosome Y
Mosaic loss of chromosome Y (Y chromosome dosage)
Mosquito bite size
Mothers against decapentaplegic homolog 1 levels
Mothers against decapentaplegic homolog 3 level in Chronic kidney disease with hypertension and no diabetes (10363_13)
Mothers against decapentaplegic homolog 4 levels
Motion sickness
Motor composite score
Motor coordination
Motor fluctuations in levodopa treated Parkinson's disease
Mouth morphology
Mouth ulcers
Moyamoya disease
MPIF 1 plasma levels
mRNA-capping enzyme level in Chronic kidney disease with hypertension and no diabetes (20135_85)
mRNA-capping enzyme levels
mRNA-decapping enzyme 1A levels
mRNA-decapping enzyme 1B levels
MSP plasma levels
Mth938 domain-containing protein level in Chronic kidney disease with hypertension and no diabetes (24216_30)
Mucin-1 levels
Mucin-1 levels (MUC1.9176.3.3)
Mucin-16 levels
Mucin-like protein 1 levels
Mucinous adenocarcinoma in colorectal cancer
Mucinous ovarian carcinoma
Muellerian-inhibiting factor level in Chronic kidney disease with hypertension and no diabetes (4923_79)
Muellerian-inhibiting factor levels
Muellerian-inhibiting factor levels (AMH.4923.79.1)
Multimerin-2 levels
Multimerin-2 levels (MMRN2.11895.21.3)
Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)
Multiple coagulation factor deficiency protein 2 levels
Multiple coagulation factor deficiency protein 2 levels (MCFD2.10476.23.3)
Multiple epidermal growth factor-like domains protein 10 levels
Multiple inositol polyphosphate phosphatase 1 levels
Multiple inositol polyphosphate phosphatase 1 levels (MINPP1.5586.66.3)
Multiple keratinocyte cancers
Multiple metachronous adenoma
Multiple myeloma
Multiple myeloma (hyperdiploidy)
Multiple myeloma (IgH translocation)
Multiple myeloma and monoclonal gammopathy
Multiple sclerosis
Multiple sclerosis (age of onset)
Multiple sclerosis (OCB status)
Multiple sclerosis (severity)
Multiple sclerosis and body mass index (pleiotropy)
Multiple sclerosis and C-reactive protein levels (pleiotropy)
Multiple sclerosis and HDL levels (pleiotropy)
Multiple sclerosis and LDL levels (pleiotropy)
Multiple sclerosis and systolic blood pressure (pleiotropy)
Multiple sclerosis and triglyceride levels (pleiotropy)
Multiple sclerosis and type 2 diabetes (pleiotropy)
Multiple sclerosis or amyotrophic lateral sclerosis
Multiple sclerosis--Brain Glutamate Levels
Multiple severe cisplatin-induced neurotixicitiies in testicular cancer survivors
Multiple system atrophy
Multiple system atrophy (pathologically confirmed)
Multisite chronic pain
Multisyllabic word repetition
Multivariate microbial feature (beta-diversity) at the dorsal forearm (dry skin)
Multivesicular body subunit 12B level in Chronic kidney disease with hypertension and no diabetes (23320_11)
Mumps
Musician's dystonia
Myalgic encephalomyelitis / chronic fatigue syndrome
Myasthenia gravis
Myc box-dependent-interacting protein 1 levels
Myc target protein 1 levels (MYCT1.13541.1.3)
Mycobacteriaceae abundance in stool
Myelin protein P0 levels
Myelin protein zero-like protein 1 levels
Myelin protein zero-like protein 2 levels
Myelin regulatory factor levels
Myeloblastin levels
Myeloid cell surface antigen CD33 level in Chronic kidney disease with hypertension and no diabetes (3166_92)
Myeloid cell surface antigen CD33 levels
Myeloid cell surface antigen CD33 levels (CD33.3166.92.1)
Myeloid clonal hematopoiesis
Myeloid Dendritic Cell %Dendritic Cell
Myeloid Dendritic Cell Absolute Count
Myeloid leukemia factor 1 level in Chronic kidney disease with hypertension and no diabetes (17820_170)
Myeloid leukemia factor 1 levels
Myeloid white cell count
Myeloid zinc finger 1 levels
Myeloid-derived growth factor levels
Myeloperoxidase levels
Myeloperoxidase-DNA complexes
Myeloproliferative neoplasms
Myo-inositol levels
Myo-inositol levels in elite athletes
Myocardial fractal dimension (slice 2)
Myocardial fractal dimension (slice 3)
Myocardial fractal dimension (slice 4)
Myocardial fractal dimension (slice 5)
Myocardial fractal dimension (slice 6)
Myocardial fractal dimension (slice 7)
Myocardial fractal dimension (slice 8)
Myocardial fractal dimension (slice 9)
Myocardial infarction
Myocardial infarction (early onset)
Myocardial infraction risk reduction in statin users
Myocardial zonula adherens protein levels
Myocilin levels
Myocyte-specific enhancer factor 2C levels
Myocyte-specific enhancer factor 2D level in Chronic kidney disease with hypertension and no diabetes (24266_2)
Myoglobin levels
Myomesin-3 levels
Myoneurin levels
Myopia
Myopia (age of diagnosis)
Myopia (pathological)
Myopic maculopathy
Myosin light chain 3 levels
Myosin light chain 5 levels
Myosin light chain 6B levels
Myosin regulatory light chain 2, atrial isoform levels
Myosin-binding protein C, slow-type levels
Myotubularin-related protein 1 levels
Myotubularin-related protein 6 levels
Myotubularin-related protein 7 level in Chronic kidney disease with hypertension and no diabetes (24493_10)
Myringotomy
Myristate (14:0) levels in elite athletes
Myristoleate (14:1n5) levels in elite athletes
Myristoleoylcarnitine (C14:1) levels in elite athletes
Myristoyl dihydrosphingomyelin (d18:0/14:0) levels
Myristoyl dihydrosphingomyelin (d18:0/14:0) levels in elite athletes
Myristoyl-linoleoyl-glycerol (14:0/18:2) [1] levels
Myristoylcarnitine (C14) levels in elite athletes
Myristoylcarnitine levels
N-(2-furoyl)glycine levels
N-(2-furoyl)glycine levels in elite athletes
N-acetyl neuraminic acid levels
N-acetyl-1-methylhistidine levels
N-acetyl-1-methylhistidine levels in elite athletes
N-acetyl-2-aminoadipate levels
N-acetyl-2-aminooctanoate (X-12511) levels
N-acetyl-2-aminooctanoate levels
N-acetyl-3-methylhistidine levels
N-acetyl-3-methylhistidine levels in elite athletes
N-acetyl-4-chlorophenylalanine levels
N-acetyl-aspartyl-glutamate (naag) levels
N-acetyl-aspartyl-glutamate (NAAG) levels in elite athletes
N-acetyl-beta-alanine levels
N-acetyl-beta-alanine levels in elite athletes
N-acetyl-cadaverine levels in elite athletes
N-acetyl-D-glucosamine kinase levels
N-acetyl-D-glucosamine kinase levels (NAGK.3894.15.2)
N-acetyl-isoputreanine (X-12688) levels
N-acetyl-isoputreanine levels
N-acetyl-L-glutamine levels
N-acetylalanine levels in elite athletes
N-acetylalliin levels
N-acetylarginine levels
N-acetylarginine levels in elite athletes
N-acetylasparagine levels
N-acetylasparagine levels in elite athletes
N-acetylaspartate (NAA) levels in elite athletes
N-acetylated-alpha-linked acidic dipeptidase 2 levels
N-acetylated-alpha-linked acidic dipeptidase 2 levels (NAALAD2.7986.98.3)
N-acetylated-alpha-linked acidic dipeptidase-like protein levels
N-acetylcarnosine levels
N-acetylcarnosine levels in elite athletes
N-acetylcitrulline levels
N-acetylcitrulline levels in elite athletes
N-acetylgalactosamine kinase level in Chronic kidney disease with hypertension and no diabetes (23631_1)
N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase levels
N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase levels (NAGPA.11208.15.3)
N-acetylglucosamine-6-sulfatase levels
N-acetylglucosamine/n-acetylgalactosamine levels
N-acetylglucosamine/N-acetylgalactosamine levels in elite athletes
N-acetylglucosaminylasparagine levels
N-acetylglutamate levels
N-acetylglutamine levels
N-acetylglutamine levels in elite athletes
N-acetylglycine levels
N-acetylglycine levels in elite athletes
N-acetylhistidine levels
N-acetylisoleucine levels in elite athletes
N-acetylkynurenine (2) levels
N-acetylkynurenine (2) levels in elite athletes
N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 levels
N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 levels (B3GNT2.7980.72.3)
N-acetylleucine levels
N-acetylleucine levels in elite athletes
N-acetylmethionine levels in elite athletes
N-acetylmethionine sulfoxide levels in elite athletes
N-acetylneuraminate levels
N-acetylneuraminate levels in elite athletes
N-acetylneuraminate lyase levels
N-acetylornithine levels
N-acetylornithine levels in chronic kidney disease
N-acetylornithine-to-myo-inositol ratio
N-acetylphenylalanine levels
N-acetylphenylalanine levels in chronic kidney disease
N-acetylphenylalanine levels in elite athletes
N-acetylproline levels in elite athletes
N-acetylputrescine levels
N-acetylputrescine levels in chronic kidney disease
N-acetylputrescine levels in elite athletes
N-acetylserine levels in elite athletes
N-acetylserotonin O-methyltransferase-like protein levels
N-acetyltaurine levels
N-acetyltaurine levels in elite athletes
N-acetyltransferase 14 levels
N-acetyltryptophan levels
N-acetyltryptophan levels in elite athletes
N-acetyltyrosine levels
N-acetylvaline levels in elite athletes
N-acylethanolamine-hydrolyzing acid amidase level in Chronic kidney disease with hypertension and no diabetes (3173_49)
N-acylethanolamine-hydrolyzing acid amidase levels
N-acylethanolamine-hydrolyzing acid amidase levels (NAAA.3173.49.2)
N-acylneuraminate-9-phosphatase levels
N-alpha-acetylarginine levels
N-alpha-acetylarginine levels in chronic kidney disease
N-alpha-acetylornithine levels
N-alpha-acetylornithine levels in elite athletes
N-alpha-acetyltransferase 10 levels
N-behenoyl-sphingadienine (d18:2/22:0) levels in elite athletes
N-delta-acetylornithine levels
N-delta-acetylornithine levels in elite athletes
N-desmethyl tamoxifen levels in tamoxifen-treated hormone-receptor-positive breast cancer
N-desmethylclozapine concentration in schizophrenia
N-docosahexaenoyl ethanolamide levels
N-formylanthranilic acid levels
N-formylanthranilic acid levels in elite athletes
N-formylmethionine levels
N-formylmethionine levels in elite athletes
N-formylphenylalanine levels in elite athletes
N-glycan levels
N-linoleoyl ethanolamide levels
N-linoleoyltaurine levels
N-methylpipecolate levels
N-methylpipecolate levels in elite athletes
N-methylproline levels in elite athletes
N-oleoylserine levels
N-oleoylserine levels in elite athletes
N-oleoyltaurine levels
N-oleoyltaurine levels in elite athletes
N-palmitoyl ethanolamide levels
N-palmitoyl-sphinganine (d18:0/16:0) levels in elite athletes
N-palmitoyl-sphingosine (d18:1/16:0) levels in elite athletes
N-palmitoylglycine levels
N-palmitoylglycine levels in elite athletes
N-palmitoylserine levels
N-palmitoyltaurine levels in elite athletes
N-stearoyl-sphingadienine (d18:2/18:0) levels
N-stearoyl-sphinganine (d18:0/18:0) levels
N-stearoyl-sphingosine (d18:1/18:0) levels
N-stearoyltaurine levels
N-stearoyltaurine levels in elite athletes
N-succinyl-phenylalanine levels
N-terminal pro B-type natriuretic peptide levels
N-terminal pro-BNP levels
N-terminal pro-BNP levels (NPPB.7655.11.3)
N-terminal prohormone brain natriuretic peptide levels
N-terminal Xaa-Pro-Lys N-methyltransferase 1 levels
N-trimethyl 5-aminovalerate (X-21365) levels
N-trimethyl 5-aminovalerate levels in elite athletes
N-vaccinoyl ethanolamide levels
N,n-dimethylalanine (X-23585) levels
N,N-dimethylalanine levels
N,N,N-trimethyl-5-aminovalerate levels
N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase levels
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 levels
N1-acetylspermidine levels
N1-methyl-2-pyridone-5-carboxamide levels
N1-Methyl-2-pyridone-5-carboxamide levels in elite athletes
N1-Methyl-4-pyridone-3-carboxamide levels in elite athletes
N1-methyladenosine levels
N1-methylinosine levels in elite athletes
N2-acetyl,N6-methyllysine levels
N2-acetyl,N6,N6-dimethyllysine levels
N2-acetyllysine levels
N2-acetyllysine levels in elite athletes
N2-methylguanosine levels
N2,N2-dimethylguanosine levels in elite athletes
N2,N5-diacetylornithine levels
N2,N5-diacetylornithine levels in elite athletes
N4-acetylcytidine levels
N6-acetyllysine levels
N6-acetyllysine levels in chronic kidney disease
N6-acetyllysine levels in elite athletes
N6-carbamoylthreonyladenosine levels
N6-carbamoylthreonyladenosine levels in elite athletes
N6-carboxymethyllysine levels in elite athletes
N6-methyllysine levels
N6,N6-dimethyllysine levels
N6,N6-dimethyllysine levels in chronic kidney disease
N6,n6,n6-trimethyllysine levels
N6,N6,N6-trimethyllysine levels in elite athletes
Na(+)/H(+) exchange regulatory cofactor NHE-RF3 levels
NACHT, LRR and PYD domains-containing protein 1 levels
NAD kinase levels
NAD-dependent protein deacetylase sirtuin-1 level in Chronic kidney disease with hypertension and no diabetes (19823_75)
NAD-dependent protein deacetylase sirtuin-2 levels
NAD-dependent protein deacetylase sirtuin-2 levels (SIRT2.5030.52.1)
NAD-dependent protein deacetylase sirtuin-3, mitochondrial levels
NAD-dependent protein deacylase sirtuin-5, mitochondrial levels
NAD(P)H dehydrogenase [quinone] 1 level in Chronic kidney disease with hypertension and no diabetes (9837_60)
NAD(P)H dehydrogenase [quinone] 1 levels
NAD(P)H dehydrogenase [quinone] 1 levels (NQO1.9837.60.3)
NAD(P)H-hydrate epimerase level in Chronic kidney disease with hypertension and no diabetes (16621_77)
NAD(P)H-hydrate epimerase levels
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial levels
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 levels
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 levels (NDUFB4.10677.9.3)
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial level in Chronic kidney disease with hypertension and no diabetes (10584_7)
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial levels
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial levels (NDUFS4.10584.7.3)
NADH-cytochrome b5 reductase 1 levels
NADH-cytochrome b5 reductase 2 levels
NADPH--cytochrome P450 reductase levels
Naive CD4+ T cell %CD4+ T cell
Naive CD4+ T cell %T cell
Naive CD8+ T cell %T cell
Naive T-cell telomere length
Naive-mature B cell Absolute Count
Nap duration in severe depression
Narcolepsy
Narcolepsy with cataplexy
Narrowest width of the femoral neck
Nasal height
Nasal polyps
Nascent polypeptide-associated complex subunit alpha levels
NASH resolution in nonalcoholic steatohepatitis
Nasopharyngeal carcinoma
Natriuretic peptide levels
Natural cytotoxicity triggering receptor 3 levels
Natural Killer %CD3- lymphocyte
Natural Killer %lymphocyte
Natural Killer Absolute Count
Natural killer cell receptor 2B4 levels
Natural Killer T %lymphocyte
Natural Killer T Absolute Count
Nausea incidence in varenicline-treated smokers
Neck circumference
Neck circumference (BMI adjusted)
Neck pain or shoulder pain
Nectin-3 levels
NEDD4-like E3 ubiquitin-protein ligase WWP1 levels
NEDD8-activating enzyme E1 regulatory subunit levels
NEDD8-conjugating enzyme UBE2F levels
Negative urgency
Negativibacillus abundance in stool
Negativibacillus sp000435195 abundance in stool
Neogenin levels
Neogenin levels (NEO1.8900.28.3)
Neonatal abstinence syndrome
Neonatal cytokine/chemokine levels (fetal genetic effect)
Neonatal total 25-hydroxyvitamin D levels (cord blood)
Neonatal total 25-hydroxyvitamin D levels (fetal genetic effect)
Neonatal total 25-hydroxyvitamin D levels (maternal genetic effect)
Neonatal white matter microstructure
Neovascular age-related macular degeneration
Nephrolithiasis
Nephropathy
Nephrotic syndrome (acquired)
Nervonoylcarnitine (C24:1) levels
Nervonoylcarnitine (C24:1) levels in elite athletes
Nesprin-2 levels
Netrin-1 levels
Netrin-4 levels
Netrin-4 levels (NTN4.3327.27.1)
Neuferricin levels
Neural cell adhesion molecule 1 levels (NCAM1.7746.230.3)
Neural cell adhesion molecule 1, 120 kDa isoform levels
Neural cell adhesion molecule 1, 120 kDa isoform levels (NCAM1.4498.62.2)
Neural cell adhesion molecule 2 levels
Neural cell adhesion molecule 2 levels (NCAM2.6507.16.3)
Neural cell adhesion molecule L1-like protein levels
Neural cell adhesion molecule L1-like protein levels (CHL1.3601.54.3)
Neuralized-like protein 4 levels
Neuranatomic and neurocognitive phenotypes
Neuregulin-1 levels
Neuregulin-1, sensory and motor neuron-derived factor isoform levels
Neuregulin-4 levels
Neurensin-1 levels (NRSN1.11654.77.3)
Neurexin-1 level in Chronic kidney disease with hypertension and no diabetes (8971_9)
Neurexin-1 levels
Neurexin-3 levels
Neurexin-3-beta levels
Neurexophilin-1 levels
Neurexophilin-2 levels
Neuritic plaque
Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)
Neuroblastoma
Neuroblastoma (11q deletion)
Neuroblastoma (high-risk)
Neuroblastoma (MYCN amplification)
Neuroblastoma (pediatric)
Neuroblastoma or malignant cutaneous melanoma
Neurocalcin-delta levels
Neurocan core protein levels
Neurociticism
Neurocognitive impairment in HIV-1 infection (continuous)
Neurocognitive impairment in HIV-1 infection (dichotomous)
Neuroendocrine convertase 1 level in Chronic kidney disease with hypertension and no diabetes (13388_57)
Neuroendocrine convertase 1 levels
Neuroendocrine convertase 1 levels (PCSK1.13388.57.3)
Neuroendocrine convertase 2 levels
Neuroendocrine protein 7B2 level in Chronic kidney disease with hypertension and no diabetes (15358_28)
Neurofascin levels
Neurofascin levels (NFASC.7179.69.3)
Neurofibrillary tangles
Neurogenic locus notch homolog protein 1 levels
Neurogenic locus notch homolog protein 2 levels
Neurogranin levels
Neuroligin-1 levels
Neuroligin-2 levels
Neuroligin-3 levels
Neuroligin-4, X-linked levels
Neurological blood protein biomarker levels
Neuromedin-B levels
Neuronal growth regulator 1 levels
Neuronal pentraxin receptor level in Chronic kidney disease with hypertension and no diabetes (15511_37)
Neuronal pentraxin receptor level in Chronic kidney disease with hypertension and no diabetes (8997_4)
Neuronal pentraxin receptor levels
Neuronal pentraxin-1 levels (NPTX1.9256.78.3)
Neuronal pentraxin-2 levels
Neuronal pentraxin-2 levels (NPTX2.6521.35.3)
Neuropathic pain
Neuropathic pain in head and neck cancer
Neuropathic pain in type 2 diabetes
Neuropathologic traits (pleiotropy)
Neuropeptide S levels
Neuropilin and tolloid-like protein 1 levels
Neuropilin-1 levels
Neuropilin-1 levels (NRP1.3214.3.2)
Neuroplastin levels
Neuropsychiatric disorders
Neuroticism
Neuroticism (age interaction)
Neuroticism (MTAG)
Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)
Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)
Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)
Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)
Neuroticism conditioned on self-rated math ability (multi-trait conditioning and joint analysis)
Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)
Neurotrimin levels
Neutral antibody levels in response to SARS-CoV-2 vaccination
Neutral ceramidase level in Chronic kidney disease with hypertension and no diabetes (3212_30)
Neutral ceramidase levels
Neutral ceramidase levels (ASAH2.3212.30.3)
Neutrophil collagenase levels
Neutrophil collagenase levels (MMP8.2954.56.2)
Neutrophil count
Neutrophil count in HIV-infection
Neutrophil cytosol factor 2 levels
Neutrophil elastase levels
Neutrophil gelatinase-associated lipocalin levels
Neutrophil granulocyte count
Neutrophil percentage of granulocytes
Neutrophil percentage of white cells
Neutrophil-activating peptide 2 levels
Neutrophil-activating peptide 2 levels (PPBP.2790.54.2)
Neutrophil-to-lymphocyte ratio
Never eat sugar vs no eggs, dairy, wheat or sugar restrictions (UKB data field 6144)
Never eat sugar vs no sugar restrictions (UKB data field 6144)
Never eat wheat vs no wheat restrictions (UKB data field 6144)
Nevus count
Nevus count or cutaneous melanoma
New onset hypertension
New onset hypertension (high renin group)
New onset hypertension (low renin group)
Next to BRCA1 gene 1 protein levels
NF-kappa-B inhibitor beta levels
NGFI-A-binding protein 1 levels
NH4_C22:4 Cholesteryl ester levels in chronic kidney disease
NHL repeat-containing protein 3 levels
NHL repeat-containing protein 3 levels (NHLRC3.9087.8.3)
NHP2-like protein 1 levels
Nickel levels
Nicotinamide riboside kinase 1 levels
Nicotinate-nucleotide pyrophosphorylase [carboxylating] levels
Nicotine dependence
Nicotine dependence and major depression (severity of comorbidity)
Nicotine dependence symptom count
Nicotine glucouronidation
Nicotine metabolite ratio in current smokers
Nicotine use
Nicotine withdrawal
Nicotine withdrawal symptom count
Nidogen-2 level in Chronic kidney disease with hypertension and no diabetes (16060_99)
Nidogen-2 level in Chronic kidney disease with hypertension and no diabetes (3633_70)
Nidogen-2 levels
Nidogen-2 levels (NID2.3633.70.5)
Night sleep phenotypes
Nischarin levels
Nisinate (24:6n3) levels
Nivolumab-induced hypothyroidism in cancer
Nivolumab-induced immune-related adverse events in cancer
NK-cell telomere length
NKG2-D type II integral membrane protein levels
NKG2-E type II integral membrane protein levels
NKG2-E type II integral membrane protein levels (KLRC3.7795.14.3)
NKG2D ligand 2 level in Chronic kidney disease with hypertension and no diabetes (22583_47)
NKG2D ligand 3 levels
NKG2D ligand 4 levels (RAET1E.7800.85.3)
NmrA-like family domain-containing protein 1 level in Chronic kidney disease with hypertension and no diabetes (13988_67)
NmrA-like family domain-containing protein 1 levels
Nocturnal enuresis
Nodal homolog levels
Nodal modulator 1 levels
Node-level brain connectivity (multivariate analysis)
Nodular sclerosis Hodgkin lymphoma
Noelin-2 levels
Noelin-3 level in Chronic kidney disease with hypertension and no diabetes (11143_32)
Noelin-3 levels
Noggin levels
Non-accommodative esotropia
Non-albumin protein levels
Non-alcoholic chronic pancreatitis
Non-alcoholic fatty liver disease activity score in non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease histology (AST)
Non-alcoholic fatty liver disease histology (lobular)
Non-alcoholic fatty liver disease histology (other)
Non-cardia gastric cancer
Non-del(5q) myelodysplastic syndromes
Non-glioblastoma glioma
Non-HDL cholesterol levels
Non-histone chromosomal protein HMG-14 levels
Non-histone chromosomal protein HMG-14 levels (HMGN1.9187.2.3)
Non-Hodgkin's lymphoma
Non-homologous end-joining factor 1 levels
Non-lobar intracerebral hemorrhage
Non-lobar intracerebral hemorrhage (MTAG)
Non-melanoma skin cancer
Non-obstructive azoospermia
Non-oily fish consumption
Non-receptor tyrosine-protein kinase TYK2 level in Chronic kidney disease with hypertension and no diabetes (5260_80)
Non-receptor tyrosine-protein kinase TYK2 levels
Non-response to antidepressants and depression
Non-response to citalopram or escitalopram and depression
Non-Richardson's syndrome vs Richardson's syndrome in progressive supranuclear palsy
Non-secretory ribonuclease levels
Non-secretory ribonuclease levels (RNASE2.8394.56.3)
Non-small cell lung cancer
Non-small cell lung cancer (survival)
Non-small cell lung cancer x BMI trajectory interaction
Non-steroidal anti-inflammatory drug-induced enteropathy
Non-substance related behavioral disinhibition
Non-surgical hip osteoarthritis
Non-surgical knee osteoarthritis
Non-tuberculous mycobacterial pulmonary disease
Non-word reading
Non-word repetition
Non(never)-lesional skin FLG expression levels in childhood atopic dermatitis
Nonadecanoate (19:0) levels in elite athletes
Nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (imputed)
Nonalcoholic steatohepatitis
Nonanoylcarnitine (C9) levels
Nonatopic asthma
Nonatopic asthma and/or BMI
Nonatopic asthma and/or waist-to-hip ratio adjusted for BMI
Nonatopic asthma or fasting glucose levels
Nonatopic asthma or type 2 diabetes
Nonaylcarnitine levels
Noncognitive aspects of educational attainment
Noncompact myelin-associated protein levels
Nonobstructive coronary artery disease
Nonsense word reading
Nonsense word repetition
Nonspecific lipid-transfer protein level in Chronic kidney disease with hypertension and no diabetes (25049_8)
Nonsyndromic cleft lip
Nonsyndromic cleft lip with cleft palate
Nonsyndromic cleft lip with or without cleft palate
Nonsyndromic cleft lip with or without cleft palate x sex interaction (2df test)
Nonsyndromic cleft palate
Nonsyndromic orofacial cleft x sex interaction
Nonsyndromic orofacial cleft x sex interaction (2df)
Nontraumatic osteonecrosis of the femoral head
Normal facial asymmetry (deformation magnitude)
Normal mucosa of esophagus-specific gene 1 protein levels (NMES1.6406.3.3)
Normalized brain volume
Nose morphology
Nose size
NSAID-induced peptic ulcer disease
NSFL1 cofactor p47 levels
NT proBNP plasma levels
NT-3 growth factor receptor levels
NT-proBNP levels in acute coronary syndrome
NTF2-related export protein 1 levels
NTF2-related export protein 1 levels (NXT1.9942.2.3)
NTF2-related export protein 2 levels
Nuclear apoptosis-inducing factor 1 levels
Nuclear distribution protein nudE homolog 1 levels
Nuclear factor erythroid 2-related factor 1 levels
Nuclear factor NF-kappa-B p105 subunit levels
Nuclear factor of activated T-cells, cytoplasmic 1 levels
Nuclear inhibitor of protein phosphatase 1 levels
Nuclear migration protein nudC levels
Nuclear nucleic acid-binding protein C1D levels
Nuclear pore complex-interacting protein family member B3 levels
Nuclear pore complex-interacting protein family member B3 levels (NPIPB3.9954.2.3)
Nuclear protein MDM1 levels
Nuclear receptor coactivator 2 levels
Nuclear receptor ROR-beta levels
Nuclear receptor subfamily 1 group D member 1 levels
Nuclear receptor subfamily 1 group D member 2 levels (NR1D2.12885.42.3)
Nuclear receptor-binding protein levels
Nuclear RNA export factor 1 levels
Nuclease-sensitive element-binding protein 1 levels
Nucleolar protein of 40 kDa level in Chronic kidney disease with hypertension and no diabetes (21811_20)
Nucleolysin TIAR levels
Nucleoside diphosphate kinase A levels
Nucleoside diphosphate kinase A levels (NME1.5909.51.3)
Nucleoside diphosphate kinase B levels
Nucleoside diphosphate kinase, mitochondrial levels
Nucleosome assembly protein 1-like 1 levels
Nucleosome assembly protein 1-like 2 levels (NAP1L2.13529.39.3)
nucleosome assembly protein 1-like 4 levels
Nucleosome-remodeling factor subunit BPTF levels
Nucleus accumbens volume
Nucleus accumbens volume change rate
Nucleus accumbens volume change rate x age interaction (1df)
Nucleus accumbens volume change rate x age interaction (2df)
Nucleus accumbens volume in trauma-exposed individuals
NudC domain-containing protein 3 levels
Number of awakenings in broad depression
Number of children
Number of children (6+ vs. 0 or 1)
Number of clonal hematopoiesis mutations
Number of common colds
Number of decayed, missing and filled tooth surfaces
Number of decayed, missing and filled tooth surfaces or use of dentures
Number of live births
Number of non-cancer illnesses (standard GWA)
Number of non-cancer illnesses (weighted GWA)
Number of pregnancies
Number of sexual partners
Number of twin births
Numerical cognitive ability
Nutritionally-regulated adipose and cardiac enriched protein homolog levels
Nutritionally-regulated adipose and cardiac enriched protein homolog levels (NRAC.13464.8.3)
O_Burkholderiales abundance
O_Coriobacteriales abundance
O_Selenomonadales abundance
O_Selenomonadales prevalence
O-acetyl-ADP-ribose deacetylase MACROD1 levels
O-cresol sulfate levels in elite athletes
O-phosphoseryl-tRNA(Sec) selenium transferase levels
O-sulfo-l-tyrosine levels
O-sulfo-L-tyrosine levels in elite athletes
Obese vs. thin
Obesity
Obesity (early onset extreme)
Obesity (extreme)
Obesity and osteoporosis
Obesity in adult survivors of childhood cancer not exposed to cranial radiation
Obesity without metabolic disease
Obesity-related traits
Obg-like ATPase 1 levels
Obsession score in obsessive compulsive disorder
Obsessive compulsive disorder severity
Obsessive compulsive disorder vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS))
Obsessive-compulsive disorder
Obsessive-compulsive disorder or autism spectrum disorder
Obsessive-compulsive symptoms
Obsessive-compulsive traits
Obstetric antiphospholipid syndrome
Obstructive heart defect
Obstructive sleep apnea
Obstructive sleep apnea trait (apnea hypopnea index, change over time)
Obstructive sleep apnea trait (apnea hypopnea index)
Obstructive sleep apnea trait (average oxyhemoglobin desaturation per event)
Obstructive sleep apnea trait (average respiratory event duration)
Obstructive sleep apnea trait (minimum oxyhemoglobin saturation across sleep episode)
Obstructive sleep apnea trait (percentage of N3 sleep time during total sleep time)
Obstructive sleep apnea trait (percentage of wake time during sleep period time)
Occipital cortical area (total cortical area interaction)
Occipital lobe volume
Occupational attainment
OCIA domain-containing protein 1 levels
Octadecadienedioate (C18:2-DC) levels
Octadecadienylcarnitine levels
Octadecandienylcarnitine levels
Octadecanedioate (C18-DC) levels
Octadecanedioate levels
Octadecanedioate levels in elite athletes
Octadecanedioylcarnitine (C18-DC) levels
Octadecanoylcarnitine levels
Octadecenedioate (c18:1-dc) (X-11538) levels
Octadecenedioate (C18:1-DC) levels
Octadecenedioylcarnitine (C18:1-DC) levels
Octadecenoylcarnitine levels
Octanoylcarnitine (c8) levels
Octanoylcarnitine (C8) levels in elite athletes
Octanoylcarnitine levels
Octanoylcarnitine levels (Biocrates platform)
Octanoylcarnitine levels (Metabolon platform)
Octanoylcarnitine-to-X-13435 ratio
Ocular disease
Ocular sarcoidosis
Odorant perception
Odorant perception (β-damascenone)
Odorant perception (β-ionone)
Odorant perception (isobutyraldehyde)
Odorant-binding protein 2a levels
Odorant-binding protein 2b level in Chronic kidney disease with hypertension and no diabetes (5680_54)
Odorant-binding protein 2b levels
Odorant-binding protein 2b levels (OBP2B.5680.54.3)
Offspring birth weight
Oily fish consumption
Oleate/vaccenate (18:1) levels in elite athletes
Oleic acid (18:1n-9) levels
Oleoyl ethanolamide levels
Oleoyl ethanolamide levels in elite athletes
Oleoyl glycine levels
Oleoyl glycine levels in chronic kidney disease
Oleoyl leucine levels
Oleoyl phenylalanine levels
Oleoyl serine levels
Oleoyl-arachidonoyl-glycerol (18:1/20:4) [1] levels
Oleoyl-arachidonoyl-glycerol (18:1/20:4) [1] levels in elite athletes
Oleoyl-arachidonoyl-glycerol (18:1/20:4) [2] levels
Oleoyl-arachidonoyl-glycerol (18:1/20:4) [2] levels in elite athletes
Oleoyl-linoleoyl-glycerol (18:1/18:2) [1] levels
Oleoyl-linoleoyl-glycerol (18:1/18:2) [1] levels in elite athletes
Oleoyl-linoleoyl-glycerol (18:1/18:2) [2] levels
Oleoyl-linoleoyl-glycerol (18:1/18:2) [2] levels in elite athletes
Oleoyl-oleoyl-glycerol (18:1/18:1) [1] levels
Oleoyl-oleoyl-glycerol (18:1/18:1) [1] levels in elite athletes
Oleoyl-oleoyl-glycerol (18:1/18:1) [2] levels in elite athletes
Oleoylcarnitine (C18:1) levels
Oleoylcarnitine (C18:1) levels in elite athletes
Oleoylcarnitine levels
Oleoylcarnitine levels (Biocrates platform)
Oleoylcarnitine levels (Metabolon platform)
Oleoylcholine levels in elite athletes
Olfactomedin-4 levels
Olfactomedin-like protein 3 levels
Oligodendrocyte-myelin glycoprotein levels
Oligophrenin-1 levels
Oligoribonuclease, mitochondrial levels
Omega-3 fatty acid levels
Omega-3 fatty acids levels (UKB data field 23444)
Omega-3 fatty acids to total fatty acids percentage (UKB data field 23451)
Omega-6 fatty acid levels
Omega-6 fatty acids levels (UKB data field 23445)
Omega-6 fatty acids to omega-3 fatty acids ratio (UKB data field 23459)
Omega-6 fatty acids to total fatty acids percentage (UKB data field 23452)
Omega-amidase NIT2 levels
Omentin plasma levels
Oncoprotein-induced transcript 3 protein levels
Oncostatin-M levels (OSM.2693.20.3)
Ondansetron-induced QT prolongation
Oocyte-secreted protein 2 levels
Opalin levels
Opalin levels (OPALIN.7736.28.3)
Open-angle glaucoma and vertical cup-disc ratio
Ophthalmic complications in type 2 diabetes
Opioid addiction
Opioid addiction (multi-trait analysis)
Opioid analgesic dose requirement in cancer pain treatment
Opioid dependence
Opioid dependence x sex interaction
Opioid exposure
Opioid overdose severity score
Opioid sensitivity
Opioid use cessation
Opioid use disorder
Opioid use disorder (broad)
Opioid use disorder (MTAG)
Opioid use disorder vs exposed controls
Opioid-binding protein/cell adhesion molecule levels
Opiorphin prepropeptide levels
Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder
Optic cup area
Optic disc area
Optic disc parameters
Optic disc radius
Optic disc size
Optic nerve head parameters (multi-trait analysis)
Optic nerve measurement (cup area)
Optic nerve measurement (cup-to-disc ratio)
Optic nerve measurement (disc area)
Optic nerve measurement (rim area)
Opticin levels
Oral cancer-overexpressed protein 1 level in Chronic kidney disease with hypertension and no diabetes (18195_3)
Oral cancer-overexpressed protein 1 levels
Oral cavity and pharyngeal cancer
Oral cavity cancer
Oral corticosteroid burst in asthma
Oral microbiome beta diversity (Bray-Curtis) in oral squamous cell carcinoma
Oral microbiome beta diversity (Euclidian distance) in oral squamous cell carcinoma
Oral microbiota abundance (Kingella) in oral squamous cell carcinoma
Orange juice liking
Oranges liking
Orbital telorism
Ornithine carbamoyltransferase, mitochondrial levels
Ornithine decarboxylase antizyme 1 levels
Ornithine decarboxylase levels
Ornithine levels
Ornithine levels in elite athletes
Orofacial cleft x maternal periconceptional multivitamin use interaction (1df)
Orofacial cleft x maternal periconceptional multivitamin use interaction (2df)
Orofacial clefts
Orofacial clefts (maternal alcohol consumption interaction)
Oropharynx cancer
Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer
Orotate levels
Orotate levels in elite athletes
Orotic acid levels
Orotidine levels in elite athletes
Orphan sodium- and chloride-dependent neurotransmitter transporter NTT5 levels
Orthostatic hypotension
Osmotic hemolysis of cold stored red blood cells
Ossification of the posterior longitudinal ligament of the spine
Osteoarthritis
Osteoarthritis (hand, severe)
Osteoarthritis (hip)
Osteoarthritis (hospital diagnosed)
Osteoarthritis (self-reported)
Osteoarthritis (with total hip replacement)
Osteoarthritis (with total knee replacement)
Osteoarthritis biomarkers
Osteoarthritis of the hand
Osteoarthritis of the hip (hospital diagnosed)
Osteoarthritis of the hip (with total joint replacement)
Osteoarthritis of the hip or knee
Osteoarthritis of the hip or knee (hospital diagnosed)
Osteoarthritis of the hip or knee (with total joint replacement)
Osteoarthritis of the knee (with total joint replacement)
Osteoarthrosis (time to event)
Osteocalcin levels
Osteoclast-stimulating factor 1 levels
Osteolysis in total hip arthroplasty
Osteolysis in total hip arthroplasty (time to prosthesis revision)
Osteomodulin levels
Osteonecrosis of the jaw
Osteoporosis
Osteoporosis-related phenotypes
Osteoporosis-related phenotypes (MTAG)
Osteoprotegerin levels
Osteosarcoma
Other erythrocyte phenotypes
Other polyunsaturated fatty acid levels than 18:2
Otitis media
Otitis media (chronic)
Otitis media (chronic/recurrent)
Otitis media (recurrent)
Otoraplin level in Chronic kidney disease with hypertension and no diabetes (15432_1)
Otoraplin levels
Otosclerosis
OTU97_1 (Bacteroides) prevalence
OTU97_100 (Ruminococcaceae) abundance
OTU97_100 (Ruminococcaceae) prevalence
OTU97_101 (Sutterella) abundance
OTU97_101 (Sutterella) prevalence
OTU97_102 (Prevotella) prevalence
OTU97_105 (Ruminococcaceae) abundance
OTU97_105 (Ruminococcaceae) prevalence
OTU97_108 (Phascolarctobacterium) abundance
OTU97_108 (Phascolarctobacterium) prevalence
OTU97_109 (Paraprevotella) prevalence
OTU97_113 (Bacteroidales) abundance
OTU97_113 (Bacteroidales) prevalence
OTU97_117 (Ruminococcus) abundance
OTU97_117 (Ruminococcus) prevalence
OTU97_119 (Desulfovibrio) abundance
OTU97_119 (Desulfovibrio) prevalence
OTU97_126 (Prevotella) prevalence
OTU97_13 (Subdoligranulum) prevalence
OTU97_130 (Butyrivibrio) abundance
OTU97_137 (Catenibacterium) prevalence
OTU97_138 (Oscillibacter) prevalence
OTU97_15 (Parasutterella) abundance
OTU97_150 (Bacteroides) abundance
OTU97_150 (Bacteroides) prevalence
OTU97_16 (Faecalibacterium) abundance
OTU97_16 (Faecalibacterium) prevalence
OTU97_163 (Bacteroides) prevalence
OTU97_17 (Parabacteroides) prevalence
OTU97_173 (Bacteroides) abundance
OTU97_173 (Bacteroides) prevalence
OTU97_19 (Bacteria) prevalence
OTU97_21 (Parasutterella) abundance
OTU97_21 (Parasutterella) prevalence
OTU97_23 (Faecalibacterium) abundance
OTU97_24 (Prevotella) abundance
OTU97_26 (Parasutterella) abundance
OTU97_26 (Parasutterella) prevalence
OTU97_27 (Bacteroides) prevalence
OTU97_277 (Prevotella) abundance
OTU97_277 (Prevotella) prevalence
OTU97_3 (Bacteroides) prevalence
OTU97_30 (Roseburia) abundance
OTU97_30 (Roseburia) prevalence
OTU97_31 (Prevotella) abundance
OTU97_33 (Holdemanella) abundance
OTU97_33 (Holdemanella) prevalence
OTU97_34 (Ruminococcus) abundance
OTU97_354 (Alloprevotella) abundance
OTU97_39 (Proteobacteria) abundance
OTU97_39 (Proteobacteria) prevalence
OTU97_4 (Alistipes) prevalence
OTU97_46 (Lachnospiraceae) prevalence
OTU97_5 (Sutterella) abundance
OTU97_5 (Sutterella) prevalence
OTU97_51 (Barnesiella) abundance
OTU97_53 (Bacteroides) abundance
OTU97_53 (Bacteroides) prevalence
OTU97_56 (Ruminococcaceae) abundance
OTU97_56 (Ruminococcaceae) prevalence
OTU97_58 (Sutterellaceae) prevalence
OTU97_6 (Sutterella) prevalence
OTU97_69 (Clostridiales) abundance
OTU97_7 (Lachnospiraceae) abundance
OTU97_73 (Prevotella) abundance
OTU97_73 (Prevotella) prevalence
OTU97_74 (Alistipes) abundance
OTU97_8 (Ruminococcaceae) abundance
OTU97_8 (Ruminococcaceae) prevalence
OTU97_80 (Ruminococcus) abundance
OTU97_80 (Ruminococcus) prevalence
OTU97_86 (Phascolarctobacterium) abundance
OTU97_86 (Phascolarctobacterium) prevalence
OTU97_95 (Cytophagales) abundance
OTU97_97 (Clostridiales) prevalence
OTU99_1 (Bacteroides) prevalence
OTU99_106 (Barnesiella) abundance
OTU99_106 (Barnesiella) prevalence
OTU99_108 (Cytophagales) abundance
OTU99_11 (Parabacteroides) prevalence
OTU99_110 (Clostridiales) prevalence
OTU99_116 (Sutterella) abundance
OTU99_116 (Sutterella) prevalence
OTU99_120 (Ruminococcaceae) abundance
OTU99_120 (Ruminococcaceae) prevalence
OTU99_123 (Phascolarctobacterium) abundance
OTU99_123 (Phascolarctobacterium) prevalence
OTU99_124 (Paraprevotella) abundance
OTU99_124 (Paraprevotella) prevalence
OTU99_13 (Subdoligranulum) prevalence
OTU99_132 (Bacteroidales) prevalence
OTU99_137 (Ruminococcus) abundance
OTU99_137 (Ruminococcus) prevalence
OTU99_140 (Desulfovibrio) abundance
OTU99_150 (Prevotella) prevalence
OTU99_155 (Butyrivibrio) abundance
OTU99_157 (Barnesiella) prevalence
OTU99_166 (Prevotella) abundance
OTU99_166 (Prevotella) prevalence
OTU99_17 (Parabacteroides) prevalence
OTU99_19 (Bacteria) prevalence
OTU99_21 (Parasutterella) prevalence
OTU99_211 (Bacteroides) prevalence
OTU99_23 (Faecalibacterium) abundance
OTU99_23 (Faecalibacterium) prevalence
OTU99_26 (Parasutterella) abundance
OTU99_26 (Parasutterella) prevalence
OTU99_271 (Prevotella) abundance
OTU99_3 (Bacteroides) prevalence
OTU99_30 (Parasutterella) abundance
OTU99_30 (Parasutterella) prevalence
OTU99_32 (Prevotella) abundance
OTU99_34 (Holdemanella) abundance
OTU99_34 (Holdemanella) prevalence
OTU99_35 (Ruminococcus) abundance
OTU99_39 (Alphaproteobacteria) abundance
OTU99_39 (Alphaproteobacteria) prevalence
OTU99_4 (Alistipes) prevalence
OTU99_40 (Proteobacteria) abundance
OTU99_40 (Proteobacteria) prevalence
OTU99_45 (Faecalibacterium) prevalence
OTU99_47 (Prevotella) abundance
OTU99_47 (Prevotella) prevalence
OTU99_5 (Sutterella) abundance
OTU99_5 (Sutterella) prevalence
OTU99_54 (Holdemanella) abundance
OTU99_55 (Barnesiella) abundance
OTU99_55 (Barnesiella) prevalence
OTU99_558 (Bacteroidales) abundance
OTU99_558 (Bacteroidales) prevalence
OTU99_58 (Bacteroides) abundance
OTU99_58 (Bacteroides) prevalence
OTU99_59 (Prevotella) abundance
OTU99_6 (Sutterella) prevalence
OTU99_62 (Ruminococcaceae) abundance
OTU99_62 (Ruminococcaceae) prevalence
OTU99_65 (Sutterellaceae) prevalence
OTU99_7 (Lachnospiraceae) abundance
OTU99_8 (Ruminococcaceae) abundance
OTU99_8 (Ruminococcaceae) prevalence
OTU99_84 (Prevotella) abundance
OTU99_85 (Alistipes) abundance
OTU99_85 (Alistipes) prevalence
OTU99_92 (Ruminococcus) abundance
OTU99_92 (Ruminococcus) prevalence
OTU99_98 (Phascolarctobacterium) prevalence
Out at first protein homolog levels
Out at first protein homolog levels (OAF.6414.8.3)
Ovarian cancer
Ovarian cancer (MTAG)
Ovarian cancer G-protein coupled receptor 1 level in Chronic kidney disease with hypertension and no diabetes (12503_5)
Ovarian cancer G-protein coupled receptor 1 levels
Ovarian cancer in BRCA1 mutation carriers
Ovarian cancer in BRCA2 mutation carriers
Ovarian cyst
Ovarian disease with few adhesions
Ovarian reserve
Overall survival in advanced colorectal cancer
Overall survival in breast cancer
Overall survival in breast cancer treated with chemotherapy (excluding Par-4 dependent chemotherapy)
Overall survival in breast cancer treated with Par-4 dependent chemotherapy
Overall survival in osteosarcoma
Overall survival in ovarian cancer
Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin
Overweight status
OX-2 membrane glycoprotein levels
Oxaliplatin-induced allergic reactions in colon cancer
Oxaliplatin-induced allergic reactions in colon cancer (extreme)
Oxaliplatin-induced peripheral sensory neuropathy in colon cancer
Oxaloacetic acid levels
Oxidized cholesteryl ester (18:2) [+O] levels
Oxidized LDL cholesterol levels
Oxidized Protein deglycase DJ-1 levels
Oxidoreductase HTATIP2 level in Chronic kidney disease with hypertension and no diabetes (7753_21)
Oxidoreductase HTATIP2 levels
Oxidoreductase HTATIP2 levels (HTATIP2.7753.21.3)
Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial levels
Oxysterols receptor LXR-beta level in Chronic kidney disease with hypertension and no diabetes (9016_12)
Oxysterols receptor LXR-beta levels
Oxysterols receptor LXR-beta levels (NR1H2.9016.12.3)
Oxytocin-neurophysin 1 levels
P wave duration
P wave terminal force
P_Actinobacteria abundance
P_Firmicutes abundance
P_Proteobacteria abundance
P-cresol glucuronide levels
P-cresol sulfate levels in elite athletes
P-cresol-glucuronide levels
P-selectin glycoprotein ligand 1 levels
P-selectin level in Chronic kidney disease with hypertension and no diabetes (4154_57)
P-selectin levels
P-selectin levels (SELP.4154.57.2)
p53 and DNA damage-regulated protein 1 levels
Paceibacteria abundance in stool
Paclitaxel disposition in epithelial ovarian cancer
Paclitaxel-induced cytotoxicity
Paclitaxel-induced neuropathy
Paediatric migraine
Paget's disease
Pain
Pain medicine use during menstruation
Pain sensitivity measurement (Pain Sensitivity Questionnaire)
Paired box protein Pax-4 levels
Paired immunoglobulin-like type 2 receptor alpha isoform FDF03-deltaTM level in Chronic kidney disease with hypertension and no diabetes (6402_8)
Paired immunoglobulin-like type 2 receptor alpha isoform FDF03-deltaTM levels
Paired immunoglobulin-like type 2 receptor alpha isoform FDF03-M14 levels
Paired immunoglobulin-like type 2 receptor alpha levels
Paired immunoglobulin-like type 2 receptor alpha levels (PILRA.8683.119.3)
Paired immunoglobulin-like type 2 receptor beta levels
Pallidum volume
Pallidum volume change rate
Pallidum volume change rate x age interaction (1df)
Pallidum volume change rate x age interaction (2df)
Palmdelphin level in Chronic kidney disease with hypertension and no diabetes (22059_56)
Palmitate (16:0) levels in elite athletes
Palmitic acid (16:0) levels
Palmitoleic acid (16:1n-7) levels
Palmitoleoyl-arachidonoyl-glycerol (16:1/20:4) [2] levels in elite athletes
Palmitoleoyl-linoleoyl-glycerol (16:1/18:2) [1] levels
Palmitoleoyl-linoleoyl-glycerol (16:1/18:2) [1] levels in elite athletes
Palmitoleoyl-protein carboxylesterase NOTUM levels
Palmitoleoylcarnitine (C16:1) levels
Palmitoleoylcarnitine (C16:1) levels in elite athletes
Palmitoleoylcarnitine levels
Palmitoloelycholine levels in elite athletes
Palmitoyl dihydrosphingomyelin (d18:0/16:0) levels in elite athletes
Palmitoyl ethanolamide levels in elite athletes
Palmitoyl-arachidonoyl-glycerol (16:0/20:4) [1] levels in elite athletes
Palmitoyl-arachidonoyl-glycerol (16:0/20:4) [2] levels
Palmitoyl-linoleoyl-glycerol (16:0/18:2) [1] levels in elite athletes
Palmitoyl-linoleoyl-glycerol (16:0/18:2) [2] levels in elite athletes
Palmitoyl-oleoyl-glycerol (16:0/18:1) [1] levels in elite athletes
Palmitoyl-oleoyl-glycerol (16:0/18:1) [2] levels in elite athletes
Palmitoyl-protein thioesterase 1 levels
Palmitoyl-protein thioesterase 1 levels (PPT1.9244.27.3)
Palmitoylcarnitine (C16) levels
Palmitoylcarnitine (C16) levels in elite athletes
Palmitoylcarnitine levels
Palmitoylcarnitine levels (Biocrates platform)
Palmitoylcarnitine levels (Metabolon platform)
Palmitoylcholine levels in elite athletes
Pancreas fat
Pancreas volume
Pancreatic beta-cell glucose sensitivity
Pancreatic cancer
Pancreatic ductal adenocarcinoma
Pancreatic hormone levels
Pancreatic lipase-related protein 2 level in Chronic kidney disease with hypertension and no diabetes (15471_29)
Pancreatic lipase-related protein 2 level in Chronic kidney disease with hypertension and no diabetes (6957_14)
Pancreatic lipase-related protein 2 levels
Pancreatic triacylglycerol lipase levels
Pancreatitis
Paneth cell defects in Crohn's disease
Panic disorder
Pantothenate levels
Pantothenate levels in elite athletes
Papillary thyroid cancer
Pappalysin-1 levels
Pappalysin-2 levels
Paracentral lobule volume
Parachlamydiales abundance in stool
Paraglaciecola abundance in stool
Parahippocampal gyrus volume
Paralemmin-1 levels
Paraoxonase activity
Paraoxonase levels
Parasitemia in Tripanosoma cruzi seropositivity
Parathion levels
Parathyroid hormone-related protein levels
Parathyroid hormone-related protein levels (PTHLH.2962.50.2)
Paraxanthine levels
Paraxanthine levels in elite athletes
PARC plasma levels
Parenchymal hematoma in thrombolytic-treated acute ischaemic stroke
Parent of origin effect on language impairment (paternal)
Parent of origin effect on receptive language ability (paternal)
Parental extreme longevity (95 years and older)
Parental lifespan
Parental longevity (both parents in top 10%)
Parental longevity (combined parental age at death)
Parental longevity (combined parental attained age, Martingale residuals)
Parental longevity (father's age at death or father's attained age)
Parental longevity (father's age at death)
Parental longevity (father's attained age)
Parental longevity (mother's age at death or mother's attained age)
Parental longevity (mother's age at death)
Parental longevity (mother's attained age)
Parkinson disease (MTAG)
Parkinson disease and lewy body pathology
Parkinson's disease
Parkinson's disease (age of onset)
Parkinson's disease (familial)
Parkinson's disease (motor and cognition)
Parkinson's disease in GBA mutation carriers
Parkinson's disease motor subtype (tremor dominant vs postural instability/gait difficulty)
Parkinson's disease motor subtype (tremor to postural instability/gait difficulty score ratio)
Parkinson's disease or first degree relation to individual with Parkinson's disease
Parkinson's disease progression (cognitive)
Parkinson's disease progression (composite)
Parkinson's disease progression (motor)
Parkinsonism in frontotemporal lobe dementia
Pars opercularis volume
Pars orbitalis volume
Pars triangularis volume
Partial epilepsies
Participation in an health questionnaire (not invited vs invited)
Patatin-like phospholipase domain-containing protein 2 level in Chronic kidney disease with hypertension and no diabetes (9802_27)
Patatin-like phospholipase domain-containing protein 2 levels
Paternal history of Alzheimer's disease
Pathological gambling
PAX-interacting protein 1 levels
PAX-interacting protein 1 levels (PAXIP1.12894.3.3)
PAXIP1-associated protein 1 level in Chronic kidney disease with hypertension and no diabetes (23967_8)
PC4 and SFRS1-interacting protein levels
PCA3 expression level
PCNA-associated factor levels
PCSK9 levels
PDL-1 on CD14- CD16+ monocyte
PDL-1 on CD14+ CD16- monocyte
PDL-1 on CD14+ CD16+ monocyte
PDL-1 on monocyte
PDZ and LIM domain protein 1 levels
PDZ and LIM domain protein 4 levels
PDZ domain-containing protein GIPC2 level in Chronic kidney disease with hypertension and no diabetes (20921_1)
Peak creatinine levels in vancomycin therapy
Peak expiratory flow
Peak hip bone mineral content
Peak insulin response
Peak plasma concentration of rosuvastatin
Peak velocity of the mitral A-wave
Peanut allergy
Peanut allergy (maternal genetic effects)
Peanut allergy (parent-of-origin effect)
PEDF plasma levels
Pediatric areal bone mineral density (concordant skeletal phenotype)
Pediatric areal bone mineral density (radius vs spine & hip discordant skeletal phenotype)
Pediatric areal bone mineral density (radius)
Pediatric asthma
Pediatric autoimmune diseases
Pediatric bone mineral content (femoral neck)
Pediatric bone mineral content (hip)
Pediatric bone mineral content (radius)
Pediatric bone mineral content (spine)
Pediatric bone mineral density (femoral neck)
Pediatric bone mineral density (hip)
Pediatric bone mineral density (spine)
Pediatric central nervous system tumors (early onset)(pleiotropy)
Pediatric central nervous system tumors (late onset)(pleiotropy)
Pediatric central nervous system tumors (pleiotropy)
Pediatric dental caries (decayed, missing and filled teeth >5)
Pediatric non-alcoholic fatty liver disease activity score
Pediatric steroid sensitive nephrotic syndrome
Peflin levels
PEG-asparaginase hypersensitivity without enzyme activity in childhood acute lymphoblastic leukaemia
Peginterferon alfa-2a treatment response in chronic hepatitis B infection
Pelvic organ prolapse
Pelvic organ prolapse (moderate/severe)
Penn alcohol craving scale in alcohol dependence (recessive genetic model)
Pentachlorophenol levels
Pentadecanoate (15:0) levels in elite athletes
Pentose acid levels
Pentraxin-related protein PTX3 levels
Pepsinogen I/II ratio
Peptic ulcer disease
Peptidase inhibitor 15 levels
Peptide chain release factor 1-like, mitochondrial levels
Peptide chain release factor 1-like, mitochondrial levels (MTRF1L.11134.30.3)
Peptide YY levels
Peptidoglycan recognition protein 1 levels
Peptidoglycan recognition protein 1 levels (PGLYRP1.3329.14.2)
Peptidoglycan recognition protein 3 levels
Peptidyl-glycine alpha-amidating monooxygenase levels
Peptidyl-glycine alpha-amidating monooxygenase levels (PAM.5620.13.3)
Peptidyl-prolyl cis-trans isomerase C level in Chronic kidney disease with hypertension and no diabetes (18819_21)
Peptidyl-prolyl cis-trans isomerase C levels
Peptidyl-prolyl cis-trans isomerase D levels
Peptidyl-prolyl cis-trans isomerase E levels
Peptidyl-prolyl cis-trans isomerase E levels (PPIE.5238.26.3)
Peptidyl-prolyl cis-trans isomerase FKBP14 levels
Peptidyl-prolyl cis-trans isomerase FKBP1B levels
Peptidyl-prolyl cis-trans isomerase FKBP2 levels
Peptidyl-prolyl cis-trans isomerase FKBP3 levels
Peptidyl-prolyl cis-trans isomerase FKBP4 levels
Peptidyl-prolyl cis-trans isomerase FKBP7 levels
Peptidyl-prolyl cis-trans isomerase G level in Chronic kidney disease with hypertension and no diabetes (18449_33)
Peptidyl-prolyl cis-trans isomerase G levels
Peptidyl-prolyl cis-trans isomerase H levels
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 levels
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 levels
Peptidyl-prolyl cis-trans isomerase-like 2 levels (PPIL2.14314.6.3)
Peptidyl-tRNA hydrolase ICT1, mitochondrial levels
Perceived intensity of aspartame
Perceived intensity of glucose
Perceived intensity of neohesperidin dihydrochalcone
Perceived intensity of sucrose
Perceived intensity of sweet substances
Perceived skin darkness
Perceived sweetness of sucrose
Perceived unattractiveness to mosquitoes
Percent glycated albumin
Percent liver fat
Percent mammographic density
Percent phonemes correct for nonsense word repetition
Percentage gas trapping
Percentage of invited food questionnaires completed
Perceptual and visual search speed (trail making test A)
perceptual and visual search speed (trail making test A) (age interaction)
Peregrin levels
Perfluorooctanesulfonate (PFOS) levels
Perfluorooctanesulfonic acid (PFOS) levels in elite athletes
Performance intelligence quotient (cesarean section interaction)
Pericalcarine cortex volume
Pericardial adipose tissue adjusted for height and weight
Pericardial fat
Perinatal depression
Periodic limb movement in sleep
Periodic limb movement index
Periodontal disease related phenotype (PCT4)
Periodontal disease-related phenotype (Socransky)
Periodontal microbiota
Periodontal pocket (adjusted for age and sex)
Periodontal pocket (adjusted for age, sex and smoking status)
Periodontal pocket (adjusted for age, sex, smoking status and plaque)
Periodontitis
Periodontitis (CDC/AAP)
Periodontitis (DPAL)
Periodontitis (Mean PAL)
Periodontitis (PAL4Q3)
Periodontitis (stage III/IV grade C)
Perioperative myocardial infarction in coronary artery bypass surgery
Periostin levels
Peripheral arterial disease (traffic-related air pollution interaction)
Peripheral artery disease
Peripheral artery disease (borderline)
Peripheral artery disease in ever smokers
Peripheral artery disease in non diabetes
Peripheral blood CD34+ cell levels
Peritoneal solute transfer rates in kidney failure treated with peritoneal dialysis
Periventricular white matter hyperintensities
Permanent dental caries (decayed and filled teeth)
Permanent tooth development
Peroxidasin homolog levels
Peroxiredoxin-1 levels
Peroxisomal 2,4-dienoyl-CoA reductase levels
Peroxisomal NADH pyrophosphatase NUDT12 levels
Peroxisomal NADH pyrophosphatase NUDT12 levels (NUDT12.13947.371.3)
Peroxisomal trans-2-enoyl-CoA reductase levels
Peroxisome proliferator-activated receptor alpha level in Chronic kidney disease with hypertension and no diabetes (12954_71)
Peroxisome proliferator-activated receptor alpha levels
Peroxisome proliferator-activated receptor gamma coactivator 1-alpha levels
Personality dimensions
Personality traits in bipolar disorder
Persulfide dioxygenase ETHE1, mitochondrial levels
PEST proteolytic signal-containing nuclear protein levels
PH and SEC7 domain-containing protein 1 levels
PH and SEC7 domain-containing protein 1 levels (PSD.13055.53.3)
PH and SEC7 domain-containing protein 2 levels
PH and SEC7 domain-containing protein 2 levels (PSD2.9118.7.3)
Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)
Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)
PHD finger protein 3 levels
Phenol sulfate levels in elite athletes
Phenylacetate levels
Phenylacetate levels in elite athletes
Phenylacetylcarnitine levels
Phenylacetylglutamate levels
Phenylacetylglutamate levels in elite athletes
Phenylacetylglutamine levels in elite athletes
Phenylalanine levels
Phenylalanine levels (Biocrates platform)
Phenylalanine levels (UKB data field 23468)
Phenylalanine levels in elite athletes
Phenylalanine--tRNA ligase, mitochondrial levels
Phenylalanylphenylalanine levels
Phenylalanyltryptophan levels
Phenylephrine infusion rate during anesthesia
Phenyllactate (pla) levels
Phenyllactate (PLA) levels in elite athletes
Phenyllactate-to-phenylalanine ratio
Phenylpyruvate levels
Philtrum width
Phocea abundance in stool
Phocea massiliensis abundance in stool
Phoneme awareness
Phonological awareness (Elision)
Phosphate levels (UKB data field 30810)
Phosphate levels in elite athletes
Phosphate-regulating neutral endopeptidase levels
Phosphate-to-erythronate ratio
Phosphatidate phosphatase PPAPDC1A levels
Phosphatidate_34:2_[M-H]1- levels
Phosphatidate(34:2)_[M-H]1- levels
Phosphatidate(39:1)_[M+H]1+ levels
Phosphatidate(40:5)_[M+OAc]1-/Phosphatidylglycerol(39:5)_[M-H]1- levels
Phosphatidate(41:2)_[M+H]1+ levels
Phosphatidate(43:4)_[M-H]1- levels
Phosphatidate(43:6)_[M-H]1- levels
Phosphatidate(44:6)_[M+OAc]1-/Phosphatidylglycerol(43:6)_[M-H]1- levels
Phosphatidate(45:6)_[M-H]1- levels
Phosphatidylcholine (14:0_20:4) levels
Phosphatidylcholine (14:0_22:6) levels
Phosphatidylcholine (15-MHDA_18:1) levels
Phosphatidylcholine (15-MHDA_18:2) levels
Phosphatidylcholine (15-MHDA_20:4) levels
Phosphatidylcholine (15:0_20:3) levels
Phosphatidylcholine (15:0_20:4) levels
Phosphatidylcholine (15:0_22:6) levels
Phosphatidylcholine (16:0_16:0) levels
Phosphatidylcholine (16:0_18:0) levels
Phosphatidylcholine (16:0_18:2) levels
Phosphatidylcholine (16:0_18:3) (a) levels
Phosphatidylcholine (16:0_20:3) (a) levels
Phosphatidylcholine (16:0_20:3) (b) levels
Phosphatidylcholine (16:0_20:4) levels
Phosphatidylcholine (16:0_20:5) levels
Phosphatidylcholine (16:0_22:6) levels
Phosphatidylcholine (16:0/22:5n3, 18:1/20:4) levels
Phosphatidylcholine (16:1_18:2) levels
Phosphatidylcholine (16:1_20:4) levels
Phosphatidylcholine (17:0_18:2) levels
Phosphatidylcholine (17:0_20:4) levels
Phosphatidylcholine (17:0_22:6) levels
Phosphatidylcholine (17:1_18:2) levels
Phosphatidylcholine (18:0_18:1) levels
Phosphatidylcholine (18:0_18:2) levels
Phosphatidylcholine (18:0_20:3) levels
Phosphatidylcholine (18:0_20:4) levels
Phosphatidylcholine (18:0_22:4) levels
Phosphatidylcholine (18:0_22:5) (n3) levels/Phosphatidylcholine (20:1_20:4) levels
Phosphatidylcholine (18:0_22:5) (n6) levels
Phosphatidylcholine (18:0_22:6) levels
Phosphatidylcholine (18:0/20:2, 20:0/18:2, 18:1/20:1) levels
Phosphatidylcholine (18:0/20:2, 20:0/18:2) levels
Phosphatidylcholine (18:0/20:5, 16:0/22:5n6) levels
Phosphatidylcholine (18:1_18:1) levels
Phosphatidylcholine (18:1_18:2) levels
Phosphatidylcholine (18:1_20:3) levels
Phosphatidylcholine (18:1_22:6) (a) levels
Phosphatidylcholine (18:2_18:2) levels
Phosphatidylcholine (18:2_20:5) levels
Phosphatidylcholine (20:0_20:4) levels
Phosphatidylcholine (28:0) levels
Phosphatidylcholine (31:0) (a) levels
Phosphatidylcholine (32:2) levels
Phosphatidylcholine (33:0) (b) levels
Phosphatidylcholine (33:1) levels
Phosphatidylcholine (33:2) levels
Phosphatidylcholine (34:5) levels
Phosphatidylcholine (35:5) levels
Phosphatidylcholine (36:0) levels
Phosphatidylcholine (36:6) (a) levels
Phosphatidylcholine (38:2) levels
Phosphatidylcholine (38:4) (b) levels
Phosphatidylcholine (38:5) (a) levels
Phosphatidylcholine (38:5) (b) levels
Phosphatidylcholine (38:6) (a) levels
Phosphatidylcholine (38:7) (c) levels
Phosphatidylcholine (39:5) (a) levels
Phosphatidylcholine (39:5) (b) levels
Phosphatidylcholine (40:7) (a) levels
Phosphatidylcholine (40:8) levels
Phosphatidylcholine (O-18:1/20:4, O-16:0/22:5n3) levels
Phosphatidylcholine acyl-alkyl C30:1 levels
Phosphatidylcholine acyl-alkyl C30:2 levels
Phosphatidylcholine acyl-alkyl C32:1 levels
Phosphatidylcholine acyl-alkyl C32:2 levels
Phosphatidylcholine acyl-alkyl C34:1 levels
Phosphatidylcholine acyl-alkyl C34:2 levels
Phosphatidylcholine acyl-alkyl C34:3 levels
Phosphatidylcholine acyl-alkyl C36:2 levels
Phosphatidylcholine acyl-alkyl C36:3 levels
Phosphatidylcholine acyl-alkyl C36:4 levels
Phosphatidylcholine acyl-alkyl C36:5 levels
Phosphatidylcholine acyl-alkyl C38:0 levels
Phosphatidylcholine acyl-alkyl C38:1 levels
Phosphatidylcholine acyl-alkyl C38:2 levels
Phosphatidylcholine acyl-alkyl C38:3 levels
Phosphatidylcholine acyl-alkyl C38:4 levels
Phosphatidylcholine acyl-alkyl C38:5 levels
Phosphatidylcholine acyl-alkyl C38:6 levels
Phosphatidylcholine acyl-alkyl C40:1 levels
Phosphatidylcholine acyl-alkyl C40:2 levels
Phosphatidylcholine acyl-alkyl C40:3 levels
Phosphatidylcholine acyl-alkyl C40:4 levels
Phosphatidylcholine acyl-alkyl C40:5 levels
Phosphatidylcholine acyl-alkyl C40:6 levels
Phosphatidylcholine acyl-alkyl C42:1 levels
Phosphatidylcholine acyl-alkyl C42:2 levels
Phosphatidylcholine acyl-alkyl C42:3 levels
Phosphatidylcholine acyl-alkyl C42:4 levels
Phosphatidylcholine acyl-alkyl C42:5 levels
Phosphatidylcholine acyl-alkyl C44:5 levels
Phosphatidylcholine acyl-alkyl C44:6 levels
Phosphatidylcholine diacyl C24:0 levels
Phosphatidylcholine diacyl C26:0 levels
Phosphatidylcholine diacyl C28:1 levels
Phosphatidylcholine diacyl C30:0 levels
Phosphatidylcholine diacyl C32:0 levels
Phosphatidylcholine diacyl C32:1 levels
Phosphatidylcholine diacyl C32:2 levels
Phosphatidylcholine diacyl C34:1 levels
Phosphatidylcholine diacyl C34:2 levels
Phosphatidylcholine diacyl C34:3 levels
Phosphatidylcholine diacyl C34:4 levels
Phosphatidylcholine diacyl C36:0 levels
Phosphatidylcholine diacyl C36:2 levels
Phosphatidylcholine diacyl C36:3 levels
Phosphatidylcholine diacyl C36:4 levels
Phosphatidylcholine diacyl C36:5 levels
Phosphatidylcholine diacyl C36:6 levels
Phosphatidylcholine diacyl C38:0 levels
Phosphatidylcholine diacyl C38:3 levels
Phosphatidylcholine diacyl C38:4 levels
Phosphatidylcholine diacyl C38:5 levels
Phosphatidylcholine diacyl C38:6 levels
Phosphatidylcholine diacyl C40:2 levels
Phosphatidylcholine diacyl C40:3 levels
Phosphatidylcholine diacyl C40:4 levels
Phosphatidylcholine diacyl C40:5 levels
Phosphatidylcholine diacyl C40:6 levels
Phosphatidylcholine diacyl C42:0 levels
Phosphatidylcholine diacyl C42:1 levels
Phosphatidylcholine diacyl C42:4 levels
Phosphatidylcholine diacyl C42:5 levels
Phosphatidylcholine diacyl C42:6 levels
Phosphatidylcholine levels
Phosphatidylcholine plasmalogen C38:6 levels
Phosphatidylcholine_31:2_[M+H]1+/Phosphatidylethanolamine_34:2_[M+H]1+/Phosphatidate_36:3_[M+NH4]1+ levels
Phosphatidylcholine_32:0_[M+H]1+/Phosphatidylethanolamine_35:0_[M+H]1+/Phosphatidate_37:1_[M+NH4]1+ levels
Phosphatidylcholine_32:0_[M+OAc]1- levels
Phosphatidylcholine_32:2_[M+H]1+/Phosphatidylethanolamine_35:2_[M+H]1+/Phosphatidate_37:3_[M+NH4]1+ levels
Phosphatidylcholine_33:2_[M+OAc]1-/Phosphatidylserine_37:1_[M-H]1- levels
Phosphatidylcholine_33:4_[M+H]1+/Phosphatidylethanolamine_36:4_[M+H]1+/Phosphatidate_38:5_[M+NH4]1+ levels
Phosphatidylcholine_34:0_[M+H]1+/Phosphatidylethanolamine_37:0_[M+H]1+/Phosphatidate_39:1_[M+NH4]1+ levels
Phosphatidylcholine_34:1_[M+H]1+/Phosphatidylethanolamine_37:1_[M+H]1+/Phosphatidate_39:2_[M+NH4]1+ levels
Phosphatidylcholine_34:2_[M+H]1+/Phosphatidylethanolamine_37:2_[M+H]1+/Phosphatidate_39:3_[M+NH4]1+ levels
Phosphatidylcholine_34:2_[M+OAc]1-/Phosphatidylserine_38:1_[M-H]1- levels
Phosphatidylcholine_34:3_[M+H]1+/Phosphatidylethanolamine_37:3_[M+H]1+/Phosphatidate_39:4_[M+NH4]1+ levels
Phosphatidylcholine_34:4_[M+H]1+/Phosphatidylethanolamine_37:4_[M+H]1+/Phosphatidate_39:5_[M+NH4]1+ levels
Phosphatidylcholine_35:2_[M+H]1+/Phosphatidylethanolamine_38:2_[M+H]1+/Phosphatidate_40:3_[M+NH4]1+ levels
Phosphatidylcholine_35:3_[M+H]1+/Phosphatidylethanolamine_38:3_[M+H]1+/Phosphatidate_40:4_[M+NH4]1+ levels
Phosphatidylcholine_35:4_[M+H]1+/Phosphatidylethanolamine_38:4_[M+H]1+/Phosphatidate_40:5_[M+NH4]1+ levels
Phosphatidylcholine_35:5_[M+OAc]1-/Phosphatidylserine_39:4_[M-H]1- levels
Phosphatidylcholine_35:6_[M+H]1+/Phosphatidylethanolamine_38:6_[M+H]1+/Phosphatidate_40:7_[M+NH4]1+ levels
Phosphatidylcholine_36:0_[M+OAc]1- levels
Phosphatidylcholine_36:1_[M+H]1+/Phosphatidylethanolamine_39:1_[M+H]1+/Phosphatidate_41:2_[M+NH4]1+ levels
Phosphatidylcholine_36:2_[M+OAc]1-/Phosphatidylserine_40:1_[M-H]1- levels
Phosphatidylcholine_36:3_[M+H]1+/Phosphatidylethanolamine_39:3_[M+H]1+/Phosphatidate_41:4_[M+NH4]1+ levels
Phosphatidylcholine_36:5_[M+H]1+/Phosphatidylethanolamine_39:5_[M+H]1+/Phosphatidate_41:6_[M+NH4]1+ levels
Phosphatidylcholine_37:3_[M+OAc]1-/Phosphatidylserine_41:2_[M-H]1- levels
Phosphatidylcholine_37:4_[M+H]1+/Phosphatidylethanolamine_40:4_[M+H]1+/Phosphatidate_42:5_[M+NH4]1+ levels
Phosphatidylcholine_37:5_[M+H]1+/Phosphatidylethanolamine_40:5_[M+H]1+/Phosphatidate_42:6_[M+NH4]1+ levels
Phosphatidylcholine_37:6_[M+H]1+/Phosphatidylethanolamine_40:6_[M+H]1+/Phosphatidate_42:7_[M+NH4]1+ levels
Phosphatidylcholine_38:2_[M+H]1+/Phosphatidylethanolamine_41:2_[M+H]1+ levels
Phosphatidylcholine_38:3_[M+H]1+/Phosphatidylethanolamine_41:3_[M+H]1+/Phosphatidate_43:4_[M+NH4]1+ levels
Phosphatidylcholine_38:5_[M+H]1+/Phosphatidylethanolamine_41:5_[M+H]1+/Phosphatidate_43:6_[M+NH4]1+ levels
Phosphatidylcholine_38:6_[M+H]1+/Phosphatidylethanolamine_41:6_[M+H]1+ levels
Phosphatidylcholine_39:6_[M+OAc]1- levels
Phosphatidylcholine_40:4_[M+H]1+/Phosphatidylethanolamine_43:4_[M+H]1+ levels
Phosphatidylcholine_40:5_[M+H]1+ levels
Phosphatidylcholine_40:6_[M+H]1+/Phosphatidylethanolamine_43:6_[M+H]1+ levels
Phosphatidylcholine_40:6_[M+OAc]1-/Phosphatidylserine_44:5_[M-H]1- levels
Phosphatidylcholine_40:7_[M+H]1+ levels
Phosphatidylcholine_40:7_[M+OAc]1-/Phosphatidylserine_44:6_[M-H]1- levels
Phosphatidylcholine_42:4_[M+OAc]1- levels
Phosphatidylcholine_44:5_[M+OAc]1- levels
Phosphatidylcholine_52:4_[M+OAc]1- levels
Phosphatidylcholine-2O_32:0_[M+H]1+ levels
Phosphatidylcholine-ether levels
Phosphatidylcholine-O_18:0_[M+H]1+/Lysophosphatidylethanolamine_21:0_[M+H]1+ levels
Phosphatidylcholine-O_30:1_[M+H]1+/Phosphatidylcholine-P_30:0_[M+H]1+/Phosphatidylethanolamine-O_33:1_[M+H]1+ levels
Phosphatidylcholine-O_31:0_[M+H]1+/Phosphatidylethanolamine-O_34:0_[M+H]1+ levels
Phosphatidylcholine-O_32:1_[M+H]1+/Phosphatidylcholine-P_32:0_[M+H]1+/Phosphatidylethanolamine-O_35:1_[M+H]1+ levels
Phosphatidylcholine-O_33:3_[M+H]1+/Phosphatidylcholine-P_33:2_[M+H]1+/Phosphatidylethanolamine-O_36:3_[M+H]1+ levels
Phosphatidylcholine-O_34:1_[M+H]1+/Phosphatidylcholine-P_34:0_[M+H]1+/Phosphatidylethanolamine-O_37:1_[M+H]1+ levels
Phosphatidylcholine-O_34:2_[M+H]1+/Phosphatidylcholine-P_34:1_[M+H]1+/Phosphatidylethanolamine-O_37:2_[M+H]1+ levels
Phosphatidylcholine-O_34:3_[M+H]1+/Phosphatidylcholine-P_34:2_[M+H]1+/Phosphatidylethanolamine-P_37:2_[M+H]1+ levels
Phosphatidylcholine-O_35:4_[M+OAc]1-/Phosphatidylcholine-P_35:3_[M+OAc]1- levels
Phosphatidylcholine-O_36:1_[M+H]1+/Phosphatidylcholine-P_36:0_[M+H]1+/Phosphatidylethanolamine-O_39:1_[M+H]1+ levels
Phosphatidylcholine-O_36:2_[M+H]1+/Phosphatidylcholine-P_36:1_[M+H]1+/Phosphatidylethanolamine-P_39:1_[M+H]1+ levels
Phosphatidylcholine-O_36:3_[M+H]1+/Phosphatidylcholine-P_36:2_[M+H]1+ levels
Phosphatidylcholine-O_36:4_[M+H]1+/Phosphatidylcholine-P_36:3_[M+H]1+ levels
Phosphatidylcholine-O_38:4_[M+H]1+/Phosphatidylcholine-P_38:3_[M+H]1+ levels
Phosphatidylcholine-O_38:5_[M+H]1+/Phosphatidylcholine-P_38:4_[M+H]1+ levels
Phosphatidylcholine-O_40:5_[M+H]1+/Phosphatidylcholine-P_40:4_[M+H]1+ levels
Phosphatidylcholine-O_40:6_[M+H]1+/Phosphatidylcholine-P_40:5_[M+H]1+ levels
Phosphatidylcholine-O_42:6_[M+OAc]1-/Phosphatidylcholine-P_42:5_[M+OAc]1- levels
Phosphatidylcholine-O_44:5_[M+H]1+/Phosphatidylcholine-P_44:4_[M+H]1+ levels
Phosphatidylcholine-O_44:5_[M+OAc]1-/Phosphatidylcholine-P_44:4_[M+OAc]1- levels
Phosphatidylcholine-O(32:0)_[M+H]1+/Phosphatidylethanolamine-O(35:0)_[M+H]1+ levels
Phosphatidylcholine-O(34:1)_[M+H]1+/Phosphatidylcholine-P(34:0)_[M+H]1+/Phosphatidylethanolamine-O(37:1)_[M+H]1+ levels
Phosphatidylcholine-O(34:3)_[M+H]1+/Phosphatidylethanolamine-P(37:2)_[M+H]1+ levels
Phosphatidylcholine-O(36:1)_[M+H]1+/Phosphatidylethanolamine-O(39:1)_[M+H]1+/Phosphatidylcholine-P(36:0)_[M+H]1+ levels
Phosphatidylcholine-O(36:3)_M+H]1+/Phosphatidylcholine-P(36:2)_M+H]1+ levels
Phosphatidylcholine-O(36:4)_[M+H]1+/Phosphatidylcholine-P(36:3)_[M+H]1+ levels
Phosphatidylcholine-O(36:5)_[M+H]1+/Phosphatidylcholine-P(36:4)_[M+H]1+ levels
Phosphatidylcholine-O(38:4)_[M+H]1+/Phosphatidylcholine-P(38:3)_[M+H]1+ levels
Phosphatidylcholine-O(38:5)_[M+H]1+/Phosphatidylcholine-P(38:4)_[M+H]1+ levels
Phosphatidylcholine-O(39:1)_[M+H]1+/Phosphatidylethanolamine-P(39:0)_[M+H]1+ levels
Phosphatidylcholine-O(40:5)_[M+H]1+/Phosphatidylcholine-P(40:4)_[M+H]1+ levels
Phosphatidylcholine-O(40:6)_[M+H]1+/Phosphatidylcholine-P(40:5)_[M+H]1+ levels
Phosphatidylcholine-sterol acyltransferase levels
Phosphatidylcholine(32:0)_[M+H]1+/Phosphatidylethanolamine(35:0)_[M+H]1+/Phosphatidate(37:1)_[M+NH4]1+ levels
Phosphatidylcholine(33:2)_[M+H]1+/Phosphatidylethanolamine(36:2)_[M+H]1+/Phosphatidate(38:3)_[M+NH4]1+ levels
Phosphatidylcholine(33:3)_[M+H]1+/Phosphatidylethanolamine(36:3)_[M+H]1+/Phosphatidate(38:4)_[M+NH4]1+ levels
Phosphatidylcholine(34:2)_[M+H]1+/Phosphatidylethanolamine(37:2)_[M+H]1+/Phosphatidate(39:3)_[M+NH4]1+ levels
Phosphatidylcholine(35:3)_[M+H]1+/Phosphatidylethanolamine(38:3)_[M+H]1+/Phosphatidate(40:4)_[M+NH4]1+ levels
Phosphatidylcholine(35:4)_[M+H]1+/Phosphatidylethanolamine(38:4)_[M+H]1+/Phosphatidate(40:5)_[M+NH4]1+ levels
Phosphatidylcholine(36:2)_[M+H]1+/Phosphatidylethanolamine(39:2)_[M+H]1+/Phosphatidate(41:3)_[M+NH4]1+ levels
Phosphatidylcholine(36:3)_[M+H]1+/Phosphatidylethanolamine(39:3)_[M+H]1+/Phosphatidate(41:4)_[M+NH4]1+ levels
Phosphatidylcholine(36:3)_[M+OAc]1-/Phosphatidylserine(40:2)_[M-H]1- levels
Phosphatidylcholine(36:4)_[M+H]1+/Phosphatidylethanolamine(39:4)_[M+H]1+/Phosphatidate(41:5)_[M+NH4]1+ levels
Phosphatidylcholine(36:5)_[M+OAc]1-/Phosphatidylserine(40:4)_[M-H]1- levels
Phosphatidylcholine(37:4)_[M+H]1+/Phosphatidylethanolamine(40:3)_[M+H]1+ levels
Phosphatidylcholine(37:4)_[M+H]1+/Phosphatidylethanolamine(40:4)_[M+H]1+/Phosphatidate(42:5)_[M+NH4]1+ levels
Phosphatidylcholine(37:6)_[M+H]1+/Phosphatidylethanolamine(40:6)_[M+H]1+/Phosphatidate(42:7)_[M+NH4]1+ levels
Phosphatidylcholine(38:2)_[M+H]1+/Phosphatidylethanolamine(41:2)_[M+H]1+ levels
Phosphatidylcholine(38:3)_[M+H]1+/Phosphatidylethanolamine(41:3)_[M+H]1+/Phosphatidate(43:4)_[M+NH4]1+ levels
Phosphatidylcholine(38:3)_[M+OAc]1-/Phosphatidylserine(42:2)_[M-H]1- levels
Phosphatidylcholine(38:4)_[M+H]1+/Phosphatidylethanolamine(41:4)_[M+H]1+ levels
Phosphatidylcholine(38:4)_[M+OAc]1-/Phosphatidylserine(42:3)_[M-H]1- levels
Phosphatidylcholine(38:5)_[M+H]1+/Phosphatidylethanolamine(41:5)_[M+H]1+/Phosphatidate(43:6)_[M+NH4]1+ levels
Phosphatidylcholine(38:6)_[M+H]1+/Phosphatidylethanolamine(41:6)_[M+H]1+ levels
Phosphatidylcholine(39:6)_[M+OAc]1-/Phosphatidylserine(43:5)_[M-H]1- levels
Phosphatidylcholine(40:4)_[M+OAc]1-/Phosphatidylserine(44:3)_[M-H]1- levels
Phosphatidylcholine(40:5)_[M+H]1+ levels
Phosphatidylcholine(40:5)_[M+OAc]1-/Phosphatidylserine(44:4)_[M-H]1- levels
Phosphatidylcholine(40:6)_[M+H]1+/Phosphatidylethanolamine(43:6)_[M+H]1+ levels
Phosphatidylcholine(40:6)_[M+OAc]1-/Phosphatidylserine(44:5)_[M-H]1- levels
Phosphatidylcholine(40:8)_[M+H]1+ levels
Phosphatidylcholine(42:4)_[M+OAc]1- levels
Phosphatidylcholine(45:0)_[M-H]1- levels
Phosphatidylcholines (34:4) levels
Phosphatidylcholines (35:2)B levels
Phosphatidylcholines (35:4) levels
Phosphatidylcholines (36:3)B levels
Phosphatidylcholines (36:3E)1 levels
Phosphatidylcholines (36:4)B levels
Phosphatidylcholines (36:5)B levels
Phosphatidylcholines (36:5)C levels
Phosphatidylcholines (37:4) levels
Phosphatidylcholines (37:5) levels
Phosphatidylcholines (38:2) levels
Phosphatidylcholines (38:4)A levels
Phosphatidylcholines (38:4)B levels
Phosphatidylcholines (38:4)C levels
Phosphatidylcholines (38:5)A levels
Phosphatidylcholines (38:5)B levels
Phosphatidylcholines (38:6)A levels
Phosphatidylcholines (39:4) levels
Phosphatidylcholines (40:5)A levels
Phosphatidylcholines (40:6)A levels
Phosphatidylcholines (40:8) levels
Phosphatidylcholines (42:5) levels
Phosphatidylcholines levels (UKB data field 23437)
Phosphatidylethanolamine (15-MHDA_18:1) levels
Phosphatidylethanolamine (15-MHDA_18:2) levels
Phosphatidylethanolamine (15-MHDA_20:4) levels
Phosphatidylethanolamine (15-MHDA_22:6) levels
Phosphatidylethanolamine (16:0_16:1) levels
Phosphatidylethanolamine (16:0_18:1) levels
Phosphatidylethanolamine (16:0_18:2) levels
Phosphatidylethanolamine (16:0_18:3) (a) levels
Phosphatidylethanolamine (16:0_18:3) (b) levels
Phosphatidylethanolamine (16:0_20:3) levels
Phosphatidylethanolamine (16:0_20:4) levels
Phosphatidylethanolamine (16:0_20:5) levels
Phosphatidylethanolamine (16:0_22:6) levels
Phosphatidylethanolamine (16:1_18:2) levels
Phosphatidylethanolamine (17:0_18:1) levels
Phosphatidylethanolamine (17:0_18:2) levels
Phosphatidylethanolamine (17:0_20:4) levels
Phosphatidylethanolamine (17:0_22:6) levels
Phosphatidylethanolamine (18:0_18:1) levels
Phosphatidylethanolamine (18:0_18:2) levels
Phosphatidylethanolamine (18:0_20:3) (a) levels
Phosphatidylethanolamine (18:0_20:4) levels
Phosphatidylethanolamine (18:0_22:5) (n3) levels
Phosphatidylethanolamine (18:0_22:5) (n6) levels
Phosphatidylethanolamine (18:0_22:6) levels
Phosphatidylethanolamine (18:1_18:1) levels
Phosphatidylethanolamine (18:1_18:2) levels
Phosphatidylethanolamine (18:1_22:6) (a) levels
Phosphatidylethanolamine (18:1_22:6) (b) levels
Phosphatidylethanolamine (38:4)A levels
Phosphatidylethanolamine (38:5) (a) levels
Phosphatidylethanolamine (38:5) (b) levels
Phosphatidylethanolamine levels
Phosphatidylethanolamine_25:0_[M-H]1- levels
Phosphatidylethanolamine_34:0_[M-H]1- levels
Phosphatidylethanolamine_34:1_[M-H]1- levels
Phosphatidylethanolamine_34:2_[M-H]1- levels
Phosphatidylethanolamine_35:2_[M-H]1- levels
Phosphatidylethanolamine_36:2_[M-H]1- levels
Phosphatidylethanolamine_36:3_[M-H]1- levels
Phosphatidylethanolamine_36:4_[M-H]1- levels
Phosphatidylethanolamine_37:2_[M-H]1- levels
Phosphatidylethanolamine_37:3_[M-H]1- levels
Phosphatidylethanolamine_38:2_[M-H]1- levels
Phosphatidylethanolamine_38:3_[M-H]1- levels
Phosphatidylethanolamine_38:4_[M-H]1- levels
Phosphatidylethanolamine_38:5_[M-H]1- levels
Phosphatidylethanolamine_38:6_[M-H]1- levels
Phosphatidylethanolamine_39:4_[M-H]1- levels
Phosphatidylethanolamine_40:6_[M-H]1- levels
Phosphatidylethanolamine-ether levels
Phosphatidylethanolamine-O_34:1_[M-H]1-/Phosphatidylethanolamine-P_34:0_[M-H]1- levels
Phosphatidylethanolamine-O_34:3_[M-H]1-/Phosphatidylethanolamine-P_34:2_[M-H]1- levels
Phosphatidylethanolamine-O_36:3_[M-H]1-/Phosphatidylethanolamine-P_36:2_[M-H]1- levels
Phosphatidylethanolamine-O_36:4_[M-H]1-/Phosphatidylethanolamine-P_36:3_[M-H]1- levels
Phosphatidylethanolamine-O_36:5_[M-H]1-/Phosphatidylethanolamine-P_36:4_[M-H]1- levels
Phosphatidylethanolamine-O_38:3_[M-H]1-/Phosphatidylethanolamine-P_38:2_[M-H]1- levels
Phosphatidylethanolamine-O_38:5_[M-H]1-/Phosphatidylethanolamine-P_38:4_[M-H]1- levels
Phosphatidylethanolamine-O_38:6_[M-H]1-/Phosphatidylethanolamine-P_38:5_[M-H]1- levels
Phosphatidylethanolamine-O_40:4_[M-H]1-/Phosphatidylethanolamine-P_40:3_[M-H]1- levels
Phosphatidylethanolamine-O_40:5_[M-H]1-/Phosphatidylethanolamine-P_40:4_[M-H]1- levels
Phosphatidylethanolamine-O_40:6_[M-H]1-/Phosphatidylethanolamine-P_40:5_[M-H]1- levels
Phosphatidylethanolamine-O(38:4)_[M-H]1-/Phosphatidylcholine-O(35:4)_[M-H]1-/Phosphatidylcholine-P(35:3)_[M-H]1- levels
Phosphatidylethanolamine-O(38:6)_[M+H]1+/Phosphatidylcholine-P(35:5)_[M+H]1+ levels
Phosphatidylethanolamine(34:2)_[M+H]1+ levels
Phosphatidylethanolamine(36:4)_[M-H]1- levels
Phosphatidylethanolamine(36:4)_[M+H]1+ levels
Phosphatidylethanolamine(38:5)_[M-H]1- levels
Phosphatidylethanolamine(40:2)_[M-H]1- levels
Phosphatidylglycerol (34:2) levels
Phosphatidylglycerol (36:1) levels
Phosphatidylglycerol (36:2) levels
Phosphatidylglycerol_34:0_[M-H]1- levels
Phosphatidylglycerol_35:3_[M-H]1- levels
Phosphatidylglycerol_36:0_[M-H]1- levels
Phosphatidylglycerol-O_38:0_[M-H]1- levels
Phosphatidylglycerol-O_40:0_[M-H]1- levels
Phosphatidylglycerol(32:1)_[M+OAc]1- levels
Phosphatidylglycerol(34:0)_[M-H]1- levels
Phosphatidylglycerol(35:3)_[M-H]1- levels
Phosphatidylglycerol(36:0)_[M-H]1- levels
Phosphatidylinositol (15-MHDA_18:1) levels/Phosphatidylinositol (17:0_18:1) levels
Phosphatidylinositol (15-MHDA_18:2) levels/Phosphatidylinositol (17:0_18:2) levels
Phosphatidylinositol (15-MHDA_20:4) levels/Phosphatidylinositol (17:0_20:4) levels
Phosphatidylinositol (16:0_16:1) levels
Phosphatidylinositol (16:0_20:3) (a) levels
Phosphatidylinositol (16:0_20:4) levels
Phosphatidylinositol (18:0_18:1) levels
Phosphatidylinositol (18:0_20:2) levels
Phosphatidylinositol (18:0_20:3) (a) levels
Phosphatidylinositol (18:0_20:3) (b) levels
Phosphatidylinositol (18:0_20:4) levels
Phosphatidylinositol (18:0_22:4) levels
Phosphatidylinositol (18:0_22:5) (n3) levels
Phosphatidylinositol (18:0_22:5) (n6) levels
Phosphatidylinositol (18:1_18:2) levels
Phosphatidylinositol (20:0_20:4) levels
Phosphatidylinositol (34:1) levels
Phosphatidylinositol (36:2) levels
Phosphatidylinositol (37:6) levels
Phosphatidylinositol (38:5) (a) levels
Phosphatidylinositol (38:5) (b) levels
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN levels
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform levels
Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha levels
Phosphatidylinositol 5-phosphate 4-kinase type-2 beta levels
Phosphatidylinositol levels
Phosphatidylinositol transfer protein beta isoform levels
Phosphatidylinositol_34:0_[M+H]1+ levels
Phosphatidylinositol_34:2_[M-H]1- levels
Phosphatidylinositol_35:0_[M-H]1- levels
Phosphatidylinositol_35:2_[M-H]1- levels
Phosphatidylinositol_36:2_[M-H]1- levels
Phosphatidylinositol_36:2_[M+H]1+ levels
Phosphatidylinositol_36:3_[M-H]1- levels
Phosphatidylinositol_36:4_[M-H]1- levels
Phosphatidylinositol_38:0_[M-H]1- levels
Phosphatidylinositol_38:4_[M-H]1- levels
Phosphatidylinositol-O_36:0_[M-H]1- levels
Phosphatidylinositol-O_36:1_[M+H]1+ levels
Phosphatidylinositol-O(33:0)_[M-H]1- levels
Phosphatidylinositol-O(36:0)_[M-H]1-/Phosphatidylglycerol(37:0)_[M+OAc]1- levels
Phosphatidylinositol(34:2)_[M-H]1- levels
Phosphatidylinositol(36:0)_[M+OAc]1- levels
Phosphatidylinositol(36:1)_[M+OAc]1- levels
Phosphatidylinositol(36:2)_[M-H]1- levels
Phosphatidylinositol(36:3)_[M-H]1- levels
Phosphatidylinositol(36:4)_[M-H]1- levels
Phosphatidylinositol(38:4)_[M-H]1- levels
Phosphatidylinositol(40:6)_[M-H]1- levels
Phosphatidylserine (36:2) levels
Phosphatidylserine (38:3) levels
Phosphatidylserine_40:3_[M+H]1+/Phosphatidylglycerol_40:5_[M+NH4]1+ levels
Phosphatidylserine_40:5_[M+H]1+/Phosphatidylglycerol_40:7_[M+NH4]1+ levels
Phosphatidylserine-O_42:6_[M+H]1+ levels
Phosphatidylserine-P_42:1_[M+H]1+/Phosphatidylglycerol-P_42:6_[M+NH4]1+ levels
Phosphatidylserine(35:2)_[M+OAc]1- levels
Phosphatidylserine(42:5)_[M+OAc]1- levels
Phosphatidylserine(42:7)_[M+OAc]1- levels
Phosphatidylserine(44:6)_[M+OAc]1- levels
Phosphocholine levels
Phosphoenolpyruvate carboxykinase [GTP], mitochondrial level in Chronic kidney disease with hypertension and no diabetes (20079_6)
Phosphoenolpyruvate carboxykinase, cytosolic [GTP] levels
Phosphoglucomutase-1 levels
Phosphoglucomutase-1 levels (PGM1.9173.21.3)
Phosphoglucomutase-2 levels
Phosphoglycerate kinase 1 levels (PGK1.5020.50.1)
Phosphoglycerate mutase 1 levels
Phosphoglycerides levels
Phosphoglycerides levels (UKB data field 23434)
Phospholipase A2 levels
Phospholipase A2, membrane associated levels
Phospholipase A2, membrane associated levels (PLA2G2A.2692.74.2)
Phospholipase D3 levels
Phospholipid levels (plasma)
Phospholipid levels in chylomicrons and extremely large VLDL
Phospholipid levels in chylomicrons and extremely large VLDL meal response (OrNLSr)
Phospholipid levels in HDL
Phospholipid levels in IDL
Phospholipid levels in large HDL
Phospholipid levels in large LDL
Phospholipid levels in large VLDL
Phospholipid levels in LDL
Phospholipid levels in medium HDL
Phospholipid levels in medium LDL
Phospholipid levels in medium VLDL
Phospholipid levels in small HDL
Phospholipid levels in small LDL
Phospholipid levels in small VLDL
Phospholipid levels in very large HDL
Phospholipid levels in very large VLDL
Phospholipid levels in very small VLDL
Phospholipid levels in VLDL
Phospholipid transfer protein level in Chronic kidney disease with hypertension and no diabetes (15475_4)
Phospholipid transfer protein levels
Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483)
Phospholipids in HDL (UKB data field 23414)
Phospholipids in IDL (UKB data field 23525)
Phospholipids in large HDL (UKB data field 23560)
Phospholipids in large LDL (UKB data field 23532)
Phospholipids in large VLDL (UKB data field 23497)
Phospholipids in LDL (UKB data field 23413)
Phospholipids in medium HDL (UKB data field 23567)
Phospholipids in medium LDL (UKB data field 23539)
Phospholipids in medium VLDL (UKB data field 23504)
Phospholipids in small HDL (UKB data field 23574)
Phospholipids in small LDL (UKB data field 23546)
Phospholipids in small VLDL (UKB data field 23511)
Phospholipids in very large HDL (UKB data field 23553)
Phospholipids in very large VLDL (UKB data field 23490)
Phospholipids in very small VLDL (UKB data field 23518)
Phospholipids in VLDL (UKB data field 23412)
Phospholipids to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23579)
Phospholipids to total lipids in IDL percentage (UKB data field 23609)
Phospholipids to total lipids in large HDL percentage (UKB data field 23634)
Phospholipids to total lipids in large LDL percentage (UKB data field 23614)
Phospholipids to total lipids in large VLDL percentage (UKB data field 23589)
Phospholipids to total lipids in medium HDL percentage (UKB data field 23639)
Phospholipids to total lipids in medium LDL percentage (UKB data field 23619)
Phospholipids to total lipids in medium VLDL percentage (UKB data field 23594)
Phospholipids to total lipids in small HDL percentage (UKB data field 23644)
Phospholipids to total lipids in small LDL percentage (UKB data field 23624)
Phospholipids to total lipids in small VLDL percentage (UKB data field 23599)
Phospholipids to total lipids in very large HDL percentage (UKB data field 23629)
Phospholipids to total lipids in very large VLDL percentage (UKB data field 23584)
Phospholipids to total lipids in very small VLDL percentage (UKB data field 23604)
Phospholipids to total lipids ratio in chylomicrons and extremely large VLDL
Phospholipids to total lipids ratio in IDL
Phospholipids to total lipids ratio in large HDL
Phospholipids to total lipids ratio in large LDL
Phospholipids to total lipids ratio in large VLDL
Phospholipids to total lipids ratio in medium HDL
Phospholipids to total lipids ratio in medium LDL
Phospholipids to total lipids ratio in medium VLDL
Phospholipids to total lipids ratio in small HDL
Phospholipids to total lipids ratio in small LDL
Phospholipids to total lipids ratio in small VLDL
Phospholipids to total lipids ratio in very large HDL
Phospholipids to total lipids ratio in very large VLDL
Phospholipids to total lipids ratio in very small VLDL
Phosphomannomutase 2 levels
Phosphomevalonate kinase level in Chronic kidney disease with hypertension and no diabetes (12450_42)
Phosphomevalonate kinase levels
Phosphopantothenate--cysteine ligase levels
Phosphopantothenoylcysteine decarboxylase levels
Phosphoribosyl pyrophosphate synthase-associated protein 1 levels
Phosphoribosyl pyrophosphate synthase-associated protein 2 levels
Phosphorus levels
Photic sneeze reflex
Photoreceptor cell layer thickness phenotypes (MTAG)
Physical activity
Physical activity (moderate intensity activity duration)
Physical activity (overall physical activity time)
Physical activity (Principal component 2)
Physical activity (Relative amplitude)
Physical activity (standard GWA)
Physical activity (Total log acceleration 12am-2am)
Physical activity (Total log acceleration 2am-4am)
Physical activity (Total log acceleration 6am-8am)
Physical activity (Total log acceleration 6pm-8pm)
Physical activity (Total log acceleration 8am-10am)
Physical activity (Total log acceleration)
Physical activity (walking duration)
Physical aggression in schizophrenia
Physical health related quality of life
Physiological dysregulation (Mahalanobis distance)
Physiological traits
Phytosterol levels
Picolinate levels
Picolinoylglycine levels
Pigment dispersion syndrome or pigmentary glaucoma
Pigment epithelium-derived factor levels
Pigment epithelium-derived factor levels (SERPINF1.9211.19.3)
PIK3CA/PIK3R1 levels
Pimelate (heptanedioate) levels in elite athletes
Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels
Pimelylcarnitine levels
Pipecolate levels in elite athletes
Pirin level in Chronic kidney disease with hypertension and no diabetes (13634_209)
Pirin levels
Pirin levels (PIR.13634.209.3)
Pit-and-Fissure caries
Pituitary adenylate cyclase-activating polypeptide 38 levels
Piwi-like protein 1 levels
Pizza liking
Placebo response in major depressive disorder (% change in symptom score)
Placenta growth factor levels
Placental abruption
Plakophilin-2 levels
Planococcaceae abundance in stool
Plantar fascial disorders
Plantar warts
Plasma aluminum levels
Plasma amyloid beta peptide concentrations (ABx-40)
Plasma amyloid beta peptide concentrations (ABx-42)
Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer
Plasma androstenedione levels in resected early stage-receptor positive breast cancer
Plasma ANGPTL8 levels
Plasma anti-thyroglobulin and anti-thyroid peroxidase levels (bivariate analysis)
Plasma anti-thyroglobulin levels
Plasma anti-thyroid peroxidase levels
Plasma barium levels
Plasma cadmium levels
Plasma calcium levels
Plasma chromium levels
Plasma clozapine levels in treatment-resistant schizophrenia
Plasma clozapine-norclozapine ratio in treatment-resistant schizophrenia
Plasma clusterin levels
Plasma cobalt levels
Plasma concentration-time curve of rosuvastatin
Plasma copper levels
Plasma cortisol levels (morning)
Plasma cystastin c levels in acute coronary syndrome
Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer
Plasma estrone levels in resected estrogen-receptor positive breast cancer
Plasma factor V levels in venous thrombosis (conditioned on rs6027)
Plasma factor VII activating protease levels
Plasma free amino acid levels
Plasma free amino acid levels (adjusted for one other PFAA)
Plasma free amino acid levels (adjusted for twenty other PFAAs)
Plasma free asparagine levels
Plasma homocysteine levels
Plasma homocysteine levels (post-methionine load test)
Plasma iron levels
Plasma kallikrein levels
Plasma kynurenine levels in major depressive disorder
Plasma kynurenine to tryptophan ratio in major depressive disorder
Plasma lactate levels
Plasma lead levels
Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer
Plasma lysine levels in alcohol use disorder treated with acamprosate
Plasma magnesium levels
Plasma manganese levels
Plasma molybdenum levels
Plasma myo-inositol levels
Plasma nickel levels
Plasma norclozapine levels in treatment-resistant schizophrenia
Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid)
Plasma omega-3 polyunsaturated fatty acid levels (alphalinolenic acid)
Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)
Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid)
Plasma omega-6 polyunsaturated fatty acid levels (adrenic acid)
Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)
Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)
Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)
Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)
Plasma p-tau181 levels
Plasma parathyroid hormone levels
Plasma PCSK9 levels
Plasma plasminogen activator levels
Plasma plasminogen levels
Plasma protease C1 inhibitor levels
Plasma protease C1 inhibitor levels (SERPING1.4479.14.2)
Plasma pyridoxal phosphate levels
Plasma pyridoxal phosphate to pyridoxal ratio
Plasma pyridoxic acid to pyridoxal phosphate ratio
Plasma renin activity levels
Plasma rubidium levels
Plasma selenium concentration
Plasma selenium levels
Plasma serine protease inhibitor levels
Plasma strontium levels
Plasma t-tau levels
Plasma thyroid-stimulating hormone levels
Plasma tin levels
Plasma titanium levels
Plasma vanadium levels
Plasma viscosity
Plasma zinc levels
Plasmacytoid Dendritic Cell %Dendritic Cell
Plasmacytoid Dendritic Cell Absolute Count
Plasminogen activator inhibitor 1 levels
Plasminogen activator inhibitor type 1 levels (PAI-1)
Plasminogen levels
Plastin-2 levels
Platelet aggregation
Platelet count
Platelet distribution width
Platelet endothelial aggregation receptor 1 levels
Platelet endothelial aggregation receptor 1 levels (PEAR1.8275.31.3)
Platelet factor 4 levels
Platelet factor 4 variant levels
Platelet factor 4 variant levels (PF4V1.5663.18.3)
Platelet factor 4/heparin antibody levels in heparin treatment
Platelet glycoprotein 4 levels
Platelet glycoprotein Ib alpha chain levels
Platelet glycoprotein Ib alpha chain levels (GP1BA.4990.87.1)
Platelet glycoprotein V levels
Platelet glycoprotein VI levels
Platelet reactivity in response to ADP
Platelet reactivity in response to clopidogrel treatment
Platelet receptor Gi24 levels
Platelet receptor Gi24 levels (C10orf54.14123.34.3)
Platelet response to aspirin
Platelet thrombus formation
Platelet-activating factor acetylhydrolase 2, cytoplasmic levels
Platelet-activating factor acetylhydrolase levels
Platelet-activating factor levels
Platelet-derived growth factor BB levels
Platelet-derived growth factor C levels
Platelet-derived growth factor D levels
Platelet-derived growth factor receptor alpha levels
Platelet-derived growth factor receptor beta level in Chronic kidney disease with hypertension and no diabetes (3459_49)
Platelet-derived growth factor receptor beta levels
Platelet-derived growth factor receptor beta levels (PDGFRB.3459.49.2)
Platelet-derived growth factor receptor-like protein levels
Platelet-derived growth factor receptor-like protein levels (PDGFRL.9713.67.3)
Platelet-derived growth factor subunit B levels
Platelet-to-lymphocyte ratio
Plateletcrit
Pleckstrin homology domain-containing family A member 1 levels
Pleckstrin homology domain-containing family A member 7 levels
Pleckstrin homology domain-containing family A member 7 levels (PLEKHA7.12731.12.3)
Pleckstrin levels
Pleiotrophin levels
Pleiotrophin levels (PTN.3045.72.2)
Plexin domain-containing protein 1 levels
Plexin domain-containing protein 2 levels
Plexin-A1 levels
Plexin-A4 levels
Plexin-B2 levels
Plexin-B3 levels
Plexin-C1 levels
Plexin-C1 levels (PLXNC1.4564.2.2)
Plexin-D1 levels
Plum liking
Pneumococcal bacteremia
Pneumococcal meningitis
Pneumoconiosis in silica exposure
Pneumonia
Pneumothorax
Poliovirus receptor levels
Political ideology
Pollinosis
Poly(A) polymerase gamma levels
Poly(A) RNA polymerase, mitochondrial levels
Poly(A) RNA polymerase, mitochondrial levels (MTPAP.9028.5.3)
Poly(ADP-ribose) glycohydrolase ARH3 levels
Poly(rC)-binding protein 1 levels
Poly(U)-binding-splicing factor PUF60 levels
Poly(U)-binding-splicing factor PUF60 levels (PUF60.10575.31.3)
Poly(U)-specific endoribonuclease levels
Polyadenylate-binding protein 2 levels
Polyadenylate-binding protein 3 levels
Polyadenylate-binding protein 4 levels
Polychlorinated biphenyl levels
Polycomb protein SCMH1 levels
Polycystic ovary syndrome
Polycystic ovary syndrome (adjusted for age and BMI)
Polycystic ovary syndrome (adjusted for age)
Polycystic ovary syndrome (indeterminate subtype)
Polycystic ovary syndrome (reproductive subtype)
Polymeric immunoglobulin receptor levels
Polymeric immunoglobulin receptor levels (PIGR.3216.2.2)
Polymyositis
Polypeptide N-acetylgalactosaminyltransferase 1 levels
Polypeptide N-acetylgalactosaminyltransferase 11 levels
Polypeptide N-acetylgalactosaminyltransferase 16 levels
Polypeptide N-acetylgalactosaminyltransferase 3 levels
Polypeptide N-acetylgalactosaminyltransferase 4 level in Chronic kidney disease with hypertension and no diabetes (21722_21)
Polyunsaturated fatty acid levels
Polyunsaturated fatty acids levels (UKB data field 23446)
Polyunsaturated fatty acids to monounsaturated fatty acids ratio (UKB data field 23458)
Polyunsaturated fatty acids to total fatty acids percentage (UKB data field 23453)
PON 1 plasma levels
Pork consumption
Porridge liking
Positive affect
Positive urgency
Post bronchodilator FEV1
Post bronchodilator FEV1 in COPD
Post bronchodilator FEV1/FVC ratio
Post bronchodilator FEV1/FVC ratio in COPD
Post bronchodilator FEV1/FVC ratio in smoking
Post bronchodilator percent predicted FEV1 in smoking
Post traumatic stress disorder symptom count in trauma-exposed individuals
Post-bronchodilator FEV1 x air pollution (CO) interaction in childhood asthma
Post-bronchodilator FEV1 x air pollution (NO2) interaction in childhood asthma
Post-term birth
Post-traumatic stress disorder
Post-traumatic stress disorder (asjusted for relatedness)
Post-traumatic stress disorder (mental health questionnaire or predicted)
Post-traumatic stress disorder (MTAG)
Post-traumatic stress disorder (phenotype risk score)
Post-traumatic stress disorder (re-experiencing symptoms)
Postburn scar height
Postcentral gyrus volume
Posterior cortical atrophy and Alzheimer's disease
Posterior thalamic nuclei volume
Posterior thigh muscle fat infiltration percentage
Posterior thigh muscle volume
Posterior urethral valves
Posterior-cingulate cortex volume
Postherpetic neuralgia
Postoperative atrial fibrillation after cardiac surgery
Postoperative atrial fibrillation in coronary artery bypass grafting surgery
Postoperative complication after cardiac surgery
Postoperative delirium after cardiac surgery
Postoperative survival time in hepatocellular carcinoma
Postoperative venous thromboembolism
Postprandial apolipoprotein A-I
Postprandial apolipoprotein B
Postprandial cholesterol esters in chylomicrons and extremely large VLDL
Postprandial cholesterol esters in IDL
Postprandial cholesterol esters in large HDL
Postprandial cholesterol esters in large LDL
Postprandial cholesterol esters in large VLDL
Postprandial cholesterol esters in medium HDL
Postprandial cholesterol esters in medium LDL
Postprandial cholesterol esters in medium VLDL
Postprandial cholesterol esters in small LDL
Postprandial cholesterol esters in small VLDL
Postprandial cholesterol esters in very large HDL
Postprandial cholesterol esters in very large VLDL
Postprandial cholesterol esters in very small VLDL
Postprandial chylomicrons and extremely large VLDL particle concentration
Postprandial citrate
Postprandial conjugated linoleic acid
Postprandial docosahexaenoic acid (22:6)
Postprandial esterified cholesterol
Postprandial estimated degree of unsaturation
Postprandial free cholesterol
Postprandial free cholesterol in chylomicrons and extremely large VLDL
Postprandial free cholesterol in IDL
Postprandial free cholesterol in large HDL
Postprandial free cholesterol in large LDL
Postprandial free cholesterol in large VLDL
Postprandial free cholesterol in medium HDL
Postprandial free cholesterol in medium LDL
Postprandial free cholesterol in medium VLDL
Postprandial free cholesterol in small HDL
Postprandial free cholesterol in small LDL
Postprandial free cholesterol in small VLDL
Postprandial free cholesterol in very large HDL
Postprandial free cholesterol in very large VLDL
Postprandial free cholesterol in very small VLDL
Postprandial glucose in prediabetes
Postprandial glutamine
Postprandial glycoprotein acetyls (mainly a1-acid glycoprotein)
Postprandial IDL particle concentration
Postprandial isoleucine
Postprandial large HDL particle concentration
Postprandial large LDL particle concentration
Postprandial large VLDL particle concentration
Postprandial leucine
Postprandial linoleic acid (18:2)
Postprandial mean diameter of HDL particles
Postprandial mean diameter of LDL particles
Postprandial mean diameter of VLDLD particles
Postprandial medium HDL particle concentration
Postprandial medium LDL particle concentration
Postprandial medium VLDL particle concentration
Postprandial monounsaturated fatty acids (16:1, 18:1)
Postprandial omega-3 fatty acids
Postprandial omega-6 fatty acids
Postprandial phospholipid levels in chylomicrons and extremely large VLDL
Postprandial phospholipid levels in IDL
Postprandial phospholipid levels in large HDL
Postprandial phospholipid levels in large LDL
Postprandial phospholipid levels in large VLDL
Postprandial phospholipid levels in medium HDL
Postprandial phospholipid levels in medium LDL
Postprandial phospholipid levels in medium VLDL
Postprandial phospholipid levels in small HDL
Postprandial phospholipid levels in small LDL
Postprandial phospholipid levels in small VLDL
Postprandial phospholipid levels in very large HDL
Postprandial phospholipid levels in very large VLDL
Postprandial phospholipid levels in very small VLDL
Postprandial polyunsaturated fatty acids
Postprandial remnant cholesterol
Postprandial saturated fatty acids
Postprandial serum total cholesterol
Postprandial serum total triglycerides
Postprandial small HDL particle concentration
Postprandial small LDL particle concentration
Postprandial small VLDL particle concentration
Postprandial sphingomyelins
Postprandial total cholesterol in chylomicrons and extremely large VLDL
Postprandial total cholesterol in HDL
Postprandial total cholesterol in HDL2
Postprandial total cholesterol in HDL3
Postprandial total cholesterol in IDL
Postprandial total cholesterol in large HDL
Postprandial total cholesterol in large LDL
Postprandial total cholesterol in large VLDL
Postprandial total cholesterol in LDL
Postprandial total cholesterol in medium HDL
Postprandial total cholesterol in medium LDL
Postprandial total cholesterol in medium VLDL
Postprandial total cholesterol in small HDL
Postprandial total cholesterol in small LDL
Postprandial total cholesterol in small VLDL
Postprandial total cholesterol in very large HDL
Postprandial total cholesterol in very large VLDL
Postprandial total cholesterol in very small VLDL
Postprandial total cholesterol in VLDL
Postprandial total fatty acids
Postprandial total lipids in chylomicrons and extremely large VLDL
Postprandial total lipids in IDL
Postprandial total lipids in large HDL
Postprandial total lipids in large LDL
Postprandial total lipids in large VLDL
Postprandial total lipids in medium HDL
Postprandial total lipids in medium LDL
Postprandial total lipids in medium VLDL
Postprandial total lipids in small HDL
Postprandial total lipids in small LDL
Postprandial total lipids in small VLDL
Postprandial total lipids in very large HDL
Postprandial total lipids in very large VLDL
Postprandial total lipids in very small VLDL
Postprandial triglyceride levels
Postprandial triglyceride response to high fat diet meal
Postprandial triglycerides in HDL
Postprandial triglycerides in LDL
Postprandial triglycerides in VLDL
Postprandial triglycerides levels in chylomicrons and extremely large VLDL
Postprandial triglycerides levels in IDL
Postprandial triglycerides levels in large HDL
Postprandial triglycerides levels in large LDL
Postprandial triglycerides levels in large VLDL
Postprandial triglycerides levels in medium HDL
Postprandial triglycerides levels in medium LDL
Postprandial triglycerides levels in medium VLDL
Postprandial triglycerides levels in small HDL
Postprandial triglycerides levels in small LDL
Postprandial triglycerides levels in small VLDL
Postprandial triglycerides levels in very large HDL
Postprandial triglycerides levels in very large VLDL
Postprandial triglycerides levels in very small VLDL
Postprandial tyrosine
Postprandial valine
Postprandial very large HDL particle concentration
Postprandial very large VLDL particle concentration
Postprandial very small VLDL particle concentration
Potassium chromate levels
Potassium levels
Potassium voltage-gated channel subfamily A member 10 levels
Potassium voltage-gated channel subfamily E member 2 levels (KCNE2.10427.2.3)
Potassium voltage-gated channel subfamily E regulatory beta subunit 5 levels
Potassium voltage-gated channel subfamily F member 1 levels
Potassium-transporting ATPase subunit beta levels (ATP4B.9994.217.3)
POTE ankyrin domain family member G levels
Poultry consumption
PR domain zinc finger protein 1 levels (PRDM1.14197.2.3)
PR domain zinc finger protein 4 levels
PR interval
PR interval in Tripanosoma cruzi seropositivity
PR segment duration
PRA1 family protein 3 levels
Pre bronchodilator FEV1
Pre bronchodilator FEV1/FVC ratio
Pre bronchodilator FEV1/FVC ratio in never-smokers
Pre-mRNA-processing factor 6 levels
Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 levels (DHX38.13645.14.3)
Pre-mRNA-splicing factor SYF2 level in Chronic kidney disease with hypertension and no diabetes (19438_68)
Pre-treatment pain in head and neck squamous cell carcinoma
Pre-treatment viral load in hepatitis C virus genotype 3
Pre-treatment viral load in HIV-1 infection
Precentral gyrus volume
Precuneus cortex volume
Predicted developmental stuttering
Predicted heart recovery rate
Predicted visceral adipose tissue
prednisolone sensitivity in B-cell precursor acute lymphoblastic leukaemia
Preeclampsia
Preeclampsia (fetal genotype effect)
Preeclampsia (maternal genotype effect)
Preferentially expressed antigen of melanoma level in Chronic kidney disease with hypertension and no diabetes (25951_17)
Prefoldin subunit 2 levels
Prefoldin subunit 3 levels
Pregn steroid monosulfate C21H34O5S levels in elite athletes
Pregnancy-specific beta-1-glycoprotein 1 level in Chronic kidney disease with hypertension and no diabetes (15631_18)
Pregnancy-specific beta-1-glycoprotein 1 levels
Pregnancy-specific beta-1-glycoprotein 11 levels
Pregnancy-specific beta-1-glycoprotein 2 levels
Pregnancy-specific beta-1-glycoprotein 3 level in Chronic kidney disease with hypertension and no diabetes (6444_15)
Pregnancy-specific beta-1-glycoprotein 3 levels
Pregnancy-specific beta-1-glycoprotein 3 levels (PSG3.6444.15.3)
Pregnancy-specific beta-1-glycoprotein 4 level in Chronic kidney disease with hypertension and no diabetes (5649_83)
Pregnancy-specific beta-1-glycoprotein 4 levels
Pregnancy-specific beta-1-glycoprotein 4 levels (PSG4.5649.83.3)
Pregnancy-specific beta-1-glycoprotein 5 levels
Pregnancy-specific beta-1-glycoprotein 8 levels
Pregnancy-specific beta-1-glycoprotein 9 levels
Pregnanediol-3-glucuronide levels
Pregnanediol-3-glucuronide levels in elite athletes
Pregnanolone/allopregnanolone sulfate levels
Pregnanolone/allopregnanolone sulfate levels in elite athletes
Pregnen-diol disulfate C21H34O8S2 levels in elite athletes
Pregnen-diol disulfate levels
Pregnenediol disulfate (C21H34O8S2) levels
Pregnenediol sulfate (C21H34O5S) levels
Pregnenetriol disulfate (X-11440) levels
Pregnenetriol disulfate levels
Pregnenetriol sulfate levels
Pregnenolone sulfate levels
Pregnenolone sulfate levels in elite athletes
Premature atrial contraction frequency
Premature menopause in childhood cancer survivors
Prenylcysteine oxidase 1 levels
Prenylcysteine oxidase-like levels
Prepronociceptin levels
Prepulse inhibition of the startle response
Preschool internalizing problems
Presence of antiphospholipid antibodies
Presence of epithelioid cells in uveal melanoma
Presubiculum volume
Preterm birth (maternal effect)
Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)
Prevalent atrial fibrillation
Prevalent type 2 diabetes
Prevotella bivia abundance in stool
Prevotella sp002437285 abundance in stool
Prevotella sp900318625 abundance in stool
Prevotellamassilia abundance in stool
Primary biliary cholangitis
Primary biliary cirrhosis
Primary central nervous system lymphoma
Primary dysmenorrhea
Primary focal segmental glomerulosclerosis in chronic kidney disease
Primary sclerosing cholangitis
Primary tooth development (number of teeth)
Primary tooth development (time to first tooth eruption)
Principal component-derived dietary pattern 1
Principal component-derived dietary pattern 11
Principal component-derived dietary pattern 12
Principal component-derived dietary pattern 13
Principal component-derived dietary pattern 14
Principal component-derived dietary pattern 16
Principal component-derived dietary pattern 17
Principal component-derived dietary pattern 18
Principal component-derived dietary pattern 19
Principal component-derived dietary pattern 2
Principal component-derived dietary pattern 20
Principal component-derived dietary pattern 21
Principal component-derived dietary pattern 26
Principal component-derived dietary pattern 3
Principal component-derived dietary pattern 31
Principal component-derived dietary pattern 36
Principal component-derived dietary pattern 4
Principal component-derived dietary pattern 42
Principal component-derived dietary pattern 43
Principal component-derived dietary pattern 46
Principal component-derived dietary pattern 52
Principal component-derived dietary pattern 7
Principal component-derived dietary pattern 8
Principal component-derived dietary pattern 9
Prion diseases
Prion-like protein doppel levels
Pro-cathepsin H levels
Pro-FMRFamide-related neuropeptide FF level in Chronic kidney disease with hypertension and no diabetes (5617_41)
Pro-FMRFamide-related neuropeptide FF levels
Pro-FMRFamide-related neuropeptide FF levels (NPFF.5617.41.3)
Pro-hydroxy-pro levels in elite athletes
Pro-interleukin-16 levels
Pro-opiomelanocortin levels
Proactivator polypeptide-like 1 levels
Proactivator polypeptide-like 1 levels (PSAPL1.8814.33.3)
Probable ATP-dependent RNA helicase DDX23 levels
Probable ATP-dependent RNA helicase DDX46 levels
Probable ATP-dependent RNA helicase DDX58 levels
Probable ATP-dependent RNA helicase DDX6 levels
Probable ATP-dependent RNA helicase DHX58 levels
Probable carboxypeptidase X1 levels
Probable E3 ubiquitin-protein ligase HERC4 level in Chronic kidney disease with hypertension and no diabetes (7860_9)
Probable E3 ubiquitin-protein ligase HERC4 levels
Probable E3 ubiquitin-protein ligase MID2 levels
Probable G-protein coupled receptor 101 levels
Probable G-protein coupled receptor 135 levels
Probable G-protein coupled receptor 135 levels (GPR135.11465.4.3)
Probable G-protein coupled receptor 142 level in Chronic kidney disease with hypertension and no diabetes (12766_33)
Probable inactive ribonuclease-like protein 13 levels
Probable RNA-binding protein 18 level in Chronic kidney disease with hypertension and no diabetes (20383_31)
Probable RNA-binding protein 23 levels
Probable RNA-binding protein 46 levels
Probable RNA-binding protein EIF1AD levels
Probable serine carboxypeptidase CPVL levels
Probable serine carboxypeptidase CPVL levels (CPVL.8891.7.3)
Problematic alcohol use
Problematic alcohol use (MTAG)
Problematic alcohol use in trauma-exposed individuals
Problematic opioid prescription use
Processed meat consumption
Procollagen C-endopeptidase enhancer 1 levels
Procollagen C-endopeptidase enhancer 1 levels (PCOLCE.11237.49.3)
Procollagen C-endopeptidase enhancer 2 levels
Procollagen C-endopeptidase enhancer 2 levels (PCOLCE2.6081.52.3)
Procollagen galactosyltransferase 1 levels
Procollagen galactosyltransferase 1 levels (COLGALT1.5638.23.3)
Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 levels
Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 levels
Proenkephalin-A levels
Proenkephalin-A levels (PENK.9076.25.3)
Progesterone levels
Progonadoliberin-1 levels
Progonadoliberin-1 levels (GNRH1.5627.53.3)
Progonadoliberin-2 levels
Progonadoliberin-2 levels (GNRH2.10708.3.3)
Programmed cell death 1 ligand 1 levels
Programmed cell death 1 ligand 2 levels
Programmed cell death 1 ligand 2 levels (PDCD1LG2.3004.67.2)
Programmed cell death 6-interacting protein levels
Programmed cell death protein 4 levels
Programmed cell death protein 5 levels
Programmed cell death protein 5 levels (PDCD5.12517.52.3)
Programmed cell death protein 6 levels
Progranulin levels
Progranulin plasma levels
Progression free survival in epithelial ovarian cancer
Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel
Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)
Progression free survival in metastatic colorectal cancer (chemotherapy interaction)
Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel
Progression-free survival in non-muscle-invasive bladder cancer
Progressive supranuclear palsy
Proheparin-binding EGF-like growth factor levels
Proinsulin levels
Prokineticin-1 levels
Prokineticin-2 level in Chronic kidney disease with hypertension and no diabetes (10754_113)
Prokineticin-2 levels
Prolactin receptor levels
Prolactin receptor levels (PRLR.5114.65.3)
Prolactin-inducible protein levels
Prolactin-releasing peptide levels
Prolargin levels
Prolargin levels (PRELP.5675.6.3)
Proliferation-associated protein 2G4 levels
Proliferative diabetic retinopathy (vs no DR)
Proliferative diabetic retinopathy (vs NPDR and no DR)
Proliferative diabetic retinopathy in type 2 diabetes
Proline levels
Proline levels (Metabolon platform)
Proline levels in elite athletes
Proline-serine-threonine phosphatase-interacting protein 1 levels
Prolow-density lipoprotein receptor-related protein 1 levels
Prolyl 4-hydroxylase subunit alpha-2 levels
Prolyl endopeptidase FAP levels
Prolylglycine levels
Prolylglycine levels in elite athletes
Promotilin levels
Properdin levels
Properdin levels (CFP.2960.66.2)
Propionibacterium freudenreichii abundance in stool
Propionylcarnitine (c3) levels
Propionylcarnitine levels
Propionylcarnitine levels (Biocrates platform)
Propionylcarnitine levels (Metabolon platform)
Propionylcarnitine-to-isovalerylcarnitine ratio
Propionylglycine levels
Proportion of activated microglia (inferior temporal cortex)
Proportion of activated microglia (midfrontal cortex)
Proprotein convertase subtilisin/kexin type 7 level in Chronic kidney disease with hypertension and no diabetes (4459_68)
Proprotein convertase subtilisin/kexin type 7 levels
Proprotein convertase subtilisin/kexin type 7 levels (PCSK7.4459.68.2)
Proprotein convertase subtilisin/kexin type 9 levels
Prorelaxin H2 levels
Prosaposin level in Chronic kidney disease with hypertension and no diabetes (6207_10)
Prosaposin levels
Prostaglandin E synthase 3 level in Chronic kidney disease with hypertension and no diabetes (17154_2)
Prostaglandin E synthase 3 levels
Prostaglandin F2 receptor negative regulator level in Chronic kidney disease with hypertension and no diabetes (12727_7)
Prostaglandin F2 receptor negative regulator levels
Prostaglandin F2 receptor negative regulator levels (PTGFRN.12727.7.3)
Prostaglandin reductase 1 levels
Prostaglandin reductase 1 levels (PTGR1.13543.7.3)
Prostaglandin reductase 2 levels
Prostaglandin reductase 3 levels
Prostaglandin-H2 D-isomerase levels
Prostaglandin-H2 D-isomerase levels (PTGDS.10514.5.3)
Prostate and testis expressed protein 1 levels
Prostate and testis expressed protein 4 levels
Prostate and testis expressed protein 4 levels (PATE4.8065.245.3)
Prostate cancer
Prostate cancer (advanced)
Prostate cancer (early onset)
Prostate cancer (survival)
Prostate-associated microseminoprotein levels
Prostate-specific antigen levels
Prostate-specific antigen levels (conditioned on lead SNPs)
Prostatic acid phosphatase levels
Protachykinin-1 levels
Protachykinin-1 levels (TAC1.9337.43.3)
Proteasome activator complex subunit 1 levels
Proteasome assembly chaperone 3 levels
Proteasome subunit alpha type-1 levels
Proteasome subunit alpha type-1 levels (PSMA1.7880.9.3)
Proteasome subunit alpha type-2 levels
Proteasome subunit alpha type-3 levels
Proteasome subunit alpha type-4 levels
Proteasome subunit alpha type-6 levels
Proteasome subunit alpha type-7 levels
Proteasome subunit beta type-4 levels
Proteasome subunit beta type-9 levels
Protein 4.1 levels
Protein ABHD14A levels
Protein AMBP levels
Protein APCDD1 levels
Protein arginine N-methyltransferase 3 levels
Protein argonaute-1 levels
Protein argonaute-3 levels
Protein biomarker
Protein BTG2 levels
Protein C levels
Protein C-ets-2 levels
Protein canopy homolog 3 levels
Protein CASC4 levels
Protein CEI levels
Protein CREG1 levels
Protein CREG1 levels (CREG1.9357.4.3)
Protein CYR61 levels
Protein delta homolog 1 levels
Protein delta homolog 2 levels
Protein DEPP level in Chronic kidney disease with hypertension and no diabetes (7178_59)
Protein DEPP levels
Protein DEPP levels (DEPP.7178.59.3)
Protein DGCR14 levels
Protein DGCR6 levels
Protein disulfide-isomerase A3 levels
Protein disulfide-isomerase A4 levels
Protein disulfide-isomerase A6 levels
Protein disulfide-isomerase TMX3 levels
Protein DJ-1 levels
Protein Dos levels
Protein ERGIC-53 levels
Protein eva-1 homolog B levels
Protein eva-1 homolog C levels
Protein eva-1 homolog C levels (EVA1C.7008.13.3)
Protein EVI2B levels (EVI2B.13028.2.3)
Protein FAM134B levels
Protein FAM151A levels
Protein FAM151A levels (FAM151A.7856.51.3)
Protein FAM162A levels
Protein FAM163A levels (FAM163A.6260.14.3)
Protein FAM163B levels
Protein FAM171A2 level in Chronic kidney disease with hypertension and no diabetes (13479_8)
Protein FAM171B levels
Protein FAM171B levels (FAM171B.8851.42.3)
Protein FAM172A levels
Protein FAM177A1 levels
Protein FAM177A1 levels (FAM177A1.8039.41.3)
Protein FAM189A2 levels (FAM189A2.5699.19.3)
Protein FAM19A5 levels
Protein FAM209B levels
Protein FAM210A level in Chronic kidney disease with hypertension and no diabetes (14593_152)
Protein FAM221B level in Chronic kidney disease with hypertension and no diabetes (25493_11)
Protein FAM234B levels
Protein FAM24B levels
Protein FAM3B level in Chronic kidney disease with hypertension and no diabetes (9177_6)
Protein FAM3B levels
Protein FAM3B levels (FAM3B.9177.6.3)
Protein FAM3D level in Chronic kidney disease with hypertension and no diabetes (13102_1)
Protein FAM3D levels
Protein FAM3D levels (FAM3D.13102.1.3)
Protein FAM49B levels
Protein FAM69C levels
Protein FEV levels
Protein flightless-1 homolog levels
Protein GPR107 levels
Protein HEXIM1 levels
Protein Hikeshi levels
Protein jagged-1 levels
Protein JTB levels
Protein kinase C and casein kinase substrate in neurons protein 1 levels
Protein kinase C and casein kinase substrate in neurons protein 3 levels
Protein kinase C beta type (splice variant beta-II) levels
Protein kinase C gamma type levels
Protein kinase C iota type levels
Protein kinase C theta type levels
Protein kinase C-binding protein NELL1 levels
Protein kinase C-binding protein NELL1 levels (NELL1.6544.33.3)
Protein kinase C-binding protein NELL2 levels
Protein kish-B levels
Protein Largen levels
Protein LDOC1 level in Chronic kidney disease with hypertension and no diabetes (8378_3)
Protein LDOC1 levels
Protein level change in low calorie diet obesity intervention
Protein levels in obesity
Protein lin-7 homolog B level in Chronic kidney disease with hypertension and no diabetes (22990_20)
Protein lin-7 homolog B levels
Protein mago nashi homolog 2 levels
Protein max levels
Protein MEMO1 levels
Protein MENT levels (MENT.5744.12.3)
Protein MRVI1 levels
Protein NATD1 levels
Protein NDRG4 levels
Protein NOV homolog levels
Protein NOV homolog levels (NOV.2737.22.2)
Protein O-glucosyltransferase 1 levels
Protein O-glucosyltransferase 1 levels (POGLUT1.6467.65.3)
Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 levels
Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 levels (POMGNT2.6359.50.3)
Protein O-mannose kinase levels
Protein p13 MTCP-1 levels
Protein PET117 homolog, mitochondrial levels
Protein phosphatase 1 regulatory subunit 14A levels
Protein phosphatase 1 regulatory subunit 3B levels
Protein phosphatase 1A levels
Protein phosphatase 1B level in Chronic kidney disease with hypertension and no diabetes (22009_1)
Protein phosphatase 1D levels
Protein phosphatase 1G level in Chronic kidney disease with hypertension and no diabetes (21823_5)
Protein phosphatase 1L levels
Protein phosphatase inhibitor 2 levels
Protein polybromo-1 levels
Protein quaking levels
Protein quantitative trait loci
Protein quantitative trait loci (liver)
Protein Red levels
Protein RIC-3 levels
Protein RIC-3 levels (RIC3.11228.37.3)
Protein ripply3 level in Chronic kidney disease with hypertension and no diabetes (24634_1)
Protein S100-A10 levels
Protein S100-A11 levels
Protein S100-A12 levels
Protein S100-A14 levels
Protein S100-A16 levels
Protein S100-A2 levels
Protein S100-A3 levels
Protein S100-A4 levels (S100A4.14116.129.3)
Protein S100-A5 levels
Protein S100-A5 levels (S100A5.14222.68.3)
Protein S100-P levels
Protein SCO1 homolog, mitochondrial levels
Protein SCO2 homolog, mitochondrial levels
Protein SEC13 homolog levels
Protein SEC13 homolog levels (SEC13.14689.3.3)
Protein sel-1 homolog 2 levels
Protein sel-1 homolog 2 levels (SEL1L2.9082.25.3)
Protein SERAC1 levels (SERAC1.8985.13.3)
Protein SET levels
Protein SGT1 homolog levels
Protein shisa-2 homolog level in Chronic kidney disease with hypertension and no diabetes (10449_31)
Protein shisa-2 homolog levels
Protein shisa-3 homolog levels (SHISA3.7057.18.3)
Protein transport protein Sec61 subunit gamma levels
Protein TSSC4 levels
Protein unc-45 homolog A levels
Protein Wnt-10a levels
Protein Wnt-11 levels
Protein Wnt-3a level in Chronic kidney disease with hypertension and no diabetes (13236_25)
Protein Wnt-3a levels
Protein Wnt-5a levels
Protein Wnt-7a levels
Protein YIPF6 levels
Protein Z-dependent protease inhibitor level in Chronic kidney disease with hypertension and no diabetes (13119_26)
Protein Z-dependent protease inhibitor levels
Protein Z-dependent protease inhibitor levels (SERPINA10.13119.26.3)
Protein zwilch homolog level in Chronic kidney disease with hypertension and no diabetes (18302_204)
Protein-glutamine gamma-glutamyltransferase 2 levels
Protein-L-isoaspartate(D-aspartate) O-methyltransferase levels
Protein-tyrosine kinase 2-beta levels
Protein-tyrosine sulfotransferase 1 levels
Protein-tyrosine sulfotransferase 1 levels (TPST1.7928.183.3)
Protein-tyrosine sulfotransferase 2 levels
Protein-tyrosine sulfotransferase 2 levels (TPST2.8024.64.3)
Proteinase-activated receptor 1 levels
Proteinuria
Proteinuria (mild)
Proteinuria (moderate to severe)
Proteinuria and chronic kidney disease
Proteinuria in chronic kidney disease
Proteinuria in preeclampsia
Proteoglycan 3 levels
Prothrombin fragments F1+2 levels in ischemic stroke
Prothrombin levels
Prothrombin time
Proto-oncogene tyrosine-protein kinase MER level in Chronic kidney disease with hypertension and no diabetes (19787_14)
Proto-oncogene tyrosine-protein kinase receptor Ret levels
Proto-oncogene tyrosine-protein kinase receptor Ret levels (RET.3220.40.2)
Proto-oncogene tyrosine-protein kinase Src levels
Protocadherin alpha-4 levels
Protocadherin alpha-7 levels
Protocadherin alpha-7 levels (PCDHA7.8758.2.3)
Protocadherin alpha-C1 levels
Protocadherin beta-2 levels
Protocadherin beta-4 levels (PCDHB4.10522.167.3)
Protocadherin beta-7 levels
Protocadherin gamma-A1 level in Chronic kidney disease with hypertension and no diabetes (6457_50)
Protocadherin gamma-A1 levels
Protocadherin gamma-A10 levels
Protocadherin gamma-A12 levels
Protocadherin gamma-A2 levels
Protocadherin gamma-B1 levels
Protocadherin gamma-C3 level in Chronic kidney disease with hypertension and no diabetes (7859_21)
Protocadherin gamma-C3 levels
Protocadherin gamma-C5 levels (PCDHGC5.7983.1.3)
Protocadherin-10 level in Chronic kidney disease with hypertension and no diabetes (8780_2)
Protocadherin-10 levels
Protocadherin-10 levels (PCDH10.8780.2.3)
Protocadherin-8 levels
Protocadherin-9 levels
Protrudin level in Chronic kidney disease with hypertension and no diabetes (13432_9)
Protrudin levels
Provencibacterium abundance in stool
Provencibacterium massiliense abundance in stool
Proximal colorectal cancer
Prudent dietary pattern
Pseudokinase FAM20A levels (FAM20A.6433.57.3)
Pseudouridine levels
Pseudouridine levels in elite athletes
Psoriasis
Psoriasis or coronary artery disease
Psoriasis or type 2 diabetes (trans-disease meta-analysis)
Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect)
Psoriasis vulgaris
Psoriatic arthritis
Psoriatic arthritis vs Cutaneous psoriasis
PSP94 plasma levels
Psychiatric diseases (pleiotropy) (HIPO component 1)
Psychiatric symptomatology
Psychiatric symptomatology and risky substance use
Psychological distress
Psychosis (atypical)
Psychosis (methamphetamine induced)
Psychosis and Alzheimer's disease
Psychosis in Alzheimer's disease
Psychosis proneness (hypomanic personality scale and perceptual aberration scale)
Psychosis proneness (hypomanic personality scale and revised physical anhedonia scale)
Psychosis proneness (hypomanic personality scale and revised social anhedonia scale)
Psychosis proneness (hypomanic personality scale)
Psychosis proneness (perceptual aberration scale and revised social anhedonia scale)
Psychosis proneness (perceptual aberration scale)
Psychosis proneness (revised physical anhedonia scale and revised social anhedonia scale)
Psychosis proneness (revised physical anhedonia scale)
Psychosis proneness (revised social anhedonia scale)
Psychotic symptoms in prion disease
PTB domain-containing engulfment adapter protein 1 levels
Pterin-4-alpha-carbinolamine dehydratase 2 levels
Pubertal anthropometrics
Puberty onset
Puberty onset (breast development)
Puberty onset (genital enlargement)
Pulmonary arterial hypertension
Pulmonary arterial hypertension (without BMPR2 mutations)
Pulmonary artery enlargement and chronic obstructive pulmonary disease
Pulmonary artery enlargement in chronic obstructive pulmonary disease
Pulmonary fibrosis
Pulmonary function
Pulmonary function (smoking interaction)
Pulmonary function decline
Pulmonary function in asthmatics
Pulmonary mycobacterium avium complex disease
Pulmonary surfactant-associated protein B levels
Pulmonary surfactant-associated protein D level in Chronic kidney disease with hypertension and no diabetes (19590_46)
Pulmonary surfactant-associated protein D levels
Pulmonary tuberculosis
Pulse pressure
Pulse pressure (alcohol consumption interaction)
Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test)
Pulse pressure x alcohol consumption interaction (2df test)
Pulse pressure x anxiety symptoms interaction (1df test)
Pulse pressure x anxiety symptoms interaction (2df test)
Pulse pressure x depressive symptoms interaction (1df test)
Pulse pressure x depressive symptoms interaction (2df test)
Pulse pressure x low social support interaction (2df test)
Pulse rate
Pure non-grapefruit juice consumption
Purine nucleoside phosphorylase levels
Pursuit maintenance gain
Pursuit maintenance gain in psychotic disorders
Putamen volume
Putamen volume change rate
Putamen volume change rate x age interaction (1df)
Putamen volume change rate x age interaction (2df)
Putative chondrosarcoma-associated gene 1 protein levels
Putative D-tyrosyl-tRNA(Tyr) deacylase 2 levels
Putative pregnancy-specific beta-1-glycoprotein 7 levels
Pyoderma gangrenosum in inflammatory bowel disease
Pyridoxal kinase levels
Pyridoxal levels in elite athletes
Pyridoxal phosphate phosphatase levels
Pyridoxamine levels
Pyridoxate levels in elite athletes
Pyridoxine-5-phosphate oxidase levels
Pyridoxine-5'-phosphate oxidase level in Chronic kidney disease with hypertension and no diabetes (17804_102)
Pyroglutamic acid levels
Pyroglutamine levels
Pyroglutamine levels in elite athletes
Pyrroline-5-carboxylate reductase 1, mitochondrial levels
Pyrroline-5-carboxylate reductase 2 levels
Pyruvate carboxylase, mitochondrial levels
Pyruvate dehydrogenase protein X component, mitochondrial levels
Pyruvate kinase PKLR levels (PKLR.11203.97.3)
Pyruvate levels
Pyruvate levels (UKB data field 23472)
Pyruvate levels in elite athletes
QC rfMRI cleaned inverse tSNR
QC SWI-to-T1 linear alignment discrepancy
QC T2 FLAIR-to-T1 linear alignment discrepancy
QRS complex (12-leadsum)
QRS complex (Cornell)
QRS complex (Sokolow-Lyon)
QRS duration
QRS duration in Tripanosoma cruzi seropositivity
QRS interval (sulfonylurea treatment interaction)
QT dynamics during exercise
QT dynamics during recovery from exercise
QT interval
QT interval (ambient particulate matter interaction)
QT interval (drug interaction)
QT interval (sulfonylurea treatment interaction)
QT interval in Tripanosoma cruzi seropositivity
QTc interval
Quantitative traits
Quinate levels in elite athletes
Quinolinate levels
Quinone oxidoreductase levels
Quinone oxidoreductase PIG3 level in Chronic kidney disease with hypertension and no diabetes (17748_21)
Quinone oxidoreductase PIG3 levels
Quinone oxidoreductase-like protein 1 levels
R-6-hydroxywarfarin levels
R-6-hydroxywarfarin to R-warfarin ratio
R-spondin-1 levels
R-spondin-3 levels
R-spondin-3 levels (RSPO3.13094.75.3)
R-spondin-4 levels
R-warfarin levels
Rab GDP dissociation inhibitor beta levels
RAB6-interacting golgin levels (GORAB.7247.1.3)
Rab9 effector protein with kelch motifs levels
Rab9 effector protein with kelch motifs levels (RABEPK.13599.15.3)
RAC-alpha serine/threonine-protein kinase levels
RAC-beta serine/threonine-protein kinase level in Chronic kidney disease with hypertension and no diabetes (5360_9)
RAC-beta serine/threonine-protein kinase levels
Radial peak diastolic strain rate
Radiation response
Radiation-induced brain injury in nasopharyngeal carcinoma
radiation-induced toxicity (patient-rated acute sticky saliva)
radiation-induced toxicity (patient-rated acute xerostomia)
radiation-induced toxicity (physician-rated acute dysphagia)
radiation-induced toxicity (physician-rated acute mucositis)
radiation-induced toxicity (physician-rated acute xerostomia)
radiation-induced toxicity (standardized total average toxicity_patient)
Radixin levels
RAF proto-oncogene serine/threonine-protein kinase levels
Ragulator complex protein LAMTOR2 levels
Ragulator complex protein LAMTOR3 levels
Ran-binding protein 3 levels
Ran-specific GTPase-activating protein levels
Random glucose levels
RANTES levels
RANTES plasma levels
Rap1 GTPase-GDP dissociation stimulator 1 levels
Rapid alternating stimulus test for letters/numbers
Rapid automised naming and rapid alternating stimulus test performance
Rapid automised naming of digits
Rapid automised naming of letters
Rapid automised naming of pictures
Ras GTPase-activating protein 1 levels
Ras GTPase-activating protein 1 levels (RASA1.5481.16.3)
Ras GTPase-activating protein-binding protein 1 levels
Ras GTPase-activating protein-binding protein 2 levels
Ras-related and estrogen-regulated growth inhibitor levels
Ras-related C3 botulinum toxin substrate 3 levels
Ras-related protein M-Ras levels
Ras-related protein R-Ras levels
Ras-related protein R-Ras2 levels
Ras-related protein Rab-11A levels
Ras-related protein Rab-13 levels
Ras-related protein Rab-17 level in Chronic kidney disease with hypertension and no diabetes (11118_107)
Ras-related protein Rab-1B levels
Ras-related protein Rab-22A levels
Ras-related protein Rab-26 levels
Ras-related protein Rab-26 levels (RAB26.6997.32.3)
Ras-related protein Rab-27A levels
Ras-related protein Rab-27B levels
Ras-related protein Rab-2A levels
Ras-related protein Rab-2B levels
Ras-related protein Rab-35 levels
Ras-related protein Rab-35 levels (RAB35.13514.121.3)
Ras-related protein Rab-39B levels
Ras-related protein Rab-3A levels
Ras-related protein Rab-43 level in Chronic kidney disease with hypertension and no diabetes (23283_9)
Ras-related protein Rab-4A levels
Ras-related protein Rab-5A levels
Ras-related protein Rab-5B levels
Ras-related protein Rab-5C levels
Ras-related protein Rab-6B levels
Ras-related protein Rab-7b levels
Ras-related protein Ral-A levels
Ras-related protein Ral-B levels
Rate of cognitive decline in Alzheimer's disease
Rate of cognitive decline in mild cognitive impairment (time interaction)
Rate of ventricular enlargement
Ratio of apolipoprotein A1 to apolipoprotein B
Ratio of apolipoprotein B to apolipoprotein A1 levels
Ratio of bis-allylic bonds to double bonds in lipids
Ratio of docosahexaenoic acid to total fatty acid levels
Ratio of linoleic acid to total fatty acids
Ratio of monounsaturated fatty acids to total fatty acids
Ratio of omega-3 fatty acids to total fatty acids
Ratio of omega-6 fatty acids to omega-3 fatty acids
Ratio of omega-6 fatty acids to total fatty acids
Ratio of polyunsaturated fatty acids to monounsaturated fatty acids
Ratio of polyunsaturated fatty acids to total fatty acids
Ratio of saturated fatty acids to total fatty acids
Ratio of the area under the curve for insulin and the area under the curve for glucose
Ratio of triglycerides to phosphoglycerides
Raw carrot liking
Raw vegetable consumption
RBC levels of [Similar to: L-Glutathione (reduced); deltaMass: -0.0338 Da]
RBC levels of [Similar to: L-Glutathione oxidized; deltaMass: 308.8758 Da]
RBC levels of 1-Methylxanthine
RBC levels of 12(13)-EpOME
RBC levels of 14-HDoHE.1
RBC levels of 2-Hydroxyglutarate (uM)
RBC levels of 2S-5S-Methionine sulfoximine
RBC levels of 3-Dehydrocarnitine
RBC levels of 5-6-Dihydrothymine
RBC levels of 5-Deoxyribose-1-phosphate
RBC levels of 9,10,EpOME
RBC levels of AA
RBC levels of acetyl-carnitine
RBC levels of Asp (uM)
RBC levels of Choline
RBC levels of cis-p-Coumarate
RBC levels of D-Glucose (mM) (uM)
RBC levels of D-Glucose 6-phosphate
RBC levels of ERGOTHIONEINE
RBC levels of Gln (uM)
RBC levels of Glutamate
RBC levels of Glycerol 3-phosphate
RBC levels of Glycocholate.1
RBC levels of Hexose phosphate (uM)
RBC levels of Hypoxanthine
RBC levels of Hypoxanthine (uM)
RBC levels of L-Carnitine
RBC levels of L-Carnitine.1
RBC levels of L-Noradrenaline
RBC levels of L-Palmitoylcarnitine
RBC levels of Malate (uM)
RBC levels of Met (uM)
RBC levels of Methionine
RBC levels of N6-Methyl-L-lysine
RBC levels of Octanoic acid (caprylate)
RBC levels of Pyridoxal
RBC levels of Pyruvate (uM)
RBC levels of Spermine
RBC levels of Spermine (uM)
RBC levels of Threonine
RBC levels of UDP-N-acetyl-D-glucosamine
RBC levels of Undecanoyl carnitine
Reaction time
Reaction time (standard GWA)
Reading ability (multivariate)
Reading and spelling
Reading disability
Reading disability or specific language impairment (pleiotropy)
Reading disability or specific language impairment adjusted for intelligence quotient (pleiotropy)
Reading or mathematical ability
Recalcitrant atopic dermatitis
Receptive language ability
Receptor for advanced glycosylation end products levels
Receptor tyrosine-protein kinase erbB-3 levels
Receptor tyrosine-protein kinase erbB-4 levels
Receptor-binding cancer antigen expressed on SiSo cells levels
Receptor-interacting serine/threonine-protein kinase 2 levels
Receptor-transporting protein 4 levels
Receptor-type tyrosine-protein kinase FLT3 levels
Receptor-type tyrosine-protein phosphatase H levels
Receptor-type tyrosine-protein phosphatase H levels (PTPRH.11222.62.3)
Receptor-type tyrosine-protein phosphatase R level in Chronic kidney disease with hypertension and no diabetes (6361_49)
Receptor-type tyrosine-protein phosphatase R levels
Receptor-type tyrosine-protein phosphatase S levels
Recombination rate (females)
Recombination rate (males)
Recoverin levels
Rectal cancer
Rectal cancer vs colon cancer
Recurrence-free survival in non-muscle-invasive bladder cancer
Recurrent major depressive disorder
Recurrent major depressive disorder x sex interaction
Red blood cell count
Red blood cell density in sickle cell anemia
Red blood cell distribution width coefficient of variation
Red blood cell fatty acid levels
Red blood cell folate levels
Red blood cell traits
Red blood cell traits (multivariate analysis)
Red cell distribution width
Red meat liking
Red vs non-red hair color
Red vs. brown/black hair color
Red wine consumption (glasses per month) (UKB data field 1578, 4419)
Redox-regulatory protein FAM213A levels
Redox-regulatory protein FAM213A levels (FAM213A.13423.94.3)
Reduced foot dorsiflexion strength in Charcot-Marie-Tooth disease type 1A
Reduction in HbA1c levels in response to sulfonylureas treatment in type 2 diabetes
Reflection (response to stress)
Refractive astigmatism
Refractive error
Refractive error (autorefraction measured)
Refractory celiac disease type II
Regenerating islet-derived protein 3-alpha levels
Regenerating islet-derived protein 3-gamma levels
Regular attendance at a gym or sports club
Regular attendance at a pub or social club
Regular attendance at a religious group
Regulation of nuclear pre-mRNA domain-containing protein 1A levels
Regulation of nuclear pre-mRNA domain-containing protein 1A levels (RPRD1A.13515.8.3)
Regulation of nuclear pre-mRNA domain-containing protein 1B levels
Regulator of G-protein signaling 1 levels
Regulator of G-protein signaling 13 level in Chronic kidney disease with hypertension and no diabetes (22548_18)
Regulator of G-protein signaling 18 levels
Regulator of G-protein signaling 19 levels
Regulator of G-protein signaling 19 levels (RGS19.12713.365.3)
Regulator of G-protein signaling 3 levels
Regulator of G-protein signaling 4 levels
Regulator of G-protein signaling 5 levels
Regulator of microtubule dynamics protein 1 levels
Regulator of microtubule dynamics protein 1 levels (RMDN1.7096.30.3)
Regulatory factor X-associated protein levels
Relapse after allogeneic hematopoietic cell transplantation (donor effect)
Relapse after allogeneic hematopoietic cell transplantation (recipient effect)
Relapse in multiple sclerosis
Relative amplitude of rest-activity cycles
Relative brain age
Relative carbohydrate intake
Relative fat intake
Relative hand skill
Relative hand skill in reading disability
Relative index of whole blood hyposectomy
Relative protein intake
Relative sugar intake
Relative wall thickness
Relaxin receptor 1 levels
Relaxin-3 levels
RELT-like protein 1 levels
RELT-like protein 2 levels
REM sleep behavior disorder (probable or isolated)
Remission after antidepressant treatment in major depression
Remission after antidepressant treatment in major depressive disorder
Remission after SSRI treatment in MDD or neuroticism
Remission after SSRI treatment in MDD or openness
Remnant cholesterol (non-HDL, non-LDL -cholesterol)
Remnant cholesterol (non-HDL, non-LDL -cholesterol) levels (UKB data field 23402)
Renal cell carcinoma
Renal cell carcinoma x sex interaction
Renal function and chronic kidney disease
Renal function-related traits (BUN)
Renal function-related traits (eGRFcrea)
Renal function-related traits (sCR)
Renal function-related traits (urea)
Renal overload gout
Renal sinus fat
Renal underexcretion gout
Renin levels
Replication protein A 32 kDa subunit levels
Repulsive guidance molecule A levels
Repulsive guidance molecule A levels (RGMA.5483.1.3)
Residual cognition
Residual cognitive resilience
Resistance to antihypertensive treatment in hypertension
Resistance to COVID-19 infection (Exposed negative vs positive)
Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (continuous)
Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (dichotomous)
Resistant hypertension
Resistin levels
Respiratory diseases
Response to (pegylated) interferon in chronic hepatitis B
Response to (pegylated) interferon in HBeAg-negative hepatitis B
Response to abacavir-containing treatment in HIV-1 infection (virologic failure)
Response to acetaminophen (hepatotoxicity)
Response to adalimumab in hidradenitis suppurativa (abscess and inflammatory nodule count increase)
Response to alcohol consumption (flushing response)
Response to allopurinol in gout (change in serum uric acid levels)
Response to amphetamines
Response to angiotensin II receptor blocker therapy
Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)
Response to anti-depressant treatment in major depressive disorder
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)
Response to anti-TNF alpha therapy in inflammatory bowel disease
Response to anti-TNF therapy in rheumatoid arthritis
Response to anticonvulsants (pain relief efficacy)
Response to antidepressant treatment (citalopram)
Response to antidepressants
Response to antidepressants (non-treatment-resistant vs treatment-resistant depression)
Response to antidepressants (pain relief efficacy)
Response to antidepressants (symptom improvement)
Response to antidepressants (symptom improvement) in major depressive disorder
Response to antidepressants (symptom remission)
Response to antidepressants and depression
Response to antidepressants in depression
Response to antidepressants in major depressive disorder
Response to antiepileptic drugs in genetic generalized epilepsy
Response to antiepileptic mood-stabilizing treatment in bipolar disorder
Response to antineoplastic agents
Response to antioxidants and zinc in age-related macular degeneration (disease progression)
Response to antipsychotic therapy (extrapyramidal side effects)
Response to antipsychotic treatment
Response to antipsychotic treatment in schizophrenia
Response to antipsychotic treatment in schizophrenia (reasoning)
Response to antipsychotic treatment in schizophrenia (working memory)
Response to arsenic trioxide
Response to beta blocker use in hypertension (systolic blood pressure)
Response to bleomycin (chromatid breaks)
Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)
Response to buprenorphine in opioid use disorder
Response to calcium-channel-Active anticonvulsants in epilepsy
Response to calcium-channel-Active anticonvulsants in focal epilepsy
Response to carbamazepine in focal epilepsy
Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)
Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)
Response to carboplatin in ovarian cancer (MTT IC50)
Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)
Response to cholinesterase inhibitors in Alzheimer's disease
Response to citalopram or escitalopram in depression
Response to citalopram treatment
Response to cladaribine
Response to clopidogrel therapy
Response to cognitive-behavioural therapy in anxiety disorder
Response to cognitive-behavioural therapy in major depressive disorder
Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis
Response to cytadine analogues (cytosine arabinoside)
Response to cytidine analogues (gemcitabine)
Response to dabigatran etexilate treatment
Response to dolutegravir in HIV infection (area under the concentration-time curve)
Response to dolutegravir in HIV infection (clearance)
Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)
Response to erlotinib
Response to esketamine (remission) in treatment resistant depression
Response to esketamine (responder status) in treatment resistant depression
Response to esketamine in treatment resistant depression
Response to exercise (triglyceride level interaction)
Response to fenofibrate (adiponectin levels)
Response to fenofibrate (HDL cholesterol levels)
Response to fenofibrate (LDL cholesterol levels)
Response to fluoro-deoxyuridine
Response to gamma-aminobutyric acid receptor agonists (pain relief efficacy)
Response to gemcitabine in pancreatic cancer
Response to haloperidol in psychosis
Response to haloperidol in schizophrenia
Response to hepatitis B vaccine
Response to hepatitis C treatment
Response to Homoharringtonine (cytotoxicity)
Response to hydroxyurea
Response to iloperidone treatment (QT prolongation)
Response to immune checkpoint inhibitors in melanoma (immune-related adverse events)
Response to influenza vaccine
Response to inhaled corticosteroid treatment in asthma (change in FEV1)
Response to interferon beta in multiple sclerosis
Response to interferon treatment in hepatitis C virus genotype 3
Response to intravenous immunoglobulin treatment in Kawasaki disease
Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer
Response to ketamine in bipolar disorder or major depression (antidepressant effects)
Response to ketamine in bipolar disorder or major depression (dissociation effects)
Response to lamotrigine and valproic acid in genetic generalized epilepsy
Response to lamotrigine in epilepsy
Response to lamotrigine in focal epilepsy
Response to lamotrigine in genetic generalized epilepsy
Response to levetiracetam in epilepsy
Response to levetiracetam in focal epilepsy
Response to levetiracetam in genetic generalized epilepsy
Response to long-chain n-3 polyunsaturated fatty acid supplementation (change in triglyceride levels)
Response to long-term oxygen therapy in chronic obstructive pulmonary disease
Response to lurasidone in schizophrenia
Response to mepolizumab in severe asthma
Response to metfomin (Glucose levels at 60 minutes adjusted for baseline glucose levels)
Response to metformin (IC50)
Response to metformin in type 2 diabetes (glycemic)
Response to metformin in type 2 diabetes (HbA1c reduction)
Response to methotrexate in juvenile idiopathic arthritis
Response to methotrexate in rheumatoid arthritis
Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)
Response to mTOR inhibitor (everolimus)
Response to nintedanib
Response to non-steroidal anti-inflammatory drugs (pain relief efficacy)
Response to norepinephrine-dopamine reuptake inhibitors (responders vs non-responders)
Response to ondansetron (change in QTc)
Response to opioid analgesics in cancer (pain decrease)
Response to oxaliplatin
Response to oxcarbazepine in focal epilepsy
Response to paclitaxel
Response to paclitaxel and epirubicin
Response to paliperidone in schizophrenia (CGI-S score)
Response to paliperidone in schizophrenia (Multivariate)
Response to paliperidone in schizophrenia (negative Marder score)
Response to paliperidone in schizophrenia (PANSS score)
Response to paliperidone in schizophrenia (positive Marder score)
Response to perphenazine in schizophrenia
Response to phenytoin in focal epilepsy
Response to placebo treatment in childhood asthma (FVC change)
Response to platinum-based chemotherapy (carboplatin)
Response to platinum-based chemotherapy (cisplatin)
Response to platinum-based chemotherapy in non-small-cell lung cancer
Response to platinum-based neoadjuvant chemotherapy in cervical cancer
Response to quetiapine in schizophrenia
Response to radiotherapy in cancer (late toxicity)
Response to radiotherapy in prostate cancer (overall toxicity)
Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)
Response to radiotherapy in prostate cancer (toxicity, urinary frequency)
Response to radiotherapy in prostate cancer (toxicity)
Response to risperidone in schizophrenia
Response to selective serotonin reuptake inhibitors and depression
Response to selective serotonin reuptake inhibitors in depression
Response to selenium supplementation (change in plasma selenium concentration)
Response to serotonin reuptake inhibitors in major depressive disorder
Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)
Response to serotonin reuptake inhibitors in non-psychotic unipolar depression
Response to serotonin-norepinephrine reuptake inhibitors (responders vs non-responders)
Response to simvastatin treatment (PCSK9 protein level change)
Response to SSRI (responders vs non-responders)
Response to SSRI (symptom remission)
Response to SSRI in MDD or conscientiouness
Response to SSRI in MDD or openness
Response to statin therapy
Response to statins (HDL cholesterol change)
Response to statins (LDL cholesterol change)
Response to statins (LDL cholesterol percent change)
Response to tamoxifen in breast cancer
Response to taxane treatment (docetaxel)
Response to taxane treatment (placlitaxel)
Response to temozolomide
Response to tenofovir alafenamide (body weight gain)
Response to TNF antagonist treatment
Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)
Response to TNF-alpha inhibitors in rheumatoid arthritis
Response to tocilizumab in rheumatoid arthritis
Response to trametinib
Response to treatment for acute lymphoblastic leukemia
Response to treatment in irritable bowel syndrome (pain frequency)
Response to treatment in irritable bowel syndrome (pain severity)
Response to treatment in irritable bowel syndrome (symptom severity)
Response to ustekinumab in psoriasis (improvement)
Response to valproic acid in focal epilepsy
Response to valproic acid in genetic generalized epilepsy
Response to vandetanib
Response to vemurafenib
Response to Vitamin E supplementation
Response to zileuton treatment in asthma (FEV1 change interaction)
Response to ziprazidone in schizophrenia
Resting CD4 regulatory T cell %CD4 regulatory T cell
Resting CD4 regulatory T cell %CD4+ T cell
Resting CD4 regulatory T cell Absolute Count
Resting heart rate
Resting metabolic rate
Resting-state electroencephalogram vigilance
Resting-state network 1 amplitude (blood oxygenation level dependent) (Default mode network)
Resting-state network 10 amplitude (blood oxygenation level dependent) (Motor)
Resting-state network 10 amplitude (Motor)
Resting-state network 10 temporal synchrony (Motor)
Resting-state network 11 amplitude (blood oxygenation level dependent) (Motor)
Resting-state network 11 temporal synchrony (Motor)
Resting-state network 12 amplitude (blood oxygenation level dependent) (Motor)
Resting-state network 12 amplitude (Motor)
Resting-state network 12 temporal synchrony (Motor)
Resting-state network 13 amplitude (blood oxygenation level dependent) (Language)
Resting-state network 14 amplitude (blood oxygenation level dependent) (Salience)
Resting-state network 14 amplitude (Salience)
Resting-state network 14 temporal synchrony (Salience)
Resting-state network 15 amplitude (blood oxygenation level dependent) (Cerebellum)
Resting-state network 16 amplitude (blood oxygenation level dependent) (Executive control)
Resting-state network 17 amplitude (blood oxygenation level dependent) (Auditory)
Resting-state network 17 temporal synchrony (Auditory)
Resting-state network 18 amplitude (blood oxygenation level dependent) (Subcortical)
Resting-state network 18 temporal synchrony (Subcortical)
Resting-state network 2 amplitude (blood oxygenation level dependent) (Visual)
Resting-state network 20 amplitude (blood oxygenation level dependent) (Precuneal default mode network)
Resting-state network 21 amplitude (blood oxygenation level dependent) (Language)
Resting-state network 21 amplitude (Language)
Resting-state network 21 temporal synchrony (Language)
Resting-state network 3 amplitude (Attention)
Resting-state network 3 amplitude (blood oxygenation level dependent) (Attention)
Resting-state network 5 amplitude (blood oxygenation level dependent) (Fronto-parietal)
Resting-state network 6 amplitude (blood oxygenation level dependent) (Fronto-parietal)
Resting-state network 6 amplitude (Fronto-parietal)
Resting-state network 7 amplitude (blood oxygenation level dependent) (Limbic default mode network)
Resting-state network 9 amplitude (blood oxygenation level dependent) (Language)
Restless legs syndrome
Restricted and repetitive behaviours in autism spectrum disorder
Reticulocalbin-3 levels
Reticulocyte count
Reticulocyte fraction of red cells
Reticulon-1 level in Chronic kidney disease with hypertension and no diabetes (24651_1)
Reticulon-4 receptor levels
Reticulon-4-interacting protein 1, mitochondrial levels
Retina-specific copper amine oxidase levels
Retinal arterial distance factor tortuosity
Retinal arteriolar caliber
Retinal arteriolar tortuosity
Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma level in Chronic kidney disease with hypertension and no diabetes (20393_10)
Retinal detachment
Retinal detachment or retinal break
Retinal detachment with retinal break
Retinal levels in elite athletes
Retinal nerve fibre layer (RNFL) thickness
Retinal nerve fibre layer thickness or ganglion cell inner plexiform layer thickness (MTAG)
Retinal vascular caliber
Retinal vascular fractal density
Retinal vascular fractal dimension
Retinal venular tortuosity
Retinaldehyde-binding protein 1 level in Chronic kidney disease with hypertension and no diabetes (12936_38)
Retinaldehyde-binding protein 1 levels
Retinaldehyde-binding protein 1 levels (RLBP1.12936.38.3)
Retinoblastoma-associated protein levels
Retinoblastoma-like protein 1 levels
Retinoblastoma-like protein 2 levels
Retinoic acid early transcript 1G protein levels
Retinoic acid early transcript 1L protein level in Chronic kidney disease with hypertension and no diabetes (20526_3)
Retinoic acid receptor responder protein 1 level in Chronic kidney disease with hypertension and no diabetes (8398_277)
Retinoic acid receptor responder protein 1 levels
Retinoic acid receptor responder protein 1 levels (RARRES1.8398.277.3)
Retinoic acid receptor responder protein 2 levels
Retinoic acid receptor responder protein 3 levels
Retinoid-binding protein 7 levels
Retinol (Vitamin A) levels
Retinol (Vitamin A) levels in elite athletes
Retinol dehydrogenase 16 level in Chronic kidney disease with hypertension and no diabetes (12881_17)
Retinol dehydrogenase 16 levels
Retinol levels
Retinol-binding protein 1 levels
Retinol-binding protein 4 levels
Retinopathy in non-diabetics
Retinopathy x type 2 diabetes interaction
Retinoschisin levels
Retroviral-like aspartic protease 1 levels
Retroviral-like aspartic protease 1 levels (ASPRV1.13023.8.3)
Revision surgery after total hip arthroplasty
Revision surgery after total joint arthroplasty
Revision surgery after total knee arthroplasty
Revision surgery due to aseptic loosening after total hip arthroplasty
Revision surgery due to aseptic loosening after total joint arthroplasty
Revision surgery due to aseptic loosening after total knee arthroplasty
Rey auditory verbal learning test (24 month visit)(adjusted for APOE e4 dosage)
rfMRI amplitudes (ICA100 node 11)
rfMRI amplitudes (ICA100 node 12)
rfMRI amplitudes (ICA100 node 27)
rfMRI amplitudes (ICA100 node 30)
rfMRI amplitudes (ICA100 node 35)
rfMRI amplitudes (ICA100 node 40)
rfMRI amplitudes (ICA100 node 44)
rfMRI amplitudes (ICA100 node 45)
rfMRI amplitudes (ICA25 node 12)
rfMRI connectivity (ICA100 edge 1001)
rfMRI connectivity (ICA100 edge 1011)
rfMRI connectivity (ICA100 edge 1083)
rfMRI connectivity (ICA100 edge 1090)
rfMRI connectivity (ICA100 edge 1091)
rfMRI connectivity (ICA100 edge 1099)
rfMRI connectivity (ICA100 edge 237)
rfMRI connectivity (ICA100 edge 380)
rfMRI connectivity (ICA100 edge 383)
rfMRI connectivity (ICA100 edge 387)
rfMRI connectivity (ICA100 edge 39)
rfMRI connectivity (ICA100 edge 391)
rfMRI connectivity (ICA100 edge 399)
rfMRI connectivity (ICA100 edge 414)
rfMRI connectivity (ICA100 edge 429)
rfMRI connectivity (ICA100 edge 43)
rfMRI connectivity (ICA100 edge 464)
rfMRI connectivity (ICA100 edge 471)
rfMRI connectivity (ICA100 edge 485)
rfMRI connectivity (ICA100 edge 488)
rfMRI connectivity (ICA100 edge 495)
rfMRI connectivity (ICA100 edge 52)
rfMRI connectivity (ICA100 edge 605)
rfMRI connectivity (ICA100 edge 614)
rfMRI connectivity (ICA100 edge 619)
rfMRI connectivity (ICA100 edge 659)
rfMRI connectivity (ICA100 edge 810)
rfMRI connectivity (ICA100 edge 912)
rfMRI connectivity (ICA100 edge 931)
rfMRI connectivity (ICA100 edge 995)
rfMRI connectivity (ICA25 edge 132)
rfMRI connectivity (ICA25 edge 65)
rfMRI connectivity ICA-features 1
rfMRI connectivity ICA-features 3
rfMRI connectivity ICA-features 4
rfMRI connectivity ICA-features 6
RGM domain family member B levels
Rhegmatogenous retinal detachment
Rheumatic fever
Rheumatic heart disease
Rheumatoid arthritis
Rheumatoid arthritis (ACPA-negative)
Rheumatoid arthritis (ACPA-positive)
Rheumatoid arthritis (rheumatoid factor and anti-cyclic citrullinated peptide seronegative)
Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
Rheumatoid factor seropositivity in rheumatoid arthritis
Rho GTPase-activating protein 1 levels
Rho GTPase-activating protein 25 levels
Rho GTPase-activating protein 30 levels
Rho GTPase-activating protein 30 levels (ARHGAP30.12807.89.3)
Rho GTPase-activating protein 45 levels
Rho GTPase-activating protein 5 levels
Rho guanine nucleotide exchange factor 1 levels
Rho guanine nucleotide exchange factor 10 levels
Rho guanine nucleotide exchange factor 10 levels (ARHGEF10.9061.3.3)
Rho guanine nucleotide exchange factor 2 level in Chronic kidney disease with hypertension and no diabetes (12848_9)
Rho guanine nucleotide exchange factor 2 levels
Rho guanine nucleotide exchange factor 25 levels
Rho guanine nucleotide exchange factor 7 level in Chronic kidney disease with hypertension and no diabetes (13932_45)
Rho guanine nucleotide exchange factor 7 levels
Rho-associated protein kinase 2 levels
Rho-related GTP-binding protein Rho6 levels
Rho-related GTP-binding protein RhoD levels
Rho-related GTP-binding protein RhoE levels
Rhophilin-2 levels
Rhophilin-2 levels (RHPN2.11439.88.3)
Ribavirin-induced anemia
Ribavirin-induced anemia in chronic hepatitis C
Ribitol levels
Ribitol levels in elite athletes
Riboflavin kinase levels
Ribokinase levels
Ribonate levels
Ribonuclease 4 levels
Ribonuclease 4 levels (RNASE4.5644.60.3)
Ribonuclease K6 level in Chronic kidney disease with hypertension and no diabetes (5646_20)
Ribonuclease K6 levels
Ribonuclease K6 levels (RNASE6.5646.20.3)
Ribonuclease P protein subunit p30 levels
Ribonuclease pancreatic levels
Ribonuclease pancreatic levels (RNASE1.7211.2.3)
Ribonuclease T2 levels
Ribonuclease UK114 levels (HRSP12.14636.25.3)
Ribonucleoside-diphosphate reductase large subunit levels
Ribonucleoside-diphosphate reductase large subunit levels (RRM1.11360.39.3)
Ribonucleoside-diphosphate reductase subunit M2 B levels
Ribonucleoside-diphosphate reductase subunit M2 B levels (RRM2B.8925.25.3)
Ribonucleoside-diphosphate reductase subunit M2 levels
Ribose-5-phosphate isomerase levels
Ribosomal protein S6 kinase alpha-1 level in Chronic kidney disease with hypertension and no diabetes (12329_21)
Ribosomal protein S6 kinase alpha-1 levels
Ribosomal protein S6 kinase beta-1 levels
Ribosome biogenesis protein TSR3 homolog levels
Ribosome maturation protein SBDS levels
Ribosome-binding protein 1 levels
Ribosyldihydronicotinamide dehydrogenase [quinone] levels
Ribosyldihydronicotinamide dehydrogenase [quinone] levels (NQO2.9754.33.3)
Ribothymidine levels
Ribothymidine levels in chronic kidney disease
Rieske domain-containing protein levels
Right colon cancer
Right hippocampal volume
Right lateral prefrontal cortical growth
Right planum temporale grey matter volume
Right unilateral cleft lip
Right unilateral cleft lip and palate
Right ventricular ejection fraction
Right ventricular ejection fraction (MTAG)
Right ventricular end diastolic volume
Right ventricular end diastolic volume (MTAG)
Right ventricular end systolic volume
Right ventricular peak atrial filling rate
Right ventricular peak ejection rate
Right ventricular stroke volume
Right ventricular stroke volume (MTAG)
Right-sided colonic diverticulosis
RING finger protein 165 levels (RNF165.11561.32.3)
RING finger protein 215 levels
RING finger protein 24 levels
RISC-loading complex subunit TARBP2 levels
Risk taking (standard GWA)
Risk-taking behavior (multivariate analysis)
Risk-taking tendency (4-domain principal component model)
Risky sexual behaviors (alcohol dependence interaction)
Risky sexual behaviors in alcohol dependence
RNA polymerase II elongation factor ELL levels
RNA polymerase II elongation factor ELL levels (ELL.11459.81.3)
RNA polymerase II elongation factor ELL2 level in Chronic kidney disease with hypertension and no diabetes (11494_4)
RNA polymerase II elongation factor ELL2 levels
RNA polymerase II subunit A C-terminal domain phosphatase SSU72 levels
RNA polymerase-associated protein RTF1 homolog levels
RNA-binding protein 24 levels
RNA-binding protein 3 levels
RNA-binding protein 40 levels
Roast chicken liking
Rocuronium dose requirement in breast cancer surgery
Ropporin-1B level in Chronic kidney disease with hypertension and no diabetes (25453_57)
Rosacea symptom severity
Rostral anterior cingulate cortex volume
Rostral middle frontal gyrus volume
Rotator cuff tears
Roundabout homolog 1 levels
RR interval (heart rate)
RR interval (tricyclic/tetracyclic antidepressant use interaction)
rRNA 2-O-methyltransferase fibrillarin levels
rRNA methyltransferase 3, mitochondrial levels (RNMTL1.9584.105.3)
RS-10-hydroxywarfarin levels
RS-10-hydroxywarfarin to RS-warfarin ratio
RS-6-hydroxywarfarin levels
RS-warfarin levels
Rubella
Rumination (response to stress)
RUN and FYVE domain-containing protein 1 levels
S-1-pyrroline-5-carboxylate levels
S-1-pyrroline-5-carboxylate levels in elite athletes
S-6-hydroxywarfarin levels
S-6-hydroxywarfarin to S-warfarin ratio
S-7-hydroxywarfarin levels
S-7-hydroxywarfarin to S-warfarin ratio
S-adenosylhomocysteine (SAH) levels
S-adenosylhomocysteine (SAH) levels in elite athletes
S-allylcysteine levels
S-carboxyethylcysteine levels
S-formylglutathione hydrolase level in Chronic kidney disease with hypertension and no diabetes (4984_83)
S-formylglutathione hydrolase levels
S-methyl-5-thioadenosine phosphorylase levels
S-methylcysteine levels
S-methylcysteine levels in elite athletes
S-methylcysteine sulfoxide levels
S-methylcysteine sulfoxide levels in elite athletes
S-methylmethionine levels in elite athletes
S-methylmethionine--homocysteine S-methyltransferase BHMT2 levels
S-phase kinase-associated protein 2 level in Chronic kidney disease with hypertension and no diabetes (22777_46)
S-phenylmercapturic acid levels in smokers
S-warfarin levels
S-warfarin to R-warfarin ratio
S100 calcium-binding protein levels
SAA plasma levels
SAFB-like transcription modulator levels
SAGA-associated factor 29 homolog levels
Sagittal craniosynostosis
Salad dressing liking
Salami liking
Salicylate levels in elite athletes
Salicylic acid levels
Saliva microbiota abundance (Oribacterium_unclassified_SGB_3339)
Salivary acidic proline-rich phosphoprotein 1/2 levels (PRH1.10502.15.3)
Salivary metabolite levels
Salmon liking
Salty food liking
Salty taste perception in obesity with metabolic syndrome
same-sex sexual behaviour
SAPHO syndrome
Sarcalumenin levels
Sarcoidosis
Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)
sarcopenia
Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 levels
Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 levels (ATP2A3.13510.7.3)
Sarcosine levels
Sarcosine levels in elite athletes
Sardines liking
SARS-CoV-2 infection
Sasang constitutional medicine type (So-Eum)
Saturated fatty acid levels
Saturated fatty acids levels (UKB data field 23448)
Saturated fatty acids to total fatty acids percentage (UKB data field 23455)
SAYSvFN domain-containing protein 1 levels
Scalp hair shape
Scarlet fever
Scavenger receptor class A member 3 levels
Scavenger receptor class A member 5 levels (SCARA5.10419.1.3)
Scavenger receptor class F member 1 level in Chronic kidney disease with hypertension and no diabetes (5129_12)
Scavenger receptor class F member 1 levels
Scavenger receptor class F member 2 levels
Scavenger receptor class F member 2 levels (SCARF2.8956.96.3)
Scavenger receptor cysteine-rich domain-containing group B protein levels
Scavenger receptor cysteine-rich type 1 protein M130 levels
Scavenger receptor cysteine-rich type 1 protein M130 levels (CD163.5028.59.1)
Schizoaffective disorder-bipolar type
Schizophrenia
Schizophrenia (age at onset)
Schizophrenia (inflammation and infection response interaction)
Schizophrenia (MTAG)
Schizophrenia (negative symptoms)
Schizophrenia (treatment resistant)
Schizophrenia or bipolar disorder
Schizophrenia vs ADHD (ordinary least squares (OLS))
Schizophrenia vs anorexia nervosa (ordinary least squares (OLS))
Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS))
Schizophrenia vs bipolar disorder (ordinary least squares (OLS))
Schizophrenia vs major depressive disorder (ordinary least squares (OLS))
Schizophrenia vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS))
Schizophrenia vs type 2 diabetes
Schizophrenia x sex interaction
Schizophrenia, bipolar disorder and depression (combined)
Schizophrenia, bipolar disorder or major depressive disorder
Schizophrenia, bipolar disorder or major depressive disorder x sex interaction
Schizophrenia, bipolar disorder or major depressive disorder x sex interaction (3df)
Schizophrenia, bipolar disorder or recurrent major depressive disorder
Schizophrenia, bipolar disorder or recurrent major depressive disorder x sex interaction
Schizophrenia, bipolar disorder or recurrent major depressive disorder x sex interaction (3df)
Schizophrenia, schizoaffective disorder or bipolar disorder
School performance E-factor 1 (overall performance)
School performance E-factor 2 (language performance relative to maths)
School performance E-factor 3 (oral performance relative to written)
Sciatica caused by lumbar disc herniation (treated with microdiscectomy)
Sclerosing cholangitis and ulcerative colitis (combined)
Sclerostin domain-containing protein 1 levels
Sclerostin levels
Scoliosis
Scyllo-inositol levels
Seasonality
Seasonality and depression
Sebacate (C10-DC) levels
Sebacate (decanedioate) levels in elite athletes
Seborrheic dermatitis
Secernin-3 level in Chronic kidney disease with hypertension and no diabetes (24923_27)
Secretagogin levels
Secreted and transmembrane protein 1 levels
Secreted and transmembrane protein 1 levels (SECTM1.13093.6.3)
Secreted frizzled-related protein 1 levels
Secreted frizzled-related protein 2 levels
Secreted frizzled-related protein 2 levels (SFRP2.7751.121.3)
Secreted frizzled-related protein 3 levels
Secreted frizzled-related protein 3 levels (FRZB.13740.51.3)
Secreted frizzled-related protein 4 levels
Secreted Ly-6/uPAR-related protein 1 levels (SLURP1.6401.73.3)
Secreting CD4 regulatory T cell %CD4 regulatory T cell
Secreting CD4 regulatory T cell %CD4+ T cell
Secretoglobin family 1C member 1 levels (SCGB1C1.5960.49.3)
Secretoglobin family 3A member 1 levels
Secretogranin-1 levels
Secretogranin-3 levels
Secretogranin-3 levels (SCG3.7957.2.3)
Secretory carrier-associated membrane protein 5 levels
Secretory phospholipase A2 receptor levels
Secretory phospholipase A2 receptor levels (PLA2R1.10916.44.3)
Sedentary behavior at work
Sedentary behaviour duration
Segment polarity protein dishevelled homolog DVL-2 levels
Segment polarity protein dishevelled homolog DVL-2 levels (DVL2.13575.40.3)
Seizure 6-like protein 2 levels
Select biomarker traits
Selective IgA deficiency
Selenide, water dikinase 1 levels
Selenoprotein H levels
Selenoprotein M levels
Selenoprotein S levels
Selenoprotein W levels
Self-rated health
Self-reported allergy
Self-reported childhood asthma in adult smokers
Self-reported math ability
Self-reported math ability (MTAG)
Self-reported risk-taking behaviour
Semaphorin-3A level in Chronic kidney disease with hypertension and no diabetes (3222_11)
Semaphorin-3A levels
Semaphorin-3A levels (SEMA3A.3222.11.2)
Semaphorin-3C levels
Semaphorin-3C levels (SEMA3C.6448.36.3)
Semaphorin-3E levels
Semaphorin-3G levels
Semaphorin-3G levels (SEMA3G.5628.21.3)
Semaphorin-4A levels
Semaphorin-4D levels
Semaphorin-4F levels
Semaphorin-6A levels
Semaphorin-6B levels
Semaphorin-6C levels
Semenogelin-1 levels
Semenogelin-1 levels (SEMG1.7115.5.3)
Semenogelin-2 levels (SEMG2.6373.54.3)
Sensation seeking
Sense of smell
Sensitivity to environmental stress and adversity
Sensorimotor dexterity
Sensory disturbances after bilateral sagittal split ramus osteotomy
Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer
Sentrin-specific protease 7 levels
Sepsis from pneumonia (survival)
Sepsis in extremely premature infants
Septic shock
Septic shock resolution
Septin-10 levels
Septin-10 levels (SEPT10.12690.33.3)
Septin-11 levels
Septin-6 levels
Sequestosome-1 level in Chronic kidney disease with hypertension and no diabetes (15448_47)
Serglycin levels
Serine dehydratase-like levels
Serine hydroxymethyltransferase, cytosolic levels
Serine levels
Serine levels (Biocrates platform)
Serine levels (Metabolon platform)
Serine levels in elite athletes
Serine palmitoyltransferase 1 levels
Serine palmitoyltransferase 2 levels
Serine protease 27 level in Chronic kidney disease with hypertension and no diabetes (15535_3)
Serine protease 27 levels
Serine protease HTRA1 levels
Serine protease inhibitor Kazal-type 1 levels
Serine protease inhibitor Kazal-type 13 levels
Serine protease inhibitor Kazal-type 14 levels
Serine protease inhibitor Kazal-type 2 level in Chronic kidney disease with hypertension and no diabetes (13405_61)
Serine protease inhibitor Kazal-type 2 levels
Serine protease inhibitor Kazal-type 2 levels (SPINK2.13405.61.3)
Serine protease inhibitor Kazal-type 4 level in Chronic kidney disease with hypertension and no diabetes (19213_1)
Serine protease inhibitor Kazal-type 4 levels
Serine protease inhibitor Kazal-type 5 levels
Serine protease inhibitor Kazal-type 6 level in Chronic kidney disease with hypertension and no diabetes (5731_1)
Serine protease inhibitor Kazal-type 6 levels
Serine protease inhibitor Kazal-type 6 levels (SPINK6.5731.1.3)
Serine protease inhibitor Kazal-type 9 levels
Serine to glycine ratio
Serine--tRNA ligase, cytoplasmic level in Chronic kidney disease with hypertension and no diabetes (18178_13)
Serine--tRNA ligase, mitochondrial levels
Serine-rich single-pass membrane protein 1 levels
Serine/threonine-protein kinase 16 levels
Serine/threonine-protein kinase 16 levels (STK16.3471.49.1)
Serine/threonine-protein kinase 17B levels
Serine/threonine-protein kinase A-Raf levels
Serine/threonine-protein kinase B-raf levels
Serine/threonine-protein kinase BRSK2 levels
Serine/threonine-protein kinase DCLK1 levels
Serine/threonine-protein kinase DCLK3 levels
Serine/threonine-protein kinase MRCK beta levels
Serine/threonine-protein kinase N1 levels
Serine/threonine-protein kinase PAK 3 levels
Serine/threonine-protein kinase PAK 5 levels
Serine/threonine-protein kinase PAK 6 levels
Serine/threonine-protein kinase receptor R3 levels
Serine/threonine-protein kinase TBK1 levels
Serine/threonine-protein kinase ULK3 levels
Serine/threonine-protein kinase VRK1 levels
Serine/threonine-protein kinase WNK3 levels
Serine/threonine-protein kinase/endoribonuclease IRE1 levels
Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform level in Chronic kidney disease with hypertension and no diabetes (22068_5)
Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform levels
Serine/threonine-protein phosphatase 2A regulatory subunit B subunit alpha levels
Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha levels (PPP2R3A.13665.35.3)
Serine/threonine-protein phosphatase 4 regulatory subunit 3A levels
Serine/threonine-protein phosphatase PP1-gamma catalytic subunit levels
Serine/threonine/tyrosine-interacting protein level in Chronic kidney disease with hypertension and no diabetes (21349_2)
Sero-negative rheumatoid arthritis
Serotonin levels in elite athletes
Serotransferrin levels
Serous borderline ovarian cancer
Serous invasive ovarian cancer
Serpin A11 levels
Serpin A12 levels
Serpin A12 levels (SERPINA12.6551.94.3)
Serpin A9 levels
Serpin B5 levels
Serpin B8 levels
Serpin H1 levels
Serpin I2 levels
Serum 25-Hydroxyvitamin D level variance
Serum 25-Hydroxyvitamin D levels
Serum 25-Hydroxyvitamin D levels x season interaction
Serum albumin levels
Serum alkaline phosphatase levels
Serum alpha-fetoprotein levels
Serum alpha1-antitrypsin levels
Serum aluminum levels
Serum amyloid A-1 protein level in Chronic kidney disease with hypertension and no diabetes (4336_2)
Serum amyloid A-1 protein levels
Serum amyloid A-1 protein levels (SAA1.4336.2.1)
Serum amyloid A-4 protein levels
Serum amyloid P-component levels
Serum amyloid P-component levels (APCS.2474.54.5)
Serum arsenic levels
Serum barium levels
Serum bilirubin levels in metabolic syndrome
Serum bilirubin levels x Mediterranean diet adherence interaction in metabolic syndrome
Serum bilirubin levels x sex interaction in metabolic syndrome
Serum C-reactive protein concentration
Serum C-reactive protein concentration in high fat diet
Serum C-reactive protein concentration in inactive individuals
Serum C-reactive protein concentration in low fat diet
Serum C-reactive protein concentration in non-obese individuals
Serum C-reactive protein concentration in obesity
Serum C-reactive protein concentration in visceral obesity (waist circumference)
Serum C-reactive protein concentration in visceral obesity (waist-hip ratio)
Serum C3d:C3 ratio (systemic complement activation)
Serum cadmium levels
Serum calciprotein particle maturation time (T50)
Serum calcium levels
Serum cancer antigen 125 (CA 125) levels
Serum cancer antigen 15.3 levels
Serum cancer antigen 19.9 levels
Serum carcinoembryonic antigen levels
Serum CC16 levels
Serum chromium levels
Serum cobalt levels
Serum copper levels
Serum creatinine levels
Serum dimethylarginine levels (asymmetric/symetric ratio)
Serum docosahexaenoic fatty acid concentration in metabolic syndrome
Serum folate levels
Serum galactose-deficient IgA1 levels
Serum galactose-deficient IgA1 levels in IgA nephropathy
Serum glutamic-oxaloacetic transaminase levels
Serum glutamic-pyruvic transaminase levels
Serum IgA levels
Serum IgE levels
Serum immune biomarker levels
Serum interleukin-6 concentration in active individuals
Serum iron levels
Serum lead levels
Serum levels of protein A4GALT
Serum levels of protein A4GNT
Serum levels of protein AAGAB
Serum levels of protein ABL2
Serum levels of protein ACAP2
Serum levels of protein ACBD7
Serum levels of protein ACE
Serum levels of protein ACE2
Serum levels of protein ACHE
Serum levels of protein ACP2
Serum levels of protein ACP5
Serum levels of protein ACYP2
Serum levels of protein ADAM12
Serum levels of protein ADAM19
Serum levels of protein ADAM23
Serum levels of protein ADAM7
Serum levels of protein ADAMDEC1
Serum levels of protein ADAMTS13
Serum levels of protein ADAMTS6
Serum levels of protein ADCYAP1
Serum levels of protein ADGRE5
Serum levels of protein ADGRF5
Serum levels of protein ADH4
Serum levels of protein ADH5
Serum levels of protein ADI1
Serum levels of protein ADM
Serum levels of protein ADRM1
Serum levels of protein ADSL
Serum levels of protein AFM
Serum levels of protein AGA
Serum levels of protein AGER
Serum levels of protein AGRP
Serum levels of protein AGT
Serum levels of protein AHSA1
Serum levels of protein AHSG
Serum levels of protein AHSP
Serum levels of protein AIF1
Serum levels of protein AIFM1
Serum levels of protein AIMP1
Serum levels of protein AKR7A2
Serum levels of protein AKT2
Serum levels of protein AKT3
Serum levels of protein ALB
Serum levels of protein ALDH1A3
Serum levels of protein ALDH3A1
Serum levels of protein ALPI
Serum levels of protein ALPPL2
Serum levels of protein AMBN
Serum levels of protein AMH
Serum levels of protein ANAPC7
Serum levels of protein ANG
Serum levels of protein ANGPTL1
Serum levels of protein ANGPTL3
Serum levels of protein ANGPTL4
Serum levels of protein ANGPTL7
Serum levels of protein ANKRD46
Serum levels of protein ANP32B
Serum levels of protein ANTXR1
Serum levels of protein ANXA2
Serum levels of protein ANXA6
Serum levels of protein AOC1
Serum levels of protein APBB1
Serum levels of protein APBB3
Serum levels of protein APCS
Serum levels of protein APLN
Serum levels of protein APLP2
Serum levels of protein APMAP
Serum levels of protein APOA1
Serum levels of protein APOA2
Serum levels of protein APOA5
Serum levels of protein APOB
Serum levels of protein APOC3
Serum levels of protein APOE
Serum levels of protein APOF
Serum levels of protein APOH
Serum levels of protein APOL1
Serum levels of protein ARF6
Serum levels of protein ARFGAP1
Serum levels of protein ARFIP1
Serum levels of protein ARG1
Serum levels of protein ARHGAP30
Serum levels of protein ARHGAP45
Serum levels of protein ARHGEF7
Serum levels of protein ARL1
Serum levels of protein ARL11
Serum levels of protein ARL3
Serum levels of protein ARMC5
Serum levels of protein ARPC3
Serum levels of protein ARRB1
Serum levels of protein ARSA
Serum levels of protein ART3
Serum levels of protein ASAH2
Serum levels of protein ASGR1
Serum levels of protein ASGR2
Serum levels of protein ASIP
Serum levels of protein ASPN
Serum levels of protein ASTL
Serum levels of protein ATF6B
Serum levels of protein ATG5
Serum levels of protein ATP13A1
Serum levels of protein ATP1B1
Serum levels of protein ATP1B2
Serum levels of protein ATP2A3
Serum levels of protein AURKB
Serum levels of protein AXIN2
Serum levels of protein AXL
Serum levels of protein AZGP1
Serum levels of protein B3GALT2
Serum levels of protein B3GALT6
Serum levels of protein B3GAT3
Serum levels of protein B3GLCT
Serum levels of protein B3GNT2
Serum levels of protein B4GALT1
Serum levels of protein B4GALT2
Serum levels of protein B4GALT7
Serum levels of protein B4GAT1
Serum levels of protein BACH1
Serum levels of protein BACH2
Serum levels of protein BAG4
Serum levels of protein BAG5
Serum levels of protein BAMBI
Serum levels of protein BCAN
Serum levels of protein BCAR3
Serum levels of protein BCHE
Serum levels of protein BCL2L1
Serum levels of protein BGN
Serum levels of protein BLVRA
Serum levels of protein BMP10
Serum levels of protein BMP15
Serum levels of protein BMP4
Serum levels of protein BMP6
Serum levels of protein BMP7
Serum levels of protein BOC
Serum levels of protein BPI
Serum levels of protein BPIFA2
Serum levels of protein BPIFB1
Serum levels of protein BRF1
Serum levels of protein BRICD5
Serum levels of protein BTD
Serum levels of protein BTNL8
Serum levels of protein C10orf105
Serum levels of protein C10orf35
Serum levels of protein C10orf54
Serum levels of protein C11orf87
Serum levels of protein C14orf180
Serum levels of protein C15orf48
Serum levels of protein C17orf78
Serum levels of protein C19orf18
Serum levels of protein C1GALT1C1
Serum levels of protein C1orf185
Serum levels of protein C1QBP
Serum levels of protein C1QC
Serum levels of protein C1QL1
Serum levels of protein C1QTNF1
Serum levels of protein C1QTNF5
Serum levels of protein C1R
Serum levels of protein C1S
Serum levels of protein C20orf173
Serum levels of protein C2orf40
Serum levels of protein C2orf66
Serum levels of protein C3
Serum levels of protein C3orf18
Serum levels of protein C4BPA
Serum levels of protein C4orf32
Serum levels of protein C5
Serum levels of protein C5;C6
Serum levels of protein C5orf46
Serum levels of protein C5orf63
Serum levels of protein C6orf25
Serum levels of protein C6orf58
Serum levels of protein C7
Serum levels of protein C8A;C8B;C8G
Serum levels of protein C8G
Serum levels of protein CA1
Serum levels of protein CA10
Serum levels of protein CA11
Serum levels of protein CA2
Serum levels of protein CA4
Serum levels of protein CA8
Serum levels of protein CABP7
Serum levels of protein CACNA2D3
Serum levels of protein CADM3
Serum levels of protein CALB1
Serum levels of protein CALCOCO2
Serum levels of protein CAMK1
Serum levels of protein CAMK1D
Serum levels of protein CAMP
Serum levels of protein CAPG
Serum levels of protein CAPN1;CAPNS1
Serum levels of protein CAPN2
Serum levels of protein CASC4
Serum levels of protein CASP2
Serum levels of protein CASQ1
Serum levels of protein CAST
Serum levels of protein CAT
Serum levels of protein CBLN1
Serum levels of protein CBR1
Serum levels of protein CBR3
Serum levels of protein CCDC126
Serum levels of protein CCDC50
Serum levels of protein CCL1
Serum levels of protein CCL11
Serum levels of protein CCL14
Serum levels of protein CCL15
Serum levels of protein CCL17
Serum levels of protein CCL18
Serum levels of protein CCL2
Serum levels of protein CCL21
Serum levels of protein CCL22
Serum levels of protein CCL23
Serum levels of protein CCL25
Serum levels of protein CCL27
Serum levels of protein CCL28
Serum levels of protein CCL3
Serum levels of protein CCL3L3
Serum levels of protein CCL4L1
Serum levels of protein CCL5
Serum levels of protein CCL7
Serum levels of protein CCL8
Serum levels of protein CCM2
Serum levels of protein CCNB1IP1
Serum levels of protein CD109
Serum levels of protein CD14
Serum levels of protein CD163
Serum levels of protein CD177
Serum levels of protein CD200
Serum levels of protein CD200R1
Serum levels of protein CD209
Serum levels of protein CD27
Serum levels of protein CD274
Serum levels of protein CD300A
Serum levels of protein CD300C
Serum levels of protein CD300E
Serum levels of protein CD33
Serum levels of protein CD34
Serum levels of protein CD4
Serum levels of protein CD47
Serum levels of protein CD48
Serum levels of protein CD5
Serum levels of protein CD55
Serum levels of protein CD58
Serum levels of protein CD59
Serum levels of protein CD5L
Serum levels of protein CD63
Serum levels of protein CD7
Serum levels of protein CD70
Serum levels of protein CD74
Serum levels of protein CD8A
Serum levels of protein CD8B
Serum levels of protein CD96
Serum levels of protein CD99L2
Serum levels of protein CDC25B
Serum levels of protein CDC34
Serum levels of protein CDC42BPB
Serum levels of protein CDCP1
Serum levels of protein CDH11
Serum levels of protein CDH12
Serum levels of protein CDH15
Serum levels of protein CDH2
Serum levels of protein CDH3
Serum levels of protein CDH6
Serum levels of protein CDH7
Serum levels of protein CDHR3
Serum levels of protein CDK2AP1
Serum levels of protein CDK5;CDK5R1
Serum levels of protein CDK8;CCNC
Serum levels of protein CDKN2B
Serum levels of protein CDNF
Serum levels of protein CDON
Serum levels of protein CDSN
Serum levels of protein CDYL2
Serum levels of protein CEACAM1
Serum levels of protein CEACAM7
Serum levels of protein CEL
Serum levels of protein CELA1
Serum levels of protein CEP57
Serum levels of protein CETN2
Serum levels of protein CETP
Serum levels of protein CFB
Serum levels of protein CFD
Serum levels of protein CFH
Serum levels of protein CFHR4
Serum levels of protein CFHR5
Serum levels of protein CFI
Serum levels of protein CFL1
Serum levels of protein CFP
Serum levels of protein CGA;FSHB
Serum levels of protein CGA;TSHB
Serum levels of protein CGREF1
Serum levels of protein CHI3L2
Serum levels of protein CHIT1
Serum levels of protein CHKB
Serum levels of protein CHL1
Serum levels of protein CHMP3
Serum levels of protein CHRDL2
Serum levels of protein CHST9
Serum levels of protein CKAP2
Serum levels of protein CKAP4
Serum levels of protein CLC
Serum levels of protein CLCA1
Serum levels of protein CLCA2
Serum levels of protein CLCNKB
Serum levels of protein CLEC12A
Serum levels of protein CLEC12B
Serum levels of protein CLEC1B
Serum levels of protein CLEC2D
Serum levels of protein CLEC2L
Serum levels of protein CLEC3B
Serum levels of protein CLEC4A
Serum levels of protein CLEC4G
Serum levels of protein CLEC7A
Serum levels of protein CLGN
Serum levels of protein CLIC1
Serum levels of protein CLK2
Serum levels of protein CLMP
Serum levels of protein CLPS
Serum levels of protein CMPK1
Serum levels of protein CNDP1
Serum levels of protein CNDP2
Serum levels of protein CNGA2
Serum levels of protein CNTFR
Serum levels of protein CNTN1
Serum levels of protein CNTN2
Serum levels of protein CNTNAP5
Serum levels of protein COCH
Serum levels of protein COL15A1
Serum levels of protein COL18A1
Serum levels of protein COL1A1
Serum levels of protein COL20A1
Serum levels of protein COL26A1
Serum levels of protein COL4A3BP
Serum levels of protein COL6A1
Serum levels of protein COLEC11
Serum levels of protein COLEC12
Serum levels of protein COLGALT1
Serum levels of protein COLQ
Serum levels of protein COPS2
Serum levels of protein COPS7B
Serum levels of protein COTL1
Serum levels of protein COX7A1
Serum levels of protein COX7A2L
Serum levels of protein CPB1
Serum levels of protein CPB2
Serum levels of protein CPM
Serum levels of protein CPN2
Serum levels of protein CPNE1
Serum levels of protein CPQ
Serum levels of protein CPT1B
Serum levels of protein CPVL
Serum levels of protein CPXM1
Serum levels of protein CRABP1
Serum levels of protein CRABP2
Serum levels of protein CRAT
Serum levels of protein CREB3L4
Serum levels of protein CREBBP
Serum levels of protein CREG1
Serum levels of protein CRHBP
Serum levels of protein CRIM1
Serum levels of protein CRISP2
Serum levels of protein CRLF1
Serum levels of protein CRLF2
Serum levels of protein CROT
Serum levels of protein CRP
Serum levels of protein CRTAC1
Serum levels of protein CRTAM
Serum levels of protein CRYZ
Serum levels of protein CSF2RA
Serum levels of protein CSF2RB
Serum levels of protein CSF3
Serum levels of protein CSGALNACT2
Serum levels of protein CSH1;CSH2
Serum levels of protein CSN1S1
Serum levels of protein CSNK2A1;CSNK2B
Serum levels of protein CSNK2B
Serum levels of protein CST1
Serum levels of protein CST2
Serum levels of protein CST3
Serum levels of protein CST4
Serum levels of protein CST5
Serum levels of protein CST6
Serum levels of protein CST7
Serum levels of protein CST8
Serum levels of protein CSTL1
Serum levels of protein CTAG1A
Serum levels of protein CTBS
Serum levels of protein CTNNB1
Serum levels of protein CTRB2
Serum levels of protein CTRL
Serum levels of protein CTSA
Serum levels of protein CTSB
Serum levels of protein CTSC
Serum levels of protein CTSD
Serum levels of protein CTSF
Serum levels of protein CTSH
Serum levels of protein CTSL
Serum levels of protein CTSO
Serum levels of protein CTSS
Serum levels of protein CTSZ
Serum levels of protein CTXN3
Serum levels of protein CXADR
Serum levels of protein CXCL1
Serum levels of protein CXCL11
Serum levels of protein CXCL16
Serum levels of protein CXCL2;CXCL3
Serum levels of protein CXCL5
Serum levels of protein CYB5D2
Serum levels of protein CYTL1
Serum levels of protein DAPK2
Serum levels of protein DBNL
Serum levels of protein DCBLD2
Serum levels of protein DCN
Serum levels of protein DCP1A
Serum levels of protein DCP1B
Serum levels of protein DCUN1D5
Serum levels of protein DDR1
Serum levels of protein DDR2
Serum levels of protein DDX23
Serum levels of protein DDX46
Serum levels of protein DEAF1
Serum levels of protein DEF6
Serum levels of protein DEFA1
Serum levels of protein DEFB1
Serum levels of protein DEFB105B
Serum levels of protein DEFB113
Serum levels of protein DEFB118
Serum levels of protein DEFB119
Serum levels of protein DEFB121
Serum levels of protein DEFB129
Serum levels of protein DEFB131
Serum levels of protein DEFB132
Serum levels of protein DERL1
Serum levels of protein DES
Serum levels of protein DHFR
Serum levels of protein DHX8
Serum levels of protein DIABLO
Serum levels of protein DKK2
Serum levels of protein DKK3
Serum levels of protein DKKL1
Serum levels of protein DLG3
Serum levels of protein DLK1
Serum levels of protein DLK2
Serum levels of protein DLL3
Serum levels of protein DMKN
Serum levels of protein DNAJB11
Serum levels of protein DNAJB12
Serum levels of protein DNAJB14
Serum levels of protein DNAJB2
Serum levels of protein DNAJB9
Serum levels of protein DNAJC10
Serum levels of protein DNAJC11
Serum levels of protein DNAJC15
Serum levels of protein DNAJC4
Serum levels of protein DNER
Serum levels of protein DPEP1
Serum levels of protein DPP7
Serum levels of protein DPT
Serum levels of protein DPYSL2
Serum levels of protein DRAXIN
Serum levels of protein DSC1
Serum levels of protein DSG1
Serum levels of protein DSG2
Serum levels of protein DTX1
Serum levels of protein DUSP13
Serum levels of protein DUSP26
Serum levels of protein DUSP4
Serum levels of protein DVL2
Serum levels of protein DYNAP
Serum levels of protein DYNLL2
Serum levels of protein DYNLRB1
Serum levels of protein DYRK3
Serum levels of protein EBI3
Serum levels of protein EBI3;IL27
Serum levels of protein ECE1
Serum levels of protein ECH1
Serum levels of protein ECI2
Serum levels of protein ECM1
Serum levels of protein EDAR
Serum levels of protein EDDM3A
Serum levels of protein EDDM3B
Serum levels of protein EDN2
Serum levels of protein EFCAB14
Serum levels of protein EFEMP1
Serum levels of protein EFNA2
Serum levels of protein EFNB1
Serum levels of protein EFNB2
Serum levels of protein EGF
Serum levels of protein EHBP1
Serum levels of protein EHD4
Serum levels of protein EHMT2
Serum levels of protein EID3
Serum levels of protein EIF1AD
Serum levels of protein EIF4EBP2
Serum levels of protein EIF5A2
Serum levels of protein ELF5
Serum levels of protein ELK1
Serum levels of protein ELL
Serum levels of protein EMID1
Serum levels of protein EMILIN3
Serum levels of protein ENAH
Serum levels of protein ENDOU
Serum levels of protein ENO2
Serum levels of protein ENOX2
Serum levels of protein ENPP5
Serum levels of protein ENTPD1
Serum levels of protein ENTPD3
Serum levels of protein ENTPD5
Serum levels of protein ENTPD6
Serum levels of protein EPHA2
Serum levels of protein EPHA5
Serum levels of protein EPHB2
Serum levels of protein EPHB3
Serum levels of protein EPHB4
Serum levels of protein EPO
Serum levels of protein EQTN
Serum levels of protein ERAP1
Serum levels of protein ERCC4
Serum levels of protein ERLIN1
Serum levels of protein ERO1A
Serum levels of protein ERO1B
Serum levels of protein ERP44
Serum levels of protein ESAM
Serum levels of protein ESD
Serum levels of protein ESRP1
Serum levels of protein ETHE1
Serum levels of protein ETNK1
Serum levels of protein EVA1B
Serum levels of protein EVA1C
Serum levels of protein EVPL
Serum levels of protein EZR
Serum levels of protein F11
Serum levels of protein F13B
Serum levels of protein F3
Serum levels of protein F5
Serum levels of protein F9
Serum levels of protein FABP1
Serum levels of protein FAM151A
Serum levels of protein FAM163A
Serum levels of protein FAM163B
Serum levels of protein FAM171B
Serum levels of protein FAM174B
Serum levels of protein FAM177A1
Serum levels of protein FAM189A2
Serum levels of protein FAM19A3
Serum levels of protein FAM209B
Serum levels of protein FAM20A
Serum levels of protein FAM210A
Serum levels of protein FAM213A
Serum levels of protein FAM3B
Serum levels of protein FAM3D
Serum levels of protein FAP
Serum levels of protein FARS2
Serum levels of protein FAS
Serum levels of protein FASLG
Serum levels of protein FBLN1
Serum levels of protein FBXL4
Serum levels of protein FCER1A
Serum levels of protein FCGR3B
Serum levels of protein FCN1
Serum levels of protein FCN2
Serum levels of protein FCN3
Serum levels of protein FCRL1
Serum levels of protein FCRL2
Serum levels of protein FCRL4
Serum levels of protein FETUB
Serum levels of protein FGF10
Serum levels of protein FGF19
Serum levels of protein FGF7
Serum levels of protein FGFBP1
Serum levels of protein FGFBP3
Serum levels of protein FGFR3
Serum levels of protein FGFRL1
Serum levels of protein FGL1
Serum levels of protein FJX1
Serum levels of protein FKBP2
Serum levels of protein FKBP7
Serum levels of protein FLNA
Serum levels of protein FLRT1
Serum levels of protein FLRT2
Serum levels of protein FLRT3
Serum levels of protein FLT3
Serum levels of protein FLT4
Serum levels of protein FMOD
Serum levels of protein FMR1
Serum levels of protein FN1
Serum levels of protein FNDC5
Serum levels of protein FOLH1
Serum levels of protein FOLR3
Serum levels of protein FOXRED1
Serum levels of protein FRZB
Serum levels of protein FST
Serum levels of protein FTH1;FTL
Serum levels of protein FUT10
Serum levels of protein FUT3
Serum levels of protein FUT5
Serum levels of protein FUT9
Serum levels of protein FZD10
Serum levels of protein GAA
Serum levels of protein GABARAPL2
Serum levels of protein GABBR1
Serum levels of protein GABBR2
Serum levels of protein GAL3ST1
Serum levels of protein GALK1
Serum levels of protein GALNT11
Serum levels of protein GALNT2
Serum levels of protein GALNT3
Serum levels of protein GBP6
Serum levels of protein GCH1
Serum levels of protein GCK
Serum levels of protein GCNT2
Serum levels of protein GCNT4
Serum levels of protein GCSH
Serum levels of protein GDA
Serum levels of protein GDF15
Serum levels of protein GDF9
Serum levels of protein GDI2
Serum levels of protein GFRA2
Serum levels of protein GFRAL
Serum levels of protein GGH
Serum levels of protein GHRL
Serum levels of protein GKN2
Serum levels of protein GLCE
Serum levels of protein GLO1
Serum levels of protein GLTPD2
Serum levels of protein GNLY
Serum levels of protein GNMT
Serum levels of protein GNPNAT1
Serum levels of protein GNPTG
Serum levels of protein GNRH1
Serum levels of protein GNS
Serum levels of protein GOLM1
Serum levels of protein GOSR2
Serum levels of protein GOT1
Serum levels of protein GP1BA
Serum levels of protein GP6
Serum levels of protein GPC1
Serum levels of protein GPC3
Serum levels of protein GPD1L
Serum levels of protein GPHB5
Serum levels of protein GPLD1
Serum levels of protein GPNMB
Serum levels of protein GPR135
Serum levels of protein GPR68
Serum levels of protein GRAMD1C
Serum levels of protein GRAP
Serum levels of protein GRAP2
Serum levels of protein GRB14
Serum levels of protein GRB7
Serum levels of protein GRIA4
Serum levels of protein GRID2
Serum levels of protein GRN
Serum levels of protein GRP
Serum levels of protein GSK3A;GSK3B
Serum levels of protein GSKIP
Serum levels of protein GSN
Serum levels of protein GSTA1
Serum levels of protein GSTM3
Serum levels of protein GSTO1
Serum levels of protein GSTT2
Serum levels of protein GXYLT1
Serum levels of protein GZMB
Serum levels of protein GZMK
Serum levels of protein H2AFZ
Serum levels of protein H6PD
Serum levels of protein HAAO
Serum levels of protein HAT1
Serum levels of protein HAVCR1
Serum levels of protein HAVCR2
Serum levels of protein HBD
Serum levels of protein HBE1
Serum levels of protein HBEGF
Serum levels of protein HBZ
Serum levels of protein HCAR2
Serum levels of protein HDGF
Serum levels of protein HDHD2
Serum levels of protein HERC1
Serum levels of protein HERC5
Serum levels of protein HFE2
Serum levels of protein HGFAC
Serum levels of protein HHLA2
Serum levels of protein HIBCH
Serum levels of protein HIF1A
Serum levels of protein HINT2
Serum levels of protein HIST2H2BE
Serum levels of protein HIST3H2A
Serum levels of protein HMGB3
Serum levels of protein HMGCS1
Serum levels of protein HMGN1
Serum levels of protein HMP19
Serum levels of protein HNF1A
Serum levels of protein HNRNPAB
Serum levels of protein HNRNPC
Serum levels of protein HNRNPH1
Serum levels of protein HNRNPM
Serum levels of protein HP
Serum levels of protein HPGD
Serum levels of protein HPGDS
Serum levels of protein HPSE
Serum levels of protein HRC
Serum levels of protein HRG
Serum levels of protein HS3ST1
Serum levels of protein HS6ST1
Serum levels of protein HSD17B1
Serum levels of protein HSD17B14
Serum levels of protein HSP90AA1;HSP90AB1
Serum levels of protein HSP90B1
Serum levels of protein HSPA1L
Serum levels of protein HSPA6
Serum levels of protein HTATIP2
Serum levels of protein HTN1
Serum levels of protein HTR2A
Serum levels of protein HTR7
Serum levels of protein IAPP
Serum levels of protein IBSP
Serum levels of protein ICAM2
Serum levels of protein ICAM4
Serum levels of protein ICOSLG
Serum levels of protein ID2
Serum levels of protein IDS
Serum levels of protein IDUA
Serum levels of protein IFIT2
Serum levels of protein IFNA10
Serum levels of protein IFNA2
Serum levels of protein IFNA7
Serum levels of protein IFNAR1
Serum levels of protein IFNLR1
Serum levels of protein IGF1
Serum levels of protein IGF2R
Serum levels of protein IGFALS
Serum levels of protein IGFBP1
Serum levels of protein IGFBP3
Serum levels of protein IGFBP7
Serum levels of protein IGFL1
Serum levels of protein IGFL3
Serum levels of protein IGFL4
Serum levels of protein IGFLR1
Serum levels of protein IGSF9B
Serum levels of protein IL10RA
Serum levels of protein IL10RB
Serum levels of protein IL11RA
Serum levels of protein IL13RA1
Serum levels of protein IL15
Serum levels of protein IL15RA
Serum levels of protein IL16
Serum levels of protein IL17RA
Serum levels of protein IL17RB
Serum levels of protein IL17RD
Serum levels of protein IL18R1
Serum levels of protein IL1B
Serum levels of protein IL1R1
Serum levels of protein IL1R2
Serum levels of protein IL1RAP
Serum levels of protein IL1RL1
Serum levels of protein IL1RL2
Serum levels of protein IL22
Serum levels of protein IL22RA1
Serum levels of protein IL22RA2
Serum levels of protein IL23R
Serum levels of protein IL34
Serum levels of protein IL36A
Serum levels of protein IL36G
Serum levels of protein IL5
Serum levels of protein IL5RA
Serum levels of protein IL6R
Serum levels of protein IL6ST
Serum levels of protein IL7
Serum levels of protein IL7R
Serum levels of protein IL9
Serum levels of protein INHBB
Serum levels of protein INPP5B
Serum levels of protein INPP5E
Serum levels of protein IRF6
Serum levels of protein ISG15
Serum levels of protein ISLR2
Serum levels of protein ISM2
Serum levels of protein ISOC1
Serum levels of protein ITGB2
Serum levels of protein ITIH1
Serum levels of protein ITIH2
Serum levels of protein ITIH3
Serum levels of protein ITIH4
Serum levels of protein ITSN1
Serum levels of protein JAG1
Serum levels of protein JAK2
Serum levels of protein JAKMIP3
Serum levels of protein JAM2
Serum levels of protein JAM3
Serum levels of protein JARID2
Serum levels of protein KAZALD1
Serum levels of protein KCNA10
Serum levels of protein KCNE2
Serum levels of protein KCNG4
Serum levels of protein KCNIP1
Serum levels of protein KCNMB3
Serum levels of protein KDELC2
Serum levels of protein KDR
Serum levels of protein KIAA1024
Serum levels of protein KIAA1549L
Serum levels of protein KIAA2013
Serum levels of protein KIF1C
Serum levels of protein KIF22
Serum levels of protein KIF3A
Serum levels of protein KIR2DL2
Serum levels of protein KITLG
Serum levels of protein KLHL12
Serum levels of protein KLHL13
Serum levels of protein KLK10
Serum levels of protein KLK12
Serum levels of protein KLK13
Serum levels of protein KLK14
Serum levels of protein KLK15
Serum levels of protein KLK6
Serum levels of protein KLK7
Serum levels of protein KLK8
Serum levels of protein KLKB1
Serum levels of protein KLRC3
Serum levels of protein KLRG1
Serum levels of protein KLRG2
Serum levels of protein KMT2C
Serum levels of protein KMT2D
Serum levels of protein KNG1
Serum levels of protein KPNA4
Serum levels of protein KRT23
Serum levels of protein KRTDAP
Serum levels of protein KYNU
Serum levels of protein LAG3
Serum levels of protein LAIR2
Serum levels of protein LAMC2
Serum levels of protein LARGE1
Serum levels of protein LAYN
Serum levels of protein LBP
Serum levels of protein LCT
Serum levels of protein LDOC1
Serum levels of protein LEAP2
Serum levels of protein LECT2
Serum levels of protein LEMD1
Serum levels of protein LGALS2
Serum levels of protein LGALS3
Serum levels of protein LGALS3BP
Serum levels of protein LGALS4
Serum levels of protein LGALS7
Serum levels of protein LGALS7B
Serum levels of protein LGALS9
Serum levels of protein LGMN
Serum levels of protein LHB
Serum levels of protein LHCGR
Serum levels of protein LIF
Serum levels of protein LILRA5
Serum levels of protein LILRB3
Serum levels of protein LILRB4
Serum levels of protein LILRB5
Serum levels of protein LIPN
Serum levels of protein LMAN2
Serum levels of protein LMAN2L
Serum levels of protein LMCD1
Serum levels of protein LOC652493
Serum levels of protein LPO
Serum levels of protein LRIT3
Serum levels of protein LRP1
Serum levels of protein LRP11
Serum levels of protein LRP12
Serum levels of protein LRP1B
Serum levels of protein LRP2
Serum levels of protein LRP8
Serum levels of protein LRPAP1
Serum levels of protein LRPPRC
Serum levels of protein LRRC15
Serum levels of protein LRRC19
Serum levels of protein LRRC37A2
Serum levels of protein LRRC4B
Serum levels of protein LRRC52
Serum levels of protein LRTM2
Serum levels of protein LSAMP
Serum levels of protein LST1
Serum levels of protein LTA;LTB
Serum levels of protein LTF
Serum levels of protein LY6G6C
Serum levels of protein LY9
Serum levels of protein LY96;TLR4
Serum levels of protein LYPD3
Serum levels of protein LYVE1
Serum levels of protein LYZ
Serum levels of protein M6PR
Serum levels of protein MADCAM1
Serum levels of protein MAGEA10
Serum levels of protein MAGEA3
Serum levels of protein MAN1A2
Serum levels of protein MAN1B1
Serum levels of protein MAN1C1
Serum levels of protein MAN2B2
Serum levels of protein MANBA
Serum levels of protein MANEA
Serum levels of protein MANF
Serum levels of protein MANSC1
Serum levels of protein MAP2K2
Serum levels of protein MAP2K3
Serum levels of protein MAP2K4
Serum levels of protein MAPK12
Serum levels of protein MAPK13
Serum levels of protein MAPK14
Serum levels of protein MAPK9
Serum levels of protein MAPKAPK5
Serum levels of protein MARCO
Serum levels of protein MASP1
Serum levels of protein MATN3
Serum levels of protein MATN4
Serum levels of protein MAVS
Serum levels of protein MAX
Serum levels of protein MAZ
Serum levels of protein MB
Serum levels of protein MBD4
Serum levels of protein MBL2
Serum levels of protein MCEE
Serum levels of protein MCF2L
Serum levels of protein MCFD2
Serum levels of protein MCL1
Serum levels of protein MCTS1
Serum levels of protein MDH1
Serum levels of protein MDM2
Serum levels of protein MDM4
Serum levels of protein METTL1
Serum levels of protein METTL24
Serum levels of protein MFAP2
Serum levels of protein MFAP3L
Serum levels of protein MFAP4
Serum levels of protein MFF
Serum levels of protein MFGE8
Serum levels of protein MFN1
Serum levels of protein MGA
Serum levels of protein MGAT2
Serum levels of protein MGAT4A
Serum levels of protein MGP
Serum levels of protein MIA
Serum levels of protein MICALL2
Serum levels of protein MIF
Serum levels of protein MINPP1
Serum levels of protein MIOX
Serum levels of protein MLEC
Serum levels of protein MLN
Serum levels of protein MMEL1
Serum levels of protein MMP1
Serum levels of protein MMP10
Serum levels of protein MMP12
Serum levels of protein MMP13
Serum levels of protein MMP14
Serum levels of protein MMP3
Serum levels of protein MMP7
Serum levels of protein MMP8
Serum levels of protein MMP9
Serum levels of protein MMRN2
Serum levels of protein MOB1A
Serum levels of protein MOCS3
Serum levels of protein MPP6
Serum levels of protein MPZL2
Serum levels of protein MRAP
Serum levels of protein MRPL14
Serum levels of protein MRPL33
Serum levels of protein MRPL58
Serum levels of protein MSR1
Serum levels of protein MST1
Serum levels of protein MSTN
Serum levels of protein MT1F
Serum levels of protein MTHFS
Serum levels of protein MTPAP
Serum levels of protein MUC1
Serum levels of protein MUL1
Serum levels of protein MUSK
Serum levels of protein MXRA7
Serum levels of protein MYC
Serum levels of protein MYCT1
Serum levels of protein MYNN
Serum levels of protein MYOM3
Serum levels of protein MYRF
Serum levels of protein MYZAP
Serum levels of protein NAAA
Serum levels of protein NAALAD2
Serum levels of protein NAB1
Serum levels of protein NAB2
Serum levels of protein NADK
Serum levels of protein NAGK
Serum levels of protein NAGPA
Serum levels of protein NAGS
Serum levels of protein NAP1L1
Serum levels of protein NAPB
Serum levels of protein NAT1
Serum levels of protein NBR1
Serum levels of protein NCF2
Serum levels of protein NCMAP
Serum levels of protein NCOA2
Serum levels of protein NCR1
Serum levels of protein NCR2
Serum levels of protein NDC80
Serum levels of protein NDNF
Serum levels of protein NDUFAF8
Serum levels of protein NDUFB4
Serum levels of protein NDUFS4
Serum levels of protein NELL1
Serum levels of protein NEO1
Serum levels of protein NEURL4
Serum levels of protein NFASC
Serum levels of protein NFU1
Serum levels of protein NHLRC3
Serum levels of protein NID1
Serum levels of protein NID2
Serum levels of protein NLGN2
Serum levels of protein NLGN3
Serum levels of protein NLGN4X
Serum levels of protein NMB
Serum levels of protein NME1
Serum levels of protein NME2
Serum levels of protein NMRAL1
Serum levels of protein NOG
Serum levels of protein NOTCH2
Serum levels of protein NOV
Serum levels of protein NPIPB3
Serum levels of protein NPNT
Serum levels of protein NPPA
Serum levels of protein NPPB
Serum levels of protein NPTX1
Serum levels of protein NPTX2
Serum levels of protein NPTXR
Serum levels of protein NQO1
Serum levels of protein NQO2
Serum levels of protein NR1H2
Serum levels of protein NR3C2
Serum levels of protein NRAS
Serum levels of protein NRP1
Serum levels of protein NRSN1
Serum levels of protein NRXN3
Serum levels of protein NSDHL
Serum levels of protein NSF
Serum levels of protein NTM
Serum levels of protein NTN4
Serum levels of protein NTRK1
Serum levels of protein NUCB1
Serum levels of protein NUDT12
Serum levels of protein NUDT9
Serum levels of protein NUP210
Serum levels of protein NXPH2
Serum levels of protein NXPH3
Serum levels of protein NXT1
Serum levels of protein OAF
Serum levels of protein OBP2B
Serum levels of protein OCIAD1
Serum levels of protein OCRL
Serum levels of protein OLA1
Serum levels of protein OLFM2
Serum levels of protein OLFM3
Serum levels of protein OOSP2
Serum levels of protein OPCML
Serum levels of protein OSCAR
Serum levels of protein OSM
Serum levels of protein P4HB
Serum levels of protein PA2G4
Serum levels of protein PAK3
Serum levels of protein PAM
Serum levels of protein PAPPA
Serum levels of protein PARP11
Serum levels of protein PAXIP1
Serum levels of protein PCDH10
Serum levels of protein PCDHA4
Serum levels of protein PCDHA7
Serum levels of protein PCDHB14
Serum levels of protein PCDHB4
Serum levels of protein PCDHGA1
Serum levels of protein PCOLCE
Serum levels of protein PCOLCE2
Serum levels of protein PCSK7
Serum levels of protein PCSK9
Serum levels of protein PCYOX1
Serum levels of protein PCYOX1L
Serum levels of protein PDCD1LG2
Serum levels of protein PDCD5
Serum levels of protein PDE11A
Serum levels of protein PDE2A
Serum levels of protein PDE3A
Serum levels of protein PDGFB
Serum levels of protein PDGFD
Serum levels of protein PDGFRL
Serum levels of protein PDIA3
Serum levels of protein PDIA4
Serum levels of protein PDK1
Serum levels of protein PDLIM4
Serum levels of protein PENK
Serum levels of protein PFDN5
Serum levels of protein PFKFB3
Serum levels of protein PFN2
Serum levels of protein PGK1
Serum levels of protein PGLYRP1
Serum levels of protein PGM1
Serum levels of protein PI3
Serum levels of protein PIGR
Serum levels of protein PIK3CG
Serum levels of protein PIK3R1
Serum levels of protein PILRA
Serum levels of protein PIP
Serum levels of protein PIR
Serum levels of protein PKD2
Serum levels of protein PKDCC
Serum levels of protein PKLR
Serum levels of protein PKN1
Serum levels of protein PLA2G12B
Serum levels of protein PLA2G2A
Serum levels of protein PLA2G7
Serum levels of protein PLA2R1
Serum levels of protein PLAT
Serum levels of protein PLAU
Serum levels of protein PLAUR
Serum levels of protein PLCG1
Serum levels of protein PLG
Serum levels of protein PLIN3
Serum levels of protein PLXDC1
Serum levels of protein PLXDC2
Serum levels of protein PLXNA1
Serum levels of protein PLXNC1
Serum levels of protein PMEL
Serum levels of protein PMEPA1
Serum levels of protein PMVK
Serum levels of protein PNLIPRP1
Serum levels of protein PNLIPRP2
Serum levels of protein PNP
Serum levels of protein PNPLA2
Serum levels of protein POFUT2
Serum levels of protein POGLUT1
Serum levels of protein POLR1C
Serum levels of protein POMC
Serum levels of protein POMGNT2
Serum levels of protein PON1
Serum levels of protein POSTN
Serum levels of protein PPARA
Serum levels of protein PPBP
Serum levels of protein PPIB
Serum levels of protein PPID
Serum levels of protein PPIE
Serum levels of protein PPIL2
Serum levels of protein PPP1R3B
Serum levels of protein PPP2R3A
Serum levels of protein PPP3R1
Serum levels of protein PPT1
Serum levels of protein PPY
Serum levels of protein PRCP
Serum levels of protein PRDM1
Serum levels of protein PRDX3
Serum levels of protein PRDX6
Serum levels of protein PRELP
Serum levels of protein PREP
Serum levels of protein PRG2
Serum levels of protein PRG3
Serum levels of protein PRLR
Serum levels of protein PROC
Serum levels of protein PRPF6
Serum levels of protein PRRG4
Serum levels of protein PRSS2
Serum levels of protein PRSS27
Serum levels of protein PRSS57
Serum levels of protein PRSS8
Serum levels of protein PSAP
Serum levels of protein PSAPL1
Serum levels of protein PSD2
Serum levels of protein PSG2
Serum levels of protein PSG3
Serum levels of protein PSG4
Serum levels of protein PSG5
Serum levels of protein PSG9
Serum levels of protein PSMA1
Serum levels of protein PSMD1
Serum levels of protein PSMD7
Serum levels of protein PSMD9
Serum levels of protein PSME3
Serum levels of protein PTGDS
Serum levels of protein PTGR1
Serum levels of protein PTHLH
Serum levels of protein PTK6
Serum levels of protein PTN
Serum levels of protein PTPN1
Serum levels of protein PTPRH
Serum levels of protein PTPRR
Serum levels of protein PUF60
Serum levels of protein PVRIG
Serum levels of protein PXDN
Serum levels of protein PXYLP1
Serum levels of protein PYY
Serum levels of protein QDPR
Serum levels of protein QPCT
Serum levels of protein QSOX1
Serum levels of protein QSOX2
Serum levels of protein RAB14
Serum levels of protein RAB17
Serum levels of protein RAB18
Serum levels of protein RAB26
Serum levels of protein RAB27A
Serum levels of protein RAB35
Serum levels of protein RAB39B
Serum levels of protein RAB5C
Serum levels of protein RAB6B
Serum levels of protein RABEPK
Serum levels of protein RAD51
Serum levels of protein RAD51D
Serum levels of protein RAET1E
Serum levels of protein RAP1GDS1
Serum levels of protein RARRES1
Serum levels of protein RARRES2
Serum levels of protein RASA1
Serum levels of protein RBBP9
Serum levels of protein RBL2
Serum levels of protein RBM19
Serum levels of protein RBM24
Serum levels of protein RBM28
Serum levels of protein RBP7
Serum levels of protein RCAN1
Serum levels of protein RCN2
Serum levels of protein RDH16
Serum levels of protein REG1A
Serum levels of protein REG3G
Serum levels of protein RELB
Serum levels of protein RELT
Serum levels of protein RET
Serum levels of protein RFESD
Serum levels of protein RFFL
Serum levels of protein RGMA
Serum levels of protein RGS8
Serum levels of protein RHOD
Serum levels of protein RIC3
Serum levels of protein RIDA
Serum levels of protein RIPK2
Serum levels of protein RLN1
Serum levels of protein RLN2
Serum levels of protein RMDN3
Serum levels of protein RMI1
Serum levels of protein RNASE1
Serum levels of protein RNASE2
Serum levels of protein RNASE3
Serum levels of protein RNASE4
Serum levels of protein RNASE6
Serum levels of protein RNF122
Serum levels of protein RNF13
Serum levels of protein RNF146
Serum levels of protein RNF149
Serum levels of protein RNF165
Serum levels of protein RNF41
Serum levels of protein RNF8
Serum levels of protein RNPEP
Serum levels of protein ROCK2
Serum levels of protein ROR1
Serum levels of protein RPLP2
Serum levels of protein RPN1
Serum levels of protein RPS10
Serum levels of protein RPSA
Serum levels of protein RRAS2
Serum levels of protein RRBP1
Serum levels of protein RRM1
Serum levels of protein RRM2B
Serum levels of protein RSPO3
Serum levels of protein RSPO4
Serum levels of protein RSRP1
Serum levels of protein RTN4R
Serum levels of protein RUFY1
Serum levels of protein RYK
Serum levels of protein S100A4
Serum levels of protein S100A5
Serum levels of protein S100A6
Serum levels of protein SCARA5
Serum levels of protein SCARF1
Serum levels of protein SCARF2
Serum levels of protein SCG2
Serum levels of protein SCG3
Serum levels of protein SCGB1A1
Serum levels of protein SCGB1C2
Serum levels of protein SCGB2A1
Serum levels of protein SCGB3A1
Serum levels of protein SCGN
Serum levels of protein SCMH1
Serum levels of protein SCO1
Serum levels of protein SCP2D1
Serum levels of protein SCUBE1
Serum levels of protein SEC11C
Serum levels of protein SEC13
Serum levels of protein SECTM1
Serum levels of protein SEL1L2
Serum levels of protein SELL
Serum levels of protein SELP
Serum levels of protein SELPLG
Serum levels of protein SEMA3A
Serum levels of protein SEMA3G
Serum levels of protein SEMA5A
Serum levels of protein SEMG1
Serum levels of protein SEMG2
Serum levels of protein SEPT10
Serum levels of protein SERPINA1
Serum levels of protein SERPINA10
Serum levels of protein SERPINA11
Serum levels of protein SERPINA12
Serum levels of protein SERPINA3
Serum levels of protein SERPINA4
Serum levels of protein SERPINA5
Serum levels of protein SERPINB1
Serum levels of protein SERPIND1
Serum levels of protein SERPINE1
Serum levels of protein SERPINE2
Serum levels of protein SERPINF1
Serum levels of protein SERPINF2
Serum levels of protein SERPINI2
Serum levels of protein SETD2
Serum levels of protein SF1
Serum levels of protein SFN
Serum levels of protein SFRP1
Serum levels of protein SFRP2
Serum levels of protein SFRP4
Serum levels of protein SFTPB
Serum levels of protein SFTPC
Serum levels of protein SFXN5
Serum levels of protein SGK3
Serum levels of protein SH2D1A
Serum levels of protein SH2D3C
Serum levels of protein SHANK3
Serum levels of protein SHBG
Serum levels of protein SHISA3
Serum levels of protein SHMT1
Serum levels of protein SIGIRR
Serum levels of protein SIGLEC12
Serum levels of protein SIGLEC14
Serum levels of protein SIGLEC6
Serum levels of protein SIRPB1
Serum levels of protein SIRPG
Serum levels of protein SIRT2
Serum levels of protein SLAMF7
Serum levels of protein SLC14A2
Serum levels of protein SLC22A16
Serum levels of protein SLC25A18
Serum levels of protein SLC26A11
Serum levels of protein SLC30A3
Serum levels of protein SLC35G2
Serum levels of protein SLC3A1
Serum levels of protein SLC3A2
Serum levels of protein SLC5A5
Serum levels of protein SLC5A8
Serum levels of protein SLC6A14
Serum levels of protein SLITRK1
Serum levels of protein SLITRK4
Serum levels of protein SLPI
Serum levels of protein SLURP1
Serum levels of protein SMAD3
Serum levels of protein SMDT1
Serum levels of protein SMIM10
Serum levels of protein SMIM9
Serum levels of protein SMOC1
Serum levels of protein SMPD1
Serum levels of protein SMPDL3A
Serum levels of protein SMR3A
Serum levels of protein SNCA
Serum levels of protein SNRPF
Serum levels of protein SNU13
Serum levels of protein SOCS3
Serum levels of protein SORCS2
Serum levels of protein SOST
Serum levels of protein SPACA3
Serum levels of protein SPACA7
Serum levels of protein SPARC
Serum levels of protein SPARCL1
Serum levels of protein SPATA20
Serum levels of protein SPHK2
Serum levels of protein SPINK1
Serum levels of protein SPINK2
Serum levels of protein SPINK5
Serum levels of protein SPINK6
Serum levels of protein SPINK9
Serum levels of protein SPINT1
Serum levels of protein SPINT3
Serum levels of protein SPOCK2
Serum levels of protein SPOCK3
Serum levels of protein SPON1
Serum levels of protein SPP1
Serum levels of protein SPRN
Serum levels of protein SPSB1
Serum levels of protein SRL
Serum levels of protein SRXN1
Serum levels of protein SSR1
Serum levels of protein ST14
Serum levels of protein ST3GAL6
Serum levels of protein ST6GALNAC1
Serum levels of protein ST6GALNAC2
Serum levels of protein ST6GALNAC6
Serum levels of protein STAP1
Serum levels of protein STAT3
Serum levels of protein STAT6
Serum levels of protein STAU2
Serum levels of protein STIM1
Serum levels of protein STIP1
Serum levels of protein STK16
Serum levels of protein STK17B
Serum levels of protein STOML2
Serum levels of protein STX1A
Serum levels of protein STX1B
Serum levels of protein STX3
Serum levels of protein STX7
Serum levels of protein STX8
Serum levels of protein SULF2
Serum levels of protein SULT1B1
Serum levels of protein SULT1E1
Serum levels of protein SULT4A1
Serum levels of protein SUMF1
Serum levels of protein SUN3
Serum levels of protein SUN5
Serum levels of protein SURF1
Serum levels of protein SWAP70
Serum levels of protein SYNCRIP
Serum levels of protein SYNGR3
Serum levels of protein SYT11
Serum levels of protein SYT17
Serum levels of protein SYTL4
Serum levels of protein TAB1;MAP3K7
Serum levels of protein TAC3
Serum levels of protein TAGLN2
Serum levels of protein TAPBPL
Serum levels of protein TARDBP
Serum levels of protein TAX1BP3
Serum levels of protein TBCE
Serum levels of protein TBX22
Serum levels of protein TCEA2
Serum levels of protein TCN1
Serum levels of protein TCN2
Serum levels of protein TCP11
Serum levels of protein TCTN2
Serum levels of protein TDO2
Serum levels of protein TEC
Serum levels of protein TENM4
Serum levels of protein TESC
Serum levels of protein TEX29
Serum levels of protein TF
Serum levels of protein TFF3
Serum levels of protein TFPI2
Serum levels of protein TFRC
Serum levels of protein TGFB1
Serum levels of protein TGFBI
Serum levels of protein TGM1
Serum levels of protein THPO
Serum levels of protein THRA
Serum levels of protein THSD1
Serum levels of protein THSD7A
Serum levels of protein THYN1
Serum levels of protein TIE1
Serum levels of protein TIGAR
Serum levels of protein TIMP2
Serum levels of protein TIMP3
Serum levels of protein TIMP4
Serum levels of protein TINF2
Serum levels of protein TIRAP
Serum levels of protein TLR2
Serum levels of protein TMCC3
Serum levels of protein TMED10
Serum levels of protein TMEM106A
Serum levels of protein TMEM106B
Serum levels of protein TMEM132A
Serum levels of protein TMEM132B
Serum levels of protein TMEM132C
Serum levels of protein TMEM185A
Serum levels of protein TMEM52B
Serum levels of protein TMEM57
Serum levels of protein TMEM87B
Serum levels of protein TMOD3
Serum levels of protein TMPRSS11D
Serum levels of protein TMX3
Serum levels of protein TNC
Serum levels of protein TNF
Serum levels of protein TNFAIP6
Serum levels of protein TNFAIP8
Serum levels of protein TNFRSF10A
Serum levels of protein TNFRSF10B
Serum levels of protein TNFRSF11A
Serum levels of protein TNFRSF11B
Serum levels of protein TNFRSF12A
Serum levels of protein TNFRSF13B
Serum levels of protein TNFRSF18
Serum levels of protein TNFRSF19
Serum levels of protein TNFRSF1A
Serum levels of protein TNFRSF1B
Serum levels of protein TNFRSF8
Serum levels of protein TNFSF11
Serum levels of protein TNFSF12
Serum levels of protein TNFSF18
Serum levels of protein TNNI3
Serum levels of protein TNNT2
Serum levels of protein TOM1L1
Serum levels of protein TOR1AIP1
Serum levels of protein TP53
Serum levels of protein TPM2
Serum levels of protein TPM3
Serum levels of protein TPPP2
Serum levels of protein TPST1
Serum levels of protein TPST2
Serum levels of protein TPT1
Serum levels of protein TRABD
Serum levels of protein TRADD
Serum levels of protein TRAT1
Serum levels of protein TRDMT1
Serum levels of protein TREM1
Serum levels of protein TREM2
Serum levels of protein TREML1
Serum levels of protein TREML4
Serum levels of protein TRH
Serum levels of protein TRIB2
Serum levels of protein TRIL
Serum levels of protein TSNARE1
Serum levels of protein TST
Serum levels of protein TUFT1
Serum levels of protein TWF1
Serum levels of protein TXNDC11
Serum levels of protein TXNDC12
Serum levels of protein TXNDC15
Serum levels of protein TXNIP
Serum levels of protein TYK2
Serum levels of protein TYMP
Serum levels of protein TYMSOS
Serum levels of protein UBA2
Serum levels of protein UBASH3B
Serum levels of protein UBC
Serum levels of protein UBE2D4
Serum levels of protein UBE2G2
Serum levels of protein UBE3A
Serum levels of protein UBXN4
Serum levels of protein UCMA
Serum levels of protein UFC1
Serum levels of protein UGT1A6
Serum levels of protein UGT2A2
Serum levels of protein UMOD
Serum levels of protein UPK3BL
Serum levels of protein UROS
Serum levels of protein USP21
Serum levels of protein UTS2
Serum levels of protein UXS1
Serum levels of protein VAPB
Serum levels of protein VCAN
Serum levels of protein VEGFA
Serum levels of protein VEGFC
Serum levels of protein VIT
Serum levels of protein VOPP1
Serum levels of protein VPS29
Serum levels of protein VRK1
Serum levels of protein VSNL1
Serum levels of protein VSTM5
Serum levels of protein VTN
Serum levels of protein VWA2
Serum levels of protein VWF
Serum levels of protein WDR1
Serum levels of protein WFDC1
Serum levels of protein WFDC10B
Serum levels of protein WFDC13
Serum levels of protein WFDC3
Serum levels of protein WFDC5
Serum levels of protein WFIKKN1
Serum levels of protein WFIKKN2
Serum levels of protein WIF1
Serum levels of protein WISP1
Serum levels of protein WISP2
Serum levels of protein WISP3
Serum levels of protein WNT3A
Serum levels of protein WNT5A
Serum levels of protein WNT7A
Serum levels of protein XCL1
Serum levels of protein XG
Serum levels of protein XXYLT1
Serum levels of protein YBX1
Serum levels of protein YBX2
Serum levels of protein YWHAB
Serum levels of protein YWHAE
Serum levels of protein YWHAQ;SFN;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ
Serum levels of protein ZAP70
Serum levels of protein ZBTB33
Serum levels of protein ZFYVE27
Serum levels of protein ZG16B
Serum levels of protein ZNF10
Serum levels of protein ZNF275
Serum levels of protein ZNF276
Serum levels of protein ZNF334
Serum levels of protein ZNRF3
Serum levels of protein ZNRF4
Serum levels of protein ZP4
Serum levels of protein ZPBP
Serum levels of protein ZPBP2
Serum levels of protein ZPLD1
Serum linoleic acid concentration in metabolic syndrome
Serum lipase activity
Serum lipopolysaccharide activity
Serum magnesium levels
Serum manganese levels
Serum metabolite concentrations in chronic kidney disease
Serum metabolite levels
Serum metabolite levels (CMS)
Serum metabolite ratios in chronic kidney disease
Serum molybdenum levels
Serum nickel levels
Serum omega-3 polyunsaturated fatty acid concentration in metabolic syndrome
Serum omega-6 polyunsaturated fatty acid concentration in metabolic syndrome
Serum omega-6 to omega-3 polyunsaturated fatty acid ratio in metabolic syndrome
Serum oxytocin levels
Serum paraoxonase/arylesterase 1 levels
Serum parathyroid hormone levels
Serum phosphate levels
Serum platinum levels after completion of cisplatin chemotherapy
Serum polyunsaturated fatty acid concentration x Mediterranean diet adherence interaction in metabolic syndrome
Serum polyunsaturated fatty acid concentration x sex interaction in metabolic syndrome
Serum prostate-specific antigen levels
Serum protein levels (sST2)
Serum rubidium levels
Serum sclerostin levels
Serum selenium levels
Serum strontium levels
Serum sulfate level
Serum tamsulosin hydrochloride concentration
Serum thyroid-stimulating hormone levels
Serum tin levels
Serum titanium levels
Serum total cholesterol levels
Serum total polyunsaturated fatty acid concentration in metabolic syndrome
Serum total protein level
Serum type 1 collagen metabolite levels
Serum urate levels
Serum urate levels in chronic kidney disease
Serum urea levels
Serum uric acid levels
Serum uric acid levels in response to allopurinol in gout
Serum uromodulin concentration
Serum uromodulin levels (antibody-based assay)
Serum uromodulin levels (aptamer-based assay)
Serum vanadium levels
Serum vitamin D-binding protein levels
Serum vitamin D-binding protein levels in type 2 diabetes
Serum zinc levels
SET-binding protein level in Chronic kidney disease with hypertension and no diabetes (24471_2)
Setpoint viral load in HIV-1 infection
Severe aortic features in Marfan syndrome
Severe aplastic anemia
Severe autoimmune type 2 diabetes
Severe bacterial meningitis
Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy
Severe COVID-19 disease
Severe COVID-19 infection
Severe COVID-19 or rheumatoid arthritis (MTAG)
Severe COVID-19 or systemic lupus erythematosus
Severe COVID-19 or systemic lupus erythematosus (inverse variance)
Severe COVID-19 or systemic lupus erythematosus (MTAG)
Severe depressive disorders in coronary artery disease
Severe diabetic retinopathy in type 2 diabetes
Severe exacerbations in childhood asthma
Severe gastric atrophy
Severe gingival inflammation
Severe influenza A (H1N1) infection
Severe insulin-deficient type 2 diabetes
Severe insulin-resistant type 2 diabetes
Severe malaria
Severe malaria (adjusted for sickle cell variant rs334)
Severe skin toxicity response to cetuximab in colorectal cancer
Severity of diagnosis of preeclampsia
Severity of nausea and vomiting of pregnancy
Sex hormone levels
Sex hormone-binding globulin levels
Sex hormone-binding globulin levels adjusted for BMI
Sex hormone-binding globulin levels in postmenopausal women
Sex hormone-binding globulin levels in premenopausal women
Sex ratio
Sexual dimorphism in anthropometric traits
Sexual dysfunction (female)
Sexual orientation
SH2 domain-containing protein 1A levels
SH2 domain-containing protein 1A levels (SH2D1A.4567.82.2)
SH2 domain-containing protein 1B levels
SH3 and multiple ankyrin repeat domains protein 3 levels
SH3 and PX domain-containing protein 2B level in Chronic kidney disease with hypertension and no diabetes (25297_11)
SH3 domain-binding glutamic acid-rich-like protein 2 levels
SH3 domain-binding glutamic acid-rich-like protein 3 levels
SH3 domain-binding protein 2 levels
Shadow of prion protein level in Chronic kidney disease with hypertension and no diabetes (13447_42)
Shadow of prion protein levels
SHBG plasma levels
SHC-transforming protein 1 levels
Shellfish liking
Shigella-associated diarrhea
Shingles
Short-chain dicarboxylacylcarnitine levels (additive genetic model)
Short-chain dicarboxylacylcarnitine levels (dominant genetic model)
Short-chain specific acyl-CoA dehydrogenase, mitochondrial levels
Short-term memory (digit-span task)
Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial levels
Shoulder impingement or rotator cuff tear
Shoulder impingement syndrome
Sialate O-acetylesterase levels
Sialic acid synthase levels
Sialic acid-binding Ig-like lectin 10 levels (SIGLEC10.6048.4.3)
Sialic acid-binding Ig-like lectin 11 level in Chronic kidney disease with hypertension and no diabetes (20538_71)
Sialic acid-binding Ig-like lectin 11 levels
Sialic acid-binding Ig-like lectin 11 levels (SIGLEC11.8913.22.3)
Sialic acid-binding Ig-like lectin 12 level in Chronic kidney disease with hypertension and no diabetes (10037_98)
Sialic acid-binding Ig-like lectin 12 level in Chronic kidney disease with hypertension and no diabetes (8352_26)
Sialic acid-binding Ig-like lectin 12 levels
Sialic acid-binding Ig-like lectin 12 levels (SIGLEC12.8352.26.3)
Sialic acid-binding Ig-like lectin 14 levels
Sialic acid-binding Ig-like lectin 14 levels (SIGLEC14.8248.222.3)
Sialic acid-binding Ig-like lectin 15 levels
Sialic acid-binding Ig-like lectin 5 levels
Sialic acid-binding Ig-like lectin 6 level in Chronic kidney disease with hypertension and no diabetes (2741_22)
Sialic acid-binding Ig-like lectin 6 levels
Sialic acid-binding Ig-like lectin 7 levels
Sialic acid-binding Ig-like lectin 7 levels (SIGLEC7.2742.68.2)
Sialic acid-binding Ig-like lectin 8 levels
Sialic acid-binding Ig-like lectin 9 levels
Sialidase-1 levels
Sialoadhesin levels
Sialomucin core protein 24 levels
Sib-shared facial trait 1000; Facial segment 60; 3D morphology of the eye sockets
Sib-shared facial trait 1015; Facial segment 61; 3D morphology of the under eyes
Sib-shared facial trait 1030; Facial segment 62; 3D morphology of the temples
Sib-shared facial trait 1039; Facial segment 63; 3D morphology of the cheekbones
Sib-shared facial trait 1045; Facial segment 63; 3D morphology of the cheekbones
Sib-shared facial trait 119; Facial segment 2; 3D morphology of the nose
Sib-shared facial trait 180; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose
Sib-shared facial trait 183; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose
Sib-shared facial trait 192; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose
Sib-shared facial trait 208; Facial segment 4; 3D morphology of the upper lip
Sib-shared facial trait 209; Facial segment 4; 3D morphology of the upper lip
Sib-shared facial trait 21; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 210; Facial segment 4; 3D morphology of the upper lip
Sib-shared facial trait 220; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 232; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 234; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 247; Facial segment 6; 3D morphology of the lower face
Sib-shared facial trait 25; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 250; Facial segment 6; 3D morphology of the lower face
Sib-shared facial trait 267; Facial segment 6; 3D morphology of the lower face
Sib-shared facial trait 280; Facial segment 7; 3D morphology of the upper face
Sib-shared facial trait 322; Facial segment 7; 3D morphology of the upper face
Sib-shared facial trait 348; Facial segment 9; 3D morphology of the upper lip
Sib-shared facial trait 349; Facial segment 9; 3D morphology of the upper lip
Sib-shared facial trait 350; Facial segment 9; 3D morphology of the upper lip
Sib-shared facial trait 354; Facial segment 9; 3D morphology of the upper lip
Sib-shared facial trait 356; Facial segment 9; 3D morphology of the upper lip
Sib-shared facial trait 372; Facial segment 10; 3D morphology of the nose sides
Sib-shared facial trait 378; Facial segment 11; 3D morphology of the nose
Sib-shared facial trait 388; Facial segment 11; 3D morphology of the nose
Sib-shared facial trait 393; Facial segment 11; 3D morphology of the nose
Sib-shared facial trait 397; Facial segment 11; 3D morphology of the nose
Sib-shared facial trait 399; Facial segment 11; 3D morphology of the nose
Sib-shared facial trait 40; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 412; Facial segment 12; 3D morphology of the cheeks
Sib-shared facial trait 42; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 422; Facial segment 12; 3D morphology of the cheeks
Sib-shared facial trait 426; Facial segment 13; 3D morphology of the chin and jaw
Sib-shared facial trait 485; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 520; Facial segment 17; 3D morphology of the upper lip
Sib-shared facial trait 522; Facial segment 17; 3D morphology of the upper lip
Sib-shared facial trait 528; Facial segment 18; 3D morphology of the philtrium
Sib-shared facial trait 529; Facial segment 18; 3D morphology of the philtrium
Sib-shared facial trait 531; Facial segment 19; 3D morphology of the upper vermillion
Sib-shared facial trait 536; Facial segment 20; 3D morphology of the nose sides
Sib-shared facial trait 541; Facial segment 21; 3D morphology of the nose sides
Sib-shared facial trait 545; Facial segment 21; 3D morphology of the nose sides
Sib-shared facial trait 559; Facial segment 22; 3D morphology of the nose apex
Sib-shared facial trait 560; Facial segment 22; 3D morphology of the nose apex
Sib-shared facial trait 568; Facial segment 22; 3D morphology of the nose apex
Sib-shared facial trait 609; Facial segment 25; 3D morphology of the cheeks
Sib-shared facial trait 619; Facial segment 26; 3D morphology of the chin and outer jaw
Sib-shared facial trait 626; Facial segment 26; 3D morphology of the chin and outer jaw
Sib-shared facial trait 628; Facial segment 27; 3D morphology of the chin and inner jaw
Sib-shared facial trait 630; Facial segment 27; 3D morphology of the chin and inner jaw
Sib-shared facial trait 661; Facial segment 29; 3D morphology of the temple lines
Sib-shared facial trait 676; Facial segment 30; 3D morphology of the eyes
Sib-shared facial trait 707; Facial segment 31; 3D morphology of the cheekbones and temples
Sib-shared facial trait 722; Facial segment 32; 3D morphology of the upper lip
Sib-shared facial trait 752; Facial segment 36; 3D morphology of the philtrium
Sib-shared facial trait 753; Facial segment 37; 3D morphology of the philtrium
Sib-shared facial trait 754; Facial segment 37; 3D morphology of the philtrium
Sib-shared facial trait 757; Facial segment 37; 3D morphology of the philtrium
Sib-shared facial trait 763; Facial segment 38; 3D morphology of the upper vermillion
Sib-shared facial trait 765; Facial segment 38; 3D morphology of the upper vermillion
Sib-shared facial trait 766; Facial segment 39; 3D morphology of the upper vermillion
Sib-shared facial trait 782; Facial segment 40; 3D morphology of the nose sides
Sib-shared facial trait 784; Facial segment 41; 3D morphology of the nose sides
Sib-shared facial trait 788; Facial segment 42; 3D morphology of the nose sides
Sib-shared facial trait 796; Facial segment 42; 3D morphology of the nose sides
Sib-shared facial trait 804; Facial segment 43; 3D morphology of the nose sides
Sib-shared facial trait 806; Facial segment 43; 3D morphology of the nose sides
Sib-shared facial trait 809; Facial segment 43; 3D morphology of the nose sides
Sib-shared facial trait 821; Facial segment 44; 3D morphology of the nose apex
Sib-shared facial trait 822; Facial segment 44; 3D morphology of the nose apex
Sib-shared facial trait 828; Facial segment 45; 3D morphology of the nose alae
Sib-shared facial trait 832; Facial segment 45; 3D morphology of the nose alae
Sib-shared facial trait 833; Facial segment 45; 3D morphology of the nose alae
Sib-shared facial trait 841; Facial segment 46; 3D morphology of the nose bridge
Sib-shared facial trait 848; Facial segment 47; 3D morphology of the nose bridge
Sib-shared facial trait 889; Facial segment 52; 3D morphology of the outer cheeks
Sib-shared facial trait 897; Facial segment 53; 3D morphology of the chin
Sib-shared facial trait 898; Facial segment 53; 3D morphology of the chin
Sib-shared facial trait 90; Facial segment 2; 3D morphology of the nose
Sib-shared facial trait 902; Facial segment 53; 3D morphology of the chin
Sib-shared facial trait 906; Facial segment 54; 3D morphology of the lower chin
Sib-shared facial trait 908; Facial segment 54; 3D morphology of the lower chin
Sib-shared facial trait 912; Facial segment 54; 3D morphology of the lower chin
Sib-shared facial trait 913; Facial segment 54; 3D morphology of the lower chin
Sib-shared facial trait 920; Facial segment 56; 3D morphology of the middle forehead
Sib-shared facial trait 927; Facial segment 56; 3D morphology of the middle forehead
Sib-shared facial trait 929; Facial segment 56; 3D morphology of the middle forehead
Sib-shared facial trait 951; Facial segment 58; 3D morphology of the temple lines
Sib-shared facial trait 963; Facial segment 59; 3D morphology of the temple lines
Sib-shared facial trait 976; Facial segment 60; 3D morphology of the eye sockets
Sick sinus syndrome
Sickle cell anemia (haemolysis)
Sideroflexin-5 levels
Sight-threatening diabetic retinopathy in type 2 diabetes
Signal peptidase complex catalytic subunit SEC11C levels (SEC11C.10658.28.3)
Signal peptide, CUB and EGF-like domain-containing protein 1 levels
Signal peptide, CUB and EGF-like domain-containing protein 3 levels
Signal recognition particle 14 kDa protein level in Chronic kidney disease with hypertension and no diabetes (17510_7)
Signal recognition particle 19 kDa protein levels
Signal transducer and activator of transcription 1-alpha/beta levels
Signal transducer and activator of transcription 3 levels
Signal transducer and activator of transcription 5A level in Chronic kidney disease with hypertension and no diabetes (20225_119)
Signal transducer and activator of transcription 5B levels
Signal transducer and activator of transcription 6 levels
Signal-regulatory protein beta-1 level in Chronic kidney disease with hypertension and no diabetes (6247_9)
Signal-regulatory protein beta-1 levels
Signal-regulatory protein beta-1 levels (SIRPB1.6247.9.3)
Signal-regulatory protein gamma levels
Signal-regulatory protein gamma levels (SIRPG.9241.40.3)
Signal-transducing adaptor protein 1 levels
Simvastatin-induced myopathy
Single Ig IL-1-related receptor level in Chronic kidney disease with hypertension and no diabetes (8326_63)
Single Ig IL-1-related receptor levels
Single Ig IL-1-related receptor levels (SIGIRR.8326.63.3)
Sitting height ratio
Sjögren's syndrome
Skeletal age
Skin aging (microtopography measurement)
Skin aging measurement
Skin and soft tissue infections
Skin autofluorescence
Skin cancer
Skin color
Skin color (Fitzpatrick scale)
Skin colour saturation
Skin phototype score
Skin pigmentation
Skin pigmentation (conditioned on rs1426654 and rs35397)
Skin pigmentation traits
Skin reflectance
Skin reflectance (Melanin index)
Skin sensitivity to sun
Skin, hair and eye pigmentation (multivariate analysis)
SLAM family member 5 levels
SLAM family member 5 levels (CD84.8770.136.3)
SLAM family member 6 levels
SLAM family member 7 levels
SLAM family member 7 levels (SLAMF7.5487.7.3)
Sleep (number of episodes)
Sleep apnea (MTAG)
Sleep apnea (MTAG) (adjusted for BMI)
Sleep apnea syndrome
Sleep depth
Sleep disturbance (changes in sleep) in depressive disorders
Sleep disturbance (decreased sleep) in depressive disorders
Sleep disturbance (increased sleep) in depressive disorders
Sleep duration
Sleep duration (long sleep)
Sleep duration (oversleepers vs undersleepers)
Sleep duration (short sleep)
Sleep health score
Sleep latency
Sleep quality
Sleep start time
Sleep time
Sleep traits (multi-trait analysis)
Sleepwalking
SLIT and NTRK-like protein 6 levels
Slit homolog 1 protein levels
Slit homolog 3 protein levels
Small cell lung carcinoma
Small EDRK-rich factor 2 levels
Small glutamine-rich tetratricopeptide repeat-containing protein alpha levels
Small glutamine-rich tetratricopeptide repeat-containing protein beta levels
Small integral membrane protein 10 level in Chronic kidney disease with hypertension and no diabetes (9379_248)
Small integral membrane protein 13 levels
Small integral membrane protein 24 levels
Small integral membrane protein 9 levels
Small intestine neuroendocrine tumor
Small nuclear ribonucleoprotein F level in Chronic kidney disease with hypertension and no diabetes (5494_52)
Small nuclear ribonucleoprotein Sm D2 levels
Small nuclear ribonucleoprotein Sm D3 levels
Small ubiquitin-related modifier 2 levels
Small ubiquitin-related modifier 3 levels
Small VCP/p97-interacting protein levels
Small vessel stroke
Small vessel stroke (CCS or TOAST classification)
Small vessel stroke (CCSp classification)
Small vessel stroke (MTAG)
Small VLDL particle concentration
Small whole fish consumption
Smoked fish liking
Smoking behavior
Smoking behaviour (age at first cigarette)
Smoking behaviour (cigarette pack-years)
Smoking behaviour (cigarettes smoked per day)
Smoking behaviour (maximum cigarettes in a 24 hour period)
Smoking cessation
Smoking cessation (MTAG)
Smoking cessation in chronic obstructive pulmonary disease
Smoking initiation
Smoking initiation (ever regular vs never regular)
Smoking initiation (ever regular vs never regular) (MTAG)
smoking initiation in schizophrenia
Smoking quantity
Smoking status
Smoking status (current vs former)
Smoking status (current vs mixed)
Smoking status (current vs never)
Smoking status (ever vs never smokers)
Smoking status (heavy vs light)
Smoking status (heavy vs never)
Smoking status (standard GWA)
Smoking status (weighted GWA)
Smoking x traumatic event in childhood (felt hated by family member) interaction
Smoking x traumatic event in childhood (sexually molested) interaction
Smooth-surface caries
Smoothelin levels
Snoring
Snurportin-1 levels
Sociability score
Social autistic-like traits
Social communication problems
Social science traits (pleiotropy) (HIPO component 1)
Sodium channel subunit beta-2 levels
Sodium channel subunit beta-4 levels
Sodium levels
Sodium- and chloride-dependent glycine transporter 1 levels
Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+) levels
Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+) levels (SLC6A14.13053.6.3)
Sodium-coupled monocarboxylate transporter 1 levels
Sodium-coupled monocarboxylate transporter 1 levels (SLC5A8.13691.10.3)
Sodium-independent sulfate anion transporter levels
Sodium/potassium-transporting ATPase subunit alpha-1 levels (ATP1A1.11993.227.3)
Sodium/potassium-transporting ATPase subunit beta-1 levels
Sodium/potassium-transporting ATPase subunit beta-2 levels
Solanidine levels
Soluble CD14 levels
Soluble CD163 levels
Soluble E-selectin levels
Soluble E-selectin levels (adjusted for ABO rs2519093 genotypes)
soluble Endothelial protein C receptor level in Chronic kidney disease with hypertension and no diabetes (24023_35)
Soluble gp130 levels
Soluble ICAM-1
Soluble interleukin-2 receptor subunit alpha
Soluble leptin receptor levels
Soluble levels of adhesion molecules
Soluble urokinase plasminogen activator receptor levels
Solute carrier family 22 member 16 level in Chronic kidney disease with hypertension and no diabetes (9969_8)
Solute carrier family 22 member 16 levels
Solute carrier family 22 member 16 levels (SLC22A16.9969.8.3)
Solute carrier family 35 member G2 level in Chronic kidney disease with hypertension and no diabetes (13501_10)
Solute carrier family 35 member G2 levels
Solute carrier family 35 member G2 levels (SLC35G2.13501.10.3)
Somatoliberin levels
Somatostatin-28 levels
Sorbate levels
Sorbitol dehydrogenase levels
Sorcin levels
Sortilin levels
Sortilin levels (ELISA)
Sortilin levels (OLINK)
Sorting nexin-1 levels
Sorting nexin-11 level in Chronic kidney disease with hypertension and no diabetes (24685_12)
Sorting nexin-17 levels
Sorting nexin-3 levels
Sorting nexin-4 levels
Sorting nexin-5 levels
Sorting nexin-7 levels
SOSS complex subunit C level in Chronic kidney disease with hypertension and no diabetes (23622_128)
Sour taste perception in obesity with metabolic syndrome
Soy sauce liking
SP D plasma levels
SPARC-like protein 1 level in Chronic kidney disease with hypertension and no diabetes (4467_49)
SPARC-like protein 1 levels
SPARC-like protein 1 levels (SPARCL1.4467.49.2)
SPARC-related modular calcium-binding protein 1 levels
SPARC-related modular calcium-binding protein 1 levels (SMOC1.13118.5.3)
SPARC-related modular calcium-binding protein 2 levels
Spastin level in Chronic kidney disease with hypertension and no diabetes (8388_24)
Spatial memory
Spatial processing
Spatial QRS-T angle
Spectrin alpha chain, non-erythrocytic 1 levels (SPTAN1.5031.10.1)
Speech perception in dyslexia
Spelling
Sperm acrosome membrane-associated protein 1 levels
Sperm acrosome membrane-associated protein 3 levels
Sperm acrosome membrane-associated protein 3 levels (SPACA3.8076.4.3)
Sperm antigen with calponin homology and coiled-coil domains 1 level in Chronic kidney disease with hypertension and no diabetes (21360_27)
Sperm flagellar protein 1 levels
Spermatogenesis-associated protein 20 levels
Spermatogenesis-associated protein 20 levels (SPATA20.11117.2.3)
Spermatogenesis-associated protein 46 level in Chronic kidney disease with hypertension and no diabetes (22786_57)
Spermatogenesis-associated protein 9 levels
Spermidine levels
Spermine synthase levels
Spherical equivalent
Spherical equivalent (joint analysis main effects and education interaction)
Spherical equivalent or myopia (age of diagnosis)
Sphingadienine levels
Sphinganine levels
Sphinganine-1-phosphate levels
Sphingolipid d18:1/d18:2 ratio
Sphingolipid levels
Sphingomyelin (34:3) levels
Sphingomyelin (37:2) levels
Sphingomyelin (41:0) levels
Sphingomyelin (41:1) (a) levels
Sphingomyelin (43:1) levels
Sphingomyelin (d16:1/19:0) levels
Sphingomyelin (d16:1/23:0) levels/Sphingomyelin (d17:1/22:0) levels
Sphingomyelin (d16:1/24:1) levels
Sphingomyelin (d17:1/14:0) levels
Sphingomyelin (d17:1/16:0, d18:1/15:0, d16:1/17:0) levels
Sphingomyelin (d17:1/16:0) levels
Sphingomyelin (d17:1/24:1) levels
Sphingomyelin (d17:2/16:0, d18:2/15:0) levels
Sphingomyelin (d17:2/16:0, d18:2/15:0) levels in elite athletes
Sphingomyelin (d18:0/14:0) levels
Sphingomyelin (d18:0/16:0) levels
Sphingomyelin (d18:0/18:0, d19:0/17:0) levels
Sphingomyelin (d18:0/18:0, d19:0/17:0) levels in elite athletes
Sphingomyelin (d18:0/20:0, d16:0/22:0) levels
Sphingomyelin (d18:0/20:0, d16:0/22:0) levels in elite athletes
Sphingomyelin (d18:0/22:0) levels
Sphingomyelin (d18:1/14:0, d16:1/16:0) levels
Sphingomyelin (d18:1/14:0, d16:1/16:0) levels in elite athletes
Sphingomyelin (d18:1/14:0) levels/Sphingomyelin (d16:1/16:0) levels
Sphingomyelin (d18:1/17:0, d17:1/18:0, d19:1/16:0) levels
Sphingomyelin (d18:1/17:0, d17:1/18:0, d19:1/16:0) levels in elite athletes
Sphingomyelin (d18:1/18:0) levels/Sphingomyelin (d16:1/20:0) levels
Sphingomyelin (d18:1/18:1, d18:2/18:0) levels
Sphingomyelin (d18:1/19:0, d19:1/18:0) levels
Sphingomyelin (d18:1/19:0, d19:1/18:0) levels in elite athletes
Sphingomyelin (d18:1/20:0, d16:1/22:0) levels
Sphingomyelin (d18:1/20:0, d16:1/22:0) levels in elite athletes
Sphingomyelin (d18:1/20:0) levels/Sphingomyelin (d16:1/22:0) levels
Sphingomyelin (d18:1/20:1, d18:2/20:0) levels
Sphingomyelin (d18:1/20:1, d18:2/20:0) levels in elite athletes
Sphingomyelin (d18:1/20:2, d18:2/20:1, d16:1/22:2) levels
Sphingomyelin (d18:1/20:2, d18:2/20:1, d16:1/22:2) levels in elite athletes
Sphingomyelin (d18:1/21:0, d17:1/22:0, d16:1/23:0) levels
Sphingomyelin (d18:1/22:1, d18:2/22:0, d16:1/24:1) levels
Sphingomyelin (d18:1/22:1, d18:2/22:0, d16:1/24:1) levels in elite athletes
Sphingomyelin (d18:1/22:2, d18:2/22:1, d16:1/24:2) levels
Sphingomyelin (d18:1/22:2, d18:2/22:1, d16:1/24:2) levels in elite athletes
Sphingomyelin (d18:1/24:1, d18:2/24:0) levels in elite athletes
Sphingomyelin (d18:1/25:0, d19:0/24:1, d20:1/23:0, d19:1/24:0) levels
Sphingomyelin (d18:1/25:0, d19:0/24:1, d20:1/23:0, d19:1/24:0) levels in elite athletes
Sphingomyelin (d18:2/14:0, d18:1/14:1) levels
Sphingomyelin (d18:2/14:0) levels
Sphingomyelin (d18:2/16:0, d18:1/16:1) levels in elite athletes
Sphingomyelin (d18:2/16:0) levels
Sphingomyelin (d18:2/18:0) levels
Sphingomyelin (d18:2/18:1) levels in elite athletes
Sphingomyelin (d18:2/20:0) levels
Sphingomyelin (d18:2/21:0, d16:2/23:0) levels
Sphingomyelin (d18:2/21:0, d16:2/23:0) levels in elite athletes
Sphingomyelin (d18:2/22:0) levels
Sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) levels
Sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) levels in elite athletes
Sphingomyelin (d18:2/23:0) levels
Sphingomyelin (d18:2/24:0) levels
Sphingomyelin (d18:2/24:1, d18:1/24:2) levels
Sphingomyelin (d18:2/24:1, d18:1/24:2) levels in elite athletes
Sphingomyelin (d18:2/24:2) levels in elite athletes
Sphingomyelin (d19:1/24:1) levels
Sphingomyelin (d36:0) levels
Sphingomyelin (d37:1) levels
Sphingomyelin (d38:0) levels
Sphingomyelin (d40:0) levels
Sphingomyelin (d42:0) levels
Sphingomyelin (d43:1) levels
Sphingomyelin (d43:2) levels
Sphingomyelin 24:0 levels
Sphingomyelin levels
Sphingomyelin phosphodiesterase levels
Sphingomyelin_32:1_[M+H]1+ levels
Sphingomyelin_33:1_[M+H]1+ levels
Sphingomyelin_34:0_[M+H]1+ levels
Sphingomyelin_34:1_[M+H]1+ levels
Sphingomyelin_34:2_[M+H]1+ levels
Sphingomyelin_35:1_[M+H]1+ levels
Sphingomyelin_36:0_[M+H]1+ levels
Sphingomyelin_36:1_[M+H]1+ levels
Sphingomyelin_36:2_[M+H]1+ levels
Sphingomyelin_37:1_[M+H]1+ levels
Sphingomyelin_38:1_[M+H]1+ levels
Sphingomyelin_38:2_[M+H]1+ levels
Sphingomyelin_39:1_[M+H]1+ levels
Sphingomyelin_40:0_[M+H]1+ levels
Sphingomyelin_40:1_[M+H]1+ levels
Sphingomyelin_40:2_[M+H]1+ levels
Sphingomyelin_40:3_[M+H]1+ levels
Sphingomyelin_42:2_[M+H]1+ levels
Sphingomyelin_43_2_[M+H]1+ levels
Sphingomyelin(32:1)_[M-CH3]1- levels
Sphingomyelin(32:1)_[M+H]1+ levels
Sphingomyelin(33:1)_[M-CH3]1- levels
Sphingomyelin(34:0)_[M-CH3]1- levels
Sphingomyelin(34:0)_[M+H]1+ levels
Sphingomyelin(34:1)_[M-CH3]1- levels
Sphingomyelin(34:1)_[M+H]1+ levels
Sphingomyelin(34:2)_[M+H]1+ levels
Sphingomyelin(36:0)_[M-CH3]1- levels
Sphingomyelin(36:0)_[M+H]1+ levels
Sphingomyelin(36:1)_[M-CH3]1- levels
Sphingomyelin(36:1)_[M+H]1+ levels
Sphingomyelin(36:2)_[M+H]1+ levels
Sphingomyelin(37:1)_[M-CH3]1- levels
Sphingomyelin(37:1)_[M+H]1+ levels
Sphingomyelin(38:0)_[M+H]1+ levels
Sphingomyelin(38:1)_[M+CH3]1- levels
Sphingomyelin(38:1)_[M+H]1+ levels
Sphingomyelin(39:1)_[M-CH3]1- levels
Sphingomyelin(39:1)_[M+H]1+ levels
Sphingomyelin(40:2)_[M-CH3]1- levels
Sphingomyelin(41:1)_[M+H]1+ levels
Sphingomyelin(41:2)_[M+H]1+ levels
Sphingomyelin(42:2)_[M+OAc]1- levels
Sphingomyelin(42:3)_[M+H]1+ levels
Sphingomyelin(42:4)_[M+H]1+ levels
Sphingomyelin(43:2)_[M-CH3]1- levels
Sphingomyelin(44:9)_[M+H]1- levels
Sphingomyeline (d43:1/d34:1) ratio in Alzheimer disease
Sphingomyeline C16:0 levels
Sphingomyeline C16:1 levels
Sphingomyeline C18:0 levels
Sphingomyeline C18:1 levels
Sphingomyeline C20:2 levels
Sphingomyeline C24:0 levels
Sphingomyeline C24:1 levels
Sphingomyelins levels (UKB data field 23438)
Sphingosine 1-phosphate levels
Sphingosine 1-phosphate levels in elite athletes
Sphingosine kinase 2 levels
Sphingosine levels
Sphingosine levels in elite athletes
Spicy food liking
Spielberger Trait Anxiety Inventory in alcohol dependence (allelic genetic model)
Spinal canal stenosis
Spindlin-1 levels
Spine bone mineral density and alcohol drinking
Spine bone size
Spirits liking
Spleen iron concentration
Spleen volume
Spliceosome RNA helicase DDX39B levels
Splicing factor 1 levels
Splicing factor 3B subunit 4 levels
Splicing factor 45 levels
Splicing factor U2AF 65 kDa subunit levels
Spline residuals of log white blood cell count in acute lymphoblastic leukemia
Spondin-1 levels
Spondin-1 levels (SPON1.4297.62.3)
Spondin-2 levels
Spondylosis
Spontaneous adipocyte lipolysis
Spontaneous coronary artery dissection
Spontaneous dizygotic twinning
Spontaneous preterm birth (preterm birth)
Spontaneous preterm birth with premature rupture of membranes
Spontaneous preterm birth without premature rupture of membranes
Sporadic neuroblastoma
Sporadic pituitary adenoma
Sporadic vestibular schwannoma
Spread type: Butter and margarine spreads vs oil-based spreads (UKB data field 1428)
Spread type: Butter and margarine vs never use spread (UKB data field 1428)
Spread type: Butter vs never use spread (UKB data field 1428)
Spread type: Flora Pro-Active/Benecol (UKB data field 1428_2)
SPRY domain-containing SOCS box protein 1 levels
Squamous cell carcinoma
Squamous cell carcinoma (MTAG)
Squamous cell lung carcinoma
SSC-A on CD14+ monocyte
SSC-A on granulocyte
SSC-A on HLA DR+ Natural Killer
SSC-A on HLA DR+ T cell
SSC-A on monocyte
SSC-A on myeloid Dendritic Cell
SSC-A on Natural Killer
SSC-A on plasmacytoid Dendritic Cell
ST2 plasma levels
ST2 protein levels
Stabilin-1 levels
Stabilin-2 levels
Stable angina pectoris
Stachydrine levels in elite athletes
Stannin levels
Stanniocalcin-1 levels
Staphylococcus aureus infection
Staphylococcus aureus nasal carriage (intermittent)
Staphylococcus aureus nasal carriage (persistent)
StAR-related lipid transfer protein 5 levels
Stathmin levels
Stathmin-2 levels
Stathmin-3 levels
Statin intolerance or statin-associated muscle symptoms
Statin-induced myopathy
Statin-induced myopathy (severe)
Stearic acid (18:0) levels
Stearidonate (18:4n3) levels
Stearidonate 18:4n3 levels
Stearoyl sphingomyelin (d18:1/18:0) levels
Stearoyl sphingomyelin (d18:1/18:0) levels in elite athletes
Stearoyl-arachidonoyl-glycerol (18:0/20:4) [1] levels
Stearoyl-arachidonoyl-glycerol (18:0/20:4) [1] levels in elite athletes
Stearoyl-arachidonoyl-glycerol (18:0/20:4) [2] levels in elite athletes
Stearoylcarnitine (C18) levels in elite athletes
Stearoylcarnitine levels
Stearoylcholine levels in elite athletes
Stem cell factor levels
Stem cell growth factor beta levels
Stem Cell Growth Factor-alpha levels
Stem Cell Growth Factor-beta levels
Stent thrombosis in response to clopidogrel treatment
Sterile alpha motif domain-containing protein 12 level in Chronic kidney disease with hypertension and no diabetes (22771_6)
Steroid induced osteonecrosis of the femoral head and systemic lupus erythematosus
Steroid induced osteonecrosis of the femoral head in systemic lupus erythematosus
Steroid receptor RNA activator 1 levels
Stimulant dependence
Stimulated adipocyte lipolysis
Stool frequency
Strabismus
Straight vs curly hair
Strenuous sports or other exercises
Strep throat
Stress sensitivity (neuroticism score x major depressive disorder status interaction)
Stress urinary incontinence
Stress-induced-phosphoprotein 1 levels
Stress-related phenotypes (multivariate analysis)
Stroke
Stroke (ischemic)
Stroke (pediatric)
Stromal cell-derived factor 1 levels
Stromal cell-derived factor 2 levels
Stromal cell-derived factor 2-like protein 1 levels
Stromal interaction molecule 1 level in Chronic kidney disease with hypertension and no diabetes (8916_32)
Stromal interaction molecule 1 levels
Stromal interaction molecule 1 levels (STIM1.9271.101.3)
Stromal membrane-associated protein 1 levels
Stromal-cell-derived factor 1 alpha levels
Stromelysin-1 level in Chronic kidney disease with hypertension and no diabetes (2788_55)
Stromelysin-1 levels
Stromelysin-2 levels
Structural maintenance of chromosomes protein 3 levels
Sub-cortical grey matter volume
Sub-foveal choroidal thickness
Subarachnoid hemorrhage
Subclinical atherosclerosis traits (other)
Subcortical brain region volumes
Subcortical volume (min-P)
Subcortical volume (MOSTest)
Subcutaneous adipose tissue
Subcutaneous adipose tissue (sex interaction)
Suberate (octanedioate) levels in elite athletes
Suberoylcarnitine (C8-DC) levels
Subiculum volume
Subjective cognitive decline in chronic migraine
Subjective response to lithium treatment
Subjective response to lithium treatment in bipolar disorder
Subjective response to placebo treatment in childhood asthma (change in cough/wheeze)
Subjective well-being
Subjective well-being (MTAG)
Subjective wellbeing conditioned on average household income before tax (multi-trait conditioning and joint analysis)
Subjective wellbeing conditioned on cognitive performance (multi-trait conditioning and joint analysis)
Subjective wellbeing conditioned on educational attainment (multi-trait conditioning and joint analysis)
Subjective wellbeing conditioned on highest math class (multi-trait conditioning and joint analysis)
Subjective wellbeing conditioned on self-rated math ability (multi-trait conditioning and joint analysis)
Subjective wellbeing conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)
Subpleural-predominant interstitial lung abnormalities
Subscapular skin fold thickness
Substance dependence
Substance use disorders (time to event)
Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial level in Chronic kidney disease with hypertension and no diabetes (22773_69)
Succinate-semialdehyde dehydrogenase, mitochondrial level in Chronic kidney disease with hypertension and no diabetes (17792_158)
Succinate-semialdehyde dehydrogenase, mitochondrial levels
Succiniclasticum abundance in stool
Succinimide levels in elite athletes
Succinoyltaurine levels
Succinylcarnitine (c4-dc) levels
Succinylcarnitine (C4-DC) levels in elite athletes
Succinylcarnitine levels
Sucrose levels in elite athletes
Sucrose liking
Sudden cardiac arrest
Sudden cardiac arrest in coronary artery disease
Suffering from nerves
Sugar-sweetened beverage consumption
Suicidal ideation
Suicidal ideation in depression or bipolar disorder
Suicidal or self-harm ideation
Suicidal thoughts and behaviors
Suicidality in mood disorders
Suicide
Suicide attempt
Suicide attempt severity in mood disorders
Suicide attempts
Suicide attempts in bipolar disorder
Suicide attempts in bipolar disorder or schizophrenia
Suicide attempts in depression or bipolar disorder
Suicide attempts in major depressive disorder
Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia
Suicide attempts in schizophrenia
Suicide behavior
Suicide ideation score in major depressive disorder
Suicide in bipolar disorder
Suicide related phenotype (feeling that the life was not worth living) in bipolar disorder
Suicide risk
Sulcal opening distance of the right calloso-marginal posterior fissure
Sulfatase-modifying factor 1 levels
Sulfatase-modifying factor 1 levels (SUMF1.6941.11.3)
Sulfatase-modifying factor 2 levels
Sulfate levels
Sulfate levels in elite athletes
Sulfate of piperine metabolite C18H21NO3 (1) levels
Sulfate of piperine metabolite C18H21NO3 (3) levels
Sulfatide (d18:1/16:0(OH) levels) levels
Sulfatide (d18:1/16:0) levels
Sulfatide (d18:1/24:0(OH) levels) levels
Sulfatide (d18:1/24:0) levels
Sulfatide (d18:1/24:1(OH) levels) levels
Sulfatide (d18:1/24:1) levels
Sulfhydryl oxidase 1 levels (QSOX1.6217.23.3)
Sulfhydryl oxidase 2 levels
Sulfiredoxin-1 levels
Sulfotransferase 1A3 levels
Sulfotransferase 1C2 levels
Sulfotransferase 4A1 levels
Sulfotransferase family cytosolic 1B member 1 levels
Sulfotransferase family cytosolic 2B member 1 levels
Sum basophil neutrophil counts
Sum eosinophil basophil counts
Sum neutrophil eosinophil counts
Sum of carotid plaque area
Sum of stenosis
SUMO-conjugating enzyme UBC9 levels
SUN domain-containing protein 3 levels
SUN domain-containing protein 3 levels (SUN3.8852.10.3)
SUN domain-containing protein 5 levels
Sunburns
Superior crus of antihelix expression
Superior frontal gyrus grey matter volume
Superior frontal gyrus volume
Superior parietal cortex volume
Superior temporal gyrus volume
Superior temporal sulcus banks volume
Superoxide dismutase [Mn], mitochondrial levels
Suppressor of cytokine signaling 3 level in Chronic kidney disease with hypertension and no diabetes (11440_58)
Suppressor of cytokine signaling 3 levels (SOCS3.11440.58.3)
Suppressor of fused homolog levels
Supramarginal gyrus volume
Supranormal left ventricular ejection fraction
Supraventricular ectopy
Surfeit locus protein 1 levels
Surgical hip osteoarthritis
Surgical knee osteoarthritis
Surgical necrotising enterocolitis in extremely premature birth
Survival in breast cancer (estrogen-receptor positive)
Survival in colon cancer
Survival in colorectal cancer (non-distant metastatic)
Survival in coronary artery disease
Survival in endocrine treated breast cancer (estrogen-receptor positive)
Survival in melanoma
Survival in microsatellite instability low/stable colorectal cancer
Survival in pancreatic cancer
Survival in rectal cancer
Survival in sporadic amyotrophic lateral sclerosis
Sushi domain-containing protein 1 levels
Sushi domain-containing protein 2 levels (SUSD2.10021.1.3)
Sushi domain-containing protein 3 levels
Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 levels (SVEP1.11178.21.3)
Sweet beverage consumption
Sweet taste perception in obesity with metabolic syndrome
Sweet taste preference
SWI/SNF complex subunit SMARCC1 levels
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related levels
Switch to non-stimulant treatment in ADHD
Switch-associated protein 70 level in Chronic kidney disease with hypertension and no diabetes (13552_7)
Switch-associated protein 70 levels
Switch-associated protein 70 levels (SWAP70.13552.7.3)
Switched memory B cell %lymphocyte
Symmetric dimethylarginine levels
Symmetric dimethylarginine levels in chronic kidney disease
Symmetrical dimethylarginine levels
Symptom severity in clozapine treated schizophrenia spectrum disorders (quantitative)
Symptoms in COVID-19 outpatients at risk of severe disease (time to remission)
Symptoms in placebo-treated COVID-19 outpatients at risk of severe disease (time to remission)
Synaptic vesicle glycoprotein 2A levels
Synaptic vesicle membrane protein VAT-1 homolog levels
Synaptogyrin-3 levels
Synaptosomal-associated protein 25 levels
Synaptosomal-associated protein 29 levels
Synaptotagmin-11 levels
Synaptotagmin-like protein 1 levels
Synaptotagmin-like protein 4 levels
Synaptotagmin-like protein 4 levels (SYTL4.11563.51.3)
Syndecan-4 levels
Syntaphilin levels
Syntaxin-10 levels (STX10.12842.43.3)
Syntaxin-12 levels
Syntaxin-1A level in Chronic kidney disease with hypertension and no diabetes (3766_51)
Syntaxin-1A levels
Syntaxin-1A levels (STX1A.3766.51.4)
Syntaxin-3 levels
Syntaxin-4 levels
Syntaxin-7 levels
Syntaxin-8 levels
Syntaxin-binding protein 6 level in Chronic kidney disease with hypertension and no diabetes (18308_30)
Syntaxin-binding protein 6 levels
Syntenin-1 levels
Syntenin-2 levels
Systemic juvenile idiopathic arthritis
Systemic lupus erythematosus
Systemic lupus erythematosus and Systemic sclerosis
Systemic lupus erythematosus or rheumatoid arthritis
Systemic mastocytosis
Systemic sclerosis
Systemic sclerosis (anti-centromere-positive)
Systemic sclerosis (anti-topoisomerase-positive)
Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)
Systemising
Systolic blood pressure
Systolic blood pressure (alcohol consumption interaction)
Systolic blood pressure (baseline)
Systolic blood pressure (cigarette smoking interaction)
Systolic blood pressure (education interaction)
Systolic blood pressure (long-term average)
Systolic blood pressure (standard GWA)
Systolic blood pressure (weighted GWA)
Systolic blood pressure and diastolic blood pressure (bivariate analysis)
Systolic blood pressure change trajectory
Systolic blood pressure in preeclampsia
Systolic blood pressure in sickle cell anemia
Systolic blood pressure night-to-day ratio in hypertension
Systolic blood pressure response to hydrochlorothiazide in hypertension
Systolic blood pressure variability
Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)
Systolic blood pressure x alcohol consumption interaction (2df test)
Systolic blood pressure x depressive symptoms interaction (2df test)
Systolic blood pressure x dichotomous lifestyle risk score interaction (1df test)
Systolic blood pressure x dichotomous lifestyle risk score interaction (2df test)
Systolic blood pressure x low social support interaction (1df test)
Systolic blood pressure x low social support interaction (2df test)
Systolic blood pressure x quantitative lifestyle risk score interaction (1df test)
Systolic blood pressure x quantitative lifestyle risk score interaction (2df test)
Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)
Systolic blood pressure x smoking status (ever vs never) interaction (2df test)
Systolic blood pressure x sodium interaction (2df test)
T cell %lymphocyte
T cell Absolute Count
T cell lymphocyte profile difference
T cell lymphocyte profile difference (1 day post influenza vaccination)
T cell lymphocyte profile difference (7 days post influenza vaccination)
T cell lymphocyte profile difference (90 days post influenza vaccination)
T wave morphology restitution during exercise
T wave morphology restitution during exercise (MTAG)
T wave morphology restitution during recovery from exercise
T wave morphology restitution during recovery from exercise (MTAG)
T-box transcription factor TBX5 level in Chronic kidney disease with hypertension and no diabetes (11202_70)
T-box transcription factor TBX5 levels
T-cell antigen CD7 levels
T-Cell Immunoglobulin and Mucin domain 1 levels
T-cell immunoglobulin and mucin domain-containing protein 4 levels
T-cell immunoreceptor with Ig and ITIM domains levels
T-cell receptor-associated transmembrane adapter 1 levels
T-cell surface glycoprotein CD3 epsilon chain levels
T-cell surface glycoprotein CD3 epsilon chain levels (CD3E.8069.85.3)
T-cell surface glycoprotein CD5 levels
T-cell surface glycoprotein CD8 alpha chain levels
T-cell surface glycoprotein CD8 beta chain level in Chronic kidney disease with hypertension and no diabetes (9310_2)
T-cell surface glycoprotein CD8 beta chain levels
T-cell surface protein tactile levels
T-complex protein 1 subunit epsilon levels
T-complex protein 1 subunit eta levels
T-complex protein 11 homolog levels
T-lymphocyte activation antigen CD86 levels
T-lymphocyte surface antigen Ly-9 levels
T-lymphocyte surface antigen Ly-9 levels (LY9.3324.51.1)
t-SNARE domain-containing protein 1 level in Chronic kidney disease with hypertension and no diabetes (7069_9)
t-SNARE domain-containing protein 1 levels
t-SNARE domain-containing protein 1 levels (TSNARE1.7069.9.4)
T/B cell
Tachykinin-4 levels
Tacrolimus trough concentration in kidney transplant patients
Tacrolimus trough level in transplant patients (heart, kidney, lung, and liver)
Tafenoquine efficacy in P. vivax malaria (recurrence by 4 months)
TAFI plasma levels
Takayasu arteritis
Takotsubo syndrome
Tandem gait
Tanning
Tapasin levels
Tapasin-related protein level in Chronic kidney disease with hypertension and no diabetes (6364_7)
Tapasin-related protein levels
Tapasin-related protein levels (TAPBPL.6364.7.3)
TAR DNA-binding protein 43 levels
Tartarate levels in elite athletes
Tartrate-resistant acid phosphatase type 5 levels
Tartronate (hydroxymalonate) levels in elite athletes
Taste perception (total score including phenylthiocarbamide) in obesity with metabolic syndrome
TATA box-binding protein-like protein 1 levels
TATA-binding protein-associated factor 2N levels
TATI plasma levels
Tau burden
Taurine levels in elite athletes
Tauro-beta-muricholate levels
Taurochenodeoxycholate levels in elite athletes
Taurochenodeoxycholic acid 3-sulfate levels
Taurocholenate sulfate levels
Taurocholenate sulfate levels in elite athletes
Taurodeoxycholate levels in elite athletes
Taurodeoxycholic acid 3-sulfate levels
Taurolithocholate 3-sulfate levels
Taurolithocholate 3-sulfate levels in elite athletes
Tauroursodeoxycholate levels in elite athletes
Tax1-binding protein 1 levels
Tax1-binding protein 3 levels
Taxane-induced peripheral neuropathy in breast cancer
TB-LM or TBLH-BMD (pleiotropy)
TBC1 domain family member 24 level in Chronic kidney disease with hypertension and no diabetes (25114_256)
Tea consumption
Tea difference liking
Tea intake (UKB data field 1488)
Tea with sugar liking
TECK plasma levels
Telomere length
Telomeric repeat-binding factor 1 levels
Temperament
Temperament (bipolar disorder)
Temporal pole volume
Tenascin levels
Tenascin levels (TNC.4155.3.2)
Tenascin-R levels
Tenascin-X levels
Teneurin-2 levels
Teneurin-3 levels
Teneurin-4 level in Chronic kidney disease with hypertension and no diabetes (11365_17)
Teneurin-4 levels
Tenofovir clearance in HIV infection
Tenomodulin levels
Tensin-2 levels
Tensin-2 levels (TNS2.11667.29.3)
Teratocarcinoma-derived growth factor 1 levels
Teratocarcinoma-derived growth factor 1 levels (TDGF1.5810.25.3)
Terminally Differentiated CD4-CD8- T cell %CD4-CD8- T cell
Terminally Differentiated CD4-CD8- T cell %T cell
Terminally Differentiated CD4-CD8- T cell Absolute Count
Terminally Differentiated CD4+ T cell %CD4+ T cell
Terminally Differentiated CD4+ T cell %T cell
Terminally Differentiated CD4+ T cell Absolute Count
Terminally Differentiated CD8+ T cell %CD8+ T cell
Terminally Differentiated CD8+ T cell %T cell
Terminally Differentiated CD8+ T cell Absolute Count
Terrisporobacter othiniensis abundance in stool
TestASV_1 (Bacteroides) prevalence
TestASV_10 (Parabacteroides) abundance
TestASV_10 (Parabacteroides) prevalence
TestASV_11 (Lachnospiraceae) abundance
TestASV_12 (Bacteroides) abundance
TestASV_14 (Lachnospiraceae) abundance
TestASV_14 (Lachnospiraceae) prevalence
TestASV_16 (Bacteroides) abundance
TestASV_16 (Bacteroides) prevalence
TestASV_17 (Bacteroides) prevalence
TestASV_18 (Prevotella) abundance
TestASV_18 (Prevotella) prevalence
TestASV_19 (Prevotella) abundance
TestASV_2 (Bacteroides) abundance
TestASV_20 (Phascolarctobacterium) abundance
TestASV_20 (Phascolarctobacterium) prevalence
TestASV_21 (Ruminococcaceae) abundance
TestASV_21 (Ruminococcaceae) prevalence
TestASV_22 (Sutterella) prevalence
TestASV_23 (Barnesiella) prevalence
TestASV_24 (Bacteroides) prevalence
TestASV_25 (Sutterella) abundance
TestASV_26 (Phascolarctobacterium) abundance
TestASV_27 (Ruminococcaceae) abundance
TestASV_27 (Ruminococcaceae) prevalence
TestASV_28 (Holdemanella) abundance
TestASV_28 (Holdemanella) prevalence
TestASV_29 (Barnesiella) abundance
TestASV_29 (Barnesiella) prevalence
TestASV_3 (Bacteroides) prevalence
TestASV_30 (Paraprevotella) prevalence
TestASV_31 (Ruminococcus) abundance
TestASV_31 (Ruminococcus) prevalence
TestASV_32 (Ruminococcaceae) abundance
TestASV_32 (Ruminococcaceae) prevalence
TestASV_33 (Paraprevotella) abundance
TestASV_34 (Phascolarctobacterium) abundance
TestASV_37 (Ruminococcaceae) abundance
TestASV_38 (Ruminococcus) abundance
TestASV_39 (Bacteroides) prevalence
TestASV_4 (Alistipes) abundance
TestASV_4 (Alistipes) prevalence
TestASV_41 (Barnesiella) abundance
TestASV_41 (Barnesiella) prevalence
TestASV_42 (Alphaproteobacteria) abundance
TestASV_43 (Parasutterella) abundance
TestASV_43 (Parasutterella) prevalence
TestASV_44 (Parasutterella) abundance
TestASV_44 (Parasutterella) prevalence
TestASV_45 (Clostridiales) abundance
TestASV_46 (Sutterella) abundance
TestASV_46 (Sutterella) prevalence
TestASV_47 (Parasutterella) prevalence
TestASV_48 (Sutterella) abundance
TestASV_49 (Parasutterella) abundance
TestASV_5 (Bacteroides) abundance
TestASV_5 (Bacteroides) prevalence
TestASV_6 (Subdoligranulum) abundance
TestASV_6 (Subdoligranulum) prevalence
TestASV_7 (Bacteroides) abundance
TestASV_7 (Bacteroides) prevalence
TestASV_8 (Bacteroides) abundance
TestASV_8 (Bacteroides) prevalence
TestASV_9 (Alistipes) prevalence
Testican-2 levels
Testican-2 levels (SPOCK2.5491.12.3)
Testican-3 levels (SPOCK3.9906.21.3)
Testicular cancer
Testicular germ cell cancer
Testicular germ cell tumor
Testin levels
Testis-expressed sequence 29 protein levels
Testis-expressed sequence 29 protein levels (TEX29.10557.6.3)
Testis-specific basic protein Y 1 levels (VCY.6295.67.3)
Testosterone levels
Testosterone levels in postmenopausal women
Testosterone levels in premenopausal women
Testosterone to estradiol ratio
Tetradecadienedioate (C14:2-DC) levels
Tetradecadienoate (14:2) (X-12442) levels
Tetradecadienoate (14:2) levels
Tetradecadienylcarnitine levels
Tetradecanedioate (C14-DC) levels
Tetradecanedioate levels
Tetradecanedioate levels in elite athletes
Tetradecanoylcarnitine levels
Tetradecenoylcarnitine levels
Tetralogy of Fallot
Tetranectin levels
Tetranectin plasma levels
Tetratricopeptide repeat protein 1 levels
Tetratricopeptide repeat protein 17 levels
Tetratricopeptide repeat protein 9B levels
ThalamNuclei lh volume CeM
ThalamNuclei lh volume CM
ThalamNuclei lh volume MDl
ThalamNuclei lh volume Pf
ThalamNuclei lh volume PuA
ThalamNuclei lh volume PuI
ThalamNuclei lh volume VAmc
ThalamNuclei lh volume VLp
ThalamNuclei lh volume VPL
ThalamNuclei rh volume CeM
ThalamNuclei rh volume CM
ThalamNuclei rh volume MDl
ThalamNuclei rh volume MGN
ThalamNuclei rh volume Pf
ThalamNuclei rh volume PuI
ThalamNuclei rh volume VAmc
ThalamNuclei rh volume VLp
Thalamus volume
Thalamus volume change rate
Thalamus volume change rate x age interaction (1df)
Thalamus volume change rate x age interaction (2df)
Theobromine levels in elite athletes
Theophylline levels
Theophylline levels in elite athletes
Theory of mind score in adolescence (Emotional Triangles Task)
Theta EEG coherence
Theta electroencephalogram power
Thiazide-induced adverse metabolic effects in hypertensive patients
Thimet oligopeptidase levels
Thionamide-induced agranulocytosis in Graves' disease
Thioproline levels
Thioproline levels in elite athletes
Thiopurine methyltransferase activity in acute lymphoblastic leukemia patients treated with mercaptopurines
Thiopurine S-methyltransferase activity
Thiopurine-induced alopecia in inflammatory bowel disease
Thiopurine-induced leukopenia in inflammatory bowel disease
Thiopurine-induced leukopenia in inflammatory bowel disease (conditioned on rs116855232)
Thiopurine-induced myelosuppression in inflammatory bowel disease
Thioredoxin domain-containing protein 11 levels
Thioredoxin domain-containing protein 12 level in Chronic kidney disease with hypertension and no diabetes (4815_25)
Thioredoxin domain-containing protein 12 levels
Thioredoxin domain-containing protein 12 levels (TXNDC12.4815.25.3)
Thioredoxin domain-containing protein 15 levels
Thioredoxin domain-containing protein 5 levels
Thioredoxin levels
Thioredoxin reductase 1, cytoplasmic levels
Thioredoxin-dependent peroxide reductase, mitochondrial levels
Thioredoxin-interacting protein levels
Thioredoxin-like protein 4A level in Chronic kidney disease with hypertension and no diabetes (21651_9)
Thiosulfate sulfurtransferase level in Chronic kidney disease with hypertension and no diabetes (12663_1)
Thiosulfate sulfurtransferase levels
Thiosulfate sulfurtransferase levels (TST.12663.1.3)
Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 1 levels
Third ventricle volume
THO complex subunit 1 levels
Thoracic aortic aneurysms
Thoracic aortic aneurysms and dissections
Thoracic aortic calcification levels
THP plasma levels
Threonate levels in elite athletes
Threonine levels
Threonine levels (Biocrates platform)
Threonine levels (Metabolon platform)
Threonine levels in elite athletes
Threonine--tRNA ligase, cytoplasmic levels
Threonylphenylalanine levels in elite athletes
Thrombin generation parameter (endogenous thrombin potential)
Thrombin generation parameter (time to peak thrombin generation)
Thrombin levels
Thrombin-activatable fibrinolysis inhibitor activation peptide
Thrombin-activatable fibrinolysis inhibitor levels
Thrombin-antithrombin complex levels in ischemic stroke
Thrombocytopenia in coronary artery bypass surgery
Thrombomodulin levels
Thrombomodulin levels in ischemic stroke
Thrombomodulin modified thrombin generation parameter (endogenous thrombin potential)
Thrombomodulin sensitivity ratio (normalized endogenous thrombin potential to thrombomodulin)
Thrombomodulin sensitivity ratio (normalized peak thrombin generation to thrombomodulin)
Thrombopoietin levels
Thrombopoietin Receptor levels
Thrombosis
Thrombosis in response to liver transplant
Thrombospondin-4 levels
Thrombospondin-type laminin G domain and EAR repeat-containing protein levels
Thumb osteoarthritis
Thumb osteoarthritis severity (hand Klsum)
Thymidine kinase 2, mitochondrial levels
Thymidine phosphorylase levels
Thymidylate synthase levels
Thymocyte nuclear protein 1 levels
Thymol sulfate levels
Thymol sulfate levels in elite athletes
Thymus and reactivation regulated chemokine levels
Thyroglobulin levels
Thyroglobulin plasma levels
Thyroid autoantibody positivity (anti-thyroglobulin (TgAb) and/or anti-thyroid peroxidase (TPOAb) levels)
Thyroid cancer
Thyroid cancer (Papillary, radiation-related)
Thyroid dysgenesis
Thyroid function
Thyroid hormone levels
Thyroid nodules
Thyroid peroxidase antibody levels
Thyroid peroxidase antibody positivity
Thyroid peroxidase autoantibody levels in type 1 diabetes
Thyroid peroxidase levels
Thyroid stimulating hormone levels
Thyroid volume
Thyroid volume in Hashimoto’s thyroiditis
Thyrotoxic hypokalemic periodic paralysis and Graves disease
Thyrotoxic hypokalemic periodic paralysis in Graves disease
Thyroxine levels
Thyroxine levels in elite athletes
Tiglylcarnitine (C5:1-DC) levels
Tiglylcarnitine (C5:1-DC) levels in elite athletes
Time to aseptic loosening in total joint arthroplasty
Time to colon cancer recurrence
Time to prostate-specific antigen progression in metastatic castration-resistant prostate cancer
Time to recovery from peripheral sensory neuropathy in colon cancer
Time to smoke first cigarette in the morning
Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)
TIMP 3 plasma levels
Tinnitus
Tinnitus (chronic, bothersome)
Tinnitus (severest)
Tinnitus in cisplatin-treated testicular cancer
Tinnitus in noise exposure
Tinnitus-related distress
Tissue factor levels
Tissue factor pathway inhibitor 2 levels
Tissue factor pathway inhibitor levels
Tissue factor pathway inhibitor levels (TFPI.3336.50.1)
Tissue-type plasminogen activator levels
Titin levels
TLR4 interactor with leucine rich repeats levels
TM2 domain-containing protein 1 level in Chronic kidney disease with hypertension and no diabetes (20229_67)
TMED109 abundance in stool
TNF receptor-associated factor 1 levels
TNF-related activation-induced cytokine levels
TNF-related apoptosis-inducing ligand levels
TNF-related apoptosis-inducing ligand receptor 2 levels
Toenail selenium levels
Toll-interacting protein levels
Toll-like receptor 1 levels
Toll-like receptor 3 level in Chronic kidney disease with hypertension and no diabetes (16918_198)
Toll-like receptor 3 levels
Toll-like receptor 4:Lymphocyte antigen 96 complex levels
Toll-like receptor 5 levels
Toll/interleukin-1 receptor domain-containing adapter protein levels
TOM1-like protein 1 levels
TOM1-like protein 2 level in Chronic kidney disease with hypertension and no diabetes (19356_20)
TOM1-like protein 2 levels
TOMM20-like protein 1 levels
Tomoregulin-1 levels
Tongue microbiota abundance (F0422_unclassified_SGB_392)
Tongue microbiota abundance (Fusobacterium_unclassified_SGB_1140)
Tongue microbiota abundance (Neisseria_flavescens_SGB_3307)
Tongue microbiota abundance (Neisseria_unclassified_SGB_1962)
Tongue microbiota abundance (Neisseria_unclassified_SGB_3316)
Tongue microbiota abundance (Oribacterium_unclassified_SGB_1215)
Tongue microbiota abundance (Oribacterium_unclassified_SGB_3339)
Tongue microbiota abundance (Oribacterium_unclassified_SGB_489)
Tongue microbiota abundance (Prevotella_buccalis_SGB_3005)
Tongue microbiota abundance (Prevotella_denticola_SGB_3531)
Tongue microbiota abundance (Prevotella_jejuni_SGB_2431)
Tongue microbiota abundance (Prevotella_sp000599605_SGB_134)
Tongue microbiota abundance (Prevotella_unclassified_SGB_144)
Tongue microbiota abundance (Prevotella_veroralis_SGB_161)
Tongue microbiota abundance (Solobacterium_unclassified_SGB_315)
Tongue microbiota abundance (Streptococcus_unclassified_SGB_2253)
Tongue microbiota abundance (Streptococcus_unclassified_SGB_3019)
Tongue microbiota abundance (Veillonella_unclassified_SGB_1075)
Tongue microbiota abundance (Veillonella_unclassified_SGB_3585)
Tonometry
Tonsillectomy
Tooth agenesis
Tooth agenesis (mandibular second premolars)
Torsin-1A-interacting protein 1 level in Chronic kidney disease with hypertension and no diabetes (9039_47)
Torsin-1A-interacting protein 1 levels
Torsin-1A-interacting protein 1 levels (TOR1AIP1.9039.47.3)
Total Acylcarnitine levels
Total Alkenylphosphatidylcholine levels
Total Alkyldiacylglycerol levels
Total Alkylphosphatidylcholine levels
Total antibody levels in response to SARS-CoV-2 vaccination
Total bilirubin levels
Total bilirubin levels in HIV-1 infection
Total bilirubin levels x insomnia interaction
Total body bone mineral density
Total body bone mineral density (age 0-15)
Total body bone mineral density (age 15-30)
Total body bone mineral density (age 30-45)
Total body bone mineral density (age 45-60)
Total body bone mineral density (age over 60)
Total body bone mineral density (MTAG)
Total bone mineral density x gut microbiota (genus Dialister) interaction
Total brain volume change rate
Total brain volume change rate x age interaction (1df)
Total brain volume change rate x age interaction (2df)
Total campesterol
Total carotid plaque area (excess vs minimal atherosclerosis)
Total Ceramide [S19] levels
Total Ceramide [S20] levels
Total Ceramide levels
Total cerebellar volume
Total cerebellar volume (excluding Crus I vermis)
Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes
Total cholesterol in chylomicron and extremely large VLDL meal response (OrNLSr)
Total cholesterol in very large VLDL meal response (OrNLSr)
Total cholesterol levels
Total cholesterol levels (UKB data field 23400)
Total cholesterol levels in HDL
Total cholesterol levels in LDL
Total cholesterol levels in medium VLDL
Total cholesterol levels in small LDL
Total cholesterol levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder
Total cholesterol minus HDL-C levels
Total cholesterol minus HDL-C levels (UKB data field 23401)
Total Cholesteryl ester levels
Total cholines levels
Total cholines levels (UKB data field 23436)
Total concentration of branched-chain amino acids (leucine + isoleucine + valine)
Total concentration of branched-chain amino acids (leucine + isoleucine + valine) (UKB data field 23464)
Total concentration of lipoprotein particles
Total concentration of lipoprotein particles (UKB data field 23427)
Total Dehydrocholesteryl ester levels
Total Dihexosylceramide levels
Total Dihydroceramide levels
Total esterified cholesterol levels
Total esterified cholesterol levels (UKB data field 23415)
Total ethanolamine levels
Total fatty acid levels
Total fatty acids levels (UKB data field 23442)
Total free cholesterol levels
Total free cholesterol levels (UKB data field 23419)
Total GM3 ganglioside levels
Total grey matter volume
Total hippocampal volume
Total intracranial volume
Total lipid levels in chylomicrons and extremely large VLDL
Total lipid levels in HDL
Total lipid levels in IDL
Total lipid levels in large HDL
Total lipid levels in large LDL
Total lipid levels in large VLDL
Total lipid levels in LDL
Total lipid levels in lipoprotein particles
Total lipid levels in medium HDL
Total lipid levels in medium LDL
Total lipid levels in medium VLDL
Total lipid levels in small HDL
Total lipid levels in small LDL
Total lipid levels in small VLDL
Total lipid levels in very large HDL
Total lipid levels in very large VLDL
Total lipid levels in very small VLDL
Total lipid levels in VLDL
Total lipids in chylomicrons and extremely large VLDL (UKB data field 23482)
Total lipids in chylomicrons and extremely large VLDL meal response (OrNLSr)
Total lipids in HDL (UKB data field 23426)
Total lipids in IDL (UKB data field 23524)
Total lipids in large HDL (UKB data field 23559)
Total lipids in large LDL (UKB data field 23531)
Total lipids in large VLDL (UKB data field 23496)
Total lipids in LDL (UKB data field 23425)
Total lipids in lipoprotein particles (UKB data field 23423)
Total lipids in medium HDL (UKB data field 23566)
Total lipids in medium LDL (UKB data field 23538)
Total lipids in medium VLDL (UKB data field 23503)
Total lipids in small HDL (UKB data field 23573)
Total lipids in small LDL (UKB data field 23545)
Total lipids in small VLDL (UKB data field 23510)
Total lipids in very large HDL (UKB data field 23552)
Total lipids in very large VLDL (UKB data field 23489)
Total lipids in very small VLDL (UKB data field 23517)
Total lipids in VLDL (UKB data field 23424)
Total Lysoalkenylphosphatidylcholine levels
Total Lysoalkylphosphatidylcholine levels
Total Lysophosphatidylcholine levels
Total Lysophosphatidylethanolamine levels
Total Lysophosphatidylinositol levels
Total Monohexosylceramide levels
Total omega-3 fatty acid levels
Total omega-6 fatty acid levels
Total Phosphatidylcholine levels
Total Phosphatidylethanolamine levels
Total Phosphatidylglycerol levels
Total Phosphatidylinositol levels
Total phospholipid levels in lipoprotein particles
Total phospholipids in lipoprotein particles (UKB data field 23411)
Total protein levels x insomnia interaction
Total sitosterol
Total Sulfatide levels
Total testosterone levels
Total thigh muscle volume z-score
Total triglycerides levels
Total triglycerides levels (UKB data field 23407)
Total Trihexosylcermide levels
Total Ubiquinone levels
Total ventricular volume
Total ventricular volume (24 month visit)
Total ventricular volume (24 month visit)(adjusted for APOE e4 dosage)
Total ventricular volume (Alzheimer's disease interaction)
Tourette syndrome
Tourette's syndrome or obsessive-compulsive disorder
TOX high mobility group box family member 3 levels
Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)
Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)
TPE interval (resting)
TPT1-like protein level in Chronic kidney disease with hypertension and no diabetes (22813_5)
TRAF family member-associated NF-kappa-B activator levels
Trafficking protein particle complex subunit 4 levels
Trafficking protein particle complex subunit 5 levels
TRAIL levels
Trans fatty acid levels
Trans-2-hexenoylglycine levels
Trans-cinnamaldehyde levels
Trans-epidermal water loss
Trans-urocanate levels
Trans-urocanate levels in elite athletes
Transaldolase levels
Transcobalamin-1 levels
Transcobalamin-1 levels (TCN1.11232.46.3)
Transcobalamin-2 levels
Transcobalamin-2 levels (TCN2.5584.21.3)
Transcription elongation factor A protein 1 levels
Transcription elongation factor A protein 2 levels
Transcription factor AP-1 levels
Transcription factor ETV7 level in Chronic kidney disease with hypertension and no diabetes (24679_35)
Transcription factor IIIB 90 kDa subunit level in Chronic kidney disease with hypertension and no diabetes (5384_67)
Transcription factor IIIB 90 kDa subunit levels
Transcription factor jun-D levels
Transcription factor RelB levels
Transcription factor RelB levels (RELB.11464.9.3)
Transcription factor SOX-2 levels
Transcription factor TFIIIB component B homolog levels
Transcription initiation factor IIA subunit 2 level in Chronic kidney disease with hypertension and no diabetes (22793_110)
Transcription initiation factor TFIID subunit 10 levels
Transcription regulator protein BACH1 levels
Transcription regulator protein BACH1 levels (BACH1.12451.62.3)
Transcription regulator protein BACH2 levels
Transcriptional activator protein Pur-alpha levels
Transcriptional activator protein Pur-beta levels
Transcriptional regulator Kaiso levels
Transcriptional repressor protein YY1 levels
Transducin beta-like protein 2 levels
Transferrin N-glycan 11 levels
Transferrin N-glycan 14 levels
Transferrin N-glycan 17 levels
Transferrin N-glycan 20 levels
Transferrin N-glycan 21 levels
Transferrin N-glycan 22 levels
Transferrin N-glycan 23 levels
Transferrin N-glycan 24 levels
Transferrin N-glycan 25 levels
Transferrin N-glycan 26 levels
Transferrin N-glycan 27 levels
Transferrin N-glycan 28 levels
Transferrin N-glycan 30 levels
Transferrin N-glycan 31 levels
Transferrin N-glycan 33 levels
Transferrin N-glycan 34 levels
Transferrin N-glycan 35 levels
Transferrin N-glycan 9 levels
Transferrin receptor protein 1 levels
Transferrin receptor protein 1 levels (TFRC.8795.48.3)
Transforming growth factor beta receptor type 3 levels
Transforming growth factor-beta-induced protein ig-h3 levels
Transforming growth factor-beta-induced protein ig-h3 levels (TGFBI.3283.21.1)
Transforming protein RhoA levels
Transgelin levels
Transgelin-2 levels
Transitional B cell Absolute Count
Translation initiation factor IF-3, mitochondrial levels
Translation machinery-associated protein 16 level in Chronic kidney disease with hypertension and no diabetes (22811_5)
Translational activator of cytochrome c oxidase 1 levels
Translationally-controlled tumor protein levels
Translin levels
Translocon-associated protein subunit alpha levels
Transmembrane and coiled-coil domain-containing protein 5A levels
Transmembrane and coiled-coil domains protein 3 levels
Transmembrane emp24 domain-containing protein 10 levels
Transmembrane emp24 domain-containing protein 10 levels (TMED10.6506.54.3)
Transmembrane emp24 domain-containing protein 4 levels
Transmembrane emp24 domain-containing protein 9 level in Chronic kidney disease with hypertension and no diabetes (21236_12)
Transmembrane gamma-carboxyglutamic acid protein 1 levels
Transmembrane glycoprotein NMB levels
Transmembrane glycoprotein NMB levels (GPNMB.8606.39.3)
Transmembrane inner ear expressed protein levels (TMIE.7992.3.3)
Transmembrane protease serine 11D levels (TMPRSS11D.6547.83.3)
Transmembrane protease serine 5 levels
Transmembrane protease serine 6 level in Chronic kidney disease with hypertension and no diabetes (11239_49)
Transmembrane protease serine 6 levels
Transmembrane protein 106A levels
Transmembrane protein 106B levels
Transmembrane protein 119 levels
Transmembrane protein 132A level in Chronic kidney disease with hypertension and no diabetes (7871_16)
Transmembrane protein 132A levels
Transmembrane protein 132A levels (TMEM132A.7871.16.3)
Transmembrane protein 132C levels
Transmembrane protein 132C levels (TMEM132C.7173.141.3)
Transmembrane protein 154 levels
Transmembrane protein 185A levels
Transmembrane protein 2 levels
Transmembrane protein 52 levels
Transmembrane protein 52B levels
Transmembrane protein 59-like levels (TMEM59L.9959.60.3)
Transmembrane protein 87B level in Chronic kidney disease with hypertension and no diabetes (13485_20)
Transmembrane protein 87B levels
Transmembrane protein 87B levels (TMEM87B.13485.20.3)
Transmembrane protein 9 levels
Transmembrane protein C16orf54 levels
Transmembrane protein C1orf162 levels
Transmembrane protein PVRIG levels
Transplant-related mortality after unrelated donor allogeneic hematopoietic cell transplantation (donor-recipient mismatch)
Transverse temporal cortex volume
Trastuzumab-induced cardiotoxicity in cancer
Trauma exposure
Trauma exposure in major depressive disorder
Trauma exposure in major depressive disorder-negative individuals
Treatment resistant depression
Treatment response for severe sepsis
Trefoil factor 2 levels
Trefoil factor 3 levels
Trefoil factor 3 levels (TFF3.4721.54.2)
Trem-like transcript 1 protein levels
Trem-like transcript 2 protein levels
Trem-like transcript 4 protein levels (TREML4.11139.4.3)
Treponema D abundance in stool
Treponemataceae abundance in stool
Treprostinil dose in pulmonary arterial hypertension
Triacylglyceride levels
Triacylglycerol (48:2) [NL-16:0] levels
Triacylglycerol (50:0) [NL-18:0] levels
Triacylglycerol (50:3) [NL-14:1] levels
Triacylglycerol (50:3) [NL-18:1] levels
Triacylglycerol (54:1) [NL-18:1] levels
Triacylglycerol (54:2) [NL-18:0] levels
Triacylglycerol (54:3) [NL-18:1] levels
Triacylglycerol (56:6) [NL-20:4] levels
Triacylglycerol (56:8) [NL-20:4] levels
Triacylglycerol 56:6 levels
Triacylglycerol_45:4_[M+NH4]1+ levels
Triacylglycerol_46:4_[M+NH4]1+ levels
Triacylglycerol_46:5_[M+NH4]1+ levels
Triacylglycerol_48:4_[M+NH4]1+ levels
Triacylglycerol_49:4_[M+NH4]1+ levels
Triacylglycerol_49:5_[M+NH4]1+ levels
Triacylglycerol_50:2_[M+NH4]1+ levels
Triacylglycerol_50:3_[M+NH4]1+ levels
Triacylglycerol_50:4_[M+NH4]1+ levels
Triacylglycerol_50:5_[M+NH4]1+ levels
Triacylglycerol_51:3_[M+NH4]1+ levels
Triacylglycerol_52:2_[M+NH4]1+ levels
Triacylglycerol_52:3_[M+NH4]1+ levels
Triacylglycerol_52:4_[M+NH4]1+ levels
Triacylglycerol_52:6_[M+NH4]1+ levels
Triacylglycerol_53:3_[M+NH4]1+ levels
Triacylglycerol_54:7_[M+NH4]1+ levels
Triacylglycerol_56:4_[M+NH4]1+ levels
Triacylglycerol_56:5_[M+NH4]1+ levels
Triacylglycerol_56:6_[M+NH4]1+ levels
Triacylglycerol_56:7_[M+NH4]1+ levels
Triacylglycerol_56:8_[M+NH4]1+ levels
Triacylglycerol_58:10_[M+NH4]1+ levels
Triacylglycerol_58:7_[M+NH4]1+ levels
Triacylglycerol_58:8_[M+NH4]1+ levels
Triacylglycerol_58:9_[M+NH4]1+ levels
Triacylglycerol(48:3)_[M+NH4]1+ levels
Triacylglycerol(50:2)_[M+NH4]1+ levels
Triacylglycerol(50:3)_[M+NH4]1+ levels
Triacylglycerol(50:4)_[M+NH4]1+ levels
Triacylglycerol(51:2)_[M+NH4]1+ levels
Triacylglycerol(51:3)_[M+NH4]1+ levels
Triacylglycerol(51:4)_[M+NH4]1+ levels
Triacylglycerol(52:1)_[M+NH4]1+ levels
Triacylglycerol(52:2)_[M+NH4]1+ levels
Triacylglycerol(52:3)_[M+NH4]1+ levels
Triacylglycerol(52:4)_[M+NH4]1+ levels
Triacylglycerol(52:5)_[M+NH4]1+ levels
Triacylglycerol(53:2)_[M+NH4]1+ levels
Triacylglycerol(53:3)_[M+NH4]1+ levels
Triacylglycerol(53:4)_[M+NH4]1+ levels
Triacylglycerol(54:3)_[M+NH4]1+ levels
Triacylglycerol(54:4)_[M+NH4]1+ levels
Triacylglycerol(54:5)_[M+NH4]1+ levels
Triacylglycerol(56:4)_[M+NH4]1+ levels
Triacylglycerol(56:6)_[M+NH4]1+ levels
Triacylglycerol(56:7)_[M+NH4]1+ levels
Triacylglycerol(58:9)_[M+NH4]1+ levels
Triamcinolone acetonide-induced ocular hypertension
Tribbles homolog 2 level in Chronic kidney disease with hypertension and no diabetes (12363_70)
Trichilemmal cysts
Trichloroethylene-induced hypersensitivity syndrome
tricyclic pyrone compound response (IC50)
Tridecenedioate (c13:1-dc) (X-11438) levels
Tridecenedioate (C13:1-DC) levels
Trigger finger
Triggering receptor expressed on myeloid cells 1 levels
Triggering receptor expressed on myeloid cells 2 levels
Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes
Triglyceride levels
Triglyceride levels (MTAG)
Triglyceride levels (parental genotype effect)
Triglyceride levels in chylomicrons and extremely large VLDL
Triglyceride levels in current drinkers
Triglyceride levels in HDL
Triglyceride levels in HIV infection
Triglyceride levels in IDL
Triglyceride levels in large HDL
Triglyceride levels in large LDL
Triglyceride levels in large VLDL
Triglyceride levels in LDL
Triglyceride levels in medium HDL
Triglyceride levels in medium LDL
Triglyceride levels in medium VLDL
Triglyceride levels in non-type 2 diabetes
Triglyceride levels in response to fenofibrate treatment (parental genotype effect)
Triglyceride levels in small HDL
Triglyceride levels in small LDL
Triglyceride levels in small VLDL
Triglyceride levels in type 2 diabetes
Triglyceride levels in very large HDL
Triglyceride levels in very large VLDL
Triglyceride levels in very small VLDL
Triglyceride levels in VLDL
Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)
Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)
Triglyceride levels x fish oil supplementation interaction (1df)
Triglyceride levels x long total sleep time interaction (1df test)
Triglyceride levels x long total sleep time interaction (2df test)
Triglyceride levels x loop diuretics use interaction
Triglyceride levels x short total sleep time interaction (1df test)
Triglyceride levels x short total sleep time interaction (2df test)
Triglyceride levels x smoking (current vs non smokers) interaction (2df test)
Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder
Triglyceride levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder
Triglyceride levels x thiazide or thiazide-like diuretics use interaction
Triglycerides
Triglycerides (56:9) levels
Triglycerides (58:10) levels
Triglycerides (58:5) levels
Triglycerides (58:9) levels
Triglycerides in chylomicrons and extremely large VLDL (UKB data field 23487)
Triglycerides in HDL (UKB data field 23410)
Triglycerides in IDL (UKB data field 23529)
Triglycerides in large LDL (UKB data field 23536)
Triglycerides in large VLDL (UKB data field 23501)
Triglycerides in LDL (UKB data field 23409)
Triglycerides in medium HDL (UKB data field 23571)
Triglycerides in medium LDL (UKB data field 23543)
Triglycerides in medium VLDL (UKB data field 23508)
Triglycerides in small HDL (UKB data field 23578)
Triglycerides in small LDL (UKB data field 23550)
Triglycerides in small VLDL (UKB data field 23515)
Triglycerides in very large HDL (UKB data field 23557)
Triglycerides in very large VLDL (UKB data field 23494)
Triglycerides in very small VLDL (UKB data field 23522)
Triglycerides in VLDL (UKB data field 23408)
Triglycerides levels in chylomicrons and extremely large VLDL meal response (OrNLSr)
Triglycerides to phosphoglycerides ratio (UKB data field 23435)
Triglycerides to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23583)
Triglycerides to total lipids in IDL percentage (UKB data field 23613)
Triglycerides to total lipids in large HDL percentage (UKB data field 23638)
Triglycerides to total lipids in large LDL percentage (UKB data field 23618)
Triglycerides to total lipids in large VLDL percentage (UKB data field 23593)
Triglycerides to total lipids in medium HDL percentage (UKB data field 23643)
Triglycerides to total lipids in medium LDL percentage (UKB data field 23623)
Triglycerides to total lipids in medium VLDL percentage (UKB data field 23598)
Triglycerides to total lipids in small HDL percentage (UKB data field 23648)
Triglycerides to total lipids in small LDL percentage (UKB data field 23628)
Triglycerides to total lipids in small VLDL percentage (UKB data field 23603)
Triglycerides to total lipids in very large HDL percentage (UKB data field 23633)
Triglycerides to total lipids in very large VLDL percentage (UKB data field 23588)
Triglycerides to total lipids in very small VLDL percentage (UKB data field 23608)
Triglycerides to total lipids ratio in chylomicrons and extremely large VLDL
Triglycerides to total lipids ratio in IDL
Triglycerides to total lipids ratio in large HDL
Triglycerides to total lipids ratio in large LDL
Triglycerides to total lipids ratio in large VLDL
Triglycerides to total lipids ratio in medium HDL
Triglycerides to total lipids ratio in medium LDL
Triglycerides to total lipids ratio in medium VLDL
Triglycerides to total lipids ratio in small HDL
Triglycerides to total lipids ratio in small LDL
Triglycerides to total lipids ratio in small VLDL
Triglycerides to total lipids ratio in very large HDL
Triglycerides to total lipids ratio in very large VLDL
Triglycerides to total lipids ratio in very small VLDL
Triglycerides x physical activity interaction (2df test)
Triglycerides-Blood Pressure (TG-BP)
Trigonelline (n'-methylnicotinate) levels
Trihexosylcermide (d18:1/16:0) levels
Trihexosylcermide (d18:1/18:0) levels
Trihexosylcermide (d18:1/20:0) levels
Trihexosylcermide (d18:1/22:0) levels
Trihexosylcermide (d18:1/24:0) levels
Trihexosylcermide (d18:1/24:1) levels
Triiodothyronine levels
Triiodothyronine levels and thyroxine levels
Triiodothyronine/thyroxine ratio
Trimethylamine levels
Trinucleotide repeat-containing gene 6B protein levels
Tripartite motif-containing protein 3 levels
Tripeptidyl-peptidase 1 levels
Triptolide cytotoxicity
TRM112-like protein level in Chronic kidney disease with hypertension and no diabetes (23615_4)
tRNA (cytosine(38)-C(5))-methyltransferase levels
tRNA (guanine-N(7)-)-methyltransferase levels
tRNA (guanine-N(7)-)-methyltransferase levels (METTL1.12514.16.3)
tRNA wybutosine-synthesizing protein 3 homolog level in Chronic kidney disease with hypertension and no diabetes (23572_186)
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like levels
Trochanter size
Tropomyosin alpha-1 chain levels
Troponin I, cardiac muscle levels
Troponin T, fast skeletal muscle levels
Trunk fat mass
Trunk fat mass adjusted for trunk lean mass
Trunk lean mass
Trypanosoma cruzi infection
Trypsin-1 levels
Trypsin-2 levels
Trypsin-2 levels (PRSS2.5034.79.1)
Trypsin-3 levels
Tryptase beta-2 levels
Tryptase gamma levels (TPSG1.14103.12.3)
Tryptophan 2,3-dioxygenase levels
Tryptophan 5-hydroxylase 1 level in Chronic kidney disease with hypertension and no diabetes (21521_17)
Tryptophan betaine levels
Tryptophan betaine levels
Tryptophan betaine levels in elite athletes
Tryptophan levels
Tryptophan levels (Biocrates platform)
Tryptophan levels in elite athletes
Tryptophan--tRNA ligase, cytoplasmic levels
Tuberculosis
Tuberculosis susceptibility in HIV infection
Tuberculosis x mycobacterium tuberculosis lineage interaction
Tubulin polymerization-promoting protein family member 2 levels
Tubulin polymerization-promoting protein family member 2 levels (TPPP2.12800.5.3)
Tubulin--tyrosine ligase levels
Tubulin-folding cofactor B levels
Tubulin-specific chaperone E levels
Tubulointerstitial nephritis antigen-like levels
Tudor-interacting repair regulator protein levels
Tuftelin-interacting protein 11 levels
Tumor biomarkers
Tumor necrosis factor alpha levels
Tumor necrosis factor alpha-induced protein 8 levels
Tumor necrosis factor beta levels
Tumor necrosis factor levels
Tumor necrosis factor ligand superfamily member 11 levels
Tumor necrosis factor ligand superfamily member 12 levels
Tumor necrosis factor ligand superfamily member 12 levels (TNFSF12.5939.42.3)
Tumor necrosis factor ligand superfamily member 13B levels
Tumor necrosis factor ligand superfamily member 14 levels
Tumor necrosis factor ligand superfamily member 15 levels
Tumor necrosis factor ligand superfamily member 18 levels
Tumor necrosis factor ligand superfamily member 6, soluble form levels
Tumor necrosis factor ligand superfamily member 8 levels
Tumor necrosis factor receptor 1 levels
Tumor necrosis factor receptor 2 levels
Tumor necrosis factor receptor superfamily member 10A levels
Tumor necrosis factor receptor superfamily member 11A levels (TNFRSF11A.8316.36.3)
Tumor necrosis factor receptor superfamily member 11B levels
Tumor necrosis factor receptor superfamily member 11B levels (TNFRSF11B.2526.53.3)
Tumor necrosis factor receptor superfamily member 13B levels
Tumor necrosis factor receptor superfamily member 13C levels
Tumor necrosis factor receptor superfamily member 14 levels
Tumor necrosis factor receptor superfamily member 16 levels (NGFR.8949.3.3)
Tumor necrosis factor receptor superfamily member 17 levels
Tumor necrosis factor receptor superfamily member 18 levels
Tumor necrosis factor receptor superfamily member 19 levels
Tumor necrosis factor receptor superfamily member 19L levels
Tumor necrosis factor receptor superfamily member 19L levels (RELT.5115.31.3)
Tumor necrosis factor receptor superfamily member 1A levels
Tumor necrosis factor receptor superfamily member 1B levels
Tumor necrosis factor receptor superfamily member 21 levels
Tumor necrosis factor receptor superfamily member 27 levels
Tumor necrosis factor receptor superfamily member 3 levels (LTBR.2636.10.2)
Tumor necrosis factor receptor superfamily member 4 levels
Tumor necrosis factor receptor superfamily member 5 levels
Tumor necrosis factor receptor superfamily member 6 levels
Tumor necrosis factor receptor superfamily member 6 levels (FAS.9459.7.3)
Tumor necrosis factor receptor superfamily member 6B levels
Tumor necrosis factor receptor superfamily member 6B levels (TNFRSF6B.5070.76.3)
Tumor necrosis factor receptor superfamily member 8 levels
Tumor necrosis factor receptor superfamily member EDAR levels
Tumor necrosis factor-inducible gene 6 protein levels
Tumor necrosis factor-inducible gene 6 protein levels (TNFAIP6.5036.50.1)
Tumor protein p53-inducible protein 11 levels
Tumor susceptibility gene 101 protein levels
Tumor-associated calcium signal transducer 2 levels
Turicibacter abundance in stool
Turicibacter sp001543345 abundance in stool
Turicibacteraceae abundance in stool
Turnip liking
Twisted gastrulation protein homolog 1 levels
Two-hour glucose
Two-hour glucose challenge
Type 1 diabetes
Type 1 diabetes (age at diagnosis)
Type 1 diabetes and autoimmune thyroid diseases
Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)
Type 1 diabetes in high risk HLA genotype individuals (time to event)
Type 1 diabetes nephropathy
Type 1 diabetes with low genetic risk score
Type 2 diabetes
Type 2 diabetes (adjusted for BMI)
Type 2 diabetes (adjusted for BMI) or polycystic ovary syndrome (pleiotropy)
Type 2 diabetes (age of onset)
Type 2 diabetes (dietary heme iron intake interaction)
Type 2 diabetes (time to event)
Type 2 diabetes nephropathy
Type 2 diabetes nephropathy including microalbuminuria
Type 2 diabetes or peripheral artery disease (MTAG)
Type 2 diabetes or polycystic ovary syndrome (pleiotropy)
Type 2 diabetes or prostate cancer (pleiotropy)
Type 2 diabetes or schizophrenia (pleiotropy)
Type 2 lactosamine alpha-2,3-sialyltransferase level in Chronic kidney disease with hypertension and no diabetes (6947_4)
Type 2 lactosamine alpha-2,3-sialyltransferase levels
Type 2 lactosamine alpha-2,3-sialyltransferase levels (ST3GAL6.6947.4.3)
Type A behavior
Type ii diabetes
Type II inositol 1,4,5-trisphosphate 5-phosphatase levels
Type III endosome membrane protein TEMP levels
Typical-onset anorexia nervosa
Tyramine O-sulfate levels in elite athletes
Tyrosine levels
Tyrosine levels (UKB data field 23469)
Tyrosine levels in elite athletes
Tyrosine--tRNA ligase, cytoplasmic levels
Tyrosine-protein kinase BTK levels
Tyrosine-protein kinase CSK levels
Tyrosine-protein kinase Fer levels
Tyrosine-protein kinase FRK levels (FRK.10034.16.3)
Tyrosine-protein kinase JAK2 levels (JAK2.4998.50.2)
Tyrosine-protein kinase Lck levels
Tyrosine-protein kinase Lyn levels
Tyrosine-protein kinase Mer levels
Tyrosine-protein kinase receptor Tie-1, soluble levels
Tyrosine-protein kinase receptor Tie-1, soluble levels (TIE1.2844.53.2)
Tyrosine-protein kinase receptor TYRO3 levels
Tyrosine-protein kinase receptor UFO levels
Tyrosine-protein kinase RYK levels
Tyrosine-protein kinase SYK levels
Tyrosine-protein kinase Tec levels
Tyrosine-protein kinase transmembrane receptor ROR1 levels
Tyrosine-protein kinase transmembrane receptor ROR1 levels (ROR1.2590.69.4)
Tyrosine-protein kinase transmembrane receptor ROR2 levels
Tyrosine-protein kinase Yes levels
Tyrosine-protein phosphatase non-receptor type 11 levels
Tyrosine-protein phosphatase non-receptor type 4 levels (PTPN4.14254.27.3)
Tyrosine-protein phosphatase non-receptor type 9 levels
Tyrosine-protein phosphatase non-receptor type substrate 1 level in Chronic kidney disease with hypertension and no diabetes (5430_66)
Tyrosine-protein phosphatase non-receptor type substrate 1 levels
Tyrosine-protein phosphatase non-receptor type substrate 1 levels (SIRPA.5430.66.3)
Tyrosyl-DNA phosphodiesterase 1 levels
UBA1066 sp900317515 abundance in stool
UBA1407 abundance in stool
UBA1409 abundance in stool
UBA1448 abundance in stool
UBA1448 sp002329405 abundance in stool
UBA3855 sp900316885 abundance in stool
UBA6398 abundance in stool
UBA8517 abundance in stool
Ubiquilin-2 levels
Ubiquilin-4 levels
Ubiquinone levels
Ubiquitin carboxyl-terminal hydrolase 14 levels
Ubiquitin carboxyl-terminal hydrolase 15 levels
Ubiquitin carboxyl-terminal hydrolase 21 levels
Ubiquitin carboxyl-terminal hydrolase 21 levels (USP21.12681.63.3)
Ubiquitin carboxyl-terminal hydrolase 25 levels
Ubiquitin carboxyl-terminal hydrolase 30 level in Chronic kidney disease with hypertension and no diabetes (21764_99)
Ubiquitin carboxyl-terminal hydrolase 8 levels
Ubiquitin carboxyl-terminal hydrolase CYLD level in Chronic kidney disease with hypertension and no diabetes (21765_10)
Ubiquitin carboxyl-terminal hydrolase isozyme L1 levels
Ubiquitin carboxyl-terminal hydrolase isozyme L5 levels
Ubiquitin D levels
Ubiquitin domain-containing protein 2 levels
Ubiquitin thioesterase otulin level in Chronic kidney disease with hypertension and no diabetes (21916_82)
Ubiquitin-associated and SH3 domain-containing protein B levels
Ubiquitin-conjugating enzyme E2 A levels
Ubiquitin-conjugating enzyme E2 C levels
Ubiquitin-conjugating enzyme E2 D1 levels
Ubiquitin-conjugating enzyme E2 D2 level in Chronic kidney disease with hypertension and no diabetes (18842_24)
Ubiquitin-conjugating enzyme E2 D2 levels
Ubiquitin-conjugating enzyme E2 D4 levels
Ubiquitin-conjugating enzyme E2 E1 levels
Ubiquitin-conjugating enzyme E2 G1 level in Chronic kidney disease with hypertension and no diabetes (17158_17)
Ubiquitin-conjugating enzyme E2 G1 levels
Ubiquitin-conjugating enzyme E2 G2 levels
Ubiquitin-conjugating enzyme E2 L3 levels
Ubiquitin-conjugating enzyme E2 N levels
Ubiquitin-conjugating enzyme E2 Q1 level in Chronic kidney disease with hypertension and no diabetes (21732_78)
Ubiquitin-conjugating enzyme E2 T levels
Ubiquitin-conjugating enzyme E2 variant 1 levels
Ubiquitin-conjugating enzyme E2 variant 2 levels
Ubiquitin-fold modifier 1 levels
Ubiquitin-fold modifier-conjugating enzyme 1 levels
Ubiquitin-like domain-containing CTD phosphatase 1 levels
Ubiquitin-like protein 4A levels
Ubiquitin-like protein ISG15 levels
Ubiquitin-like protein ISG15 levels (ISG15.14151.4.3)
Ubiquitin-protein ligase E3A levels
UBP9 abundance in stool
UBX domain-containing protein 4 levels
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 levels
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 level in Chronic kidney disease with hypertension and no diabetes (9297_12)
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 levels
UDP-glucose 4-epimerase levels
UDP-glucose 6-dehydrogenase levels
UDP-glucuronic acid decarboxylase 1 levels
UDP-glucuronosyltransferase 1-1 levels
UDP-glucuronosyltransferase 1-6 levels
UDP-glucuronosyltransferase 1-6 levels (UGT1A6.7891.45.3)
UDP-glucuronosyltransferase 1-8 levels
UDP-glucuronosyltransferase 2A1 level in Chronic kidney disease with hypertension and no diabetes (8907_11)
UDP-glucuronosyltransferase 2B15 level in Chronic kidney disease with hypertension and no diabetes (25080_16)
UDP-N-acetylhexosamine pyrophosphorylase levels
Ulcerative colitis
Ulcerative colitis or Crohn's disease
Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS))
Ultradistal forearm bone mineral density
Umami taste perception in obesity with metabolic syndrome
Umbilical hernia
UMP-CMP kinase levels
Uncharacterized family 31 glucosidase KIAA1161 levels
Uncharacterized family 31 glucosidase KIAA1161 levels (KIAA1161.8068.43.3)
Uncharacterized metallophosphoesterase CSTP1 level in Chronic kidney disease with hypertension and no diabetes (21108_5)
Uncharacterized protein C10orf105 levels
Uncharacterized protein C10orf35 levels
Uncharacterized protein C11orf70 level in Chronic kidney disease with hypertension and no diabetes (23213_21)
Uncharacterized protein C11orf87 levels
Uncharacterized protein C11orf94 levels
Uncharacterized protein C14orf93 levels
Uncharacterized protein C17orf78 levels
Uncharacterized protein C17orf78 levels (C17orf78.8545.14.3)
Uncharacterized protein C1orf115 levels
Uncharacterized protein C1orf185 levels
Uncharacterized protein C20orf173 levels
Uncharacterized protein C22orf15 levels
Uncharacterized protein C2orf66 level in Chronic kidney disease with hypertension and no diabetes (5677_15)
Uncharacterized protein C2orf66 levels
Uncharacterized protein C2orf66 levels (C2orf66.5677.15.3)
Uncharacterized protein C4orf32 levels
Uncharacterized protein C5orf46 level in Chronic kidney disease with hypertension and no diabetes (9100_32)
Uncharacterized protein C6orf226 levels (C6orf226.8078.15.3)
Uncharacterized protein C7orf69 levels
Uncharacterized protein C7orf73 levels
Uncharacterized protein KIAA0040 levels
Uncharacterized protein KIAA1644 levels
Uncharacterized protein KIAA2013 levels
Uncontrolled blood pressure in combination therapy (beta blocker and thiazide diuretic)
Unconventional myosin-VI levels
Undecenoylcarnitine (c11:1) (X-17337) levels
Undecenoylcarnitine (C11:1) levels
Unilateral cleft lip
Unilateral cleft lip and palate
Unique cartilage matrix-associated protein levels
Univariate microbial feature (asv: asv006) at the antecubital fossa (moist skin)
Univariate microbial feature (asv: asv070) at the antecubital fossa (moist skin)
Univariate microbial feature (asv: asv086) at the dorsal forearm (dry skin)
Univariate microbial feature (asv: asv093) at the forehead (sebaceous skin)
Univariate microbial feature (family: rhodobacteraceae) at the antecubital fossa (moist skin)
Univariate microbial feature (genus: anaerococcus) at the dorsal forearm (dry skin)
Univariate microbial feature (genus: micrococcus) at the dorsal forearm (dry skin)
Univariate microbial feature (order: bacteroidales) at the dorsal forearm (dry skin)
Unstable angina pectoris
Unswitched memory B cell %lymphocyte
UPF0160 protein MYG1, mitochondrial levels
UPF0258 protein KIAA1024 level in Chronic kidney disease with hypertension and no diabetes (9075_121)
UPF0258 protein KIAA1024 levels
UPF0488 protein C8orf33 levels (C8orf33.9613.16.3)
UPF0606 protein KIAA1549L level in Chronic kidney disease with hypertension and no diabetes (11145_72)
UPF0606 protein KIAA1549L levels
UPF0696 protein C11orf68 levels
UPF0705 protein C11orf49 level in Chronic kidney disease with hypertension and no diabetes (22367_17)
Upper cheek morphology
Upper eyelid morphology
Upper eyelid sagging severity
Uracil levels in elite athletes
Urate levels
Urate levels (BMI interaction)
Urate levels in elite athletes
Urate levels in lean individuals
Urate levels in obese individuals
Urate levels in overweight individuals
Urate-to-histidine ratio
Urea levels
Urea levels in elite athletes
Urea transporter 2 levels
Urgency urinary incontinence
Uric acid clearance
Uric acid elevation in response to thiazide-like diuretic in hypertension
Uric acid levels
Uridine diphosphate glucose pyrophosphatase level in Chronic kidney disease with hypertension and no diabetes (19794_10)
Uridine levels
Uridine levels in elite athletes
Uridine phosphorylase 1 levels
Uridine-cytidine kinase 2 levels
Urinary 1,3-butadiene metabolite levels in smokers
Urinary albumin excretion
Urinary albumin excretion (no hypertensive medication)
Urinary albumin excretion rate in type 1 diabetes
Urinary albumin-to-creatinine ratio
Urinary albumin-to-creatinine ratio in diabetes
Urinary albumin-to-creatinine ratio in non-diabetics
Urinary bladder cancer
Urinary calcium excretion
Urinary creatinine levels
Urinary electrolytes (magnesium/calcium ratio)
Urinary magnesium excretion
Urinary magnesium-to-creatinine ratio
Urinary metabolite levels in chronic kidney disease
Urinary metabolite modules (eigenmetabolites) in chronic kidney disease
Urinary metabolite ratios in chronic kidney disease
Urinary metabolites
Urinary metabolites (H-NMR features)
Urinary microalbumin levels
Urinary potassium excretion
Urinary potassium to creatinine ratio
Urinary sodium excretion
Urinary sodium to creatinine ratio
Urinary sodium to potassium ratio
Urinary symptoms in response to radiotherapy in prostate cancer
Urinary tract infection frequency
Urinary uric acid excretion
Urinary uric acid to urinary creatinine ratio
Urinary uromodulin levels
Urinary uromodulin levels (indexed to creatinine)
Urinary uromodulin levels (raw)
Urine 6-bromotryptophan levels in chronic kidney disease
Urine 6-hydroxymelatonin sulfate-to-creatinine ratio
Urine pH measurement
Urokinase plasminogen activator surface receptor levels
Urokinase-type plasminogen activator levels
Urokinase-type plasminogen activator levels (PLAU.4158.54.2)
Urolithiasis
Uromodulin levels
Uromodulin-like 1 levels
Uronyl 2-sulfotransferase levels
Uroplakin-3b-like protein level in Chronic kidney disease with hypertension and no diabetes (6633_43)
Uroplakin-3b-like protein levels
Uroporphyrinogen decarboxylase levels
Uroporphyrinogen-III synthase levels
Uroporphyrinogen-III synthase levels (UROS.11248.43.3)
Urotensin-2 level in Chronic kidney disease with hypertension and no diabetes (6020_52)
Urotensin-2 levels
Urotensin-2 receptor levels
Ursodeoxycholate levels in elite athletes
Urticaria
Uterine fibroid size (maximum dimension)
Uterine fibroid size (maximum volume)
Uterine fibroids
Uterine fibroids (MTAG)
Uterine fibroids and heavy menstrual bleeding
Uterine leiomyoma or breast cancer (pleiotropy)
Uterine leiomyoma or ER negative breast cancer (pleiotropy)
Uterine leiomyoma or ER positive breast cancer (pleiotropy)
Uterine leiomyomata
Uterine prolapse
Uveal melanoma
Uveal melanoma (TNM stage 1 or 2)
Uveal melanoma (TNM stage 3 or 4)
Uveal melanoma with any chromosomal aberration
Uveal melanoma with chromosome 3 loss
Uveal melanoma with epithelioid cells
Uveitis
V-set and immunoglobulin domain-containing protein 2 levels
V-set and immunoglobulin domain-containing protein 2 levels (VSIG2.8018.43.3)
V-type immunoglobulin domain-containing suppressor of T-cell activation levels
Vaccenic acid (18:1n-7) levels
Vaccine-related adverse events
Vacuolar protein sorting-associated protein 26A levels
Vacuolar protein sorting-associated protein 28 homolog levels
Vacuolar protein sorting-associated protein 4B levels
Vacuolar protein sorting-associated protein 53 homolog level in Chronic kidney disease with hypertension and no diabetes (25103_45)
Vacuolar protein sorting-associated protein VTA1 homolog levels
Vaginal discharge (itching)
Vaginal discharge (metrorrhagia)
Vaginal discharge (smell)
Vaginal microbiome alpha diversity (Pielou Evenness)
Vaginal microbiome alpha diversity (Shannon Index)
Vaginal microbiome beta diversity (Bray-curtis Dissimilarity)
Vaginal microbiome beta diversity (Unweighted Unifrac)
Vaginal microbiome beta diversity (Weighted Unifrac)
Vaginal microbiome composition (community state type)
Vaginal microbiome composition (G. vaginalis)
Vaginal microbiome composition (L. crispatus)
Vaginal microbiome composition (Shannon diversity index)
Vaginal microbiome dominance (s_Lactobacillus iners)
Vaginal microbiome MetaCyc pathway (ALL-CHORISMATE-PWY|superpathway of chorismate metabolism)
Vaginal microbiome MetaCyc pathway (ANAEROFRUCAT-PWY|homolactic fermentation)
Vaginal microbiome MetaCyc pathway (ARGORNPROST-PWY|arginine, ornithine and proline interconversion)
Vaginal microbiome MetaCyc pathway (ARO-PWY|chorismate biosynthesis I)
Vaginal microbiome MetaCyc pathway (ASPASN-PWY|superpathway of L-aspartate and L-asparagine biosynthesis)
Vaginal microbiome MetaCyc pathway (CATECHOL-ORTHO-CLEAVAGE-PWY|catechol degradation to β-ketoadipate)
Vaginal microbiome MetaCyc pathway (CENTFERM-PWY|pyruvate fermentation to butanoate)
Vaginal microbiome MetaCyc pathway (COA-PWY|coenzyme A biosynthesis I)
Vaginal microbiome MetaCyc pathway (CODH-PWY|reductive acetyl coenzyme A pathway)
Vaginal microbiome MetaCyc pathway (COLANSYN-PWY|colanic acid building blocks biosynthesis)
Vaginal microbiome MetaCyc pathway (COMPLETE-ARO-PWY|superpathway of aromatic amino acid biosynthesis)
Vaginal microbiome MetaCyc pathway (DTDPRHAMSYN-PWY|dTDP-L-rhamnose biosynthesis I)
Vaginal microbiome MetaCyc pathway (ENTBACSYN-PWY|enterobactin biosynthesis)
Vaginal microbiome MetaCyc pathway (FAO-PWY|fatty acid β-oxidation I)
Vaginal microbiome MetaCyc pathway (FASYN-ELONG-PWY|fatty acid elongation -- saturated)
Vaginal microbiome MetaCyc pathway (FASYN-INITIAL-PWY|superpathway of fatty acid biosynthesis initiation (E. coli))
Vaginal microbiome MetaCyc pathway (FERMENTATION-PWY|mixed acid fermentation)
Vaginal microbiome MetaCyc pathway (FOLSYN-PWY|superpathway of tetrahydrofolate biosynthesis and salvage)
Vaginal microbiome MetaCyc pathway (FUC-RHAMCAT-PWY|superpathway of fucose and rhamnose degradation)
Vaginal microbiome MetaCyc pathway (FUCCAT-PWY|fucose degradation)
Vaginal microbiome MetaCyc pathway (GALACT-GLUCUROCAT-PWY|superpathway of hexuronide and hexuronate degradation)
Vaginal microbiome MetaCyc pathway (GLUCOSE1PMETAB-PWY|glucose and glucose-1-phosphate degradation)
Vaginal microbiome MetaCyc pathway (GLUTORN-PWY|L-ornithine biosynthesis)
Vaginal microbiome MetaCyc pathway (GLYCOGENSYNTH-PWY|glycogen biosynthesis I (from ADP-D-Glucose))
Vaginal microbiome MetaCyc pathway (GLYOXYLATE-BYPASS|glyoxylate cycle)
Vaginal microbiome MetaCyc pathway (GOLPDLCAT-PWY|superpathway of glycerol degradation to 1,3-propanediol)
Vaginal microbiome MetaCyc pathway (HEMESYN2-PWY|heme biosynthesis II (anaerobic))
Vaginal microbiome MetaCyc pathway (HEXITOLDEGSUPER-PWY|superpathway of hexitol degradation (bacteria))
Vaginal microbiome MetaCyc pathway (HISDEG-PWY|L-histidine degradation I)
Vaginal microbiome MetaCyc pathway (HISTSYN-PWY|L-histidine biosynthesis)
Vaginal microbiome MetaCyc pathway (HSERMETANA-PWY|L-methionine biosynthesis III)
Vaginal microbiome MetaCyc pathway (KDO-NAGLIPASYN-PWY|superpathway of (Kdo)2-lipid A biosynthesis)
Vaginal microbiome MetaCyc pathway (LACTOSECAT-PWY|lactose and galactose degradation I)
Vaginal microbiome MetaCyc pathway (LEU-DEG2-PWY|L-leucine degradation I)
Vaginal microbiome MetaCyc pathway (METH-ACETATE-PWY|methanogenesis from acetate)
Vaginal microbiome MetaCyc pathway (NAD-BIOSYNTHESIS-II|NAD salvage pathway II)
Vaginal microbiome MetaCyc pathway (NAGLIPASYN-PWY|lipid IVA biosynthesis)
Vaginal microbiome MetaCyc pathway (NONMEVIPP-PWY|methylerythritol phosphate pathway I)
Vaginal microbiome MetaCyc pathway (NONOXIPENT-PWY|pentose phosphate pathway (non-oxidative branch))
Vaginal microbiome MetaCyc pathway (OANTIGEN-PWY|O-antigen building blocks biosynthesis (E. coli))
Vaginal microbiome MetaCyc pathway (P122-PWY|heterolactic fermentation)
Vaginal microbiome MetaCyc pathway (P125-PWY|superpathway of (R,R)-butanediol biosynthesis)
Vaginal microbiome MetaCyc pathway (P161-PWY|acetylene degradation)
Vaginal microbiome MetaCyc pathway (P162-PWY|L-glutamate degradation V (via hydroxyglutarate))
Vaginal microbiome MetaCyc pathway (P163-PWY|L-lysine fermentation to acetate and butanoate)
Vaginal microbiome MetaCyc pathway (P164-PWY|purine nucleobases degradation I (anaerobic))
Vaginal microbiome MetaCyc pathway (P221-PWY|octane oxidation)
Vaginal microbiome MetaCyc pathway (P23-PWY|reductive TCA cycle I)
Vaginal microbiome MetaCyc pathway (P381-PWY|adenosylcobalamin biosynthesis II (late cobalt incorporation))
Vaginal microbiome MetaCyc pathway (P42-PWY|incomplete reductive TCA cycle)
Vaginal microbiome MetaCyc pathway (P441-PWY|superpathway of N-acetylneuraminate degradation)
Vaginal microbiome MetaCyc pathway (P461-PWY|hexitol fermentation to lactate, formate, ethanol and acetate)
Vaginal microbiome MetaCyc pathway (P562-PWY|myo-inositol degradation I)
Vaginal microbiome MetaCyc pathway (PANTO-PWY|phosphopantothenate biosynthesis I)
Vaginal microbiome MetaCyc pathway (PANTOSYN-PWY|pantothenate and coenzyme A biosynthesis I)
Vaginal microbiome MetaCyc pathway (PENTOSE-P-PWY|pentose phosphate pathway)
Vaginal microbiome MetaCyc pathway (PHOSLIPSYN-PWY|superpathway of phospholipid biosynthesis I (bacteria))
Vaginal microbiome MetaCyc pathway (POLYAMINSYN3-PWY|superpathway of polyamine biosynthesis II)
Vaginal microbiome MetaCyc pathway (POLYISOPRENSYN-PWY|polyisoprenoid biosynthesis (E. coli))
Vaginal microbiome MetaCyc pathway (PROTOCATECHUATE-ORTHO-CLEAVAGE-PWY|protocatechuate degradation II (ortho-cleavage pathway))
Vaginal microbiome MetaCyc pathway (PRPP-PWY|superpathway of histidine, purine, and pyrimidine biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-1269|CMP-3-deoxy-D-manno-octulosonate biosynthesis I)
Vaginal microbiome MetaCyc pathway (PWY-1622|formaldehyde assimilation I (serine pathway))
Vaginal microbiome MetaCyc pathway (PWY-181|photorespiration)
Vaginal microbiome MetaCyc pathway (PWY-1861|formaldehyde assimilation II (RuMP Cycle))
Vaginal microbiome MetaCyc pathway (PWY-2942|L-lysine biosynthesis III)
Vaginal microbiome MetaCyc pathway (PWY-3001|superpathway of L-isoleucine biosynthesis I)
Vaginal microbiome MetaCyc pathway (PWY-3781|aerobic respiration I (cytochrome c))
Vaginal microbiome MetaCyc pathway (PWY-5005|biotin biosynthesis II)
Vaginal microbiome MetaCyc pathway (PWY-5022|4-aminobutanoate degradation V)
Vaginal microbiome MetaCyc pathway (PWY-5100|pyruvate fermentation to acetate and lactate II)
Vaginal microbiome MetaCyc pathway (PWY-5101|L-isoleucine biosynthesis II)
Vaginal microbiome MetaCyc pathway (PWY-5121|superpathway of geranylgeranyl diphosphate biosynthesis II (via MEP))
Vaginal microbiome MetaCyc pathway (PWY-5177|glutaryl-CoA degradation)
Vaginal microbiome MetaCyc pathway (PWY-5180|toluene degradation I (aerobic) (via o-cresol))
Vaginal microbiome MetaCyc pathway (PWY-5182|toluene degradation II (aerobic) (via 4-methylcatechol))
Vaginal microbiome MetaCyc pathway (PWY-5304|superpathway of sulfur oxidation (Acidianus ambivalens))
Vaginal microbiome MetaCyc pathway (PWY-5347|superpathway of L-methionine biosynthesis (transsulfuration))
Vaginal microbiome MetaCyc pathway (PWY-5384|sucrose degradation IV (sucrose phosphorylase))
Vaginal microbiome MetaCyc pathway (PWY-5415|catechol degradation I (meta-cleavage pathway))
Vaginal microbiome MetaCyc pathway (PWY-5505|L-glutamate and L-glutamine biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-5507|adenosylcobalamin biosynthesis I (early cobalt insertion))
Vaginal microbiome MetaCyc pathway (PWY-5659|GDP-mannose biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-5686|UMP biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-5695|urate biosynthesis/inosine 5'-phosphate degradation)
Vaginal microbiome MetaCyc pathway (PWY-5705|allantoin degradation to glyoxylate III)
Vaginal microbiome MetaCyc pathway (PWY-5741|ethylmalonyl-CoA pathway)
Vaginal microbiome MetaCyc pathway (PWY-5747|2-methylcitrate cycle II)
Vaginal microbiome MetaCyc pathway (PWY-5837|1,4-dihydroxy-2-naphthoate biosynthesis I)
Vaginal microbiome MetaCyc pathway (PWY-5838|superpathway of menaquinol-8 biosynthesis I)
Vaginal microbiome MetaCyc pathway (PWY-5845|superpathway of menaquinol-9 biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-5850|superpathway of menaquinol-6 biosynthesis I)
Vaginal microbiome MetaCyc pathway (PWY-5855|ubiquinol-7 biosynthesis (prokaryotic))
Vaginal microbiome MetaCyc pathway (PWY-5856|ubiquinol-9 biosynthesis (prokaryotic))
Vaginal microbiome MetaCyc pathway (PWY-5857|ubiquinol-10 biosynthesis (prokaryotic))
Vaginal microbiome MetaCyc pathway (PWY-5860|superpathway of demethylmenaquinol-6 biosynthesis I)
Vaginal microbiome MetaCyc pathway (PWY-5861|superpathway of demethylmenaquinol-8 biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-5862|superpathway of demethylmenaquinol-9 biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-5863|superpathway of phylloquinol biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-5896|superpathway of menaquinol-10 biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-5897|superpathway of menaquinol-11 biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-5910|superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate))
Vaginal microbiome MetaCyc pathway (PWY-5913|TCA cycle VI (obligate autotrophs))
Vaginal microbiome MetaCyc pathway (PWY-5918|superpathay of heme biosynthesis from glutamate)
Vaginal microbiome MetaCyc pathway (PWY-5971|palmitate biosynthesis II (bacteria and plants))
Vaginal microbiome MetaCyc pathway (PWY-5973|cis-vaccenate biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-5989|stearate biosynthesis II (bacteria and plants))
Vaginal microbiome MetaCyc pathway (PWY-6121|5-aminoimidazole ribonucleotide biosynthesis I)
Vaginal microbiome MetaCyc pathway (PWY-6122|5-aminoimidazole ribonucleotide biosynthesis II)
Vaginal microbiome MetaCyc pathway (PWY-6123|inosine-5'-phosphate biosynthesis I)
Vaginal microbiome MetaCyc pathway (PWY-6147|6-hydroxymethyl-dihydropterin diphosphate biosynthesis I)
Vaginal microbiome MetaCyc pathway (PWY-6151|S-adenosyl-L-methionine cycle I)
Vaginal microbiome MetaCyc pathway (PWY-6163|chorismate biosynthesis from 3-dehydroquinate)
Vaginal microbiome MetaCyc pathway (PWY-621|sucrose degradation III (sucrose invertase))
Vaginal microbiome MetaCyc pathway (PWY-6269|adenosylcobalamin salvage from cobinamide II)
Vaginal microbiome MetaCyc pathway (PWY-6277|superpathway of 5-aminoimidazole ribonucleotide biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-6282|palmitoleate biosynthesis I (from (5Z)-dodec-5-enoate))
Vaginal microbiome MetaCyc pathway (PWY-6353|purine nucleotides degradation II (aerobic))
Vaginal microbiome MetaCyc pathway (PWY-6383|mono-trans, poly-cis decaprenyl phosphate biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-6396|superpathway of 2,3-butanediol biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-6397|mycolyl-arabinogalactan-peptidoglycan complex biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-6471|peptidoglycan biosynthesis IV (Enterococcus faecium))
Vaginal microbiome MetaCyc pathway (PWY-6507|4-deoxy-L-threo-hex-4-enopyranuronate degradation)
Vaginal microbiome MetaCyc pathway (PWY-6519|8-amino-7-oxononanoate biosynthesis I)
Vaginal microbiome MetaCyc pathway (PWY-6562|norspermidine biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-6588|pyruvate fermentation to acetone)
Vaginal microbiome MetaCyc pathway (PWY-6612|superpathway of tetrahydrofolate biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-6628|superpathway of L-phenylalanine biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-6630|superpathway of L-tyrosine biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-6700|queuosine biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-6703|preQ0 biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-6708|ubiquinol-8 biosynthesis (prokaryotic))
Vaginal microbiome MetaCyc pathway (PWY-6737|starch degradation V)
Vaginal microbiome MetaCyc pathway (PWY-6749|CMP-legionaminate biosynthesis I)
Vaginal microbiome MetaCyc pathway (PWY-6891|thiazole biosynthesis II (Bacillus))
Vaginal microbiome MetaCyc pathway (PWY-6892|thiazole biosynthesis I (E. coli))
Vaginal microbiome MetaCyc pathway (PWY-6895|superpathway of thiamin diphosphate biosynthesis II)
Vaginal microbiome MetaCyc pathway (PWY-6897|thiamin salvage II)
Vaginal microbiome MetaCyc pathway (PWY-6901|superpathway of glucose and xylose degradation)
Vaginal microbiome MetaCyc pathway (PWY-6969|TCA cycle V (2-oxoglutarate:ferredoxin oxidoreductase))
Vaginal microbiome MetaCyc pathway (PWY-7007|methyl ketone biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-7094|fatty acid salvage)
Vaginal microbiome MetaCyc pathway (PWY-7111|pyruvate fermentation to isobutanol (engineered))
Vaginal microbiome MetaCyc pathway (PWY-7159|chlorophyllide a biosynthesis III (aerobic, light independent))
Vaginal microbiome MetaCyc pathway (PWY-7184|pyrimidine deoxyribonucleotides de novo biosynthesis I)
Vaginal microbiome MetaCyc pathway (PWY-7187|pyrimidine deoxyribonucleotides de novo biosynthesis II)
Vaginal microbiome MetaCyc pathway (PWY-7196|superpathway of pyrimidine ribonucleosides salvage)
Vaginal microbiome MetaCyc pathway (PWY-7197|pyrimidine deoxyribonucleotide phosphorylation)
Vaginal microbiome MetaCyc pathway (PWY-7199|pyrimidine deoxyribonucleosides salvage)
Vaginal microbiome MetaCyc pathway (PWY-7200|superpathway of pyrimidine deoxyribonucleoside salvage)
Vaginal microbiome MetaCyc pathway (PWY-7208|superpathway of pyrimidine nucleobases salvage)
Vaginal microbiome MetaCyc pathway (PWY-7219|adenosine ribonucleotides de novo biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-7220|adenosine deoxyribonucleotides de novo biosynthesis II)
Vaginal microbiome MetaCyc pathway (PWY-7221|guanosine ribonucleotides de novo biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-7222|guanosine deoxyribonucleotides de novo biosynthesis II)
Vaginal microbiome MetaCyc pathway (PWY-7234|inosine-5'-phosphate biosynthesis III)
Vaginal microbiome MetaCyc pathway (PWY-7237|myo-, chiro- and scillo-inositol degradation)
Vaginal microbiome MetaCyc pathway (PWY-7315|dTDP-N-acetylthomosamine biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-7323|superpathway of GDP-mannose-derived O-antigen building blocks biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-7328|superpathway of UDP-glucose-derived O-antigen building blocks biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-7332|superpathway of UDP-N-acetylglucosamine-derived O-antigen building blocks biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-7371|1,4-dihydroxy-6-naphthoate biosynthesis II)
Vaginal microbiome MetaCyc pathway (PWY-7373|superpathway of demethylmenaquinol-6 biosynthesis II)
Vaginal microbiome MetaCyc pathway (PWY-7376|cob(II)yrinate a,c-diamide biosynthesis II (late cobalt incorporation))
Vaginal microbiome MetaCyc pathway (PWY-7392|taxadiene biosynthesis (engineered))
Vaginal microbiome MetaCyc pathway (PWY-7400|L-arginine biosynthesis IV (archaebacteria))
Vaginal microbiome MetaCyc pathway (PWY-7431|aromatic biogenic amine degradation (bacteria))
Vaginal microbiome MetaCyc pathway (PWY-7456|mannan degradation)
Vaginal microbiome MetaCyc pathway (PWY-7539|6-hydroxymethyl-dihydropterin diphosphate biosynthesis III (Chlamydia))
Vaginal microbiome MetaCyc pathway (PWY-7560|methylerythritol phosphate pathway II)
Vaginal microbiome MetaCyc pathway (PWY-7663|gondoate biosynthesis (anaerobic))
Vaginal microbiome MetaCyc pathway (PWY-7664|oleate biosynthesis IV (anaerobic))
Vaginal microbiome MetaCyc pathway (PWY-922|mevalonate pathway I)
Vaginal microbiome MetaCyc pathway (PWY0-1061|superpathway of L-alanine biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY0-1241|ADP-L-glycero-β-D-manno-heptose biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY0-1261|anhydromuropeptides recycling)
Vaginal microbiome MetaCyc pathway (PWY0-1296|purine ribonucleosides degradation)
Vaginal microbiome MetaCyc pathway (PWY0-1298|superpathway of pyrimidine deoxyribonucleosides degradation)
Vaginal microbiome MetaCyc pathway (PWY0-1319|CDP-diacylglycerol biosynthesis II)
Vaginal microbiome MetaCyc pathway (PWY0-1415|superpathway of heme biosynthesis from uroporphyrinogen-III)
Vaginal microbiome MetaCyc pathway (PWY0-1533|methylphosphonate degradation I)
Vaginal microbiome MetaCyc pathway (PWY0-1586|peptidoglycan maturation (meso-diaminopimelate containing))
Vaginal microbiome MetaCyc pathway (PWY0-162|superpathway of pyrimidine ribonucleotides de novo biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY0-166|superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis (E. coli))
Vaginal microbiome MetaCyc pathway (PWY0-321|phenylacetate degradation I (aerobic))
Vaginal microbiome MetaCyc pathway (PWY0-42|2-methylcitrate cycle I)
Vaginal microbiome MetaCyc pathway (PWY1G-0|mycothiol biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY490-3|nitrate reduction VI (assimilatory))
Vaginal microbiome MetaCyc pathway (PWY4FS-7|phosphatidylglycerol biosynthesis I (plastidic))
Vaginal microbiome MetaCyc pathway (PWY4FS-8|phosphatidylglycerol biosynthesis II (non-plastidic))
Vaginal microbiome MetaCyc pathway (PYRIDNUCSAL-PWY|NAD salvage pathway I)
Vaginal microbiome MetaCyc pathway (PYRIDOXSYN-PWY|pyridoxal 5'-phosphate biosynthesis I)
Vaginal microbiome MetaCyc pathway (REDCITCYC|TCA cycle VIII (helicobacter))
Vaginal microbiome MetaCyc pathway (RIBOSYN2-PWY|flavin biosynthesis I (bacteria and plants))
Vaginal microbiome MetaCyc pathway (RUMP-PWY|formaldehyde oxidation I)
Vaginal microbiome MetaCyc pathway (SALVADEHYPOX-PWY|adenosine nucleotides degradation II)
Vaginal microbiome MetaCyc pathway (SULFATE-CYS-PWY|superpathway of sulfate assimilation and cysteine biosynthesis)
Vaginal microbiome MetaCyc pathway (TCA-GLYOX-BYPASS|superpathway of glyoxylate bypass and TCA)
Vaginal microbiome MetaCyc pathway (TCA|TCA cycle I (prokaryotic))
Vaginal microbiome MetaCyc pathway (TEICHOICACID-PWY|teichoic acid (poly-glycerol) biosynthesis)
Vaginal microbiome MetaCyc pathway (THISYN-PWY|superpathway of thiamin diphosphate biosynthesis I)
Vaginal microbiome MetaCyc pathway (THRESYN-PWY|superpathway of L-threonine biosynthesis)
Vaginal microbiome MetaCyc pathway (TRNA-CHARGING-PWY|tRNA charging)
Vaginal microbiome MetaCyc pathway (TRPSYN-PWY|L-tryptophan biosynthesis)
Vaginal microbiome MetaCyc pathway (TYRFUMCAT-PWY|L-tyrosine degradation I)
Vaginal microbiome MetaCyc pathway (UBISYN-PWY|superpathway of ubiquinol-8 biosynthesis (prokaryotic))
Vaginal microbiome presence (c_Actinobacteria)
Vaginal microbiome presence (c_Gammaproteobacteria)
Vaginal microbiome presence (f_Bifidobacteriaceae)
Vaginal microbiome presence (f_Lachnospiraceae)
Vaginal microbiome presence (g_Anaerococcus)
Vaginal microbiome presence (g_Dialister)
Vaginal microbiome presence (g_Prevotella)
Vaginal microbiome presence (o_Bacteroidales)
Vaginal microbiome presence (o_Peptostreptococcales-Tissierellales)
Vaginal microbiome presence (p_Actinobacteriota)
Vaginal microbiome presence (p_Proteobacteria)
Vaginal microbiome presence (s_Aerococcus christensenii)
Vaginal microbiome presence (s_Finegoldia magna)
Vaginal microbiome presence (s_Gardnerella vaginalis)
Vaginal microbiome presence (s_Lactobacillus jensenii)
Vaginal microbiome presence (s_Lactobacillus paragasseri/gasseri)
Vaginal microbiome presence (s_Prevotella bivia)
Vaginal microbiome presence (s_Prevotella timonensis)
Vaginal microbiome relative abundance (c_Actinobacteria)
Vaginal microbiome relative abundance (c_Clostridia)
Vaginal microbiome relative abundance (c_Gammaproteobacteria)
Vaginal microbiome relative abundance (f_Aerococcaceae)
Vaginal microbiome relative abundance (f_Bifidobacteriaceae)
Vaginal microbiome relative abundance (f_Lachnospiraceae)
Vaginal microbiome relative abundance (f_Peptostreptococcales-Tissierellales)
Vaginal microbiome relative abundance (g_Anaerococcus)
Vaginal microbiome relative abundance (g_Atopobium)
Vaginal microbiome relative abundance (g_Dialister)
Vaginal microbiome relative abundance (g_Lactobacillus)
Vaginal microbiome relative abundance (g_Megasphaera)
Vaginal microbiome relative abundance (g_Prevotella)
Vaginal microbiome relative abundance (g_Streptococcus)
Vaginal microbiome relative abundance (Lactobacillus crispatus or Lactobacillus iners or Gardnerella vaginalis) (pleiotropy)
Vaginal microbiome relative abundance (o_Bacteroidales)
Vaginal microbiome relative abundance (o_Campylobacterales)
Vaginal microbiome relative abundance (o_Fusobacteriales)
Vaginal microbiome relative abundance (p_Actinobacteriota)
Vaginal microbiome relative abundance (p_Firmicutes)
Vaginal microbiome relative abundance (p_Proteobacteria)
Vaginal microbiome relative abundance (pleiotropy)
Vaginal microbiome relative abundance (s_Aerococcus christensenii)
Vaginal microbiome relative abundance (s_Atopobium vaginae)
Vaginal microbiome relative abundance (s_Dialister micraerophilus)
Vaginal microbiome relative abundance (s_Dialister propionicifaciens)
Vaginal microbiome relative abundance (s_Finegoldia magna)
Vaginal microbiome relative abundance (s_Gardnerella vaginalis)
Vaginal microbiome relative abundance (s_Lactobacillus crispatus)
Vaginal microbiome relative abundance (s_Lactobacillus iners)
Vaginal microbiome relative abundance (s_Lactobacillus jensenii)
Vaginal microbiome relative abundance (s_Lactobacillus mulieris)
Vaginal microbiome relative abundance (s_Lactobacillus paragasseri/gasseri)
Vaginal microbiome relative abundance (s_Lactobacillus reuteri)
Vaginal microbiome relative abundance (s_Megasphaera genomosp type 1)
Vaginal microbiome relative abundance (s_Peptoniphilus vaginalis)
Vaginal microbiome relative abundance (s_Prevotella bivia)
Valacyclovir hydrolase levels
Valerate levels in elite athletes
Valerylcarnitine levels
Valine levels
Valine levels (Biocrates platform)
Valine levels (UKB data field 23467)
Valine levels in elite athletes
Valine--tRNA ligase level in Chronic kidney disease with hypertension and no diabetes (13083_18)
Valine--tRNA ligase levels
Valine--tRNA ligase levels (VARS.13083.18.3)
Valine-to-isovalerylcarnitine ratio
Valine-to-proline ratio
Valylglutamine levels in elite athletes
Valylglycine levels in elite athletes
Valylleucine levels in elite athletes
Vanillactate levels
Vanillactate levels in elite athletes
Vanillic acid glycine levels
Vanillylmandelate (VMA) levels in elite athletes
Variable charge X-linked protein 1 level in Chronic kidney disease with hypertension and no diabetes (23426_1)
Varicella zoster virus glycoproteins E and I antibody levels
Varicose veins
Vascular brain injury
Vascular cell adhesion protein 1 levels
Vascular cell adhesion protein 1 levels (VCAM1.2967.8.1)
Vascular endothelial function
Vascular endothelial growth factor A levels
Vascular endothelial growth factor A, isoform 121 levels
Vascular endothelial growth factor B levels
Vascular endothelial growth factor C levels
vascular endothelial growth factor D levels
Vascular endothelial growth factor levels
Vascular endothelial growth factor receptor 1 levels
Vascular endothelial growth factor receptor 2 levels
Vascular endothelial growth factor receptor 3 levels
Vascular endothelial growth factor receptor 3 levels (FLT4.2358.19.2)
Vascular non-inflammatory molecule 2 level in Chronic kidney disease with hypertension and no diabetes (15480_2)
Vascular non-inflammatory molecule 2 levels
Vasoactive Intestinal Peptide levels
Vasodilator-stimulated phosphoprotein levels
Vasorin levels
Vaspin levels
Vegetable consumption
Vegetables liking
VEGFR 3 plasma levels
Vein graft stenosis in coronary artery bypass grafting
Velopharyngeal dysfunction
Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks)
Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 12 weeks)
Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 24 weeks)
Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 12 weeks)
Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 24 weeks)
Venous thromboembolism
Venous thromboembolism adjusted for sickle cell variant rs77121243-T
Venous thromboembolism in pregnancy
Venous thromboembolism or factor VII levels (pleiotropy)
Venous thromboembolism or factor VIII levels (pleiotropy)
Venous thromboembolism or factor XI levels (pleiotropy)
Venous thromboembolism or fibrinogen levels (pleiotropy)
Venous thromboembolism or plasminogen activator inhibitor 1 levels (pleiotropy)
Venous thromboembolism or tissue plasminogen activator levels (pleiotropy)
Venous thromboembolism or von Willebrand factor levels (pleiotropy)
Ventral diencephalon volume
Ventral hernia
Ventral thalamic nuclei volume
Ventricular arrhythmia
Ventricular ectopy
Ventricular ectopy or supraventricular ectopy (pleiotropy)
Verbal aggression in schizophrenia
Verbal declarative memory
Verbal intelligence quotient (cesarean section interaction)
Verbal learning
Verbal learning (oral presentation)
Verbal learning (visual presentation)
Verbal memory performance (delayed recall level)
Verbal memory performance (immediate recall change)
Verbal memory performance (immediate recall level)
Verbal memory performance (residualized delayed recall change)
Verbal memory performance (residualized delayed recall level)
Verbal short term memory
Verbal short term memory (paragraph recall test)
Verbal-numerical reasoning
Versican core protein levels
Vertex-wise cortical surface area
Vertex-wise cortical thickness
Vertex-wise sulcal depth
Vertical cup-disc ratio
Vertical cup-disc ratio (adjusted for vertical disc diameter)
Vertical cup-disc ratio (multi-trait analysis)
Vertigo
Very large VLDL particle concentration
Very Late Antigen-4 level in Chronic kidney disease with hypertension and no diabetes (21688_50)
Very long-chain acyl-CoA synthetase levels
Very long-chain saturated fatty acid levels (fatty acid 20:0)
Very long-chain saturated fatty acid levels (fatty acid 22:0)
Very long-chain saturated fatty acid levels (fatty acid 24:0)
Very long-chain specific acyl-CoA dehydrogenase, mitochondrial levels
Very low density lipoprotein cholesterol levels
Very low-density lipoprotein receptor levels
Vesicle transport through interaction with t-SNAREs homolog 1A levels
Vesicle transport through interaction with t-SNAREs homolog 1B levels
Vesicle-associated membrane protein 3 levels
Vesicle-associated membrane protein 4 levels
Vesicle-associated membrane protein 7 levels
Vesicle-fusing ATPase levels
Vesicle-trafficking protein SEC22a levels
Vesicoureteral reflux
Vesicular integral-membrane protein VIP36 level in Chronic kidney disease with hypertension and no diabetes (7638_30)
Vesicular integral-membrane protein VIP36 levels
Vesicular, overexpressed in cancer, prosurvival protein 1 levels
Vigilin levels
Vigorous physical activity
Vimentin levels
Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia
VIP36-like protein levels
VIP36-like protein levels (LMAN2L.8013.9.3)
Virologic severity in Herpes simplex virus type 2 infection
Visceral adipose tissue
Visceral adipose tissue adjusted for BMI
Visceral adipose tissue normalized
Visceral adipose tissue volume
Visceral adipose tissue volumes
Visceral adipose tissue volumes (adjusted for BMI and height)
Visceral adipose tissue volumes to abdominal adipose tissue volumes ratio
Visceral adipose tissue volumes to gluteofemoral adipose tissue volumes ratio
Visceral adipose tissue/subcutaneous adipose tissue ratio
Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI
Visceral fat
Visceral fat, circulating phospholipid PC(16:0/2:0) and white matter microstructure (shared variance)
Visfatin levels
Visfatin levels in type 2 diabetes
Visual backward masking performance (SOA25)
Visuospatial ability
Vitamin B levels in ischemic stroke
Vitamin B12 levels
Vitamin C levels
Vitamin D insufficiency
Vitamin D levels
Vitamin D levels (dietary vitamin D intake interaction)
Vitamin D-binding protein levels
Vitamin D-binding protein levels (adjusted for GC haplotype)
Vitamin D-binding protein levels (GC.6581.50.3)
Vitamin D3 receptor levels
Vitamin E levels
Vitamin K-dependent protein C levels
Vitamin K-dependent protein S levels
Vitamin levels
Vitiligo
Vitiligo (non-segmental)
Vitrin level in Chronic kidney disease with hypertension and no diabetes (6234_74)
Vitrin levels
Vitrin levels (VIT.6234.74.3)
Vitronectin level in Chronic kidney disease with hypertension and no diabetes (13125_45)
Vitronectin levels
Vitronectin levels (VTN.8280.238.3)
VLDL cholesterol levels
VLDL cholesterol levels (UKB data field 23403)
Vogt-Koyanagi-Harada syndrome
Voltage-dependent calcium channel subunit alpha-2/delta-3 levels
Voltage-dependent calcium channel subunit alpha-2/delta-3 levels (CACNA2D3.8885.6.3)
Voltage-dependent L-type calcium channel subunit beta-4 levels
Voltage-gated potassium channel subunit beta-2 levels
Voltage-gated potassium channel subunit beta-3 level in Chronic kidney disease with hypertension and no diabetes (23370_39)
Volumetric brain MRI
von Willebrand factor A domain-containing protein 2 levels
von Willebrand factor levels
Voxel-wise structural brain imaging measurements
Voxel-wise structural brain imaging measurements in Alzheimer’s disease
VPS10 domain-containing receptor SorCS1 levels
vWF and FVIII levels
vWF levels
vWF levels in ischaemic stroke and hyperhomocysteinaemia
Waist circumference
Waist Circumference - Triglycerides (WC-TG)
Waist circumference adjusted for BMI (adjusted for smoking behaviour)
Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)
Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)
Waist circumference adjusted for BMI in active individuals
Waist circumference adjusted for BMI in inactive individuals
Waist circumference adjusted for BMI in non-smokers
Waist circumference adjusted for BMI in smokers
Waist circumference adjusted for body mass index
Waist circumference and related phenotypes
Waist circumference variance
Waist-hip index
Waist-hip ratio
Waist-hip ratio and fasting glucose (pairwise)
Waist-hip ratio and fasting insulin (pairwise)
Waist-hip ratio and HDL-C (pairwise)
Waist-hip ratio and LDL-C (pairwise)
Waist-hip ratio and systolic blood pressure (pairwise)
Waist-hip ratio and triglycerides (pairwise)
Waist-hip ratio and type 2 diabetes (pairwise)
Waist-hip ratio variance
Waist-to-hip circumference ratio (dietary energy interaction)
Waist-to-hip circumference ratio (ever vs never smoking interaction)
Waist-to-hip circumference ratio (smoking years interaction)
Waist-to-hip ratio adjusted for BMI
Waist-to-hip ratio adjusted for BMI (additive genetic model)
Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)
Waist-to-hip ratio adjusted for BMI (age <50)
Waist-to-hip ratio adjusted for BMI (age >50)
Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)
Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)
Waist-to-hip ratio adjusted for BMI (recessive genetic model)
Waist-to-hip ratio adjusted for BMI (smoking interaction)
Waist-to-hip ratio adjusted for BMI in active individuals
Waist-to-hip ratio adjusted for BMI in inactive individuals
Waist-to-hip ratio adjusted for BMI in non-smokers
Waist-to-hip ratio adjusted for BMI in smokers
Waist-to-hip ratio adjusted for BMI x sex interaction
Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)
Waist-to-hip ratio adjusted for body mass index
Waldenström macroglobulinemia / lymphoplasmacytic lymphoma
Walking pace
WAP four-disulfide core domain protein 1 level in Chronic kidney disease with hypertension and no diabetes (9316_67)
WAP four-disulfide core domain protein 1 levels
WAP four-disulfide core domain protein 10A levels
WAP four-disulfide core domain protein 13 levels
WAP four-disulfide core domain protein 3 levels
WAP four-disulfide core domain protein 6 levels
WAP four-disulfide core domain protein 8 levels
WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1 levels
WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 level in Chronic kidney disease with hypertension and no diabetes (3235_50)
WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 levels
WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 levels (WFIKKN2.13408.23.3)
Warfarin dose variability
Warfarin maintenance dose
Warfarin maintenance dose (adjusted for clinical factors)
Water consumption (glasses per day) (UKB data field 1528)
WD repeat-containing protein 1 levels (WDR1.10723.41.3)
WD repeat-containing protein 18 level in Chronic kidney disease with hypertension and no diabetes (25307_8)
Wegener's granulomatosis
Weight
Weight gain in amisulpride-treated first-episode psychosis
Weight loss (gastric bypass surgery)
Weight loss in chronic obstructive pulmonary disease
Weight-to-muscle ratio
Well-being spectrum (multivariate analysis)
Wellbeing index
Western dietary pattern
wg lh intensity-contrast bankssts
wg lh intensity-contrast caudalmiddlefrontal
wg lh intensity-contrast cuneus
wg lh intensity-contrast entorhinal
wg lh intensity-contrast frontalpole
wg lh intensity-contrast fusiform
wg lh intensity-contrast inferiorparietal
wg lh intensity-contrast inferiortemporal
wg lh intensity-contrast insula
wg lh intensity-contrast isthmuscingulate
wg lh intensity-contrast lateraloccipital
wg lh intensity-contrast lateralorbitofrontal
wg lh intensity-contrast lingual
wg lh intensity-contrast medialorbitofrontal
wg lh intensity-contrast middletemporal
wg lh intensity-contrast paracentral
wg lh intensity-contrast parahippocampal
wg lh intensity-contrast parsopercularis
wg lh intensity-contrast parsorbitalis
wg lh intensity-contrast parstriangularis
wg lh intensity-contrast postcentral
wg lh intensity-contrast posteriorcingulate
wg lh intensity-contrast precentral
wg lh intensity-contrast precuneus
wg lh intensity-contrast rostralanteriorcingulate
wg lh intensity-contrast rostralmiddlefrontal
wg lh intensity-contrast superiorfrontal
wg lh intensity-contrast superiorparietal
wg lh intensity-contrast superiortemporal
wg lh intensity-contrast supramarginal
wg lh intensity-contrast temporalpole
wg rh intensity-contrast bankssts
wg rh intensity-contrast caudalmiddlefrontal
wg rh intensity-contrast cuneus
wg rh intensity-contrast entorhinal
wg rh intensity-contrast frontalpole
wg rh intensity-contrast fusiform
wg rh intensity-contrast inferiorparietal
wg rh intensity-contrast inferiortemporal
wg rh intensity-contrast insula
wg rh intensity-contrast isthmuscingulate
wg rh intensity-contrast lateraloccipital
wg rh intensity-contrast lateralorbitofrontal
wg rh intensity-contrast lingual
wg rh intensity-contrast medialorbitofrontal
wg rh intensity-contrast middletemporal
wg rh intensity-contrast paracentral
wg rh intensity-contrast parahippocampal
wg rh intensity-contrast parsopercularis
wg rh intensity-contrast parsorbitalis
wg rh intensity-contrast parstriangularis
wg rh intensity-contrast posteriorcingulate
wg rh intensity-contrast precentral
wg rh intensity-contrast precuneus
wg rh intensity-contrast rostralanteriorcingulate
wg rh intensity-contrast rostralmiddlefrontal
wg rh intensity-contrast superiorfrontal
wg rh intensity-contrast superiorparietal
wg rh intensity-contrast superiortemporal
wg rh intensity-contrast supramarginal
wg rh intensity-contrast temporalpole
Whiskey liking
White blood cell count
White blood cell count (basophil)
White blood cell count (eosinophil)
White blood cell count (lymphocyte)
White blood cell count (monocyte)
White blood cell count (neutrophil)
White blood cell types
White bread liking
White coat effect (clinic diastolic blood pressure minus ambulatory diastolic blood pressure)
White coat effect (clinic systolic blood pressure minus ambulatory systolic blood pressure)
White matter fractional anisotropy x age interaction (2df)
White matter growth
White matter hyperintensities
White matter hyperintensities in ischemic stroke
White matter hyperintensity burden
White matter hyperintensity volume
White matter hyperintensity volume (adjusted for hypertension)
White matter hyperintensity volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy
White matter hyperintensity volume x hypertension interaction (2df)
White matter integrity
White matter integrity (bipolar disorder risk interaction)
White matter integrity (fractional anisotropy)
White matter integrity (mean diffusivity)
White matter lesion progression
White matter lesion progression (adjusted for white matter lesion burden at baseline)
White matter lesions (Fazekas score)
White matter mean diffusivity x age interaction (2df)
White matter microstructure (axial diusivities)
White matter microstructure (fractional anisotropy)
White matter microstructure (global fractional anisotropy)
White matter microstructure (mean diusivities)
White matter microstructure (mode of anisotropy)
White matter microstructure (radial diusivities)
Whole blood low cut reduction viscosity
Whole brain free water diffusion (multivariate analysis)
Whole brain grey matter density
Whole brain restricted directional diffusion (multivariate analysis)
Whole brain restricted isotropic diffusion (multivariate analysis)
Whole grain cereal liking
Whole-brain volume
Whole-brain volume (12 month visit)
Whole-brain volume (12 month visit)(adjusted for APOE e4 dosage)
Whole-brain volume (24 month visit)(adjusted for APOE e4 dosage)
Whole-brain volume (Alzheimer's disease interaction)
Whole-brain volume (baseline)
Widow's peak
Wilms tumor
Wnt inhibitory factor 1 levels
WNT1-inducible-signaling pathway protein 1 level in Chronic kidney disease with hypertension and no diabetes (13692_154)
WNT1-inducible-signaling pathway protein 1 levels
WNT1-inducible-signaling pathway protein 1 levels (WISP1.13692.154.3)
WNT1-inducible-signaling pathway protein 2 levels
WNT1-inducible-signaling pathway protein 3 levels
Word reading
Word spelling
Working memory
Working memory x anxiety interaction
World class endurance athleticism
Worry
Worry too long after an embarrassing experience
Worry/vulnerability (special factor of neuroticism)
Written spelling
WU polyomavirus VP1 antibody levels
WW domain-containing oxidoreductase levels
X-01911 levels
X-02249 levels
X-02269 levels
X-03056--N-[3- 2-Oxopyrrolidin-1-yl propyl]acetamide levels
X-03094 levels
X-04499--3,4-dihydroxybutyrate levels
X-04499--3,4-dihydroxybutyrate-to-C-glycosyltryptophan ratio
X-07765 levels
X-08402 levels
X-09789 levels
X-10395 levels
X-10510-to-palmitoyl sphingomyelin ratio
X-11244 levels
X-11247 levels
X-11255 levels
X-11261 levels
X-11299 levels
X-11308 levels
X-11315 levels
X-11315-to-pyroglutamine ratio
X-11372 levels
X-11381 levels
X-11421 levels
X-11440 levels
X-11440-to-4-androsten-3beta,17beta-diol disulfate 2 ratio
X-11441 levels
X-11442 levels
X-11444 levels
X-11444-to-X-12844 ratio
X-11469 levels
X-11470 levels
X-11478 levels
X-11491 levels
X-11522 levels
X-11529 levels
X-11530 levels
X-11538 levels
X-11550 levels
X-11593 levels
X-11593--O-methylascorbate levels
X-11786--methylcysteine levels
X-11787 levels
X-11792 levels
X-11793 levels
X-11793--oxidized bilirubin levels
X-11795 levels
X-11849 levels
X-11880 levels
X-12026 levels
X-12038 levels
X-12063 levels
X-12092 levels
X-12093 levels
X-12095--N1-methyl-3-pyridone-4-carboxamide levels
X-12100 levels
X-12100--hydroxytryptophan levels
X-12101 levels
X-12112 levels
X-12117 levels
X-12125 levels
X-12244--N-acetylcarnosine levels
X-12410 levels
X-12411 levels
X-12435 levels
X-12442--5,8-tetradecadienoate levels
X-12456 levels
X-12510 levels
X-12510--2-aminooctanoic acid levels
X-12544 levels
X-12556 levels
X-12627 levels
X-12689 levels
X-12707 levels
X-12713 levels
X-12714 levels
X-12749 levels
X-12798 levels
X-12798-to-phenylalanine ratio
X-12822 levels
X-12839 levels
X-12844 levels
X-12847 levels
X-12850 levels
X-12851 levels
X-12990--docosapentaenoic acid n6-DPA levels
X-13215 levels
X-13215-to-X-13671 ratio
X-13429 levels
X-13431 levels
X-13431--nonanoylcarnitine levels
X-13435 levels
X-13477 levels
X-13671 levels
X-13684 levels
X-13844 levels
X-13866 levels
X-14189--leucylalanine levels
X-14205--alpha-glutamyltyrosine levels
X-14208 levels
X-14208--phenylalanylserine levels
X-14304--leucylalanine levels
X-14473 levels
X-14625 levels
X-14626 levels
X-14632 levels
X-14939 levels
X-15469 levels
X-15486 levels
X-15503 levels
X-16087 levels
X-16397 levels
X-16570 levels
X-16935 levels
X-16946 levels
X-17325 levels
X-17357 levels
X-17653 levels
X-17654 levels
X-17676 levels
X-17690 levels
X-18601 levels
X-18886 levels
X-18888 levels
X-18899 levels
X-18921 levels
X-18922 levels
X-19141 levels
X-19438 levels
X-21285 levels
X-21286 levels
X-21312 levels
X-21319 levels
X-21339 levels
X-21353 levels
X-21364 levels
X-21410 levels
X-21441 levels
X-21448 levels
X-21467 levels
X-21470 levels
X-21471 levels
X-21607 levels
X-21736 levels
X-21792 levels
X-21796 levels
X-21829 levels
X-22162 levels
X-22520 levels
X-23590 levels
X-23593 levels
X-23639 levels
X-23641 levels
X-23644 levels
X-23654 levels
X-23659 levels
X-23680 levels
X-23756 levels
X-23780 levels
X-23787 levels
X-24020 levels
X-24241 levels
X-24243 levels
X-24295 levels
X-24309 levels
X-24328 levels
X-24334 levels
X-24337 levels
X-24418 levels
X-24422 levels
X-24462 levels
X-24494 levels
X-24512 levels
X-24518 levels
X-24531 levels
X-24544 levels
X-24546 levels
X-24556 levels
X-24588 levels
X-24669 levels
X-24699 levels
X-24736 levels
X-24747 levels
X-24748 levels
X-24801 levels
X-24809 levels
X-24811 levels
X-24849 levels
X-24870 levels
X-24947 levels
X-24949 levels
X-24983 levels
X-25109 levels
X-25371 levels
X-25419 levels
X-25420 levels
X-25422 levels
X-25433 levels
X-25790 levels
X-25810 levels
X-26054 levels
X-26109 levels
X-26111 levels
X-C motif chemokine ligand 1 levels
X-ray repair cross-complementing protein 6 levels
Xanthine levels
Xanthosine levels in elite athletes
Xanthurenate levels
Xerostomia (moderate to severe) in oropharyngeal cancer
Ximenoylcarnitine (C26:1) levels
Ximenoylcarnitine (C26:1) levels in elite athletes
Xleu levels
Xyloside xylosyltransferase 1 levels
Y-box-binding protein 2 levels
Years ovulating
Yeast infection
YKL 40 plasma levels
YKL-40 levels
Youthful appearance (self-reported)
YTH domain-containing protein 1 levels
Yu-Zhi constitution type in type 2 diabetes
Zinc finger CCHC domain-containing protein 18 level in Chronic kidney disease with hypertension and no diabetes (22833_74)
Zinc finger protein 10 levels
Zinc finger protein 175 levels
Zinc finger protein 18 levels
Zinc finger protein 180 levels
Zinc finger protein 23 levels
Zinc finger protein 275 levels
Zinc finger protein 276 level in Chronic kidney disease with hypertension and no diabetes (14692_3)
Zinc finger protein 329 levels
Zinc finger protein 334 levels
Zinc finger protein 34 levels
Zinc finger protein 526 levels
Zinc finger protein 566 levels
Zinc fingers and homeoboxes protein 1 levels
Zinc fingers and homeoboxes protein 3 levels
Zinc transporter 3 levels
Zinc-alpha-2-glycoprotein levels
Zinc-alpha-2-glycoprotein levels (AZGP1.9312.8.3)
Zona pellucida sperm-binding protein 4 levels (ZP4.7766.25.3)
Zona pellucida-binding protein 2 levels
Zona pellucida-like domain-containing protein 1 levels